activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	1675255	CHEMBL867052	Inhibitory activity against ALK	B	CN1CCN(CCc2ccc(NC(=O)c3cc(-c4ccc5c(c4)OCO5)cnc3O)cc2)CC1		CHEMBL199723	=	IC50	nM	400.0	CHEMBL4247	Homo sapiens	IC50	uM	0.4
	1675255	CHEMBL867052	Inhibitory activity against ALK	B	CN1CCN(CCc2ccc(NC(=O)c3cc(-c4ccc5c(c4)OCO5)cnc3O)cc2)CC1		CHEMBL199723	=	IC50	nM	400.0	CHEMBL4247	Homo sapiens	IC50	uM	0.4
	1675257	CHEMBL867052	Inhibitory activity against ALK	B	CN1CCN(CCc2ccc(NC(=O)c3cc(-c4ccc5c(c4)OCO5)cnc3O)cc2)CC1		CHEMBL199723	=	Ki	nM	200.0	CHEMBL4247	Homo sapiens	Ki	uM	0.2
	1675268	CHEMBL867052	Inhibitory activity against ALK	B	CN1CCN(Cc2ccc(NC(=O)c3cc(-c4ccc5c(c4)OCO5)cn(C)c3=O)cc2)CC1		CHEMBL201277	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	1675270	CHEMBL867052	Inhibitory activity against ALK	B	CN1CCN(Cc2ccc(NC(=O)c3cc(-c4ccc5c(c4)OCO5)cnc3Cl)cc2)CC1		CHEMBL199298	=	IC50	nM	26800.0	CHEMBL4247	Homo sapiens	IC50	uM	26.8
	1675272	CHEMBL867052	Inhibitory activity against ALK	B	COc1ncc(-c2ccc3c(c2)OCO3)cc1C(=O)Nc1ccc(CN2CCN(C)CC2)cc1		CHEMBL427188	=	IC50	nM	20300.0	CHEMBL4247	Homo sapiens	IC50	uM	20.3
	1675274	CHEMBL867052	Inhibitory activity against ALK	B	Cc1cc(CN2CCN(C)CC2)ccc1NC(=O)c1cc(-c2ccc3c(c2)OCO3)cnc1O		CHEMBL198399	=	IC50	nM	14500.0	CHEMBL4247	Homo sapiens	IC50	uM	14.5
	1675276	CHEMBL867052	Inhibitory activity against ALK	B	COc1cc(CN2CCN(C)CC2)ccc1NC(=O)c1cc(-c2ccc3c(c2)OCO3)cnc1O		CHEMBL201639	=	IC50	nM	13800.0	CHEMBL4247	Homo sapiens	IC50	uM	13.8
	1675279	CHEMBL867052	Inhibitory activity against ALK	B	CN1CCN(Cc2ccc(N(C)C(=O)c3cc(-c4ccc5c(c4)OCO5)cnc3O)cc2)CC1		CHEMBL201638	=	IC50	nM	3700.0	CHEMBL4247	Homo sapiens	IC50	uM	3.7
	1675281	CHEMBL867052	Inhibitory activity against ALK	B	CN1CCN(Cc2ccc(NC(=O)c3cc(-c4ccncc4)cnc3O)cc2)CC1		CHEMBL197652	=	IC50	nM	19500.0	CHEMBL4247	Homo sapiens	IC50	uM	19.5
Not Determined	1675282	CHEMBL867052	Inhibitory activity against ALK	B	CN1CCN(Cc2ccc(NC(=O)c3cc(-c4ccncc4)cnc3O)cc2)CC1		CHEMBL197652		Ki			CHEMBL4247	Homo sapiens	Ki		
	1675283	CHEMBL867052	Inhibitory activity against ALK	B	COc1cc(-c2cnc(O)c(C(=O)Nc3ccc(CN4CCN(C)CC4)cc3)c2)cc(OC)c1OC		CHEMBL202831	=	IC50	nM	7500.0	CHEMBL4247	Homo sapiens	IC50	uM	7.5
Not Determined	1675284	CHEMBL867052	Inhibitory activity against ALK	B	COc1cc(-c2cnc(O)c(C(=O)Nc3ccc(CN4CCN(C)CC4)cc3)c2)cc(OC)c1OC		CHEMBL202831		Ki			CHEMBL4247	Homo sapiens	Ki		
	1675285	CHEMBL867052	Inhibitory activity against ALK	B	CN1CCN(Cc2ccc(NC(=O)c3cc(-c4ccc5nccnc5c4)cnc3O)cc2)CC1		CHEMBL202830	=	IC50	nM	5500.0	CHEMBL4247	Homo sapiens	IC50	uM	5.5
Not Determined	1675286	CHEMBL867052	Inhibitory activity against ALK	B	CN1CCN(Cc2ccc(NC(=O)c3cc(-c4ccc5nccnc5c4)cnc3O)cc2)CC1		CHEMBL202830		Ki			CHEMBL4247	Homo sapiens	Ki		
	1675287	CHEMBL867052	Inhibitory activity against ALK	B	Cc1nc2cc(-c3cnc(O)c(C(=O)Nc4ccc(CN5CCN(C)CC5)cc4)c3)ccc2s1		CHEMBL201553	=	IC50	nM	3800.0	CHEMBL4247	Homo sapiens	IC50	uM	3.8
Not Determined	1675288	CHEMBL867052	Inhibitory activity against ALK	B	Cc1nc2cc(-c3cnc(O)c(C(=O)Nc4ccc(CN5CCN(C)CC5)cc4)c3)ccc2s1		CHEMBL201553		Ki			CHEMBL4247	Homo sapiens	Ki		
	1675289	CHEMBL867052	Inhibitory activity against ALK	B	COc1ccc(-c2cnc(O)c(C(=O)Nc3ccc(CN4CCN(C)CC4)cc3)c2)cn1		CHEMBL203354	=	IC50	nM	3000.0	CHEMBL4247	Homo sapiens	IC50	uM	3.0
Not Determined	1675290	CHEMBL867052	Inhibitory activity against ALK	B	COc1ccc(-c2cnc(O)c(C(=O)Nc3ccc(CN4CCN(C)CC4)cc3)c2)cn1		CHEMBL203354		Ki			CHEMBL4247	Homo sapiens	Ki		
	1675291	CHEMBL867052	Inhibitory activity against ALK	B	CN1CCN(CCCc2ccc(NC(=O)c3cc(-c4ccc5c(c4)OCO5)cnc3O)cc2)CC1		CHEMBL381738	=	IC50	nM	1300.0	CHEMBL4247	Homo sapiens	IC50	uM	1.3
	1675292	CHEMBL867052	Inhibitory activity against ALK	B	CN1CCN(CCCc2ccc(NC(=O)c3cc(-c4ccc5c(c4)OCO5)cnc3O)cc2)CC1		CHEMBL381738	=	Ki	nM	1100.0	CHEMBL4247	Homo sapiens	Ki	uM	1.1
	1675293	CHEMBL867052	Inhibitory activity against ALK	B	CN1CCN(Cc2ccc(NC(=O)c3cc(-c4ccc5c(c4)OCO5)cnc3O)cc2)CC1		CHEMBL370800	=	IC50	nM	900.0	CHEMBL4247	Homo sapiens	IC50	uM	0.9
	1675294	CHEMBL867052	Inhibitory activity against ALK	B	CN1CCN(Cc2ccc(NC(=O)c3cc(-c4ccc5c(c4)OCO5)cnc3O)cc2)CC1		CHEMBL370800	=	Ki	nM	500.0	CHEMBL4247	Homo sapiens	Ki	uM	0.5
	1675295	CHEMBL867052	Inhibitory activity against ALK	B	CN1CCN(c2ccc(NC(=O)c3cc(-c4ccc5c(c4)OCO5)cnc3O)cc2)CC1		CHEMBL436509	=	IC50	nM	700.0	CHEMBL4247	Homo sapiens	IC50	uM	0.7
	1675296	CHEMBL867052	Inhibitory activity against ALK	B	CN1CCN(c2ccc(NC(=O)c3cc(-c4ccc5c(c4)OCO5)cnc3O)cc2)CC1		CHEMBL436509	=	Ki	nM	600.0	CHEMBL4247	Homo sapiens	Ki	uM	0.6
	1977701	CHEMBL897768	Inhibition of ALK at 3 uM	B	CO/N=C/c1c(N)ncnc1N1CCN(C(=O)Nc2ccc(OC(C)C)cc2)CC1		CHEMBL269594	=	Inhibition	%	31.0	CHEMBL4247	Homo sapiens	Inhibition	%	31.0
	2025112	CHEMBL886937	Inhibition of ALK at 1 uM relative to control	B	CN(C)c1cc2cc(n1)CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL247067	=	Inhibition	%	55.0	CHEMBL4247	Homo sapiens	Inhibition	%	55.0
	2025225	CHEMBL886937	Inhibition of ALK at 1 uM relative to control	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	Inhibition	%	103.0	CHEMBL4247	Homo sapiens	Inhibition	%	103.0
	2025226	CHEMBL886937	Inhibition of ALK at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1ccc(c(N3CCCC3)n1)CCCn1cc2c2ccccc21		CHEMBL396327	=	Inhibition	%	74.0	CHEMBL4247	Homo sapiens	Inhibition	%	74.0
	2025227	CHEMBL886937	Inhibition of ALK at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1cc(nc(N3CCCC3)c1)CCCn1cc2c2ccccc21		CHEMBL397771	=	Inhibition	%	58.0	CHEMBL4247	Homo sapiens	Inhibition	%	58.0
	2147188	CHEMBL927932	Activity of human ALK kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	95.0	CHEMBL4247	Homo sapiens	Activity	%	95.0
	2197993	CHEMBL1005535	Decrease in ALK phosphorylation in human Karpas299 cells after 4 hrs	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	<	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
	2197994	CHEMBL1005536	Decrease in ALK phosphorylation in human SUDHL1 cells after 4 hrs	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	<	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
	2198009	CHEMBL1006339	Inhibition of Tel-fused ALK kinase-mediated mouse BaF3 cell proliferation	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	uM	0.004
	2206834	CHEMBL974024	Inhibition of ALK by cellular assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(N)nc2N(C)C1=O		CHEMBL459850	>	EC50	nM	2000.0	CHEMBL4247	Homo sapiens	EC50	nM	2000.0
	2206929	CHEMBL974024	Inhibition of ALK by cellular assay	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	EC50	nM	3.0	CHEMBL4247	Homo sapiens	EC50	nM	3.0
	2206969	CHEMBL974026	Inhibition of ALK	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	20.0	CHEMBL4247	Homo sapiens	IC50	nM	20.0
	2250930	CHEMBL1022474	Inhibition of ALK	B	Nc1nccc(-c2cc3c([nH]2)[C@@H](CCF)CNC3=O)n1		CHEMBL524266	>	IC50	nM	4000.0	CHEMBL4247	Homo sapiens	IC50	uM	4.0
	2389226	CHEMBL944259	Inhibition of ALK at 10 uM	B	O=c1cc2oc3cc(O)c(O)cc3c(-c3cccc(Cl)c3Cl)c-2cc1O		CHEMBL473332	=	Inhibition	%	36.0	CHEMBL4247	Homo sapiens	INH	%	36.0
	2396060	CHEMBL1006299	Inhibition of ALK at 1 uM relative to control	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)Nc2cccc(NC(C)=O)c2)cc1		CHEMBL515560	=	Inhibition	%	1.0	CHEMBL4247	Homo sapiens	INH	%	1.0
	2408036	CHEMBL955914	Inhibition of ALK	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	nM	1.0
	2470106	CHEMBL1032249	Inhibition of ALK at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL4247	Homo sapiens	INH	%	10.0
	2476634	CHEMBL1035898	Binding affinity to human ALK at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	11.0	CHEMBL4247	Homo sapiens	Activity	%	11.0
Not Evaluated	2476837	CHEMBL1035898	Binding affinity to human ALK at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Evaluated	2478676	CHEMBL1035898	Binding affinity to human ALK at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL4247	Homo sapiens	Activity		
	2478879	CHEMBL1035898	Binding affinity to human ALK at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	=	Activity	%	28.2	CHEMBL4247	Homo sapiens	Activity	%	28.2
Not Evaluated	2479734	CHEMBL1035898	Binding affinity to human ALK at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	2480733	CHEMBL1035898	Binding affinity to human ALK at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL4247	Homo sapiens	Activity		
	2482701	CHEMBL987152	Inhibition of GST tagged ALK	B	Nc1ccc(N)c2c1C(=O)c1ccccc1C2=O		CHEMBL86771	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	2490362	CHEMBL1025530	Inhibition of ALK at 1 uM	B	CCOc1cc2ncc(C(N)=O)c(Nc3ccc(F)cc3F)c2cc1N1CCN(C)CC1		CHEMBL481806	=	Inhibition	%	23.0	CHEMBL4247	Homo sapiens	INH	%	23.0
	2506923	CHEMBL942601	Inhibition of ALK at 10 uM	B	COc1cc(O)ccc1-c1ccc2c(-c3nc4c(N5CCN(C)CC5)cccc4[nH]3)n[nH]c2c1		CHEMBL474619	<	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	2506924	CHEMBL942601	Inhibition of ALK at 10 uM	B	CN1CCN(c2cccc3nc(-c4n[nH]c5cc(-c6ccc(N)cc6)ccc45)[nH]c23)CC1		CHEMBL480391	<	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	2512034	CHEMBL970561	Inhibition of ALK at 1 uM	B	CC(=O)N1CCN(C(=O)Cc2ccc(Nc3ncc(F)c(Nc4ccc(C(=O)Nc5ccccc5Cl)cc4)n3)cc2)CC1		CHEMBL508307	=	Inhibition	%	21.0	CHEMBL4247	Homo sapiens	INH	%	21.0
	2567220	CHEMBL973703	Inhibition of human ALK assessed as residual enzyme activity at 0.1 uM	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	Activity	%	23.0	CHEMBL4247	Homo sapiens	Activity	%	23.0
Not Evaluated	2577355	CHEMBL1035898	Binding affinity to human ALK at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL4247	Homo sapiens	Activity		
	2584863	CHEMBL955777	Inhibition of Alk	B	O=c1[nH]cnc2[nH]c(-c3ccnc(/C=C/c4ccc(CN5CCOCC5)cc4)c3)cc12		CHEMBL461139	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	2584895	CHEMBL955777	Inhibition of Alk	B	CN(C)CCOc1ccc(/C=C/c2cc(-c3cc4c(=O)[nH]cnc4[nH]3)ccn2)cc1		CHEMBL461140	=	IC50	nM	4100.0	CHEMBL4247	Homo sapiens	IC50	uM	4.1
	2593560	CHEMBL1035898	Binding affinity to human ALK at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	22.2	CHEMBL4247	Homo sapiens	Activity	%	22.2
Not Evaluated	2593763	CHEMBL1035898	Binding affinity to human ALK at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Evaluated	2593826	CHEMBL1035898	Binding affinity to human ALK at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Evaluated	2594029	CHEMBL1035898	Binding affinity to human ALK at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Evaluated	2594972	CHEMBL1035898	Binding affinity to human ALK at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Evaluated	2595241	CHEMBL1035898	Binding affinity to human ALK at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL4247	Homo sapiens	Activity		
	2595804	CHEMBL1017875	Inhibition of ALK assessed as enzyme activity relative to control	B	C[C@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL457871	=	Activity	%	6.6	CHEMBL4247	Homo sapiens	Activity	%	6.6
Not Evaluated	2596169	CHEMBL1035898	Binding affinity to human ALK at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL4247	Homo sapiens	Activity		
	2596372	CHEMBL1035898	Binding affinity to human ALK at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342	=	Activity	%	2.2	CHEMBL4247	Homo sapiens	Activity	%	2.2
Not Evaluated	2597641	CHEMBL1035898	Binding affinity to human ALK at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Evaluated	2597844	CHEMBL1035898	Binding affinity to human ALK at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL4247	Homo sapiens	Activity		
	2600113	CHEMBL1025725	Inhibition of ALK	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL514873	=	IC50	nM	0.4	CHEMBL4247	Homo sapiens	IC50	nM	0.4
Not Determined	2600114	CHEMBL1025725	Inhibition of ALK	B	COc1cc2c(cc1Nc1nc(Nc3ccoc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL515519		IC50			CHEMBL4247	Homo sapiens	IC50		
	2618906	CHEMBL1033170	Inhibition of ALK	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL507625	=	IC50	nM	0.5	CHEMBL4247	Homo sapiens	IC50	nM	0.5
	2677431	CHEMBL1036439	Inhibition of 6xHis-tagged human NPM-ALK expressed in insect cells	B	Brc1ccc2[nH]c3c(c2c1)CCN(CC(c1ccccc1)c1ccccc1)c1nccc(I)c1-3		CHEMBL549826	=	IC50	nM	5000.0	CHEMBL4247	Homo sapiens	IC50	uM	5.0
	2677432	CHEMBL1036439	Inhibition of 6xHis-tagged human NPM-ALK expressed in insect cells	B	COc1nc(C)cc2c1-c1[nH]c3cc(N4CCN(C)CC4)ccc3c1CCN2CCc1ccccc1		CHEMBL551570	=	IC50	nM	5100.0	CHEMBL4247	Homo sapiens	IC50	uM	5.1
	2677435	CHEMBL1036439	Inhibition of 6xHis-tagged human NPM-ALK expressed in insect cells	B	C[C@@H](c1ccccc1)N1CCc2c([nH]c3ccc(Br)cc23)-c2c1ccnc2Cl		CHEMBL556596	=	IC50	nM	5800.0	CHEMBL4247	Homo sapiens	IC50	uM	5.8
	2677436	CHEMBL1036439	Inhibition of 6xHis-tagged human NPM-ALK expressed in insect cells	B	Oc1ccc(CCN2CCc3c([nH]c4ccc(Br)cc34)-c3c(I)ccnc32)cc1		CHEMBL557491	=	IC50	nM	6200.0	CHEMBL4247	Homo sapiens	IC50	uM	6.2
	2677437	CHEMBL1036439	Inhibition of 6xHis-tagged human NPM-ALK expressed in insect cells	B	Oc1ccc(CCN2CCc3c([nH]c4ccc(Br)cc34)-c3c2ccnc3Cl)cc1		CHEMBL564679	=	IC50	nM	7100.0	CHEMBL4247	Homo sapiens	IC50	uM	7.1
	2677438	CHEMBL1036439	Inhibition of 6xHis-tagged human NPM-ALK expressed in insect cells	B	C[C@@H](c1ccccc1)N1CCc2c([nH]c3ccc(Br)cc23)-c2c(I)ccnc21		CHEMBL560446	=	IC50	nM	8300.0	CHEMBL4247	Homo sapiens	IC50	uM	8.3
	2677440	CHEMBL1036439	Inhibition of 6xHis-tagged human NPM-ALK expressed in insect cells	B	Clc1nccc2c1-c1[nH]c3ccc(Br)cc3c1CCN2CCc1c[nH]c2ccccc12		CHEMBL562943	=	IC50	nM	9300.0	CHEMBL4247	Homo sapiens	IC50	uM	9.3
	2677443	CHEMBL1036439	Inhibition of 6xHis-tagged human NPM-ALK expressed in insect cells	B	Cc1cc(Cl)c2c(n1)N(CCc1ccccc1)CCc1c-2[nH]c2ccccc12		CHEMBL563080	=	IC50	nM	11800.0	CHEMBL4247	Homo sapiens	IC50	uM	11.8
	2677452	CHEMBL1036439	Inhibition of 6xHis-tagged human NPM-ALK expressed in insect cells	B	Cc1cc2c(c(=O)[nH]1)-c1[nH]c3ccccc3c1CCN2CCc1ccccc1		CHEMBL564365	=	IC50	nM	18000.0	CHEMBL4247	Homo sapiens	IC50	uM	18.0
	2677455	CHEMBL1036439	Inhibition of 6xHis-tagged human NPM-ALK expressed in insect cells	B	Cc1cc2c(c(Cl)n1)-c1[nH]c3ccccc3c1CCN2CCc1ccccc1		CHEMBL560245	=	IC50	nM	21300.0	CHEMBL4247	Homo sapiens	IC50	uM	21.3
	2677461	CHEMBL1036439	Inhibition of 6xHis-tagged human NPM-ALK expressed in insect cells	B	COc1nc(C)cc2c1-c1[nH]c3ccccc3c1CCN2CCc1ccccc1		CHEMBL563555	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	2677466	CHEMBL1036439	Inhibition of 6xHis-tagged human NPM-ALK expressed in insect cells	B	COc1cc(C)nc2c1-c1[nH]c3ccccc3c1CCN2CCc1ccccc1		CHEMBL563257	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	2677475	CHEMBL1036439	Inhibition of 6xHis-tagged human NPM-ALK expressed in insect cells	B	Clc1nccc2c1-c1[nH]c3ccc(Br)cc3c1CCN2CC(c1ccccc1)c1ccccc1		CHEMBL551906	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	2721547	CHEMBL1060955	Inhibition of ALK at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	2897396	CHEMBL1050837	Binding constant for ALK kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	uM	10.0
	2897397	CHEMBL1050837	Binding constant for ALK kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	uM	10.0
	2897398	CHEMBL1050837	Binding constant for ALK kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	7100.0	CHEMBL4247	Homo sapiens	Kd	nM	7100.0
	2897399	CHEMBL1050837	Binding constant for ALK kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	1200.0	CHEMBL4247	Homo sapiens	Kd	nM	1200.0
	2897400	CHEMBL1050837	Binding constant for ALK kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	670.0	CHEMBL4247	Homo sapiens	Kd	nM	670.0
	2897401	CHEMBL1050837	Binding constant for ALK kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	uM	10.0
	2897402	CHEMBL1050837	Binding constant for ALK kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	uM	10.0
	2897403	CHEMBL1050837	Binding constant for ALK kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	2200.0	CHEMBL4247	Homo sapiens	Kd	nM	2200.0
	2897404	CHEMBL1050837	Binding constant for ALK kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	uM	10.0
	2897405	CHEMBL1050837	Binding constant for ALK kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	7100.0	CHEMBL4247	Homo sapiens	Kd	nM	7100.0
	2897406	CHEMBL1050837	Binding constant for ALK kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	uM	10.0
	2897407	CHEMBL1050837	Binding constant for ALK kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	uM	10.0
	2897408	CHEMBL1050837	Binding constant for ALK kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	uM	10.0
	2897409	CHEMBL1050837	Binding constant for ALK kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	uM	10.0
	2897410	CHEMBL1050837	Binding constant for ALK kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	uM	10.0
	2897411	CHEMBL1050837	Binding constant for ALK kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	270.0	CHEMBL4247	Homo sapiens	Kd	nM	270.0
	2897412	CHEMBL1050837	Binding constant for ALK kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	uM	10.0
	2897413	CHEMBL1050837	Binding constant for ALK kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Kd	nM	2300.0	CHEMBL4247	Homo sapiens	Kd	nM	2300.0
	2897414	CHEMBL1050837	Binding constant for ALK kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	uM	10.0
	2897415	CHEMBL1050837	Binding constant for ALK kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	uM	10.0
	2897416	CHEMBL1050837	Binding constant for ALK kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	uM	10.0
	2897417	CHEMBL1050837	Binding constant for ALK kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	uM	10.0
	2897418	CHEMBL1050837	Binding constant for ALK kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	32.0	CHEMBL4247	Homo sapiens	Kd	nM	32.0
	2897419	CHEMBL1050837	Binding constant for ALK kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	490.0	CHEMBL4247	Homo sapiens	Kd	nM	490.0
	2897420	CHEMBL1050837	Binding constant for ALK kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	170.0	CHEMBL4247	Homo sapiens	Kd	nM	170.0
	2897421	CHEMBL1050837	Binding constant for ALK kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	3100.0	CHEMBL4247	Homo sapiens	Kd	nM	3100.0
	2897422	CHEMBL1050837	Binding constant for ALK kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	uM	10.0
	2897423	CHEMBL1050837	Binding constant for ALK kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	2100.0	CHEMBL4247	Homo sapiens	Kd	nM	2100.0
	2897791	CHEMBL1050837	Binding constant for ALK kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	1600.0	CHEMBL4247	Homo sapiens	Kd	nM	1600.0
	2897792	CHEMBL1050837	Binding constant for ALK kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	uM	10.0
	2897793	CHEMBL1050837	Binding constant for ALK kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	1400.0	CHEMBL4247	Homo sapiens	Kd	nM	1400.0
	2897794	CHEMBL1050837	Binding constant for ALK kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	uM	10.0
	2897795	CHEMBL1050837	Binding constant for ALK kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	uM	10.0
	2897796	CHEMBL1050837	Binding constant for ALK kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	uM	10.0
	2897797	CHEMBL1050837	Binding constant for ALK kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	3500.0	CHEMBL4247	Homo sapiens	Kd	nM	3500.0
	2897798	CHEMBL1050837	Binding constant for ALK kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	uM	10.0
	2897799	CHEMBL1050837	Binding constant for ALK kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	uM	10.0
	2897800	CHEMBL1050837	Binding constant for ALK kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	uM	10.0
	2921441	CHEMBL1057570	Inhibition of ALK assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	96.0	CHEMBL4247	Homo sapiens	Activity	%	96.0
	2928460	CHEMBL1049958	Binding affinity to ALK assessed as percentage of kinase remaining bound to the bead at 1 uM by T7 phage display based binding assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	99.0	CHEMBL4247	Homo sapiens	Activity	%	99.0
	2947556	CHEMBL1047346	Inhibition of ALK at 100 uM	B	COc1cc2nccc(Oc3ccc(NC(=O)N4CCN(c5ccccc5)C4=O)cc3F)c2cc1OC		CHEMBL573761	=	Inhibition	%	0.0	CHEMBL4247	Homo sapiens	INH	%	0.0
	2948182	CHEMBL1042395	Inhibition of ALK	B	O=C1Nc2ccccc2-c2ccnc3[nH]cc(c23)C1c1ccc(O)cc1		CHEMBL584052	=	Ki	nM	17.0	CHEMBL4247	Homo sapiens	Ki	microM	0.017
	2993555	CHEMBL1040930	Inhibition of human recombinant Alk	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
	3052526	CHEMBL1047777	Residual activity of ALK at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	178.0	CHEMBL4247	Homo sapiens	Residual activity	%	178.0
	3052778	CHEMBL1046511	Residual activity of ALK at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	180.0	CHEMBL4247	Homo sapiens	Residual activity	%	180.0
	3054087	CHEMBL1066605	Residual activity of ALK at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	106.0	CHEMBL4247	Homo sapiens	Residual activity	%	106.0
	3055374	CHEMBL1047777	Residual activity of ALK at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	171.0	CHEMBL4247	Homo sapiens	Residual activity	%	171.0
	3055626	CHEMBL1046511	Residual activity of ALK at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	329.0	CHEMBL4247	Homo sapiens	Residual activity	%	329.0
	3056931	CHEMBL1066605	Residual activity of ALK at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	102.0	CHEMBL4247	Homo sapiens	Residual activity	%	102.0
	3058251	CHEMBL1047777	Residual activity of ALK at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	169.0	CHEMBL4247	Homo sapiens	Residual activity	%	169.0
	3058503	CHEMBL1046511	Residual activity of ALK at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	414.0	CHEMBL4247	Homo sapiens	Residual activity	%	414.0
	3062440	CHEMBL1048633	Binding affinity to human ALK at 200 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595545	=	Activity	%	60.0	CHEMBL4247	Homo sapiens	Activity	%	60.0
	3063575	CHEMBL1045161	Binding affinity to human ALK at 500 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595546	=	Activity	%	5.2	CHEMBL4247	Homo sapiens	Activity	%	5.2
	3063665	CHEMBL1038876	Binding affinity to human ALK at 50 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CNC(=O)C[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL609010	=	Activity	%	92.0	CHEMBL4247	Homo sapiens	Activity	%	92.0
	3065846	CHEMBL1068652	Inhibition of ALK at 10 uM	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Inhibition	%	0.0	CHEMBL4247	Homo sapiens	INH	%	0.0
	3066912	CHEMBL1068652	Inhibition of ALK at 10 uM	B	O=C1Nc2ccccc2/C1=C1\C(=O)N(CCCc2ccccc2)c2ccccc21		CHEMBL607196	=	Inhibition	%	0.0	CHEMBL4247	Homo sapiens	INH	%	0.0
	3072849	CHEMBL1066605	Residual activity of ALK at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	114.0	CHEMBL4247	Homo sapiens	Residual activity	%	114.0
	3098421	CHEMBL1067020	Inhibition of human ALK at 0.1 uM	B	COc1ccccc1NC(=O)CC(Nc1ccc(Oc2ccnc3cc(-c4cn(C)cn4)sc23)c(F)c1)C(F)(F)F		CHEMBL591924	<	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	3101503	CHEMBL1071418	Inhibition of ALK by ELISA-based kinase assay	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	IC50	nM	5400.0	CHEMBL4247	Homo sapiens	IC50	uM	5.4
	3101504	CHEMBL1071418	Inhibition of ALK by ELISA-based kinase assay	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	2300.0	CHEMBL4247	Homo sapiens	IC50	uM	2.3
	3101505	CHEMBL1071418	Inhibition of ALK by ELISA-based kinase assay	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	IC50	nM	18000.0	CHEMBL4247	Homo sapiens	IC50	uM	18.0
	3101506	CHEMBL1071418	Inhibition of ALK by ELISA-based kinase assay	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	IC50	nM	1200.0	CHEMBL4247	Homo sapiens	IC50	uM	1.2
	3101507	CHEMBL1071418	Inhibition of ALK by ELISA-based kinase assay	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	>	IC50	nM	50000.0	CHEMBL4247	Homo sapiens	IC50	uM	50.0
	3101508	CHEMBL1071418	Inhibition of ALK by ELISA-based kinase assay	B	O=C1Nc2ccccc2/C1=C\c1ccc(O)cc1		CHEMBL103307	>	IC50	nM	50000.0	CHEMBL4247	Homo sapiens	IC50	uM	50.0
	3101509	CHEMBL1071418	Inhibition of ALK by ELISA-based kinase assay	B	Cc1cccc2c1/C(=C/c1ccc(N(C)C)c3ccccc13)C(=O)N2		CHEMBL597960	>	IC50	nM	50000.0	CHEMBL4247	Homo sapiens	IC50	uM	50.0
	3101510	CHEMBL1071418	Inhibition of ALK by ELISA-based kinase assay	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccc(N)cc32)[nH]1		CHEMBL597181	=	IC50	nM	4800.0	CHEMBL4247	Homo sapiens	IC50	uM	4.8
	3101511	CHEMBL1071418	Inhibition of ALK by ELISA-based kinase assay	B	Nc1ccc2c(c1)/C(=C/c1ccc[nH]1)C(=O)N2		CHEMBL232144	=	IC50	nM	11000.0	CHEMBL4247	Homo sapiens	IC50	uM	11.0
	3101512	CHEMBL1071418	Inhibition of ALK by ELISA-based kinase assay	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccc(-c4cccnc4)cc32)[nH]1		CHEMBL602074	=	IC50	nM	3800.0	CHEMBL4247	Homo sapiens	IC50	uM	3.8
	3117913	CHEMBL1072189	Inhibition of ALK	B	CC(=O)N1CCC(Nc2ncc3c(n2)-c2c(c(C(N)=O)nn2C)CC3)CC1		CHEMBL599224	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	3117966	CHEMBL1072189	Inhibition of ALK	B	Cn1nc(C(N)=O)c2c1-c1nc(NC3CCN(C(=O)c4ccccc4)CC3)ncc1CC2		CHEMBL599428	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	3118019	CHEMBL1072189	Inhibition of ALK	B	CNC(=O)c1nn(C)c2c1CCc1cnc(NC3CCN(C(=O)C4CCN(S(C)(=O)=O)CC4)CC3)nc1-2		CHEMBL597754	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	3127438	CHEMBL1074429	Inhibition of ALK by scintillation proximity assay	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	3127472	CHEMBL1074429	Inhibition of ALK by scintillation proximity assay	B	CC(C)(C)C(=O)N1Cc2c(NC(=O)c3cc(F)cc(F)c3)n[nH]c2C1(C)C		CHEMBL604712	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	3191045	CHEMBL1101912	Inhibition of ALK at 10 uM	B	C[C@H](O)CNc1nccc(-n2ccnc2-c2cccc(NC(=O)c3ccc(Cl)c(C(F)(F)F)c3)c2)n1		CHEMBL1082876	=	Inhibition	%	0.8	CHEMBL4247	Homo sapiens	INH	%	0.8
	3213780	CHEMBL1107584	Inhibition of ALK at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	1.0	CHEMBL4247	Homo sapiens	INH	%	1.0
	3224746	CHEMBL1102597	Inhibition of ALK at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	3225005	CHEMBL1102597	Inhibition of ALK at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	3291446	CHEMBL1109160	Inhibition of ALK assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	3294610	CHEMBL1103922	Inhibition of ALK	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=O)c5cnn(-c6ccccc6)c5C(F)(F)F)cc4F)c3s2)c1		CHEMBL1094718	<	Inhibition	%	40.0	CHEMBL4247	Homo sapiens	INH	%	40.0
	3307895	CHEMBL1119346	Inhibition of human ALK	B	Cc1cn(-c2cc(NC(=O)Nc3ccc(-c4nc5[nH]ncc5[nH]4)c(C)c3)cc(C(F)(F)F)c2)cn1		CHEMBL1084036	=	Inhibition	%	61.0	CHEMBL4247	Homo sapiens	INH	%	61.0
	3315891	CHEMBL1120237	Inhibition of Alk	B	CC(C)COC(=O)Nc1ccc(-c2cnc3c(-c4ccc(N5CCN(C)CC5)cc4)cnn3c2N)cc1		CHEMBL1085511	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	3316767	CHEMBL1120192	Inhibition of ALK at 1 uM	B	O=C(Nc1cccc(-n2ccc3c(NC(=O)c4ccccc4)nccc32)c1)c1ccc(N2CCOCC2)c(C(F)(F)F)c1		CHEMBL1084450	=	Inhibition	%	11.0	CHEMBL4247	Homo sapiens	INH	%	11.0
	3331773	CHEMBL1168570	Inhibition of ALK by time-resolved fluorescence assay	B	O=C(O)C(F)(F)F.O=C(c1ccc(-c2cnc3c(c2)N(Cc2ccccc2)CCN3)cc1)N1CCC[C@H]1CN1CCCC1		CHEMBL1202141	=	IC50	nM	256.0	CHEMBL4247	Homo sapiens	IC50	nM	256.0
	3331774	CHEMBL1168570	Inhibition of ALK by time-resolved fluorescence assay	B	O=C1CNc2ncc(-c3ccc(C(=O)N4CCC[C@H]4CN4CCCC4)cc3)cc2N1Cc1ccccc1		CHEMBL1164280	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
	3331775	CHEMBL1168570	Inhibition of ALK by time-resolved fluorescence assay	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2c(Cl)cccc2Cl)CCN3)cc1)N1CCC[C@H]1CN1CCCC1		CHEMBL1165334	=	IC50	nM	27.0	CHEMBL4247	Homo sapiens	IC50	nM	27.0
	3331776	CHEMBL1168570	Inhibition of ALK by time-resolved fluorescence assay	B	O=C1CNc2ncc(-c3ccc(C(=O)N4CCC[C@H]4CN4CCCC4)cc3)cc2N1Cc1c(Cl)cccc1Cl		CHEMBL1165317	=	IC50	nM	278.0	CHEMBL4247	Homo sapiens	IC50	nM	278.0
	3331777	CHEMBL1168570	Inhibition of ALK by time-resolved fluorescence assay	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(F)ccc2F)CCN3)cc1)N1CCC[C@H]1CN1CCCC1		CHEMBL1165318	=	IC50	nM	15.0	CHEMBL4247	Homo sapiens	IC50	nM	15.0
	3331778	CHEMBL1168570	Inhibition of ALK by time-resolved fluorescence assay	B	O=C1CNc2ncc(-c3ccc(C(=O)N4CCC[C@H]4CN4CCCC4)cc3)cc2N1Cc1cc(F)ccc1F		CHEMBL1165421	=	IC50	nM	145.0	CHEMBL4247	Homo sapiens	IC50	nM	145.0
	3331779	CHEMBL1168570	Inhibition of ALK by time-resolved fluorescence assay	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	=	IC50	nM	33.0	CHEMBL4247	Homo sapiens	IC50	nM	33.0
	3331780	CHEMBL1168570	Inhibition of ALK by time-resolved fluorescence assay	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
	3331781	CHEMBL1168570	Inhibition of ALK by time-resolved fluorescence assay	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(Cl)cccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164389	=	IC50	nM	506.0	CHEMBL4247	Homo sapiens	IC50	nM	506.0
	3331782	CHEMBL1168570	Inhibition of ALK by time-resolved fluorescence assay	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	=	IC50	nM	11.0	CHEMBL4247	Homo sapiens	IC50	nM	11.0
	3331783	CHEMBL1168570	Inhibition of ALK by time-resolved fluorescence assay	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	=	IC50	nM	11.0	CHEMBL4247	Homo sapiens	IC50	nM	11.0
	3331784	CHEMBL1168570	Inhibition of ALK by time-resolved fluorescence assay	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(S(=O)(=O)c3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1163505	=	IC50	nM	465.0	CHEMBL4247	Homo sapiens	IC50	nM	465.0
	3331785	CHEMBL1168570	Inhibition of ALK by time-resolved fluorescence assay	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(C(=O)Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1163508	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
	3331786	CHEMBL1168570	Inhibition of ALK by time-resolved fluorescence assay	B	CN1CCN(c2ccc(-c3cnc4c(c3)C(Oc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1163514	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
	3331787	CHEMBL1168570	Inhibition of ALK by time-resolved fluorescence assay	B	CN1CCN(c2ccc(-c3cnc4c(c3)C(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1164267	=	IC50	nM	1538.0	CHEMBL4247	Homo sapiens	IC50	nM	1538.0
	3331788	CHEMBL1168570	Inhibition of ALK by time-resolved fluorescence assay	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4C)cn2)CC1		CHEMBL1163511	>	IC50	nM	3000.0	CHEMBL4247	Homo sapiens	IC50	nM	3000.0
Not Determined	3331789	CHEMBL1168571	Inhibition of ALK phosphorylation in human Karpas-299 cells by immunoblotting and ELISA	B	CCOC(=O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163512		IC50			CHEMBL4247	Homo sapiens	IC50		
Not Determined	3331790	CHEMBL1168571	Inhibition of ALK phosphorylation in human Karpas-299 cells by immunoblotting and ELISA	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510		IC50			CHEMBL4247	Homo sapiens	IC50		
Not Determined	3331791	CHEMBL1168571	Inhibition of ALK phosphorylation in human Karpas-299 cells by immunoblotting and ELISA	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518		IC50			CHEMBL4247	Homo sapiens	IC50		
	3331792	CHEMBL1168571	Inhibition of ALK phosphorylation in human Karpas-299 cells by immunoblotting and ELISA	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	=	IC50	nM	450.0	CHEMBL4247	Homo sapiens	IC50	nM	450.0
	3331793	CHEMBL1168571	Inhibition of ALK phosphorylation in human Karpas-299 cells by immunoblotting and ELISA	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	=	IC50	nM	250.0	CHEMBL4247	Homo sapiens	IC50	nM	250.0
	3331794	CHEMBL1168571	Inhibition of ALK phosphorylation in human Karpas-299 cells by immunoblotting and ELISA	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	=	IC50	nM	150.0	CHEMBL4247	Homo sapiens	IC50	nM	150.0
	3331795	CHEMBL1168571	Inhibition of ALK phosphorylation in human Karpas-299 cells by immunoblotting and ELISA	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	=	IC50	nM	250.0	CHEMBL4247	Homo sapiens	IC50	nM	250.0
	3331796	CHEMBL1168570	Inhibition of ALK by time-resolved fluorescence assay	B	CCOC(=O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163512	>	IC50	nM	3000.0	CHEMBL4247	Homo sapiens	IC50	nM	3000.0
	3331797	CHEMBL1168570	Inhibition of ALK by time-resolved fluorescence assay	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	=	IC50	nM	1302.0	CHEMBL4247	Homo sapiens	IC50	nM	1302.0
	3331798	CHEMBL1168570	Inhibition of ALK by time-resolved fluorescence assay	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	=	IC50	nM	121.0	CHEMBL4247	Homo sapiens	IC50	nM	121.0
	3331799	CHEMBL1168570	Inhibition of ALK by time-resolved fluorescence assay	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	=	IC50	nM	40.0	CHEMBL4247	Homo sapiens	IC50	nM	40.0
	3331800	CHEMBL1168570	Inhibition of ALK by time-resolved fluorescence assay	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
	3331801	CHEMBL1168570	Inhibition of ALK by time-resolved fluorescence assay	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
	3331802	CHEMBL1168570	Inhibition of ALK by time-resolved fluorescence assay	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	=	IC50	nM	17.0	CHEMBL4247	Homo sapiens	IC50	nM	17.0
	3331803	CHEMBL1168571	Inhibition of ALK phosphorylation in human Karpas-299 cells by immunoblotting and ELISA	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	=	IC50	nM	200.0	CHEMBL4247	Homo sapiens	IC50	nM	200.0
	3331825	CHEMBL1168784	Inhibition of ALK at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	=	Inhibition	%	96.7	CHEMBL4247	Homo sapiens	INH	%	96.7
	3333240	CHEMBL1168784	Inhibition of ALK at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	=	Inhibition	%	98.0	CHEMBL4247	Homo sapiens	INH	%	98.0
	3334645	CHEMBL1168784	Inhibition of ALK at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	=	Inhibition	%	98.0	CHEMBL4247	Homo sapiens	INH	%	98.0
	3336065	CHEMBL1168784	Inhibition of ALK at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	=	Inhibition	%	97.0	CHEMBL4247	Homo sapiens	INH	%	97.0
	3337451	CHEMBL1168784	Inhibition of ALK at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	3337699	CHEMBL1168784	Inhibition of ALK at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	3339030	CHEMBL1168784	Inhibition of ALK at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	=	Inhibition	%	85.6	CHEMBL4247	Homo sapiens	INH	%	85.6
	3339286	CHEMBL1168784	Inhibition of ALK at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	=	Inhibition	%	83.4	CHEMBL4247	Homo sapiens	INH	%	83.4
	3340593	CHEMBL1168784	Inhibition of ALK at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	=	Inhibition	%	99.0	CHEMBL4247	Homo sapiens	INH	%	99.0
	3342009	CHEMBL1168784	Inhibition of ALK at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	=	Inhibition	%	98.0	CHEMBL4247	Homo sapiens	INH	%	98.0
	3345955	CHEMBL1173926	Inhibition of human recombinant histidine-tagged ALK (103-1459) expressed in Sf9 cells by ELISA	B	N#Cc1c(SCC(=O)c2ccccc2)nc2c(c1-c1ccsc1)CCCC2		CHEMBL1170563	=	IC50	nM	35000.0	CHEMBL4247	Homo sapiens	IC50	uM	35.0
	3345956	CHEMBL1173926	Inhibition of human recombinant histidine-tagged ALK (103-1459) expressed in Sf9 cells by ELISA	B	N#Cc1c(N)nc(SCC(=O)c2ccccc2)c(C#N)c1-c1ccsc1		CHEMBL1171960	=	IC50	nM	1700.0	CHEMBL4247	Homo sapiens	IC50	uM	1.7
	3345957	CHEMBL1173926	Inhibition of human recombinant histidine-tagged ALK (103-1459) expressed in Sf9 cells by ELISA	B	N#Cc1c(N)nc(SCC(=O)c2ccc(Cl)cc2)c(C#N)c1-c1ccsc1		CHEMBL1172147	=	IC50	nM	9700.0	CHEMBL4247	Homo sapiens	IC50	uM	9.7
	3345958	CHEMBL1173926	Inhibition of human recombinant histidine-tagged ALK (103-1459) expressed in Sf9 cells by ELISA	B	N#Cc1c(SCc2ccc(F)cc2)nc2c(c1-c1cccs1)CCCC2		CHEMBL1172697	=	IC50	nM	4000.0	CHEMBL4247	Homo sapiens	IC50	uM	4.0
	3345959	CHEMBL1173926	Inhibition of human recombinant histidine-tagged ALK (103-1459) expressed in Sf9 cells by ELISA	B	N#Cc1c(SCc2ccccc2)nc2c(c1-c1cccs1)CCCC2		CHEMBL1171912	=	IC50	nM	2100.0	CHEMBL4247	Homo sapiens	IC50	uM	2.1
Not Determined	3345960	CHEMBL1173926	Inhibition of human recombinant histidine-tagged ALK (103-1459) expressed in Sf9 cells by ELISA	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828		IC50			CHEMBL4247	Homo sapiens	IC50		
	3358452	CHEMBL1174066	Inhibition of ALK at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	23.0	CHEMBL4247	Homo sapiens	INH	%	23.0
	3358894	CHEMBL1174066	Inhibition of ALK at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	52.0	CHEMBL4247	Homo sapiens	INH	%	52.0
	3407682	CHEMBL1219735	Inhibition of ALK at 1 uM by radiometric method	B	CCOC(=O)CCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215218	=	Inhibition	%	80.0	CHEMBL4247	Homo sapiens	INH	%	80.0
	3407683	CHEMBL1219735	Inhibition of ALK at 1 uM by radiometric method	B	CN(C)CCCc1c(/C=C2\C(=O)Nc3ccc(NS(=O)(=O)c4ccccc4)cc32)[nH]c2c1C(=O)CCC2		CHEMBL1215346	=	Inhibition	%	85.0	CHEMBL4247	Homo sapiens	INH	%	85.0
	3420227	CHEMBL1226923	Inhibition of Alk	B	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
	3443339	CHEMBL1243991	Inhibition of ALK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	25.0	CHEMBL4247	Homo sapiens	INH	%	25.0
	3443556	CHEMBL1243991	Inhibition of ALK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	74.0	CHEMBL4247	Homo sapiens	INH	%	74.0
	3444711	CHEMBL1243991	Inhibition of ALK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	7.0	CHEMBL4247	Homo sapiens	INH	%	7.0
	3445026	CHEMBL1244722	Binding affinity to ALK	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	71.0	CHEMBL4247	Homo sapiens	Kd	nM	71.0
	3445335	CHEMBL1243991	Inhibition of ALK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	6.0	CHEMBL4247	Homo sapiens	INH	%	6.0
	3445552	CHEMBL1243991	Inhibition of ALK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	31.0	CHEMBL4247	Homo sapiens	INH	%	31.0
	3445770	CHEMBL1243991	Inhibition of ALK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	64.0	CHEMBL4247	Homo sapiens	INH	%	64.0
	3445960	CHEMBL1243991	Inhibition of ALK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	11.0	CHEMBL4247	Homo sapiens	INH	%	11.0
	3448878	CHEMBL1244722	Binding affinity to ALK	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	270.0	CHEMBL4247	Homo sapiens	Kd	nM	270.0
	3449098	CHEMBL1244722	Binding affinity to ALK	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	170.0	CHEMBL4247	Homo sapiens	Kd	nM	170.0
	3449558	CHEMBL1244722	Binding affinity to ALK	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	uM	10.0
	3449983	CHEMBL1244722	Binding affinity to ALK	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	uM	10.0
	3450912	CHEMBL1244722	Binding affinity to ALK	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	uM	10.0
	3451202	CHEMBL1244722	Binding affinity to ALK	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	uM	10.0
	3463172	CHEMBL1251632	Inhibition of ALK at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	17.0	CHEMBL4247	Homo sapiens	INH	%	17.0
	3463391	CHEMBL1251632	Inhibition of ALK at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	10.0	CHEMBL4247	Homo sapiens	INH	%	10.0
	3463935	CHEMBL1251632	Inhibition of ALK at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	9.0	CHEMBL4247	Homo sapiens	INH	%	9.0
	3523901	CHEMBL1273642	Inhibition of ALK	B	CC(C)c1n[nH]c(Cl)c1-c1ccnc(Nc2ccc(N3CCC(N(C)C)CC3)cn2)n1		CHEMBL1272116	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	3523902	CHEMBL1273642	Inhibition of ALK	B	CC(C)c1n[nH]c(C(F)(F)F)c1-c1ccnc(Nc2ccc(N3CCC(N(C)C)CC3)cn2)n1		CHEMBL1272171	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	3525328	CHEMBL1274094	Inhibition of ALK1	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL496862	=	IC50	nM	4000.0	CHEMBL4247	Homo sapiens	IC50	uM	4.0
	3526997	CHEMBL1274129	Inhibition of ALK	B	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccccc1		CHEMBL1270230	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	3528088	CHEMBL1272704	Inhibition of ALK	B	C=Cn1nc(C(N)=O)c2c1-c1nc(Nc3cc(N4CCN(C)CC4)ccc3OC(F)(F)F)ncc1CC2		CHEMBL1793896	=	IC50	nM	2375.0	CHEMBL4247	Homo sapiens	IC50	uM	2.375
	3528247	CHEMBL1272704	Inhibition of ALK	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3C)CC4)c2)CC1		CHEMBL1272140	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	3528248	CHEMBL1272704	Inhibition of ALK	B	Cn1nc(C(N)=O)c2c1-c1nc(Nc3cc(N4CCNCC4)ccc3OC(F)(F)F)ncc1CC2		CHEMBL1271644	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	3528249	CHEMBL1272704	Inhibition of ALK	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCF)CC4)c2)CC1		CHEMBL1793892	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	5120325	CHEMBL1648170	Inhibition of human ALK at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	101.0	CHEMBL4247	Homo sapiens	INH	%	101.0
	5123784	CHEMBL1649024	Inhibition of ALK at 1 uM	B	CCN1C(=O)CCC(C)(C)c2ccc(Nc3ncc(Cl)c(Nc4c(F)cccc4C(=O)NC)n3)cc21		CHEMBL1644812	=	Inhibition	%	99.0	CHEMBL4247	Homo sapiens	INH	%	99.0
	5126178	CHEMBL1648480	Inhibition of ALK	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	=	IC50	nM	5.0	CHEMBL4247	Homo sapiens	IC50	nM	5.0
	5126179	CHEMBL1648480	Inhibition of ALK	B	COc1cc(N2CCOCC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCOCC3)cc2OC)n1		CHEMBL1642253	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
	5126180	CHEMBL1648480	Inhibition of ALK	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(Nc3ccc(N4CCOCC4)cc3OC)n1)c2OC		CHEMBL1642254	=	IC50	nM	34.0	CHEMBL4247	Homo sapiens	IC50	nM	34.0
	5126181	CHEMBL1648480	Inhibition of ALK	B	COCCN1CCc2cc(Nc3ncc(Cl)c(Nc4ccc(N5CCOCC5)cc4OC)n3)c(OC)cc2CC1		CHEMBL1642255	=	IC50	nM	7.0	CHEMBL4247	Homo sapiens	IC50	nM	7.0
	5126182	CHEMBL1648480	Inhibition of ALK	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccc(N4CCOCC4)cc3OC)n1)CCN(CC(F)F)CC2		CHEMBL1642256	=	IC50	nM	58.0	CHEMBL4247	Homo sapiens	IC50	nM	58.0
	5126183	CHEMBL1648480	Inhibition of ALK	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccc(N4CCOCC4)cc3OC)n1)CCN(CCS(C)(=O)=O)CC2		CHEMBL1642257	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
	5126184	CHEMBL1648480	Inhibition of ALK	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccc(N4CCOCC4)cc3OC)n1)CCN(CC(=O)N(C)C)CC2		CHEMBL1642258	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
	5126185	CHEMBL1648480	Inhibition of ALK	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccc(N4CCOCC4)cc3)n1)CCN(CC(=O)N(C)C)CC2		CHEMBL1642259	=	IC50	nM	49.0	CHEMBL4247	Homo sapiens	IC50	nM	49.0
	5126186	CHEMBL1648480	Inhibition of ALK	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3OC)n1)CCN(CC(=O)N(C)C)CC2		CHEMBL1642260	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
	5126187	CHEMBL1648480	Inhibition of ALK	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccc(C(N)=O)cc3OC)n1)CCN(CC(=O)N(C)C)CC2		CHEMBL1642261	=	IC50	nM	6.0	CHEMBL4247	Homo sapiens	IC50	nM	6.0
	5126188	CHEMBL1648480	Inhibition of ALK	B	CNC(=O)CN1CCc2cc(Nc3ncc(Cl)c(Nc4ccc(N5CCOCC5)cc4OC)n3)c(OC)cc2CC1		CHEMBL1642262	=	IC50	nM	6.0	CHEMBL4247	Homo sapiens	IC50	nM	6.0
	5126189	CHEMBL1648480	Inhibition of ALK	B	COCCOc1ccc(Nc2nc(Nc3cc4c(cc3OC)CCN(CC(=O)N(C)C)CC4)ncc2Cl)c(OC)c1		CHEMBL1642263	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
	5126190	CHEMBL1648480	Inhibition of ALK	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccc(C#N)cc3OC)n1)CCN(CC(=O)N(C)C)CC2		CHEMBL1642264	=	IC50	nM	7.0	CHEMBL4247	Homo sapiens	IC50	nM	7.0
	5126191	CHEMBL1648480	Inhibition of ALK	B	COc1ccc(Nc2nc(Nc3cc4c(cc3OC)CCN(CC(=O)N(C)C)CC4)ncc2Cl)c(OC)c1		CHEMBL1642265	=	IC50	nM	5.0	CHEMBL4247	Homo sapiens	IC50	nM	5.0
	5126192	CHEMBL1648481	Inhibition of ALK by cell based assay	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	=	IC50	nM	50.0	CHEMBL4247	Homo sapiens	IC50	nM	50.0
	5126193	CHEMBL1648481	Inhibition of ALK by cell based assay	B	COc1cc(N2CCOCC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCOCC3)cc2OC)n1		CHEMBL1642253	=	IC50	nM	120.0	CHEMBL4247	Homo sapiens	IC50	nM	120.0
	5126194	CHEMBL1648481	Inhibition of ALK by cell based assay	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(Nc3ccc(N4CCOCC4)cc3OC)n1)c2OC		CHEMBL1642254	=	IC50	nM	175.0	CHEMBL4247	Homo sapiens	IC50	nM	175.0
	5126195	CHEMBL1648481	Inhibition of ALK by cell based assay	B	COCCN1CCc2cc(Nc3ncc(Cl)c(Nc4ccc(N5CCOCC5)cc4OC)n3)c(OC)cc2CC1		CHEMBL1642255	=	IC50	nM	150.0	CHEMBL4247	Homo sapiens	IC50	nM	150.0
	5126196	CHEMBL1648481	Inhibition of ALK by cell based assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccc(N4CCOCC4)cc3OC)n1)CCN(CCS(C)(=O)=O)CC2		CHEMBL1642257	=	IC50	nM	100.0	CHEMBL4247	Homo sapiens	IC50	nM	100.0
	5126197	CHEMBL1648481	Inhibition of ALK by cell based assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccc(N4CCOCC4)cc3OC)n1)CCN(CC(=O)N(C)C)CC2		CHEMBL1642258	=	IC50	nM	30.0	CHEMBL4247	Homo sapiens	IC50	nM	30.0
	5126198	CHEMBL1648481	Inhibition of ALK by cell based assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3OC)n1)CCN(CC(=O)N(C)C)CC2		CHEMBL1642260	=	IC50	nM	65.0	CHEMBL4247	Homo sapiens	IC50	nM	65.0
	5126199	CHEMBL1648481	Inhibition of ALK by cell based assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccc(C(N)=O)cc3OC)n1)CCN(CC(=O)N(C)C)CC2		CHEMBL1642261	=	IC50	nM	65.0	CHEMBL4247	Homo sapiens	IC50	nM	65.0
	5126200	CHEMBL1648481	Inhibition of ALK by cell based assay	B	CNC(=O)CN1CCc2cc(Nc3ncc(Cl)c(Nc4ccc(N5CCOCC5)cc4OC)n3)c(OC)cc2CC1		CHEMBL1642262	=	IC50	nM	100.0	CHEMBL4247	Homo sapiens	IC50	nM	100.0
	5126201	CHEMBL1648481	Inhibition of ALK by cell based assay	B	COCCOc1ccc(Nc2nc(Nc3cc4c(cc3OC)CCN(CC(=O)N(C)C)CC4)ncc2Cl)c(OC)c1		CHEMBL1642263	=	IC50	nM	40.0	CHEMBL4247	Homo sapiens	IC50	nM	40.0
	5126202	CHEMBL1648481	Inhibition of ALK by cell based assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccc(C#N)cc3OC)n1)CCN(CC(=O)N(C)C)CC2		CHEMBL1642264	=	IC50	nM	65.0	CHEMBL4247	Homo sapiens	IC50	nM	65.0
	5126203	CHEMBL1648481	Inhibition of ALK by cell based assay	B	COc1ccc(Nc2nc(Nc3cc4c(cc3OC)CCN(CC(=O)N(C)C)CC4)ncc2Cl)c(OC)c1		CHEMBL1642265	=	IC50	nM	40.0	CHEMBL4247	Homo sapiens	IC50	nM	40.0
	5126256	CHEMBL1648483	Selectivity for ratio of IC50 for ALK by cell based assay to IC50 for ALK	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccc(N4CCOCC4)cc3OC)n1)CCN(CC(=O)N(C)C)CC2		CHEMBL1642258	=	Ratio IC50		7.0	CHEMBL4247	Homo sapiens	Ratio IC50		7.0
	5152419	CHEMBL1656371	Inhibition of ALK by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL2012519	=	IC50	nM	763.0	CHEMBL4247	Homo sapiens	IC50	nM	763.0
	5152431	CHEMBL1656371	Inhibition of ALK by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)CC(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1651521	=	IC50	nM	763.0	CHEMBL4247	Homo sapiens	IC50	nM	763.0
	5152443	CHEMBL1656371	Inhibition of ALK by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)CC(=O)/C=C/C[C@H](C)OC2=O		CHEMBL1651522	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
	5152455	CHEMBL1656371	Inhibition of ALK by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)CCCCCC(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1651523	=	IC50	nM	3500.0	CHEMBL4247	Homo sapiens	IC50	nM	3500.0
	5206205	CHEMBL1671207	Inhibition of ALK at 10 uM	B	O=C(NC[C@@H]1CCCN1)c1ccc(-c2cnc3ccc(NCC4CC4)nn23)cc1		CHEMBL1222990	=	Inhibition	%	90.0	CHEMBL4247	Homo sapiens	INH	%	90.0
	5242942	CHEMBL1685636	Inhibition of ALK at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	47.0	CHEMBL4247	Homo sapiens	INH	%	47.0
	5243781	CHEMBL1685885	Inhibition of ALK at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	4.0	CHEMBL4247	Homo sapiens	INH	%	4.0
	5243894	CHEMBL1685636	Inhibition of ALK at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	27.0	CHEMBL4247	Homo sapiens	INH	%	27.0
	5244002	CHEMBL1685885	Inhibition of ALK at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	5.0	CHEMBL4247	Homo sapiens	INH	%	5.0
	5244875	CHEMBL1685636	Inhibition of ALK at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	87.0	CHEMBL4247	Homo sapiens	INH	%	87.0
	5244983	CHEMBL1685885	Inhibition of ALK at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	51.0	CHEMBL4247	Homo sapiens	INH	%	51.0
	5245134	CHEMBL1685636	Inhibition of ALK at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	122.0	CHEMBL4247	Homo sapiens	INH	%	122.0
	5245964	CHEMBL1685885	Inhibition of ALK at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	59.0	CHEMBL4247	Homo sapiens	INH	%	59.0
	5249821	CHEMBL1687353	Inhibition of ALK	B	COc1ccc(Cn2ncc(NC(=O)c3cc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)ccc3C)c2N)cc1		CHEMBL1684800	=	IC50	nM	2.71	CHEMBL4247	Homo sapiens	IC50	nM	2.71
	5249841	CHEMBL1687326	Inhibition of ALK at 10 uM	B	COc1ccc(Cn2ncc(NC(=O)c3cc(NC(=O)Nc4ccc(Cl)c(C(F)(F)F)c4)ccc3C)c2N)cc1		CHEMBL1684800	=	Inhibition	%	7.7	CHEMBL4247	Homo sapiens	INH	%	7.7
	6198102	CHEMBL1776513	Inhibition of ALK assessed as [33P]gamma-ATP incorporation into substrate after 60 mins by gamma counting	B	CN1CCN(c2ccc(OC(F)(F)F)c(Nc3ncc4c(n3)-c3c(c(C(N)=O)nn3CCO)CC4)c2)CC1		CHEMBL1738758	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	6201213	CHEMBL1781770	Inhibition of ALK assessed as biotin-EGPWLEEEEEAYGWMDF peptide phosphorylation by TR-FRET assay	B	CCOc1ccc2c3c(oc2c1)C(C)(C)c1cc(OCCN(CC)CC)ccc1C3=O		CHEMBL1779097	=	IC50	nM	1340.0	CHEMBL4247	Homo sapiens	IC50	uM	1.34
	6201214	CHEMBL1781770	Inhibition of ALK assessed as biotin-EGPWLEEEEEAYGWMDF peptide phosphorylation by TR-FRET assay	B	CCN(CC)CCOc1ccc2c(c1)C(C)(C)c1oc3cc(OC)ccc3c1C2=O		CHEMBL1779183	=	IC50	nM	2080.0	CHEMBL4247	Homo sapiens	IC50	uM	2.08
	6201215	CHEMBL1781770	Inhibition of ALK assessed as biotin-EGPWLEEEEEAYGWMDF peptide phosphorylation by TR-FRET assay	B	CCCOc1ccc2c3c(oc2c1)C(C)(C)c1cc(OCCN(CC)CC)ccc1C3=O		CHEMBL1779184	=	IC50	nM	2470.0	CHEMBL4247	Homo sapiens	IC50	uM	2.47
	6201216	CHEMBL1781770	Inhibition of ALK assessed as biotin-EGPWLEEEEEAYGWMDF peptide phosphorylation by TR-FRET assay	B	CCN(CC)CCOc1ccc2c(c1)C(C)(C)c1oc3cc(F)ccc3c1C2=O		CHEMBL1779185	=	IC50	nM	850.0	CHEMBL4247	Homo sapiens	IC50	uM	0.85
	6201217	CHEMBL1781770	Inhibition of ALK assessed as biotin-EGPWLEEEEEAYGWMDF peptide phosphorylation by TR-FRET assay	B	CCN(CC)CCOc1ccc2c(c1)C(C)(C)c1oc3cc(Br)ccc3c1C2=O		CHEMBL1779186	=	IC50	nM	770.0	CHEMBL4247	Homo sapiens	IC50	uM	0.77
	6201218	CHEMBL1781770	Inhibition of ALK assessed as biotin-EGPWLEEEEEAYGWMDF peptide phosphorylation by TR-FRET assay	B	CCN(CC)CCOc1ccc2c(c1)C(C)(C)c1oc3cc(Cl)ccc3c1C2=O		CHEMBL1779187	=	IC50	nM	660.0	CHEMBL4247	Homo sapiens	IC50	uM	0.66
	6201219	CHEMBL1781770	Inhibition of ALK assessed as biotin-EGPWLEEEEEAYGWMDF peptide phosphorylation by TR-FRET assay	B	CCN(CC)CCOc1ccc2c(c1)C(C)(C)c1oc3cc(C(F)(F)F)ccc3c1C2=O		CHEMBL1779188	=	IC50	nM	3470.0	CHEMBL4247	Homo sapiens	IC50	uM	3.47
	6201220	CHEMBL1781770	Inhibition of ALK assessed as biotin-EGPWLEEEEEAYGWMDF peptide phosphorylation by TR-FRET assay	B	CCN(CC)CCOc1ccc2c(c1)C(C)(C)c1[nH]c3cc(Br)ccc3c1C2=O		CHEMBL1779189	=	IC50	nM	100.0	CHEMBL4247	Homo sapiens	IC50	uM	0.1
	6201221	CHEMBL1781770	Inhibition of ALK assessed as biotin-EGPWLEEEEEAYGWMDF peptide phosphorylation by TR-FRET assay	B	CCN(CC)CCOc1ccc2c(c1)C(C)(C)c1[nH]c3cc([N+](=O)[O-])ccc3c1C2=O		CHEMBL1779190	=	IC50	nM	80.0	CHEMBL4247	Homo sapiens	IC50	uM	0.08
	6201222	CHEMBL1781770	Inhibition of ALK assessed as biotin-EGPWLEEEEEAYGWMDF peptide phosphorylation by TR-FRET assay	B	CCN(CC)CCOc1ccc2c(c1)C(C)(C)c1[nH]c3cc(Cl)ccc3c1C2=O		CHEMBL1779191	=	IC50	nM	40.0	CHEMBL4247	Homo sapiens	IC50	uM	0.04
	6201223	CHEMBL1781770	Inhibition of ALK assessed as biotin-EGPWLEEEEEAYGWMDF peptide phosphorylation by TR-FRET assay	B	CCN(CC)CCOc1ccc2c(c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1779192	=	IC50	nM	8.0	CHEMBL4247	Homo sapiens	IC50	uM	0.008
	6201224	CHEMBL1781770	Inhibition of ALK assessed as biotin-EGPWLEEEEEAYGWMDF peptide phosphorylation by TR-FRET assay	B	CC1(C)c2cc(OCCN3CCS(=O)(=O)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL1779193	=	IC50	nM	3.7	CHEMBL4247	Homo sapiens	IC50	nM	3.7
	6201225	CHEMBL1781770	Inhibition of ALK assessed as biotin-EGPWLEEEEEAYGWMDF peptide phosphorylation by TR-FRET assay	B	CC(=O)NCCOc1ccc2c(c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1779194	=	IC50	nM	11.6	CHEMBL4247	Homo sapiens	IC50	nM	11.6
	6201226	CHEMBL1781770	Inhibition of ALK assessed as biotin-EGPWLEEEEEAYGWMDF peptide phosphorylation by TR-FRET assay	B	CC1(C)c2cc(OCCNC(N)=O)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL1779195	=	IC50	nM	26.2	CHEMBL4247	Homo sapiens	IC50	nM	26.2
	6201227	CHEMBL1781770	Inhibition of ALK assessed as biotin-EGPWLEEEEEAYGWMDF peptide phosphorylation by TR-FRET assay	B	CC1(C)c2cc(N3CCCCC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL1779196	=	IC50	nM	33.4	CHEMBL4247	Homo sapiens	IC50	nM	33.4
	6201228	CHEMBL1781770	Inhibition of ALK assessed as biotin-EGPWLEEEEEAYGWMDF peptide phosphorylation by TR-FRET assay	B	CC1(C)c2cc(N3CCOCC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL1779197	=	IC50	nM	18.5	CHEMBL4247	Homo sapiens	IC50	nM	18.5
	6201229	CHEMBL1781770	Inhibition of ALK assessed as biotin-EGPWLEEEEEAYGWMDF peptide phosphorylation by TR-FRET assay	B	CC1(C)c2cc(N3CCC(O)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL1779198	=	IC50	nM	11.4	CHEMBL4247	Homo sapiens	IC50	nM	11.4
	6201230	CHEMBL1781770	Inhibition of ALK assessed as biotin-EGPWLEEEEEAYGWMDF peptide phosphorylation by TR-FRET assay	B	CC1(C)c2cc(N3CCN(S(C)(=O)=O)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL1779199	=	IC50	nM	37.4	CHEMBL4247	Homo sapiens	IC50	nM	37.4
	6201231	CHEMBL1781770	Inhibition of ALK assessed as biotin-EGPWLEEEEEAYGWMDF peptide phosphorylation by TR-FRET assay	B	CC(C)N1CCN(c2ccc3c(c2)C(C)(C)c2[nH]c4cc(C#N)ccc4c2C3=O)CC1		CHEMBL1779200	=	IC50	nM	1.8	CHEMBL4247	Homo sapiens	IC50	nM	1.8
	6201232	CHEMBL1781770	Inhibition of ALK assessed as biotin-EGPWLEEEEEAYGWMDF peptide phosphorylation by TR-FRET assay	B	CC1(C)c2cc(N3CCN(C4COC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL1779201	=	IC50	nM	27.0	CHEMBL4247	Homo sapiens	IC50	nM	27.0
	6201233	CHEMBL1781770	Inhibition of ALK assessed as biotin-EGPWLEEEEEAYGWMDF peptide phosphorylation by TR-FRET assay	B	CC1(C)c2cc(C3CCN(C4COC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL1779202	=	IC50	nM	1.5	CHEMBL4247	Homo sapiens	IC50	nM	1.5
	6201868	CHEMBL1781432	Competitive inhibition of ALK phosphorylation by Lineweaver-Burk plot analysis	B	CCOc1ccc2c3c(oc2c1)C(C)(C)c1cc(OCCN(CC)CC)ccc1C3=O		CHEMBL1779097	=	Ki	nM	170.0	CHEMBL4247	Homo sapiens	Ki	uM	0.17
	6210047	CHEMBL1781229	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate at 10 uM after 60 mins by mobility shift assay	B	Oc1ccc(Nc2ncnc3ccc(Br)cc23)cc1		CHEMBL1778712	>	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	6210070	CHEMBL1781027	Inhibition of EML4-ALK at 4 uM by mobility shift assay	B	Cc1cc(-c2cccc(N)c2)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL1778718	=	Inhibition	%	98.7	CHEMBL4247	Homo sapiens	INH	%	98.7
	6210071	CHEMBL1781026	Inhibition of ALK at 4 uM by mobility shift assay	B	Cc1cc(-c2cccc(N)c2)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL1778718	=	Inhibition	%	97.6	CHEMBL4247	Homo sapiens	INH	%	97.6
	6210072	CHEMBL1781025	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate after 60 mins by mobility shift assay	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1-c1ccc(NCCN)cc1		CHEMBL1778725	=	IC50	nM	415.3	CHEMBL4247	Homo sapiens	IC50	nM	415.3
	6210073	CHEMBL1781025	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate after 60 mins by mobility shift assay	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1-c1cccc(NCCN)c1		CHEMBL1778724	=	IC50	nM	604.5	CHEMBL4247	Homo sapiens	IC50	nM	604.5
	6210074	CHEMBL1781025	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate after 60 mins by mobility shift assay	B	Cc1cc(-c2ccc(NCCN)cc2)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL1778723	=	IC50	nM	149.3	CHEMBL4247	Homo sapiens	IC50	nM	149.3
	6210075	CHEMBL1781025	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate after 60 mins by mobility shift assay	B	Cc1cc(-c2cccc(NCCN)c2)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL1778722	=	IC50	nM	89.1	CHEMBL4247	Homo sapiens	IC50	nM	89.1
	6210076	CHEMBL1781025	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate after 60 mins by mobility shift assay	B	Cc1cc(-c2ccc(N)cc2)c(/C=C2\C(=O)Nc3ccc(N)cc32)[nH]1		CHEMBL1778721	=	IC50	nM	68.3	CHEMBL4247	Homo sapiens	IC50	nM	68.3
	6210077	CHEMBL1781025	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate after 60 mins by mobility shift assay	B	Cc1cc(-c2cccc(N)c2)c(/C=C2\C(=O)Nc3ccc(N)cc32)[nH]1		CHEMBL1778720	=	IC50	nM	50.8	CHEMBL4247	Homo sapiens	IC50	nM	50.8
	6210078	CHEMBL1781025	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate after 60 mins by mobility shift assay	B	Cc1cc(-c2ccc(N)cc2)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL1778719	=	IC50	nM	367.6	CHEMBL4247	Homo sapiens	IC50	nM	367.6
	6210079	CHEMBL1781025	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate after 60 mins by mobility shift assay	B	Cc1cc(-c2cccc(N)c2)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL1778718	=	IC50	nM	61.8	CHEMBL4247	Homo sapiens	IC50	nM	61.8
	6210080	CHEMBL1781025	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate after 60 mins by mobility shift assay	B	CC1CN(Cc2c(-c3cccs3)[nH]c3ncccc23)CC(C)O1		CHEMBL1778717	=	IC50	nM	9290.0	CHEMBL4247	Homo sapiens	IC50	uM	9.29
	6210081	CHEMBL1781025	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate after 60 mins by mobility shift assay	B	O=[N+]([O-])c1ccc2ncnc(Nc3ccc(O)cc3)c2c1		CHEMBL1778716	=	IC50	nM	8660.0	CHEMBL4247	Homo sapiens	IC50	uM	8.66
	6210082	CHEMBL1781025	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate after 60 mins by mobility shift assay	B	Oc1ccccc1-c1nc(Nc2ccc(Cl)cc2)c2ccccc2n1		CHEMBL1778715	=	IC50	nM	6460.0	CHEMBL4247	Homo sapiens	IC50	uM	6.46
	6210083	CHEMBL1781025	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate after 60 mins by mobility shift assay	B	Oc1ccc(Nc2nc(-c3ccccc3O)nc3ccccc23)cc1		CHEMBL1487936	=	IC50	nM	4240.0	CHEMBL4247	Homo sapiens	IC50	uM	4.24
	6210084	CHEMBL1781025	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate after 60 mins by mobility shift assay	B	Cc1ccc(NC2=NC(=O)/C(=C3\C(=O)Nc4ccccc43)S2)cc1		CHEMBL1778714	=	IC50	nM	3750.0	CHEMBL4247	Homo sapiens	IC50	uM	3.75
	6210085	CHEMBL1781025	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate after 60 mins by mobility shift assay	B	CCOC(=O)c1ccc(Nc2nc(Nc3ccc(Cl)cc3)c3nccnc3n2)cc1		CHEMBL1778713	=	IC50	nM	3470.0	CHEMBL4247	Homo sapiens	IC50	uM	3.47
	6210086	CHEMBL1781025	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate after 60 mins by mobility shift assay	B	Oc1ccc(Nc2ncnc3ccc(Br)cc23)cc1		CHEMBL1778712	=	IC50	nM	2850.0	CHEMBL4247	Homo sapiens	IC50	uM	2.85
	6210087	CHEMBL1781025	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate after 60 mins by mobility shift assay	B	COc1cc(-c2nc3cc(C)ccn3c2/N=C/c2cc(Cl)ccc2O)ccc1O		CHEMBL1778711	=	IC50	nM	2400.0	CHEMBL4247	Homo sapiens	IC50	uM	2.4
	6210088	CHEMBL1781025	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate after 60 mins by mobility shift assay	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	=	IC50	nM	2400.0	CHEMBL4247	Homo sapiens	IC50	uM	2.4
	6210089	CHEMBL1781025	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate after 60 mins by mobility shift assay	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	IC50	nM	1810.0	CHEMBL4247	Homo sapiens	IC50	uM	1.81
	6210090	CHEMBL1781025	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate after 60 mins by mobility shift assay	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1ccccc1		CHEMBL1778710	=	IC50	nM	1730.0	CHEMBL4247	Homo sapiens	IC50	uM	1.73
	6210091	CHEMBL1781025	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate after 60 mins by mobility shift assay	B	CCc1nc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL382706	=	IC50	nM	1380.0	CHEMBL4247	Homo sapiens	IC50	uM	1.38
	6210092	CHEMBL1781025	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate after 60 mins by mobility shift assay	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)O		CHEMBL1778707	=	IC50	nM	910.0	CHEMBL4247	Homo sapiens	IC50	uM	0.91
	6210093	CHEMBL1781025	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate after 60 mins by mobility shift assay	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	IC50	nM	850.0	CHEMBL4247	Homo sapiens	IC50	uM	0.85
	6210094	CHEMBL1781025	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate after 60 mins by mobility shift assay	B	COc1c(OCCN2CCCCC2)cc(F)c2c(-c3ccc(O)c(Cl)c3)nc3[nH]nc(C)c3c12		CHEMBL1778709	<=	IC50	nM	99.0	CHEMBL4247	Homo sapiens	IC50	nM	99.0
	6210095	CHEMBL1781025	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate after 60 mins by mobility shift assay	B	COc1cc2c(-c3ccc(O)cc3)nc3[nH]nc(C)c3c2cc1OC		CHEMBL1778706	<=	IC50	nM	99.0	CHEMBL4247	Homo sapiens	IC50	nM	99.0
	6210096	CHEMBL1781229	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate at 10 uM after 60 mins by mobility shift assay	B	CCc1nc(/C=C2\C(=O)Nc3ccccc32)c[nH]1		CHEMBL196814	>	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	6210097	CHEMBL1781229	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate at 10 uM after 60 mins by mobility shift assay	B	O=C(OCc1cc(=O)oc2cc(O)c(O)cc12)c1cc2ccccc2cc1O		CHEMBL1778726	>	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	6210098	CHEMBL1781229	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate at 10 uM after 60 mins by mobility shift assay	B	Oc1ccc(C2Oc3cc(O)cc(O)c3CC2O)cc1		CHEMBL1326092	>	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	6210099	CHEMBL1781229	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate at 10 uM after 60 mins by mobility shift assay	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	>	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	6210100	CHEMBL1781229	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate at 10 uM after 60 mins by mobility shift assay	B	NC(Cc1cc(O)c(O)cc1O)C(O)O		CHEMBL1778727	>	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	6210101	CHEMBL1781229	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate at 10 uM after 60 mins by mobility shift assay	B	O=C1Nc2ccccc2/C1=C/c1c[nH]nc1-c1cccs1		CHEMBL372132	>	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	6210102	CHEMBL1781229	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate at 10 uM after 60 mins by mobility shift assay	B	Oc1cc(C(O)O)c2cc(Oc3ccc4nc(O)cc(C(O)O)c4c3)ccc2n1		CHEMBL1778728	>	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	6210103	CHEMBL1781229	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate at 10 uM after 60 mins by mobility shift assay	B	Oc1ccc(-n2cccc2)cc1C(O)O		CHEMBL1778729	>	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	6210104	CHEMBL1781229	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate at 10 uM after 60 mins by mobility shift assay	B	Cn1cc(/C=C2\C(=O)Nc3ccccc32)c2ccccc21		CHEMBL471375	>	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	6210105	CHEMBL1781229	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate at 10 uM after 60 mins by mobility shift assay	B	COc1cc(N2CCCC2)ccc1/C=C1\C(=O)NC(=O)N(c2cccnc2)C1=O		CHEMBL1778730	>	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	6210106	CHEMBL1781229	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate at 10 uM after 60 mins by mobility shift assay	B	CC(=O)COc1ccc2c(c1)O/C(=C\c1ccc([N+](=O)[O-])cc1)C2=O		CHEMBL1778731	>	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	6210107	CHEMBL1781229	Inhibition of ALK using FL-Peptide 13, 5-FAM-KKSRGDYMTMQIG-CONH2 substrate at 10 uM after 60 mins by mobility shift assay	B	O=C1c2c(cc(O)c(O)c2O)CCCC1O		CHEMBL1778708	>	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	6262755	CHEMBL1798624	Inhibition of ALK	B	Cc1ccc(C(=O)NCCO)cc1-n1cnc(OCc2ccc(F)cc2F)c(Cl)c1=O		CHEMBL1738710	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	6264860	CHEMBL1798383	Inhibition of ALK	B	COc1cc(N2CCOCC2)ccc1Nc1ncc(Cl)c(N[C@@H]2CCCC[C@@H]2NS(C)(=O)=O)n1		CHEMBL1796241	=	IC50	nM	330.0	CHEMBL4247	Homo sapiens	IC50	nM	330.0
Not Determined	6264861	CHEMBL1798384	Inhibition of autophosphorylation of NPM-ALK in human Karpas-299 cells	B	COc1cc(N2CCOCC2)ccc1Nc1ncc(Cl)c(N[C@@H]2CCCC[C@@H]2NS(C)(=O)=O)n1		CHEMBL1796241		IC50			CHEMBL4247	Homo sapiens	IC50		
	6264863	CHEMBL1798383	Inhibition of ALK	B	COc1cc(N2CCOCC2)ccc1Nc1ncc(Cl)c(N[C@@H]2CCCC[C@H]2NS(C)(=O)=O)n1		CHEMBL1796242	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
	6264864	CHEMBL1798384	Inhibition of autophosphorylation of NPM-ALK in human Karpas-299 cells	B	COc1cc(N2CCOCC2)ccc1Nc1ncc(Cl)c(N[C@@H]2CCCC[C@H]2NS(C)(=O)=O)n1		CHEMBL1796242	=	IC50	nM	65.0	CHEMBL4247	Homo sapiens	IC50	nM	65.0
	6264866	CHEMBL1798383	Inhibition of ALK	B	COc1cc(N2CCOCC2)ccc1Nc1ncc(Cl)c(N[C@H]2CCCC[C@@H]2NS(C)(=O)=O)n1		CHEMBL1796243	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
Not Determined	6264867	CHEMBL1798384	Inhibition of autophosphorylation of NPM-ALK in human Karpas-299 cells	B	COc1cc(N2CCOCC2)ccc1Nc1ncc(Cl)c(N[C@H]2CCCC[C@@H]2NS(C)(=O)=O)n1		CHEMBL1796243		IC50			CHEMBL4247	Homo sapiens	IC50		
	6264869	CHEMBL1798383	Inhibition of ALK	B	CCN1CCc2ccc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(C)(=O)=O)n3)cc2CC1		CHEMBL1796244	=	IC50	nM	9.0	CHEMBL4247	Homo sapiens	IC50	nM	9.0
	6264870	CHEMBL1798384	Inhibition of autophosphorylation of NPM-ALK in human Karpas-299 cells	B	CCN1CCc2ccc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(C)(=O)=O)n3)cc2CC1		CHEMBL1796244	=	IC50	nM	60.0	CHEMBL4247	Homo sapiens	IC50	nM	60.0
	6264872	CHEMBL1798383	Inhibition of ALK	B	COCCN1CCc2ccc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(C)(=O)=O)n3)cc2CC1		CHEMBL1796245	=	IC50	nM	9.0	CHEMBL4247	Homo sapiens	IC50	nM	9.0
	6264873	CHEMBL1798384	Inhibition of autophosphorylation of NPM-ALK in human Karpas-299 cells	B	COCCN1CCc2ccc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(C)(=O)=O)n3)cc2CC1		CHEMBL1796245	=	IC50	nM	73.0	CHEMBL4247	Homo sapiens	IC50	nM	73.0
	6264875	CHEMBL1798383	Inhibition of ALK	B	CCN1CCc2ccc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NC(=O)C(F)(F)F)n3)cc2CC1		CHEMBL1796246	=	IC50	nM	26.0	CHEMBL4247	Homo sapiens	IC50	nM	26.0
	6264876	CHEMBL1798384	Inhibition of autophosphorylation of NPM-ALK in human Karpas-299 cells	B	CCN1CCc2ccc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NC(=O)C(F)(F)F)n3)cc2CC1		CHEMBL1796246	=	IC50	nM	200.0	CHEMBL4247	Homo sapiens	IC50	nM	200.0
	6264878	CHEMBL1798383	Inhibition of ALK	B	COCCN1CCc2ccc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NC(=O)C(F)(F)F)n3)cc2CC1		CHEMBL1796247	=	IC50	nM	22.0	CHEMBL4247	Homo sapiens	IC50	nM	22.0
	6264879	CHEMBL1798384	Inhibition of autophosphorylation of NPM-ALK in human Karpas-299 cells	B	COCCN1CCc2ccc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NC(=O)C(F)(F)F)n3)cc2CC1		CHEMBL1796247	=	IC50	nM	100.0	CHEMBL4247	Homo sapiens	IC50	nM	100.0
	6264881	CHEMBL1798383	Inhibition of ALK	B	COCCN1CCc2ccc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4N)n3)cc2CC1		CHEMBL1796248	=	IC50	nM	680.0	CHEMBL4247	Homo sapiens	IC50	nM	680.0
Not Determined	6264882	CHEMBL1798384	Inhibition of autophosphorylation of NPM-ALK in human Karpas-299 cells	B	COCCN1CCc2ccc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4N)n3)cc2CC1		CHEMBL1796248		IC50			CHEMBL4247	Homo sapiens	IC50		
	6264884	CHEMBL1798383	Inhibition of ALK	B	CCS(=O)(=O)N[C@@H]1CCCC[C@H]1Nc1nc(Nc2ccc3c(c2)CCN(CCOC)CC3)ncc1Cl		CHEMBL1796249	=	IC50	nM	50.0	CHEMBL4247	Homo sapiens	IC50	nM	50.0
Not Determined	6264885	CHEMBL1798384	Inhibition of autophosphorylation of NPM-ALK in human Karpas-299 cells	B	CCS(=O)(=O)N[C@@H]1CCCC[C@H]1Nc1nc(Nc2ccc3c(c2)CCN(CCOC)CC3)ncc1Cl		CHEMBL1796249		IC50			CHEMBL4247	Homo sapiens	IC50		
	6264887	CHEMBL1798383	Inhibition of ALK	B	COCCN1CCc2ccc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(=O)(=O)C(C)C)n3)cc2CC1		CHEMBL1796250	=	IC50	nM	130.0	CHEMBL4247	Homo sapiens	IC50	nM	130.0
Not Determined	6264888	CHEMBL1798384	Inhibition of autophosphorylation of NPM-ALK in human Karpas-299 cells	B	COCCN1CCc2ccc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(=O)(=O)C(C)C)n3)cc2CC1		CHEMBL1796250		IC50			CHEMBL4247	Homo sapiens	IC50		
	6264890	CHEMBL1798383	Inhibition of ALK	B	COCCN1CCc2ccc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(=O)(=O)CC(F)(F)F)n3)cc2CC1		CHEMBL1796251	=	IC50	nM	31.0	CHEMBL4247	Homo sapiens	IC50	nM	31.0
	6264891	CHEMBL1798384	Inhibition of autophosphorylation of NPM-ALK in human Karpas-299 cells	B	COCCN1CCc2ccc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(=O)(=O)CC(F)(F)F)n3)cc2CC1		CHEMBL1796251	=	IC50	nM	300.0	CHEMBL4247	Homo sapiens	IC50	nM	300.0
	6264893	CHEMBL1798383	Inhibition of ALK	B	COCCN1CCc2ccc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(=O)(=O)C4CC4)n3)cc2CC1		CHEMBL1796252	=	IC50	nM	110.0	CHEMBL4247	Homo sapiens	IC50	nM	110.0
Not Determined	6264894	CHEMBL1798384	Inhibition of autophosphorylation of NPM-ALK in human Karpas-299 cells	B	COCCN1CCc2ccc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(=O)(=O)C4CC4)n3)cc2CC1		CHEMBL1796252		IC50			CHEMBL4247	Homo sapiens	IC50		
	6264896	CHEMBL1798383	Inhibition of ALK	B	CCN1CCc2ccc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NC(=O)N(C)C)n3)cc2CC1		CHEMBL1795355	=	IC50	nM	370.0	CHEMBL4247	Homo sapiens	IC50	nM	370.0
Not Determined	6264897	CHEMBL1798384	Inhibition of autophosphorylation of NPM-ALK in human Karpas-299 cells	B	CCN1CCc2ccc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NC(=O)N(C)C)n3)cc2CC1		CHEMBL1795355		IC50			CHEMBL4247	Homo sapiens	IC50		
	6264899	CHEMBL1798383	Inhibition of ALK	B	CCN1CCc2ccc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NC(C)=O)n3)cc2CC1		CHEMBL1796253	=	IC50	nM	9.0	CHEMBL4247	Homo sapiens	IC50	nM	9.0
	6264900	CHEMBL1798384	Inhibition of autophosphorylation of NPM-ALK in human Karpas-299 cells	B	CCN1CCc2ccc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NC(C)=O)n3)cc2CC1		CHEMBL1796253	=	IC50	nM	65.0	CHEMBL4247	Homo sapiens	IC50	nM	65.0
	6264908	CHEMBL1799791	Inhibition of ALK at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796254	=	Inhibition	%	97.0	CHEMBL4247	Homo sapiens	INH	%	97.0
	6265585	CHEMBL1798383	Inhibition of ALK	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796254	=	IC50	nM	6.0	CHEMBL4247	Homo sapiens	IC50	nM	6.0
	6265586	CHEMBL1798384	Inhibition of autophosphorylation of NPM-ALK in human Karpas-299 cells	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796254	=	IC50	nM	65.0	CHEMBL4247	Homo sapiens	IC50	nM	65.0
	6265620	CHEMBL1798383	Inhibition of ALK	B	COCCN1CCc2ccc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4O)n3)cc2CC1		CHEMBL1796255	>	IC50	nM	3000.0	CHEMBL4247	Homo sapiens	IC50	nM	3000.0
Not Determined	6265621	CHEMBL1798384	Inhibition of autophosphorylation of NPM-ALK in human Karpas-299 cells	B	COCCN1CCc2ccc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4O)n3)cc2CC1		CHEMBL1796255		IC50			CHEMBL4247	Homo sapiens	IC50		
	6265623	CHEMBL1798383	Inhibition of ALK	B	COCCN1CCc2ccc(Nc3ncc(Cl)c(NC4CCCCC4)n3)cc2CC1		CHEMBL1796256	=	IC50	nM	78.0	CHEMBL4247	Homo sapiens	IC50	nM	78.0
Not Determined	6265624	CHEMBL1798384	Inhibition of autophosphorylation of NPM-ALK in human Karpas-299 cells	B	COCCN1CCc2ccc(Nc3ncc(Cl)c(NC4CCCCC4)n3)cc2CC1		CHEMBL1796256		IC50			CHEMBL4247	Homo sapiens	IC50		
	6265632	CHEMBL1799791	Inhibition of ALK at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4N(C)S(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796257	=	Inhibition	%	100.0	CHEMBL4247	Homo sapiens	INH	%	100.0
	6265689	CHEMBL1798383	Inhibition of ALK	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4N(C)S(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796257	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
	6265690	CHEMBL1798384	Inhibition of autophosphorylation of NPM-ALK in human Karpas-299 cells	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4N(C)S(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796257	=	IC50	nM	15.0	CHEMBL4247	Homo sapiens	IC50	nM	15.0
	6265692	CHEMBL1798383	Inhibition of ALK	B	CCN([C@@H]1CCCC[C@H]1Nc1nc(Nc2cc3c(cc2OC)CCN(CCOC)CC3)ncc1Cl)S(C)(=O)=O		CHEMBL1796258	=	IC50	nM	20.0	CHEMBL4247	Homo sapiens	IC50	nM	20.0
	6265693	CHEMBL1798384	Inhibition of autophosphorylation of NPM-ALK in human Karpas-299 cells	B	CCN([C@@H]1CCCC[C@H]1Nc1nc(Nc2cc3c(cc2OC)CCN(CCOC)CC3)ncc1Cl)S(C)(=O)=O		CHEMBL1796258	=	IC50	nM	150.0	CHEMBL4247	Homo sapiens	IC50	nM	150.0
	6265695	CHEMBL1798383	Inhibition of ALK	B	COCCN1CCc2ccc(Nc3ncc(Cl)c(N[C@H]4CC[C@H](NS(C)(=O)=O)CC4)n3)cc2CC1		CHEMBL1796259	=	IC50	nM	100.0	CHEMBL4247	Homo sapiens	IC50	nM	100.0
Not Determined	6265696	CHEMBL1798384	Inhibition of autophosphorylation of NPM-ALK in human Karpas-299 cells	B	COCCN1CCc2ccc(Nc3ncc(Cl)c(N[C@H]4CC[C@H](NS(C)(=O)=O)CC4)n3)cc2CC1		CHEMBL1796259		IC50			CHEMBL4247	Homo sapiens	IC50		
	6265698	CHEMBL1798383	Inhibition of ALK	B	COCCN1CCc2ccc(Nc3ncc(Cl)c(N[C@H]4CC[C@@H](NS(C)(=O)=O)CC4)n3)cc2CC1		CHEMBL1796260	=	IC50	nM	220.0	CHEMBL4247	Homo sapiens	IC50	nM	220.0
Not Determined	6265699	CHEMBL1798384	Inhibition of autophosphorylation of NPM-ALK in human Karpas-299 cells	B	COCCN1CCc2ccc(Nc3ncc(Cl)c(N[C@H]4CC[C@@H](NS(C)(=O)=O)CC4)n3)cc2CC1		CHEMBL1796260		IC50			CHEMBL4247	Homo sapiens	IC50		
	6265701	CHEMBL1798383	Inhibition of ALK	B	COCCN1CCc2ccc(Nc3ncc(Cl)c(N[C@@H]4CCC[C@@H](NS(C)(=O)=O)C4)n3)cc2CC1		CHEMBL1796261	>	IC50	nM	3000.0	CHEMBL4247	Homo sapiens	IC50	nM	3000.0
Not Determined	6265702	CHEMBL1798384	Inhibition of autophosphorylation of NPM-ALK in human Karpas-299 cells	B	COCCN1CCc2ccc(Nc3ncc(Cl)c(N[C@@H]4CCC[C@@H](NS(C)(=O)=O)C4)n3)cc2CC1		CHEMBL1796261		IC50			CHEMBL4247	Homo sapiens	IC50		
	6265704	CHEMBL1798383	Inhibition of ALK	B	COCCN1CCc2ccc(Nc3ncc(Cl)c(N[C@@H]4CCC[C@H](NS(C)(=O)=O)C4)n3)cc2CC1		CHEMBL1796262	>	IC50	nM	3000.0	CHEMBL4247	Homo sapiens	IC50	nM	3000.0
Not Determined	6265705	CHEMBL1798384	Inhibition of autophosphorylation of NPM-ALK in human Karpas-299 cells	B	COCCN1CCc2ccc(Nc3ncc(Cl)c(N[C@@H]4CCC[C@H](NS(C)(=O)=O)C4)n3)cc2CC1		CHEMBL1796262		IC50			CHEMBL4247	Homo sapiens	IC50		
	6301964	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	CCOC(=O)/C=C/c1c(Oc2ccc(F)cc2)nc[nH]c1=O		CHEMBL1807766	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6301965	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	CC(=O)/C=C/c1c(Oc2ccc(C(C)(C)C)cc2)nc[nH]c1=O		CHEMBL1807761	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6301966	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	CC(=O)/C=C/c1c(Oc2ccc(F)cc2)nc[nH]c1=O		CHEMBL1807765	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6301967	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	CCOC(=O)/C=C/c1c(Oc2ccc(C)cc2)nc[nH]c1=O		CHEMBL1807760	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6301968	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	CCOC(=O)/C=C/c1c(Oc2ccccc2Cl)nc[nH]c1=O		CHEMBL1807764	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6301969	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	CC(=O)/C=C/c1c(Oc2ccc(C)cc2)nc[nH]c1=O		CHEMBL1807759	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6301970	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	CC(=O)/C=C/c1c(Oc2ccccc2Cl)nc[nH]c1=O		CHEMBL1807763	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6301971	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	CCOC(=O)/C=C/c1c(Oc2cccc(C(=O)OC)c2)nc[nH]c1=O		CHEMBL1807758	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6301972	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	CCOC(=O)/C=C/c1c(Oc2ccc(C(C)(C)C)cc2)nc[nH]c1=O		CHEMBL1807762	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6301973	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	COC(=O)c1cccc(Oc2nc[nH]c(=O)c2/C=C/C(C)=O)c1		CHEMBL1807757	=	IC50	nM	3030.0	CHEMBL4247	Homo sapiens	IC50	uM	3.03
	6301974	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	COC(=O)c1cc(OC)ccc1Oc1nc[nH]c(=O)c1/C=C/C(C)=O		CHEMBL1807767	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6301975	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	CCOC(=O)/C=C/c1c(Oc2ccc(OC)cc2C(=O)OC)nc[nH]c1=O		CHEMBL1807768	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6301976	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	COc1cccc(OC)c1Oc1nc[nH]c(=O)c1/C=C/C(C)=O		CHEMBL1807769	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6301977	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	CCOC(=O)/C=C/c1c(Oc2c(OC)cccc2OC)nc[nH]c1=O		CHEMBL1807770	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6301978	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	CC(=O)/C=C/c1c(Oc2cccc(C#N)c2)nc[nH]c1=O		CHEMBL1807771	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6301979	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	CCOC(=O)/C=C/c1c(Oc2cccc(C#N)c2)nc[nH]c1=O		CHEMBL1807772	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6301980	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	COc1cc(Cl)ccc1Oc1nc[nH]c(=O)c1/C=C/C(C)=O		CHEMBL1808087	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6301981	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	CCOC(=O)/C=C/c1c(Oc2ccc(Cl)cc2OC)nc[nH]c1=O		CHEMBL1808088	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6301982	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	COc1cccc(Oc2nc[nH]c(=O)c2/C=C/C(C)=O)c1		CHEMBL1808089	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6301983	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	CCOC(=O)/C=C/c1c(Oc2cccc(OC)c2)nc[nH]c1=O		CHEMBL1808090	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6301984	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	CC(=O)/C=C/c1c(Oc2c(Cl)cccc2Cl)nc[nH]c1=O		CHEMBL1808091	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6301985	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	CCOC(=O)/C=C/c1c(Oc2c(Cl)cccc2Cl)nc[nH]c1=O		CHEMBL1808092	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6301986	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	600.0	CHEMBL4247	Homo sapiens	IC50	uM	0.6
	6301987	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	CC(=O)/C=C/c1c(Oc2ccc(NC(C)=O)cc2)nc[nH]c1=O		CHEMBL1808093	=	IC50	nM	6640.0	CHEMBL4247	Homo sapiens	IC50	uM	6.64
	6301988	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	CC(=O)/C=C/c1c(Oc2cccc(C(C)=O)c2)nc[nH]c1=O		CHEMBL1808094	=	IC50	nM	6250.0	CHEMBL4247	Homo sapiens	IC50	uM	6.25
	6301989	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	CC(=O)/C=C/c1c(Oc2ccc(O)cc2)nc[nH]c1=O		CHEMBL1808095	=	IC50	nM	7570.0	CHEMBL4247	Homo sapiens	IC50	uM	7.57
	6301990	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	CC(=O)/C=C/c1c(Oc2ccc(C#N)cc2)nc[nH]c1=O		CHEMBL1808096	=	IC50	nM	6910.0	CHEMBL4247	Homo sapiens	IC50	uM	6.91
	6301991	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	COc1cc(Oc2nc[nH]c(=O)c2/C=C/C(C)=O)c(C(C)=O)cc1OC		CHEMBL1808097	=	IC50	nM	7540.0	CHEMBL4247	Homo sapiens	IC50	uM	7.54
	6301992	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	CC(=O)/C=C/c1c(Oc2ccccc2C(C)=O)nc[nH]c1=O		CHEMBL1808098	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6301993	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	CC(=O)/C=C/c1c(Oc2ccc(C(C)=O)c(F)c2)nc[nH]c1=O		CHEMBL1808099	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6301994	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	COC(=O)c1ccc(OC)cc1Oc1nc[nH]c(=O)c1/C=C/C(C)=O		CHEMBL1808100	=	IC50	nM	10180.0	CHEMBL4247	Homo sapiens	IC50	uM	10.18
	6301995	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	CC(=O)/C=C/c1c(Oc2ccc(C)cc2C(C)=O)nc[nH]c1=O		CHEMBL1808101	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6301996	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	CCOC(=O)c1ccccc1Oc1nc[nH]c(=O)c1/C=C/C(C)=O		CHEMBL1808102	=	IC50	nM	7540.0	CHEMBL4247	Homo sapiens	IC50	uM	7.54
	6301997	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	CC(=O)/C=C/c1c(Oc2c(C)cc(C(C)=O)cc2C)nc[nH]c1=O		CHEMBL1808103	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6301998	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	COC(=O)c1cc(Cl)ccc1Oc1nc[nH]c(=O)c1/C=C/C(C)=O		CHEMBL1808104	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6301999	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	CCCCCCOC(=O)c1ccccc1Oc1nc[nH]c(=O)c1/C=C/C(C)=O		CHEMBL1808105	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6302000	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	CCOC(=O)c1ccc(Oc2nc[nH]c(=O)c2/C=C/C(C)=O)cc1		CHEMBL1808106	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6302001	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	CC(=O)/C=C/c1c(Oc2cc(C(F)(F)F)ccc2Cl)nc[nH]c1=O		CHEMBL1808107	=	IC50	nM	9870.0	CHEMBL4247	Homo sapiens	IC50	uM	9.87
	6302002	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	COC(=O)c1cccc(Oc2nc[nH]c(=O)c2CCC(C)=O)c1		CHEMBL1808108	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6302003	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	COC(=O)c1cccc(Oc2nc[nH]c(=O)c2C2CC(C)=NN2C(C)=O)c1		CHEMBL1806514	=	IC50	nM	9000.0	CHEMBL4247	Homo sapiens	IC50	uM	9.0
	6302004	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	COC(=O)c1cccc(Oc2nc[nH]c(=O)c2C2CC(C)=NN2C)c1		CHEMBL1808220	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6302005	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	COC(=O)c1cccc(Oc2nc[nH]c(=O)c2C2CC(C)=NN2)c1		CHEMBL1808221	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6302006	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	COC(=O)c1cccc(Oc2nc[nH]c(=O)c2-c2ccncc2)c1		CHEMBL1808222	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6302007	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	COC(=O)c1cccc(Oc2nc[nH]c(=O)c2-c2cccc(N)c2)c1		CHEMBL1808223	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6302008	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	COC(=O)c1cccc(Oc2nc[nH]c(=O)c2-c2cccc(OC)c2)c1		CHEMBL1808224	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6302009	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	COC(=O)c1cccc(Oc2nc[nH]c(=O)c2-c2ccccc2)c1		CHEMBL1808225	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
	6302010	CHEMBL1810103	Inhibition of 6xHis-tagged NPM-ALK using biotinylated-poly(GT) peptide as substrate after 60 mins	B	COC(=O)c1cccc(Oc2nc[nH]c(=O)c2-c2cccc(C)c2)c1		CHEMBL1808226	>	IC50	nM	40000.0	CHEMBL4247	Homo sapiens	IC50	uM	40.0
Not Active	6307603	CHEMBL1816863	Inhibition of recombinant ALK assessed as 33Pi incorporation after 60 mins by scintillation counting	B	C=C[C@]1(C)C=C2[C@@H](O)[C@@H]3OC(=O)[C@@]4(C)CC[C@H]5C[C@]5([C@@H]34)[C@@]2(O)C(=O)C1		CHEMBL1812030		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Not Active	6307604	CHEMBL1816863	Inhibition of recombinant ALK assessed as 33Pi incorporation after 60 mins by scintillation counting	B	C=C[C@@]1(C)C=C2C(=O)C(O)=C3[C@](C)(C(=O)O)CC[C@@H]4C[C@]34[C@]2(O)C(=O)C1		CHEMBL516554		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	6307605	CHEMBL1816863	Inhibition of recombinant ALK assessed as 33Pi incorporation after 60 mins by scintillation counting	B	Cc1cc(O)cc2oc3cc(O)cc(O)c3c(=O)c12		CHEMBL466154	=	IC50	nM	41300.0	CHEMBL4247	Homo sapiens	IC50	uM	41.3
	6307606	CHEMBL1816863	Inhibition of recombinant ALK assessed as 33Pi incorporation after 60 mins by scintillation counting	B	Cc1c(O)c(O)cc2oc3cc(O)cc(O)c3c(=O)c12		CHEMBL454440	=	IC50	nM	1100.0	CHEMBL4247	Homo sapiens	IC50	uM	1.1
	6339279	CHEMBL1828297	Inhibition of ALK activity by TR-FRET assay	B	CC1(C)c2cc(N3CCN(C4COC4)CC3)c(CCC3CCCC3)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL1823361	=	IC50	nM	186.0	CHEMBL4247	Homo sapiens	IC50	nM	186.0
	6339280	CHEMBL1828297	Inhibition of ALK activity by TR-FRET assay	B	CC(C)c1cc2c(cc1N1CCN(C3COC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1823223	=	IC50	nM	66.4	CHEMBL4247	Homo sapiens	IC50	nM	66.4
	6339281	CHEMBL1828297	Inhibition of ALK activity by TR-FRET assay	B	CCCc1cc2c(cc1N1CCN(C3COC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1823222	=	IC50	nM	15.1	CHEMBL4247	Homo sapiens	IC50	nM	15.1
	6339282	CHEMBL1828297	Inhibition of ALK activity by TR-FRET assay	B	CCc1cc2c(cc1N1CCN(C3COC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1823221	=	IC50	nM	2.9	CHEMBL4247	Homo sapiens	IC50	nM	2.9
	6339283	CHEMBL1828297	Inhibition of ALK activity by TR-FRET assay	B	C#Cc1cc2c(cc1N1CCN(C3COC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1823220	=	IC50	nM	2.7	CHEMBL4247	Homo sapiens	IC50	nM	2.7
	6339284	CHEMBL1828297	Inhibition of ALK activity by TR-FRET assay	B	Cc1cc2c(cc1N1CCN(C3COC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1823219	=	IC50	nM	10.6	CHEMBL4247	Homo sapiens	IC50	nM	10.6
	6339285	CHEMBL1828297	Inhibition of ALK activity by TR-FRET assay	B	CC1(C)c2cc(N3CCN(C4COC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL1779201	=	IC50	nM	27.0	CHEMBL4247	Homo sapiens	IC50	nM	27.0
	6339286	CHEMBL1828297	Inhibition of ALK activity by TR-FRET assay	B	CC1(C)c2cc(C3CCN(C4COC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL1779202	=	IC50	nM	1.5	CHEMBL4247	Homo sapiens	IC50	nM	1.5
	6341017	CHEMBL1827642	Activity of ALK kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL4247	Homo sapiens	Activity	%	100.0
	6348221	CHEMBL1825977	Inhibition of human recombinant ALK assessed as phosphorylated product using PLC-gamma/GST substrate by modified ELISA method	B	COc1cc(Nc2ncc3ccc(-c4ccccc4)n3n2)cc(OC)c1OC		CHEMBL1822511	=	IC50	nM	212.0	CHEMBL4247	Homo sapiens	IC50	nM	212.0
	6348222	CHEMBL1825977	Inhibition of human recombinant ALK assessed as phosphorylated product using PLC-gamma/GST substrate by modified ELISA method	B	c1ccc(-c2ccc3cnc(Nc4ccc(N5CCOCC5)cc4)nn23)cc1		CHEMBL1822512	>	IC50	nM	2000.0	CHEMBL4247	Homo sapiens	IC50	nM	2000.0
	6348223	CHEMBL1825977	Inhibition of human recombinant ALK assessed as phosphorylated product using PLC-gamma/GST substrate by modified ELISA method	B	CN1CCN(c2ccc(Nc3ncc4ccc(-c5ccccc5)n4n3)cc2)CC1		CHEMBL1822513	=	IC50	nM	48.0	CHEMBL4247	Homo sapiens	IC50	nM	48.0
	6348224	CHEMBL1825977	Inhibition of human recombinant ALK assessed as phosphorylated product using PLC-gamma/GST substrate by modified ELISA method	B	COCCN1CCc2ccc(Nc3ncc4ccc(-c5ccccc5)n4n3)cc2CC1		CHEMBL1822514	=	IC50	nM	38.0	CHEMBL4247	Homo sapiens	IC50	nM	38.0
	6348225	CHEMBL1825977	Inhibition of human recombinant ALK assessed as phosphorylated product using PLC-gamma/GST substrate by modified ELISA method	B	COc1ccccc1-c1ccc2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nn12		CHEMBL1822515	=	IC50	nM	20.0	CHEMBL4247	Homo sapiens	IC50	nM	20.0
	6348226	CHEMBL1825977	Inhibition of human recombinant ALK assessed as phosphorylated product using PLC-gamma/GST substrate by modified ELISA method	B	CN1CCN(c2ccc(Nc3ncc4ccc(-c5ccccc5C(N)=O)n4n3)cc2)CC1		CHEMBL1822516	=	IC50	nM	726.0	CHEMBL4247	Homo sapiens	IC50	nM	726.0
	6348227	CHEMBL1825977	Inhibition of human recombinant ALK assessed as phosphorylated product using PLC-gamma/GST substrate by modified ELISA method	B	CN1CCN(c2ccc(Nc3ncc4ccc(-c5ccccc5S(C)(=O)=O)n4n3)cc2)CC1		CHEMBL1822517	=	IC50	nM	883.0	CHEMBL4247	Homo sapiens	IC50	nM	883.0
	6348228	CHEMBL1825977	Inhibition of human recombinant ALK assessed as phosphorylated product using PLC-gamma/GST substrate by modified ELISA method	B	CN1CCN(c2ccc(Nc3ncc4ccc(-c5ccccc5NS(C)(=O)=O)n4n3)cc2)CC1		CHEMBL1822518	=	IC50	nM	260.0	CHEMBL4247	Homo sapiens	IC50	nM	260.0
	6348229	CHEMBL1825977	Inhibition of human recombinant ALK assessed as phosphorylated product using PLC-gamma/GST substrate by modified ELISA method	B	CN1CCN(c2ccc(Nc3ncc4ccc(-c5ccccc5N(C)S(C)(=O)=O)n4n3)cc2)CC1		CHEMBL1821735	=	IC50	nM	7.0	CHEMBL4247	Homo sapiens	IC50	nM	7.0
	6349164	CHEMBL1825977	Inhibition of human recombinant ALK assessed as phosphorylated product using PLC-gamma/GST substrate by modified ELISA method	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL1822519	=	IC50	nM	9.0	CHEMBL4247	Homo sapiens	IC50	nM	9.0
	6349165	CHEMBL1825977	Inhibition of human recombinant ALK assessed as phosphorylated product using PLC-gamma/GST substrate by modified ELISA method	B	COc1cc(N2CCN(C[C@H](C)O)CC2)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL1822520	=	IC50	nM	5.0	CHEMBL4247	Homo sapiens	IC50	nM	5.0
	6349166	CHEMBL1825977	Inhibition of human recombinant ALK assessed as phosphorylated product using PLC-gamma/GST substrate by modified ELISA method	B	COc1cc(N2CCN(C[C@@H](C)O)CC2)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL1822521	=	IC50	nM	3.8	CHEMBL4247	Homo sapiens	IC50	nM	3.8
	6349167	CHEMBL1825977	Inhibition of human recombinant ALK assessed as phosphorylated product using PLC-gamma/GST substrate by modified ELISA method	B	COc1cc(N2CCN(N3CCOCC3)CC2)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL1822522	=	IC50	nM	9.0	CHEMBL4247	Homo sapiens	IC50	nM	9.0
	6349168	CHEMBL1825977	Inhibition of human recombinant ALK assessed as phosphorylated product using PLC-gamma/GST substrate by modified ELISA method	B	COc1cc(N2CCN(N3CCN(C)CC3)CC2)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL1822523	=	IC50	nM	8.8	CHEMBL4247	Homo sapiens	IC50	nM	8.8
	6349169	CHEMBL1825977	Inhibition of human recombinant ALK assessed as phosphorylated product using PLC-gamma/GST substrate by modified ELISA method	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2ccc(-c3ccccc3N(C)S(C)(=O)=O)n2n1		CHEMBL1822524	=	IC50	nM	9.0	CHEMBL4247	Homo sapiens	IC50	nM	9.0
	6349170	CHEMBL1825977	Inhibition of human recombinant ALK assessed as phosphorylated product using PLC-gamma/GST substrate by modified ELISA method	B	COc1cc(N2CCN(C[C@H](C)O)CC2)ccc1Nc1ncc2ccc(-c3ccccc3N(C)S(C)(=O)=O)n2n1		CHEMBL1822525	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
	6349171	CHEMBL1825977	Inhibition of human recombinant ALK assessed as phosphorylated product using PLC-gamma/GST substrate by modified ELISA method	B	COc1cc(N2CCN(C[C@@H](C)O)CC2)ccc1Nc1ncc2ccc(-c3ccccc3N(C)S(C)(=O)=O)n2n1		CHEMBL1822526	=	IC50	nM	15.0	CHEMBL4247	Homo sapiens	IC50	nM	15.0
	6349172	CHEMBL1825977	Inhibition of human recombinant ALK assessed as phosphorylated product using PLC-gamma/GST substrate by modified ELISA method	B	COc1cc(N2CCC(N3CCOCC3)CC2)ccc1Nc1ncc2ccc(-c3ccccc3N(C)S(C)(=O)=O)n2n1		CHEMBL1822527	=	IC50	nM	7.0	CHEMBL4247	Homo sapiens	IC50	nM	7.0
	6350145	CHEMBL1825356	Inhibition of ALK in human KARPAS299 cells assessed as growth factor-induced autophosphorylation by sandwich ELISA method	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	20.0	CHEMBL4247	Homo sapiens	IC50	nM	20.0
	6350146	CHEMBL1825357	Inhibition of ALK at 1 uM	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Inhibition	%	99.0	CHEMBL4247	Homo sapiens	INH	%	99.0
	6350147	CHEMBL1825358	Inhibition of ALK	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	<	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	nM	1.0
	6375432	CHEMBL1840248	Inhibition of ALK at 1 uM by radiometric assay	B	CC1(C)[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)NCCNC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)CC[C@]3(C)CC[C@]21C		CHEMBL1836927	=	Inhibition	%	69.0	CHEMBL4247	Homo sapiens	INH	%	69.0
	6386371	CHEMBL1840402	Inhibition of recombinant ALK	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	6387488	CHEMBL1839963	Inhibition of ALK juxtamembrane domain-mediated proliferation of mouse BAF3 cells transformed with TEL-Kinase construct	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	=	IC50	nM	3078.0	CHEMBL4247	Homo sapiens	IC50	nM	3078.0
	7567342	CHEMBL1908641	Binding constant for ALK kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	2300.0	CHEMBL4247	Homo sapiens	Kd	nM	2300.0
	7567801	CHEMBL1908641	Binding constant for ALK kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7568298	CHEMBL1908641	Binding constant for ALK kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7568730	CHEMBL1908641	Binding constant for ALK kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	490.0	CHEMBL4247	Homo sapiens	Kd	nM	490.0
	7569315	CHEMBL1908641	Binding constant for ALK kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7569805	CHEMBL1908641	Binding constant for ALK kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7570268	CHEMBL1908641	Binding constant for ALK kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	2700.0	CHEMBL4247	Homo sapiens	Kd	nM	2700.0
	7570695	CHEMBL1908641	Binding constant for ALK kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	170.0	CHEMBL4247	Homo sapiens	Kd	nM	170.0
	7571291	CHEMBL1908641	Binding constant for ALK kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	Kd	nM	160.0	CHEMBL4247	Homo sapiens	Kd	nM	160.0
	7571306	CHEMBL1908641	Binding constant for ALK kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	3.3	CHEMBL4247	Homo sapiens	Kd	nM	3.3
	7571782	CHEMBL1908641	Binding constant for ALK kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	1500.0	CHEMBL4247	Homo sapiens	Kd	nM	1500.0
	7572245	CHEMBL1908641	Binding constant for ALK kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7572661	CHEMBL1908641	Binding constant for ALK kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	1.1	CHEMBL4247	Homo sapiens	Kd	nM	1.1
	7573287	CHEMBL1908641	Binding constant for ALK kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7573763	CHEMBL1908641	Binding constant for ALK kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	840.0	CHEMBL4247	Homo sapiens	Kd	nM	840.0
	7574232	CHEMBL1908641	Binding constant for ALK kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	270.0	CHEMBL4247	Homo sapiens	Kd	nM	270.0
	7574640	CHEMBL1908641	Binding constant for ALK kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7574808	CHEMBL1908641	Binding constant for ALK kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	31.0	CHEMBL4247	Homo sapiens	Kd	nM	31.0
	7575269	CHEMBL1908641	Binding constant for ALK kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	1200.0	CHEMBL4247	Homo sapiens	Kd	nM	1200.0
	7575740	CHEMBL1908641	Binding constant for ALK kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7576205	CHEMBL1908641	Binding constant for ALK kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7576613	CHEMBL1908641	Binding constant for ALK kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	650.0	CHEMBL4247	Homo sapiens	Kd	nM	650.0
	7576782	CHEMBL1908641	Binding constant for ALK kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7577241	CHEMBL1908641	Binding constant for ALK kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	69.0	CHEMBL4247	Homo sapiens	Kd	nM	69.0
	7577719	CHEMBL1908641	Binding constant for ALK kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	660.0	CHEMBL4247	Homo sapiens	Kd	nM	660.0
	7578189	CHEMBL1908641	Binding constant for ALK kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	1100.0	CHEMBL4247	Homo sapiens	Kd	nM	1100.0
	7578594	CHEMBL1908641	Binding constant for ALK kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	2100.0	CHEMBL4247	Homo sapiens	Kd	nM	2100.0
	7578790	CHEMBL1908641	Binding constant for ALK kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7579164	CHEMBL1908641	Binding constant for ALK kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7579614	CHEMBL1908641	Binding constant for ALK kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	670.0	CHEMBL4247	Homo sapiens	Kd	nM	670.0
	7580088	CHEMBL1908641	Binding constant for ALK kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7581148	CHEMBL1908641	Binding constant for ALK kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7581533	CHEMBL1908641	Binding constant for ALK kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7581978	CHEMBL1908641	Binding constant for ALK kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7582471	CHEMBL1908641	Binding constant for ALK kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7582871	CHEMBL1908641	Binding constant for ALK kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	3100.0	CHEMBL4247	Homo sapiens	Kd	nM	3100.0
	7583494	CHEMBL1908641	Binding constant for ALK kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	1600.0	CHEMBL4247	Homo sapiens	Kd	nM	1600.0
	7583891	CHEMBL1908641	Binding constant for ALK kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7584336	CHEMBL1908641	Binding constant for ALK kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7584365	CHEMBL1908641	Binding constant for ALK kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7584827	CHEMBL1908641	Binding constant for ALK kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	240.0	CHEMBL4247	Homo sapiens	Kd	nM	240.0
	7585231	CHEMBL1908641	Binding constant for ALK kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7585824	CHEMBL1908641	Binding constant for ALK kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7586232	CHEMBL1908641	Binding constant for ALK kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7586707	CHEMBL1908641	Binding constant for ALK kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7587161	CHEMBL1908641	Binding constant for ALK kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7587785	CHEMBL1908641	Binding constant for ALK kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7588215	CHEMBL1908641	Binding constant for ALK kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7588686	CHEMBL1908641	Binding constant for ALK kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7589137	CHEMBL1908641	Binding constant for ALK kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7589732	CHEMBL1908641	Binding constant for ALK kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	71.0	CHEMBL4247	Homo sapiens	Kd	nM	71.0
	7590199	CHEMBL1908641	Binding constant for ALK kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	=	Kd	nM	0.55	CHEMBL4247	Homo sapiens	Kd	nM	0.55
	7590673	CHEMBL1908641	Binding constant for ALK kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7591124	CHEMBL1908641	Binding constant for ALK kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7591281	CHEMBL1908641	Binding constant for ALK kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7591703	CHEMBL1908641	Binding constant for ALK kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	3500.0	CHEMBL4247	Homo sapiens	Kd	nM	3500.0
	7592175	CHEMBL1908641	Binding constant for ALK kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7592648	CHEMBL1908641	Binding constant for ALK kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7593101	CHEMBL1908641	Binding constant for ALK kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	690.0	CHEMBL4247	Homo sapiens	Kd	nM	690.0
	7593248	CHEMBL1908641	Binding constant for ALK kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	1400.0	CHEMBL4247	Homo sapiens	Kd	nM	1400.0
	7593683	CHEMBL1908641	Binding constant for ALK kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7594155	CHEMBL1908641	Binding constant for ALK kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7594628	CHEMBL1908641	Binding constant for ALK kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7595216	CHEMBL1908641	Binding constant for ALK kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7595660	CHEMBL1908641	Binding constant for ALK kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	7700.0	CHEMBL4247	Homo sapiens	Kd	nM	7700.0
	7596134	CHEMBL1908641	Binding constant for ALK kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7596605	CHEMBL1908641	Binding constant for ALK kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	2200.0	CHEMBL4247	Homo sapiens	Kd	nM	2200.0
	7596610	CHEMBL1908641	Binding constant for ALK kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7597188	CHEMBL1908641	Binding constant for ALK kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7597641	CHEMBL1908641	Binding constant for ALK kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7598114	CHEMBL1908641	Binding constant for ALK kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	7598584	CHEMBL1908641	Binding constant for ALK kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	32.0	CHEMBL4247	Homo sapiens	Kd	nM	32.0
	7841903	CHEMBL1913894	Inhibition of ALK using biotinylated substrate preincubated for 15 mins before substrate addition measured after 30 mins by fluorescence microplate analysis	B	Cl.N=C(N)N/N=C\c1c(-c2ccc([N+](=O)[O-])cc2)nc2sc(Br)cn12		CHEMBL1910608	>	IC50	nM	20000.0	CHEMBL4247	Homo sapiens	IC50	nM	20000.0
	7841909	CHEMBL1913894	Inhibition of ALK using biotinylated substrate preincubated for 15 mins before substrate addition measured after 30 mins by fluorescence microplate analysis	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	54.64	CHEMBL4247	Homo sapiens	IC50	nM	54.64
	7841923	CHEMBL1913894	Inhibition of ALK using biotinylated substrate preincubated for 15 mins before substrate addition measured after 30 mins by fluorescence microplate analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	2.36	CHEMBL4247	Homo sapiens	IC50	nM	2.36
	7922739	CHEMBL1919420	Inhibition of human recombinant ALK at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12	Outside typical range	CHEMBL1915438	=	Inhibition	%	-15.0	CHEMBL4247	Homo sapiens	INH	%	-15.0
	7939622	CHEMBL1921400	Inhibition of human ALK	B	[O-][n+]1ccc2c(-c3ccc(F)cc3Cl)ccnc2c1-c1c(Cl)cccc1Cl		CHEMBL1916359	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	7943722	CHEMBL1921565	Inhibition of Alk	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
	7943762	CHEMBL1921419	Inhibition of Alk at 10 uM	B	O=C1CC(c2cccc(NC(=O)c3ccc(Cl)c(C(F)(F)F)c3)c2)=Nc2cnn(Cc3ccccc3)c2N1		CHEMBL1917776	=	Inhibition	%	0.0	CHEMBL4247	Homo sapiens	INH	%	0.0
	7951032	CHEMBL1925015	Inhibition of ALK	B	CCOc1cccc2c1c(/C=C1\C(=O)NN=C1c1snnc1C)cn2C		CHEMBL398610	=	IC50	nM	47.0	CHEMBL4247	Homo sapiens	IC50	nM	47.0
	7951033	CHEMBL1925061	Inhibition of nucleophosmin-fused ALK autophosphorylation in human Karpas299 cells	B	CCOc1cccc2c1c(/C=C1\C(=O)NN=C1c1snnc1C)cn2C		CHEMBL398610	=	IC50	nM	300.0	CHEMBL4247	Homo sapiens	IC50	nM	300.0
	7951035	CHEMBL1925015	Inhibition of ALK	B	Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2cccc(OCc3ccccc3)c12		CHEMBL1922961	=	IC50	nM	23.0	CHEMBL4247	Homo sapiens	IC50	nM	23.0
	7951036	CHEMBL1925015	Inhibition of ALK	B	Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2cccc(OCc3ccccn3)c12		CHEMBL1922962	=	IC50	nM	158.0	CHEMBL4247	Homo sapiens	IC50	nM	158.0
	7951037	CHEMBL1925015	Inhibition of ALK	B	Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2cccc(OCc3cccnc3)c12		CHEMBL1922963	=	IC50	nM	34.0	CHEMBL4247	Homo sapiens	IC50	nM	34.0
	7951038	CHEMBL1925015	Inhibition of ALK	B	Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2cccc(OCc3ccncc3)c12		CHEMBL1922964	=	IC50	nM	55.0	CHEMBL4247	Homo sapiens	IC50	nM	55.0
	7951039	CHEMBL1925015	Inhibition of ALK	B	Cc1nc(COc2cccc3c2c(/C=C2\C(=O)NN=C2c2snnc2C)cn3C)cs1		CHEMBL1922965	=	IC50	nM	2999.0	CHEMBL4247	Homo sapiens	IC50	nM	2999.0
	7951040	CHEMBL1925015	Inhibition of ALK	B	Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2cccc(OCCN(C)C)c12		CHEMBL1922966	=	IC50	nM	291.0	CHEMBL4247	Homo sapiens	IC50	nM	291.0
	7951041	CHEMBL1925015	Inhibition of ALK	B	Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2cccc(OCc3ccccc3F)c12		CHEMBL1922967	=	IC50	nM	13.0	CHEMBL4247	Homo sapiens	IC50	nM	13.0
	7951042	CHEMBL1925015	Inhibition of ALK	B	Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2cccc(OCc3cccc(F)c3)c12		CHEMBL1922968	=	IC50	nM	20.0	CHEMBL4247	Homo sapiens	IC50	nM	20.0
	7951043	CHEMBL1925015	Inhibition of ALK	B	Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2cccc(OCc3ccc(F)cc3)c12		CHEMBL1922969	=	IC50	nM	12.0	CHEMBL4247	Homo sapiens	IC50	nM	12.0
	7951044	CHEMBL1925015	Inhibition of ALK	B	Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2cccc(OCc3c(F)cccc3F)c12		CHEMBL1922970	=	IC50	nM	12.0	CHEMBL4247	Homo sapiens	IC50	nM	12.0
	7951045	CHEMBL1925015	Inhibition of ALK	B	Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2cccc(OCc3ccc(F)cc3F)c12		CHEMBL1922971	=	IC50	nM	12.0	CHEMBL4247	Homo sapiens	IC50	nM	12.0
	7951046	CHEMBL1925015	Inhibition of ALK	B	Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2cccc(OCc3c(F)cccc3Cl)c12		CHEMBL1922972	=	IC50	nM	21.0	CHEMBL4247	Homo sapiens	IC50	nM	21.0
	7951047	CHEMBL1925015	Inhibition of ALK	B	Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2cccc(OCc3c(F)ccc(F)c3Cl)c12		CHEMBL1922973	=	IC50	nM	14.0	CHEMBL4247	Homo sapiens	IC50	nM	14.0
	7951048	CHEMBL1925015	Inhibition of ALK	B	Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2cccc(OCc3c(F)ccc(Cl)c3F)c12		CHEMBL1922974	=	IC50	nM	5.0	CHEMBL4247	Homo sapiens	IC50	nM	5.0
	7951049	CHEMBL1925015	Inhibition of ALK	B	Cn1cc(/C=C2\C(=O)NN=C2c2cccnc2)c2c(OCc3ccccc3)cccc21		CHEMBL1922975	=	IC50	nM	54.0	CHEMBL4247	Homo sapiens	IC50	nM	54.0
	7951050	CHEMBL1925015	Inhibition of ALK	B	Cn1cc(/C=C2\C(=O)NN=C2c2nccs2)c2c(OCc3ccccc3)cccc21		CHEMBL1922976	=	IC50	nM	46.0	CHEMBL4247	Homo sapiens	IC50	nM	46.0
	7951051	CHEMBL1925015	Inhibition of ALK	B	Cn1cc(/C=C2\C(=O)NN=C2c2nc(C(F)(F)F)cs2)c2c(OCc3ccccc3)cccc21		CHEMBL1922977	=	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	7951052	CHEMBL1925015	Inhibition of ALK	B	CN(C)c1nnc(C2=NNC(=O)/C2=C\c2cn(C)c3cccc(OCc4ccccc4)c23)s1		CHEMBL1922978	=	IC50	nM	4600.0	CHEMBL4247	Homo sapiens	IC50	uM	4.6
	7951053	CHEMBL1925015	Inhibition of ALK	B	Cn1cc(/C=C2\C(=O)NN=C2c2cccs2)c2c(OCc3ccccc3)cccc21		CHEMBL1922979	=	IC50	nM	104.0	CHEMBL4247	Homo sapiens	IC50	nM	104.0
	7951054	CHEMBL1925015	Inhibition of ALK	B	Cn1cc(/C=C2\C(=O)NN=C2c2nccs2)c2c(OCc3ccccc3F)cccc21		CHEMBL1922980	=	IC50	nM	46.0	CHEMBL4247	Homo sapiens	IC50	nM	46.0
	7951055	CHEMBL1925015	Inhibition of ALK	B	Cn1cc(/C=C2\C(=O)NN=C2c2nccs2)c2c(OCc3cccc(F)c3)cccc21		CHEMBL1922981	=	IC50	nM	25.0	CHEMBL4247	Homo sapiens	IC50	nM	25.0
	7951056	CHEMBL1925015	Inhibition of ALK	B	Cn1cc(/C=C2\C(=O)NN=C2c2nccs2)c2c(OCc3ccc(F)cc3)cccc21		CHEMBL1922982	=	IC50	nM	63.0	CHEMBL4247	Homo sapiens	IC50	nM	63.0
	7951057	CHEMBL1925015	Inhibition of ALK	B	CC(Oc1cccc2c1c(/C=C1\C(=O)NN=C1c1nccs1)cn2C)c1ccccc1		CHEMBL1922983	=	IC50	nM	42.0	CHEMBL4247	Homo sapiens	IC50	nM	42.0
	7951058	CHEMBL1925015	Inhibition of ALK	B	Cn1cc(/C=C2\C(=O)NN=C2c2nccs2)c2c(OCc3c(F)cccc3F)cccc21		CHEMBL1922984	=	IC50	nM	9.0	CHEMBL4247	Homo sapiens	IC50	nM	9.0
	7951059	CHEMBL1925015	Inhibition of ALK	B	Cn1cc(/C=C2\C(=O)NN=C2c2nccs2)c2c(OCc3c(F)cccc3Cl)cccc21		CHEMBL1922985	=	IC50	nM	13.0	CHEMBL4247	Homo sapiens	IC50	nM	13.0
	7951060	CHEMBL1925015	Inhibition of ALK	B	Cn1cc(/C=C2\C(=O)NN=C2c2nccs2)c2c(OCc3cccc(F)c3F)cccc21		CHEMBL1922986	=	IC50	nM	14.0	CHEMBL4247	Homo sapiens	IC50	nM	14.0
	7951061	CHEMBL1925015	Inhibition of ALK	B	Cn1cc(/C=C2\C(=O)NN=C2c2nccs2)c2c(OCc3cc(F)ccc3F)cccc21		CHEMBL1922987	=	IC50	nM	17.0	CHEMBL4247	Homo sapiens	IC50	nM	17.0
	7951062	CHEMBL1925015	Inhibition of ALK	B	Cn1cc(/C=C2\C(=O)NN=C2c2nccs2)c2c(OCc3ccc(F)cc3F)cccc21		CHEMBL1922988	=	IC50	nM	229.0	CHEMBL4247	Homo sapiens	IC50	nM	229.0
	7951063	CHEMBL1925061	Inhibition of nucleophosmin-fused ALK autophosphorylation in human Karpas299 cells	B	Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2cccc(OCc3ccccc3)c12		CHEMBL1922961	=	IC50	nM	650.0	CHEMBL4247	Homo sapiens	IC50	nM	650.0
	7951064	CHEMBL1925061	Inhibition of nucleophosmin-fused ALK autophosphorylation in human Karpas299 cells	B	Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2cccc(OCc3cccnc3)c12		CHEMBL1922963	=	IC50	nM	2500.0	CHEMBL4247	Homo sapiens	IC50	nM	2500.0
	7951065	CHEMBL1925061	Inhibition of nucleophosmin-fused ALK autophosphorylation in human Karpas299 cells	B	Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2cccc(OCc3ccncc3)c12		CHEMBL1922964	=	IC50	nM	1600.0	CHEMBL4247	Homo sapiens	IC50	nM	1600.0
	7951066	CHEMBL1925061	Inhibition of nucleophosmin-fused ALK autophosphorylation in human Karpas299 cells	B	Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2cccc(OCc3ccccc3F)c12		CHEMBL1922967	=	IC50	nM	400.0	CHEMBL4247	Homo sapiens	IC50	nM	400.0
	7951067	CHEMBL1925061	Inhibition of nucleophosmin-fused ALK autophosphorylation in human Karpas299 cells	B	Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2cccc(OCc3cccc(F)c3)c12		CHEMBL1922968	=	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	7951068	CHEMBL1925061	Inhibition of nucleophosmin-fused ALK autophosphorylation in human Karpas299 cells	B	Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2cccc(OCc3ccc(F)cc3)c12		CHEMBL1922969	=	IC50	nM	400.0	CHEMBL4247	Homo sapiens	IC50	nM	400.0
	7951069	CHEMBL1925061	Inhibition of nucleophosmin-fused ALK autophosphorylation in human Karpas299 cells	B	Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2cccc(OCc3c(F)cccc3F)c12		CHEMBL1922970	=	IC50	nM	300.0	CHEMBL4247	Homo sapiens	IC50	nM	300.0
	7951070	CHEMBL1925061	Inhibition of nucleophosmin-fused ALK autophosphorylation in human Karpas299 cells	B	Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2cccc(OCc3ccc(F)cc3F)c12		CHEMBL1922971	=	IC50	nM	200.0	CHEMBL4247	Homo sapiens	IC50	nM	200.0
	7951071	CHEMBL1925061	Inhibition of nucleophosmin-fused ALK autophosphorylation in human Karpas299 cells	B	Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2cccc(OCc3c(F)cccc3Cl)c12		CHEMBL1922972	=	IC50	nM	200.0	CHEMBL4247	Homo sapiens	IC50	nM	200.0
	7951072	CHEMBL1925061	Inhibition of nucleophosmin-fused ALK autophosphorylation in human Karpas299 cells	B	Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2cccc(OCc3c(F)ccc(F)c3Cl)c12		CHEMBL1922973	=	IC50	nM	300.0	CHEMBL4247	Homo sapiens	IC50	nM	300.0
	7951073	CHEMBL1925061	Inhibition of nucleophosmin-fused ALK autophosphorylation in human Karpas299 cells	B	Cc1nnsc1C1=NNC(=O)/C1=C\c1cn(C)c2cccc(OCc3c(F)ccc(Cl)c3F)c12		CHEMBL1922974	=	IC50	nM	400.0	CHEMBL4247	Homo sapiens	IC50	nM	400.0
	7951074	CHEMBL1925061	Inhibition of nucleophosmin-fused ALK autophosphorylation in human Karpas299 cells	B	Cn1cc(/C=C2\C(=O)NN=C2c2nccs2)c2c(OCc3ccccc3)cccc21		CHEMBL1922976	=	IC50	nM	300.0	CHEMBL4247	Homo sapiens	IC50	nM	300.0
	7951075	CHEMBL1925061	Inhibition of nucleophosmin-fused ALK autophosphorylation in human Karpas299 cells	B	Cn1cc(/C=C2\C(=O)NN=C2c2nccs2)c2c(OCc3ccccc3F)cccc21		CHEMBL1922980	=	IC50	nM	400.0	CHEMBL4247	Homo sapiens	IC50	nM	400.0
	7951076	CHEMBL1925061	Inhibition of nucleophosmin-fused ALK autophosphorylation in human Karpas299 cells	B	Cn1cc(/C=C2\C(=O)NN=C2c2nccs2)c2c(OCc3cccc(F)c3)cccc21		CHEMBL1922981	=	IC50	nM	120.0	CHEMBL4247	Homo sapiens	IC50	nM	120.0
	7951077	CHEMBL1925061	Inhibition of nucleophosmin-fused ALK autophosphorylation in human Karpas299 cells	B	CC(Oc1cccc2c1c(/C=C1\C(=O)NN=C1c1nccs1)cn2C)c1ccccc1		CHEMBL1922983	=	IC50	nM	500.0	CHEMBL4247	Homo sapiens	IC50	nM	500.0
	7951078	CHEMBL1925061	Inhibition of nucleophosmin-fused ALK autophosphorylation in human Karpas299 cells	B	Cn1cc(/C=C2\C(=O)NN=C2c2nccs2)c2c(OCc3c(F)cccc3F)cccc21		CHEMBL1922984	=	IC50	nM	100.0	CHEMBL4247	Homo sapiens	IC50	nM	100.0
	7951079	CHEMBL1925061	Inhibition of nucleophosmin-fused ALK autophosphorylation in human Karpas299 cells	B	Cn1cc(/C=C2\C(=O)NN=C2c2nccs2)c2c(OCc3c(F)cccc3Cl)cccc21		CHEMBL1922985	=	IC50	nM	200.0	CHEMBL4247	Homo sapiens	IC50	nM	200.0
	7951080	CHEMBL1925061	Inhibition of nucleophosmin-fused ALK autophosphorylation in human Karpas299 cells	B	Cn1cc(/C=C2\C(=O)NN=C2c2nccs2)c2c(OCc3cccc(F)c3F)cccc21		CHEMBL1922986	=	IC50	nM	90.0	CHEMBL4247	Homo sapiens	IC50	nM	90.0
	7951081	CHEMBL1925061	Inhibition of nucleophosmin-fused ALK autophosphorylation in human Karpas299 cells	B	Cn1cc(/C=C2\C(=O)NN=C2c2nccs2)c2c(OCc3cc(F)ccc3F)cccc21		CHEMBL1922987	=	IC50	nM	200.0	CHEMBL4247	Homo sapiens	IC50	nM	200.0
	7951326	CHEMBL1926220	Inhibition of recombinant human ALK	B	Cc1ccc(O)cc1CC[C@@H]1[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)/C=C/CC(C)C		CHEMBL1922224	=	IC50	nM	9330.0	CHEMBL4247	Homo sapiens	IC50	uM	9.33
	7951327	CHEMBL1926220	Inhibition of recombinant human ALK	B	Cc1ccc(O)cc1CC[C@@H]1C(=O)CC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)/C=C/CC(C)C		CHEMBL518060	=	IC50	nM	4160.0	CHEMBL4247	Homo sapiens	IC50	uM	4.16
	7951328	CHEMBL1926220	Inhibition of recombinant human ALK	B	C=C(CC[C@@H](C)[C@H]1CC[C@H]2[C@H](CCc3cc(O)ccc3C)C(=O)CC[C@@]21C)C(C)C		CHEMBL1922225	=	IC50	nM	4360.0	CHEMBL4247	Homo sapiens	IC50	uM	4.36
	7951329	CHEMBL1926220	Inhibition of recombinant human ALK	B	Cc1ccc(O)cc1CC[C@@H]1C(=O)CC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)C		CHEMBL456936	=	IC50	nM	4730.0	CHEMBL4247	Homo sapiens	IC50	uM	4.73
	7951330	CHEMBL1926220	Inhibition of recombinant human ALK	B	Cc1ccc(O)cc1CC[C@H]1[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC[C@H]1O		CHEMBL517956	=	IC50	nM	7550.0	CHEMBL4247	Homo sapiens	IC50	uM	7.55
	7951331	CHEMBL1926220	Inhibition of recombinant human ALK	B	Cc1ccc(O)cc1CC[C@@H]1C(=O)CC[C@@]2(C)[C@H]1C[C@H](O)[C@@H]2[C@H](C)CCCC(C)C		CHEMBL456294	>	IC50	nM	100000.0	CHEMBL4247	Homo sapiens	IC50	uM	100.0
	7951332	CHEMBL1926220	Inhibition of recombinant human ALK	B	C=C(CC[C@@H](C)[C@H]1CC[C@H]2[C@H](CCc3cc(O)ccc3C)[C@H](O)CC[C@@]21C)C(C)C		CHEMBL515982	>	IC50	nM	100000.0	CHEMBL4247	Homo sapiens	IC50	uM	100.0
	7951333	CHEMBL1926220	Inhibition of recombinant human ALK	B	Cc1ccc(O)cc1CC[C@H]1[C@@H]2C[C@H](O)[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC[C@H]1O		CHEMBL464351	>	IC50	nM	100000.0	CHEMBL4247	Homo sapiens	IC50	uM	100.0
	7956677	CHEMBL1926253	Inhibition of human GST-tagged ALK expressed in SF21 insect cells using PLCgamma/GST as substrate after 15 mins by time-resolved fluorescence assay	B	C[C@H](O)CN1CCN(c2ccc(Nc3ncc4ccc(-c5ccccc5N(C)S(C)(=O)=O)n4n3)cc2)CC1		CHEMBL1923569	=	IC50	nM	30.0	CHEMBL4247	Homo sapiens	IC50	nM	30.0
	7956684	CHEMBL1926253	Inhibition of human GST-tagged ALK expressed in SF21 insect cells using PLCgamma/GST as substrate after 15 mins by time-resolved fluorescence assay	B	COc1cc(N2CCN(C[C@H](C)O)CC2)ccc1Nc1ncc2ccc(-c3ccccc3N(C)S(C)(=O)=O)n2n1		CHEMBL1822525	=	IC50	nM	9.0	CHEMBL4247	Homo sapiens	IC50	nM	9.0
	7959669	CHEMBL1932325	Inhibition of ALK	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL4247	Homo sapiens	IC50	uM	30.0
	7959670	CHEMBL1932325	Inhibition of ALK	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	30000.0	CHEMBL4247	Homo sapiens	IC50	uM	30.0
	7997503	CHEMBL1942591	Inhibition of ALK using Bio-Gastrintide as substrate by TR-FRET assay in presence of 30 uM of ATP	B	CCCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1940182	=	IC50	nM	1.1	CHEMBL4247	Homo sapiens	IC50	nM	1.1
	7997504	CHEMBL1942591	Inhibition of ALK using Bio-Gastrintide as substrate by TR-FRET assay in presence of 30 uM of ATP	B	Cc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1940181	=	IC50	nM	1.1	CHEMBL4247	Homo sapiens	IC50	nM	1.1
	7997505	CHEMBL1942591	Inhibition of ALK using Bio-Gastrintide as substrate by TR-FRET assay in presence of 30 uM of ATP	B	CC1(C)c2cc(N3CCC(N4CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL1940180	=	IC50	nM	16.0	CHEMBL4247	Homo sapiens	IC50	nM	16.0
	7997506	CHEMBL1942591	Inhibition of ALK using Bio-Gastrintide as substrate by TR-FRET assay in presence of 30 uM of ATP	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	=	IC50	nM	1.9	CHEMBL4247	Homo sapiens	IC50	nM	1.9
	7997507	CHEMBL1942591	Inhibition of ALK using Bio-Gastrintide as substrate by TR-FRET assay in presence of 30 uM of ATP	B	CCc1cc2c(cc1N1CCN(C3COC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1823221	=	IC50	nM	2.9	CHEMBL4247	Homo sapiens	IC50	nM	2.9
	7997508	CHEMBL1942591	Inhibition of ALK using Bio-Gastrintide as substrate by TR-FRET assay in presence of 30 uM of ATP	B	CCc1cc2c(cc1N1CCN(C3CCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1940179	=	IC50	nM	2.4	CHEMBL4247	Homo sapiens	IC50	nM	2.4
	7997509	CHEMBL1942591	Inhibition of ALK using Bio-Gastrintide as substrate by TR-FRET assay in presence of 30 uM of ATP	B	CCc1cc2c(cc1N1CCN(C3CC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1940178	=	IC50	nM	5.2	CHEMBL4247	Homo sapiens	IC50	nM	5.2
	7997510	CHEMBL1942591	Inhibition of ALK using Bio-Gastrintide as substrate by TR-FRET assay in presence of 30 uM of ATP	B	CC1(C)c2ccc(N3CCN(C4COC4)CC3)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL1940177	=	IC50	nM	69.3	CHEMBL4247	Homo sapiens	IC50	nM	69.3
	7997511	CHEMBL1942591	Inhibition of ALK using Bio-Gastrintide as substrate by TR-FRET assay in presence of 30 uM of ATP	B	CC1(C)c2ccc(N3CCN(C4CC4)CC3)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL1940176	=	IC50	nM	233.0	CHEMBL4247	Homo sapiens	IC50	nM	233.0
	7997512	CHEMBL1942591	Inhibition of ALK using Bio-Gastrintide as substrate by TR-FRET assay in presence of 30 uM of ATP	B	CC1(C)c2ccc(C3CCN(C4COC4)CC3)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL1940175	=	IC50	nM	67.0	CHEMBL4247	Homo sapiens	IC50	nM	67.0
	7997513	CHEMBL1942591	Inhibition of ALK using Bio-Gastrintide as substrate by TR-FRET assay in presence of 30 uM of ATP	B	CC1(C)c2ccc(C3CCN(C4CC4)CC3)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL1940174	=	IC50	nM	44.0	CHEMBL4247	Homo sapiens	IC50	nM	44.0
	8013047	CHEMBL1947296	Inhibition of ALK using ATP as substrate	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	8015789	CHEMBL1947647	Inhibition of baculovirus expressed GST-tagged human ALK cytoplasmic domain using PLCgamma as substrate after 15 mins by time-resolved fluorescence analysis	B	COCCN1CCc2cc(Nc3ncc(Cl)c(Nc4ccc(N5CCOCC5)cc4OC)n3)c(OC)cc2CC1		CHEMBL1642255	=	IC50	nM	7.0	CHEMBL4247	Homo sapiens	IC50	nM	7.0
	8015790	CHEMBL1947647	Inhibition of baculovirus expressed GST-tagged human ALK cytoplasmic domain using PLCgamma as substrate after 15 mins by time-resolved fluorescence analysis	B	CN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccccc4)n3)cc2)CC1		CHEMBL1946607	=	IC50	nM	67.0	CHEMBL4247	Homo sapiens	IC50	nM	67.0
	8015791	CHEMBL1947647	Inhibition of baculovirus expressed GST-tagged human ALK cytoplasmic domain using PLCgamma as substrate after 15 mins by time-resolved fluorescence analysis	B	COc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL1946608	=	IC50	nM	22.0	CHEMBL4247	Homo sapiens	IC50	nM	22.0
	8015792	CHEMBL1947647	Inhibition of baculovirus expressed GST-tagged human ALK cytoplasmic domain using PLCgamma as substrate after 15 mins by time-resolved fluorescence analysis	B	Clc1cnc2nc1Nc1cccc(c1)CCc1cccc(c1)N2		CHEMBL1946609	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
	8015793	CHEMBL1947647	Inhibition of baculovirus expressed GST-tagged human ALK cytoplasmic domain using PLCgamma as substrate after 15 mins by time-resolved fluorescence analysis	B	Clc1cnc2nc1Nc1cccc(c1)CCc1cc(ccc1N1CCOCC1)N2		CHEMBL1946610	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
	8015794	CHEMBL1947647	Inhibition of baculovirus expressed GST-tagged human ALK cytoplasmic domain using PLCgamma as substrate after 15 mins by time-resolved fluorescence analysis	B	Clc1cnc2nc1Nc1cccc(c1)CCc1cc(ccc1OCCN1CCCC1)N2		CHEMBL1946611	=	IC50	nM	283.0	CHEMBL4247	Homo sapiens	IC50	nM	283.0
	8015795	CHEMBL1947647	Inhibition of baculovirus expressed GST-tagged human ALK cytoplasmic domain using PLCgamma as substrate after 15 mins by time-resolved fluorescence analysis	B	CN1CCN(c2ccc3cc2CCc2cccc(c2)Nc2nc(ncc2Cl)N3)CC1		CHEMBL1946612	=	IC50	nM	92.0	CHEMBL4247	Homo sapiens	IC50	nM	92.0
	8015796	CHEMBL1947647	Inhibition of baculovirus expressed GST-tagged human ALK cytoplasmic domain using PLCgamma as substrate after 15 mins by time-resolved fluorescence analysis	B	COc1ccc2cc1Nc1nc(ncc1Cl)Nc1cccc(c1)CC2		CHEMBL1944658	=	IC50	nM	360.0	CHEMBL4247	Homo sapiens	IC50	nM	360.0
	8015797	CHEMBL1947647	Inhibition of baculovirus expressed GST-tagged human ALK cytoplasmic domain using PLCgamma as substrate after 15 mins by time-resolved fluorescence analysis	B	COc1ccc2cc1Nc1nc(ncc1Cl)Nc1ccc(N3CCOCC3)c(c1)CC2		CHEMBL1946613	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	8015798	CHEMBL1947647	Inhibition of baculovirus expressed GST-tagged human ALK cytoplasmic domain using PLCgamma as substrate after 15 mins by time-resolved fluorescence analysis	B	COc1ccc2cc1Nc1nc(ncc1Cl)Nc1ccc(N3CCN(C)CC3)c(c1)CC2		CHEMBL1946614	=	IC50	nM	3.1	CHEMBL4247	Homo sapiens	IC50	nM	3.1
	8015799	CHEMBL1947647	Inhibition of baculovirus expressed GST-tagged human ALK cytoplasmic domain using PLCgamma as substrate after 15 mins by time-resolved fluorescence analysis	B	CNC(=O)c1ccc2cc1Nc1nc(ncc1Cl)Nc1ccc(N3CCN(C)CC3)c(c1)CC2		CHEMBL1946799	=	IC50	nM	35.0	CHEMBL4247	Homo sapiens	IC50	nM	35.0
	8015800	CHEMBL1947647	Inhibition of baculovirus expressed GST-tagged human ALK cytoplasmic domain using PLCgamma as substrate after 15 mins by time-resolved fluorescence analysis	B	CC(C)S(=O)(=O)c1ccc2cc1Nc1nc(ncc1Cl)Nc1ccc(N3CCN(C)CC3)c(c1)CC2		CHEMBL1946800	=	IC50	nM	3.7	CHEMBL4247	Homo sapiens	IC50	nM	3.7
	8015801	CHEMBL1947647	Inhibition of baculovirus expressed GST-tagged human ALK cytoplasmic domain using PLCgamma as substrate after 15 mins by time-resolved fluorescence analysis	B	CN1CCN(c2ccc3cc2CCc2ccc(N(C)S(C)(=O)=O)c(c2)Nc2nc(ncc2Cl)N3)CC1		CHEMBL1946801	=	IC50	nM	3.4	CHEMBL4247	Homo sapiens	IC50	nM	3.4
	8015802	CHEMBL1947647	Inhibition of baculovirus expressed GST-tagged human ALK cytoplasmic domain using PLCgamma as substrate after 15 mins by time-resolved fluorescence analysis	B	COc1cc(N2CCN(C)CC2)c2cc1Nc1ncc(Cl)c(n1)Nc1cccc(c1)CC2		CHEMBL1946802	=	IC50	nM	5.0	CHEMBL4247	Homo sapiens	IC50	nM	5.0
	8015803	CHEMBL1947647	Inhibition of baculovirus expressed GST-tagged human ALK cytoplasmic domain using PLCgamma as substrate after 15 mins by time-resolved fluorescence analysis	B	COc1cc(N2CCN(C)CC2)c2cc1Nc1ncc(Cl)c(n1)Nc1cc(ccc1S(=O)(=O)C(C)C)CC2		CHEMBL1946803	=	IC50	nM	1.5	CHEMBL4247	Homo sapiens	IC50	nM	1.5
	8015804	CHEMBL1947647	Inhibition of baculovirus expressed GST-tagged human ALK cytoplasmic domain using PLCgamma as substrate after 15 mins by time-resolved fluorescence analysis	B	COc1cc(N2CCN(C)CC2)c2cc1Nc1ncc(Cl)c(n1)Nc1cc(ccc1N(C)S(C)(=O)=O)CC2		CHEMBL1946804	=	IC50	nM	0.51	CHEMBL4247	Homo sapiens	IC50	nM	0.51
	8015805	CHEMBL1947647	Inhibition of baculovirus expressed GST-tagged human ALK cytoplasmic domain using PLCgamma as substrate after 15 mins by time-resolved fluorescence analysis	B	CN1CCN(c2ccc3cc2/C=C\c2cccc(c2)Nc2nc(ncc2Cl)N3)CC1		CHEMBL1946999	=	IC50	nM	392.0	CHEMBL4247	Homo sapiens	IC50	nM	392.0
	8015806	CHEMBL1947647	Inhibition of baculovirus expressed GST-tagged human ALK cytoplasmic domain using PLCgamma as substrate after 15 mins by time-resolved fluorescence analysis	B	COc1ccc2cc1Nc1nc(ncc1Cl)Nc1ccc(N3CCN(C)CC3)c(c1)/C=C\2		CHEMBL1947000	=	IC50	nM	259.0	CHEMBL4247	Homo sapiens	IC50	nM	259.0
	8015807	CHEMBL1947647	Inhibition of baculovirus expressed GST-tagged human ALK cytoplasmic domain using PLCgamma as substrate after 15 mins by time-resolved fluorescence analysis	B	COc1cc(N2CCN(C)CC2)c2cc1Nc1ncc(Cl)c(n1)Nc1cc(ccc1N(C)S(C)(=O)=O)/C=C\2		CHEMBL1947001	=	IC50	nM	7.0	CHEMBL4247	Homo sapiens	IC50	nM	7.0
	8015808	CHEMBL1947646	Inhibition of NPM-ALK autophosphorylation in human ALCL SUP-M2 cells after 2 to 3 hrs by sandwich ELISA	B	COCCN1CCc2cc(Nc3ncc(Cl)c(Nc4ccc(N5CCOCC5)cc4OC)n3)c(OC)cc2CC1		CHEMBL1642255	=	IC50	nM	150.0	CHEMBL4247	Homo sapiens	IC50	nM	150.0
Not Determined	8015809	CHEMBL1947646	Inhibition of NPM-ALK autophosphorylation in human ALCL SUP-M2 cells after 2 to 3 hrs by sandwich ELISA	B	CN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccccc4)n3)cc2)CC1		CHEMBL1946607		IC50			CHEMBL4247	Homo sapiens	IC50		
	8015810	CHEMBL1947646	Inhibition of NPM-ALK autophosphorylation in human ALCL SUP-M2 cells after 2 to 3 hrs by sandwich ELISA	B	COc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL1946608	=	IC50	nM	100.0	CHEMBL4247	Homo sapiens	IC50	nM	100.0
Not Determined	8015811	CHEMBL1947646	Inhibition of NPM-ALK autophosphorylation in human ALCL SUP-M2 cells after 2 to 3 hrs by sandwich ELISA	B	Clc1cnc2nc1Nc1cccc(c1)CCc1cccc(c1)N2		CHEMBL1946609		IC50			CHEMBL4247	Homo sapiens	IC50		
Not Determined	8015812	CHEMBL1947646	Inhibition of NPM-ALK autophosphorylation in human ALCL SUP-M2 cells after 2 to 3 hrs by sandwich ELISA	B	Clc1cnc2nc1Nc1cccc(c1)CCc1cc(ccc1N1CCOCC1)N2		CHEMBL1946610		IC50			CHEMBL4247	Homo sapiens	IC50		
Not Determined	8015813	CHEMBL1947646	Inhibition of NPM-ALK autophosphorylation in human ALCL SUP-M2 cells after 2 to 3 hrs by sandwich ELISA	B	Clc1cnc2nc1Nc1cccc(c1)CCc1cc(ccc1OCCN1CCCC1)N2		CHEMBL1946611		IC50			CHEMBL4247	Homo sapiens	IC50		
Not Determined	8015814	CHEMBL1947646	Inhibition of NPM-ALK autophosphorylation in human ALCL SUP-M2 cells after 2 to 3 hrs by sandwich ELISA	B	CN1CCN(c2ccc3cc2CCc2cccc(c2)Nc2nc(ncc2Cl)N3)CC1		CHEMBL1946612		IC50			CHEMBL4247	Homo sapiens	IC50		
Not Determined	8015815	CHEMBL1947646	Inhibition of NPM-ALK autophosphorylation in human ALCL SUP-M2 cells after 2 to 3 hrs by sandwich ELISA	B	COc1ccc2cc1Nc1nc(ncc1Cl)Nc1cccc(c1)CC2		CHEMBL1944658		IC50			CHEMBL4247	Homo sapiens	IC50		
Not Determined	8015816	CHEMBL1947646	Inhibition of NPM-ALK autophosphorylation in human ALCL SUP-M2 cells after 2 to 3 hrs by sandwich ELISA	B	COc1ccc2cc1Nc1nc(ncc1Cl)Nc1ccc(N3CCOCC3)c(c1)CC2		CHEMBL1946613		IC50			CHEMBL4247	Homo sapiens	IC50		
	8015817	CHEMBL1947646	Inhibition of NPM-ALK autophosphorylation in human ALCL SUP-M2 cells after 2 to 3 hrs by sandwich ELISA	B	COc1ccc2cc1Nc1nc(ncc1Cl)Nc1ccc(N3CCN(C)CC3)c(c1)CC2		CHEMBL1946614	=	IC50	nM	150.0	CHEMBL4247	Homo sapiens	IC50	nM	150.0
	8015818	CHEMBL1947646	Inhibition of NPM-ALK autophosphorylation in human ALCL SUP-M2 cells after 2 to 3 hrs by sandwich ELISA	B	CNC(=O)c1ccc2cc1Nc1nc(ncc1Cl)Nc1ccc(N3CCN(C)CC3)c(c1)CC2		CHEMBL1946799	=	IC50	nM	1200.0	CHEMBL4247	Homo sapiens	IC50	nM	1200.0
	8015819	CHEMBL1947646	Inhibition of NPM-ALK autophosphorylation in human ALCL SUP-M2 cells after 2 to 3 hrs by sandwich ELISA	B	CC(C)S(=O)(=O)c1ccc2cc1Nc1nc(ncc1Cl)Nc1ccc(N3CCN(C)CC3)c(c1)CC2		CHEMBL1946800	=	IC50	nM	70.0	CHEMBL4247	Homo sapiens	IC50	nM	70.0
	8015820	CHEMBL1947646	Inhibition of NPM-ALK autophosphorylation in human ALCL SUP-M2 cells after 2 to 3 hrs by sandwich ELISA	B	CN1CCN(c2ccc3cc2CCc2ccc(N(C)S(C)(=O)=O)c(c2)Nc2nc(ncc2Cl)N3)CC1		CHEMBL1946801	=	IC50	nM	120.0	CHEMBL4247	Homo sapiens	IC50	nM	120.0
	8015821	CHEMBL1947646	Inhibition of NPM-ALK autophosphorylation in human ALCL SUP-M2 cells after 2 to 3 hrs by sandwich ELISA	B	COc1cc(N2CCN(C)CC2)c2cc1Nc1ncc(Cl)c(n1)Nc1cccc(c1)CC2		CHEMBL1946802	=	IC50	nM	800.0	CHEMBL4247	Homo sapiens	IC50	nM	800.0
	8015822	CHEMBL1947646	Inhibition of NPM-ALK autophosphorylation in human ALCL SUP-M2 cells after 2 to 3 hrs by sandwich ELISA	B	COc1cc(N2CCN(C)CC2)c2cc1Nc1ncc(Cl)c(n1)Nc1cc(ccc1S(=O)(=O)C(C)C)CC2		CHEMBL1946803	=	IC50	nM	30.0	CHEMBL4247	Homo sapiens	IC50	nM	30.0
	8015823	CHEMBL1947646	Inhibition of NPM-ALK autophosphorylation in human ALCL SUP-M2 cells after 2 to 3 hrs by sandwich ELISA	B	COc1cc(N2CCN(C)CC2)c2cc1Nc1ncc(Cl)c(n1)Nc1cc(ccc1N(C)S(C)(=O)=O)CC2		CHEMBL1946804	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
Not Determined	8015824	CHEMBL1947646	Inhibition of NPM-ALK autophosphorylation in human ALCL SUP-M2 cells after 2 to 3 hrs by sandwich ELISA	B	CN1CCN(c2ccc3cc2/C=C\c2cccc(c2)Nc2nc(ncc2Cl)N3)CC1		CHEMBL1946999		IC50			CHEMBL4247	Homo sapiens	IC50		
Not Determined	8015825	CHEMBL1947646	Inhibition of NPM-ALK autophosphorylation in human ALCL SUP-M2 cells after 2 to 3 hrs by sandwich ELISA	B	COc1ccc2cc1Nc1nc(ncc1Cl)Nc1ccc(N3CCN(C)CC3)c(c1)/C=C\2		CHEMBL1947000		IC50			CHEMBL4247	Homo sapiens	IC50		
	8015826	CHEMBL1947646	Inhibition of NPM-ALK autophosphorylation in human ALCL SUP-M2 cells after 2 to 3 hrs by sandwich ELISA	B	COc1cc(N2CCN(C)CC2)c2cc1Nc1ncc(Cl)c(n1)Nc1cc(ccc1N(C)S(C)(=O)=O)/C=C\2		CHEMBL1947001	=	IC50	nM	120.0	CHEMBL4247	Homo sapiens	IC50	nM	120.0
	8028883	CHEMBL1948192	Inhibition of ALK	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	200.0	CHEMBL4247	Homo sapiens	IC50	nM	200.0
	8061354	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-0.45	CHEMBL4247	Homo sapiens	Inhibition	%	-0.45
	8061531	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-2.43	CHEMBL4247	Homo sapiens	Inhibition	%	-2.43
	8061862	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	2.39	CHEMBL4247	Homo sapiens	Inhibition	%	2.39
	8062053	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	5.12	CHEMBL4247	Homo sapiens	Inhibition	%	5.12
	8062393	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	1.93	CHEMBL4247	Homo sapiens	Inhibition	%	1.93
	8062555	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	31.61	CHEMBL4247	Homo sapiens	Inhibition	%	31.61
	8062877	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.87	CHEMBL4247	Homo sapiens	Inhibition	%	1.87
	8063233	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	2.22	CHEMBL4247	Homo sapiens	Inhibition	%	2.22
	8063400	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.83	CHEMBL4247	Homo sapiens	Inhibition	%	1.83
	8063732	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.12	CHEMBL4247	Homo sapiens	Inhibition	%	1.12
	8063914	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	9.81	CHEMBL4247	Homo sapiens	Inhibition	%	9.81
	8064253	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	3.93	CHEMBL4247	Homo sapiens	Inhibition	%	3.93
	8064463	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.27	CHEMBL4247	Homo sapiens	Inhibition	%	1.27
	8064825	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	1.69	CHEMBL4247	Homo sapiens	Inhibition	%	1.69
	8064991	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	2.05	CHEMBL4247	Homo sapiens	Inhibition	%	2.05
	8065331	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	2.39	CHEMBL4247	Homo sapiens	Inhibition	%	2.39
	8065506	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	2.44	CHEMBL4247	Homo sapiens	Inhibition	%	2.44
	8065730	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	3.89	CHEMBL4247	Homo sapiens	Inhibition	%	3.89
	8065845	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	0.57	CHEMBL4247	Homo sapiens	Inhibition	%	0.57
	8066055	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.3	CHEMBL4247	Homo sapiens	Inhibition	%	1.3
	8066279	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	0.99	CHEMBL4247	Homo sapiens	Inhibition	%	0.99
	8066415	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	4.78	CHEMBL4247	Homo sapiens	Inhibition	%	4.78
	8066581	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.28	CHEMBL4247	Homo sapiens	Inhibition	%	1.28
	8066805	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.76	CHEMBL4247	Homo sapiens	Inhibition	%	1.76
	8066929	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	2.06	CHEMBL4247	Homo sapiens	Inhibition	%	2.06
	8067328	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.66	CHEMBL4247	Homo sapiens	Inhibition	%	2.66
	8067449	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.96	CHEMBL4247	Homo sapiens	Inhibition	%	1.96
	8067673	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.44	CHEMBL4247	Homo sapiens	Inhibition	%	0.44
	8067883	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	0.3	CHEMBL4247	Homo sapiens	Inhibition	%	0.3
	8068018	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	5.68	CHEMBL4247	Homo sapiens	Inhibition	%	5.68
	8068406	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	1.63	CHEMBL4247	Homo sapiens	Inhibition	%	1.63
	8068531	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	3.65	CHEMBL4247	Homo sapiens	Inhibition	%	3.65
	8068755	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-0.03	CHEMBL4247	Homo sapiens	Inhibition	%	-0.03
	8068929	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	3.54	CHEMBL4247	Homo sapiens	Inhibition	%	3.54
	8069278	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.88	CHEMBL4247	Homo sapiens	Inhibition	%	1.88
	8069349	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	44.76	CHEMBL4247	Homo sapiens	Inhibition	%	44.76
	8069573	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	10.35	CHEMBL4247	Homo sapiens	Inhibition	%	10.35
	8069734	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.63	CHEMBL4247	Homo sapiens	Inhibition	%	2.63
	8070084	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.01	CHEMBL4247	Homo sapiens	Inhibition	%	1.01
	8070256	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	1.63	CHEMBL4247	Homo sapiens	Inhibition	%	1.63
	8070605	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	1.28	CHEMBL4247	Homo sapiens	Inhibition	%	1.28
	8070903	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	62.85	CHEMBL4247	Homo sapiens	Inhibition	%	62.85
	8071060	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	0.72	CHEMBL4247	Homo sapiens	Inhibition	%	0.72
	8071410	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	2.05	CHEMBL4247	Homo sapiens	Inhibition	%	2.05
	8071583	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	3.57	CHEMBL4247	Homo sapiens	Inhibition	%	3.57
	8071807	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	1.26	CHEMBL4247	Homo sapiens	Inhibition	%	1.26
	8071932	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	3.08	CHEMBL4247	Homo sapiens	Inhibition	%	3.08
	8072246	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-1.0	CHEMBL4247	Homo sapiens	Inhibition	%	-1.0
	8072403	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.88	CHEMBL4247	Homo sapiens	Inhibition	%	1.88
	8072627	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.19	CHEMBL4247	Homo sapiens	Inhibition	%	1.19
	8072752	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.57	CHEMBL4247	Homo sapiens	Inhibition	%	0.57
	8073143	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	4.4	CHEMBL4247	Homo sapiens	Inhibition	%	4.4
	8073268	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	0.95	CHEMBL4247	Homo sapiens	Inhibition	%	0.95
	8073611	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.89	CHEMBL4247	Homo sapiens	Inhibition	%	0.89
	8073844	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.13	CHEMBL4247	Homo sapiens	Inhibition	%	0.13
	8074220	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	2.23	CHEMBL4247	Homo sapiens	Inhibition	%	2.23
	8074350	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.27	CHEMBL4247	Homo sapiens	Inhibition	%	0.27
	8074574	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.78	CHEMBL4247	Homo sapiens	Inhibition	%	0.78
	8074731	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	4.05	CHEMBL4247	Homo sapiens	Inhibition	%	4.05
	8074858	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	6.26	CHEMBL4247	Homo sapiens	Inhibition	%	6.26
	8075082	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	51.71	CHEMBL4247	Homo sapiens	Inhibition	%	51.71
	8075193	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	2.77	CHEMBL4247	Homo sapiens	Inhibition	%	2.77
	8075430	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-0.84	CHEMBL4247	Homo sapiens	Inhibition	%	-0.84
	8075654	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	0.01	CHEMBL4247	Homo sapiens	Inhibition	%	0.01
	8075795	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	1.24	CHEMBL4247	Homo sapiens	Inhibition	%	1.24
	8076161	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.81	CHEMBL4247	Homo sapiens	Inhibition	%	-0.81
	8076309	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	8.13	CHEMBL4247	Homo sapiens	Inhibition	%	8.13
	8076667	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	86.33	CHEMBL4247	Homo sapiens	Inhibition	%	86.33
	8076769	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	1.45	CHEMBL4247	Homo sapiens	Inhibition	%	1.45
	8076993	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.45	CHEMBL4247	Homo sapiens	Inhibition	%	-0.45
	8077240	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	0.41	CHEMBL4247	Homo sapiens	Inhibition	%	0.41
	8077368	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	3.05	CHEMBL4247	Homo sapiens	Inhibition	%	3.05
	8077743	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	2.16	CHEMBL4247	Homo sapiens	Inhibition	%	2.16
	8077886	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	1.95	CHEMBL4247	Homo sapiens	Inhibition	%	1.95
	8078249	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-2.35	CHEMBL4247	Homo sapiens	Inhibition	%	-2.35
	8078575	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	2.45	CHEMBL4247	Homo sapiens	Inhibition	%	2.45
	8078825	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	19.62	CHEMBL4247	Homo sapiens	Inhibition	%	19.62
	8078941	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	3.61	CHEMBL4247	Homo sapiens	Inhibition	%	3.61
	8079165	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	2.36	CHEMBL4247	Homo sapiens	Inhibition	%	2.36
	8079323	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.7	CHEMBL4247	Homo sapiens	Inhibition	%	-0.7
	8079465	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	5.89	CHEMBL4247	Homo sapiens	Inhibition	%	5.89
	8079689	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	1.75	CHEMBL4247	Homo sapiens	Inhibition	%	1.75
	8079828	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	8.38	CHEMBL4247	Homo sapiens	Inhibition	%	8.38
	8080157	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	4.92	CHEMBL4247	Homo sapiens	Inhibition	%	4.92
	8080409	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-0.71	CHEMBL4247	Homo sapiens	Inhibition	%	-0.71
	8080748	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.66	CHEMBL4247	Homo sapiens	Inhibition	%	0.66
	8080912	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	4.65	CHEMBL4247	Homo sapiens	Inhibition	%	4.65
	8081271	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	4.79	CHEMBL4247	Homo sapiens	Inhibition	%	4.79
	8081415	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	97.45	CHEMBL4247	Homo sapiens	Inhibition	%	97.45
	8081742	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	0.73	CHEMBL4247	Homo sapiens	Inhibition	%	0.73
	8081994	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	4.93	CHEMBL4247	Homo sapiens	Inhibition	%	4.93
	8082331	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.87	CHEMBL4247	Homo sapiens	Inhibition	%	0.87
	8082504	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-2.83	CHEMBL4247	Homo sapiens	Inhibition	%	-2.83
	8082851	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.79	CHEMBL4247	Homo sapiens	Inhibition	%	2.79
	8083007	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	86.58	CHEMBL4247	Homo sapiens	Inhibition	%	86.58
	8083231	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	3.7	CHEMBL4247	Homo sapiens	Inhibition	%	3.7
	8083330	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	4.45	CHEMBL4247	Homo sapiens	Inhibition	%	4.45
	8083584	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-2.37	CHEMBL4247	Homo sapiens	Inhibition	%	-2.37
	8083808	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	2.16	CHEMBL4247	Homo sapiens	Inhibition	%	2.16
	8083918	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.26	CHEMBL4247	Homo sapiens	Inhibition	%	1.26
	8084103	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-1.85	CHEMBL4247	Homo sapiens	Inhibition	%	-1.85
	8084327	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	3.06	CHEMBL4247	Homo sapiens	Inhibition	%	3.06
	8084445	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	3.48	CHEMBL4247	Homo sapiens	Inhibition	%	3.48
	8084830	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	11.1	CHEMBL4247	Homo sapiens	Inhibition	%	11.1
	8084928	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.61	CHEMBL4247	Homo sapiens	Inhibition	%	0.61
	8085152	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.09	CHEMBL4247	Homo sapiens	Inhibition	%	1.09
	8085408	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-4.96	CHEMBL4247	Homo sapiens	Inhibition	%	-4.96
	8085516	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	4.21	CHEMBL4247	Homo sapiens	Inhibition	%	4.21
	8085740	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	1.58	CHEMBL4247	Homo sapiens	Inhibition	%	1.58
	8085929	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	16.07	CHEMBL4247	Homo sapiens	Inhibition	%	16.07
	8086044	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.86	CHEMBL4247	Homo sapiens	Inhibition	%	2.86
	8086268	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	4.13	CHEMBL4247	Homo sapiens	Inhibition	%	4.13
	8086430	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	2.7	CHEMBL4247	Homo sapiens	Inhibition	%	2.7
	8086753	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.59	CHEMBL4247	Homo sapiens	Inhibition	%	1.59
	8086964	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	6.0	CHEMBL4247	Homo sapiens	Inhibition	%	6.0
	8087346	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	1.63	CHEMBL4247	Homo sapiens	Inhibition	%	1.63
	8087460	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	12.37	CHEMBL4247	Homo sapiens	Inhibition	%	12.37
	8087822	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	8.37	CHEMBL4247	Homo sapiens	Inhibition	%	8.37
	8087964	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	3.59	CHEMBL4247	Homo sapiens	Inhibition	%	3.59
	8088188	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	5.18	CHEMBL4247	Homo sapiens	Inhibition	%	5.18
	8088336	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.29	CHEMBL4247	Homo sapiens	Inhibition	%	0.29
	8088688	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	3.25	CHEMBL4247	Homo sapiens	Inhibition	%	3.25
	8088781	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	1.5	CHEMBL4247	Homo sapiens	Inhibition	%	1.5
	8089005	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	8.1	CHEMBL4247	Homo sapiens	Inhibition	%	8.1
	8089133	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	55.71	CHEMBL4247	Homo sapiens	Inhibition	%	55.71
	8089505	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	2.57	CHEMBL4247	Homo sapiens	Inhibition	%	2.57
	8089625	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	1.53	CHEMBL4247	Homo sapiens	Inhibition	%	1.53
	8089849	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	0.79	CHEMBL4247	Homo sapiens	Inhibition	%	0.79
	8090029	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	5.16	CHEMBL4247	Homo sapiens	Inhibition	%	5.16
	8090194	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	62.82	CHEMBL4247	Homo sapiens	Inhibition	%	62.82
	8090585	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.79	CHEMBL4247	Homo sapiens	Inhibition	%	2.79
	8090724	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	3.1	CHEMBL4247	Homo sapiens	Inhibition	%	3.1
	8090948	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	1.46	CHEMBL4247	Homo sapiens	Inhibition	%	1.46
	8091153	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.33	CHEMBL4247	Homo sapiens	Inhibition	%	2.33
	8091290	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	9.12	CHEMBL4247	Homo sapiens	Inhibition	%	9.12
	8091669	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	2.14	CHEMBL4247	Homo sapiens	Inhibition	%	2.14
	8091785	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	4.54	CHEMBL4247	Homo sapiens	Inhibition	%	4.54
	8092009	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	9.47	CHEMBL4247	Homo sapiens	Inhibition	%	9.47
	8092146	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-2.73	CHEMBL4247	Homo sapiens	Inhibition	%	-2.73
	8092521	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	2.96	CHEMBL4247	Homo sapiens	Inhibition	%	2.96
	8092669	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	2.13	CHEMBL4247	Homo sapiens	Inhibition	%	2.13
	8093022	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	6.34	CHEMBL4247	Homo sapiens	Inhibition	%	6.34
	8093334	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	1.23	CHEMBL4247	Homo sapiens	Inhibition	%	1.23
	8093474	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	78.19	CHEMBL4247	Homo sapiens	Inhibition	%	78.19
	8093837	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	10.38	CHEMBL4247	Homo sapiens	Inhibition	%	10.38
	8094181	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	5.19	CHEMBL4247	Homo sapiens	Inhibition	%	5.19
	8094361	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	2.41	CHEMBL4247	Homo sapiens	Inhibition	%	2.41
	8094536	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	82.31	CHEMBL4247	Homo sapiens	Inhibition	%	82.31
	8094760	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	88.33	CHEMBL4247	Homo sapiens	Inhibition	%	88.33
	8094916	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	4.11	CHEMBL4247	Homo sapiens	Inhibition	%	4.11
	8095280	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	4.22	CHEMBL4247	Homo sapiens	Inhibition	%	4.22
	8095483	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.76	CHEMBL4247	Homo sapiens	Inhibition	%	2.76
	8095624	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	76.18	CHEMBL4247	Homo sapiens	Inhibition	%	76.18
	8095848	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	82.14	CHEMBL4247	Homo sapiens	Inhibition	%	82.14
	8095996	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	1.67	CHEMBL4247	Homo sapiens	Inhibition	%	1.67
	8096337	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	4.02	CHEMBL4247	Homo sapiens	Inhibition	%	4.02
	8096476	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-0.15	CHEMBL4247	Homo sapiens	Inhibition	%	-0.15
	8096700	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	2.04	CHEMBL4247	Homo sapiens	Inhibition	%	2.04
	8096856	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	4.5	CHEMBL4247	Homo sapiens	Inhibition	%	4.5
	8097003	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	0.25	CHEMBL4247	Homo sapiens	Inhibition	%	0.25
	8097227	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	0.57	CHEMBL4247	Homo sapiens	Inhibition	%	0.57
	8097314	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	0.59	CHEMBL4247	Homo sapiens	Inhibition	%	0.59
	8097534	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	2.86	CHEMBL4247	Homo sapiens	Inhibition	%	2.86
	8097684	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-0.2	CHEMBL4247	Homo sapiens	Inhibition	%	-0.2
	8097908	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	10.18	CHEMBL4247	Homo sapiens	Inhibition	%	10.18
	8098041	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-3.78	CHEMBL4247	Homo sapiens	Inhibition	%	-3.78
	8098385	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.33	CHEMBL4247	Homo sapiens	Inhibition	%	-0.33
	8098565	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	2.74	CHEMBL4247	Homo sapiens	Inhibition	%	2.74
	8098974	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	88.84	CHEMBL4247	Homo sapiens	Inhibition	%	88.84
	8099118	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	2.87	CHEMBL4247	Homo sapiens	Inhibition	%	2.87
	8099484	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	2.65	CHEMBL4247	Homo sapiens	Inhibition	%	2.65
	8099678	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.92	CHEMBL4247	Homo sapiens	Inhibition	%	0.92
	8100049	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	12.44	CHEMBL4247	Homo sapiens	Inhibition	%	12.44
	8100195	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	3.06	CHEMBL4247	Homo sapiens	Inhibition	%	3.06
	8100535	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	5.34	CHEMBL4247	Homo sapiens	Inhibition	%	5.34
	8100899	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	8.58	CHEMBL4247	Homo sapiens	Inhibition	%	8.58
	8101059	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	3.85	CHEMBL4247	Homo sapiens	Inhibition	%	3.85
	8101425	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-2.74	CHEMBL4247	Homo sapiens	Inhibition	%	-2.74
	8101610	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-1.6	CHEMBL4247	Homo sapiens	Inhibition	%	-1.6
	8101863	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	0.85	CHEMBL4247	Homo sapiens	Inhibition	%	0.85
	8102242	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-0.3	CHEMBL4247	Homo sapiens	Inhibition	%	-0.3
	8102373	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-1.37	CHEMBL4247	Homo sapiens	Inhibition	%	-1.37
	8102597	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	0.5	CHEMBL4247	Homo sapiens	Inhibition	%	0.5
	8102717	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	2.9	CHEMBL4247	Homo sapiens	Inhibition	%	2.9
	8102895	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.38	CHEMBL4247	Homo sapiens	Inhibition	%	1.38
	8103119	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	2.45	CHEMBL4247	Homo sapiens	Inhibition	%	2.45
	8103315	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	5.79	CHEMBL4247	Homo sapiens	Inhibition	%	5.79
	8103453	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	9.68	CHEMBL4247	Homo sapiens	Inhibition	%	9.68
	8103677	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.23	CHEMBL4247	Homo sapiens	Inhibition	%	0.23
	8103827	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	3.72	CHEMBL4247	Homo sapiens	Inhibition	%	3.72
	8104012	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.32	CHEMBL4247	Homo sapiens	Inhibition	%	0.32
	8104236	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	1.45	CHEMBL4247	Homo sapiens	Inhibition	%	1.45
	8104384	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	22.31	CHEMBL4247	Homo sapiens	Inhibition	%	22.31
	8104530	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-3.07	CHEMBL4247	Homo sapiens	Inhibition	%	-3.07
	8104754	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-0.11	CHEMBL4247	Homo sapiens	Inhibition	%	-0.11
	8104868	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	3.58	CHEMBL4247	Homo sapiens	Inhibition	%	3.58
	8105232	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.35	CHEMBL4247	Homo sapiens	Inhibition	%	1.35
	8105398	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	6.43	CHEMBL4247	Homo sapiens	Inhibition	%	6.43
	8105622	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-0.85	CHEMBL4247	Homo sapiens	Inhibition	%	-0.85
	8105760	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-0.68	CHEMBL4247	Homo sapiens	Inhibition	%	-0.68
	8106040	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.96	CHEMBL4247	Homo sapiens	Inhibition	%	1.96
	8106205	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	1.19	CHEMBL4247	Homo sapiens	Inhibition	%	1.19
	8106429	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-2.64	CHEMBL4247	Homo sapiens	Inhibition	%	-2.64
	8106585	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	15.45	CHEMBL4247	Homo sapiens	Inhibition	%	15.45
	8106938	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	4.19	CHEMBL4247	Homo sapiens	Inhibition	%	4.19
	8107059	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	0.6	CHEMBL4247	Homo sapiens	Inhibition	%	0.6
	8107455	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.22	CHEMBL4247	Homo sapiens	Inhibition	%	1.22
	8107656	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	9.07	CHEMBL4247	Homo sapiens	Inhibition	%	9.07
	8108015	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	10.08	CHEMBL4247	Homo sapiens	Inhibition	%	10.08
	8108173	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	3.52	CHEMBL4247	Homo sapiens	Inhibition	%	3.52
	8108572	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	2.26	CHEMBL4247	Homo sapiens	Inhibition	%	2.26
	8108719	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	8.57	CHEMBL4247	Homo sapiens	Inhibition	%	8.57
	8109085	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.65	CHEMBL4247	Homo sapiens	Inhibition	%	0.65
	8109199	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	5.33	CHEMBL4247	Homo sapiens	Inhibition	%	5.33
	8109423	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	3.48	CHEMBL4247	Homo sapiens	Inhibition	%	3.48
	8109553	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.34	CHEMBL4247	Homo sapiens	Inhibition	%	1.34
	8109948	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	5.48	CHEMBL4247	Homo sapiens	Inhibition	%	5.48
	8110080	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	2.73	CHEMBL4247	Homo sapiens	Inhibition	%	2.73
	8110359	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	6.45	CHEMBL4247	Homo sapiens	Inhibition	%	6.45
	8110749	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-0.07	CHEMBL4247	Homo sapiens	Inhibition	%	-0.07
	8110907	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-6.6	CHEMBL4247	Homo sapiens	Inhibition	%	-6.6
	8111254	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	1.34	CHEMBL4247	Homo sapiens	Inhibition	%	1.34
	8111381	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	0.71	CHEMBL4247	Homo sapiens	Inhibition	%	0.71
	8111605	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-0.46	CHEMBL4247	Homo sapiens	Inhibition	%	-0.46
	8111771	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.22	CHEMBL4247	Homo sapiens	Inhibition	%	1.22
	8111976	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	3.9	CHEMBL4247	Homo sapiens	Inhibition	%	3.9
	8112337	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.43	CHEMBL4247	Homo sapiens	Inhibition	%	0.43
	8112505	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	5.76	CHEMBL4247	Homo sapiens	Inhibition	%	5.76
	8112729	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	4.32	CHEMBL4247	Homo sapiens	Inhibition	%	4.32
	8112901	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-0.16	CHEMBL4247	Homo sapiens	Inhibition	%	-0.16
	8113053	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	24.53	CHEMBL4247	Homo sapiens	Inhibition	%	24.53
	8113277	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	2.7	CHEMBL4247	Homo sapiens	Inhibition	%	2.7
	8113413	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	3.74	CHEMBL4247	Homo sapiens	Inhibition	%	3.74
	8113761	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	4.68	CHEMBL4247	Homo sapiens	Inhibition	%	4.68
	8113877	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-3.29	CHEMBL4247	Homo sapiens	Inhibition	%	-3.29
	8114277	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	3.0	CHEMBL4247	Homo sapiens	Inhibition	%	3.0
	8114409	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	4.06	CHEMBL4247	Homo sapiens	Inhibition	%	4.06
	8114633	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	3.35	CHEMBL4247	Homo sapiens	Inhibition	%	3.35
	8114685	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	2.91	CHEMBL4247	Homo sapiens	Inhibition	%	2.91
	8114909	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	4.07	CHEMBL4247	Homo sapiens	Inhibition	%	4.07
	8115075	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	2.84	CHEMBL4247	Homo sapiens	Inhibition	%	2.84
	8115240	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-0.9	CHEMBL4247	Homo sapiens	Inhibition	%	-0.9
	8115464	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-2.16	CHEMBL4247	Homo sapiens	Inhibition	%	-2.16
	8115584	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	3.68	CHEMBL4247	Homo sapiens	Inhibition	%	3.68
	8115941	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	1.45	CHEMBL4247	Homo sapiens	Inhibition	%	1.45
	8116100	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-0.91	CHEMBL4247	Homo sapiens	Inhibition	%	-0.91
	8116303	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	4.76	CHEMBL4247	Homo sapiens	Inhibition	%	4.76
	8116527	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	1.83	CHEMBL4247	Homo sapiens	Inhibition	%	1.83
	8116661	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	1.35	CHEMBL4247	Homo sapiens	Inhibition	%	1.35
	8117057	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	13.85	CHEMBL4247	Homo sapiens	Inhibition	%	13.85
	8117228	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	1.21	CHEMBL4247	Homo sapiens	Inhibition	%	1.21
	8117610	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	3.58	CHEMBL4247	Homo sapiens	Inhibition	%	3.58
	8117740	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	1.08	CHEMBL4247	Homo sapiens	Inhibition	%	1.08
	8118102	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-1.0	CHEMBL4247	Homo sapiens	Inhibition	%	-1.0
	8118218	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-1.97	CHEMBL4247	Homo sapiens	Inhibition	%	-1.97
	8118442	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	5.82	CHEMBL4247	Homo sapiens	Inhibition	%	5.82
	8118614	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	5.12	CHEMBL4247	Homo sapiens	Inhibition	%	5.12
	8118974	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	4.37	CHEMBL4247	Homo sapiens	Inhibition	%	4.37
	8119245	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	97.79	CHEMBL4247	Homo sapiens	Inhibition	%	97.79
	8119404	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	22.84	CHEMBL4247	Homo sapiens	Inhibition	%	22.84
	8119795	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-2.6	CHEMBL4247	Homo sapiens	Inhibition	%	-2.6
	8119914	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	0.89	CHEMBL4247	Homo sapiens	Inhibition	%	0.89
	8120277	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	2.45	CHEMBL4247	Homo sapiens	Inhibition	%	2.45
	8120437	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-1.23	CHEMBL4247	Homo sapiens	Inhibition	%	-1.23
	8120661	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.47	CHEMBL4247	Homo sapiens	Inhibition	%	-0.47
	8120862	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	4.92	CHEMBL4247	Homo sapiens	Inhibition	%	4.92
	8120990	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-0.35	CHEMBL4247	Homo sapiens	Inhibition	%	-0.35
	8121214	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	2.81	CHEMBL4247	Homo sapiens	Inhibition	%	2.81
	8121386	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.1	CHEMBL4247	Homo sapiens	Inhibition	%	1.1
	8121553	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	1.31	CHEMBL4247	Homo sapiens	Inhibition	%	1.31
	8121940	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	4.26	CHEMBL4247	Homo sapiens	Inhibition	%	4.26
	8122061	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	4.89	CHEMBL4247	Homo sapiens	Inhibition	%	4.89
	8122285	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-1.14	CHEMBL4247	Homo sapiens	Inhibition	%	-1.14
	8122423	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	1.5	CHEMBL4247	Homo sapiens	Inhibition	%	1.5
	8122767	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	7.26	CHEMBL4247	Homo sapiens	Inhibition	%	7.26
	8122934	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	3.75	CHEMBL4247	Homo sapiens	Inhibition	%	3.75
	8123300	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	0.14	CHEMBL4247	Homo sapiens	Inhibition	%	0.14
	8123578	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	88.91	CHEMBL4247	Homo sapiens	Inhibition	%	88.91
	8123728	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	2.44	CHEMBL4247	Homo sapiens	Inhibition	%	2.44
	8123952	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	6.69	CHEMBL4247	Homo sapiens	Inhibition	%	6.69
	8124119	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-1.9	CHEMBL4247	Homo sapiens	Inhibition	%	-1.9
	8124238	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	3.6	CHEMBL4247	Homo sapiens	Inhibition	%	3.6
	8124462	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	5.36	CHEMBL4247	Homo sapiens	Inhibition	%	5.36
	8124601	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.5	CHEMBL4247	Homo sapiens	Inhibition	%	1.5
	8124990	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.05	CHEMBL4247	Homo sapiens	Inhibition	%	0.05
	8125191	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	1.79	CHEMBL4247	Homo sapiens	Inhibition	%	1.79
	8125545	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.19	CHEMBL4247	Homo sapiens	Inhibition	%	0.19
	8125713	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	0.46	CHEMBL4247	Homo sapiens	Inhibition	%	0.46
	8125877	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	4.47	CHEMBL4247	Homo sapiens	Inhibition	%	4.47
	8126101	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.15	CHEMBL4247	Homo sapiens	Inhibition	%	0.15
	8126265	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	6.94	CHEMBL4247	Homo sapiens	Inhibition	%	6.94
	8126604	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	12.6	CHEMBL4247	Homo sapiens	Inhibition	%	12.6
	8126740	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	4.55	CHEMBL4247	Homo sapiens	Inhibition	%	4.55
	8127086	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	4.84	CHEMBL4247	Homo sapiens	Inhibition	%	4.84
	8127253	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	4.16	CHEMBL4247	Homo sapiens	Inhibition	%	4.16
	8127477	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	4.12	CHEMBL4247	Homo sapiens	Inhibition	%	4.12
	8127619	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	5.04	CHEMBL4247	Homo sapiens	Inhibition	%	5.04
	8127907	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	1.5	CHEMBL4247	Homo sapiens	Inhibition	%	1.5
	8128283	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	1.7	CHEMBL4247	Homo sapiens	Inhibition	%	1.7
	8128450	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-4.64	CHEMBL4247	Homo sapiens	Inhibition	%	-4.64
	8128793	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	32.32	CHEMBL4247	Homo sapiens	Inhibition	%	32.32
	8128930	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	3.25	CHEMBL4247	Homo sapiens	Inhibition	%	3.25
	8129154	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	3.11	CHEMBL4247	Homo sapiens	Inhibition	%	3.11
	8129325	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-1.95	CHEMBL4247	Homo sapiens	Inhibition	%	-1.95
	8129514	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	2.02	CHEMBL4247	Homo sapiens	Inhibition	%	2.02
	8129877	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	1.54	CHEMBL4247	Homo sapiens	Inhibition	%	1.54
	8130038	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.79	CHEMBL4247	Homo sapiens	Inhibition	%	2.79
	8130434	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	1.71	CHEMBL4247	Homo sapiens	Inhibition	%	1.71
	8130594	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	2.57	CHEMBL4247	Homo sapiens	Inhibition	%	2.57
	8130934	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	3.34	CHEMBL4247	Homo sapiens	Inhibition	%	3.34
	8131073	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	15.06	CHEMBL4247	Homo sapiens	Inhibition	%	15.06
	8131297	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	3.92	CHEMBL4247	Homo sapiens	Inhibition	%	3.92
	8131417	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	4.48	CHEMBL4247	Homo sapiens	Inhibition	%	4.48
	8131808	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	7.35	CHEMBL4247	Homo sapiens	Inhibition	%	7.35
	8131949	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	6.2	CHEMBL4247	Homo sapiens	Inhibition	%	6.2
	8132235	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	12.73	CHEMBL4247	Homo sapiens	Inhibition	%	12.73
	8132606	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	3.57	CHEMBL4247	Homo sapiens	Inhibition	%	3.57
	8132774	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	0.91	CHEMBL4247	Homo sapiens	Inhibition	%	0.91
	8133119	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	-0.45	CHEMBL4247	Homo sapiens	Inhibition	%	-0.45
	8133481	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	2.51	CHEMBL4247	Homo sapiens	Inhibition	%	2.51
	8133653	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.08	CHEMBL4247	Homo sapiens	Inhibition	%	-0.08
	8133833	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	1.71	CHEMBL4247	Homo sapiens	Inhibition	%	1.71
	8134057	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	10.26	CHEMBL4247	Homo sapiens	Inhibition	%	10.26
	8134205	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-1.19	CHEMBL4247	Homo sapiens	Inhibition	%	-1.19
	8134365	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	3.31	CHEMBL4247	Homo sapiens	Inhibition	%	3.31
	8134589	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	1.85	CHEMBL4247	Homo sapiens	Inhibition	%	1.85
	8134773	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-2.22	CHEMBL4247	Homo sapiens	Inhibition	%	-2.22
	8134933	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	24.4	CHEMBL4247	Homo sapiens	Inhibition	%	24.4
	8135157	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	3.44	CHEMBL4247	Homo sapiens	Inhibition	%	3.44
	8135272	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	3.77	CHEMBL4247	Homo sapiens	Inhibition	%	3.77
	8135637	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	5.39	CHEMBL4247	Homo sapiens	Inhibition	%	5.39
	8135758	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-0.41	CHEMBL4247	Homo sapiens	Inhibition	%	-0.41
	8135982	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	0.66	CHEMBL4247	Homo sapiens	Inhibition	%	0.66
	8136150	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	1.22	CHEMBL4247	Homo sapiens	Inhibition	%	1.22
	8136294	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	21.78	CHEMBL4247	Homo sapiens	Inhibition	%	21.78
	8136518	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	4.91	CHEMBL4247	Homo sapiens	Inhibition	%	4.91
	8136584	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	22.45	CHEMBL4247	Homo sapiens	Inhibition	%	22.45
	8136808	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	69.91	CHEMBL4247	Homo sapiens	Inhibition	%	69.91
	8136943	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	0.6	CHEMBL4247	Homo sapiens	Inhibition	%	0.6
	8137106	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	0.92	CHEMBL4247	Homo sapiens	Inhibition	%	0.92
	8137330	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	0.42	CHEMBL4247	Homo sapiens	Inhibition	%	0.42
	8137450	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	3.1	CHEMBL4247	Homo sapiens	Inhibition	%	3.1
	8137822	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	0.86	CHEMBL4247	Homo sapiens	Inhibition	%	0.86
	8137988	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-1.14	CHEMBL4247	Homo sapiens	Inhibition	%	-1.14
	8138391	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	2.68	CHEMBL4247	Homo sapiens	Inhibition	%	2.68
	8138539	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	1.1	CHEMBL4247	Homo sapiens	Inhibition	%	1.1
	8138921	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	4.11	CHEMBL4247	Homo sapiens	Inhibition	%	4.11
	8139106	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	5.88	CHEMBL4247	Homo sapiens	Inhibition	%	5.88
	8139489	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	5.05	CHEMBL4247	Homo sapiens	Inhibition	%	5.05
	8139603	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	4.27	CHEMBL4247	Homo sapiens	Inhibition	%	4.27
	8139827	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	4.07	CHEMBL4247	Homo sapiens	Inhibition	%	4.07
	8139968	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	3.34	CHEMBL4247	Homo sapiens	Inhibition	%	3.34
	8140315	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	4.3	CHEMBL4247	Homo sapiens	Inhibition	%	4.3
	8140474	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	2.63	CHEMBL4247	Homo sapiens	Inhibition	%	2.63
	8140841	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	6.26	CHEMBL4247	Homo sapiens	Inhibition	%	6.26
	8141143	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	90.04	CHEMBL4247	Homo sapiens	Inhibition	%	90.04
	8141273	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	3.88	CHEMBL4247	Homo sapiens	Inhibition	%	3.88
	8141657	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	3.35	CHEMBL4247	Homo sapiens	Inhibition	%	3.35
	8141776	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-3.56	CHEMBL4247	Homo sapiens	Inhibition	%	-3.56
	8142000	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-1.77	CHEMBL4247	Homo sapiens	Inhibition	%	-1.77
	8142161	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	8.08	CHEMBL4247	Homo sapiens	Inhibition	%	8.08
	8142329	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	1.02	CHEMBL4247	Homo sapiens	Inhibition	%	1.02
	8142553	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	1.57	CHEMBL4247	Homo sapiens	Inhibition	%	1.57
	8142729	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	6.49	CHEMBL4247	Homo sapiens	Inhibition	%	6.49
	8142878	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-4.4	CHEMBL4247	Homo sapiens	Inhibition	%	-4.4
	8143102	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-3.45	CHEMBL4247	Homo sapiens	Inhibition	%	-3.45
	8143257	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	3.7	CHEMBL4247	Homo sapiens	Inhibition	%	3.7
	8143444	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	3.04	CHEMBL4247	Homo sapiens	Inhibition	%	3.04
	8143668	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	4.7	CHEMBL4247	Homo sapiens	Inhibition	%	4.7
	8143827	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	3.25	CHEMBL4247	Homo sapiens	Inhibition	%	3.25
	8144165	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-0.91	CHEMBL4247	Homo sapiens	Inhibition	%	-0.91
	8144304	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	7.82	CHEMBL4247	Homo sapiens	Inhibition	%	7.82
	8144658	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	5.07	CHEMBL4247	Homo sapiens	Inhibition	%	5.07
	8144811	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.91	CHEMBL4247	Homo sapiens	Inhibition	%	1.91
	8145035	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.88	CHEMBL4247	Homo sapiens	Inhibition	%	2.88
	8145172	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	4.32	CHEMBL4247	Homo sapiens	Inhibition	%	4.32
	8145485	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	85.32	CHEMBL4247	Homo sapiens	Inhibition	%	85.32
	8145609	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	1.35	CHEMBL4247	Homo sapiens	Inhibition	%	1.35
	8145833	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	2.65	CHEMBL4247	Homo sapiens	Inhibition	%	2.65
	8145994	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	1.74	CHEMBL4247	Homo sapiens	Inhibition	%	1.74
	8146338	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	1.12	CHEMBL4247	Homo sapiens	Inhibition	%	1.12
	8146498	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	35.24	CHEMBL4247	Homo sapiens	Inhibition	%	35.24
	8146889	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	20.84	CHEMBL4247	Homo sapiens	Inhibition	%	20.84
	8147058	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	5.6	CHEMBL4247	Homo sapiens	Inhibition	%	5.6
	8147424	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.89	CHEMBL4247	Homo sapiens	Inhibition	%	1.89
	8147577	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	3.34	CHEMBL4247	Homo sapiens	Inhibition	%	3.34
	8147988	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	5.2	CHEMBL4247	Homo sapiens	Inhibition	%	5.2
	8148146	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	3.77	CHEMBL4247	Homo sapiens	Inhibition	%	3.77
	8148484	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	1.84	CHEMBL4247	Homo sapiens	Inhibition	%	1.84
	8148623	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	2.0	CHEMBL4247	Homo sapiens	Inhibition	%	2.0
	8148847	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	3.19	CHEMBL4247	Homo sapiens	Inhibition	%	3.19
	8148985	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	4.85	CHEMBL4247	Homo sapiens	Inhibition	%	4.85
	8149368	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-2.83	CHEMBL4247	Homo sapiens	Inhibition	%	-2.83
	8149502	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	6.67	CHEMBL4247	Homo sapiens	Inhibition	%	6.67
	8149824	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	2.46	CHEMBL4247	Homo sapiens	Inhibition	%	2.46
	8150173	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-1.81	CHEMBL4247	Homo sapiens	Inhibition	%	-1.81
	8150333	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	4.6	CHEMBL4247	Homo sapiens	Inhibition	%	4.6
	8150677	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	2.57	CHEMBL4247	Homo sapiens	Inhibition	%	2.57
	8150842	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	83.86	CHEMBL4247	Homo sapiens	Inhibition	%	83.86
	8151066	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	85.42	CHEMBL4247	Homo sapiens	Inhibition	%	85.42
	8151229	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-1.6	CHEMBL4247	Homo sapiens	Inhibition	%	-1.6
	8151406	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	35.42	CHEMBL4247	Homo sapiens	Inhibition	%	35.42
	8151768	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.6	CHEMBL4247	Homo sapiens	Inhibition	%	1.6
	8151922	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	3.3	CHEMBL4247	Homo sapiens	Inhibition	%	3.3
	8152146	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	5.15	CHEMBL4247	Homo sapiens	Inhibition	%	5.15
	8152334	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	15.04	CHEMBL4247	Homo sapiens	Inhibition	%	15.04
	8152492	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	2.99	CHEMBL4247	Homo sapiens	Inhibition	%	2.99
	8152716	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	3.91	CHEMBL4247	Homo sapiens	Inhibition	%	3.91
	8152830	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	4.29	CHEMBL4247	Homo sapiens	Inhibition	%	4.29
	8153193	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.64	CHEMBL4247	Homo sapiens	Inhibition	%	2.64
	8153330	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	4.45	CHEMBL4247	Homo sapiens	Inhibition	%	4.45
	8153711	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-0.48	CHEMBL4247	Homo sapiens	Inhibition	%	-0.48
	8153844	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	1.99	CHEMBL4247	Homo sapiens	Inhibition	%	1.99
	8154068	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	4.23	CHEMBL4247	Homo sapiens	Inhibition	%	4.23
	8154165	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	14.22	CHEMBL4247	Homo sapiens	Inhibition	%	14.22
	8154515	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	7.58	CHEMBL4247	Homo sapiens	Inhibition	%	7.58
	8154674	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.88	CHEMBL4247	Homo sapiens	Inhibition	%	1.88
	8154898	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	3.83	CHEMBL4247	Homo sapiens	Inhibition	%	3.83
	8155018	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.7	CHEMBL4247	Homo sapiens	Inhibition	%	0.7
	8155418	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	3.84	CHEMBL4247	Homo sapiens	Inhibition	%	3.84
	8155579	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-1.66	CHEMBL4247	Homo sapiens	Inhibition	%	-1.66
	8155757	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.99	CHEMBL4247	Homo sapiens	Inhibition	%	1.99
	8155981	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	5.07	CHEMBL4247	Homo sapiens	Inhibition	%	5.07
	8156119	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	2.18	CHEMBL4247	Homo sapiens	Inhibition	%	2.18
	8156331	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	6.28	CHEMBL4247	Homo sapiens	Inhibition	%	6.28
	8156555	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	4.09	CHEMBL4247	Homo sapiens	Inhibition	%	4.09
	8156705	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	2.87	CHEMBL4247	Homo sapiens	Inhibition	%	2.87
	8157072	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	6.29	CHEMBL4247	Homo sapiens	Inhibition	%	6.29
	8157192	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	3.26	CHEMBL4247	Homo sapiens	Inhibition	%	3.26
	8157557	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	2.22	CHEMBL4247	Homo sapiens	Inhibition	%	2.22
	8157687	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	6.42	CHEMBL4247	Homo sapiens	Inhibition	%	6.42
	8157911	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	2.63	CHEMBL4247	Homo sapiens	Inhibition	%	2.63
	8158072	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	0.01	CHEMBL4247	Homo sapiens	Inhibition	%	0.01
	8158322	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	6.27	CHEMBL4247	Homo sapiens	Inhibition	%	6.27
	8158704	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	5.33	CHEMBL4247	Homo sapiens	Inhibition	%	5.33
	8158873	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.02	CHEMBL4247	Homo sapiens	Inhibition	%	2.02
	8159232	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	7.04	CHEMBL4247	Homo sapiens	Inhibition	%	7.04
	8159352	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	2.26	CHEMBL4247	Homo sapiens	Inhibition	%	2.26
	8159576	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-2.59	CHEMBL4247	Homo sapiens	Inhibition	%	-2.59
	8159707	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	7.98	CHEMBL4247	Homo sapiens	Inhibition	%	7.98
	8160072	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.4	CHEMBL4247	Homo sapiens	Inhibition	%	1.4
	8160209	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	3.56	CHEMBL4247	Homo sapiens	Inhibition	%	3.56
	8160583	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-2.24	CHEMBL4247	Homo sapiens	Inhibition	%	-2.24
	8160877	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	10.65	CHEMBL4247	Homo sapiens	Inhibition	%	10.65
	8161027	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	2.33	CHEMBL4247	Homo sapiens	Inhibition	%	2.33
	8161394	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	3.96	CHEMBL4247	Homo sapiens	Inhibition	%	3.96
	8161519	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	6.8	CHEMBL4247	Homo sapiens	Inhibition	%	6.8
	8161743	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	2.43	CHEMBL4247	Homo sapiens	Inhibition	%	2.43
	8161881	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	6.97	CHEMBL4247	Homo sapiens	Inhibition	%	6.97
	8162235	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	7.95	CHEMBL4247	Homo sapiens	Inhibition	%	7.95
	8162395	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-3.93	CHEMBL4247	Homo sapiens	Inhibition	%	-3.93
	8162648	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	3.95	CHEMBL4247	Homo sapiens	Inhibition	%	3.95
	8163020	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	7.33	CHEMBL4247	Homo sapiens	Inhibition	%	7.33
	8163189	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	4.05	CHEMBL4247	Homo sapiens	Inhibition	%	4.05
	8163413	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	2.92	CHEMBL4247	Homo sapiens	Inhibition	%	2.92
	8163547	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	6.43	CHEMBL4247	Homo sapiens	Inhibition	%	6.43
	8163894	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-1.88	CHEMBL4247	Homo sapiens	Inhibition	%	-1.88
	8164028	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	98.2	CHEMBL4247	Homo sapiens	Inhibition	%	98.2
	8164392	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-0.41	CHEMBL4247	Homo sapiens	Inhibition	%	-0.41
	8164547	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	8.62	CHEMBL4247	Homo sapiens	Inhibition	%	8.62
	8164771	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	4.04	CHEMBL4247	Homo sapiens	Inhibition	%	4.04
	8164915	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	2.88	CHEMBL4247	Homo sapiens	Inhibition	%	2.88
	8165209	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	94.43	CHEMBL4247	Homo sapiens	Inhibition	%	94.43
	8165350	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	5.11	CHEMBL4247	Homo sapiens	Inhibition	%	5.11
	8165574	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	2.14	CHEMBL4247	Homo sapiens	Inhibition	%	2.14
	8165717	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	31.72	CHEMBL4247	Homo sapiens	Inhibition	%	31.72
	8166067	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	4.74	CHEMBL4247	Homo sapiens	Inhibition	%	4.74
	8166205	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	1.3	CHEMBL4247	Homo sapiens	Inhibition	%	1.3
	8166559	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	3.1	CHEMBL4247	Homo sapiens	Inhibition	%	3.1
	8166884	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	39.29	CHEMBL4247	Homo sapiens	Inhibition	%	39.29
	8166972	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	3.52	CHEMBL4247	Homo sapiens	Inhibition	%	3.52
	8167196	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	1.15	CHEMBL4247	Homo sapiens	Inhibition	%	1.15
	8167337	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	32.17	CHEMBL4247	Homo sapiens	Inhibition	%	32.17
	8167725	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	2.25	CHEMBL4247	Homo sapiens	Inhibition	%	2.25
	8167858	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	5.2	CHEMBL4247	Homo sapiens	Inhibition	%	5.2
	8168206	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	0.35	CHEMBL4247	Homo sapiens	Inhibition	%	0.35
	8168347	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	86.26	CHEMBL4247	Homo sapiens	Inhibition	%	86.26
	8168571	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	3.18	CHEMBL4247	Homo sapiens	Inhibition	%	3.18
	8168707	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.55	CHEMBL4247	Homo sapiens	Inhibition	%	1.55
	8169095	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	18.74	CHEMBL4247	Homo sapiens	Inhibition	%	18.74
	8169237	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	3.16	CHEMBL4247	Homo sapiens	Inhibition	%	3.16
	8169541	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	90.8	CHEMBL4247	Homo sapiens	Inhibition	%	90.8
	8169899	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	3.85	CHEMBL4247	Homo sapiens	Inhibition	%	3.85
	8170044	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	2.49	CHEMBL4247	Homo sapiens	Inhibition	%	2.49
	8170393	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.99	CHEMBL4247	Homo sapiens	Inhibition	%	2.99
	8170533	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	2.54	CHEMBL4247	Homo sapiens	Inhibition	%	2.54
	8170757	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-2.65	CHEMBL4247	Homo sapiens	Inhibition	%	-2.65
	8170892	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	4.75	CHEMBL4247	Homo sapiens	Inhibition	%	4.75
	8171089	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	0.57	CHEMBL4247	Homo sapiens	Inhibition	%	0.57
	8171313	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	5.55	CHEMBL4247	Homo sapiens	Inhibition	%	5.55
	8171530	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	3.72	CHEMBL4247	Homo sapiens	Inhibition	%	3.72
	8171671	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	95.69	CHEMBL4247	Homo sapiens	Inhibition	%	95.69
	8172048	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-1.54	CHEMBL4247	Homo sapiens	Inhibition	%	-1.54
	8172180	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	5.27	CHEMBL4247	Homo sapiens	Inhibition	%	5.27
	8172404	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	2.88	CHEMBL4247	Homo sapiens	Inhibition	%	2.88
	8172532	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	3.89	CHEMBL4247	Homo sapiens	Inhibition	%	3.89
	8172898	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	7.82	CHEMBL4247	Homo sapiens	Inhibition	%	7.82
	8173034	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-1.84	CHEMBL4247	Homo sapiens	Inhibition	%	-1.84
	8173258	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-1.06	CHEMBL4247	Homo sapiens	Inhibition	%	-1.06
	8173423	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	3.94	CHEMBL4247	Homo sapiens	Inhibition	%	3.94
	8173564	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	11.0	CHEMBL4247	Homo sapiens	Inhibition	%	11.0
	8173788	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	4.13	CHEMBL4247	Homo sapiens	Inhibition	%	4.13
	8173875	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	3.67	CHEMBL4247	Homo sapiens	Inhibition	%	3.67
	8174231	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	2.92	CHEMBL4247	Homo sapiens	Inhibition	%	2.92
	8174379	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	10.85	CHEMBL4247	Homo sapiens	Inhibition	%	10.85
	8174603	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.84	CHEMBL4247	Homo sapiens	Inhibition	%	1.84
	8174725	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	4.7	CHEMBL4247	Homo sapiens	Inhibition	%	4.7
	8175092	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	0.19	CHEMBL4247	Homo sapiens	Inhibition	%	0.19
	8175228	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	4.56	CHEMBL4247	Homo sapiens	Inhibition	%	4.56
	8175452	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	23.73	CHEMBL4247	Homo sapiens	Inhibition	%	23.73
	8175484	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	1.97	CHEMBL4247	Homo sapiens	Inhibition	%	1.97
	8175708	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	11.82	CHEMBL4247	Homo sapiens	Inhibition	%	11.82
	8175871	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	3.45	CHEMBL4247	Homo sapiens	Inhibition	%	3.45
	8176024	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	78.54	CHEMBL4247	Homo sapiens	Inhibition	%	78.54
	8176248	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	6.31	CHEMBL4247	Homo sapiens	Inhibition	%	6.31
	8176397	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-1.21	CHEMBL4247	Homo sapiens	Inhibition	%	-1.21
	8176753	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	16.42	CHEMBL4247	Homo sapiens	Inhibition	%	16.42
	8176883	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-0.73	CHEMBL4247	Homo sapiens	Inhibition	%	-0.73
	8177107	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	3.68	CHEMBL4247	Homo sapiens	Inhibition	%	3.68
	8177249	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	-0.37	CHEMBL4247	Homo sapiens	Inhibition	%	-0.37
	8177611	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	13.81	CHEMBL4247	Homo sapiens	Inhibition	%	13.81
	8177775	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	7.96	CHEMBL4247	Homo sapiens	Inhibition	%	7.96
	8178139	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	9.22	CHEMBL4247	Homo sapiens	Inhibition	%	9.22
	8178227	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	12.93	CHEMBL4247	Homo sapiens	Inhibition	%	12.93
	8178451	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.82	CHEMBL4247	Homo sapiens	Inhibition	%	2.82
	8178578	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	4.4	CHEMBL4247	Homo sapiens	Inhibition	%	4.4
	8178951	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	3.12	CHEMBL4247	Homo sapiens	Inhibition	%	3.12
	8179074	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.85	CHEMBL4247	Homo sapiens	Inhibition	%	1.85
	8179298	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	4.55	CHEMBL4247	Homo sapiens	Inhibition	%	4.55
	8179442	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	1.39	CHEMBL4247	Homo sapiens	Inhibition	%	1.39
	8179803	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.67	CHEMBL4247	Homo sapiens	Inhibition	%	1.67
	8180060	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	2.9	CHEMBL4247	Homo sapiens	Inhibition	%	2.9
	8180214	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	19.16	CHEMBL4247	Homo sapiens	Inhibition	%	19.16
	8180594	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	17.33	CHEMBL4247	Homo sapiens	Inhibition	%	17.33
	8180742	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	1.86	CHEMBL4247	Homo sapiens	Inhibition	%	1.86
	8181099	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	2.56	CHEMBL4247	Homo sapiens	Inhibition	%	2.56
	8181454	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-1.33	CHEMBL4247	Homo sapiens	Inhibition	%	-1.33
	8181594	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	4.03	CHEMBL4247	Homo sapiens	Inhibition	%	4.03
	8181957	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	58.27	CHEMBL4247	Homo sapiens	Inhibition	%	58.27
	8182120	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	3.27	CHEMBL4247	Homo sapiens	Inhibition	%	3.27
	8182484	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.18	CHEMBL4247	Homo sapiens	Inhibition	%	3.18
	8182800	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	5.03	CHEMBL4247	Homo sapiens	Inhibition	%	5.03
	8182922	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	2.82	CHEMBL4247	Homo sapiens	Inhibition	%	2.82
	8183146	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	3.76	CHEMBL4247	Homo sapiens	Inhibition	%	3.76
	8183295	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	2.9	CHEMBL4247	Homo sapiens	Inhibition	%	2.9
	8183648	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	-1.39	CHEMBL4247	Homo sapiens	Inhibition	%	-1.39
	8183790	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	4.24	CHEMBL4247	Homo sapiens	Inhibition	%	4.24
	8184150	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	4.89	CHEMBL4247	Homo sapiens	Inhibition	%	4.89
	8184416	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	6.61	CHEMBL4247	Homo sapiens	Inhibition	%	6.61
	8184563	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-2.31	CHEMBL4247	Homo sapiens	Inhibition	%	-2.31
	8184787	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	2.96	CHEMBL4247	Homo sapiens	Inhibition	%	2.96
	8184944	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	4.64	CHEMBL4247	Homo sapiens	Inhibition	%	4.64
	8185093	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	8.32	CHEMBL4247	Homo sapiens	Inhibition	%	8.32
	8185317	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-0.48	CHEMBL4247	Homo sapiens	Inhibition	%	-0.48
	8185448	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	8.35	CHEMBL4247	Homo sapiens	Inhibition	%	8.35
	8185803	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	14.24	CHEMBL4247	Homo sapiens	Inhibition	%	14.24
	8185942	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	3.37	CHEMBL4247	Homo sapiens	Inhibition	%	3.37
	8186166	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	4.86	CHEMBL4247	Homo sapiens	Inhibition	%	4.86
	8186307	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	2.49	CHEMBL4247	Homo sapiens	Inhibition	%	2.49
	8186471	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	5.68	CHEMBL4247	Homo sapiens	Inhibition	%	5.68
	8186695	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	1.29	CHEMBL4247	Homo sapiens	Inhibition	%	1.29
	8186834	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	6.53	CHEMBL4247	Homo sapiens	Inhibition	%	6.53
	8187156	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	3.62	CHEMBL4247	Homo sapiens	Inhibition	%	3.62
	8187504	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	2.4	CHEMBL4247	Homo sapiens	Inhibition	%	2.4
	8187652	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	8.1	CHEMBL4247	Homo sapiens	Inhibition	%	8.1
	8188005	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	1.59	CHEMBL4247	Homo sapiens	Inhibition	%	1.59
	8188148	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	1.16	CHEMBL4247	Homo sapiens	Inhibition	%	1.16
	8188372	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	5.53	CHEMBL4247	Homo sapiens	Inhibition	%	5.53
	8188507	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-3.22	CHEMBL4247	Homo sapiens	Inhibition	%	-3.22
	8188781	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.3	CHEMBL4247	Homo sapiens	Inhibition	%	4.3
	8189153	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	0.72	CHEMBL4247	Homo sapiens	Inhibition	%	0.72
	8189309	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	7.86	CHEMBL4247	Homo sapiens	Inhibition	%	7.86
	8189682	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.2	CHEMBL4247	Homo sapiens	Inhibition	%	0.2
	8189814	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	3.38	CHEMBL4247	Homo sapiens	Inhibition	%	3.38
	8190038	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	31.9	CHEMBL4247	Homo sapiens	Inhibition	%	31.9
	8190170	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	2.62	CHEMBL4247	Homo sapiens	Inhibition	%	2.62
	8190534	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	3.8	CHEMBL4247	Homo sapiens	Inhibition	%	3.8
	8190671	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	8.04	CHEMBL4247	Homo sapiens	Inhibition	%	8.04
	8191059	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	5.62	CHEMBL4247	Homo sapiens	Inhibition	%	5.62
	8191197	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	3.32	CHEMBL4247	Homo sapiens	Inhibition	%	3.32
	8191421	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	11.73	CHEMBL4247	Homo sapiens	Inhibition	%	11.73
	8191517	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	4.41	CHEMBL4247	Homo sapiens	Inhibition	%	4.41
	8191863	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	5.73	CHEMBL4247	Homo sapiens	Inhibition	%	5.73
	8192012	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.66	CHEMBL4247	Homo sapiens	Inhibition	%	2.66
	8192236	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	4.03	CHEMBL4247	Homo sapiens	Inhibition	%	4.03
	8192365	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	0.25	CHEMBL4247	Homo sapiens	Inhibition	%	0.25
	8192733	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	4.09	CHEMBL4247	Homo sapiens	Inhibition	%	4.09
	8192869	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-1.6	CHEMBL4247	Homo sapiens	Inhibition	%	-1.6
	8193141	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	11.07	CHEMBL4247	Homo sapiens	Inhibition	%	11.07
	8193510	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	4.12	CHEMBL4247	Homo sapiens	Inhibition	%	4.12
	8193667	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	2.94	CHEMBL4247	Homo sapiens	Inhibition	%	2.94
	8193891	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	12.71	CHEMBL4247	Homo sapiens	Inhibition	%	12.71
	8194040	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-1.38	CHEMBL4247	Homo sapiens	Inhibition	%	-1.38
	8194395	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	4.66	CHEMBL4247	Homo sapiens	Inhibition	%	4.66
	8194526	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	6.47	CHEMBL4247	Homo sapiens	Inhibition	%	6.47
	8194893	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	5.19	CHEMBL4247	Homo sapiens	Inhibition	%	5.19
	8195026	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	3.71	CHEMBL4247	Homo sapiens	Inhibition	%	3.71
	8195250	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	5.43	CHEMBL4247	Homo sapiens	Inhibition	%	5.43
	8195414	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	3.92	CHEMBL4247	Homo sapiens	Inhibition	%	3.92
	8195777	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	3.63	CHEMBL4247	Homo sapiens	Inhibition	%	3.63
	8195875	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	4.23	CHEMBL4247	Homo sapiens	Inhibition	%	4.23
	8196099	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	4.29	CHEMBL4247	Homo sapiens	Inhibition	%	4.29
	8196216	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	1.23	CHEMBL4247	Homo sapiens	Inhibition	%	1.23
	8196590	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	2.29	CHEMBL4247	Homo sapiens	Inhibition	%	2.29
	8196718	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	-0.53	CHEMBL4247	Homo sapiens	Inhibition	%	-0.53
	8197083	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	4.22	CHEMBL4247	Homo sapiens	Inhibition	%	4.22
	8197220	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-0.08	CHEMBL4247	Homo sapiens	Inhibition	%	-0.08
	8197444	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	1.27	CHEMBL4247	Homo sapiens	Inhibition	%	1.27
	8197495	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	1.8	CHEMBL4247	Homo sapiens	Inhibition	%	1.8
	8197719	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	4.91	CHEMBL4247	Homo sapiens	Inhibition	%	4.91
	8197859	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	1.53	CHEMBL4247	Homo sapiens	Inhibition	%	1.53
	8198240	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-0.77	CHEMBL4247	Homo sapiens	Inhibition	%	-0.77
	8198378	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-2.28	CHEMBL4247	Homo sapiens	Inhibition	%	-2.28
	8198732	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	13.84	CHEMBL4247	Homo sapiens	Inhibition	%	13.84
	8198863	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	3.63	CHEMBL4247	Homo sapiens	Inhibition	%	3.63
	8199087	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	4.31	CHEMBL4247	Homo sapiens	Inhibition	%	4.31
	8199235	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	4.99	CHEMBL4247	Homo sapiens	Inhibition	%	4.99
	8199593	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	2.52	CHEMBL4247	Homo sapiens	Inhibition	%	2.52
	8199756	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	20.77	CHEMBL4247	Homo sapiens	Inhibition	%	20.77
	8200118	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	8.19	CHEMBL4247	Homo sapiens	Inhibition	%	8.19
	8200446	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	2.8	CHEMBL4247	Homo sapiens	Inhibition	%	2.8
	8200561	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	5.36	CHEMBL4247	Homo sapiens	Inhibition	%	5.36
	8200935	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	5.55	CHEMBL4247	Homo sapiens	Inhibition	%	5.55
	8201065	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	-3.76	CHEMBL4247	Homo sapiens	Inhibition	%	-3.76
	8201289	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	6.72	CHEMBL4247	Homo sapiens	Inhibition	%	6.72
	8201424	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	4.77	CHEMBL4247	Homo sapiens	Inhibition	%	4.77
	8201781	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.66	CHEMBL4247	Homo sapiens	Inhibition	%	-0.66
	8202060	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	1.6	CHEMBL4247	Homo sapiens	Inhibition	%	1.6
	8202200	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	5.8	CHEMBL4247	Homo sapiens	Inhibition	%	5.8
	8202424	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-1.31	CHEMBL4247	Homo sapiens	Inhibition	%	-1.31
	8202591	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	0.29	CHEMBL4247	Homo sapiens	Inhibition	%	0.29
	8202716	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	4.07	CHEMBL4247	Homo sapiens	Inhibition	%	4.07
	8202940	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	5.67	CHEMBL4247	Homo sapiens	Inhibition	%	5.67
	8203070	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	4.6	CHEMBL4247	Homo sapiens	Inhibition	%	4.6
	8203425	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	1.38	CHEMBL4247	Homo sapiens	Inhibition	%	1.38
	8203571	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	4.24	CHEMBL4247	Homo sapiens	Inhibition	%	4.24
	8203929	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	4.64	CHEMBL4247	Homo sapiens	Inhibition	%	4.64
	8204095	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	3.06	CHEMBL4247	Homo sapiens	Inhibition	%	3.06
	8204319	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	5.54	CHEMBL4247	Homo sapiens	Inhibition	%	5.54
	8204456	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	5.32	CHEMBL4247	Homo sapiens	Inhibition	%	5.32
	8204785	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	2.67	CHEMBL4247	Homo sapiens	Inhibition	%	2.67
	8204900	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	1.72	CHEMBL4247	Homo sapiens	Inhibition	%	1.72
	8205124	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	8.84	CHEMBL4247	Homo sapiens	Inhibition	%	8.84
	8205273	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	2.05	CHEMBL4247	Homo sapiens	Inhibition	%	2.05
	8205633	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	2.69	CHEMBL4247	Homo sapiens	Inhibition	%	2.69
	8205772	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	15.51	CHEMBL4247	Homo sapiens	Inhibition	%	15.51
	8205996	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	1.68	CHEMBL4247	Homo sapiens	Inhibition	%	1.68
	8206128	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	2.15	CHEMBL4247	Homo sapiens	Inhibition	%	2.15
	8206404	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.6	CHEMBL4247	Homo sapiens	Inhibition	%	2.6
	8206771	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	1.3	CHEMBL4247	Homo sapiens	Inhibition	%	1.3
	8206951	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	2.82	CHEMBL4247	Homo sapiens	Inhibition	%	2.82
	8207301	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	5.48	CHEMBL4247	Homo sapiens	Inhibition	%	5.48
	8207431	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	14.98	CHEMBL4247	Homo sapiens	Inhibition	%	14.98
	8207787	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	18.82	CHEMBL4247	Homo sapiens	Inhibition	%	18.82
	8207932	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.15	CHEMBL4247	Homo sapiens	Inhibition	%	2.15
	8208156	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	3.78	CHEMBL4247	Homo sapiens	Inhibition	%	3.78
	8208288	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	3.73	CHEMBL4247	Homo sapiens	Inhibition	%	3.73
	8208678	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	2.78	CHEMBL4247	Homo sapiens	Inhibition	%	2.78
	8208811	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	34.14	CHEMBL4247	Homo sapiens	Inhibition	%	34.14
	8209140	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	1.79	CHEMBL4247	Homo sapiens	Inhibition	%	1.79
	8209480	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	1.41	CHEMBL4247	Homo sapiens	Inhibition	%	1.41
	8209630	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	9.86	CHEMBL4247	Homo sapiens	Inhibition	%	9.86
	8209854	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	2.73	CHEMBL4247	Homo sapiens	Inhibition	%	2.73
	8209990	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	5.24	CHEMBL4247	Homo sapiens	Inhibition	%	5.24
	8210355	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	3.58	CHEMBL4247	Homo sapiens	Inhibition	%	3.58
	8210491	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-2.08	CHEMBL4247	Homo sapiens	Inhibition	%	-2.08
	8210750	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-1.04	CHEMBL4247	Homo sapiens	Inhibition	%	-1.04
	8211118	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	3.59	CHEMBL4247	Homo sapiens	Inhibition	%	3.59
	8211288	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	4.63	CHEMBL4247	Homo sapiens	Inhibition	%	4.63
	8211635	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	7.43	CHEMBL4247	Homo sapiens	Inhibition	%	7.43
	8211764	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	23.89	CHEMBL4247	Homo sapiens	Inhibition	%	23.89
	8211988	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	72.32	CHEMBL4247	Homo sapiens	Inhibition	%	72.32
	8212120	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	2.82	CHEMBL4247	Homo sapiens	Inhibition	%	2.82
	8212485	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	1.12	CHEMBL4247	Homo sapiens	Inhibition	%	1.12
	8212618	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	5.23	CHEMBL4247	Homo sapiens	Inhibition	%	5.23
	8212842	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	3.15	CHEMBL4247	Homo sapiens	Inhibition	%	3.15
	8213012	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	7.11	CHEMBL4247	Homo sapiens	Inhibition	%	7.11
	8213141	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.63	CHEMBL4247	Homo sapiens	Inhibition	%	2.63
	8213365	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	5.84	CHEMBL4247	Homo sapiens	Inhibition	%	5.84
	8213469	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	4.33	CHEMBL4247	Homo sapiens	Inhibition	%	4.33
	8213806	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	4.86	CHEMBL4247	Homo sapiens	Inhibition	%	4.86
	8214177	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	3.11	CHEMBL4247	Homo sapiens	Inhibition	%	3.11
	8214314	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	4.18	CHEMBL4247	Homo sapiens	Inhibition	%	4.18
	8214672	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	-0.94	CHEMBL4247	Homo sapiens	Inhibition	%	-0.94
	8214824	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-1.3	CHEMBL4247	Homo sapiens	Inhibition	%	-1.3
	8215075	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	0.41	CHEMBL4247	Homo sapiens	Inhibition	%	0.41
	8215299	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	2.67	CHEMBL4247	Homo sapiens	Inhibition	%	2.67
	8215452	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	12.36	CHEMBL4247	Homo sapiens	Inhibition	%	12.36
	8215616	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	4.15	CHEMBL4247	Homo sapiens	Inhibition	%	4.15
	8215840	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	4.73	CHEMBL4247	Homo sapiens	Inhibition	%	4.73
	8215959	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	82.59	CHEMBL4247	Homo sapiens	Inhibition	%	82.59
	8216302	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	1.39	CHEMBL4247	Homo sapiens	Inhibition	%	1.39
	8216438	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	7.12	CHEMBL4247	Homo sapiens	Inhibition	%	7.12
	8216662	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	5.54	CHEMBL4247	Homo sapiens	Inhibition	%	5.54
	8216800	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	2.06	CHEMBL4247	Homo sapiens	Inhibition	%	2.06
	8217158	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	5.21	CHEMBL4247	Homo sapiens	Inhibition	%	5.21
	8217332	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.41	CHEMBL4247	Homo sapiens	Inhibition	%	0.41
	8217687	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	4.25	CHEMBL4247	Homo sapiens	Inhibition	%	4.25
	8217788	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-2.28	CHEMBL4247	Homo sapiens	Inhibition	%	-2.28
	8218012	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.12	CHEMBL4247	Homo sapiens	Inhibition	%	-1.12
	8218127	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.17	CHEMBL4247	Homo sapiens	Inhibition	%	2.17
	8218478	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	3.26	CHEMBL4247	Homo sapiens	Inhibition	%	3.26
	8218621	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	19.03	CHEMBL4247	Homo sapiens	Inhibition	%	19.03
	8218845	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	2.32	CHEMBL4247	Homo sapiens	Inhibition	%	2.32
	8218976	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	10.86	CHEMBL4247	Homo sapiens	Inhibition	%	10.86
	8219136	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-2.58	CHEMBL4247	Homo sapiens	Inhibition	%	-2.58
	8219360	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	3.94	CHEMBL4247	Homo sapiens	Inhibition	%	3.94
	8219610	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	4.91	CHEMBL4247	Homo sapiens	Inhibition	%	4.91
	8219771	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	4.4	CHEMBL4247	Homo sapiens	Inhibition	%	4.4
	8220164	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	0.57	CHEMBL4247	Homo sapiens	Inhibition	%	0.57
	8220293	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	69.53	CHEMBL4247	Homo sapiens	Inhibition	%	69.53
	8220631	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	3.73	CHEMBL4247	Homo sapiens	Inhibition	%	3.73
	8220993	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	25.36	CHEMBL4247	Homo sapiens	Inhibition	%	25.36
	8221129	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-1.89	CHEMBL4247	Homo sapiens	Inhibition	%	-1.89
	8221486	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	68.08	CHEMBL4247	Homo sapiens	Inhibition	%	68.08
	8221651	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	2.22	CHEMBL4247	Homo sapiens	Inhibition	%	2.22
	8222006	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	9.85	CHEMBL4247	Homo sapiens	Inhibition	%	9.85
	8222328	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	2.32	CHEMBL4247	Homo sapiens	Inhibition	%	2.32
	8222462	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	8.67	CHEMBL4247	Homo sapiens	Inhibition	%	8.67
	8222686	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	1.53	CHEMBL4247	Homo sapiens	Inhibition	%	1.53
	8222804	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	8.56	CHEMBL4247	Homo sapiens	Inhibition	%	8.56
	8223172	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	8.5	CHEMBL4247	Homo sapiens	Inhibition	%	8.5
	8223301	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	3.09	CHEMBL4247	Homo sapiens	Inhibition	%	3.09
	8223686	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-0.54	CHEMBL4247	Homo sapiens	Inhibition	%	-0.54
	8223936	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	2.91	CHEMBL4247	Homo sapiens	Inhibition	%	2.91
	8224098	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	3.97	CHEMBL4247	Homo sapiens	Inhibition	%	3.97
	8224322	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	0.36	CHEMBL4247	Homo sapiens	Inhibition	%	0.36
	8224492	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	3.93	CHEMBL4247	Homo sapiens	Inhibition	%	3.93
	8224627	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	5.36	CHEMBL4247	Homo sapiens	Inhibition	%	5.36
	8224851	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	8.17	CHEMBL4247	Homo sapiens	Inhibition	%	8.17
	8224965	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	2.22	CHEMBL4247	Homo sapiens	Inhibition	%	2.22
	8225323	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	3.58	CHEMBL4247	Homo sapiens	Inhibition	%	3.58
	8225461	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	0.48	CHEMBL4247	Homo sapiens	Inhibition	%	0.48
	8225685	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.99	CHEMBL4247	Homo sapiens	Inhibition	%	0.99
	8225820	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	80.74	CHEMBL4247	Homo sapiens	Inhibition	%	80.74
	8225978	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.4	CHEMBL4247	Homo sapiens	Inhibition	%	0.4
	8226202	CHEMBL1962241	GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.82	CHEMBL4247	Homo sapiens	Inhibition	%	1.82
	8226327	CHEMBL1962240	GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	3.59	CHEMBL4247	Homo sapiens	Inhibition	%	3.59
inactive	9507957	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9507958	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1n[nH]c2ncc(Br)cc12		CHEMBL2002105	=	Ki	nM	63095.73	CHEMBL4247	Homo sapiens	pKi		4.2
active	9507959	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Ki	nM	3981.07	CHEMBL4247	Homo sapiens	pKi		5.4
active	9507960	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCCCN(CCC#N)C(=O)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1983348	=	Ki	nM	1584.89	CHEMBL4247	Homo sapiens	pKi		5.8
inactive	9507961	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	<	Ki	nM	3162.28	CHEMBL4247	Homo sapiens	pKi		5.5
active	9507962	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	=	Ki	nM	316.23	CHEMBL4247	Homo sapiens	pKi		6.5
active	9507963	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCOC(=O)Cc1nc2c3cc(Br)ccc3[nH]c(=O)n2n1		CHEMBL1974480	=	Ki	nM	3981.07	CHEMBL4247	Homo sapiens	pKi		5.4
inactive	9507964	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL2000934	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9507965	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1ncnc2c1C(=O)Nc1ccccc1N2		CHEMBL1980671	=	Ki	nM	10000.0	CHEMBL4247	Homo sapiens	pKi		5.0
inactive	9507966	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1cccc(Cl)c1)Nc1nc(CCNc2ncnc3ccsc23)cs1		CHEMBL1986177	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9507967	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9507968	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9507969	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	c1ccc2c(c1)Cc1c[nH]nc1-2		CHEMBL1989423	<	Ki	nM	39810.72	CHEMBL4247	Homo sapiens	pKi		4.4
inactive	9507970	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccnc(Nc2cc(C)nc(-c3ccccc3)n2)c1		CHEMBL1985367	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9507971	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	=	Ki	nM	794.33	CHEMBL4247	Homo sapiens	pKi		6.1
active	9507972	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1nc(N2CCNCC2)nc2ccccc12		CHEMBL1996510	=	Ki	nM	3981.07	CHEMBL4247	Homo sapiens	pKi		5.4
inactive	9507973	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	7943.28	CHEMBL4247	Homo sapiens	pKi		5.1
inactive	9507974	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cn1cc(-c2cccc(NC(=O)c3ccc(C(C)(C)C)cc3)c2CO)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O		CHEMBL2001584	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9507975	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1967998	=	Ki	nM	100.0	CHEMBL4247	Homo sapiens	pKi		7.0
active	9507976	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(C#N)ccc21		CHEMBL1978562	=	Ki	nM	3162.28	CHEMBL4247	Homo sapiens	pKi		5.5
inactive	9507977	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9507978	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9507979	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC(=O)c1cc(Cl)cc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1984788	=	Ki	nM	1000.0	CHEMBL4247	Homo sapiens	pKi		6.0
active	9507980	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccnc2[nH]c3cc(C(C)C)ccc3c(=O)c12		CHEMBL1989471	=	Ki	nM	3162.28	CHEMBL4247	Homo sapiens	pKi		5.5
active	9507981	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	=	Ki	nM	501.19	CHEMBL4247	Homo sapiens	pKi		6.3
inactive	9507982	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9507983	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9507984	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9507985	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC(=O)c1cc2c(-c3ccc(Br)cc3)cncc2s1		CHEMBL1978195	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9507986	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9507987	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Ki	nM	2511.89	CHEMBL4247	Homo sapiens	pKi		5.6
inactive	9507988	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1ccc(CN(C)C)cc1Nc1nccc(-c2c(-c3cccc(NC(=O)Cc4ccccc4)c3)nc3sccn23)n1		CHEMBL1966842	<	Ki	nM	3162.28	CHEMBL4247	Homo sapiens	pKi		5.5
active	9507989	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCN1CCN(c2ccc(Nc3ncc(C)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1974061	=	Ki	nM	39.81	CHEMBL4247	Homo sapiens	pKi		7.4
inactive	9507990	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9507991	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9507992	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	=	Ki	nM	12.59	CHEMBL4247	Homo sapiens	pKi		7.9
inactive	9507993	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cn1cncc1C(OCc1c(-c2ccc(OC(F)(F)F)cc2)cc(C#N)c(=O)n1C)c1ccc(C#N)cc1		CHEMBL127898	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9507994	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9507995	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9507996	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	=	Ki	nM	199.53	CHEMBL4247	Homo sapiens	pKi		6.7
inactive	9507997	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(O)c1cc(-c2cccs2)n2nccc2n1		CHEMBL1977619	<	Ki	nM	12589.25	CHEMBL4247	Homo sapiens	pKi		4.9
inactive	9507998	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	N#Cc1ccc2nc(N)n(-c3nc4c(s3)CCCC4)c2c1		CHEMBL1996345	<	Ki	nM	3981.07	CHEMBL4247	Homo sapiens	pKi		5.4
active	9507999	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COCOc1cccc(OCOC)c1-c1ccc(NS(C)(=O)=O)cc1C(=O)OC		CHEMBL2004025	=	Ki	nM	1584.89	CHEMBL4247	Homo sapiens	pKi		5.8
active	9508000	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccc(-c2cc3c(NCCN)ccc(C(N)=O)c3[nH]2)cc1		CHEMBL1996048	=	Ki	nM	398.11	CHEMBL4247	Homo sapiens	pKi		6.4
inactive	9508001	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C1c2cc([N+](=O)[O-])ccc2-n2c1nc1cccc(Br)c1c2=O		CHEMBL1976158	<	Ki	nM	3162.28	CHEMBL4247	Homo sapiens	pKi		5.5
active	9508002	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL461876	=	Ki	nM	1.259	CHEMBL4247	Homo sapiens	pKi		8.9
inactive	9508003	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1		CHEMBL1965033	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9508004	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	=	Ki	nM	158.49	CHEMBL4247	Homo sapiens	pKi		6.8
active	9508005	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Ki	nM	3162.28	CHEMBL4247	Homo sapiens	pKi		5.5
active	9508006	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc(O)c(NC(C)=O)c4)n3)cc2)CC1		CHEMBL1999485	=	Ki	nM	501.19	CHEMBL4247	Homo sapiens	pKi		6.3
active	9508007	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1n[nH]c2cccc(-c3ccc(F)cc3)c12		CHEMBL1971519	=	Ki	nM	63095.73	CHEMBL4247	Homo sapiens	pKi		4.2
active	9508008	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1ccc(C2=NNc3cccc4c(OC)ccc2c34)cc1OC		CHEMBL1997335	=	Ki	nM	1584.89	CHEMBL4247	Homo sapiens	pKi		5.8
active	9508009	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	=	Ki	nM	251.19	CHEMBL4247	Homo sapiens	pKi		6.6
inactive	9508010	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508011	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508012	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(O)C1CN(Cc2ccc(OCc3cccc(C(F)(F)F)c3)cc2)C1		CHEMBL1971132	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9508013	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508014	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL1998159	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508015	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cc(=O)[nH]c2[nH]nc(-c3cccc(C(F)(F)F)c3)c12		CHEMBL1991377	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9508016	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	<	Ki	nM	1995.26	CHEMBL4247	Homo sapiens	pKi		5.7
inactive	9508017	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9508018	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	=	Ki	nM	251.19	CHEMBL4247	Homo sapiens	pKi		6.6
inactive	9508019	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Oc1cnc2ccc(-c3ccncc3)cc2c1		CHEMBL1973868	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9508020	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCCCC#Cc1ccc(CN2CC(C(=O)O)C2)cc1		CHEMBL1972462	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9508021	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9508022	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Ki	nM	1584.89	CHEMBL4247	Homo sapiens	pKi		5.8
active	9508023	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	3.162	CHEMBL4247	Homo sapiens	pKi		8.5
inactive	9508024	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC1CCN(C(=O)c2ccc3c(c2)[nH]c(=O)c2cccn23)CC1		CHEMBL1967620	<	Ki	nM	3162.28	CHEMBL4247	Homo sapiens	pKi		5.5
inactive	9508025	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508026	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9508027	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Ki	nM	1584.89	CHEMBL4247	Homo sapiens	pKi		5.8
inactive	9508028	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9508029	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	79.43	CHEMBL4247	Homo sapiens	pKi		7.1
active	9508030	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	=	Ki	nM	1995.26	CHEMBL4247	Homo sapiens	pKi		5.7
inactive	9508031	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508032	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCCCNC(=O)c1cn(C(CC)CC)c(=O)c2cc(OC)c(OC)cc12		CHEMBL1982700	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9508033	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	=	Ki	nM	63.1	CHEMBL4247	Homo sapiens	pKi		7.2
inactive	9508034	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(N)=O)cc2)n1		CHEMBL1977634	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9508035	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	=	Ki	nM	501.19	CHEMBL4247	Homo sapiens	pKi		6.3
inactive	9508036	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508037	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(=O)Nc1cc2ccccn2n1		CHEMBL1976872	<	Ki	nM	12589.25	CHEMBL4247	Homo sapiens	pKi		4.9
inactive	9508038	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1nccc2cnc(-c3ccccc3)n12		CHEMBL1969156	<	Ki	nM	12589.25	CHEMBL4247	Homo sapiens	pKi		4.9
active	9508039	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	=	Ki	nM	501.19	CHEMBL4247	Homo sapiens	pKi		6.3
inactive	9508040	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	3981.07	CHEMBL4247	Homo sapiens	pKi		5.4
inactive	9508041	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	c1ccc(-c2c[nH]c3ncnc(N4CCCCC4)c23)cc1		CHEMBL1998953	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9508042	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2)c1		CHEMBL1971606	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9508043	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508044	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	5011.87	CHEMBL4247	Homo sapiens	pKi		5.3
inactive	9508045	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508046	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508047	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508048	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(OC(F)F)ccc12		CHEMBL1981215	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9508049	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1974457	<	Ki	nM	5011.87	CHEMBL4247	Homo sapiens	pKi		5.3
inactive	9508050	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	<	Ki	nM	3981.07	CHEMBL4247	Homo sapiens	pKi		5.4
active	9508051	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1999414	=	Ki	nM	501.19	CHEMBL4247	Homo sapiens	pKi		6.3
inactive	9508052	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cc(F)cc12		CHEMBL1967336	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9508053	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1Cl)c1ccccc1F		CHEMBL2001228	<	Ki	nM	3162.28	CHEMBL4247	Homo sapiens	pKi		5.5
active	9508054	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	=	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9508055	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	N#Cc1ccc(-c2ccncc2)cc1NCc1ccccc1		CHEMBL1967992	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9508056	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9508057	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508058	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCOC(=O)Cc1nc2c(N)cccc2[nH]1		CHEMBL1981671	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9508059	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL2006450	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9508060	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9508061	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	=	Ki	nM	79.43	CHEMBL4247	Homo sapiens	pKi		7.1
inactive	9508062	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)ccc(F)c12		CHEMBL2001987	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9508063	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCc1c(-c2ccc(C(C)=O)cc2)[nH]c2nccnc12		CHEMBL1994555	=	Ki	nM	5011.87	CHEMBL4247	Homo sapiens	pKi		5.3
inactive	9508064	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9508065	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3coc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1983640	=	Ki	nM	794.33	CHEMBL4247	Homo sapiens	pKi		6.1
inactive	9508066	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9508067	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	=	Ki	nM	158.49	CHEMBL4247	Homo sapiens	pKi		6.8
inactive	9508068	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	<	Ki	nM	3981.07	CHEMBL4247	Homo sapiens	pKi		5.4
active	9508069	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	c1ccc(CNc2nc(Nc3cc(C4CC4)[nH]n3)c3sccc3n2)cc1		CHEMBL1997924	=	Ki	nM	63.1	CHEMBL4247	Homo sapiens	pKi		7.2
inactive	9508070	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508071	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508072	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN(C)c1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)c1ccccc1		CHEMBL1978267	<	Ki	nM	3162.28	CHEMBL4247	Homo sapiens	pKi		5.5
active	9508073	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	=	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508074	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9508075	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O		CHEMBL485556	=	Ki	nM	1584.89	CHEMBL4247	Homo sapiens	pKi		5.8
inactive	9508076	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)CC(CO)NC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1992334	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9508077	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508078	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508079	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9508080	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	=	Ki	nM	1000.0	CHEMBL4247	Homo sapiens	pKi		6.0
active	9508081	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1997025	=	Ki	nM	2511.89	CHEMBL4247	Homo sapiens	pKi		5.6
active	9508082	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=c1[nH]c2cc(Br)cnc2[nH]1		CHEMBL1975921	=	Ki	nM	63095.73	CHEMBL4247	Homo sapiens	pKi		4.2
inactive	9508083	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508084	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9508085	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=c1[nH]n2ccccc2c1Br		CHEMBL2004033	=	Ki	nM	5011.87	CHEMBL4247	Homo sapiens	pKi		5.3
active	9508086	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(CCC(=O)O)(c1ccc(O)c(N)c1)c1ccc(O)c(N)c1		CHEMBL1975923	=	Ki	nM	1584.89	CHEMBL4247	Homo sapiens	pKi		5.8
active	9508087	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cc(Nc2nc(Cl)cc(NCc3ccccc3)n2)n[nH]1		CHEMBL2005449	=	Ki	nM	794.33	CHEMBL4247	Homo sapiens	pKi		6.1
inactive	9508088	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(O)C1CN(Cc2ccc(OCc3ccccc3)cc2Cl)C1		CHEMBL1987998	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9508089	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4ccccc4)cc[nH]c3=O)nc12		CHEMBL1992527	=	Ki	nM	79.43	CHEMBL4247	Homo sapiens	pKi		7.1
active	9508090	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC(=O)c1cc2ccncc2s1		CHEMBL1971534	=	Ki	nM	63095.73	CHEMBL4247	Homo sapiens	pKi		4.2
inactive	9508091	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	3981.07	CHEMBL4247	Homo sapiens	pKi		5.4
inactive	9508092	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1ccccc1N1CCCC1)c1ccc2ccccc2n1		CHEMBL2002799	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9508093	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc([N+](=O)[O-])cc2)n1		CHEMBL242865	=	Ki	nM	1584.89	CHEMBL4247	Homo sapiens	pKi		5.8
active	9508094	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1ccc2cc(NCCc3ccccc3)cc(Nc3ncccn3)c2n1		CHEMBL550275	=	Ki	nM	1584.89	CHEMBL4247	Homo sapiens	pKi		5.8
inactive	9508095	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508096	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	[2H]C([2H])([2H])Oc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1998110	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9508097	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9508098	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	630.96	CHEMBL4247	Homo sapiens	pKi		6.2
inactive	9508099	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508100	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508101	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(Cl)cc4)c3)c12		CHEMBL1990590	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9508102	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1nn(C)c2c1c(=O)c1cc(Cl)ccc1n2OCC(C)C		CHEMBL1977814	=	Ki	nM	5011.87	CHEMBL4247	Homo sapiens	pKi		5.3
active	9508103	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	=	Ki	nM	1995.26	CHEMBL4247	Homo sapiens	pKi		5.7
active	9508104	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	OCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1974617	=	Ki	nM	79432.82	CHEMBL4247	Homo sapiens	pKi		4.1
inactive	9508105	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9508106	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cc(Nc2ncnc(N3CCCc4cc(C)ccc43)n2)cc(OC)c1OC		CHEMBL1992125	=	Ki	nM	1584.89	CHEMBL4247	Homo sapiens	pKi		5.8
inactive	9508107	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508108	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508109	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9508110	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	398.11	CHEMBL4247	Homo sapiens	pKi		6.4
active	9508111	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	=	Ki	nM	794.33	CHEMBL4247	Homo sapiens	pKi		6.1
inactive	9508112	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508113	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508114	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9508115	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	5.012	CHEMBL4247	Homo sapiens	pKi		8.3
active	9508116	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	OCCc1ccc(Nc2ncnc3[nH]cc(-c4ccccc4)c23)cc1		CHEMBL1998773	=	Ki	nM	3981.07	CHEMBL4247	Homo sapiens	pKi		5.4
inactive	9508117	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9508118	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1ccccc1Nc1nc(Nc2cnn(C)c2)ncc1Br		CHEMBL1983106	=	Ki	nM	1000.0	CHEMBL4247	Homo sapiens	pKi		6.0
inactive	9508119	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	<	Ki	nM	3981.07	CHEMBL4247	Homo sapiens	pKi		5.4
inactive	9508120	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9508121	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	=	Ki	nM	630.96	CHEMBL4247	Homo sapiens	pKi		6.2
inactive	9508122	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508123	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508124	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508125	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2ccc(F)cc12		CHEMBL2007603	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9508126	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9508127	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Cc1cccs1)Nc1nc2ccccc2s1		CHEMBL1421720	=	Ki	nM	2511.89	CHEMBL4247	Homo sapiens	pKi		5.6
active	9508128	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1nnc2cncc(Cl)n12		CHEMBL1968130	=	Ki	nM	31622.78	CHEMBL4247	Homo sapiens	pKi		4.5
inactive	9508129	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508130	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508131	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508132	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508133	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCN(CC)CCNc1ccc(O)c2ccccc12		CHEMBL576113	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9508134	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508135	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508136	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	<	Ki	nM	2511.89	CHEMBL4247	Homo sapiens	pKi		5.6
inactive	9508137	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9508138	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=c1[nH]cnc2c(Cl)cccc12		CHEMBL1949855	=	Ki	nM	39810.72	CHEMBL4247	Homo sapiens	pKi		4.4
inactive	9508139	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9508140	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	=	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508141	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508142	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508143	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	7943.28	CHEMBL4247	Homo sapiens	pKi		5.1
inactive	9508144	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cc(OCc2ccc(Cl)c(Cl)c2)ccc1CN1CC(C(=O)O)C1		CHEMBL1990223	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9508145	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508146	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(=O)NCCO)cc2)n1		CHEMBL2006149	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9508147	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(O)c1ccccc1Nc1nc(Nc2ccccc2)ncc1F		CHEMBL244793	=	Ki	nM	63.1	CHEMBL4247	Homo sapiens	pKi		7.2
inactive	9508148	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)(c1cc(Br)c(O)c(I)c1)c1cc(Br)c(O)c(I)c1		CHEMBL1964382	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9508149	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN(C)CC(O)COc1ccc(Nc2nccc(Nc3cc(Cl)ccc3Cl)n2)cc1		CHEMBL101311	=	Ki	nM	1000.0	CHEMBL4247	Homo sapiens	pKi		6.0
inactive	9508150	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508151	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9508152	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cc(=O)n2ccc(CN(C)C)c(O)c2n1		CHEMBL1988581	=	Ki	nM	100.0	CHEMBL4247	Homo sapiens	pKi		7.0
inactive	9508153	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(=O)O)cc2)n1		CHEMBL2005699	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9508154	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508155	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	<	Ki	nM	2511.89	CHEMBL4247	Homo sapiens	pKi		5.6
active	9508156	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCN(C(C)=O)c1ccc(Nc2nc(NC3CC3)c3nc[nH]c3n2)cc1		CHEMBL2006564	=	Ki	nM	125.89	CHEMBL4247	Homo sapiens	pKi		6.9
inactive	9508157	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1ccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)cc1OC		CHEMBL1964399	<	Ki	nM	3162.28	CHEMBL4247	Homo sapiens	pKi		5.5
inactive	9508158	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9508159	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	=	Ki	nM	3.981	CHEMBL4247	Homo sapiens	pKi		8.4
active	9508160	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	630.96	CHEMBL4247	Homo sapiens	pKi		6.2
inactive	9508161	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2ccccc21		CHEMBL1978167	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9508162	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cnc(Nc2ccc(N3CCN(C)CC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1995703	=	Ki	nM	501.19	CHEMBL4247	Homo sapiens	pKi		6.3
active	9508163	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	=	Ki	nM	630.96	CHEMBL4247	Homo sapiens	pKi		6.2
inactive	9508164	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508165	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	<	Ki	nM	3981.07	CHEMBL4247	Homo sapiens	pKi		5.4
inactive	9508166	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9508167	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Ki	nM	630.96	CHEMBL4247	Homo sapiens	pKi		6.2
active	9508168	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(=O)c1cccc(-c2ccc3nccn3n2)c1		CHEMBL1994159	=	Ki	nM	50118.72	CHEMBL4247	Homo sapiens	pKi		4.3
inactive	9508169	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9508170	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	=	Ki	nM	316.23	CHEMBL4247	Homo sapiens	pKi		6.5
inactive	9508171	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508172	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)C(CO)NC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1971223	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9508173	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508174	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508175	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1998470	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9508176	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN(Cc1ccccc1)c1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1969920	<	Ki	nM	5011.87	CHEMBL4247	Homo sapiens	pKi		5.3
inactive	9508177	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1ccccc1-c1ccnc(Nc2cccc(S(C)(=O)=O)c2)n1		CHEMBL1975903	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9508178	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9508179	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cn1cc(Nc2ncc(Br)c(Nc3ccccc3C(N)=O)n2)cn1		CHEMBL1994669	=	Ki	nM	125.89	CHEMBL4247	Homo sapiens	pKi		6.9
inactive	9508180	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	19952.62	CHEMBL4247	Homo sapiens	pKi		4.7
inactive	9508181	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	<	Ki	nM	1995.26	CHEMBL4247	Homo sapiens	pKi		5.7
inactive	9508182	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508183	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508184	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9508185	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	N#Cc1ccc2nc(N)n(-c3nccs3)c2c1		CHEMBL1988805	=	Ki	nM	5011.87	CHEMBL4247	Homo sapiens	pKi		5.3
active	9508186	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	=	Ki	nM	25.12	CHEMBL4247	Homo sapiens	pKi		7.6
active	9508187	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	=	Ki	nM	125.89	CHEMBL4247	Homo sapiens	pKi		6.9
inactive	9508188	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9508189	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	=	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508190	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9508191	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1ccc(-c2ccc3cn[nH]c3c2)cc1)Nc1cccc(F)c1		CHEMBL1969942	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9512111	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1978567	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9512112	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9512113	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	=	Ki	nM	2511.89	CHEMBL4247	Homo sapiens	pKi		5.6
inactive	9512114	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	c1ccc(CNc2cc(-c3c[nH]c4ncccc34)ncn2)cc1		CHEMBL2002346	<	Ki	nM	3162.28	CHEMBL4247	Homo sapiens	pKi		5.5
inactive	9512115	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512116	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9512117	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1[nH]n(-c2nc3ccccc3[nH]2)c(=O)c1C1OC(=O)c2ccccc21		CHEMBL3145328	=	Ki	nM	199.53	CHEMBL4247	Homo sapiens	pKi		6.7
inactive	9512118	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512119	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9512120	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512121	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9512122	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1cc2nc(-c3ccccc3)cn2cn1		CHEMBL1972365	=	Ki	nM	7943.28	CHEMBL4247	Homo sapiens	pKi		5.1
inactive	9512123	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9512124	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL49120	=	Ki	nM	3981.07	CHEMBL4247	Homo sapiens	pKi		5.4
inactive	9512125	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9512126	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	100.0	CHEMBL4247	Homo sapiens	pKi		7.0
inactive	9512127	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	<	Ki	nM	3162.28	CHEMBL4247	Homo sapiens	pKi		5.5
inactive	9512128	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512129	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9512130	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCC(=O)Nc1ccc(C(=O)N2CCNCC2)c(O)c1		CHEMBL1988141	=	Ki	nM	630.96	CHEMBL4247	Homo sapiens	pKi		6.2
inactive	9512131	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512132	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)cnc2c(-c3ccc4c(c3)OCO4)cnn12		CHEMBL1977134	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9512133	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccc2c(c1)C(=O)Nc1ccccc1N2		CHEMBL1970873	<	Ki	nM	50118.72	CHEMBL4247	Homo sapiens	pKi		4.3
inactive	9512134	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COCC#Cc1cccc2c1Cc1c(-c3cccs3)n[nH]c1-2		CHEMBL1985206	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9512135	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9512136	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9512137	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	C=CCc1cccc2c(=NO)cc(-c3ccccc3)oc12		CHEMBL1977749	=	Ki	nM	251.19	CHEMBL4247	Homo sapiens	pKi		6.6
active	9512138	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1ncnc2scc(-c3ccccc3)c12		CHEMBL1975212	=	Ki	nM	39810.72	CHEMBL4247	Homo sapiens	pKi		4.4
active	9512139	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=c1[nH][nH]c2ccc(Br)cc12		CHEMBL2001613	=	Ki	nM	79432.82	CHEMBL4247	Homo sapiens	pKi		4.1
inactive	9512140	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	<	Ki	nM	1584.89	CHEMBL4247	Homo sapiens	pKi		5.8
active	9512141	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1ccc2[nH]cc(C=C3C(=O)Nc4ccccc43)c2c1		CHEMBL1997275	=	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9512142	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC(=O)c1cc2c(-c3ccc(Nc4nc5ccccc5o4)cc3)cnc(N)c2s1		CHEMBL1993904	=	Ki	nM	2511.89	CHEMBL4247	Homo sapiens	pKi		5.6
active	9512143	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cccc(-c2cccc3onc(N)c23)c1		CHEMBL1980376	=	Ki	nM	100000.0	CHEMBL4247	Homo sapiens	pKi		4.0
inactive	9512144	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2ccc(Cl)cc12		CHEMBL1967513	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9512145	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(C#N)cc4)c3)c12		CHEMBL2000724	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9512146	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9512147	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN(Cc1cc(Cl)c(O)c2ncccc12)C1CCCCC1		CHEMBL1982413	=	Ki	nM	3162.28	CHEMBL4247	Homo sapiens	pKi		5.5
inactive	9512148	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512149	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9512150	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	=	Ki	nM	1584.89	CHEMBL4247	Homo sapiens	pKi		5.8
inactive	9512151	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512152	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(F)c(F)cc12		CHEMBL1981792	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9512153	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(NCCc1cccs1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1987535	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9512154	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9512155	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	=	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9512156	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Clc1cc(Nc2nc(NC3CC3)c3sccc3n2)ccc1N1CCOCC1		CHEMBL2002586	=	Ki	nM	2511.89	CHEMBL4247	Homo sapiens	pKi		5.6
active	9512157	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC(=O)c1cc(-c2cccs2)n2nccc2n1		CHEMBL1987815	=	Ki	nM	79432.82	CHEMBL4247	Homo sapiens	pKi		4.1
inactive	9512158	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512159	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1981133	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9512160	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)Oc1cc(Nc2nc(NC(C)c3ccc(F)cn3)ncc2Cl)n[nH]1		CHEMBL2007421	=	Ki	nM	125.89	CHEMBL4247	Homo sapiens	pKi		6.9
active	9512161	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	=	Ki	nM	794.33	CHEMBL4247	Homo sapiens	pKi		6.1
inactive	9512162	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512163	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c(=O)n(C)c1		CHEMBL1973138	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9512164	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9512165	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=c1[nH]c2ccc(Cl)cc2c2ncnn12		CHEMBL1992673	=	Ki	nM	31622.78	CHEMBL4247	Homo sapiens	pKi		4.5
active	9512166	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	=	Ki	nM	630.96	CHEMBL4247	Homo sapiens	pKi		6.2
active	9512167	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	=	Ki	nM	1.0	CHEMBL4247	Homo sapiens	pKi		9.0
active	9512168	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN(C)C1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1969151	=	Ki	nM	1584.89	CHEMBL4247	Homo sapiens	pKi		5.8
inactive	9512169	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9512170	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COC(=O)c1c(N)nc2ccccn12		CHEMBL1981492	=	Ki	nM	25118.86	CHEMBL4247	Homo sapiens	pKi		4.6
active	9512171	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(F)ccc21		CHEMBL1993335	=	Ki	nM	2511.89	CHEMBL4247	Homo sapiens	pKi		5.6
active	9512172	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)NC1=NNC(=O)C1=Cc1cc2ccccc2[nH]1		CHEMBL1988692	=	Ki	nM	794.33	CHEMBL4247	Homo sapiens	pKi		6.1
active	9512173	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1nc(Cl)cc(-c2c[nH]c3ncccc23)n1		CHEMBL2007574	=	Ki	nM	3981.07	CHEMBL4247	Homo sapiens	pKi		5.4
inactive	9512174	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512175	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512176	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	<	Ki	nM	3981.07	CHEMBL4247	Homo sapiens	pKi		5.4
inactive	9512177	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512178	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)NCCO)c2)n1		CHEMBL1998680	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9512179	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512180	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	<	Ki	nM	3981.07	CHEMBL4247	Homo sapiens	pKi		5.4
inactive	9512181	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512182	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9512183	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1970317	=	Ki	nM	1995.26	CHEMBL4247	Homo sapiens	pKi		5.7
inactive	9512184	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512185	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512186	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCOCC(C)Oc1cccc2[nH]nc(N)c12		CHEMBL2002736	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9512187	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCCNC(=O)c1ccc(Nc2nc(CC)c3cc[nH]c3n2)cc1		CHEMBL1997007	=	Ki	nM	5011.87	CHEMBL4247	Homo sapiens	pKi		5.3
inactive	9512188	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9512189	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1990228	=	Ki	nM	25.12	CHEMBL4247	Homo sapiens	pKi		7.6
inactive	9512190	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	<	Ki	nM	3981.07	CHEMBL4247	Homo sapiens	pKi		5.4
inactive	9512191	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1nc2c(O)cccc2s1)Nc1ccccc1-c1ccccc1		CHEMBL2002690	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9512192	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9512193	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1ccc(-c2cccn3c(=O)[nH]nc23)cc1		CHEMBL1975503	=	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9512194	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12		CHEMBL1980540	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512195	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9512196	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	=	Ki	nM	100.0	CHEMBL4247	Homo sapiens	pKi		7.0
inactive	9512197	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1ccc(CN(C)C)cc1Nc1nccc(-c2c(-c3cccc(NC(=O)c4c(F)cccc4F)c3)nc3sccn23)n1		CHEMBL1997051	<	Ki	nM	3162.28	CHEMBL4247	Homo sapiens	pKi		5.5
active	9512198	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C1Nc2ccccc2C1=Cc1c[nH]c2ccccc12		CHEMBL1986590	=	Ki	nM	1995.26	CHEMBL4247	Homo sapiens	pKi		5.7
inactive	9512199	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512200	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCC(N)C3)c21		CHEMBL1870106	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9512201	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512202	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9512203	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CS(=O)(=O)c1cccc(-c2cnn3c(C(N)=O)cc(-c4ccccc4)nc23)c1		CHEMBL1998477	=	Ki	nM	5011.87	CHEMBL4247	Homo sapiens	pKi		5.3
inactive	9512204	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9512205	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	398.11	CHEMBL4247	Homo sapiens	pKi		6.4
active	9512206	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	c1ccc(-c2ccnc3[nH]ccc23)cc1		CHEMBL482538	=	Ki	nM	7943.28	CHEMBL4247	Homo sapiens	pKi		5.1
inactive	9512207	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512208	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccc(C)c(NC(=O)c2cc(-c3ccco3)nc3ccccc23)c1		CHEMBL1984296	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9512209	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	=	Ki	nM	630.96	CHEMBL4247	Homo sapiens	pKi		6.2
inactive	9512210	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1nn(C)c2sc(C(N)=O)c(N)c12		CHEMBL1996837	<	Ki	nM	12589.25	CHEMBL4247	Homo sapiens	pKi		4.9
inactive	9512211	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9512212	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCN1CCN(c2ccc(Nc3ncc(C(F)(F)F)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1971914	=	Ki	nM	15.85	CHEMBL4247	Homo sapiens	pKi		7.8
inactive	9512213	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9512214	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CNCC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1964441	=	Ki	nM	2511.89	CHEMBL4247	Homo sapiens	pKi		5.6
inactive	9512215	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1c(F)cccc1F		CHEMBL1991410	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9512216	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	ON=C(c1nc2ccccc2[nH]1)c1nc2ccccc2[nH]1		CHEMBL546797	=	Ki	nM	1584.89	CHEMBL4247	Homo sapiens	pKi		5.8
active	9512217	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	=	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512218	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512219	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCOCCO)c2)n1		CHEMBL1978271	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9512220	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9512221	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc(OCCCn4cccc4)c4[nH]nc(N)c34)cc2)c1		CHEMBL2007266	=	Ki	nM	5011.87	CHEMBL4247	Homo sapiens	pKi		5.3
inactive	9512222	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	<	Ki	nM	2511.89	CHEMBL4247	Homo sapiens	pKi		5.6
inactive	9512223	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN(C)c1ccc(NC(=O)CC2Nc3ccccc3NC2=O)cc1		CHEMBL1985469	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9512224	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(CCC(=O)Nc1cc(C(F)(F)F)ccc1Cl)NN=Cc1c[nH]c2ccccc12		CHEMBL1994308	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9512225	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCN1CCN(c2ccc(Nc3nccc(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1983430	=	Ki	nM	1000.0	CHEMBL4247	Homo sapiens	pKi		6.0
active	9512226	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1nc(=O)[nH]c2sccc12		CHEMBL2007097	=	Ki	nM	79432.82	CHEMBL4247	Homo sapiens	pKi		4.1
active	9512227	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	199.53	CHEMBL4247	Homo sapiens	pKi		6.7
active	9512228	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	=	Ki	nM	125.89	CHEMBL4247	Homo sapiens	pKi		6.9
active	9512229	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	=	Ki	nM	1000.0	CHEMBL4247	Homo sapiens	pKi		6.0
active	9512230	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	=	Ki	nM	63.1	CHEMBL4247	Homo sapiens	pKi		7.2
inactive	9512231	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9512232	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5ccc(NC(=O)CCCN(C)C)cc5)cnc(N)c34)cc2)c1		CHEMBL1986367	=	Ki	nM	398.11	CHEMBL4247	Homo sapiens	pKi		6.4
active	9512233	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cn1cc(Nc2ncc(Br)c(Nc3ccccc3)n2)cn1		CHEMBL1976878	=	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512234	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512235	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512236	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9512237	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cnc(Nc2nc(NC(C)C)ncc2Br)s1		CHEMBL1973013	=	Ki	nM	1995.26	CHEMBL4247	Homo sapiens	pKi		5.7
active	9512238	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	=	Ki	nM	100.0	CHEMBL4247	Homo sapiens	pKi		7.0
inactive	9512239	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9512240	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9512241	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1ccc(-n2ccc3cnc(Nc4cc(OC)c(OC)c(OC)c4)nc32)cc1		CHEMBL1975927	=	Ki	nM	2511.89	CHEMBL4247	Homo sapiens	pKi		5.6
inactive	9512242	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	<	Ki	nM	3981.07	CHEMBL4247	Homo sapiens	pKi		5.4
inactive	9512243	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9512244	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(Nc1cncc(-n2cnc3ccc(C#N)cc32)n1)c1ccccc1F		CHEMBL1977138	=	Ki	nM	63.1	CHEMBL4247	Homo sapiens	pKi		7.2
active	9512245	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	=	Ki	nM	100.0	CHEMBL4247	Homo sapiens	pKi		7.0
active	9512246	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	c1ccc(C2CCc3[nH]ncc3C2)cc1		CHEMBL2000879	=	Ki	nM	50118.72	CHEMBL4247	Homo sapiens	pKi		4.3
inactive	9512247	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	<	Ki	nM	3162.28	CHEMBL4247	Homo sapiens	pKi		5.5
inactive	9512248	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN(C)c1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)Cc1ccccc1		CHEMBL1969483	<	Ki	nM	3162.28	CHEMBL4247	Homo sapiens	pKi		5.5
inactive	9512249	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	<	Ki	nM	2511.89	CHEMBL4247	Homo sapiens	pKi		5.6
active	9512250	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	c1nc(-c2ccc3c(c2)OCO3)c2cc[nH]c2n1		CHEMBL2004515	=	Ki	nM	5011.87	CHEMBL4247	Homo sapiens	pKi		5.3
active	9512251	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C1Nc2cc(-c3ccc(O)cc3)ccc2C1=Cc1ccc[nH]1		CHEMBL1980329	=	Ki	nM	12.59	CHEMBL4247	Homo sapiens	pKi		7.9
active	9512252	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1cccc(C2Nc3ccc4ccccc4c3C3C=CCC32)c1)c1ccc(F)cc1		CHEMBL1992042	=	Ki	nM	3162.28	CHEMBL4247	Homo sapiens	pKi		5.5
inactive	9512253	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9512254	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Ki	nM	158.49	CHEMBL4247	Homo sapiens	pKi		6.8
inactive	9512255	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512256	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)s2)c1		CHEMBL1994724	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9512257	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cc(-c2csc3c(C=CC(=O)NCCN(C)C)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1989267	=	Ki	nM	5011.87	CHEMBL4247	Homo sapiens	pKi		5.3
inactive	9512258	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512259	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9512260	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCN(CC)CCNC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1970290	=	Ki	nM	501.19	CHEMBL4247	Homo sapiens	pKi		6.3
inactive	9512261	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1ccc2c(C(=O)O)n(-c3ccccc3)nc2c1		CHEMBL1974574	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9512262	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512263	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512264	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512265	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	5011.87	CHEMBL4247	Homo sapiens	pKi		5.3
inactive	9512266	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9512267	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	C#Cc1cn(C2CCCC2)c2ncnc(N)c12		CHEMBL1993877	=	Ki	nM	316.23	CHEMBL4247	Homo sapiens	pKi		6.5
inactive	9512268	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	5011.87	CHEMBL4247	Homo sapiens	pKi		5.3
inactive	9512269	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9512270	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cccc(NC(=O)N2CCC(c3nc4c(C(N)=O)cccc4[nH]3)CC2)c1		CHEMBL1973363	=	Ki	nM	3162.28	CHEMBL4247	Homo sapiens	pKi		5.5
active	9512271	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	63.1	CHEMBL4247	Homo sapiens	pKi		7.2
active	9512272	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	=	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512273	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN(C)c1ccc(N)c2ccccc12		CHEMBL1998253	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9512274	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(Cl)ccc12		CHEMBL1981744	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9512275	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512276	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512277	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccccc1-c1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL2000029	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9512278	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL1973961	=	Ki	nM	39.81	CHEMBL4247	Homo sapiens	pKi		7.4
inactive	9512279	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512280	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512281	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCCO)c2)n1		CHEMBL1994977	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9512282	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Oc1ccc2nc(-c3ccc(Sc4ccc(-c5nc6ccc(O)cc6[nH]5)cc4)cc3)[nH]c2c1		CHEMBL2001149	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9512283	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512284	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCOc1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)Cc1ccccc1		CHEMBL2000078	<	Ki	nM	3162.28	CHEMBL4247	Homo sapiens	pKi		5.5
active	9512285	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1ccc2c(c1)c(-c1cc3nc(Br)cnc3[nH]1)cn2C		CHEMBL2005478	=	Ki	nM	3162.28	CHEMBL4247	Homo sapiens	pKi		5.5
active	9512286	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	630.96	CHEMBL4247	Homo sapiens	pKi		6.2
active	9512287	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cccc(OC)c1CNc1nc(NC2CCCCC2)nc2ccc(Cl)cc12		CHEMBL1996646	=	Ki	nM	1995.26	CHEMBL4247	Homo sapiens	pKi		5.7
inactive	9512288	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1979773	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9512289	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512290	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Cc1ccccc1)Nc1cc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)ccc1Cl		CHEMBL2005482	<	Ki	nM	3162.28	CHEMBL4247	Homo sapiens	pKi		5.5
active	9512291	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCCN(C)C)cc2NC3=O)ccc1O		CHEMBL1996702	=	Ki	nM	251.19	CHEMBL4247	Homo sapiens	pKi		6.6
active	9512292	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	2511.89	CHEMBL4247	Homo sapiens	pKi		5.6
inactive	9512293	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccccc1Nc1nccc(-c2c(-c3cccc(NC(=O)Cc4ccccc4)c3)nc3sccn23)n1		CHEMBL1997909	<	Ki	nM	3162.28	CHEMBL4247	Homo sapiens	pKi		5.5
inactive	9512294	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1ccc(-c2ccc(=O)[nH]n2)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL2007124	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9512295	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	<	Ki	nM	3981.07	CHEMBL4247	Homo sapiens	pKi		5.4
active	9512296	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	N#Cc1ccc2c(c1)C(c1ccc3c(n1)CCCC3O)C(=O)N2		CHEMBL1985681	=	Ki	nM	2511.89	CHEMBL4247	Homo sapiens	pKi		5.6
inactive	9512297	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COCCN(C)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL2002660	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9512298	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	=	Ki	nM	50.12	CHEMBL4247	Homo sapiens	pKi		7.3
active	9512299	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9512300	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	=	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512301	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	<	Ki	nM	2511.89	CHEMBL4247	Homo sapiens	pKi		5.6
inactive	9512302	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	<	Ki	nM	1995.26	CHEMBL4247	Homo sapiens	pKi		5.7
active	9512303	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1ncnc2c1N=C(c1ccccc1)CCN2		CHEMBL262623	=	Ki	nM	10000.0	CHEMBL4247	Homo sapiens	pKi		5.0
active	9512304	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(O)c1c(Cl)ccc2cc(-n3cccc3)cnc12		CHEMBL1967875	=	Ki	nM	3981.07	CHEMBL4247	Homo sapiens	pKi		5.4
inactive	9512305	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9512306	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL2004118	=	Ki	nM	3981.07	CHEMBL4247	Homo sapiens	pKi		5.4
inactive	9512307	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1cc(S(=O)(=O)NC(=O)c2ccc(-c3ccc(F)cc3)cc2)ccc1NC1CCCCC1		CHEMBL1996795	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9512308	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512309	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512310	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512311	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	<	Ki	nM	3981.07	CHEMBL4247	Homo sapiens	pKi		5.4
active	9512312	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)(C)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1995211	=	Ki	nM	1995.26	CHEMBL4247	Homo sapiens	pKi		5.7
active	9512313	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	=	Ki	nM	199.53	CHEMBL4247	Homo sapiens	pKi		6.7
inactive	9512314	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	<	Ki	nM	2511.89	CHEMBL4247	Homo sapiens	pKi		5.6
active	9512315	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC(=O)c1ccc(NC2CCCCC2N)nc1Nc1cccc(Cl)c1		CHEMBL1982753	=	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512316	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cccc(CNC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2006299	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9512317	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Oc1cc(O)cc(C=Cc2ccc(O)c(O)c2)c1		CHEMBL1972346	=	Ki	nM	251.19	CHEMBL4247	Homo sapiens	pKi		6.6
inactive	9512318	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccc(-c2cc3nc(Br)cnc3[nH]2)cc1		CHEMBL1965169	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9512319	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCN1c2cc(N)ccc2-c2ccc(N)cc2C1(O)c1ccccc1		CHEMBL1991818	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9512320	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Ki	nM	630.96	CHEMBL4247	Homo sapiens	pKi		6.2
active	9512321	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(O)CO)c5)cnc(N)c34)cc2)cc1		CHEMBL1965170	=	Ki	nM	2511.89	CHEMBL4247	Homo sapiens	pKi		5.6
inactive	9512322	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512323	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9512324	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Clc1ccc2c(c1)nnc1nnnn12		CHEMBL1986503	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9512325	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9512326	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1c(-c2nc3ccccc3[nH]2)c(O)cc2oc(C)cc(=O)c12		CHEMBL1972355	=	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512327	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)c(Cl)c1		CHEMBL1997892	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9512328	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)(O)c1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL2001641	=	Ki	nM	79432.82	CHEMBL4247	Homo sapiens	pKi		4.1
active	9512329	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccc(-c2cc(-c3cc(Br)ccc3O)[nH]c(=O)c2C#N)s1		CHEMBL1997193	=	Ki	nM	1995.26	CHEMBL4247	Homo sapiens	pKi		5.7
inactive	9512330	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512331	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)O)c2)n1		CHEMBL1964902	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9512332	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512333	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512334	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512335	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512336	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9512337	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)n2)s1		CHEMBL1983715	=	Ki	nM	1000.0	CHEMBL4247	Homo sapiens	pKi		6.0
inactive	9512338	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512339	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512340	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9512341	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9512342	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	=	Ki	nM	316.23	CHEMBL4247	Homo sapiens	pKi		6.5
active	9512343	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cn1cc(Nc2ncc(Cl)c(Nc3ccccc3)n2)cn1		CHEMBL1991999	=	Ki	nM	1584.89	CHEMBL4247	Homo sapiens	pKi		5.8
active	9512344	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	=	Ki	nM	1584.89	CHEMBL4247	Homo sapiens	pKi		5.8
inactive	9512345	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516258	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516259	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516260	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9516261	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516262	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9516263	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)Cc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL1980763	=	Ki	nM	2511.89	CHEMBL4247	Homo sapiens	pKi		5.6
inactive	9516264	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516265	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516266	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCCCNc1nc(N)c(C(=O)c2ccccc2)s1		CHEMBL2007479	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9516267	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2F)c1		CHEMBL1986851	=	Ki	nM	1000.0	CHEMBL4247	Homo sapiens	pKi		6.0
inactive	9516268	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516269	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)C(CO)NC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1971223	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9516270	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	=	Ki	nM	199.53	CHEMBL4247	Homo sapiens	pKi		6.7
active	9516271	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4ccc(OC(F)F)cc4)cc3)c12		CHEMBL1972220	=	Ki	nM	316.23	CHEMBL4247	Homo sapiens	pKi		6.5
inactive	9516272	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9516273	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	630.96	CHEMBL4247	Homo sapiens	pKi		6.2
active	9516274	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Fc1cccc(CNc2ncnc3[nH]cnc23)c1		CHEMBL2003785	=	Ki	nM	63095.73	CHEMBL4247	Homo sapiens	pKi		4.2
inactive	9516275	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516276	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9516277	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516278	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCOc1ccccc1-c1cccc(-c2n[nH]c3nc(O)cc(C)c23)c1		CHEMBL1983070	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9516279	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cn1cc(Nc2ncc(Br)c(Nc3ccccc3S(C)(=O)=O)n2)cn1		CHEMBL2000645	=	Ki	nM	2511.89	CHEMBL4247	Homo sapiens	pKi		5.6
inactive	9516280	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516281	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2003514	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9516282	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9516283	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9516284	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4c(Cl)cccc4Cl)s3)cc2)CC1		CHEMBL1989043	=	Ki	nM	316.23	CHEMBL4247	Homo sapiens	pKi		6.5
inactive	9516285	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9516286	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9516287	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	=	Ki	nM	50.12	CHEMBL4247	Homo sapiens	pKi		7.3
inactive	9516288	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9516289	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	3162.28	CHEMBL4247	Homo sapiens	pKi		5.5
inactive	9516290	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCOC(=O)c1nc2c(=O)[nH]c3cc([N+](=O)[O-])c(NC(C)=O)cc3n2c1C		CHEMBL1997611	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9516291	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Ki	nM	794.33	CHEMBL4247	Homo sapiens	pKi		6.1
inactive	9516292	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516293	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9516294	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	100.0	CHEMBL4247	Homo sapiens	pKi		7.0
inactive	9516295	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516296	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9516297	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(=O)Nc1ccc(-n2nc3ccc(N)nc3n2)cc1		CHEMBL2002723	=	Ki	nM	1995.26	CHEMBL4247	Homo sapiens	pKi		5.7
active	9516298	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1nnc2ccc(-c3ccccc3)cn12		CHEMBL1987143	=	Ki	nM	12589.25	CHEMBL4247	Homo sapiens	pKi		4.9
inactive	9516299	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516300	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9516301	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	630.96	CHEMBL4247	Homo sapiens	pKi		6.2
inactive	9516302	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Brc1ccc2cnc(Nc3ccncn3)cc2c1		CHEMBL1984686	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9516303	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	=	Ki	nM	501.19	CHEMBL4247	Homo sapiens	pKi		6.3
inactive	9516304	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516305	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516306	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516307	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9516308	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=S(=O)(Nc1ccc2c(c1)C(=NO)c1ccccc1-2)c1cccc(Br)c1		CHEMBL1973793	=	Ki	nM	2511.89	CHEMBL4247	Homo sapiens	pKi		5.6
active	9516309	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1		CHEMBL1969588	=	Ki	nM	316.23	CHEMBL4247	Homo sapiens	pKi		6.5
active	9516310	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	10.0	CHEMBL4247	Homo sapiens	pKi		8.0
active	9516311	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCC1CC(NS(=O)(=O)C2CC2)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1992073	=	Ki	nM	1000.0	CHEMBL4247	Homo sapiens	pKi		6.0
inactive	9516312	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9516313	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516314	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516315	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(NC(CCO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1986143	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9516316	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1ncnc2sccc12		CHEMBL1972934	=	Ki	nM	39810.72	CHEMBL4247	Homo sapiens	pKi		4.4
inactive	9516317	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3sccc3n2)cc1		CHEMBL2007559	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9516318	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Cc1ccc(-c2cccnc2)cc1)Nc1ccc(SC(F)F)cc1		CHEMBL1992581	=	Ki	nM	3162.28	CHEMBL4247	Homo sapiens	pKi		5.5
active	9516319	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	=	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516320	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516321	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9516322	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	=	Ki	nM	50.12	CHEMBL4247	Homo sapiens	pKi		7.3
active	9516323	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	C=Cc1ccc(-c2cccc3nnc(N)n23)cc1		CHEMBL1983573	=	Ki	nM	63095.73	CHEMBL4247	Homo sapiens	pKi		4.2
active	9516324	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	=	Ki	nM	158.49	CHEMBL4247	Homo sapiens	pKi		6.8
inactive	9516325	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516326	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(=O)OCCn1nc(-c2cccc(Br)c2)c2c(C(F)(F)F)cc(=O)[nH]c21		CHEMBL1984847	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9516327	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9516328	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	=	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516329	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Cc1ccc(OC(F)(F)F)cc1)N1CCC2(CC1)NCCc1c2[nH]c2ccccc12		CHEMBL1996576	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9516330	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccccc1Nc1nccc(-c2c(-c3cccc(NC(=O)c4ccccc4)c3)nc3sccn23)n1		CHEMBL1988076	<	Ki	nM	3162.28	CHEMBL4247	Homo sapiens	pKi		5.5
inactive	9516331	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9516332	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516333	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516334	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9516335	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Ki	nM	794.33	CHEMBL4247	Homo sapiens	pKi		6.1
inactive	9516336	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516337	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cc2ncc3c(N)nc4c(C)c(N)ccc4c3c2cc1OC		CHEMBL235157	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9516338	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516339	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516340	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516341	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9516342	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	=	Ki	nM	1584.89	CHEMBL4247	Homo sapiens	pKi		5.8
inactive	9516343	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516344	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	<	Ki	nM	2511.89	CHEMBL4247	Homo sapiens	pKi		5.6
inactive	9516345	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cccc(CNC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2004159	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9516346	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	N#CC1=C(c2ccccc2)CC(c2ccc(Cl)cc2)C(C(=O)c2ccccc2)C1=O		CHEMBL1978371	=	Ki	nM	5011.87	CHEMBL4247	Homo sapiens	pKi		5.3
inactive	9516347	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516348	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516349	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9516350	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	c1cnc2[nH]cc(-c3ccnc(NC4CCCCC4)n3)c2c1		CHEMBL385478	=	Ki	nM	1000.0	CHEMBL4247	Homo sapiens	pKi		6.0
inactive	9516351	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	1584.89	CHEMBL4247	Homo sapiens	pKi		5.8
active	9516352	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CS(=O)(=O)c1ccccc1Nc1nc(Nc2ccccc2)ncc1Cl		CHEMBL1969400	=	Ki	nM	316.23	CHEMBL4247	Homo sapiens	pKi		6.5
inactive	9516353	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516354	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cc(OCc2cccc(C(F)(F)F)c2)ccc1CN1CC(C(=O)O)C1		CHEMBL1966501	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9516355	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	=	Ki	nM	1.585	CHEMBL4247	Homo sapiens	pKi		8.8
inactive	9516356	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516357	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516358	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC1CCN(C(=O)CC#N)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1966175	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9516359	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516360	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC#Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL2007375	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9516361	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9516362	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	=	Ki	nM	3162.28	CHEMBL4247	Homo sapiens	pKi		5.5
active	9516363	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	=	Ki	nM	630.96	CHEMBL4247	Homo sapiens	pKi		6.2
inactive	9516364	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CS(=O)(=O)c1cccc(C(=O)Nc2nc3ccccc3n2CCCO)c1		CHEMBL1973016	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9516365	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1n[nH]c2c(OCCCn3cccc3)ccc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL1965387	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9516366	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	c1cc2c(s1)CCc1cn[nH]c1-2		CHEMBL2001539	<	Ki	nM	15848.93	CHEMBL4247	Homo sapiens	pKi		4.8
active	9516367	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cc(-c2ncnc3[nH]ccc23)ccc1F		CHEMBL1997041	=	Ki	nM	5011.87	CHEMBL4247	Homo sapiens	pKi		5.3
active	9516368	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cc(-c2ccc3c(c2)Nc2c(O)cccc2NC3=O)ccc1O		CHEMBL550418	=	Ki	nM	1584.89	CHEMBL4247	Homo sapiens	pKi		5.8
active	9516369	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	79.43	CHEMBL4247	Homo sapiens	pKi		7.1
inactive	9516370	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	3981.07	CHEMBL4247	Homo sapiens	pKi		5.4
inactive	9516371	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCOc1ccc(C=C2SC(=N)NC2=O)c(O)c1		CHEMBL1971289	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9516372	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	=	Ki	nM	1995.26	CHEMBL4247	Homo sapiens	pKi		5.7
inactive	9516373	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516374	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1ccc2c(c1)c(-c1cc3nccnc3[nH]1)cn2C		CHEMBL1233887	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9516375	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1ncnc2c1C(=O)NCCN2		CHEMBL1992607	=	Ki	nM	63095.73	CHEMBL4247	Homo sapiens	pKi		4.2
inactive	9516376	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1		CHEMBL1991800	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516377	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCCC(=O)O)cc2)n1		CHEMBL2003689	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9516378	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9516379	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1996649	=	Ki	nM	2511.89	CHEMBL4247	Homo sapiens	pKi		5.6
inactive	9516380	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	<	Ki	nM	1995.26	CHEMBL4247	Homo sapiens	pKi		5.7
inactive	9516381	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1986756	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9516382	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2ccncc2)c1-c1ccccc1		CHEMBL1419458	=	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9516383	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)n2)s1		CHEMBL1083785	=	Ki	nM	2511.89	CHEMBL4247	Homo sapiens	pKi		5.6
inactive	9516384	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	<	Ki	nM	1995.26	CHEMBL4247	Homo sapiens	pKi		5.7
inactive	9516385	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516386	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516387	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	<	Ki	nM	1584.89	CHEMBL4247	Homo sapiens	pKi		5.8
inactive	9516388	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9516389	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cn1cc(Nc2ncc(Br)c(Nc3cccc(C(N)=O)c3)n2)cn1		CHEMBL2005953	=	Ki	nM	3162.28	CHEMBL4247	Homo sapiens	pKi		5.5
inactive	9516390	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN(CCC#N)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1974998	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9516391	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516392	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516393	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9516394	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9516395	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9516396	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	=	Ki	nM	15.85	CHEMBL4247	Homo sapiens	pKi		7.8
inactive	9516397	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9516398	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN(C)CCc1ccc(Nc2nccc(-c3c(-c4cccc(C(O)CO)c4)nc4ccccn34)n2)cc1		CHEMBL1974090	=	Ki	nM	3162.28	CHEMBL4247	Homo sapiens	pKi		5.5
active	9516399	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	=	Ki	nM	501.19	CHEMBL4247	Homo sapiens	pKi		6.3
active	9516400	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC(=O)c1ccc2nc(-c3ccc([N+](=O)[O-])o3)cn2c1		CHEMBL1973359	=	Ki	nM	630.96	CHEMBL4247	Homo sapiens	pKi		6.2
inactive	9516401	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9516402	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1979690	=	Ki	nM	25.12	CHEMBL4247	Homo sapiens	pKi		7.6
inactive	9516403	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9516404	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9516405	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCCc4ccccc4)cc[nH]c3=O)nc12		CHEMBL2005714	=	Ki	nM	125.89	CHEMBL4247	Homo sapiens	pKi		6.9
active	9516406	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL1991186	=	Ki	nM	158.49	CHEMBL4247	Homo sapiens	pKi		6.8
inactive	9516407	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516408	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516409	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1ncnc2c1c(-c1ccc(Oc3ccc(CO)cc3)cc1)cn2C1CCOC1		CHEMBL1976376	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9516410	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(NN=Cc1cc(Br)c(O)c(Br)c1)Nc1ccccc1		CHEMBL1983575	=	Ki	nM	501.19	CHEMBL4247	Homo sapiens	pKi		6.3
inactive	9516411	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC(=O)c1cccc2[nH]c(-c3ccc(-n4ccc(CN5CCCCC5)c4)cc3)nc12		CHEMBL2006873	<	Ki	nM	3162.28	CHEMBL4247	Homo sapiens	pKi		5.5
inactive	9516412	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	N#Cc1cccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)n1		CHEMBL1968868	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9516413	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	=	Ki	nM	199.53	CHEMBL4247	Homo sapiens	pKi		6.7
active	9516414	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	=	Ki	nM	25.12	CHEMBL4247	Homo sapiens	pKi		7.6
active	9516415	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	=	Ki	nM	794.33	CHEMBL4247	Homo sapiens	pKi		6.1
inactive	9516416	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1ccc([N+](=O)[O-])cc1)N1CCc2[nH]c3c(Cl)cc(Cl)cc3c2C1		CHEMBL1976196	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9516417	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516418	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1ccccc1CNC(=N)Nc1nccc(-c2cccs2)n1		CHEMBL1997197	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9516419	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C1Cc2cc(-c3ccccc3)cnc2N1		CHEMBL1983630	=	Ki	nM	63095.73	CHEMBL4247	Homo sapiens	pKi		4.2
inactive	9516420	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516421	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516422	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9516423	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1ncc(-c2ccncc2)c2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1970083	=	Ki	nM	25.12	CHEMBL4247	Homo sapiens	pKi		7.6
inactive	9516424	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516425	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9516426	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	12.59	CHEMBL4247	Homo sapiens	pKi		7.9
inactive	9516427	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9516428	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1cc(=O)[nH]n1-c1ccccn1		CHEMBL1995765	=	Ki	nM	31622.78	CHEMBL4247	Homo sapiens	pKi		4.5
inactive	9516429	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516430	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9516431	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCCNC(=O)c1ccc(Nc2nc(CCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL1984760	=	Ki	nM	3981.07	CHEMBL4247	Homo sapiens	pKi		5.4
inactive	9516432	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	<	Ki	nM	3981.07	CHEMBL4247	Homo sapiens	pKi		5.4
inactive	9516433	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9516434	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN(C)CC1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL360847	=	Ki	nM	3162.28	CHEMBL4247	Homo sapiens	pKi		5.5
inactive	9516435	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCO)c2)n1		CHEMBL2007073	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9516436	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cc(F)ccc1F		CHEMBL1995811	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9516437	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516438	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9516439	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC(=O)c1cccc2cn[nH]c12		CHEMBL451401	<	Ki	nM	31622.78	CHEMBL4247	Homo sapiens	pKi		4.5
inactive	9516440	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516441	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9516442	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCNCC4)cc3)n2)s1		CHEMBL1242995	=	Ki	nM	199.53	CHEMBL4247	Homo sapiens	pKi		6.7
inactive	9516443	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516444	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516445	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9516446	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	<	Ki	nM	2511.89	CHEMBL4247	Homo sapiens	pKi		5.6
inactive	9516447	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516448	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516449	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516450	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516451	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516452	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516453	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516454	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CS(=O)(=O)Nc1ccc(Nc2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1988872	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9516455	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516456	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)N(CCN)CCO)c2)n1		CHEMBL1993634	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9516457	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	<	Ki	nM	2511.89	CHEMBL4247	Homo sapiens	pKi		5.6
active	9516458	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=c1[nH]nc2c(-c3ccccc3)cccn12		CHEMBL2002182	=	Ki	nM	100000.0	CHEMBL4247	Homo sapiens	pKi		4.0
inactive	9516459	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1		CHEMBL2003638	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9516460	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	=	Ki	nM	398.11	CHEMBL4247	Homo sapiens	pKi		6.4
inactive	9516461	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1cccc(F)c1)Nc1cccc(-c2ccc3cn[nH]c3c2)c1		CHEMBL1983393	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9516462	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCCC3CCO)nc12		CHEMBL2006674	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9516463	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN(C)c1ccc(Nc2cc(-c3csc(Br)c3)[nH]n2)cc1		CHEMBL1984236	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9516464	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1cnccn1)Nc1cccc2c(O)cccc12		CHEMBL1992371	=	Ki	nM	3162.28	CHEMBL4247	Homo sapiens	pKi		5.5
inactive	9516465	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516466	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516467	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(N3CC4COCC4C3)cc12		CHEMBL2002599	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9516468	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9516469	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1n[nH]c2ccc(-c3cccnc3)cc12		CHEMBL1967252	=	Ki	nM	12589.25	CHEMBL4247	Homo sapiens	pKi		4.9
active	9516470	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL2004637	=	Ki	nM	3162.28	CHEMBL4247	Homo sapiens	pKi		5.5
active	9516471	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)C(C)Nc1ncc(Cl)c(Nc2nccs2)n1		CHEMBL1993374	=	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9516472	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)N(CCCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1994318	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9516473	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516474	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCCC(=O)O)c2)n1		CHEMBL1999506	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9516475	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	=	Ki	nM	1000.0	CHEMBL4247	Homo sapiens	pKi		6.0
inactive	9516476	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9516477	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	=	Ki	nM	15.85	CHEMBL4247	Homo sapiens	pKi		7.8
inactive	9516478	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9516479	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NNc1cc(N2CCOCC2)nc(OCCc2ccccn2)n1		CHEMBL1996208	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9516480	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	=	Ki	nM	1000.0	CHEMBL4247	Homo sapiens	pKi		6.0
inactive	9516481	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9516482	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCOC(=O)c1c(C)n(-c2ccc(I)cc2)c2c1cc(O)c1ccccc12		CHEMBL1970352	=	Ki	nM	2511.89	CHEMBL4247	Homo sapiens	pKi		5.6
inactive	9516483	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516484	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516485	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9516486	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN(C)c1ccc(-c2cc(-c3ccc([N+](=O)[O-])cc3)nc(NS(=O)(=O)c3ccc(N)cc3)n2)cc1		CHEMBL1980167	=	Ki	nM	1995.26	CHEMBL4247	Homo sapiens	pKi		5.7
inactive	9516487	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9516488	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9516489	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9516490	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCOc1ccc(-c2nc3ccccn3c2-c2ccnc(Nc3cccc(CCN(C)C)c3)n2)cc1		CHEMBL1983875	=	Ki	nM	316.23	CHEMBL4247	Homo sapiens	pKi		6.5
active	9516491	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	=	Ki	nM	199.53	CHEMBL4247	Homo sapiens	pKi		6.7
inactive	9516492	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9520403	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	=	Ki	nM	199.53	CHEMBL4247	Homo sapiens	pKi		6.7
inactive	9520404	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9520405	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9520406	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9520407	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9520408	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NCc1cc(Nc2ncnc(-c3ccccc3)n2)ccc1O		CHEMBL1980246	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9520409	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)csc12		CHEMBL1991986	=	Ki	nM	158.49	CHEMBL4247	Homo sapiens	pKi		6.8
active	9520410	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(-c3ccc(CO)cc3)s1)CC2		CHEMBL1983980	=	Ki	nM	2511.89	CHEMBL4247	Homo sapiens	pKi		5.6
active	9520411	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	Ki	nM	199.53	CHEMBL4247	Homo sapiens	pKi		6.7
active	9520412	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCNCC4)cc3)n2)s1		CHEMBL1999484	=	Ki	nM	251.19	CHEMBL4247	Homo sapiens	pKi		6.6
inactive	9520413	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9520414	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1ccc(NCc2ccc(-c3ccc(F)cc3)nc2)cc1		CHEMBL1986899	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9520415	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9520416	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	=	Ki	nM	398.11	CHEMBL4247	Homo sapiens	pKi		6.4
inactive	9520417	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	3981.07	CHEMBL4247	Homo sapiens	pKi		5.4
inactive	9520418	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cccc(Cl)c2)cc1		CHEMBL1968606	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9520419	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	=	Ki	nM	3.981	CHEMBL4247	Homo sapiens	pKi		8.4
active	9520420	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	=	Ki	nM	1000.0	CHEMBL4247	Homo sapiens	pKi		6.0
active	9520421	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	=	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9520422	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	<	Ki	nM	1995.26	CHEMBL4247	Homo sapiens	pKi		5.7
inactive	9570119	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9570120	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(C)(C)CCOc1cc(-c2ccc(C(N)=O)cc2)cc2[nH]nc(N)c12		CHEMBL2001398	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9570121	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9570122	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9570123	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	63.1	CHEMBL4247	Homo sapiens	pKi		7.2
active	9570124	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	50.12	CHEMBL4247	Homo sapiens	pKi		7.3
inactive	9570125	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9570126	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	=	Ki	nM	251.19	CHEMBL4247	Homo sapiens	pKi		6.6
inactive	9570127	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9570128	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9570129	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccc[nH]2)C(=O)N3)c1)Cc1ccccc1		CHEMBL1980407	=	Ki	nM	199.53	CHEMBL4247	Homo sapiens	pKi		6.7
inactive	9570130	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9570131	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9570132	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9570133	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1966628	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9570134	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9570135	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9570136	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=c1[nH][nH]c2cccc(-c3ccccc3)c12		CHEMBL1989834	<	Ki	nM	15848.93	CHEMBL4247	Homo sapiens	pKi		4.8
active	9570137	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Cn1cc(Nc2ncc(Br)c(Nc3ccccc3Cl)n2)cn1		CHEMBL1983634	=	Ki	nM	63.1	CHEMBL4247	Homo sapiens	pKi		7.2
inactive	9570138	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCCc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1987430	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
active	9570139	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL244378	=	Ki	nM	1584.89	CHEMBL4247	Homo sapiens	pKi		5.8
inactive	9570140	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9570141	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1ccccc1		CHEMBL1993413	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9570142	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9570143	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	c1ccc(Nc2ncnc3ccccc23)cc1		CHEMBL289959	<	Ki	nM	19952.62	CHEMBL4247	Homo sapiens	pKi		4.7
inactive	9570144	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=c1cc(-c2ccccc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958399	<	Ki	nM	5011.87	CHEMBL4247	Homo sapiens	pKi		5.3
inactive	9570145	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Oc1cccc(-c2c[nH]c3ncccc23)c1		CHEMBL1972752	<	Ki	nM	3162.28	CHEMBL4247	Homo sapiens	pKi		5.5
inactive	9570146	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9570147	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9570148	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9570149	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(O)C1CN(Cc2ccc(OCc3cccc(C(F)(F)F)c3)cc2Cl)C1		CHEMBL1986265	<	Ki	nM	6309.57	CHEMBL4247	Homo sapiens	pKi		5.2
inactive	9570150	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9570151	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	=	Ki	nM	251.19	CHEMBL4247	Homo sapiens	pKi		6.6
active	9570152	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	Fc1ccc(-c2ccc3nccn3n2)cn1		CHEMBL1967211	=	Ki	nM	100000.0	CHEMBL4247	Homo sapiens	pKi		4.0
inactive	9570153	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9570154	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CN1c2ccc(N)cc2C(c2ccccc2)c2cc(N)ccc21		CHEMBL1991734	=	Ki	nM	1000.0	CHEMBL4247	Homo sapiens	pKi		6.0
inactive	9570155	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
inactive	9570156	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	<	Ki	nM	1258.93	CHEMBL4247	Homo sapiens	pKi		5.9
active	9570157	CHEMBL1963704	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ALK	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	=	Ki	nM	199.53	CHEMBL4247	Homo sapiens	pKi		6.7
	10838548	CHEMBL2014121	Inhibition of ALK at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	5.0	CHEMBL4247	Homo sapiens	INH	%	5.0
	10838549	CHEMBL2014122	Inhibition of ALK F1174L mutant at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	9.0	CHEMBL4247	Homo sapiens	INH	%	9.0
	10838550	CHEMBL2014123	Inhibition of ALK R1275Q mutant at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	6.0	CHEMBL4247	Homo sapiens	INH	%	6.0
	10843865	CHEMBL2015703	Inhibition of human ALK using ATP as substrate	B	CC(C)Cn1c2ccc(Nc3ncccn3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL2010872	=	IC50	nM	132.0	CHEMBL4247	Homo sapiens	IC50	nM	132.0
	10850670	CHEMBL2019790	Inhibition of human ALK at 1 uM	B	Cn1cc(-c2cccc(-c3cnc(N)c(C(=O)N[C@H]4C5CC6CC4C[C@@](O)(C6)C5)n3)c2)cn1		CHEMBL2018022	>	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	10863751	CHEMBL2024906	Inhibition of ALK by TR-FRET assay	B	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	IC50	nM	363.0	CHEMBL4247	Homo sapiens	IC50	nM	363.0
	10870062	CHEMBL2025255	Inhibition of ALK at 200 nM	B	CN1CCN(Cc2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)N(C)C)n3)cc2)CC1		CHEMBL2022968	>	Inhibition	%	80.0	CHEMBL4247	Homo sapiens	INH	%	80.0
	10877767	CHEMBL2025774	Inhibition of ALK phosphorylation in human Karpas-299 cells after 1 hr	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)NCc4ccc(C)cc4)C3)n2)cc(OC)c1OC		CHEMBL2023534	=	IC50	nM	384.0	CHEMBL4247	Homo sapiens	IC50	uM	0.384
	10877803	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	COc1cc(Nc2nccc(N3CCC[C@@H](C(=O)NCc4ccc(C)cc4)C3)n2)cc(OC)c1OC		CHEMBL2024002	=	IC50	nM	4120.0	CHEMBL4247	Homo sapiens	IC50	uM	4.12
	10877804	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)NCc4cccc(N5CCOCC5)c4)C3)n2)cc(OC)c1OC		CHEMBL2024001	=	IC50	nM	31.0	CHEMBL4247	Homo sapiens	IC50	uM	0.031
	10877805	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)NCc4cccc(Oc5ccccc5)c4)C3)n2)cc(OC)c1OC		CHEMBL2024000	=	IC50	nM	192.0	CHEMBL4247	Homo sapiens	IC50	uM	0.192
	10877806	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)NCc4ccc(-c5ccccc5)cc4)C3)n2)cc(OC)c1OC		CHEMBL2023999	=	IC50	nM	138.0	CHEMBL4247	Homo sapiens	IC50	uM	0.138
	10877807	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)NCc4cccc(-c5ccccc5)c4)C3)n2)cc(OC)c1OC		CHEMBL2023998	=	IC50	nM	19.0	CHEMBL4247	Homo sapiens	IC50	uM	0.019
	10877808	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	COC(=O)c1ccc(CNC(=O)[C@H]2CCCN(c3ccnc(Nc4cc(OC)c(OC)c(OC)c4)n3)C2)cc1		CHEMBL2023997	=	IC50	nM	1700.0	CHEMBL4247	Homo sapiens	IC50	uM	1.7
	10877809	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	COC(=O)c1cccc(CNC(=O)[C@H]2CCCN(c3ccnc(Nc4cc(OC)c(OC)c(OC)c4)n3)C2)c1		CHEMBL2023996	=	IC50	nM	60.0	CHEMBL4247	Homo sapiens	IC50	uM	0.06
	10877810	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)NCc4ccc([N+](=O)[O-])cc4)C3)n2)cc(OC)c1OC		CHEMBL2023995	=	IC50	nM	2930.0	CHEMBL4247	Homo sapiens	IC50	uM	2.93
	10877811	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)NCc4cccc([N+](=O)[O-])c4)C3)n2)cc(OC)c1OC		CHEMBL2023994	=	IC50	nM	70.0	CHEMBL4247	Homo sapiens	IC50	uM	0.07
	10877812	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)NCc4ccc(Cl)cc4)C3)n2)cc(OC)c1OC		CHEMBL2023993	=	IC50	nM	95.0	CHEMBL4247	Homo sapiens	IC50	uM	0.095
	10877813	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)NCc4cccc(Cl)c4)C3)n2)cc(OC)c1OC		CHEMBL2023992	=	IC50	nM	80.0	CHEMBL4247	Homo sapiens	IC50	uM	0.08
	10877814	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)NCc4ccccc4Cl)C3)n2)cc(OC)c1OC		CHEMBL2023991	=	IC50	nM	587.0	CHEMBL4247	Homo sapiens	IC50	uM	0.587
	10877815	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)NCc4ccc(OC(F)(F)F)cc4)C3)n2)cc(OC)c1OC		CHEMBL2023990	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	uM	0.01
	10877816	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)NCc4cccc(OC(F)(F)F)c4)C3)n2)cc(OC)c1OC		CHEMBL2023556	=	IC50	nM	16.0	CHEMBL4247	Homo sapiens	IC50	uM	0.016
	10877817	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)NCc4cccc(C)c4)C3)n2)cc(OC)c1OC		CHEMBL2023555	=	IC50	nM	83.0	CHEMBL4247	Homo sapiens	IC50	uM	0.083
	10877818	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)NCc4ccccc4C)C3)n2)cc(OC)c1OC		CHEMBL2023554	=	IC50	nM	341.0	CHEMBL4247	Homo sapiens	IC50	uM	0.341
	10877819	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)N[C@H](C)c4ccccc4)C3)n2)cc(OC)c1OC		CHEMBL2023553	=	IC50	nM	2010.0	CHEMBL4247	Homo sapiens	IC50	uM	2.01
	10877820	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)N[C@@H](C)c4ccccc4)C3)n2)cc(OC)c1OC		CHEMBL2023552	=	IC50	nM	2600.0	CHEMBL4247	Homo sapiens	IC50	uM	2.6
	10877821	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)NCC(=O)c4ccccc4)C3)n2)cc(OC)c1OC		CHEMBL2023551	=	IC50	nM	2940.0	CHEMBL4247	Homo sapiens	IC50	uM	2.94
	10877822	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)NCCCc4ccccc4)C3)n2)cc(OC)c1OC		CHEMBL2023550	=	IC50	nM	6710.0	CHEMBL4247	Homo sapiens	IC50	uM	6.71
	10877823	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)NCCc4ccccc4)C3)n2)cc(OC)c1OC		CHEMBL2023549	=	IC50	nM	358.0	CHEMBL4247	Homo sapiens	IC50	uM	0.358
	10877824	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)NCc4ccccc4)C3)n2)cc(OC)c1OC		CHEMBL2023548	=	IC50	nM	364.0	CHEMBL4247	Homo sapiens	IC50	uM	0.364
	10877825	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)Nc4ccccc4)C3)n2)cc(OC)c1OC		CHEMBL2023547	=	IC50	nM	833.0	CHEMBL4247	Homo sapiens	IC50	uM	0.833
	10877826	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)NCc4ccc(C)cc4)C3)n2)cc(OC)c1		CHEMBL2023546	=	IC50	nM	325.0	CHEMBL4247	Homo sapiens	IC50	uM	0.325
	10877827	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	Cc1ccc(CNC(=O)[C@H]2CCCN(c3ccnc(Nc4ccc5c(c4)OCCO5)n3)C2)cc1		CHEMBL2023545	=	IC50	nM	1480.0	CHEMBL4247	Homo sapiens	IC50	uM	1.48
	10877828	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	COc1ccc(Nc2nccc(N3CCC[C@H](C(=O)NCc4ccc(C)cc4)C3)n2)cc1OC		CHEMBL2023544	=	IC50	nM	1730.0	CHEMBL4247	Homo sapiens	IC50	uM	1.73
	10877829	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	CCc1ccc(Nc2nccc(N3CCC[C@H](C(=O)NCc4ccc(C)cc4)C3)n2)cc1		CHEMBL2023543	>	IC50	nM	25000.0	CHEMBL4247	Homo sapiens	IC50	uM	25.0
	10877830	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	CCc1cccc(Nc2nccc(N3CCC[C@H](C(=O)NCc4ccc(C)cc4)C3)n2)c1		CHEMBL2023542	=	IC50	nM	912.0	CHEMBL4247	Homo sapiens	IC50	uM	0.912
	10877831	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	COc1ccc(Nc2nccc(N3CCC[C@H](C(=O)NCc4ccc(C)cc4)C3)n2)cc1		CHEMBL2023541	=	IC50	nM	3100.0	CHEMBL4247	Homo sapiens	IC50	uM	3.1
	10877832	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	COc1cccc(Nc2nccc(N3CCC[C@H](C(=O)NCc4ccc(C)cc4)C3)n2)c1		CHEMBL2023540	=	IC50	nM	1020.0	CHEMBL4247	Homo sapiens	IC50	uM	1.02
	10877833	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	Cc1ccc(CNC(=O)[C@H]2CCCN(c3ccnc(Nc4ccc(Cl)cc4)n3)C2)cc1		CHEMBL2023539	=	IC50	nM	6300.0	CHEMBL4247	Homo sapiens	IC50	uM	6.3
	10877834	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	Cc1ccc(CNC(=O)[C@H]2CCCN(c3ccnc(Nc4cccc(Cl)c4)n3)C2)cc1		CHEMBL2023538	=	IC50	nM	2010.0	CHEMBL4247	Homo sapiens	IC50	uM	2.01
	10877835	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	Cc1ccc(CNC(=O)[C@H]2CCCN(c3ccnc(NCc4ccccc4)n3)C2)cc1		CHEMBL2023537	>	IC50	nM	25000.0	CHEMBL4247	Homo sapiens	IC50	uM	25.0
	10877836	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	Cc1ccc(CNC(=O)[C@H]2CCCN(c3ccnc(Nc4ccccc4)n3)C2)cc1		CHEMBL2023536	=	IC50	nM	2320.0	CHEMBL4247	Homo sapiens	IC50	uM	2.32
	10877837	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	CNc1nccc(N2CCC[C@H](C(=O)NCc3ccc(C)cc3)C2)n1		CHEMBL2023535	>	IC50	nM	25000.0	CHEMBL4247	Homo sapiens	IC50	uM	25.0
	10877838	CHEMBL2025772	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate after 90 mins by TR-FRET assay	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)NCc4ccc(C)cc4)C3)n2)cc(OC)c1OC		CHEMBL2023534	=	IC50	nM	174.0	CHEMBL4247	Homo sapiens	IC50	uM	0.174
	10877839	CHEMBL2025774	Inhibition of ALK phosphorylation in human Karpas-299 cells after 1 hr	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)NCc4cccc(OC(F)(F)F)c4)C3)n2)cc(OC)c1OC		CHEMBL2023556	=	IC50	nM	59.0	CHEMBL4247	Homo sapiens	IC50	uM	0.059
	10877840	CHEMBL2025774	Inhibition of ALK phosphorylation in human Karpas-299 cells after 1 hr	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)NCc4cccc(Cl)c4)C3)n2)cc(OC)c1OC		CHEMBL2023992	=	IC50	nM	226.0	CHEMBL4247	Homo sapiens	IC50	uM	0.226
	10877841	CHEMBL2025774	Inhibition of ALK phosphorylation in human Karpas-299 cells after 1 hr	B	COC(=O)c1cccc(CNC(=O)[C@H]2CCCN(c3ccnc(Nc4cc(OC)c(OC)c(OC)c4)n3)C2)c1		CHEMBL2023996	=	IC50	nM	61.0	CHEMBL4247	Homo sapiens	IC50	uM	0.061
	10877842	CHEMBL2025774	Inhibition of ALK phosphorylation in human Karpas-299 cells after 1 hr	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)NCc4cccc(-c5ccccc5)c4)C3)n2)cc(OC)c1OC		CHEMBL2023998	=	IC50	nM	224.0	CHEMBL4247	Homo sapiens	IC50	uM	0.224
	10877843	CHEMBL2025774	Inhibition of ALK phosphorylation in human Karpas-299 cells after 1 hr	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)NCc4cccc(N5CCOCC5)c4)C3)n2)cc(OC)c1OC		CHEMBL2024001	=	IC50	nM	28.0	CHEMBL4247	Homo sapiens	IC50	uM	0.028
	10877844	CHEMBL2025775	Ratio of IC50 for ALK phosphorylation in human Karpas-299 cells to IC50 for human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620)	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)NCc4ccc(C)cc4)C3)n2)cc(OC)c1OC		CHEMBL2023534	=	Ratio IC50		2.2	CHEMBL4247	Homo sapiens	Ratio IC50		2.2
	10877845	CHEMBL2025775	Ratio of IC50 for ALK phosphorylation in human Karpas-299 cells to IC50 for human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620)	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)NCc4cccc(OC(F)(F)F)c4)C3)n2)cc(OC)c1OC		CHEMBL2023556	=	Ratio IC50		3.7	CHEMBL4247	Homo sapiens	Ratio IC50		3.7
	10877846	CHEMBL2025775	Ratio of IC50 for ALK phosphorylation in human Karpas-299 cells to IC50 for human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620)	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)NCc4cccc(Cl)c4)C3)n2)cc(OC)c1OC		CHEMBL2023992	=	Ratio IC50		2.8	CHEMBL4247	Homo sapiens	Ratio IC50		2.8
	10878747	CHEMBL2025775	Ratio of IC50 for ALK phosphorylation in human Karpas-299 cells to IC50 for human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620)	B	COC(=O)c1cccc(CNC(=O)[C@H]2CCCN(c3ccnc(Nc4cc(OC)c(OC)c(OC)c4)n3)C2)c1		CHEMBL2023996	=	Ratio IC50		1.0	CHEMBL4247	Homo sapiens	Ratio IC50		1.0
	10878748	CHEMBL2025775	Ratio of IC50 for ALK phosphorylation in human Karpas-299 cells to IC50 for human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620)	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)NCc4cccc(-c5ccccc5)c4)C3)n2)cc(OC)c1OC		CHEMBL2023998	=	Ratio IC50		11.8	CHEMBL4247	Homo sapiens	Ratio IC50		11.8
	10878749	CHEMBL2025775	Ratio of IC50 for ALK phosphorylation in human Karpas-299 cells to IC50 for human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620)	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)NCc4cccc(N5CCOCC5)c4)C3)n2)cc(OC)c1OC		CHEMBL2024001	=	Ratio IC50		0.9	CHEMBL4247	Homo sapiens	Ratio IC50		0.9
	10878751	CHEMBL2025860	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620) expressed in SF9 cells using Biotin-Ahx- EQEDEPEGIYGVLF-OH as substrate at 1 uM after 90 mins by TR-FRET assay relative to control	B	COc1cc(Nc2nccc(N3CCC[C@H](C(=O)NCc4ccccc4Cl)C3)n2)cc(OC)c1OC		CHEMBL2023991	<	Inhibition	%	30.0	CHEMBL4247	Homo sapiens	INH	%	30.0
	10886025	CHEMBL2033405	Inhibition of ALK in human HEK293 cells after 1 hr by competition binding assay	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	10000.0	CHEMBL4247	Homo sapiens	Kd	nM	10000.0
	10921233	CHEMBL2044751	Inhibition of ALK	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)CCCC(=O)N3C)ncc1Cl		CHEMBL1644799	=	IC50	nM	15.0	CHEMBL4247	Homo sapiens	IC50	nM	15.0
	10921234	CHEMBL2044751	Inhibition of ALK	B	CNC(=O)c1cccc(Nc2nc(Nc3ccc4c(c3)CCCC(=O)N4C)ncc2Cl)c1		CHEMBL2042693	=	IC50	nM	568.0	CHEMBL4247	Homo sapiens	IC50	nM	568.0
	10921235	CHEMBL2044751	Inhibition of ALK	B	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)CCCC(=O)N3C)ncc1Cl		CHEMBL2042694	=	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	nM	1.0
	10921236	CHEMBL2044751	Inhibition of ALK	B	CN1C(=O)CCCc2cc(Nc3ncc(Cl)c(N[C@H]4[C@@H](C(N)=O)[C@@H]5C=C[C@H]4C5)n3)ccc21		CHEMBL2042695	=	IC50	nM	18.0	CHEMBL4247	Homo sapiens	IC50	nM	18.0
	10921237	CHEMBL2044751	Inhibition of ALK	B	CN1C(=O)CCCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@@H]4C(N)=O)n3)ccc21		CHEMBL2042696	=	IC50	nM	180.0	CHEMBL4247	Homo sapiens	IC50	nM	180.0
	10921238	CHEMBL2044751	Inhibition of ALK	B	CN1C(=O)CCCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4C(N)=O)n3)ccc21		CHEMBL2042697	=	IC50	nM	2139.0	CHEMBL4247	Homo sapiens	IC50	nM	2139.0
	10921239	CHEMBL2044751	Inhibition of ALK	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(Nc3ccccc3C(=O)NC)n1)c2OC		CHEMBL2042827	=	IC50	nM	11.0	CHEMBL4247	Homo sapiens	IC50	nM	11.0
	10921240	CHEMBL2044751	Inhibition of ALK	B	CCN1C(=O)CCCc2cc(Nc3ncc(Cl)c(Nc4ccccc4C(=O)NC)n3)c(OC)cc21		CHEMBL2042828	=	IC50	nM	5.0	CHEMBL4247	Homo sapiens	IC50	nM	5.0
	10921241	CHEMBL2044751	Inhibition of ALK	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)c2OC		CHEMBL2042829	=	IC50	nM	14.0	CHEMBL4247	Homo sapiens	IC50	nM	14.0
	10921242	CHEMBL2044751	Inhibition of ALK	B	CCN1C(=O)CCCc2cc(Nc3ncc(Cl)c(N[C@H]4[C@@H](C(N)=O)[C@@H]5C=C[C@H]4C5)n3)c(OC)cc21		CHEMBL2042830	=	IC50	nM	7.0	CHEMBL4247	Homo sapiens	IC50	nM	7.0
	10921243	CHEMBL2044751	Inhibition of ALK	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)N(C)C)n1)c2OC		CHEMBL2042831	=	IC50	nM	8.0	CHEMBL4247	Homo sapiens	IC50	nM	8.0
	10921244	CHEMBL2044751	Inhibition of ALK	B	CCN1C(=O)CCCc2cc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)N(C)C)n3)c(OC)cc21		CHEMBL2042981	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
	10921245	CHEMBL2044751	Inhibition of ALK	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)c2OC		CHEMBL2042982	=	IC50	nM	5.0	CHEMBL4247	Homo sapiens	IC50	nM	5.0
	10921246	CHEMBL2044751	Inhibition of ALK	B	CCN1C(=O)CCCc2cc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)c(OC)cc21		CHEMBL2042983	=	IC50	nM	2.7	CHEMBL4247	Homo sapiens	IC50	nM	2.7
	10921247	CHEMBL2044750	Inhibition of NPM-ALK autophosphorylation in human KARPAS299 cells	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)CCCC(=O)N3C)ncc1Cl		CHEMBL1644799	=	IC50	nM	30.0	CHEMBL4247	Homo sapiens	IC50	nM	30.0
Not Determined	10921248	CHEMBL2044750	Inhibition of NPM-ALK autophosphorylation in human KARPAS299 cells	B	CNC(=O)c1cccc(Nc2nc(Nc3ccc4c(c3)CCCC(=O)N4C)ncc2Cl)c1		CHEMBL2042693		IC50			CHEMBL4247	Homo sapiens	IC50		
	10921249	CHEMBL2044750	Inhibition of NPM-ALK autophosphorylation in human KARPAS299 cells	B	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)CCCC(=O)N3C)ncc1Cl		CHEMBL2042694	=	IC50	nM	20.0	CHEMBL4247	Homo sapiens	IC50	nM	20.0
	10921250	CHEMBL2044750	Inhibition of NPM-ALK autophosphorylation in human KARPAS299 cells	B	CN1C(=O)CCCc2cc(Nc3ncc(Cl)c(N[C@H]4[C@@H](C(N)=O)[C@@H]5C=C[C@H]4C5)n3)ccc21		CHEMBL2042695	=	IC50	nM	100.0	CHEMBL4247	Homo sapiens	IC50	nM	100.0
	10921251	CHEMBL2044750	Inhibition of NPM-ALK autophosphorylation in human KARPAS299 cells	B	CN1C(=O)CCCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@@H]4C(N)=O)n3)ccc21		CHEMBL2042696	=	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
Not Determined	10921252	CHEMBL2044750	Inhibition of NPM-ALK autophosphorylation in human KARPAS299 cells	B	CN1C(=O)CCCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4C(N)=O)n3)ccc21		CHEMBL2042697		IC50			CHEMBL4247	Homo sapiens	IC50		
	10921253	CHEMBL2044750	Inhibition of NPM-ALK autophosphorylation in human KARPAS299 cells	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(Nc3ccccc3C(=O)NC)n1)c2OC		CHEMBL2042827	=	IC50	nM	200.0	CHEMBL4247	Homo sapiens	IC50	nM	200.0
	10921254	CHEMBL2044750	Inhibition of NPM-ALK autophosphorylation in human KARPAS299 cells	B	CCN1C(=O)CCCc2cc(Nc3ncc(Cl)c(Nc4ccccc4C(=O)NC)n3)c(OC)cc21		CHEMBL2042828	=	IC50	nM	40.0	CHEMBL4247	Homo sapiens	IC50	nM	40.0
	10921255	CHEMBL2044750	Inhibition of NPM-ALK autophosphorylation in human KARPAS299 cells	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)c2OC		CHEMBL2042829	=	IC50	nM	45.0	CHEMBL4247	Homo sapiens	IC50	nM	45.0
	10921256	CHEMBL2044750	Inhibition of NPM-ALK autophosphorylation in human KARPAS299 cells	B	CCN1C(=O)CCCc2cc(Nc3ncc(Cl)c(N[C@H]4[C@@H](C(N)=O)[C@@H]5C=C[C@H]4C5)n3)c(OC)cc21		CHEMBL2042830	=	IC50	nM	40.0	CHEMBL4247	Homo sapiens	IC50	nM	40.0
	10921257	CHEMBL2044750	Inhibition of NPM-ALK autophosphorylation in human KARPAS299 cells	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)N(C)C)n1)c2OC		CHEMBL2042831	=	IC50	nM	65.0	CHEMBL4247	Homo sapiens	IC50	nM	65.0
	10921258	CHEMBL2044750	Inhibition of NPM-ALK autophosphorylation in human KARPAS299 cells	B	CCN1C(=O)CCCc2cc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)N(C)C)n3)c(OC)cc21		CHEMBL2042981	=	IC50	nM	30.0	CHEMBL4247	Homo sapiens	IC50	nM	30.0
	10921259	CHEMBL2044750	Inhibition of NPM-ALK autophosphorylation in human KARPAS299 cells	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)c2OC		CHEMBL2042982	=	IC50	nM	50.0	CHEMBL4247	Homo sapiens	IC50	nM	50.0
	10921260	CHEMBL2044750	Inhibition of NPM-ALK autophosphorylation in human KARPAS299 cells	B	CCN1C(=O)CCCc2cc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)c(OC)cc21		CHEMBL2042983	=	IC50	nM	30.0	CHEMBL4247	Homo sapiens	IC50	nM	30.0
	10921336	CHEMBL2046142	Inhibition of NPM-ALK autophosphorylation in human KARPAS299 cells in presence of mouse plasma	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)c2OC		CHEMBL2042829	=	IC50	nM	225.0	CHEMBL4247	Homo sapiens	IC50	nM	225.0
	10921340	CHEMBL2044758	Inhibition of ALK at 1 uM	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)c2OC		CHEMBL2042829	=	Inhibition	%	97.0	CHEMBL4247	Homo sapiens	INH	%	97.0
	10921341	CHEMBL2044756	Inhibition of ALK at 0.1 uM	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)c2OC		CHEMBL2042829	=	Inhibition	%	89.0	CHEMBL4247	Homo sapiens	INH	%	89.0
	10925136	CHEMBL2046099	Inhibition of human ALK assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	CC(C)Nc1cc(-c2oc3ccccc3c(=O)c2-c2ccc(F)cc2)ccn1		CHEMBL2041958	=	Activity	%	88.0	CHEMBL4247	Homo sapiens	Activity	%	88.0
	10925137	CHEMBL2046099	Inhibition of human ALK assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	O=c1c(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)oc2ccccc12		CHEMBL2041962	=	Activity	%	91.0	CHEMBL4247	Homo sapiens	Activity	%	91.0
	10981577	CHEMBL2067582	Inhibition of ALK tyrosine phosphorylation in human Karpas-299 cells after 2 hrs in presence of mouse plasma	B	COc1cc2c(cc1Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)CCC(N1CCN(C)CC1)CC2		CHEMBL2064723	=	IC50	nM	150.0	CHEMBL4247	Homo sapiens	IC50	nM	150.0
	10981578	CHEMBL2067582	Inhibition of ALK tyrosine phosphorylation in human Karpas-299 cells after 2 hrs in presence of mouse plasma	B	COc1cc2c(cc1Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)CCC(N1CCN(C)CC1)CC2		CHEMBL2064723	=	IC50	nM	150.0	CHEMBL4247	Homo sapiens	IC50	nM	150.0
	10981579	CHEMBL2067582	Inhibition of ALK tyrosine phosphorylation in human Karpas-299 cells after 2 hrs in presence of mouse plasma	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CCC(N1CCN(C)CC1)CC2		CHEMBL2064722	=	IC50	nM	20.0	CHEMBL4247	Homo sapiens	IC50	nM	20.0
	10981580	CHEMBL2067582	Inhibition of ALK tyrosine phosphorylation in human Karpas-299 cells after 2 hrs in presence of mouse plasma	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CCC(N1CCN(C)CC1)CC2		CHEMBL2064722	=	IC50	nM	200.0	CHEMBL4247	Homo sapiens	IC50	nM	200.0
	10981581	CHEMBL2067582	Inhibition of ALK tyrosine phosphorylation in human Karpas-299 cells after 2 hrs in presence of mouse plasma	B	COc1cc2c(cc1Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)CCC(N1CCOCC1)CC2		CHEMBL2064667	=	IC50	nM	120.0	CHEMBL4247	Homo sapiens	IC50	nM	120.0
	10981582	CHEMBL2067582	Inhibition of ALK tyrosine phosphorylation in human Karpas-299 cells after 2 hrs in presence of mouse plasma	B	COc1cc2c(cc1Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)CCC(N1CCOCC1)CC2		CHEMBL2064667	=	IC50	nM	40.0	CHEMBL4247	Homo sapiens	IC50	nM	40.0
	10981583	CHEMBL2067582	Inhibition of ALK tyrosine phosphorylation in human Karpas-299 cells after 2 hrs in presence of mouse plasma	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CC[C@@H](N1CCOCC1)CC2		CHEMBL2064666	=	IC50	nM	20.0	CHEMBL4247	Homo sapiens	IC50	nM	20.0
	10981584	CHEMBL2067582	Inhibition of ALK tyrosine phosphorylation in human Karpas-299 cells after 2 hrs in presence of mouse plasma	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CC[C@H](N1CCOCC1)CC2		CHEMBL2064665	=	IC50	nM	120.0	CHEMBL4247	Homo sapiens	IC50	nM	120.0
	10981585	CHEMBL2067582	Inhibition of ALK tyrosine phosphorylation in human Karpas-299 cells after 2 hrs in presence of mouse plasma	B	COCCNC1CCc2cc(Nc3ncc(Cl)c(N[C@H]4[C@@H](C(N)=O)[C@@H]5C=C[C@H]4C5)n3)c(OC)cc2CC1		CHEMBL2064664	=	IC50	nM	65.0	CHEMBL4247	Homo sapiens	IC50	nM	65.0
	10981586	CHEMBL2067582	Inhibition of ALK tyrosine phosphorylation in human Karpas-299 cells after 2 hrs in presence of mouse plasma	B	COCCNC1CCc2cc(Nc3ncc(Cl)c(N[C@H]4[C@@H](C(N)=O)[C@@H]5C=C[C@H]4C5)n3)c(OC)cc2CC1		CHEMBL2064664	=	IC50	nM	40.0	CHEMBL4247	Homo sapiens	IC50	nM	40.0
	10981587	CHEMBL2067582	Inhibition of ALK tyrosine phosphorylation in human Karpas-299 cells after 2 hrs in presence of mouse plasma	B	COCCN[C@@H]1CCc2ccc(Nc3ncc(Cl)c(N[C@H]4[C@@H](C(N)=O)[C@@H]5C=C[C@H]4C5)n3)c(OC)c2CC1		CHEMBL2064663	=	IC50	nM	30.0	CHEMBL4247	Homo sapiens	IC50	nM	30.0
	10981588	CHEMBL2067582	Inhibition of ALK tyrosine phosphorylation in human Karpas-299 cells after 2 hrs in presence of mouse plasma	B	COCCN[C@H]1CCc2ccc(Nc3ncc(Cl)c(N[C@H]4[C@@H](C(N)=O)[C@@H]5C=C[C@H]4C5)n3)c(OC)c2CC1		CHEMBL2064662	=	IC50	nM	65.0	CHEMBL4247	Homo sapiens	IC50	nM	65.0
	10981589	CHEMBL2067582	Inhibition of ALK tyrosine phosphorylation in human Karpas-299 cells after 2 hrs in presence of mouse plasma	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccc(N4CCOCC4)cc3OC)n1)CCN(CC(=O)N(C)C)CC2		CHEMBL1642258	=	IC50	nM	30.0	CHEMBL4247	Homo sapiens	IC50	nM	30.0
	10981590	CHEMBL2067582	Inhibition of ALK tyrosine phosphorylation in human Karpas-299 cells after 2 hrs in presence of mouse plasma	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)c2OC		CHEMBL2042829	=	IC50	nM	45.0	CHEMBL4247	Homo sapiens	IC50	nM	45.0
	10981591	CHEMBL2067581	Inhibition of human ALK cytoplasmic domain expressed in baculovirus using GST-PLCgamma as substrate preincubated for 15 mins before substrate addition measured after 1 hr by time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)CCC(N1CCN(C)CC1)CC2		CHEMBL2064723	=	IC50	nM	15.0	CHEMBL4247	Homo sapiens	IC50	nM	15.0
	10981592	CHEMBL2067581	Inhibition of human ALK cytoplasmic domain expressed in baculovirus using GST-PLCgamma as substrate preincubated for 15 mins before substrate addition measured after 1 hr by time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)CCC(N1CCN(C)CC1)CC2		CHEMBL2064723	=	IC50	nM	17.0	CHEMBL4247	Homo sapiens	IC50	nM	17.0
	10981593	CHEMBL2067581	Inhibition of human ALK cytoplasmic domain expressed in baculovirus using GST-PLCgamma as substrate preincubated for 15 mins before substrate addition measured after 1 hr by time resolved fluorescence assay	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CCC(N1CCN(C)CC1)CC2		CHEMBL2064722	=	IC50	nM	3.1	CHEMBL4247	Homo sapiens	IC50	nM	3.1
	10981594	CHEMBL2067581	Inhibition of human ALK cytoplasmic domain expressed in baculovirus using GST-PLCgamma as substrate preincubated for 15 mins before substrate addition measured after 1 hr by time resolved fluorescence assay	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CCC(N1CCN(C)CC1)CC2		CHEMBL2064722	=	IC50	nM	16.2	CHEMBL4247	Homo sapiens	IC50	nM	16.2
	10981595	CHEMBL2067581	Inhibition of human ALK cytoplasmic domain expressed in baculovirus using GST-PLCgamma as substrate preincubated for 15 mins before substrate addition measured after 1 hr by time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)CCC(N1CCOCC1)CC2		CHEMBL2064667	=	IC50	nM	16.0	CHEMBL4247	Homo sapiens	IC50	nM	16.0
	10981596	CHEMBL2067581	Inhibition of human ALK cytoplasmic domain expressed in baculovirus using GST-PLCgamma as substrate preincubated for 15 mins before substrate addition measured after 1 hr by time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)CCC(N1CCOCC1)CC2		CHEMBL2064667	=	IC50	nM	6.0	CHEMBL4247	Homo sapiens	IC50	nM	6.0
	10981597	CHEMBL2067581	Inhibition of human ALK cytoplasmic domain expressed in baculovirus using GST-PLCgamma as substrate preincubated for 15 mins before substrate addition measured after 1 hr by time resolved fluorescence assay	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CC[C@@H](N1CCOCC1)CC2		CHEMBL2064666	=	IC50	nM	1.9	CHEMBL4247	Homo sapiens	IC50	nM	1.9
	10981598	CHEMBL2067581	Inhibition of human ALK cytoplasmic domain expressed in baculovirus using GST-PLCgamma as substrate preincubated for 15 mins before substrate addition measured after 1 hr by time resolved fluorescence assay	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CC[C@H](N1CCOCC1)CC2		CHEMBL2064665	=	IC50	nM	35.0	CHEMBL4247	Homo sapiens	IC50	nM	35.0
	10981599	CHEMBL2067581	Inhibition of human ALK cytoplasmic domain expressed in baculovirus using GST-PLCgamma as substrate preincubated for 15 mins before substrate addition measured after 1 hr by time resolved fluorescence assay	B	COCCNC1CCc2cc(Nc3ncc(Cl)c(N[C@H]4[C@@H](C(N)=O)[C@@H]5C=C[C@H]4C5)n3)c(OC)cc2CC1		CHEMBL2064664	=	IC50	nM	11.0	CHEMBL4247	Homo sapiens	IC50	nM	11.0
	10981600	CHEMBL2067581	Inhibition of human ALK cytoplasmic domain expressed in baculovirus using GST-PLCgamma as substrate preincubated for 15 mins before substrate addition measured after 1 hr by time resolved fluorescence assay	B	COCCNC1CCc2cc(Nc3ncc(Cl)c(N[C@H]4[C@@H](C(N)=O)[C@@H]5C=C[C@H]4C5)n3)c(OC)cc2CC1		CHEMBL2064664	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
	10981601	CHEMBL2067581	Inhibition of human ALK cytoplasmic domain expressed in baculovirus using GST-PLCgamma as substrate preincubated for 15 mins before substrate addition measured after 1 hr by time resolved fluorescence assay	B	COCCN[C@@H]1CCc2ccc(Nc3ncc(Cl)c(N[C@H]4[C@@H](C(N)=O)[C@@H]5C=C[C@H]4C5)n3)c(OC)c2CC1		CHEMBL2064663	=	IC50	nM	9.0	CHEMBL4247	Homo sapiens	IC50	nM	9.0
	10981602	CHEMBL2067581	Inhibition of human ALK cytoplasmic domain expressed in baculovirus using GST-PLCgamma as substrate preincubated for 15 mins before substrate addition measured after 1 hr by time resolved fluorescence assay	B	COCCN[C@H]1CCc2ccc(Nc3ncc(Cl)c(N[C@H]4[C@@H](C(N)=O)[C@@H]5C=C[C@H]4C5)n3)c(OC)c2CC1		CHEMBL2064662	=	IC50	nM	21.0	CHEMBL4247	Homo sapiens	IC50	nM	21.0
	10981603	CHEMBL2067581	Inhibition of human ALK cytoplasmic domain expressed in baculovirus using GST-PLCgamma as substrate preincubated for 15 mins before substrate addition measured after 1 hr by time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccc(N4CCOCC4)cc3OC)n1)CCN(CC(=O)N(C)C)CC2		CHEMBL1642258	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
	10981604	CHEMBL2067581	Inhibition of human ALK cytoplasmic domain expressed in baculovirus using GST-PLCgamma as substrate preincubated for 15 mins before substrate addition measured after 1 hr by time resolved fluorescence assay	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)c2OC		CHEMBL2042829	=	IC50	nM	14.0	CHEMBL4247	Homo sapiens	IC50	nM	14.0
	10984734	CHEMBL2072030	Inhibition of human Alk at 1 uM	B	Nc1cc(Nc2cnccn2)nc(-c2ccnc(N3CCNCC3)c2)c1		CHEMBL2069349	<	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	11018492	CHEMBL2091521	Inhibition of ALK at 10 uM	B	Nc1n[nH]c2nc(Nc3cccc(NC(=O)Nc4ccc(F)c(Cl)c4)c3)ncc12		CHEMBL2089212	=	Inhibition	%	26.0	CHEMBL4247	Homo sapiens	INH	%	26.0
	12046239	CHEMBL2157259	Inhibition of ALK at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	6.2	CHEMBL4247	Homo sapiens	INH	%	6.2
	12051573	CHEMBL2154713	Inhibition of ALK	B	CC(C)Oc1cc(-n2cnc3ccc(N[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL2151321	=	IC50	nM	34.1	CHEMBL4247	Homo sapiens	IC50	nM	34.1
	12051595	CHEMBL2154974	Inhibition of ALK at 10 uM	B	CC(C)Oc1cc(-n2cnc3ccc(N[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL2151321	>	Inhibition	%	30.0	CHEMBL4247	Homo sapiens	INH	%	30.0
	12074594	CHEMBL2160991	Inhibition of ALK at 0.1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	12074604	CHEMBL2161001	Inhibition of ALK at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	>	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	12076560	CHEMBL2161942	Inhibition of GST-tagged human ALK cytoplasmic domain (1058-1620) expressed in Sf21 insect cells using GST-tagged human recombinant PLC-gamma/substrate by ELISA	B	COc1cc(C2CCN(CC(N)=O)CC2)ccc1Nc1ncc2ccc(-c3ncccc3OC)n2n1		CHEMBL2158514	=	IC50	nM	1061.0	CHEMBL4247	Homo sapiens	IC50	nM	1061.0
	12076572	CHEMBL2161942	Inhibition of GST-tagged human ALK cytoplasmic domain (1058-1620) expressed in Sf21 insect cells using GST-tagged human recombinant PLC-gamma/substrate by ELISA	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL2158524	=	IC50	nM	187.0	CHEMBL4247	Homo sapiens	IC50	nM	187.0
	12076581	CHEMBL2161942	Inhibition of GST-tagged human ALK cytoplasmic domain (1058-1620) expressed in Sf21 insect cells using GST-tagged human recombinant PLC-gamma/substrate by ELISA	B	C[C@H](O)CN1CCN(c2cc(F)c(Nc3ncc4ccc(-c5ccccc5N(C)S(C)(=O)=O)n4n3)cc2F)CC1		CHEMBL2158522	=	IC50	nM	91.0	CHEMBL4247	Homo sapiens	IC50	nM	91.0
	12076590	CHEMBL2161942	Inhibition of GST-tagged human ALK cytoplasmic domain (1058-1620) expressed in Sf21 insect cells using GST-tagged human recombinant PLC-gamma/substrate by ELISA	B	COc1c(Nc2ncc3ccc(-c4ccccc4N(C)S(C)(=O)=O)n3n2)ccc(N2CCN(C[C@H](C)O)CC2)c1F		CHEMBL2158520	=	IC50	nM	56.0	CHEMBL4247	Homo sapiens	IC50	nM	56.0
	12076593	CHEMBL2161942	Inhibition of GST-tagged human ALK cytoplasmic domain (1058-1620) expressed in Sf21 insect cells using GST-tagged human recombinant PLC-gamma/substrate by ELISA	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2ccc(-c3ccccc3N(C)S(C)(=O)=O)n2n1		CHEMBL2158523	=	IC50	nM	28.0	CHEMBL4247	Homo sapiens	IC50	nM	28.0
	12076594	CHEMBL2161942	Inhibition of GST-tagged human ALK cytoplasmic domain (1058-1620) expressed in Sf21 insect cells using GST-tagged human recombinant PLC-gamma/substrate by ELISA	B	COc1cc(C2CCN(CC(N)=O)CC2)ccc1Nc1ncc2ccc(-c3ccccc3C#N)n2n1		CHEMBL2158513	=	IC50	nM	19.0	CHEMBL4247	Homo sapiens	IC50	nM	19.0
	12076595	CHEMBL2161942	Inhibition of GST-tagged human ALK cytoplasmic domain (1058-1620) expressed in Sf21 insect cells using GST-tagged human recombinant PLC-gamma/substrate by ELISA	B	COc1cc(C2CCN(CC(N)=O)CC2)ccc1Nc1ncc2ccc(-c3ccccc3N(C)S(C)(=O)=O)n2n1		CHEMBL2158516	=	IC50	nM	15.0	CHEMBL4247	Homo sapiens	IC50	nM	15.0
	12076596	CHEMBL2161942	Inhibition of GST-tagged human ALK cytoplasmic domain (1058-1620) expressed in Sf21 insect cells using GST-tagged human recombinant PLC-gamma/substrate by ELISA	B	COc1cc(N2CCN(C[C@H](C)O)CC2)c(F)cc1Nc1ncc2ccc(-c3ccccc3N(C)S(C)(=O)=O)n2n1		CHEMBL2158521	=	IC50	nM	14.0	CHEMBL4247	Homo sapiens	IC50	nM	14.0
	12076597	CHEMBL2161942	Inhibition of GST-tagged human ALK cytoplasmic domain (1058-1620) expressed in Sf21 insect cells using GST-tagged human recombinant PLC-gamma/substrate by ELISA	B	COc1ccc(-c2ccc3cnc(Nc4ccc(C5CCN(CC(N)=O)CC5)cc4OC)nn23)c(OC)c1		CHEMBL2158512	=	IC50	nM	12.0	CHEMBL4247	Homo sapiens	IC50	nM	12.0
	12076992	CHEMBL2161942	Inhibition of GST-tagged human ALK cytoplasmic domain (1058-1620) expressed in Sf21 insect cells using GST-tagged human recombinant PLC-gamma/substrate by ELISA	B	COc1cc(C2CCN(CC(N)=O)CC2)ccc1Nc1ncc2c(O)cc(-c3ccccc3N(C)S(C)(=O)=O)n2n1		CHEMBL2158517	=	IC50	nM	11.0	CHEMBL4247	Homo sapiens	IC50	nM	11.0
	12076993	CHEMBL2161942	Inhibition of GST-tagged human ALK cytoplasmic domain (1058-1620) expressed in Sf21 insect cells using GST-tagged human recombinant PLC-gamma/substrate by ELISA	B	COc1cc(C2CCN(C(=O)C3CCN3)CC2)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL2158587	=	IC50	nM	11.0	CHEMBL4247	Homo sapiens	IC50	nM	11.0
	12076994	CHEMBL2161942	Inhibition of GST-tagged human ALK cytoplasmic domain (1058-1620) expressed in Sf21 insect cells using GST-tagged human recombinant PLC-gamma/substrate by ELISA	B	CNC(=O)CN1CCC(c2ccc(Nc3ncc4ccc(-c5ccccc5OC)n4n3)c(OC)c2)CC1		CHEMBL2158511	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
	12076995	CHEMBL2161942	Inhibition of GST-tagged human ALK cytoplasmic domain (1058-1620) expressed in Sf21 insect cells using GST-tagged human recombinant PLC-gamma/substrate by ELISA	B	COc1cc(C2CCNCC2)ccc1Nc1ncc2ccc(-c3ccccc3N(C)S(C)(=O)=O)n2n1		CHEMBL2158527	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
	12076996	CHEMBL2161942	Inhibition of GST-tagged human ALK cytoplasmic domain (1058-1620) expressed in Sf21 insect cells using GST-tagged human recombinant PLC-gamma/substrate by ELISA	B	COc1cc(N2CCN(C[C@H](C)O)CC2)ccc1Nc1ncc2ccc(-c3ccccc3N(C)S(C)(=O)=O)n2n1		CHEMBL1822525	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
	12076997	CHEMBL2161942	Inhibition of GST-tagged human ALK cytoplasmic domain (1058-1620) expressed in Sf21 insect cells using GST-tagged human recombinant PLC-gamma/substrate by ELISA	B	COc1cc(C2CCN(CC(N)=O)CC2)ccc1Nc1ncc2ccc(-c3ccncc3OC)n2n1		CHEMBL2158515	=	IC50	nM	9.0	CHEMBL4247	Homo sapiens	IC50	nM	9.0
	12076998	CHEMBL2161942	Inhibition of GST-tagged human ALK cytoplasmic domain (1058-1620) expressed in Sf21 insect cells using GST-tagged human recombinant PLC-gamma/substrate by ELISA	B	COc1cc(C2CCN(C(=O)C(C)(C)N)CC2)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL2158586	=	IC50	nM	7.0	CHEMBL4247	Homo sapiens	IC50	nM	7.0
	12076999	CHEMBL2161942	Inhibition of GST-tagged human ALK cytoplasmic domain (1058-1620) expressed in Sf21 insect cells using GST-tagged human recombinant PLC-gamma/substrate by ELISA	B	COc1cc(C2CCN(CC(N)=O)CC2)ccc1Nc1ncc2c(C)cc(-c3ccccc3N(C)S(C)(=O)=O)n2n1		CHEMBL2158518	=	IC50	nM	6.0	CHEMBL4247	Homo sapiens	IC50	nM	6.0
	12077000	CHEMBL2161942	Inhibition of GST-tagged human ALK cytoplasmic domain (1058-1620) expressed in Sf21 insect cells using GST-tagged human recombinant PLC-gamma/substrate by ELISA	B	COc1cc(C2CCN(CC(N)=O)CC2)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL1934334	=	IC50	nM	6.0	CHEMBL4247	Homo sapiens	IC50	nM	6.0
	12077001	CHEMBL2161942	Inhibition of GST-tagged human ALK cytoplasmic domain (1058-1620) expressed in Sf21 insect cells using GST-tagged human recombinant PLC-gamma/substrate by ELISA	B	COc1cc(C2CCN(C)CC2)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL2158529	=	IC50	nM	6.0	CHEMBL4247	Homo sapiens	IC50	nM	6.0
	12077002	CHEMBL2161942	Inhibition of GST-tagged human ALK cytoplasmic domain (1058-1620) expressed in Sf21 insect cells using GST-tagged human recombinant PLC-gamma/substrate by ELISA	B	COc1cc(C2CCN(C[C@@H](C)O)CC2)ccc1Nc1ncc2ccc(-c3ccccc3N(C)S(C)(=O)=O)n2n1		CHEMBL2158526	=	IC50	nM	6.0	CHEMBL4247	Homo sapiens	IC50	nM	6.0
	12077003	CHEMBL2161942	Inhibition of GST-tagged human ALK cytoplasmic domain (1058-1620) expressed in Sf21 insect cells using GST-tagged human recombinant PLC-gamma/substrate by ELISA	B	COc1cc(C2CCN(CCO)CC2)ccc1Nc1ncc2ccc(-c3ccccc3N(C)S(C)(=O)=O)n2n1		CHEMBL2158525	=	IC50	nM	6.0	CHEMBL4247	Homo sapiens	IC50	nM	6.0
	12077004	CHEMBL2161942	Inhibition of GST-tagged human ALK cytoplasmic domain (1058-1620) expressed in Sf21 insect cells using GST-tagged human recombinant PLC-gamma/substrate by ELISA	B	COc1cc(C2CCN(CC(N)=O)CC2)ccc1Nc1ncc2c(Cl)cc(-c3ccccc3N(C)S(C)(=O)=O)n2n1		CHEMBL2158519	=	IC50	nM	4.7	CHEMBL4247	Homo sapiens	IC50	nM	4.7
	12077005	CHEMBL2161942	Inhibition of GST-tagged human ALK cytoplasmic domain (1058-1620) expressed in Sf21 insect cells using GST-tagged human recombinant PLC-gamma/substrate by ELISA	B	COc1cc(C2CCN(C[C@@H](C)O)CC2)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL2158528	=	IC50	nM	3.4	CHEMBL4247	Homo sapiens	IC50	nM	3.4
	12077006	CHEMBL2161942	Inhibition of GST-tagged human ALK cytoplasmic domain (1058-1620) expressed in Sf21 insect cells using GST-tagged human recombinant PLC-gamma/substrate by ELISA	B	COc1cc(C2CCN(CC(O)CF)CC2)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL2158530	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
	12077007	CHEMBL2161942	Inhibition of GST-tagged human ALK cytoplasmic domain (1058-1620) expressed in Sf21 insect cells using GST-tagged human recombinant PLC-gamma/substrate by ELISA	B	COc1cc(C2CCN(C[C@H](O)CO)CC2)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL2158531	=	IC50	nM	2.9	CHEMBL4247	Homo sapiens	IC50	nM	2.9
	12104319	CHEMBL2175668	Inhibition of human ALK assessed as residual enzyme activity at 1 uM by Ambit kinome assay	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3cc(F)cc(F)c3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1		CHEMBL2172315	=	Activity	%	2.7	CHEMBL4247	Homo sapiens	Activity	%	2.7
	12104320	CHEMBL2175668	Inhibition of human ALK assessed as residual enzyme activity at 1 uM by Ambit kinome assay	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1		CHEMBL2172308	=	Activity	%	0.55	CHEMBL4247	Homo sapiens	Activity	%	0.55
	12105215	CHEMBL2175678	Binding affinity to human ALK by Ambit titration assay	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3cc(F)cc(F)c3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1		CHEMBL2172315	=	Kd	nM	0.24	CHEMBL4247	Homo sapiens	Kd	nM	0.24
	12105216	CHEMBL2175678	Binding affinity to human ALK by Ambit titration assay	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1		CHEMBL2172308	=	Kd	nM	0.36	CHEMBL4247	Homo sapiens	Kd	nM	0.36
Active	12105225	CHEMBL2175795	Inhibition of ALK L1196M mutant	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3cc(F)cc(F)c3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1		CHEMBL2172315		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	12105226	CHEMBL2175795	Inhibition of ALK L1196M mutant	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1		CHEMBL2172308		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	12105227	CHEMBL2175794	Inhibition of ALK R1275Q mutant	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3cc(F)cc(F)c3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1		CHEMBL2172315		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	12105228	CHEMBL2175794	Inhibition of ALK R1275Q mutant	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1		CHEMBL2172308		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	12105378	CHEMBL2176367	Inhibition of ALK Tyr1604 phosphorylation by cell based assay	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CC(C(C)(C)O)C4)cc32)CC1		CHEMBL2172312	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	uM	0.002
	12105379	CHEMBL2176367	Inhibition of ALK Tyr1604 phosphorylation by cell based assay	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CNCC(C)(C)O)cc32)CC1		CHEMBL2172311	=	IC50	nM	1.6	CHEMBL4247	Homo sapiens	IC50	uM	0.0016
	12105380	CHEMBL2176367	Inhibition of ALK Tyr1604 phosphorylation by cell based assay	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCC(C(C)(C)O)C4)cc32)CC1		CHEMBL2172310	=	IC50	nM	8.0	CHEMBL4247	Homo sapiens	IC50	uM	0.008
	12105381	CHEMBL2176367	Inhibition of ALK Tyr1604 phosphorylation by cell based assay	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCC[C@H]4C(C)(C)O)cc32)CC1		CHEMBL2172309	=	IC50	nM	13.0	CHEMBL4247	Homo sapiens	IC50	uM	0.013
	12105382	CHEMBL2176367	Inhibition of ALK Tyr1604 phosphorylation by cell based assay	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1		CHEMBL2172308	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	uM	0.004
	12105383	CHEMBL2176367	Inhibition of ALK Tyr1604 phosphorylation by cell based assay	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCC[C@H]4C(N)=O)cc32)CC1		CHEMBL2172307	=	IC50	nM	8.0	CHEMBL4247	Homo sapiens	IC50	uM	0.008
	12105384	CHEMBL2176367	Inhibition of ALK Tyr1604 phosphorylation by cell based assay	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCC(C(N)=O)CC4)cc32)CC1		CHEMBL2172306	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	uM	0.004
	12105385	CHEMBL2176367	Inhibition of ALK Tyr1604 phosphorylation by cell based assay	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCC(C(=O)O)CC4)cc32)CC1		CHEMBL2172305	=	IC50	nM	345.0	CHEMBL4247	Homo sapiens	IC50	uM	0.345
	12105386	CHEMBL2176367	Inhibition of ALK Tyr1604 phosphorylation by cell based assay	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCCCC4C(=O)O)cc32)CC1		CHEMBL2172336	=	IC50	nM	144.0	CHEMBL4247	Homo sapiens	IC50	uM	0.144
	12105387	CHEMBL2176367	Inhibition of ALK Tyr1604 phosphorylation by cell based assay	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCC(CN)CC4)cc32)CC1		CHEMBL2172335	=	IC50	nM	8.0	CHEMBL4247	Homo sapiens	IC50	uM	0.008
	12105388	CHEMBL2176367	Inhibition of ALK Tyr1604 phosphorylation by cell based assay	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCNC(=O)C4)cc32)CC1		CHEMBL2172334	=	IC50	nM	6.0	CHEMBL4247	Homo sapiens	IC50	uM	0.006
	12105389	CHEMBL2176367	Inhibition of ALK Tyr1604 phosphorylation by cell based assay	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCNCC4)cc32)CC1		CHEMBL2172333	=	IC50	nM	5.0	CHEMBL4247	Homo sapiens	IC50	uM	0.005
	12105390	CHEMBL2176367	Inhibition of ALK Tyr1604 phosphorylation by cell based assay	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(Oc4ccccn4)cc32)CC1		CHEMBL2172337	=	IC50	nM	109.0	CHEMBL4247	Homo sapiens	IC50	uM	0.109
	12105391	CHEMBL2176367	Inhibition of ALK Tyr1604 phosphorylation by cell based assay	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(Cn4cncn4)cc32)CC1		CHEMBL2172332	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	uM	0.004
	12105392	CHEMBL2176367	Inhibition of ALK Tyr1604 phosphorylation by cell based assay	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCS(=O)(=O)CC4)cc32)CC1		CHEMBL2172331	=	IC50	nM	8.0	CHEMBL4247	Homo sapiens	IC50	uM	0.008
	12105393	CHEMBL2176367	Inhibition of ALK Tyr1604 phosphorylation by cell based assay	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCCCC4)cc32)CC1		CHEMBL2172330	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	uM	0.004
	12105394	CHEMBL2176367	Inhibition of ALK Tyr1604 phosphorylation by cell based assay	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccccc32)CC1		CHEMBL2172329	=	IC50	nM	147.0	CHEMBL4247	Homo sapiens	IC50	uM	0.147
	12105395	CHEMBL2176367	Inhibition of ALK Tyr1604 phosphorylation by cell based assay	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccccc3)[nH]c3ccc(CN4CCCCC4)cc32)CC1		CHEMBL2172328	=	IC50	nM	5.0	CHEMBL4247	Homo sapiens	IC50	uM	0.005
	12105396	CHEMBL2176367	Inhibition of ALK Tyr1604 phosphorylation by cell based assay	B	NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccccc3)[nH]c3ccc(CN4CCCCC4)cc32)CC1		CHEMBL2172327	=	IC50	nM	44.0	CHEMBL4247	Homo sapiens	IC50	uM	0.044
	12105397	CHEMBL2176367	Inhibition of ALK Tyr1604 phosphorylation by cell based assay	B	CCN(CC)C(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccccc3)[nH]c3ccc(CN4CCCCC4)cc32)CC1		CHEMBL2172326	=	IC50	nM	562.0	CHEMBL4247	Homo sapiens	IC50	uM	0.562
	12105398	CHEMBL2176367	Inhibition of ALK Tyr1604 phosphorylation by cell based assay	B	CCNC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccccc3)[nH]c3ccc(CN4CCCCC4)cc32)CC1		CHEMBL2172325	=	IC50	nM	7.0	CHEMBL4247	Homo sapiens	IC50	uM	0.007
	12105399	CHEMBL2176367	Inhibition of ALK Tyr1604 phosphorylation by cell based assay	B	CCOC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccccc3)[nH]c3ccc(CN4CCCCC4)cc32)CC1		CHEMBL2172324	=	IC50	nM	18.0	CHEMBL4247	Homo sapiens	IC50	uM	0.018
	12105400	CHEMBL2176367	Inhibition of ALK Tyr1604 phosphorylation by cell based assay	B	COC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccccc3)[nH]c3ccc(CN4CCCCC4)cc32)CC1		CHEMBL2172323	=	IC50	nM	54.0	CHEMBL4247	Homo sapiens	IC50	uM	0.054
	12105401	CHEMBL2176367	Inhibition of ALK Tyr1604 phosphorylation by cell based assay	B	C=CCNS(=O)(=O)c1cccc(C(=O)/N=c2\[nH]c3cc(CN4CCCCC4)ccc3n2[C@H]2CC[C@@H](CO)CC2)c1		CHEMBL2172322	=	IC50	nM	48.0	CHEMBL4247	Homo sapiens	IC50	uM	0.048
	12106388	CHEMBL2176371	Inhibition of ALK enzyme	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(C#N)c(F)c3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1		CHEMBL2172304	=	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	uM	0.001
	12106389	CHEMBL2176371	Inhibition of ALK enzyme	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)c(Cl)c3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1		CHEMBL2172303	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	uM	0.003
	12106390	CHEMBL2176371	Inhibition of ALK enzyme	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3cccc(Cl)c3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1		CHEMBL2172302	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	uM	0.002
	12106391	CHEMBL2176371	Inhibition of ALK enzyme	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3cc(F)cc(Cl)c3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1		CHEMBL2172301	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	uM	0.003
	12106392	CHEMBL2176371	Inhibition of ALK enzyme	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3cccc(C#N)c3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1		CHEMBL2172321	=	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	uM	0.001
	12106393	CHEMBL2176371	Inhibition of ALK enzyme	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3cc(F)cc(C#N)c3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1		CHEMBL2172320	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	uM	0.003
	12106394	CHEMBL2176371	Inhibition of ALK enzyme	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)c(F)c3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1		CHEMBL2172319	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	uM	0.002
	12106395	CHEMBL2176371	Inhibition of ALK enzyme	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3cccnc3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1		CHEMBL2172318	=	IC50	nM	6.0	CHEMBL4247	Homo sapiens	IC50	uM	0.006
	12106396	CHEMBL2176371	Inhibition of ALK enzyme	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(C#N)cc3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1		CHEMBL2172317	=	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	uM	0.001
	12106397	CHEMBL2176371	Inhibition of ALK enzyme	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccncc3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1		CHEMBL2172316	=	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	uM	0.001
	12106398	CHEMBL2176371	Inhibition of ALK enzyme	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3cc(F)cc(F)c3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1		CHEMBL2172315	=	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	uM	0.001
	12106399	CHEMBL2176371	Inhibition of ALK enzyme	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3cccc(F)c3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1		CHEMBL2172314	=	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	uM	0.001
	12106400	CHEMBL2176371	Inhibition of ALK enzyme	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccccc3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1		CHEMBL2172313	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	uM	0.002
	12106401	CHEMBL2176371	Inhibition of ALK enzyme	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CC(C(C)(C)O)C4)cc32)CC1		CHEMBL2172312	=	IC50	nM	1.5	CHEMBL4247	Homo sapiens	IC50	uM	0.0015
	12106402	CHEMBL2176371	Inhibition of ALK enzyme	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CNCC(C)(C)O)cc32)CC1		CHEMBL2172311	=	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	uM	0.001
	12106403	CHEMBL2176371	Inhibition of ALK enzyme	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCC(C(C)(C)O)C4)cc32)CC1		CHEMBL2172310	=	IC50	nM	1.9	CHEMBL4247	Homo sapiens	IC50	uM	0.0019
	12106404	CHEMBL2176371	Inhibition of ALK enzyme	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCC[C@H]4C(C)(C)O)cc32)CC1		CHEMBL2172309	=	IC50	nM	2.6	CHEMBL4247	Homo sapiens	IC50	uM	0.0026
	12106405	CHEMBL2176371	Inhibition of ALK enzyme	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1		CHEMBL2172308	=	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	uM	0.001
	12106406	CHEMBL2176371	Inhibition of ALK enzyme	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCC[C@H]4C(N)=O)cc32)CC1		CHEMBL2172307	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	uM	0.002
	12106407	CHEMBL2176371	Inhibition of ALK enzyme	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCC(C(N)=O)CC4)cc32)CC1		CHEMBL2172306	=	IC50	nM	1.4	CHEMBL4247	Homo sapiens	IC50	uM	0.0014
	12106408	CHEMBL2176371	Inhibition of ALK enzyme	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCC(C(=O)O)CC4)cc32)CC1		CHEMBL2172305	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	uM	0.002
	12106409	CHEMBL2176371	Inhibition of ALK enzyme	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCCCC4C(=O)O)cc32)CC1		CHEMBL2172336	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	uM	0.003
	12106410	CHEMBL2176371	Inhibition of ALK enzyme	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCC(CN)CC4)cc32)CC1		CHEMBL2172335	=	IC50	nM	1.2	CHEMBL4247	Homo sapiens	IC50	uM	0.0012
	12106411	CHEMBL2176371	Inhibition of ALK enzyme	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCNC(=O)C4)cc32)CC1		CHEMBL2172334	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	uM	0.002
	12106412	CHEMBL2176371	Inhibition of ALK enzyme	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCNCC4)cc32)CC1		CHEMBL2172333	=	IC50	nM	1.6	CHEMBL4247	Homo sapiens	IC50	uM	0.0016
	12106413	CHEMBL2176371	Inhibition of ALK enzyme	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(Oc4ccccn4)cc32)CC1		CHEMBL2172337	=	IC50	nM	8.3	CHEMBL4247	Homo sapiens	IC50	uM	0.0083
	12106414	CHEMBL2176371	Inhibition of ALK enzyme	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(Cn4cncn4)cc32)CC1		CHEMBL2172332	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	uM	0.002
	12106415	CHEMBL2176371	Inhibition of ALK enzyme	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCS(=O)(=O)CC4)cc32)CC1		CHEMBL2172331	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	uM	0.002
	12106416	CHEMBL2176371	Inhibition of ALK enzyme	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCCCC4)cc32)CC1		CHEMBL2172330	=	IC50	nM	1.6	CHEMBL4247	Homo sapiens	IC50	uM	0.0016
	12106417	CHEMBL2176371	Inhibition of ALK enzyme	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccccc32)CC1		CHEMBL2172329	=	IC50	nM	7.0	CHEMBL4247	Homo sapiens	IC50	uM	0.007
	12106418	CHEMBL2176371	Inhibition of ALK enzyme	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccccc3)[nH]c3ccc(CN4CCCCC4)cc32)CC1		CHEMBL2172328	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	uM	0.002
	12106419	CHEMBL2176371	Inhibition of ALK enzyme	B	NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccccc3)[nH]c3ccc(CN4CCCCC4)cc32)CC1		CHEMBL2172327	=	IC50	nM	18.0	CHEMBL4247	Homo sapiens	IC50	uM	0.018
	12106420	CHEMBL2176371	Inhibition of ALK enzyme	B	CCN(CC)C(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccccc3)[nH]c3ccc(CN4CCCCC4)cc32)CC1		CHEMBL2172326	=	IC50	nM	24.0	CHEMBL4247	Homo sapiens	IC50	uM	0.024
	12106421	CHEMBL2176371	Inhibition of ALK enzyme	B	CCNC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccccc3)[nH]c3ccc(CN4CCCCC4)cc32)CC1		CHEMBL2172325	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	uM	0.002
	12106422	CHEMBL2176371	Inhibition of ALK enzyme	B	CCOC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccccc3)[nH]c3ccc(CN4CCCCC4)cc32)CC1		CHEMBL2172324	=	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	uM	0.001
	12106423	CHEMBL2176371	Inhibition of ALK enzyme	B	COC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccccc3)[nH]c3ccc(CN4CCCCC4)cc32)CC1		CHEMBL2172323	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	uM	0.003
	12106424	CHEMBL2176371	Inhibition of ALK enzyme	B	C=CCNS(=O)(=O)c1cccc(C(=O)/N=c2\[nH]c3cc(CN4CCCCC4)ccc3n2[C@H]2CC[C@@H](CO)CC2)c1		CHEMBL2172322	=	IC50	nM	5.0	CHEMBL4247	Homo sapiens	IC50	uM	0.005
	12137906	CHEMBL2188364	Inhibition of ALK at 0.1 uM	B	CCNc1nc(Nc2cc(F)c(C(=O)N3CCOCC3)cc2OC)ncc1C(F)(F)F		CHEMBL2178134	>	Inhibition	%	65.0	CHEMBL4247	Homo sapiens	INH	%	65.0
	12150607	CHEMBL2188540	Inhibition of human recombinant ALK by radiometric kinase assay	B	CN1CCN(c2ccc(Nc3ncc4nc(Nc5ccccc5)n(C5CCCC5)c4n3)cc2)CC1		CHEMBL2178352	=	IC50	nM	2300.0	CHEMBL4247	Homo sapiens	IC50	uM	2.3
	12173740	CHEMBL2212078	Inhibition of ALK assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	7.2	CHEMBL4247	Homo sapiens	Activity	%	7.2
	12224275	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	107.0	CHEMBL4247	Homo sapiens	Residual Activity	%	107.0
	12224276	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	89.0	CHEMBL4247	Homo sapiens	Residual Activity	%	89.0
	12224277	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	88.0	CHEMBL4247	Homo sapiens	Residual Activity	%	88.0
	12224278	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	77.0	CHEMBL4247	Homo sapiens	Residual Activity	%	77.0
	12224279	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	78.0	CHEMBL4247	Homo sapiens	Residual Activity	%	78.0
	12224280	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	79.0	CHEMBL4247	Homo sapiens	Residual Activity	%	79.0
	12224281	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	56.0	CHEMBL4247	Homo sapiens	Residual Activity	%	56.0
	12224282	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	100.0	CHEMBL4247	Homo sapiens	Residual Activity	%	100.0
	12224283	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	93.0	CHEMBL4247	Homo sapiens	Residual Activity	%	93.0
	12224284	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	85.0	CHEMBL4247	Homo sapiens	Residual Activity	%	85.0
	12224285	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	81.0	CHEMBL4247	Homo sapiens	Residual Activity	%	81.0
	12224286	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	70.0	CHEMBL4247	Homo sapiens	Residual Activity	%	70.0
	12224287	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	81.0	CHEMBL4247	Homo sapiens	Residual Activity	%	81.0
	12224288	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	89.0	CHEMBL4247	Homo sapiens	Residual Activity	%	89.0
	12224289	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	83.0	CHEMBL4247	Homo sapiens	Residual Activity	%	83.0
	12224290	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	80.0	CHEMBL4247	Homo sapiens	Residual Activity	%	80.0
	12224291	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	88.0	CHEMBL4247	Homo sapiens	Residual Activity	%	88.0
	12224292	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	92.0	CHEMBL4247	Homo sapiens	Residual Activity	%	92.0
	12224293	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	56.0	CHEMBL4247	Homo sapiens	Residual Activity	%	56.0
	12224294	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	30.0	CHEMBL4247	Homo sapiens	Residual Activity	%	30.0
	12224295	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	78.0	CHEMBL4247	Homo sapiens	Residual Activity	%	78.0
	12224296	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	84.0	CHEMBL4247	Homo sapiens	Residual Activity	%	84.0
	12224297	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	84.0	CHEMBL4247	Homo sapiens	Residual Activity	%	84.0
	12224298	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	91.0	CHEMBL4247	Homo sapiens	Residual Activity	%	91.0
	12224299	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	89.0	CHEMBL4247	Homo sapiens	Residual Activity	%	89.0
	12224300	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	75.0	CHEMBL4247	Homo sapiens	Residual Activity	%	75.0
	12224301	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	68.0	CHEMBL4247	Homo sapiens	Residual Activity	%	68.0
	12224302	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	19.0	CHEMBL4247	Homo sapiens	Residual Activity	%	19.0
	12224303	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	73.0	CHEMBL4247	Homo sapiens	Residual Activity	%	73.0
	12224304	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	74.0	CHEMBL4247	Homo sapiens	Residual Activity	%	74.0
	12224305	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	85.0	CHEMBL4247	Homo sapiens	Residual Activity	%	85.0
	12224306	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	83.0	CHEMBL4247	Homo sapiens	Residual Activity	%	83.0
	12224307	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	90.0	CHEMBL4247	Homo sapiens	Residual Activity	%	90.0
	12224308	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	81.0	CHEMBL4247	Homo sapiens	Residual Activity	%	81.0
	12224309	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	74.0	CHEMBL4247	Homo sapiens	Residual Activity	%	74.0
	12224310	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	74.0	CHEMBL4247	Homo sapiens	Residual Activity	%	74.0
	12224311	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	74.0	CHEMBL4247	Homo sapiens	Residual Activity	%	74.0
	12224312	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	82.0	CHEMBL4247	Homo sapiens	Residual Activity	%	82.0
	12224313	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	82.0	CHEMBL4247	Homo sapiens	Residual Activity	%	82.0
	12224314	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	76.0	CHEMBL4247	Homo sapiens	Residual Activity	%	76.0
	12224315	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	92.0	CHEMBL4247	Homo sapiens	Residual Activity	%	92.0
	12224316	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	80.0	CHEMBL4247	Homo sapiens	Residual Activity	%	80.0
	12224317	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	0.0	CHEMBL4247	Homo sapiens	Residual Activity	%	0.0
	12224318	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	63.0	CHEMBL4247	Homo sapiens	Residual Activity	%	63.0
	12224319	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	79.0	CHEMBL4247	Homo sapiens	Residual Activity	%	79.0
	12224320	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	76.0	CHEMBL4247	Homo sapiens	Residual Activity	%	76.0
	12224321	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	84.0	CHEMBL4247	Homo sapiens	Residual Activity	%	84.0
	12224322	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	37.0	CHEMBL4247	Homo sapiens	Residual Activity	%	37.0
	12224323	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	96.0	CHEMBL4247	Homo sapiens	Residual Activity	%	96.0
	12224324	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	100.0	CHEMBL4247	Homo sapiens	Residual Activity	%	100.0
	12224325	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	80.0	CHEMBL4247	Homo sapiens	Residual Activity	%	80.0
	12224326	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	76.0	CHEMBL4247	Homo sapiens	Residual Activity	%	76.0
	12224327	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	72.0	CHEMBL4247	Homo sapiens	Residual Activity	%	72.0
	12224328	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	76.0	CHEMBL4247	Homo sapiens	Residual Activity	%	76.0
	12224329	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	94.0	CHEMBL4247	Homo sapiens	Residual Activity	%	94.0
	12224330	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	83.0	CHEMBL4247	Homo sapiens	Residual Activity	%	83.0
	12224331	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	107.0	CHEMBL4247	Homo sapiens	Residual Activity	%	107.0
	12224332	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	81.0	CHEMBL4247	Homo sapiens	Residual Activity	%	81.0
	12224333	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	84.0	CHEMBL4247	Homo sapiens	Residual Activity	%	84.0
	12224334	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	73.0	CHEMBL4247	Homo sapiens	Residual Activity	%	73.0
	12224335	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	68.0	CHEMBL4247	Homo sapiens	Residual Activity	%	68.0
	12224336	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	32.0	CHEMBL4247	Homo sapiens	Residual Activity	%	32.0
	12224337	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	88.0	CHEMBL4247	Homo sapiens	Residual Activity	%	88.0
	12224338	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	78.0	CHEMBL4247	Homo sapiens	Residual Activity	%	78.0
	12224339	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	110.0	CHEMBL4247	Homo sapiens	Residual Activity	%	110.0
	12224340	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	80.0	CHEMBL4247	Homo sapiens	Residual Activity	%	80.0
	12224341	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	71.0	CHEMBL4247	Homo sapiens	Residual Activity	%	71.0
	12224342	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	69.0	CHEMBL4247	Homo sapiens	Residual Activity	%	69.0
	12224343	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	49.0	CHEMBL4247	Homo sapiens	Residual Activity	%	49.0
	12224344	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	54.0	CHEMBL4247	Homo sapiens	Residual Activity	%	54.0
	12224345	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	82.0	CHEMBL4247	Homo sapiens	Residual Activity	%	82.0
	12224346	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	69.0	CHEMBL4247	Homo sapiens	Residual Activity	%	69.0
	12224347	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	94.0	CHEMBL4247	Homo sapiens	Residual Activity	%	94.0
	12224348	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	86.0	CHEMBL4247	Homo sapiens	Residual Activity	%	86.0
	12224349	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	77.0	CHEMBL4247	Homo sapiens	Residual Activity	%	77.0
	12224350	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	66.0	CHEMBL4247	Homo sapiens	Residual Activity	%	66.0
	12224351	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	69.0	CHEMBL4247	Homo sapiens	Residual Activity	%	69.0
	12224352	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	8.0	CHEMBL4247	Homo sapiens	Residual Activity	%	8.0
	12224353	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	113.0	CHEMBL4247	Homo sapiens	Residual Activity	%	113.0
	12224354	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	0.0	CHEMBL4247	Homo sapiens	Residual Activity	%	0.0
	12224355	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	74.0	CHEMBL4247	Homo sapiens	Residual Activity	%	74.0
	12224356	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	77.0	CHEMBL4247	Homo sapiens	Residual Activity	%	77.0
	12224357	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	91.0	CHEMBL4247	Homo sapiens	Residual Activity	%	91.0
	12224358	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	116.0	CHEMBL4247	Homo sapiens	Residual Activity	%	116.0
	12224359	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	44.0	CHEMBL4247	Homo sapiens	Residual Activity	%	44.0
	12224360	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	88.0	CHEMBL4247	Homo sapiens	Residual Activity	%	88.0
	12224361	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	82.0	CHEMBL4247	Homo sapiens	Residual Activity	%	82.0
	12224362	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	122.0	CHEMBL4247	Homo sapiens	Residual Activity	%	122.0
	12224363	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	97.0	CHEMBL4247	Homo sapiens	Residual Activity	%	97.0
	12224364	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	52.0	CHEMBL4247	Homo sapiens	Residual Activity	%	52.0
	12224365	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	79.0	CHEMBL4247	Homo sapiens	Residual Activity	%	79.0
	12224366	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	77.0	CHEMBL4247	Homo sapiens	Residual Activity	%	77.0
	12224367	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	70.0	CHEMBL4247	Homo sapiens	Residual Activity	%	70.0
	12224368	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	81.0	CHEMBL4247	Homo sapiens	Residual Activity	%	81.0
	12224369	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	91.0	CHEMBL4247	Homo sapiens	Residual Activity	%	91.0
	12224370	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	117.0	CHEMBL4247	Homo sapiens	Residual Activity	%	117.0
	12224371	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	81.0	CHEMBL4247	Homo sapiens	Residual Activity	%	81.0
	12224372	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	99.0	CHEMBL4247	Homo sapiens	Residual Activity	%	99.0
	12224373	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	86.0	CHEMBL4247	Homo sapiens	Residual Activity	%	86.0
	12224374	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	92.0	CHEMBL4247	Homo sapiens	Residual Activity	%	92.0
	12224375	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	77.0	CHEMBL4247	Homo sapiens	Residual Activity	%	77.0
	12224376	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	10.0	CHEMBL4247	Homo sapiens	Residual Activity	%	10.0
	12224377	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	95.0	CHEMBL4247	Homo sapiens	Residual Activity	%	95.0
	12224378	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	81.0	CHEMBL4247	Homo sapiens	Residual Activity	%	81.0
	12224379	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	88.0	CHEMBL4247	Homo sapiens	Residual Activity	%	88.0
	12224380	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	87.0	CHEMBL4247	Homo sapiens	Residual Activity	%	87.0
	12224381	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	98.0	CHEMBL4247	Homo sapiens	Residual Activity	%	98.0
	12224382	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	85.0	CHEMBL4247	Homo sapiens	Residual Activity	%	85.0
	12224383	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	89.0	CHEMBL4247	Homo sapiens	Residual Activity	%	89.0
	12224384	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	88.0	CHEMBL4247	Homo sapiens	Residual Activity	%	88.0
	12224385	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	83.0	CHEMBL4247	Homo sapiens	Residual Activity	%	83.0
	12224386	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	100.0	CHEMBL4247	Homo sapiens	Residual Activity	%	100.0
	12224387	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	73.0	CHEMBL4247	Homo sapiens	Residual Activity	%	73.0
	12224388	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	81.0	CHEMBL4247	Homo sapiens	Residual Activity	%	81.0
	12224389	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	75.0	CHEMBL4247	Homo sapiens	Residual Activity	%	75.0
	12224390	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	64.0	CHEMBL4247	Homo sapiens	Residual Activity	%	64.0
	12224391	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	78.0	CHEMBL4247	Homo sapiens	Residual Activity	%	78.0
	12224392	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	68.0	CHEMBL4247	Homo sapiens	Residual Activity	%	68.0
	12224393	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	81.0	CHEMBL4247	Homo sapiens	Residual Activity	%	81.0
	12224394	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	86.0	CHEMBL4247	Homo sapiens	Residual Activity	%	86.0
	12224395	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	71.0	CHEMBL4247	Homo sapiens	Residual Activity	%	71.0
	12224396	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	82.0	CHEMBL4247	Homo sapiens	Residual Activity	%	82.0
	12224397	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	81.0	CHEMBL4247	Homo sapiens	Residual Activity	%	81.0
	12224398	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	73.0	CHEMBL4247	Homo sapiens	Residual Activity	%	73.0
	12224399	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	24.0	CHEMBL4247	Homo sapiens	Residual Activity	%	24.0
	12224400	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	85.0	CHEMBL4247	Homo sapiens	Residual Activity	%	85.0
	12224401	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	71.0	CHEMBL4247	Homo sapiens	Residual Activity	%	71.0
	12224402	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	82.0	CHEMBL4247	Homo sapiens	Residual Activity	%	82.0
	12224403	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	70.0	CHEMBL4247	Homo sapiens	Residual Activity	%	70.0
	12224404	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	16.0	CHEMBL4247	Homo sapiens	Residual Activity	%	16.0
	12224405	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	80.0	CHEMBL4247	Homo sapiens	Residual Activity	%	80.0
	12224406	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	70.0	CHEMBL4247	Homo sapiens	Residual Activity	%	70.0
	12224407	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	61.0	CHEMBL4247	Homo sapiens	Residual Activity	%	61.0
	12224408	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	65.0	CHEMBL4247	Homo sapiens	Residual Activity	%	65.0
	12224409	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	42.0	CHEMBL4247	Homo sapiens	Residual Activity	%	42.0
	12224410	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	69.0	CHEMBL4247	Homo sapiens	Residual Activity	%	69.0
	12224411	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	67.0	CHEMBL4247	Homo sapiens	Residual Activity	%	67.0
	12224412	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	65.0	CHEMBL4247	Homo sapiens	Residual Activity	%	65.0
	12224413	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	35.0	CHEMBL4247	Homo sapiens	Residual Activity	%	35.0
	12224414	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	72.0	CHEMBL4247	Homo sapiens	Residual Activity	%	72.0
	12224415	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	65.0	CHEMBL4247	Homo sapiens	Residual Activity	%	65.0
	12224416	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	73.0	CHEMBL4247	Homo sapiens	Residual Activity	%	73.0
	12224417	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	70.0	CHEMBL4247	Homo sapiens	Residual Activity	%	70.0
	12224418	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	76.0	CHEMBL4247	Homo sapiens	Residual Activity	%	76.0
	12224419	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	74.0	CHEMBL4247	Homo sapiens	Residual Activity	%	74.0
	12224420	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	78.0	CHEMBL4247	Homo sapiens	Residual Activity	%	78.0
	12224421	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	58.0	CHEMBL4247	Homo sapiens	Residual Activity	%	58.0
	12224422	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	64.0	CHEMBL4247	Homo sapiens	Residual Activity	%	64.0
	12224423	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	82.0	CHEMBL4247	Homo sapiens	Residual Activity	%	82.0
	12224424	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	73.0	CHEMBL4247	Homo sapiens	Residual Activity	%	73.0
	12224425	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	63.0	CHEMBL4247	Homo sapiens	Residual Activity	%	63.0
	12224426	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	88.0	CHEMBL4247	Homo sapiens	Residual Activity	%	88.0
	12224427	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	85.0	CHEMBL4247	Homo sapiens	Residual Activity	%	85.0
	12224428	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	84.0	CHEMBL4247	Homo sapiens	Residual Activity	%	84.0
	12224429	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	80.0	CHEMBL4247	Homo sapiens	Residual Activity	%	80.0
	12224430	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	81.0	CHEMBL4247	Homo sapiens	Residual Activity	%	81.0
	12224431	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	83.0	CHEMBL4247	Homo sapiens	Residual Activity	%	83.0
	12224432	CHEMBL2219373	Millipore: Percentage of residual kinase activity of ALK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	90.0	CHEMBL4247	Homo sapiens	Residual Activity	%	90.0
	12224433	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	86.0	CHEMBL4247	Homo sapiens	Residual Activity	%	86.0
	12224434	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	44.0	CHEMBL4247	Homo sapiens	Residual Activity	%	44.0
	12224435	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	22.0	CHEMBL4247	Homo sapiens	Residual Activity	%	22.0
	12224436	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	58.0	CHEMBL4247	Homo sapiens	Residual Activity	%	58.0
	12224437	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	72.0	CHEMBL4247	Homo sapiens	Residual Activity	%	72.0
	12224438	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	108.0	CHEMBL4247	Homo sapiens	Residual Activity	%	108.0
	12224439	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	31.0	CHEMBL4247	Homo sapiens	Residual Activity	%	31.0
	12224440	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	107.0	CHEMBL4247	Homo sapiens	Residual Activity	%	107.0
	12224441	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	112.0	CHEMBL4247	Homo sapiens	Residual Activity	%	112.0
	12224442	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	59.0	CHEMBL4247	Homo sapiens	Residual Activity	%	59.0
	12224443	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	81.0	CHEMBL4247	Homo sapiens	Residual Activity	%	81.0
	12224444	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	75.0	CHEMBL4247	Homo sapiens	Residual Activity	%	75.0
	12224445	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	88.0	CHEMBL4247	Homo sapiens	Residual Activity	%	88.0
	12224446	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	49.0	CHEMBL4247	Homo sapiens	Residual Activity	%	49.0
	12226808	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	65.0	CHEMBL4247	Homo sapiens	Residual Activity	%	65.0
	12226809	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	118.0	CHEMBL4247	Homo sapiens	Residual Activity	%	118.0
	12226810	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	69.0	CHEMBL4247	Homo sapiens	Residual Activity	%	69.0
	12226811	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	65.0	CHEMBL4247	Homo sapiens	Residual Activity	%	65.0
	12226812	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	72.0	CHEMBL4247	Homo sapiens	Residual Activity	%	72.0
	12226813	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	11.0	CHEMBL4247	Homo sapiens	Residual Activity	%	11.0
	12226814	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	99.0	CHEMBL4247	Homo sapiens	Residual Activity	%	99.0
	12226815	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	42.0	CHEMBL4247	Homo sapiens	Residual Activity	%	42.0
	12226816	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	101.0	CHEMBL4247	Homo sapiens	Residual Activity	%	101.0
	12226817	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	123.0	CHEMBL4247	Homo sapiens	Residual Activity	%	123.0
	12226818	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	134.0	CHEMBL4247	Homo sapiens	Residual Activity	%	134.0
	12226819	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	39.0	CHEMBL4247	Homo sapiens	Residual Activity	%	39.0
	12226820	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	58.0	CHEMBL4247	Homo sapiens	Residual Activity	%	58.0
	12226821	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	3.0	CHEMBL4247	Homo sapiens	Residual Activity	%	3.0
	12226822	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	49.0	CHEMBL4247	Homo sapiens	Residual Activity	%	49.0
	12226823	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	65.0	CHEMBL4247	Homo sapiens	Residual Activity	%	65.0
	12226824	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	105.0	CHEMBL4247	Homo sapiens	Residual Activity	%	105.0
	12226825	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	38.0	CHEMBL4247	Homo sapiens	Residual Activity	%	38.0
	12226826	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	63.0	CHEMBL4247	Homo sapiens	Residual Activity	%	63.0
	12226827	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	95.0	CHEMBL4247	Homo sapiens	Residual Activity	%	95.0
	12226828	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	82.0	CHEMBL4247	Homo sapiens	Residual Activity	%	82.0
	12226829	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	95.0	CHEMBL4247	Homo sapiens	Residual Activity	%	95.0
	12226830	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	89.0	CHEMBL4247	Homo sapiens	Residual Activity	%	89.0
	12226831	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	32.0	CHEMBL4247	Homo sapiens	Residual Activity	%	32.0
	12226832	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	102.0	CHEMBL4247	Homo sapiens	Residual Activity	%	102.0
	12226833	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	112.0	CHEMBL4247	Homo sapiens	Residual Activity	%	112.0
	12226834	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	132.0	CHEMBL4247	Homo sapiens	Residual Activity	%	132.0
	12226835	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	93.0	CHEMBL4247	Homo sapiens	Residual Activity	%	93.0
	12226836	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	4.0	CHEMBL4247	Homo sapiens	Residual Activity	%	4.0
	12226837	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	26.0	CHEMBL4247	Homo sapiens	Residual Activity	%	26.0
	12226838	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	47.0	CHEMBL4247	Homo sapiens	Residual Activity	%	47.0
	12226839	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	105.0	CHEMBL4247	Homo sapiens	Residual Activity	%	105.0
	12226840	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	107.0	CHEMBL4247	Homo sapiens	Residual Activity	%	107.0
	12226841	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	13.0	CHEMBL4247	Homo sapiens	Residual Activity	%	13.0
	12226842	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	96.0	CHEMBL4247	Homo sapiens	Residual Activity	%	96.0
	12226843	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	111.0	CHEMBL4247	Homo sapiens	Residual Activity	%	111.0
	12226844	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	64.0	CHEMBL4247	Homo sapiens	Residual Activity	%	64.0
	12226845	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	27.0	CHEMBL4247	Homo sapiens	Residual Activity	%	27.0
	12226846	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	57.0	CHEMBL4247	Homo sapiens	Residual Activity	%	57.0
	12226847	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	104.0	CHEMBL4247	Homo sapiens	Residual Activity	%	104.0
	12226848	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	108.0	CHEMBL4247	Homo sapiens	Residual Activity	%	108.0
	12226849	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	112.0	CHEMBL4247	Homo sapiens	Residual Activity	%	112.0
	12226850	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	57.0	CHEMBL4247	Homo sapiens	Residual Activity	%	57.0
	12226851	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	73.0	CHEMBL4247	Homo sapiens	Residual Activity	%	73.0
	12226852	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	32.0	CHEMBL4247	Homo sapiens	Residual Activity	%	32.0
	12226853	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	53.0	CHEMBL4247	Homo sapiens	Residual Activity	%	53.0
	12226854	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	19.0	CHEMBL4247	Homo sapiens	Residual Activity	%	19.0
	12226855	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	33.0	CHEMBL4247	Homo sapiens	Residual Activity	%	33.0
	12226856	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	112.0	CHEMBL4247	Homo sapiens	Residual Activity	%	112.0
	12226857	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	113.0	CHEMBL4247	Homo sapiens	Residual Activity	%	113.0
	12226858	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	58.0	CHEMBL4247	Homo sapiens	Residual Activity	%	58.0
	12226859	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	27.0	CHEMBL4247	Homo sapiens	Residual Activity	%	27.0
	12226860	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	50.0	CHEMBL4247	Homo sapiens	Residual Activity	%	50.0
	12226861	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	49.0	CHEMBL4247	Homo sapiens	Residual Activity	%	49.0
	12226862	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	46.0	CHEMBL4247	Homo sapiens	Residual Activity	%	46.0
	12226863	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	72.0	CHEMBL4247	Homo sapiens	Residual Activity	%	72.0
	12226864	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	60.0	CHEMBL4247	Homo sapiens	Residual Activity	%	60.0
	12226865	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	48.0	CHEMBL4247	Homo sapiens	Residual Activity	%	48.0
	12226866	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	91.0	CHEMBL4247	Homo sapiens	Residual Activity	%	91.0
	12226867	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	76.0	CHEMBL4247	Homo sapiens	Residual Activity	%	76.0
	12226868	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	90.0	CHEMBL4247	Homo sapiens	Residual Activity	%	90.0
	12226869	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	35.0	CHEMBL4247	Homo sapiens	Residual Activity	%	35.0
	12226870	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	77.0	CHEMBL4247	Homo sapiens	Residual Activity	%	77.0
	12226871	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	2.0	CHEMBL4247	Homo sapiens	Residual Activity	%	2.0
	12226872	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	82.0	CHEMBL4247	Homo sapiens	Residual Activity	%	82.0
	12226873	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	1.0	CHEMBL4247	Homo sapiens	Residual Activity	%	1.0
	12226874	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	57.0	CHEMBL4247	Homo sapiens	Residual Activity	%	57.0
	12226875	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	38.0	CHEMBL4247	Homo sapiens	Residual Activity	%	38.0
	12226876	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	69.0	CHEMBL4247	Homo sapiens	Residual Activity	%	69.0
	12226877	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	126.0	CHEMBL4247	Homo sapiens	Residual Activity	%	126.0
	12226878	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	29.0	CHEMBL4247	Homo sapiens	Residual Activity	%	29.0
	12226879	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	44.0	CHEMBL4247	Homo sapiens	Residual Activity	%	44.0
	12226880	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	56.0	CHEMBL4247	Homo sapiens	Residual Activity	%	56.0
	12226881	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	93.0	CHEMBL4247	Homo sapiens	Residual Activity	%	93.0
	12226882	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	84.0	CHEMBL4247	Homo sapiens	Residual Activity	%	84.0
	12226883	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	18.0	CHEMBL4247	Homo sapiens	Residual Activity	%	18.0
	12226884	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	76.0	CHEMBL4247	Homo sapiens	Residual Activity	%	76.0
	12226885	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	93.0	CHEMBL4247	Homo sapiens	Residual Activity	%	93.0
	12226886	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	15.0	CHEMBL4247	Homo sapiens	Residual Activity	%	15.0
	12226887	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	69.0	CHEMBL4247	Homo sapiens	Residual Activity	%	69.0
	12226888	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	65.0	CHEMBL4247	Homo sapiens	Residual Activity	%	65.0
	12226889	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	74.0	CHEMBL4247	Homo sapiens	Residual Activity	%	74.0
	12226890	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	97.0	CHEMBL4247	Homo sapiens	Residual Activity	%	97.0
	12226891	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	93.0	CHEMBL4247	Homo sapiens	Residual Activity	%	93.0
	12226892	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	93.0	CHEMBL4247	Homo sapiens	Residual Activity	%	93.0
	12226893	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	89.0	CHEMBL4247	Homo sapiens	Residual Activity	%	89.0
	12226894	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	48.0	CHEMBL4247	Homo sapiens	Residual Activity	%	48.0
	12226895	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	1.0	CHEMBL4247	Homo sapiens	Residual Activity	%	1.0
	12226896	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	83.0	CHEMBL4247	Homo sapiens	Residual Activity	%	83.0
	12226897	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	79.0	CHEMBL4247	Homo sapiens	Residual Activity	%	79.0
	12226898	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	91.0	CHEMBL4247	Homo sapiens	Residual Activity	%	91.0
	12226899	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	64.0	CHEMBL4247	Homo sapiens	Residual Activity	%	64.0
	12226900	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	92.0	CHEMBL4247	Homo sapiens	Residual Activity	%	92.0
	12226901	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	83.0	CHEMBL4247	Homo sapiens	Residual Activity	%	83.0
	12226902	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	75.0	CHEMBL4247	Homo sapiens	Residual Activity	%	75.0
	12226903	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	56.0	CHEMBL4247	Homo sapiens	Residual Activity	%	56.0
	12226904	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	65.0	CHEMBL4247	Homo sapiens	Residual Activity	%	65.0
	12226905	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	99.0	CHEMBL4247	Homo sapiens	Residual Activity	%	99.0
	12226906	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	45.0	CHEMBL4247	Homo sapiens	Residual Activity	%	45.0
	12226907	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	49.0	CHEMBL4247	Homo sapiens	Residual Activity	%	49.0
	12226908	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	87.0	CHEMBL4247	Homo sapiens	Residual Activity	%	87.0
	12226909	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	71.0	CHEMBL4247	Homo sapiens	Residual Activity	%	71.0
	12226910	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	31.0	CHEMBL4247	Homo sapiens	Residual Activity	%	31.0
	12226911	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	59.0	CHEMBL4247	Homo sapiens	Residual Activity	%	59.0
	12226912	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	81.0	CHEMBL4247	Homo sapiens	Residual Activity	%	81.0
	12226913	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	94.0	CHEMBL4247	Homo sapiens	Residual Activity	%	94.0
	12226914	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	37.0	CHEMBL4247	Homo sapiens	Residual Activity	%	37.0
	12226915	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	34.0	CHEMBL4247	Homo sapiens	Residual Activity	%	34.0
	12226916	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	52.0	CHEMBL4247	Homo sapiens	Residual Activity	%	52.0
	12226917	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	68.0	CHEMBL4247	Homo sapiens	Residual Activity	%	68.0
	12226918	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	2.0	CHEMBL4247	Homo sapiens	Residual Activity	%	2.0
	12226919	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	73.0	CHEMBL4247	Homo sapiens	Residual Activity	%	73.0
	12226920	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	26.0	CHEMBL4247	Homo sapiens	Residual Activity	%	26.0
	12226921	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	62.0	CHEMBL4247	Homo sapiens	Residual Activity	%	62.0
	12226922	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	31.0	CHEMBL4247	Homo sapiens	Residual Activity	%	31.0
	12226923	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	1.0	CHEMBL4247	Homo sapiens	Residual Activity	%	1.0
	12226924	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	61.0	CHEMBL4247	Homo sapiens	Residual Activity	%	61.0
	12226925	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	64.0	CHEMBL4247	Homo sapiens	Residual Activity	%	64.0
	12226926	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	29.0	CHEMBL4247	Homo sapiens	Residual Activity	%	29.0
	12226927	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	58.0	CHEMBL4247	Homo sapiens	Residual Activity	%	58.0
	12226928	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	8.0	CHEMBL4247	Homo sapiens	Residual Activity	%	8.0
	12226929	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	19.0	CHEMBL4247	Homo sapiens	Residual Activity	%	19.0
	12226930	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	51.0	CHEMBL4247	Homo sapiens	Residual Activity	%	51.0
	12226931	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	6.0	CHEMBL4247	Homo sapiens	Residual Activity	%	6.0
	12226932	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	10.0	CHEMBL4247	Homo sapiens	Residual Activity	%	10.0
	12226933	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	45.0	CHEMBL4247	Homo sapiens	Residual Activity	%	45.0
	12226934	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	65.0	CHEMBL4247	Homo sapiens	Residual Activity	%	65.0
	12226935	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	58.0	CHEMBL4247	Homo sapiens	Residual Activity	%	58.0
	12226936	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	49.0	CHEMBL4247	Homo sapiens	Residual Activity	%	49.0
	12226937	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	61.0	CHEMBL4247	Homo sapiens	Residual Activity	%	61.0
	12226938	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	52.0	CHEMBL4247	Homo sapiens	Residual Activity	%	52.0
	12226939	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	42.0	CHEMBL4247	Homo sapiens	Residual Activity	%	42.0
	12226940	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	40.0	CHEMBL4247	Homo sapiens	Residual Activity	%	40.0
	12226941	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	18.0	CHEMBL4247	Homo sapiens	Residual Activity	%	18.0
	12226942	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	67.0	CHEMBL4247	Homo sapiens	Residual Activity	%	67.0
	12226943	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	96.0	CHEMBL4247	Homo sapiens	Residual Activity	%	96.0
	12226944	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	81.0	CHEMBL4247	Homo sapiens	Residual Activity	%	81.0
	12226945	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	87.0	CHEMBL4247	Homo sapiens	Residual Activity	%	87.0
	12226946	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	69.0	CHEMBL4247	Homo sapiens	Residual Activity	%	69.0
	12226947	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	67.0	CHEMBL4247	Homo sapiens	Residual Activity	%	67.0
	12226948	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	91.0	CHEMBL4247	Homo sapiens	Residual Activity	%	91.0
	12226949	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	67.0	CHEMBL4247	Homo sapiens	Residual Activity	%	67.0
	12226950	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	82.0	CHEMBL4247	Homo sapiens	Residual Activity	%	82.0
	12226951	CHEMBL2219374	Millipore: Percentage of residual kinase activity of ALK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	75.0	CHEMBL4247	Homo sapiens	Residual Activity	%	75.0
	12693297	CHEMBL2341971	Inhibition of ALK (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	3500.0	CHEMBL4247	Homo sapiens	IC50	nM	3500.0
	12730048	CHEMBL2352070	Inhibition of ALK (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	96.0	CHEMBL4247	Homo sapiens	Activity	%	96.0
	12730938	CHEMBL2350111	Inhibition of ALK (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	88.0	CHEMBL4247	Homo sapiens	Activity	%	88.0
	12731185	CHEMBL2350239	Inhibition of ALK (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	105.0	CHEMBL4247	Homo sapiens	Activity	%	105.0
Not Active	13340087	CHEMBL2394291	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay	B	O=C(Nc1cc(Sc2ncnc3nc[nH]c23)c(O)c2ccccc12)c1ccccc1[N+](=O)[O-]		CHEMBL2391420		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Not Active	13340088	CHEMBL2394291	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay	B	O=C(Nc1cc(Sc2ncnc3nc[nH]c23)c(O)c2ccccc12)c1ccc(Cl)cc1		CHEMBL2391419		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Not Active	13340089	CHEMBL2394291	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay	B	Cn1nnnc1Sc1cc(NC(=O)c2ccc(Cl)cc2)c2ccccc2c1O		CHEMBL2391418		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Not Active	13340090	CHEMBL2394291	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay	B	O=C(Nc1cc(Sc2ncn[nH]2)c(O)c2ccccc12)c1cccc(Cl)c1		CHEMBL2391413		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Not Active	13340091	CHEMBL2394291	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay	B	O=C(/C=C/c1ccc([N+](=O)[O-])cc1)Nc1cc(Sc2ncn[nH]2)c(O)c2ccccc12		CHEMBL2391412		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Not Active	13340092	CHEMBL2394291	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay	B	Cc1cccc(C(=O)Nc2cc(Sc3ncn[nH]3)c(O)c3ccccc23)c1		CHEMBL2391411		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Not Active	13340093	CHEMBL2394291	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay	B	COc1cccc(C(=O)Nc2cc(Sc3ncn[nH]3)c(O)c3ccccc23)c1		CHEMBL2391410		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Not Active	13340094	CHEMBL2394291	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay	B	O=C(Nc1cc(Sc2ncn[nH]2)c(O)c2ccccc12)c1cccc([N+](=O)[O-])c1		CHEMBL2391409		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Not Active	13340095	CHEMBL2394291	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay	B	COc1ccc(C(=O)Nc2cc(Sc3ncn[nH]3)c(O)c3ccccc23)cc1		CHEMBL2391407		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Not Active	13340096	CHEMBL2394291	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay	B	O=C(Nc1cc(Sc2ncn[nH]2)c(O)c2ccccc12)c1ccc(Cl)cc1		CHEMBL2391405		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Not Active	13340097	CHEMBL2394291	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay	B	O=C(/C=C/c1ccccc1)Nc1cc(Sc2ncn[nH]2)c(O)c2ccccc12		CHEMBL2391404		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Not Active	13340098	CHEMBL2394291	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay	B	O=C(Nc1cc(Sc2ncn[nH]2)c(O)c2ccccc12)c1ccc2ccccc2c1		CHEMBL2391403		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	13340099	CHEMBL2394291	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Inhibition	%	97.89	CHEMBL4247	Homo sapiens	INH	%	97.89
	13340113	CHEMBL2394291	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay	B	O=C(Nc1cc(Sc2ncn[nH]2)c(O)c2ccccc12)c1ccccc1[N+](=O)[O-]		CHEMBL2391406	=	Inhibition	%	56.83	CHEMBL4247	Homo sapiens	INH	%	56.83
	13340779	CHEMBL2394291	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay	B	COc1ccc(/C=C/C(=O)Nc2cc(Sc3ncn[nH]3)c(O)c3ccccc23)cc1OC		CHEMBL2391408	=	Inhibition	%	14.87	CHEMBL4247	Homo sapiens	INH	%	14.87
	13340794	CHEMBL2394291	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay	B	Cc1nnc(Sc2cc(NC(=O)c3ccc(Cl)cc3)c3ccccc3c2O)s1		CHEMBL2391416	=	Inhibition	%	9.25	CHEMBL4247	Homo sapiens	INH	%	9.25
	13340806	CHEMBL2394291	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay	B	O=C(Nc1cc(Sc2nncs2)c(O)c2ccccc12)c1ccc(Cl)cc1		CHEMBL2391417	=	Inhibition	%	4.2	CHEMBL4247	Homo sapiens	INH	%	4.2
	13340807	CHEMBL2394291	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay	B	O=C(Nc1cc(Sc2ncn[nH]2)c(O)c2ccccc12)c1ccc([N+](=O)[O-])cc1		CHEMBL2391414	=	Inhibition	%	3.37	CHEMBL4247	Homo sapiens	INH	%	3.37
	13340811	CHEMBL2394291	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay	B	O=C(/C=C/c1ccc(Cl)cc1)Nc1cc(Sc2ncn[nH]2)c(O)c2ccccc12		CHEMBL2391415	=	Inhibition	%	0.7	CHEMBL4247	Homo sapiens	INH	%	0.7
	13365809	CHEMBL2406365	Inhibition of NPM-fused ALK (unknown origin) expressed in mouse BAF3 cells after 2 to 3 days by luciferase reporter gene assay	B	Cc1cc(Nc2cc(Nc3ccccc3S(=O)(=O)C(C)C)c(Cl)cn2)c(OC(C)C)cc1C1CCN(C)CC1		CHEMBL2403832	=	IC50	nM	4240.0	CHEMBL4247	Homo sapiens	IC50	nM	4240.0
	13365870	CHEMBL2406365	Inhibition of NPM-fused ALK (unknown origin) expressed in mouse BAF3 cells after 2 to 3 days by luciferase reporter gene assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CC(F)F)CC1		CHEMBL2403839	=	IC50	nM	305.7	CHEMBL4247	Homo sapiens	IC50	nM	305.7
	13365874	CHEMBL2406365	Inhibition of NPM-fused ALK (unknown origin) expressed in mouse BAF3 cells after 2 to 3 days by luciferase reporter gene assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(C2CCN(C)CC2)CC1		CHEMBL2403838	=	IC50	nM	258.4	CHEMBL4247	Homo sapiens	IC50	nM	258.4
	13365878	CHEMBL2406365	Inhibition of NPM-fused ALK (unknown origin) expressed in mouse BAF3 cells after 2 to 3 days by luciferase reporter gene assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	150.8	CHEMBL4247	Homo sapiens	IC50	nM	150.8
	13365884	CHEMBL2406365	Inhibition of NPM-fused ALK (unknown origin) expressed in mouse BAF3 cells after 2 to 3 days by luciferase reporter gene assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CC(=O)O)CC1		CHEMBL2403840	=	IC50	nM	88.9	CHEMBL4247	Homo sapiens	IC50	nM	88.9
	13365893	CHEMBL2406365	Inhibition of NPM-fused ALK (unknown origin) expressed in mouse BAF3 cells after 2 to 3 days by luciferase reporter gene assay	B	Cc1cc(Nc2ncc(C)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCO)CC1		CHEMBL2403828	=	IC50	nM	63.6	CHEMBL4247	Homo sapiens	IC50	nM	63.6
	13365896	CHEMBL2406365	Inhibition of NPM-fused ALK (unknown origin) expressed in mouse BAF3 cells after 2 to 3 days by luciferase reporter gene assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNC(=O)C1		CHEMBL2403830	=	IC50	nM	48.3	CHEMBL4247	Homo sapiens	IC50	nM	48.3
	13365900	CHEMBL2406365	Inhibition of NPM-fused ALK (unknown origin) expressed in mouse BAF3 cells after 2 to 3 days by luciferase reporter gene assay	B	COCCN1CCC(c2cc(OC(C)C)c(Nc3ncc(C)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL2403829	=	IC50	nM	44.0	CHEMBL4247	Homo sapiens	IC50	nM	44.0
	13365902	CHEMBL2406365	Inhibition of NPM-fused ALK (unknown origin) expressed in mouse BAF3 cells after 2 to 3 days by luciferase reporter gene assay	B	COCCN1CCC(c2cc(OC(C)C)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL2403837	=	IC50	nM	43.5	CHEMBL4247	Homo sapiens	IC50	nM	43.5
	13365903	CHEMBL2406316	Inhibition of TEL-fused ALK (unknown origin) by cell-based assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	40.7	CHEMBL4247	Homo sapiens	IC50	nM	40.7
	13365904	CHEMBL2406365	Inhibition of NPM-fused ALK (unknown origin) expressed in mouse BAF3 cells after 2 to 3 days by luciferase reporter gene assay	B	Cc1cc(Nc2ncc(C)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403846	=	IC50	nM	40.6	CHEMBL4247	Homo sapiens	IC50	nM	40.6
	13365906	CHEMBL2406365	Inhibition of NPM-fused ALK (unknown origin) expressed in mouse BAF3 cells after 2 to 3 days by luciferase reporter gene assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C3CCC3)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403847	=	IC50	nM	38.1	CHEMBL4247	Homo sapiens	IC50	nM	38.1
	13367099	CHEMBL2406365	Inhibition of NPM-fused ALK (unknown origin) expressed in mouse BAF3 cells after 2 to 3 days by luciferase reporter gene assay	B	CC(C)Oc1nc(C2CCNCC2)ncc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL2403831	=	IC50	nM	36.4	CHEMBL4247	Homo sapiens	IC50	nM	36.4
	13367102	CHEMBL2406365	Inhibition of NPM-fused ALK (unknown origin) expressed in mouse BAF3 cells after 2 to 3 days by luciferase reporter gene assay	B	CCN1CCC(c2cc(OC(C)C)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL2403834	=	IC50	nM	32.1	CHEMBL4247	Homo sapiens	IC50	nM	32.1
	13367104	CHEMBL2406365	Inhibition of NPM-fused ALK (unknown origin) expressed in mouse BAF3 cells after 2 to 3 days by luciferase reporter gene assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(C(C)C)CC1		CHEMBL2403835	=	IC50	nM	29.9	CHEMBL4247	Homo sapiens	IC50	nM	29.9
	13367105	CHEMBL2406365	Inhibition of NPM-fused ALK (unknown origin) expressed in mouse BAF3 cells after 2 to 3 days by luciferase reporter gene assay	B	CCN1CCC(c2cc(OC(C)C)c(Nc3ncc(C)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL2403827	=	IC50	nM	29.4	CHEMBL4247	Homo sapiens	IC50	nM	29.4
	13367108	CHEMBL2406365	Inhibition of NPM-fused ALK (unknown origin) expressed in mouse BAF3 cells after 2 to 3 days by luciferase reporter gene assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	26.0	CHEMBL4247	Homo sapiens	IC50	nM	26.0
	13367109	CHEMBL2406365	Inhibition of NPM-fused ALK (unknown origin) expressed in mouse BAF3 cells after 2 to 3 days by luciferase reporter gene assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(C(=O)CN(C)C)CC1		CHEMBL2403842	=	IC50	nM	25.8	CHEMBL4247	Homo sapiens	IC50	nM	25.8
	13367111	CHEMBL2406365	Inhibition of NPM-fused ALK (unknown origin) expressed in mouse BAF3 cells after 2 to 3 days by luciferase reporter gene assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)N(C)C)n2)c(OC(C)C)cc1C1CCN(C)CC1		CHEMBL2403833	=	IC50	nM	25.0	CHEMBL4247	Homo sapiens	IC50	nM	25.0
	13367112	CHEMBL2406365	Inhibition of NPM-fused ALK (unknown origin) expressed in mouse BAF3 cells after 2 to 3 days by luciferase reporter gene assay	B	CC(C)Oc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL2403844	=	IC50	nM	24.8	CHEMBL4247	Homo sapiens	IC50	nM	24.8
	13367128	CHEMBL2406365	Inhibition of NPM-fused ALK (unknown origin) expressed in mouse BAF3 cells after 2 to 3 days by luciferase reporter gene assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC2CCC2)cc1C1CCNCC1		CHEMBL2403848	=	IC50	nM	17.3	CHEMBL4247	Homo sapiens	IC50	nM	17.3
	13367130	CHEMBL2406365	Inhibition of NPM-fused ALK (unknown origin) expressed in mouse BAF3 cells after 2 to 3 days by luciferase reporter gene assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CC(N)=O)CC1		CHEMBL2403841	=	IC50	nM	16.5	CHEMBL4247	Homo sapiens	IC50	nM	16.5
	13367148	CHEMBL2406365	Inhibition of NPM-fused ALK (unknown origin) expressed in mouse BAF3 cells after 2 to 3 days by luciferase reporter gene assay	B	Cc1cc(Nc2ncc(C)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(C)CC1		CHEMBL2403843	=	IC50	nM	14.6	CHEMBL4247	Homo sapiens	IC50	nM	14.6
	13367160	CHEMBL2406365	Inhibition of NPM-fused ALK (unknown origin) expressed in mouse BAF3 cells after 2 to 3 days by luciferase reporter gene assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(C)CC1		CHEMBL2403849	=	IC50	nM	11.5	CHEMBL4247	Homo sapiens	IC50	nM	11.5
	13367164	CHEMBL2406365	Inhibition of NPM-fused ALK (unknown origin) expressed in mouse BAF3 cells after 2 to 3 days by luciferase reporter gene assay	B	CC(C)Oc1cc(C2CCNCC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL2403845	=	IC50	nM	10.6	CHEMBL4247	Homo sapiens	IC50	nM	10.6
	13367174	CHEMBL2406365	Inhibition of NPM-fused ALK (unknown origin) expressed in mouse BAF3 cells after 2 to 3 days by luciferase reporter gene assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCO)CC1		CHEMBL2403836	=	IC50	nM	8.1	CHEMBL4247	Homo sapiens	IC50	nM	8.1
	13367191	CHEMBL2406365	Inhibition of NPM-fused ALK (unknown origin) expressed in mouse BAF3 cells after 2 to 3 days by luciferase reporter gene assay	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	IC50	nM	3.7	CHEMBL4247	Homo sapiens	IC50	nM	3.7
	13367201	CHEMBL2406317	Inhibition of EML4-fused ALK (unknown origin) by cell-based assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	2.2	CHEMBL4247	Homo sapiens	IC50	nM	2.2
	13367230	CHEMBL2406347	Inhibition of ALK (unknown origin) after 60 mins	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	0.2	CHEMBL4247	Homo sapiens	IC50	uM	0.0002
	13372388	CHEMBL2406472	Inhibition of ALK autophosphorylation in human Karpas-299 cells	B	C[C@@H](Oc1c(N)ncc2c(C3=CCN(C(N)=O)CC3)coc12)c1c(Cl)ccc(F)c1Cl		CHEMBL2401832	=	IC50	nM	500.0	CHEMBL4247	Homo sapiens	IC50	uM	0.5
	13372425	CHEMBL2406475	Inhibition of ALK (unknown origin) autophosphorylation	B	C[C@@H](Oc1c(N)ncc2c(C3=CCN(C(N)=O)CC3)coc12)c1c(Cl)ccc(F)c1Cl		CHEMBL2401832	=	IC50	nM	40.0	CHEMBL4247	Homo sapiens	IC50	uM	0.04
	13374063	CHEMBL2406429	Inhibition of ALK (unknown origin) transfected in mouse BA/F3 cells	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	40.7	CHEMBL4247	Homo sapiens	IC50	nM	40.7
	13374067	CHEMBL2406433	Inhibition of ALK (unknown origin)	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	0.2	CHEMBL4247	Homo sapiens	IC50	pM	200.0
	13379782	CHEMBL2406184	Inhibition of ALK (unknown origin)	B	CC(=O)N1CCc2[nH]c(/C=C3\C(=O)Nc4ccc([N+](=O)[O-])cc43)cc2C1		CHEMBL2403378	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	13379783	CHEMBL2406184	Inhibition of ALK (unknown origin)	B	CC(=O)N1CCc2[nH]c(/C=C3\C(=O)Nc4ccc(C#N)cc43)cc2C1		CHEMBL2403377	=	IC50	nM	1600.0	CHEMBL4247	Homo sapiens	IC50	uM	1.6
	13379784	CHEMBL2406184	Inhibition of ALK (unknown origin)	B	CC(=O)N1CCc2[nH]c(/C=C3\C(=O)Nc4ccc(C(F)(F)F)cc43)cc2C1		CHEMBL2403376	=	IC50	nM	9500.0	CHEMBL4247	Homo sapiens	IC50	uM	9.5
	13379785	CHEMBL2406184	Inhibition of ALK (unknown origin)	B	CC(=O)N1CCc2[nH]c(/C=C3\C(=O)Nc4ccc(OC(C)C)cc43)cc2C1		CHEMBL2403375	=	IC50	nM	3300.0	CHEMBL4247	Homo sapiens	IC50	uM	3.3
	13379786	CHEMBL2406184	Inhibition of ALK (unknown origin)	B	CC(=O)Nc1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCN(C(=O)N1CCOCC1)C3)C(=O)N2		CHEMBL2403374	=	IC50	nM	210.0	CHEMBL4247	Homo sapiens	IC50	uM	0.21
	13379787	CHEMBL2406184	Inhibition of ALK (unknown origin)	B	CN1CCC(Nc2ccc3c(c2)/C(=C/c2cc4c([nH]2)CCN(C(=O)N2CCOCC2)C4)C(=O)N3)CC1		CHEMBL2403373	=	IC50	nM	76.0	CHEMBL4247	Homo sapiens	IC50	uM	0.076
	13379788	CHEMBL2406184	Inhibition of ALK (unknown origin)	B	O=C1Nc2ccc(C(F)(F)F)cc2/C1=C/c1cc2c([nH]1)CCN(C(=O)N1CCOCC1)C2		CHEMBL2403372	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	13379789	CHEMBL2406184	Inhibition of ALK (unknown origin)	B	COc1ccc2c(c1)/C(=C/c1[nH]c3c(c1Cl)CN(C(C)=O)CC3)C(=O)N2		CHEMBL2403371	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	13379790	CHEMBL2406184	Inhibition of ALK (unknown origin)	B	COc1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCN(C(=O)N1CCOCC1)C3)C(=O)N2		CHEMBL2403370	=	IC50	nM	660.0	CHEMBL4247	Homo sapiens	IC50	uM	0.66
	13379791	CHEMBL2406184	Inhibition of ALK (unknown origin)	B	COc1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCN(C(=O)N1CCN(C)CC1)C3)C(=O)N2		CHEMBL2403369	=	IC50	nM	550.0	CHEMBL4247	Homo sapiens	IC50	uM	0.55
	13379792	CHEMBL2406184	Inhibition of ALK (unknown origin)	B	COc1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCN(C(=O)c1cnoc1C)C3)C(=O)N2		CHEMBL2403368	=	IC50	nM	1400.0	CHEMBL4247	Homo sapiens	IC50	uM	1.4
	13379793	CHEMBL2406184	Inhibition of ALK (unknown origin)	B	COc1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCN(C(C)=O)C3)C(=O)N2		CHEMBL2403367	=	IC50	nM	1500.0	CHEMBL4247	Homo sapiens	IC50	uM	1.5
	13379794	CHEMBL2406184	Inhibition of ALK (unknown origin)	B	COc1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCN(C(=O)CCN)C3)C(=O)N2		CHEMBL2403366	=	IC50	nM	370.0	CHEMBL4247	Homo sapiens	IC50	uM	0.37
	13379795	CHEMBL2406184	Inhibition of ALK (unknown origin)	B	COc1ccc2c(c1)/C(=C/c1[nH]c(C)c(C(=O)NCCCN)c1C)C(=O)N2		CHEMBL2403365	<	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	uM	1.0
	13418823	CHEMBL2422659	Inhibition of ALK (unknown origin)	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	5.012	CHEMBL4247	Homo sapiens	pIC50		8.3
Dose-dependent effect	13437600	CHEMBL2423631	Inhibition of ALK in human KARPAS299 cells assessed as phosphorylated ALK level after 6 hrs by Western blotting analysis	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5ccc(F)c(F)c5)c4)c3c2)cn1		CHEMBL2418762		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-dependent effect	13437601	CHEMBL2423631	Inhibition of ALK in human KARPAS299 cells assessed as phosphorylated ALK level after 6 hrs by Western blotting analysis	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cc(F)ccc5F)c4)c3c2)cn1		CHEMBL2418761		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-dependent effect	13437602	CHEMBL2423631	Inhibition of ALK in human KARPAS299 cells assessed as phosphorylated ALK level after 6 hrs by Western blotting analysis	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cccc(Cl)c5)c4)c3c2)cn1		CHEMBL2418754		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-dependent effect	13437603	CHEMBL2423631	Inhibition of ALK in human KARPAS299 cells assessed as phosphorylated ALK level after 6 hrs by Western blotting analysis	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5ccc(F)cc5)c4)c3c2)cn1		CHEMBL2418753		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-dependent effect	13437604	CHEMBL2423631	Inhibition of ALK in human KARPAS299 cells assessed as phosphorylated ALK level after 6 hrs by Western blotting analysis	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cccc(F)c5)c4)c3c2)cn1		CHEMBL2418752		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	13437610	CHEMBL2423630	Inhibition of ALK in human KARPAS299 cells assessed as phosphorylated Stat3 level after 6 hrs by Western blotting analysis	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5ccc(F)c(F)c5)c4)c3c2)cn1		CHEMBL2418762	=	IC50	nM	985.6	CHEMBL4247	Homo sapiens	IC50	nM	985.6
	13437611	CHEMBL2423630	Inhibition of ALK in human KARPAS299 cells assessed as phosphorylated Stat3 level after 6 hrs by Western blotting analysis	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cc(F)ccc5F)c4)c3c2)cn1		CHEMBL2418761	=	IC50	nM	1592.0	CHEMBL4247	Homo sapiens	IC50	nM	1592.0
	13437612	CHEMBL2423630	Inhibition of ALK in human KARPAS299 cells assessed as phosphorylated Stat3 level after 6 hrs by Western blotting analysis	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cccc(Cl)c5)c4)c3c2)cn1		CHEMBL2418754	=	IC50	nM	985.6	CHEMBL4247	Homo sapiens	IC50	nM	985.6
	13437613	CHEMBL2423630	Inhibition of ALK in human KARPAS299 cells assessed as phosphorylated Stat3 level after 6 hrs by Western blotting analysis	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5ccc(F)cc5)c4)c3c2)cn1		CHEMBL2418753	=	IC50	nM	3011.0	CHEMBL4247	Homo sapiens	IC50	nM	3011.0
	13437614	CHEMBL2423630	Inhibition of ALK in human KARPAS299 cells assessed as phosphorylated Stat3 level after 6 hrs by Western blotting analysis	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cccc(F)c5)c4)c3c2)cn1		CHEMBL2418752	=	IC50	nM	138.5	CHEMBL4247	Homo sapiens	IC50	nM	138.5
	13437615	CHEMBL2423631	Inhibition of ALK in human KARPAS299 cells assessed as phosphorylated ALK level after 6 hrs by Western blotting analysis	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5ccc(F)c(F)c5)c4)c3c2)cn1		CHEMBL2418762	=	IC50	nM	3300.0	CHEMBL4247	Homo sapiens	IC50	nM	3300.0
	13437616	CHEMBL2423631	Inhibition of ALK in human KARPAS299 cells assessed as phosphorylated ALK level after 6 hrs by Western blotting analysis	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cc(F)ccc5F)c4)c3c2)cn1		CHEMBL2418761	=	IC50	nM	900.0	CHEMBL4247	Homo sapiens	IC50	nM	900.0
	13437617	CHEMBL2423631	Inhibition of ALK in human KARPAS299 cells assessed as phosphorylated ALK level after 6 hrs by Western blotting analysis	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cccc(Cl)c5)c4)c3c2)cn1		CHEMBL2418754	=	IC50	nM	3121.0	CHEMBL4247	Homo sapiens	IC50	nM	3121.0
	13437618	CHEMBL2423631	Inhibition of ALK in human KARPAS299 cells assessed as phosphorylated ALK level after 6 hrs by Western blotting analysis	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5ccc(F)cc5)c4)c3c2)cn1		CHEMBL2418753	=	IC50	nM	3914.0	CHEMBL4247	Homo sapiens	IC50	nM	3914.0
	13437619	CHEMBL2423631	Inhibition of ALK in human KARPAS299 cells assessed as phosphorylated ALK level after 6 hrs by Western blotting analysis	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cccc(F)c5)c4)c3c2)cn1		CHEMBL2418752	=	IC50	nM	219.5	CHEMBL4247	Homo sapiens	IC50	nM	219.5
	13437657	CHEMBL2423640	Inhibition of human ALK L1196M mutant after 30 mins by TR-FRET assay	B	Cc1nn(Cc2cc(F)cc(F)c2)c(C)c1-c1c[nH]c2ncc(-c3cnn(C)c3)cc12		CHEMBL2418749	=	IC50	nM	310.2	CHEMBL4247	Homo sapiens	IC50	nM	310.2
	13437658	CHEMBL2423640	Inhibition of human ALK L1196M mutant after 30 mins by TR-FRET assay	B	Cc1nn(Cc2cc(F)ccc2F)c(C)c1-c1c[nH]c2ncc(-c3cnn(C)c3)cc12		CHEMBL2418748	=	IC50	nM	428.0	CHEMBL4247	Homo sapiens	IC50	nM	428.0
	13437659	CHEMBL2423640	Inhibition of human ALK L1196M mutant after 30 mins by TR-FRET assay	B	Cc1nn(Cc2cccc(F)c2)c(C)c1-c1c[nH]c2ncc(-c3cnn(C)c3)cc12		CHEMBL2418747	=	IC50	nM	274.9	CHEMBL4247	Homo sapiens	IC50	nM	274.9
	13437660	CHEMBL2423640	Inhibition of human ALK L1196M mutant after 30 mins by TR-FRET assay	B	Cc1nn(Cc2cccc(F)c2)cc1-c1c[nH]c2ncc(-c3cnn(C)c3)cc12		CHEMBL2418746	=	IC50	nM	56.0	CHEMBL4247	Homo sapiens	IC50	nM	56.0
	13437661	CHEMBL2423640	Inhibition of human ALK L1196M mutant after 30 mins by TR-FRET assay	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cc(F)cc(F)c5)c4)c3c2)cn1		CHEMBL2418763	=	IC50	nM	47.0	CHEMBL4247	Homo sapiens	IC50	nM	47.0
	13437662	CHEMBL2423640	Inhibition of human ALK L1196M mutant after 30 mins by TR-FRET assay	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5ccc(F)c(F)c5)c4)c3c2)cn1		CHEMBL2418762	=	IC50	nM	379.0	CHEMBL4247	Homo sapiens	IC50	nM	379.0
	13437663	CHEMBL2423640	Inhibition of human ALK L1196M mutant after 30 mins by TR-FRET assay	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cc(F)ccc5F)c4)c3c2)cn1		CHEMBL2418761	=	IC50	nM	124.0	CHEMBL4247	Homo sapiens	IC50	nM	124.0
	13437664	CHEMBL2423640	Inhibition of human ALK L1196M mutant after 30 mins by TR-FRET assay	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cccc(O)c5)c4)c3c2)cn1		CHEMBL2418760	=	IC50	nM	200.5	CHEMBL4247	Homo sapiens	IC50	nM	200.5
Not Determined	13437665	CHEMBL2423640	Inhibition of human ALK L1196M mutant after 30 mins by TR-FRET assay	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cccc(N)c5)c4)c3c2)cn1		CHEMBL2418759		IC50			CHEMBL4247	Homo sapiens	IC50		
Not Determined	13437666	CHEMBL2423640	Inhibition of human ALK L1196M mutant after 30 mins by TR-FRET assay	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cccc([N+](=O)[O-])c5)c4)c3c2)cn1		CHEMBL2418758		IC50			CHEMBL4247	Homo sapiens	IC50		
	13437667	CHEMBL2423640	Inhibition of human ALK L1196M mutant after 30 mins by TR-FRET assay	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cccc(C(=O)O)c5)c4)c3c2)cn1		CHEMBL2418757	=	IC50	nM	811.0	CHEMBL4247	Homo sapiens	IC50	nM	811.0
	13437668	CHEMBL2423640	Inhibition of human ALK L1196M mutant after 30 mins by TR-FRET assay	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cccc(C(F)(F)F)c5)c4)c3c2)cn1		CHEMBL2418756	=	IC50	nM	465.4	CHEMBL4247	Homo sapiens	IC50	nM	465.4
	13437669	CHEMBL2423640	Inhibition of human ALK L1196M mutant after 30 mins by TR-FRET assay	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cccc(C#N)c5)c4)c3c2)cn1		CHEMBL2418755	=	IC50	nM	150.0	CHEMBL4247	Homo sapiens	IC50	nM	150.0
	13437670	CHEMBL2423640	Inhibition of human ALK L1196M mutant after 30 mins by TR-FRET assay	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cccc(Cl)c5)c4)c3c2)cn1		CHEMBL2418754	=	IC50	nM	143.0	CHEMBL4247	Homo sapiens	IC50	nM	143.0
	13437671	CHEMBL2423640	Inhibition of human ALK L1196M mutant after 30 mins by TR-FRET assay	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5ccc(F)cc5)c4)c3c2)cn1		CHEMBL2418753	=	IC50	nM	256.4	CHEMBL4247	Homo sapiens	IC50	nM	256.4
	13437672	CHEMBL2423640	Inhibition of human ALK L1196M mutant after 30 mins by TR-FRET assay	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cccc(F)c5)c4)c3c2)cn1		CHEMBL2418752	=	IC50	nM	35.0	CHEMBL4247	Homo sapiens	IC50	nM	35.0
	13437673	CHEMBL2423640	Inhibition of human ALK L1196M mutant after 30 mins by TR-FRET assay	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5ccccc5F)c4)c3c2)cn1		CHEMBL2418751	=	IC50	nM	223.0	CHEMBL4247	Homo sapiens	IC50	nM	223.0
	13437674	CHEMBL2423640	Inhibition of human ALK L1196M mutant after 30 mins by TR-FRET assay	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5ccccc5)c4)c3c2)cn1		CHEMBL2418750	=	IC50	nM	141.0	CHEMBL4247	Homo sapiens	IC50	nM	141.0
	13437675	CHEMBL2423641	Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assay	B	Cc1nn(Cc2cc(F)cc(F)c2)c(C)c1-c1c[nH]c2ncc(-c3cnn(C)c3)cc12		CHEMBL2418749	=	IC50	nM	26.0	CHEMBL4247	Homo sapiens	IC50	nM	26.0
	13437676	CHEMBL2423641	Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assay	B	Cc1nn(Cc2cc(F)ccc2F)c(C)c1-c1c[nH]c2ncc(-c3cnn(C)c3)cc12		CHEMBL2418748	=	IC50	nM	63.0	CHEMBL4247	Homo sapiens	IC50	nM	63.0
	13437677	CHEMBL2423641	Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assay	B	Cc1nn(Cc2cccc(F)c2)c(C)c1-c1c[nH]c2ncc(-c3cnn(C)c3)cc12		CHEMBL2418747	=	IC50	nM	31.0	CHEMBL4247	Homo sapiens	IC50	nM	31.0
	13437678	CHEMBL2423641	Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assay	B	Cc1nn(Cc2cccc(F)c2)cc1-c1c[nH]c2ncc(-c3cnn(C)c3)cc12		CHEMBL2418746	=	IC50	nM	6.0	CHEMBL4247	Homo sapiens	IC50	nM	6.0
	13437679	CHEMBL2423641	Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assay	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cc(F)cc(F)c5)c4)c3c2)cn1		CHEMBL2418763	=	IC50	nM	6.0	CHEMBL4247	Homo sapiens	IC50	nM	6.0
	13437680	CHEMBL2423641	Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assay	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5ccc(F)c(F)c5)c4)c3c2)cn1		CHEMBL2418762	=	IC50	nM	84.0	CHEMBL4247	Homo sapiens	IC50	nM	84.0
	13437681	CHEMBL2423641	Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assay	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cc(F)ccc5F)c4)c3c2)cn1		CHEMBL2418761	=	IC50	nM	29.0	CHEMBL4247	Homo sapiens	IC50	nM	29.0
	13437682	CHEMBL2423641	Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assay	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cccc(O)c5)c4)c3c2)cn1		CHEMBL2418760	=	IC50	nM	41.0	CHEMBL4247	Homo sapiens	IC50	nM	41.0
	13437683	CHEMBL2423641	Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assay	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cccc(N)c5)c4)c3c2)cn1		CHEMBL2418759	=	IC50	nM	28.0	CHEMBL4247	Homo sapiens	IC50	nM	28.0
	13437684	CHEMBL2423641	Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assay	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cccc([N+](=O)[O-])c5)c4)c3c2)cn1		CHEMBL2418758	=	IC50	nM	70.0	CHEMBL4247	Homo sapiens	IC50	nM	70.0
	13437685	CHEMBL2423641	Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assay	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cccc(C(=O)O)c5)c4)c3c2)cn1		CHEMBL2418757	=	IC50	nM	98.0	CHEMBL4247	Homo sapiens	IC50	nM	98.0
	13437686	CHEMBL2423641	Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assay	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cccc(C(F)(F)F)c5)c4)c3c2)cn1		CHEMBL2418756	=	IC50	nM	247.0	CHEMBL4247	Homo sapiens	IC50	nM	247.0
	13437687	CHEMBL2423641	Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assay	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cccc(C#N)c5)c4)c3c2)cn1		CHEMBL2418755	=	IC50	nM	32.0	CHEMBL4247	Homo sapiens	IC50	nM	32.0
	13437688	CHEMBL2423641	Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assay	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cccc(Cl)c5)c4)c3c2)cn1		CHEMBL2418754	=	IC50	nM	30.0	CHEMBL4247	Homo sapiens	IC50	nM	30.0
	13437689	CHEMBL2423641	Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assay	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5ccc(F)cc5)c4)c3c2)cn1		CHEMBL2418753	=	IC50	nM	70.0	CHEMBL4247	Homo sapiens	IC50	nM	70.0
	13437690	CHEMBL2423641	Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assay	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cccc(F)c5)c4)c3c2)cn1		CHEMBL2418752	=	IC50	nM	5.6	CHEMBL4247	Homo sapiens	IC50	nM	5.6
	13437691	CHEMBL2423641	Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assay	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5ccccc5F)c4)c3c2)cn1		CHEMBL2418751	=	IC50	nM	85.0	CHEMBL4247	Homo sapiens	IC50	nM	85.0
	13437692	CHEMBL2423641	Inhibition of wild type human recombinant ALK after 30 mins by TR-FRET assay	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5ccccc5)c4)c3c2)cn1		CHEMBL2418750	=	IC50	nM	90.0	CHEMBL4247	Homo sapiens	IC50	nM	90.0
	13439899	CHEMBL2428328	Competitive binding affinity to ALK (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	13445405	CHEMBL2428328	Competitive binding affinity to ALK (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	100.0	CHEMBL4247	Homo sapiens	INH	%	100.0
	13448464	CHEMBL2428328	Competitive binding affinity to ALK (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	=	Inhibition	%	78.0	CHEMBL4247	Homo sapiens	INH	%	78.0
	13451719	CHEMBL2428328	Competitive binding affinity to ALK (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	66.0	CHEMBL4247	Homo sapiens	INH	%	66.0
	13472941	CHEMBL2438115	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Inhibition	%	97.89	CHEMBL4247	Homo sapiens	INH	%	97.89
	13472942	CHEMBL2438115	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay relative to control	B	O=C(Nc1ccc(O)c(Sc2ncnc3nc[nH]c23)c1)c1ccc([N+](=O)[O-])cc1		CHEMBL2436643	=	Inhibition	%	21.91	CHEMBL4247	Homo sapiens	INH	%	21.91
Not Active	13472943	CHEMBL2438115	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay relative to control	B	Cn1nnnc1Sc1cc(NC(=O)c2ccc([N+](=O)[O-])cc2)ccc1O		CHEMBL2436642		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Not Active	13472944	CHEMBL2438115	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay relative to control	B	O=C(Nc1ccc(O)c(Sc2nncs2)c1)c1ccc([N+](=O)[O-])cc1		CHEMBL2436641		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	13472945	CHEMBL2438115	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay relative to control	B	Cc1nnc(Sc2cc(NC(=O)c3ccc([N+](=O)[O-])cc3)ccc2O)s1		CHEMBL2436640	=	Inhibition	%	13.98	CHEMBL4247	Homo sapiens	INH	%	13.98
Not Active	13472946	CHEMBL2438115	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay relative to control	B	O=C(Nc1ccc(O)c(Sc2ncn[nH]2)c1)c1ccc([N+](=O)[O-])cc1		CHEMBL2436639		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	13472947	CHEMBL2438115	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay relative to control	B	CC(C)c1cc(C(C)C)c(S(=O)(=O)Nc2ccc(O)c(Sc3ncn[nH]3)c2)c(C(C)C)c1		CHEMBL2436638	=	Inhibition	%	17.12	CHEMBL4247	Homo sapiens	INH	%	17.12
Not Active	13472948	CHEMBL2438115	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay relative to control	B	O=[N+]([O-])c1ccc(S(=O)(=O)Nc2ccc(O)c(Sc3ncnc4nc[nH]c34)c2)cc1		CHEMBL2436637		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Not Active	13472949	CHEMBL2438115	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay relative to control	B	Cn1nnnc1Sc1cc(NS(=O)(=O)c2ccc([N+](=O)[O-])cc2)ccc1O		CHEMBL2436636		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	13472950	CHEMBL2438115	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay relative to control	B	O=[N+]([O-])c1ccc(S(=O)(=O)Nc2ccc(O)c(Sc3nncs3)c2)cc1		CHEMBL2436635	=	Inhibition	%	11.37	CHEMBL4247	Homo sapiens	INH	%	11.37
	13472951	CHEMBL2438115	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay relative to control	B	Cc1nnc(Sc2cc(NS(=O)(=O)c3ccc([N+](=O)[O-])cc3)ccc2O)s1		CHEMBL2436634	=	Inhibition	%	21.81	CHEMBL4247	Homo sapiens	INH	%	21.81
	13472952	CHEMBL2438115	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay relative to control	B	O=[N+]([O-])c1ccc(S(=O)(=O)Nc2ccc(O)c(Sc3ncn[nH]3)c2)cc1		CHEMBL2436727	=	Inhibition	%	49.43	CHEMBL4247	Homo sapiens	INH	%	49.43
	13472953	CHEMBL2438115	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay relative to control	B	CS(=O)(=O)Nc1ccc(O)c(Sc2ncn[nH]2)c1		CHEMBL2436726	=	Inhibition	%	15.86	CHEMBL4247	Homo sapiens	INH	%	15.86
	13472954	CHEMBL2438115	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay relative to control	B	Cc1cc(C)c(S(=O)(=O)Nc2ccc(O)c(Sc3nc[nH]n3)c2)c(C)c1		CHEMBL1510393	=	Inhibition	%	17.98	CHEMBL4247	Homo sapiens	INH	%	17.98
	13472955	CHEMBL2438115	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay relative to control	B	O=S(=O)(Nc1ccc(O)c(Sc2ncn[nH]2)c1)c1c(Cl)cccc1Cl		CHEMBL2436725	=	Inhibition	%	10.32	CHEMBL4247	Homo sapiens	INH	%	10.32
Not Active	13472956	CHEMBL2438115	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay relative to control	B	O=S(=O)(Nc1ccc(O)c(Sc2ncn[nH]2)c1)c1ccc(Cl)cc1		CHEMBL2436724		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	13472957	CHEMBL2438115	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay relative to control	B	O=S(=O)(Nc1ccc(O)c(Sc2ncn[nH]2)c1)c1cccc2ccccc12		CHEMBL2436723	=	Inhibition	%	10.02	CHEMBL4247	Homo sapiens	INH	%	10.02
	13472958	CHEMBL2438115	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay relative to control	B	Cc1ccc(S(=O)(=O)Nc2ccc(O)c(Sc3nc[nH]n3)c2)cc1		CHEMBL1497487	=	Inhibition	%	15.33	CHEMBL4247	Homo sapiens	INH	%	15.33
	13472959	CHEMBL2438115	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay relative to control	B	COc1ccc(S(=O)(=O)Nc2ccc(O)c(Sc3nc[nH]n3)c2)cc1		CHEMBL1491588	=	Inhibition	%	29.5	CHEMBL4247	Homo sapiens	INH	%	29.5
Not Active	13472960	CHEMBL2438115	Inhibition of ALK (unknown origin) at 10 uM after 30 mins by fluorescence assay relative to control	B	O=S(=O)(Nc1ccc(O)c(Sc2ncn[nH]2)c1)c1ccc2ccccc2c1		CHEMBL2436644		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	13476405	CHEMBL2439129	Inhibition of human wild type ALK at 1 uM by qPCR analysis relative to control	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]ccc6c5)c4c3)cc2)CC1		CHEMBL2436978	>	Inhibition	%	90.0	CHEMBL4247	Homo sapiens	INH	%	90.0
	13499590	CHEMBL2447155	Inhibition of ALK (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	C[C@@H](Sc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2442124	=	IC50	nM	348.9	CHEMBL4247	Homo sapiens	IC50	nM	348.9
	13507655	CHEMBL2444019	Inhibition of Alk (unknown origin)	B	CN(C)c1ccc(Oc2cc(O)cc(O)c2-c2cc(C(=O)NC3CCN(C4CCC5(CC4)OCCO5)CC3)no2)cc1		CHEMBL2443026	>	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
	13507656	CHEMBL2444019	Inhibition of Alk (unknown origin)	B	CC(C)Nc1ccc(Oc2cc(O)cc(O)c2-c2cc(C(=O)NC3CCN(C)CC3)no2)cc1		CHEMBL2443139	>	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
	13507657	CHEMBL2444019	Inhibition of Alk (unknown origin)	B	CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc(N(C)C)cc3)on2)CC1		CHEMBL2443138	>	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
	13507658	CHEMBL2444019	Inhibition of Alk (unknown origin)	B	CN1CCC(NC(=O)c2cc(-c3c(O)cc(O)cc3Oc3ccc([N+](=O)[O-])cc3)on2)CC1		CHEMBL2443044	>	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
	13836312	CHEMBL3090920	Inhibition of ALK (unknown origin) after 90 mins by TR-FRET/IMAP fluorescence polarization assay	B	CNS(=O)(=O)Nc1cccc(Cc2c(C)c3cc(Cl)c(OC(=O)N(C)C)cc3oc2=O)c1		CHEMBL3086065	>	IC50	nM	5000.0	CHEMBL4247	Homo sapiens	IC50	uM	5.0
	13842834	CHEMBL3096886	Inhibition of ALK (unknown origin)	B	Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1-c1nc2ccc(N3CCCC3)cc2o1		CHEMBL3093151	=	IC50	nM	340.0	CHEMBL4247	Homo sapiens	IC50	uM	0.34
	13848524	CHEMBL3097423	Ratio of crizotinib IC50 to compound IC50 for NPM-fused ALK phosphorylation (unknown origin) expressed in human karpas 299 cells after 90 mins by Sandwich-ELISA	B	C[C@@H](Oc1cc(-c2ccc3c(c2)NC(=O)C32CCN(C)CC2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL3091723	=	Ratio IC50		2.8	CHEMBL4247	Homo sapiens	Ratio IC50		2.8
	13848539	CHEMBL3095077	Inhibition of NPM-fused ALK phosphorylation (unknown origin) expressed in human karpas 299 cells after 90 mins by Sandwich-ELISA	B	C[C@@H](Oc1cc(-c2ccc3c(c2)NC(=O)C32CCN(C)CC2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL3091723	=	IC50	nM	39.0	CHEMBL4247	Homo sapiens	IC50	nM	39.0
	13848542	CHEMBL3095080	Inhibition of human ALK (unknown origin) using poly[Glu:Tyr] as substrate by nanoliter kinase assay	B	C[C@@H](Oc1cc(-c2ccc3c(c2)NC(=O)C32CCN(C)CC2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL3091723	<	IC50	nM	0.5	CHEMBL4247	Homo sapiens	IC50	nM	0.5
	13848545	CHEMBL3095083	Binding affinity to human ALK at 100 nM by scanEDGE assay	B	C[C@@H](Oc1cc(-c2ccc3c(c2)NC(=O)C32CCN(C)CC2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL3091723	<	Activity	%	10.0	CHEMBL4247	Homo sapiens	Activity	%	10.0
	13848553	CHEMBL3095077	Inhibition of NPM-fused ALK phosphorylation (unknown origin) expressed in human karpas 299 cells after 90 mins by Sandwich-ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	110.0	CHEMBL4247	Homo sapiens	IC50	nM	110.0
	13848556	CHEMBL3095080	Inhibition of human ALK (unknown origin) using poly[Glu:Tyr] as substrate by nanoliter kinase assay	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O		CHEMBL14249	=	Km	nM	50000.0	CHEMBL4247	Homo sapiens	Km	uM	50.0
	13872210	CHEMBL3102397	Inhibition of human ALK assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	97.0	CHEMBL4247	Homo sapiens	Activity	%	97.0
	13878442	CHEMBL3108330	Inhibition of ALK (unknown origin)	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	IC50	nM	3320.0	CHEMBL4247	Homo sapiens	IC50	uM	3.32
	13878443	CHEMBL3108330	Inhibition of ALK (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	30.0	CHEMBL4247	Homo sapiens	IC50	uM	0.03
	13878444	CHEMBL3108330	Inhibition of ALK (unknown origin)	B	Cc1c(O)c(O)c(O)c(C=O)c1-c1cc2c(C=O)c(C)c(O)c(O)c2o1		CHEMBL3104855	=	IC50	nM	250.0	CHEMBL4247	Homo sapiens	IC50	uM	0.25
	13878445	CHEMBL3108330	Inhibition of ALK (unknown origin)	B	Cc1c(O)c(O)c(O)c2c1COC2=O		CHEMBL3104854	=	IC50	nM	5020.0	CHEMBL4247	Homo sapiens	IC50	uM	5.02
	13878446	CHEMBL3108330	Inhibition of ALK (unknown origin)	B	COCc1c(C)c(O)c(O)c(O)c1C=O		CHEMBL3104853	=	IC50	nM	9330.0	CHEMBL4247	Homo sapiens	IC50	uM	9.33
	13878447	CHEMBL3108330	Inhibition of ALK (unknown origin)	B	COC1OC(=O)c2c(O)c(O)c(O)c(C)c21		CHEMBL3104852	=	IC50	nM	9760.0	CHEMBL4247	Homo sapiens	IC50	uM	9.76
	13878448	CHEMBL3108330	Inhibition of ALK (unknown origin)	B	Cc1c(O)c(O)c2c(c1C=O)[C@@H]1O[C@H](O2)c2c(C)c(O)c(O)c(O)c2C1=O		CHEMBL3104851	=	IC50	nM	180.0	CHEMBL4247	Homo sapiens	IC50	uM	0.18
	13897475	CHEMBL3111648	Inhibition of recombinant ALK (unknown origin) assessed as incorporation of [gamma-33P]-ATP into substrate by radiometric assay	B	COC(=O)c1cc(O)c(O)c(C[C@]2(C)[C@@H](C)CC[C@@]3(C)C(C)=CCC[C@H]32)c1		CHEMBL3109404	=	IC50	nM	2190.0	CHEMBL4247	Homo sapiens	IC50	uM	2.19
	13897476	CHEMBL3111648	Inhibition of recombinant ALK (unknown origin) assessed as incorporation of [gamma-33P]-ATP into substrate by radiometric assay	B	COc1cc2nc(C)oc2c(C[C@]2(C)[C@@H](C)CC[C@@]3(C)C(C)=CCC[C@H]32)c1O		CHEMBL3109402	=	IC50	nM	3380.0	CHEMBL4247	Homo sapiens	IC50	uM	3.38
	13897477	CHEMBL3111648	Inhibition of recombinant ALK (unknown origin) assessed as incorporation of [gamma-33P]-ATP into substrate by radiometric assay	B	CC1=CCC[C@@H]2[C@@]1(C)CC[C@H](C)[C@@]2(C)CC1=C(O)C(=O)C=C(NCCC(C)C)C1=O		CHEMBL3109401	=	IC50	nM	970.0	CHEMBL4247	Homo sapiens	IC50	uM	0.97
Active	13897499	CHEMBL3111820	Inhibition of recombinant ALK (unknown origin) assessed as incorporation of [gamma-33P]-ATP into substrate at 10 uM by radiometric assay	B	CC1=CCC[C@@H]2[C@@]1(C)CC[C@H](C)[C@@]2(C)Cc1c2oc(C)nc2cc2nc(C)oc12		CHEMBL3109403		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	13897500	CHEMBL3111820	Inhibition of recombinant ALK (unknown origin) assessed as incorporation of [gamma-33P]-ATP into substrate at 10 uM by radiometric assay	B	CSCCCNC1=CC(=O)C(O)=C(C[C@]2(C)[C@@H](C)CC[C@@]3(C)C(C)=CCC[C@H]32)C1=O		CHEMBL3108787		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	13897501	CHEMBL3111820	Inhibition of recombinant ALK (unknown origin) assessed as incorporation of [gamma-33P]-ATP into substrate at 10 uM by radiometric assay	B	CC1=CCC[C@@H]2[C@@]1(C)CC[C@H](C)[C@@]2(C)CC1=C(O)C(=O)C=C(NCCc2c[nH]c3ccccc23)C1=O		CHEMBL3109400		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	13897502	CHEMBL3111820	Inhibition of recombinant ALK (unknown origin) assessed as incorporation of [gamma-33P]-ATP into substrate at 10 uM by radiometric assay	B	CC1=CCC[C@@H]2[C@@]1(C)CC[C@H](C)[C@@]2(C)CC1=C(O)C(=O)C=C(NCCc2ccccc2)C1=O		CHEMBL3109399		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	13898056	CHEMBL3111820	Inhibition of recombinant ALK (unknown origin) assessed as incorporation of [gamma-33P]-ATP into substrate at 10 uM by radiometric assay	B	CC1=CCC[C@@H]2[C@@]1(C)CC[C@H](C)[C@@]2(C)CC1=C(O)C(=O)C=C(NCCc2ccc(O)cc2)C1=O		CHEMBL3109398		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	13905070	CHEMBL3118804	Inhibition of recombinant wild type ALK catalytic domain (1064 to 1427) (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate in presence of 700 uM ATP	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	13905071	CHEMBL3119707	Inhibition of recombinant wild type ALK catalytic domain (1064 to 1427) (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate preincubated for 10 mins followed by ATP addition measured after 15 mins by ELISA	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	IC50	nM	56.0	CHEMBL4247	Homo sapiens	IC50	uM	0.056
Active	13905072	CHEMBL3118804	Inhibition of recombinant wild type ALK catalytic domain (1064 to 1427) (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate in presence of 700 uM ATP	B	COc1ccc(-c2ccc3nc4cncc(/C=C/c5ccccc5)n4c3c2)cc1		CHEMBL3115504		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	13905073	CHEMBL3118804	Inhibition of recombinant wild type ALK catalytic domain (1064 to 1427) (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate in presence of 700 uM ATP	B	COc1ccc(-c2cncc3nc4ccc(/C=C/c5ccccc5)cc4n23)cc1		CHEMBL3115503		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Not Determined	13905074	CHEMBL3119006	Inhibition of NPM/ALK L1196M mutant (unknown origin) transfected in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by [3H]-thymidine incorporation assay	B	Brc1ccc2nc3cc(Nc4ccccc4)ncn3c2c1		CHEMBL3115496		IC50			CHEMBL4247	Homo sapiens	IC50		
Not Determined	13905075	CHEMBL3119706	Inhibition of crizotinib-resistant recombinant ALK catalytic domain (1064 to 1427) L1196M mutant (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate preincubated for 10 mins followed by ATP addition measured after 15 mins by ELISA	B	COc1ccc(-c2cncc3nc4ccc(-c5ccc(N6CCN(C)CC6)cc5)cc4n23)cc1		CHEMBL3115502		IC50			CHEMBL4247	Homo sapiens	IC50		
Not Determined	13905076	CHEMBL3119706	Inhibition of crizotinib-resistant recombinant ALK catalytic domain (1064 to 1427) L1196M mutant (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate preincubated for 10 mins followed by ATP addition measured after 15 mins by ELISA	B	COc1ccc(-c2cncc3nc4ccc(-c5ccc(NC(C)=O)cc5)cc4n23)cc1		CHEMBL3115501		IC50			CHEMBL4247	Homo sapiens	IC50		
Not Determined	13905077	CHEMBL3119706	Inhibition of crizotinib-resistant recombinant ALK catalytic domain (1064 to 1427) L1196M mutant (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate preincubated for 10 mins followed by ATP addition measured after 15 mins by ELISA	B	Clc1cncc2nc3ccc(Br)cc3n12		CHEMBL3115499		IC50			CHEMBL4247	Homo sapiens	IC50		
Not Determined	13905078	CHEMBL3119706	Inhibition of crizotinib-resistant recombinant ALK catalytic domain (1064 to 1427) L1196M mutant (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate preincubated for 10 mins followed by ATP addition measured after 15 mins by ELISA	B	Clc1cncc2nc3ccccc3n12		CHEMBL3115498		IC50			CHEMBL4247	Homo sapiens	IC50		
Not Determined	13905079	CHEMBL3119706	Inhibition of crizotinib-resistant recombinant ALK catalytic domain (1064 to 1427) L1196M mutant (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate preincubated for 10 mins followed by ATP addition measured after 15 mins by ELISA	B	COc1ccc(-c2cc3nc4ccc(Br)cc4n3cn2)cc1		CHEMBL3115497		IC50			CHEMBL4247	Homo sapiens	IC50		
Not Determined	13905080	CHEMBL3119706	Inhibition of crizotinib-resistant recombinant ALK catalytic domain (1064 to 1427) L1196M mutant (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate preincubated for 10 mins followed by ATP addition measured after 15 mins by ELISA	B	Clc1cc2nc3ccc(Br)cc3n2cn1		CHEMBL3115495		IC50			CHEMBL4247	Homo sapiens	IC50		
Not Determined	13905081	CHEMBL3119706	Inhibition of crizotinib-resistant recombinant ALK catalytic domain (1064 to 1427) L1196M mutant (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate preincubated for 10 mins followed by ATP addition measured after 15 mins by ELISA	B	COc1cccc(Nc2cc3nc4ccccc4n3cn2)c1		CHEMBL3115494		IC50			CHEMBL4247	Homo sapiens	IC50		
Not Determined	13905082	CHEMBL3119706	Inhibition of crizotinib-resistant recombinant ALK catalytic domain (1064 to 1427) L1196M mutant (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate preincubated for 10 mins followed by ATP addition measured after 15 mins by ELISA	B	Clc1cc2nc3ccccc3n2cn1		CHEMBL3115491		IC50			CHEMBL4247	Homo sapiens	IC50		
	13905083	CHEMBL3119707	Inhibition of recombinant wild type ALK catalytic domain (1064 to 1427) (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate preincubated for 10 mins followed by ATP addition measured after 15 mins by ELISA	B	Clc1cncc2nc3ccc(Br)cc3n12		CHEMBL3115499	>	IC50	nM	50000.0	CHEMBL4247	Homo sapiens	IC50	uM	50.0
	13905084	CHEMBL3119707	Inhibition of recombinant wild type ALK catalytic domain (1064 to 1427) (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate preincubated for 10 mins followed by ATP addition measured after 15 mins by ELISA	B	Clc1cc2nc3ccc(Br)cc3n2cn1		CHEMBL3115495	>	IC50	nM	50000.0	CHEMBL4247	Homo sapiens	IC50	uM	50.0
	13905087	CHEMBL3119707	Inhibition of recombinant wild type ALK catalytic domain (1064 to 1427) (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate preincubated for 10 mins followed by ATP addition measured after 15 mins by ELISA	B	CN1CCN(c2ccc(-c3ccc4nc5cncc(-c6ccc(N7CCN(C)CC7)cc6)n5c4c3)cc2)CC1		CHEMBL3115500	>	IC50	nM	100000.0	CHEMBL4247	Homo sapiens	IC50	uM	100.0
	13905088	CHEMBL3119707	Inhibition of recombinant wild type ALK catalytic domain (1064 to 1427) (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate preincubated for 10 mins followed by ATP addition measured after 15 mins by ELISA	B	Clc1cncc2nc3ccccc3n12		CHEMBL3115498	>	IC50	nM	100000.0	CHEMBL4247	Homo sapiens	IC50	uM	100.0
	13905089	CHEMBL3119707	Inhibition of recombinant wild type ALK catalytic domain (1064 to 1427) (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate preincubated for 10 mins followed by ATP addition measured after 15 mins by ELISA	B	Clc1cc2nc3ccccc3n2cn1		CHEMBL3115491	>	IC50	nM	100000.0	CHEMBL4247	Homo sapiens	IC50	uM	100.0
	13905090	CHEMBL3119707	Inhibition of recombinant wild type ALK catalytic domain (1064 to 1427) (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate preincubated for 10 mins followed by ATP addition measured after 15 mins by ELISA	B	Brc1ccc2nc3cc(Nc4ccccc4)ncn3c2c1		CHEMBL3115496	=	IC50	nM	69000.0	CHEMBL4247	Homo sapiens	IC50	uM	69.0
	13905091	CHEMBL3119707	Inhibition of recombinant wild type ALK catalytic domain (1064 to 1427) (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate preincubated for 10 mins followed by ATP addition measured after 15 mins by ELISA	B	c1ccc(Nc2cc3nc4ccccc4n3cn2)cc1		CHEMBL3115492	=	IC50	nM	52000.0	CHEMBL4247	Homo sapiens	IC50	uM	52.0
	13905092	CHEMBL3119707	Inhibition of recombinant wild type ALK catalytic domain (1064 to 1427) (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate preincubated for 10 mins followed by ATP addition measured after 15 mins by ELISA	B	COc1cccc(Nc2cc3nc4ccccc4n3cn2)c1		CHEMBL3115494	=	IC50	nM	51000.0	CHEMBL4247	Homo sapiens	IC50	uM	51.0
	13905093	CHEMBL3119706	Inhibition of crizotinib-resistant recombinant ALK catalytic domain (1064 to 1427) L1196M mutant (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate preincubated for 10 mins followed by ATP addition measured after 15 mins by ELISA	B	Brc1ccc2nc3cc(Nc4ccccc4)ncn3c2c1		CHEMBL3115496	=	IC50	nM	49000.0	CHEMBL4247	Homo sapiens	IC50	uM	49.0
	13905094	CHEMBL3119706	Inhibition of crizotinib-resistant recombinant ALK catalytic domain (1064 to 1427) L1196M mutant (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate preincubated for 10 mins followed by ATP addition measured after 15 mins by ELISA	B	CN1CCN(c2ccc(-c3ccc4nc5cncc(-c6ccc(N7CCN(C)CC7)cc6)n5c4c3)cc2)CC1		CHEMBL3115500	=	IC50	nM	29000.0	CHEMBL4247	Homo sapiens	IC50	uM	29.0
	13905095	CHEMBL3118805	Competitive inhibition of recombinant wild type ALK catalytic domain (1064 to 1427) (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate in presence of 1000 uM ATP	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	EC50	nM	22840.0	CHEMBL4247	Homo sapiens	EC50	uM	22.84
	13905096	CHEMBL3119707	Inhibition of recombinant wild type ALK catalytic domain (1064 to 1427) (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate preincubated for 10 mins followed by ATP addition measured after 15 mins by ELISA	B	COc1ccc(-c2cncc3nc4ccc(-c5ccc(NC(C)=O)cc5)cc4n23)cc1		CHEMBL3115501	=	IC50	nM	18000.0	CHEMBL4247	Homo sapiens	IC50	uM	18.0
	13905098	CHEMBL3119706	Inhibition of crizotinib-resistant recombinant ALK catalytic domain (1064 to 1427) L1196M mutant (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate preincubated for 10 mins followed by ATP addition measured after 15 mins by ELISA	B	O=[N+]([O-])c1cccc(Nc2cc3nc4ccccc4n3cn2)c1		CHEMBL3115493	=	IC50	nM	14000.0	CHEMBL4247	Homo sapiens	IC50	uM	14.0
	13905099	CHEMBL3119707	Inhibition of recombinant wild type ALK catalytic domain (1064 to 1427) (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate preincubated for 10 mins followed by ATP addition measured after 15 mins by ELISA	B	COc1ccc(-c2cncc3nc4ccc(-c5ccc(N6CCN(C)CC6)cc5)cc4n23)cc1		CHEMBL3115502	=	IC50	nM	14000.0	CHEMBL4247	Homo sapiens	IC50	uM	14.0
	13905101	CHEMBL3119706	Inhibition of crizotinib-resistant recombinant ALK catalytic domain (1064 to 1427) L1196M mutant (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate preincubated for 10 mins followed by ATP addition measured after 15 mins by ELISA	B	c1ccc(Nc2cc3nc4ccccc4n3cn2)cc1		CHEMBL3115492	=	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	13905102	CHEMBL3119706	Inhibition of crizotinib-resistant recombinant ALK catalytic domain (1064 to 1427) L1196M mutant (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate preincubated for 10 mins followed by ATP addition measured after 15 mins by ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	13905103	CHEMBL3119707	Inhibition of recombinant wild type ALK catalytic domain (1064 to 1427) (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate preincubated for 10 mins followed by ATP addition measured after 15 mins by ELISA	B	COc1ccc(-c2cc3nc4ccc(Br)cc4n3cn2)cc1		CHEMBL3115497	=	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	13905104	CHEMBL3119707	Inhibition of recombinant wild type ALK catalytic domain (1064 to 1427) (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate preincubated for 10 mins followed by ATP addition measured after 15 mins by ELISA	B	O=[N+]([O-])c1cccc(Nc2cc3nc4ccccc4n3cn2)c1		CHEMBL3115493	=	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	13905105	CHEMBL3119006	Inhibition of NPM/ALK L1196M mutant (unknown origin) transfected in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by [3H]-thymidine incorporation assay	B	COc1ccc(-c2cc3nc4ccc(Br)cc4n3cn2)cc1		CHEMBL3115497	=	IC50	nM	9000.0	CHEMBL4247	Homo sapiens	IC50	uM	9.0
	13905108	CHEMBL3119706	Inhibition of crizotinib-resistant recombinant ALK catalytic domain (1064 to 1427) L1196M mutant (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate preincubated for 10 mins followed by ATP addition measured after 15 mins by ELISA	B	COc1ccc(-c2cncc3nc4ccc(/C=C/c5ccccc5)cc4n23)cc1		CHEMBL3115503	=	IC50	nM	4500.0	CHEMBL4247	Homo sapiens	IC50	uM	4.5
	13905109	CHEMBL3119707	Inhibition of recombinant wild type ALK catalytic domain (1064 to 1427) (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate preincubated for 10 mins followed by ATP addition measured after 15 mins by ELISA	B	COc1ccc(-c2cncc3nc4ccc(/C=C/c5ccccc5)cc4n23)cc1		CHEMBL3115503	=	IC50	nM	3500.0	CHEMBL4247	Homo sapiens	IC50	uM	3.5
	13905111	CHEMBL3119006	Inhibition of NPM/ALK L1196M mutant (unknown origin) transfected in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by [3H]-thymidine incorporation assay	B	Clc1cncc2nc3ccc(Br)cc3n12		CHEMBL3115499	=	IC50	nM	2200.0	CHEMBL4247	Homo sapiens	IC50	uM	2.2
	13905112	CHEMBL3118806	Competitive inhibition of recombinant wild type ALK catalytic domain (1064 to 1427) (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate in presence of 100 uM ATP	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	EC50	nM	2042.0	CHEMBL4247	Homo sapiens	EC50	uM	2.042
	13905113	CHEMBL3119707	Inhibition of recombinant wild type ALK catalytic domain (1064 to 1427) (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate preincubated for 10 mins followed by ATP addition measured after 15 mins by ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	1600.0	CHEMBL4247	Homo sapiens	IC50	uM	1.6
	13905114	CHEMBL3119706	Inhibition of crizotinib-resistant recombinant ALK catalytic domain (1064 to 1427) L1196M mutant (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate preincubated for 10 mins followed by ATP addition measured after 15 mins by ELISA	B	COc1ccc(-c2ccc3nc4cncc(/C=C/c5ccccc5)n4c3c2)cc1		CHEMBL3115504	=	IC50	nM	1500.0	CHEMBL4247	Homo sapiens	IC50	uM	1.5
	13905119	CHEMBL3119006	Inhibition of NPM/ALK L1196M mutant (unknown origin) transfected in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by [3H]-thymidine incorporation assay	B	COc1ccc(-c2ccc3nc4cncc(/C=C/c5ccccc5)n4c3c2)cc1		CHEMBL3115504	=	IC50	nM	780.0	CHEMBL4247	Homo sapiens	IC50	uM	0.78
	13905120	CHEMBL3119707	Inhibition of recombinant wild type ALK catalytic domain (1064 to 1427) (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate preincubated for 10 mins followed by ATP addition measured after 15 mins by ELISA	B	COc1ccc(-c2ccc3nc4cncc(/C=C/c5ccccc5)n4c3c2)cc1		CHEMBL3115504	=	IC50	nM	650.0	CHEMBL4247	Homo sapiens	IC50	uM	0.65
	13905121	CHEMBL3119005	Competitive inhibition of recombinant wild type ALK catalytic domain (1064 to 1427) (unknown origin) expressed in baculovirus expression system using ARDIYRASFFRKGGCAMLPVK as substrate in presence of 10 uM ATP	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	EC50	nM	575.3	CHEMBL4247	Homo sapiens	EC50	uM	0.5753
	13905123	CHEMBL3119006	Inhibition of NPM/ALK L1196M mutant (unknown origin) transfected in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by [3H]-thymidine incorporation assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	260.0	CHEMBL4247	Homo sapiens	IC50	uM	0.26
	13905124	CHEMBL3119006	Inhibition of NPM/ALK L1196M mutant (unknown origin) transfected in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by [3H]-thymidine incorporation assay	B	CN1CCN(c2ccc(-c3ccc4nc5cncc(-c6ccc(N7CCN(C)CC7)cc6)n5c4c3)cc2)CC1		CHEMBL3115500	=	IC50	nM	200.0	CHEMBL4247	Homo sapiens	IC50	uM	0.2
	13906502	CHEMBL3117718	Inhibition of ALK (unknown origin) at 10 uM after 30 mins relative to control	B	COc1ccc(S(=O)(=O)Nc2cc(Sc3ncnc4nc[nH]c34)c(O)c3ccccc23)cc1OC		CHEMBL3113284	=	Inhibition	%	10.2	CHEMBL4247	Homo sapiens	INH	%	10.2
Not Active	13907193	CHEMBL3118670	Inhibition of ALK (unknown origin) at 10 uM	B	CCCCCCCCCC(NC(=O)CNC(=O)OCc1ccccc1)C(=O)NCCc1ccccc1		CHEMBL3113587		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	13918697	CHEMBL3118217	Inhibition of human ALK	B	C[C@H](Nc1nc(Nc2cn(C)cn2)c2cc[nH]c2n1)c1ncc(F)cn1		CHEMBL3116050	=	IC50	nM	50.0	CHEMBL4247	Homo sapiens	IC50	uM	0.05
	13941155	CHEMBL3128775	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to Km levels of ATP addition measured after 1 hr by microfluidic mobility shift assay	B	Cc1nc([C@@](C)(O)CO)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3124972	=	Ki	nM	1.1	CHEMBL4247	Homo sapiens	Ki	nM	1.1
	13941156	CHEMBL3128775	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to Km levels of ATP addition measured after 1 hr by microfluidic mobility shift assay	B	Cc1nc(C2(O)CCS(=O)(=O)C2)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128068	=	Ki	nM	2.6	CHEMBL4247	Homo sapiens	Ki	nM	2.6
	13941157	CHEMBL3128775	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to Km levels of ATP addition measured after 1 hr by microfluidic mobility shift assay	B	Cc1nc(C2(O)CCOC2)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128067	=	Ki	nM	0.6	CHEMBL4247	Homo sapiens	Ki	nM	0.6
	13941158	CHEMBL3128775	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to Km levels of ATP addition measured after 1 hr by microfluidic mobility shift assay	B	Cc1nc(C2(O)CN(C)C2)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128066	=	Ki	nM	0.3	CHEMBL4247	Homo sapiens	Ki	nM	0.3
	13941159	CHEMBL3128775	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to Km levels of ATP addition measured after 1 hr by microfluidic mobility shift assay	B	Cc1nccn1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128065	=	Ki	nM	190.0	CHEMBL4247	Homo sapiens	Ki	nM	190.0
	13941160	CHEMBL3128775	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to Km levels of ATP addition measured after 1 hr by microfluidic mobility shift assay	B	Cc1nc(C(C)(C)O)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128064	=	Ki	nM	0.4	CHEMBL4247	Homo sapiens	Ki	nM	0.4
	13941161	CHEMBL3128775	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to Km levels of ATP addition measured after 1 hr by microfluidic mobility shift assay	B	Cc1nc(C(C)(C)O)ccc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128063	=	Ki	nM	6.1	CHEMBL4247	Homo sapiens	Ki	nM	6.1
	13941162	CHEMBL3128775	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to Km levels of ATP addition measured after 1 hr by microfluidic mobility shift assay	B	COc1ncncc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128062	=	Ki	nM	15.0	CHEMBL4247	Homo sapiens	Ki	nM	15.0
	13941163	CHEMBL3128775	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to Km levels of ATP addition measured after 1 hr by microfluidic mobility shift assay	B	COc1ncccc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128061	=	Ki	nM	1.3	CHEMBL4247	Homo sapiens	Ki	nM	1.3
	13941164	CHEMBL3128775	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to Km levels of ATP addition measured after 1 hr by microfluidic mobility shift assay	B	C[C@@H](Oc1cc(-c2cnnn2C)cnc1N)c1cc(F)ccc1-n1nccn1		CHEMBL3128060	=	Ki	nM	70.0	CHEMBL4247	Homo sapiens	Ki	nM	70.0
	13941165	CHEMBL3128775	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to Km levels of ATP addition measured after 1 hr by microfluidic mobility shift assay	B	C[C@@H](Oc1cc(-c2ccnn2C)cnc1N)c1cc(F)ccc1-n1nccn1		CHEMBL3128059	=	Ki	nM	7.5	CHEMBL4247	Homo sapiens	Ki	nM	7.5
	13941166	CHEMBL3128775	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to Km levels of ATP addition measured after 1 hr by microfluidic mobility shift assay	B	C[C@@H](Oc1cc(-c2cn(C)nc2C#N)cnc1N)c1cc(F)ccc1-n1nccn1		CHEMBL3128058	=	Ki	nM	2.8	CHEMBL4247	Homo sapiens	Ki	nM	2.8
	13941167	CHEMBL3128775	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to Km levels of ATP addition measured after 1 hr by microfluidic mobility shift assay	B	Cc1nn(C)cc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128075	=	Ki	nM	2.6	CHEMBL4247	Homo sapiens	Ki	nM	2.6
	13941168	CHEMBL3128775	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to Km levels of ATP addition measured after 1 hr by microfluidic mobility shift assay	B	Cc1n[nH]cc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128074	=	Ki	nM	2.6	CHEMBL4247	Homo sapiens	Ki	nM	2.6
	13941169	CHEMBL3128775	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to Km levels of ATP addition measured after 1 hr by microfluidic mobility shift assay	B	COc1ccc(F)cc1[C@@H](C)Oc1cc(-c2c[nH]nc2C)cnc1N		CHEMBL3128073	=	Ki	nM	2.0	CHEMBL4247	Homo sapiens	Ki	nM	2.0
	13941170	CHEMBL3128775	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to Km levels of ATP addition measured after 1 hr by microfluidic mobility shift assay	B	Cc1n[nH]cc1-c1cnc(N)c(O[C@@H](C)c2cc(F)ccc2C#N)c1		CHEMBL3128072	=	Ki	nM	11.0	CHEMBL4247	Homo sapiens	Ki	nM	11.0
	13941171	CHEMBL3128775	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to Km levels of ATP addition measured after 1 hr by microfluidic mobility shift assay	B	Cc1n[nH]cc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2F)c1		CHEMBL3128071	=	Ki	nM	16.0	CHEMBL4247	Homo sapiens	Ki	nM	16.0
	13941172	CHEMBL3128775	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to Km levels of ATP addition measured after 1 hr by microfluidic mobility shift assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1cc(F)ccc1Cl		CHEMBL3128070	=	Ki	nM	5.0	CHEMBL4247	Homo sapiens	Ki	nM	5.0
	13941173	CHEMBL3128775	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to Km levels of ATP addition measured after 1 hr by microfluidic mobility shift assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Ki	nM	8.2	CHEMBL4247	Homo sapiens	Ki	nM	8.2
	13941174	CHEMBL3129276	Inhibition of ALK-fusion driven cell proliferation in human NCI-H3122 cells harboring ALK L1196M mutant after 72 hrs by CellTiter Glo assay	F	Cc1nc([C@](C)(O)CO)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128069	=	IC50	nM	21.0	CHEMBL4247	Homo sapiens	IC50	nM	21.0
	13941207	CHEMBL3129286	Ratio of crizotinib IC50 to compound IC50 for human EML4-fused ALK L1152R mutant expressed in mouse NIH-3T3 cells	B	Cc1nc([C@](C)(O)CO)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128069	=	Ratio IC50		293.0	CHEMBL4247	Homo sapiens	Ratio IC50		293.0
	13941208	CHEMBL3129285	Ratio of crizotinib IC50 to compound IC50 for human EML4-fused ALK F1174L mutant expressed in mouse NIH-3T3 cells	B	Cc1nc([C@](C)(O)CO)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128069	=	Ratio IC50		825.0	CHEMBL4247	Homo sapiens	Ratio IC50		825.0
	13941209	CHEMBL3129284	Ratio of crizotinib IC50 to compound IC50 for human EML4-fused ALK C1156Y mutant expressed in mouse NIH-3T3 cells	B	Cc1nc([C@](C)(O)CO)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128069	=	Ratio IC50		797.0	CHEMBL4247	Homo sapiens	Ratio IC50		797.0
	13941210	CHEMBL3129283	Ratio of crizotinib IC50 to compound IC50 for human EML4-fused ALK S1206Y mutant expressed in mouse NIH-3T3 cells	B	Cc1nc([C@](C)(O)CO)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128069	=	Ratio IC50		139.0	CHEMBL4247	Homo sapiens	Ratio IC50		139.0
	13941211	CHEMBL3129281	Ratio of crizotinib IC50 to compound IC50 for human EML4-fused ALK G1269A mutant expressed in mouse NIH-3T3 cells	B	Cc1nc([C@](C)(O)CO)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128069	=	Ratio IC50		67.0	CHEMBL4247	Homo sapiens	Ratio IC50		67.0
	13941212	CHEMBL3129282	Ratio of crizotinib IC50 to compound IC50 for human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells	B	Cc1nc([C@](C)(O)CO)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128069	=	Ratio IC50		128.0	CHEMBL4247	Homo sapiens	Ratio IC50		128.0
	13941215	CHEMBL3129271	Inhibition of human EML4-fused ALK L1152R mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	Cc1nc([C@](C)(O)CO)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128069	=	IC50	nM	3.5	CHEMBL4247	Homo sapiens	IC50	nM	3.5
	13941216	CHEMBL3129271	Inhibition of human EML4-fused ALK L1152R mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	1026.0	CHEMBL4247	Homo sapiens	IC50	nM	1026.0
	13941217	CHEMBL3129270	Inhibition of human EML4-fused ALK F1174L mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	Cc1nc([C@](C)(O)CO)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128069	=	IC50	nM	0.2	CHEMBL4247	Homo sapiens	IC50	nM	0.2
	13941218	CHEMBL3129270	Inhibition of human EML4-fused ALK F1174L mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	165.0	CHEMBL4247	Homo sapiens	IC50	nM	165.0
	13941219	CHEMBL3129268	Inhibition of human EML4-fused ALK C1156Y mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	Cc1nc([C@](C)(O)CO)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128069	=	IC50	nM	0.6	CHEMBL4247	Homo sapiens	IC50	nM	0.6
	13941220	CHEMBL3129268	Inhibition of human EML4-fused ALK C1156Y mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	478.0	CHEMBL4247	Homo sapiens	IC50	nM	478.0
	13941221	CHEMBL3129267	Inhibition of human EML4-fused ALK S1206Y mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	Cc1nc([C@](C)(O)CO)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128069	=	IC50	nM	4.5	CHEMBL4247	Homo sapiens	IC50	nM	4.5
	13941222	CHEMBL3129267	Inhibition of human EML4-fused ALK S1206Y mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	626.0	CHEMBL4247	Homo sapiens	IC50	nM	626.0
	13941223	CHEMBL3129266	Inhibition of human EML4-fused ALK G1269A mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	Cc1nc([C@](C)(O)CO)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128069	=	IC50	nM	9.0	CHEMBL4247	Homo sapiens	IC50	nM	9.0
	13941224	CHEMBL3129266	Inhibition of human EML4-fused ALK G1269A mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	605.0	CHEMBL4247	Homo sapiens	IC50	nM	605.0
	13941225	CHEMBL3129264	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	Cc1nc([C@](C)(O)CO)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128069	=	IC50	nM	6.6	CHEMBL4247	Homo sapiens	IC50	nM	6.6
	13941226	CHEMBL3129264	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	Cc1nc([C@@](C)(O)CO)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3124972	=	IC50	nM	55.0	CHEMBL4247	Homo sapiens	IC50	nM	55.0
	13941227	CHEMBL3129264	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	Cc1nc(C2(O)CCS(=O)(=O)C2)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128068	=	IC50	nM	19.0	CHEMBL4247	Homo sapiens	IC50	nM	19.0
	13941228	CHEMBL3129264	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	Cc1nc(C2(O)CCOC2)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128067	=	IC50	nM	58.0	CHEMBL4247	Homo sapiens	IC50	nM	58.0
	13941229	CHEMBL3129264	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	Cc1nc(C2(O)CN(C)C2)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128066	=	IC50	nM	52.0	CHEMBL4247	Homo sapiens	IC50	nM	52.0
	13941230	CHEMBL3129264	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	Cc1nc(C(C)(C)O)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128064	=	IC50	nM	27.0	CHEMBL4247	Homo sapiens	IC50	nM	27.0
	13941231	CHEMBL3129264	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	Cc1nc(C(C)(C)O)ccc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128063	=	IC50	nM	325.0	CHEMBL4247	Homo sapiens	IC50	nM	325.0
	13941232	CHEMBL3129264	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	COc1ncncc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128062	=	IC50	nM	772.0	CHEMBL4247	Homo sapiens	IC50	nM	772.0
	13941233	CHEMBL3129264	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	COc1ncccc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128061	=	IC50	nM	256.0	CHEMBL4247	Homo sapiens	IC50	nM	256.0
	13941234	CHEMBL3129264	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@@H](Oc1cc(-c2cnnn2C)cnc1N)c1cc(F)ccc1-n1nccn1		CHEMBL3128060	=	IC50	nM	2650.0	CHEMBL4247	Homo sapiens	IC50	nM	2650.0
	13941235	CHEMBL3129264	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@@H](Oc1cc(-c2ccnn2C)cnc1N)c1cc(F)ccc1-n1nccn1		CHEMBL3128059	=	IC50	nM	677.0	CHEMBL4247	Homo sapiens	IC50	nM	677.0
	13941236	CHEMBL3129264	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@@H](Oc1cc(-c2cn(C)nc2C#N)cnc1N)c1cc(F)ccc1-n1nccn1		CHEMBL3128058	=	IC50	nM	105.0	CHEMBL4247	Homo sapiens	IC50	nM	105.0
	13941237	CHEMBL3129264	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	Cc1nn(C)cc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128075	=	IC50	nM	176.0	CHEMBL4247	Homo sapiens	IC50	nM	176.0
	13941238	CHEMBL3129264	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	Cc1n[nH]cc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128074	=	IC50	nM	60.0	CHEMBL4247	Homo sapiens	IC50	nM	60.0
	13941239	CHEMBL3129264	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	COc1ccc(F)cc1[C@@H](C)Oc1cc(-c2c[nH]nc2C)cnc1N		CHEMBL3128073	=	IC50	nM	69.0	CHEMBL4247	Homo sapiens	IC50	nM	69.0
	13941240	CHEMBL3129264	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	Cc1n[nH]cc1-c1cnc(N)c(O[C@@H](C)c2cc(F)ccc2C#N)c1		CHEMBL3128072	=	IC50	nM	805.0	CHEMBL4247	Homo sapiens	IC50	nM	805.0
	13941241	CHEMBL3129264	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	Cc1n[nH]cc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2F)c1		CHEMBL3128071	=	IC50	nM	1254.0	CHEMBL4247	Homo sapiens	IC50	nM	1254.0
	13941242	CHEMBL3129264	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1cc(F)ccc1Cl		CHEMBL3128070	=	IC50	nM	387.0	CHEMBL4247	Homo sapiens	IC50	nM	387.0
	13941243	CHEMBL3129264	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	843.0	CHEMBL4247	Homo sapiens	IC50	nM	843.0
	13941244	CHEMBL3128775	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to Km levels of ATP addition measured after 1 hr by microfluidic mobility shift assay	B	Cc1nc([C@](C)(O)CO)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128069	=	Ki	nM	0.2	CHEMBL4247	Homo sapiens	Ki	nM	0.2
	13941310	CHEMBL3129275	Inhibition of ALK-fusion driven cell proliferation in human NCI-H3122 cells harboring ALK G1269A mutant after 72 hrs by CellTiter Glo assay	F	Cc1nc([C@](C)(O)CO)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128069	=	IC50	nM	24.0	CHEMBL4247	Homo sapiens	IC50	nM	24.0
	13941311	CHEMBL3129275	Inhibition of ALK-fusion driven cell proliferation in human NCI-H3122 cells harboring ALK G1269A mutant after 72 hrs by CellTiter Glo assay	F	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	623.0	CHEMBL4247	Homo sapiens	IC50	nM	623.0
	13941312	CHEMBL3129276	Inhibition of ALK-fusion driven cell proliferation in human NCI-H3122 cells harboring ALK L1196M mutant after 72 hrs by CellTiter Glo assay	F	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	838.0	CHEMBL4247	Homo sapiens	IC50	nM	838.0
	13941313	CHEMBL3129277	Inhibition of ALK-fusion driven cell proliferation in human KARPAS299 cells after 72 hrs by CellTiter Glo assay	F	Cc1nc([C@](C)(O)CO)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128069	=	IC50	nM	1.7	CHEMBL4247	Homo sapiens	IC50	nM	1.7
	13941314	CHEMBL3129277	Inhibition of ALK-fusion driven cell proliferation in human KARPAS299 cells after 72 hrs by CellTiter Glo assay	F	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	62.0	CHEMBL4247	Homo sapiens	IC50	nM	62.0
	13941317	CHEMBL3129280	Inhibition of ALK-fusion driven cell proliferation in human NCI-H3122 cells after 72 hrs by CellTiter Glo assay	F	Cc1nc([C@](C)(O)CO)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128069	=	IC50	nM	1.3	CHEMBL4247	Homo sapiens	IC50	nM	1.3
	13941318	CHEMBL3129280	Inhibition of ALK-fusion driven cell proliferation in human NCI-H3122 cells after 72 hrs by CellTiter Glo assay	F	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	108.0	CHEMBL4247	Homo sapiens	IC50	nM	108.0
	13941319	CHEMBL3128713	Inhibition of human wild type EML4-fused ALK expressed in mouse NIH-3T3 cells assessed as phosphorylated ALK level after 1 hr by sandwich ELISA	B	Cc1nc([C@](C)(O)CO)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128069	=	IC50	nM	0.8	CHEMBL4247	Homo sapiens	IC50	nM	0.8
	13941320	CHEMBL3128713	Inhibition of human wild type EML4-fused ALK expressed in mouse NIH-3T3 cells assessed as phosphorylated ALK level after 1 hr by sandwich ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	80.0	CHEMBL4247	Homo sapiens	IC50	nM	80.0
	13953269	CHEMBL3132656	Inhibition of human ALK assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	99.0	CHEMBL4247	Homo sapiens	Activity	%	99.0
	13954651	CHEMBL3132656	Inhibition of human ALK assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	101.0	CHEMBL4247	Homo sapiens	Activity	%	101.0
	13954706	CHEMBL3132656	Inhibition of human ALK assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	88.0	CHEMBL4247	Homo sapiens	Activity	%	88.0
	13973383	CHEMBL3134652	Inhibition of ALK1 (unknown origin) using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting	B	Oc1cccc(Nc2ccnc3[nH]c4ccccc4c23)c1		CHEMBL3133821	=	IC50	nM	220.0	CHEMBL4247	Homo sapiens	IC50	nM	220.0
	14529025	CHEMBL3226250	Inhibition of ALK (unknown origin)	B	COc1ccc(-c2nc3c(N[C@H]4[C@@H](C(N)=O)[C@@H]5C=C[C@H]4C5)c(Cl)cnc3[nH]2)cc1		CHEMBL3218846	=	IC50	nM	199.0	CHEMBL4247	Homo sapiens	IC50	nM	199.0
	14529026	CHEMBL3226250	Inhibition of ALK (unknown origin)	B	COc1cccc(-c2nc3c(N[C@H]4[C@@H](C(N)=O)[C@@H]5C=C[C@H]4C5)c(Cl)cnc3[nH]2)c1		CHEMBL3218847	=	IC50	nM	212.0	CHEMBL4247	Homo sapiens	IC50	nM	212.0
	14529027	CHEMBL3226250	Inhibition of ALK (unknown origin)	B	COc1ccccc1-c1nc2c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)c(Cl)cnc2[nH]1		CHEMBL3218848	=	IC50	nM	16.0	CHEMBL4247	Homo sapiens	IC50	nM	16.0
	14529028	CHEMBL3226250	Inhibition of ALK (unknown origin)	B	NC(=O)[C@H]1[C@@H]2C=C[C@@H](C2)[C@H]1Nc1c(Cl)cnc2[nH]c(-c3cccc(N4CCOCC4)c3)nc12		CHEMBL3218849	=	IC50	nM	85.0	CHEMBL4247	Homo sapiens	IC50	nM	85.0
	14529029	CHEMBL3226250	Inhibition of ALK (unknown origin)	B	NC(=O)[C@H]1[C@@H]2C=C[C@@H](C2)[C@H]1Nc1c(Cl)cnc2[nH]c(-c3ccc(N4CCOCC4)cc3)nc12		CHEMBL3218850	=	IC50	nM	121.0	CHEMBL4247	Homo sapiens	IC50	nM	121.0
	14529030	CHEMBL3226250	Inhibition of ALK (unknown origin)	B	CN1CCN(c2ccc(-c3nc4c(N[C@H]5[C@@H](C(N)=O)[C@@H]6C=C[C@H]5C6)c(Cl)cnc4[nH]3)cc2)CC1		CHEMBL3218851	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
	14529031	CHEMBL3226250	Inhibition of ALK (unknown origin)	B	Cn1cc(-c2nc3c(N[C@H]4[C@@H](C(N)=O)[C@@H]5C=C[C@H]4C5)c(Cl)cnc3[nH]2)cn1		CHEMBL3218852	=	IC50	nM	270.0	CHEMBL4247	Homo sapiens	IC50	nM	270.0
	14529032	CHEMBL3226250	Inhibition of ALK (unknown origin)	B	NC(=O)[C@H]1[C@@H]2C=C[C@@H](C2)[C@H]1Nc1c(Cl)cnc2[nH]c(-c3cnn(C4CCNCC4)c3)nc12		CHEMBL3218853	=	IC50	nM	42.0	CHEMBL4247	Homo sapiens	IC50	nM	42.0
	14529033	CHEMBL3226250	Inhibition of ALK (unknown origin)	B	COc1cc(N2CCOCC2)ccc1-c1nc2c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)c(Cl)cnc2[nH]1		CHEMBL3218854	=	IC50	nM	7.0	CHEMBL4247	Homo sapiens	IC50	nM	7.0
	14529034	CHEMBL3226250	Inhibition of ALK (unknown origin)	B	COc1cc(N2CCN(C)CC2)ccc1-c1nc2c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)c(Cl)cnc2[nH]1		CHEMBL3218855	=	IC50	nM	0.69	CHEMBL4247	Homo sapiens	IC50	nM	0.69
	14529035	CHEMBL3226250	Inhibition of ALK (unknown origin)	B	COc1cc(N2CCC(N3CCOCC3)CC2)ccc1-c1nc2c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)c(Cl)cnc2[nH]1		CHEMBL3218856	=	IC50	nM	0.31	CHEMBL4247	Homo sapiens	IC50	nM	0.31
	14529036	CHEMBL3226250	Inhibition of ALK (unknown origin)	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1-c1nc2c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)c(Cl)cnc2[nH]1		CHEMBL3218857	=	IC50	nM	0.76	CHEMBL4247	Homo sapiens	IC50	nM	0.76
	14529037	CHEMBL3226250	Inhibition of ALK (unknown origin)	B	COc1cc(CN2CCOCC2)ccc1-c1nc2c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)c(Cl)cnc2[nH]1		CHEMBL3218858	=	IC50	nM	6.7	CHEMBL4247	Homo sapiens	IC50	nM	6.7
	14529038	CHEMBL3226250	Inhibition of ALK (unknown origin)	B	COc1cc(CN2CCN(C)CC2)ccc1-c1nc2c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)c(Cl)cnc2[nH]1		CHEMBL3218859	=	IC50	nM	0.65	CHEMBL4247	Homo sapiens	IC50	nM	0.65
	14529039	CHEMBL3226250	Inhibition of ALK (unknown origin)	B	NC(=O)[C@H]1[C@@H]2C=C[C@@H](C2)[C@H]1Nc1c(Br)cnc2[nH]c(-c3ccc(N4CCOCC4)cc3)nc12		CHEMBL3218860	=	IC50	nM	29.0	CHEMBL4247	Homo sapiens	IC50	nM	29.0
	14529040	CHEMBL3226250	Inhibition of ALK (unknown origin)	B	CN1CCN(c2ccc(-c3nc4c(N[C@H]5[C@@H](C(N)=O)[C@@H]6C=C[C@H]5C6)c(Br)cnc4[nH]3)cc2)CC1		CHEMBL3218861	=	IC50	nM	2.7	CHEMBL4247	Homo sapiens	IC50	nM	2.7
	14529041	CHEMBL3226250	Inhibition of ALK (unknown origin)	B	NC(=O)[C@H]1[C@@H]2C=C[C@@H](C2)[C@H]1Nc1ccnc2[nH]c(-c3ccc(N4CCOCC4)cc3)nc12		CHEMBL3218862	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
	14529042	CHEMBL3226250	Inhibition of ALK (unknown origin)	B	CN1CCN(c2ccc(-c3nc4c(N[C@H]5[C@@H](C(N)=O)[C@@H]6C=C[C@H]5C6)ccnc4[nH]3)cc2)CC1		CHEMBL3218863	>	IC50	nM	3000.0	CHEMBL4247	Homo sapiens	IC50	nM	3000.0
Not Determined	14529043	CHEMBL3226251	Inhibition of NPM-ALK autophosphorylation in human ALK-positive ALCL SUP-M2 cells	B	COc1ccc(-c2nc3c(N[C@H]4[C@@H](C(N)=O)[C@@H]5C=C[C@H]4C5)c(Cl)cnc3[nH]2)cc1		CHEMBL3218846		IC50			CHEMBL4247	Homo sapiens	IC50		
Not Determined	14529044	CHEMBL3226251	Inhibition of NPM-ALK autophosphorylation in human ALK-positive ALCL SUP-M2 cells	B	COc1cccc(-c2nc3c(N[C@H]4[C@@H](C(N)=O)[C@@H]5C=C[C@H]4C5)c(Cl)cnc3[nH]2)c1		CHEMBL3218847		IC50			CHEMBL4247	Homo sapiens	IC50		
	14529045	CHEMBL3226251	Inhibition of NPM-ALK autophosphorylation in human ALK-positive ALCL SUP-M2 cells	B	COc1ccccc1-c1nc2c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)c(Cl)cnc2[nH]1		CHEMBL3218848	=	IC50	nM	200.0	CHEMBL4247	Homo sapiens	IC50	nM	200.0
Not Determined	14529046	CHEMBL3226251	Inhibition of NPM-ALK autophosphorylation in human ALK-positive ALCL SUP-M2 cells	B	NC(=O)[C@H]1[C@@H]2C=C[C@@H](C2)[C@H]1Nc1c(Cl)cnc2[nH]c(-c3cccc(N4CCOCC4)c3)nc12		CHEMBL3218849		IC50			CHEMBL4247	Homo sapiens	IC50		
Not Determined	14529047	CHEMBL3226251	Inhibition of NPM-ALK autophosphorylation in human ALK-positive ALCL SUP-M2 cells	B	NC(=O)[C@H]1[C@@H]2C=C[C@@H](C2)[C@H]1Nc1c(Cl)cnc2[nH]c(-c3ccc(N4CCOCC4)cc3)nc12		CHEMBL3218850		IC50			CHEMBL4247	Homo sapiens	IC50		
	14529048	CHEMBL3226251	Inhibition of NPM-ALK autophosphorylation in human ALK-positive ALCL SUP-M2 cells	B	CN1CCN(c2ccc(-c3nc4c(N[C@H]5[C@@H](C(N)=O)[C@@H]6C=C[C@H]5C6)c(Cl)cnc4[nH]3)cc2)CC1		CHEMBL3218851	=	IC50	nM	30.0	CHEMBL4247	Homo sapiens	IC50	nM	30.0
Not Determined	14529049	CHEMBL3226251	Inhibition of NPM-ALK autophosphorylation in human ALK-positive ALCL SUP-M2 cells	B	Cn1cc(-c2nc3c(N[C@H]4[C@@H](C(N)=O)[C@@H]5C=C[C@H]4C5)c(Cl)cnc3[nH]2)cn1		CHEMBL3218852		IC50			CHEMBL4247	Homo sapiens	IC50		
Not Determined	14529050	CHEMBL3226251	Inhibition of NPM-ALK autophosphorylation in human ALK-positive ALCL SUP-M2 cells	B	NC(=O)[C@H]1[C@@H]2C=C[C@@H](C2)[C@H]1Nc1c(Cl)cnc2[nH]c(-c3cnn(C4CCNCC4)c3)nc12		CHEMBL3218853		IC50			CHEMBL4247	Homo sapiens	IC50		
	14529051	CHEMBL3226251	Inhibition of NPM-ALK autophosphorylation in human ALK-positive ALCL SUP-M2 cells	B	COc1cc(N2CCOCC2)ccc1-c1nc2c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)c(Cl)cnc2[nH]1		CHEMBL3218854	=	IC50	nM	40.0	CHEMBL4247	Homo sapiens	IC50	nM	40.0
	14529052	CHEMBL3226251	Inhibition of NPM-ALK autophosphorylation in human ALK-positive ALCL SUP-M2 cells	B	COc1cc(N2CCN(C)CC2)ccc1-c1nc2c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)c(Cl)cnc2[nH]1		CHEMBL3218855	=	IC50	nM	8.0	CHEMBL4247	Homo sapiens	IC50	nM	8.0
	14529053	CHEMBL3226251	Inhibition of NPM-ALK autophosphorylation in human ALK-positive ALCL SUP-M2 cells	B	COc1cc(N2CCC(N3CCOCC3)CC2)ccc1-c1nc2c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)c(Cl)cnc2[nH]1		CHEMBL3218856	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
	14529054	CHEMBL3226251	Inhibition of NPM-ALK autophosphorylation in human ALK-positive ALCL SUP-M2 cells	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1-c1nc2c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)c(Cl)cnc2[nH]1		CHEMBL3218857	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
	14529055	CHEMBL3226251	Inhibition of NPM-ALK autophosphorylation in human ALK-positive ALCL SUP-M2 cells	B	COc1cc(CN2CCOCC2)ccc1-c1nc2c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)c(Cl)cnc2[nH]1		CHEMBL3218858	=	IC50	nM	60.0	CHEMBL4247	Homo sapiens	IC50	nM	60.0
	14529056	CHEMBL3226251	Inhibition of NPM-ALK autophosphorylation in human ALK-positive ALCL SUP-M2 cells	B	COc1cc(CN2CCN(C)CC2)ccc1-c1nc2c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)c(Cl)cnc2[nH]1		CHEMBL3218859	=	IC50	nM	8.0	CHEMBL4247	Homo sapiens	IC50	nM	8.0
Not Determined	14529057	CHEMBL3226251	Inhibition of NPM-ALK autophosphorylation in human ALK-positive ALCL SUP-M2 cells	B	NC(=O)[C@H]1[C@@H]2C=C[C@@H](C2)[C@H]1Nc1c(Br)cnc2[nH]c(-c3ccc(N4CCOCC4)cc3)nc12		CHEMBL3218860		IC50			CHEMBL4247	Homo sapiens	IC50		
	14529058	CHEMBL3226251	Inhibition of NPM-ALK autophosphorylation in human ALK-positive ALCL SUP-M2 cells	B	CN1CCN(c2ccc(-c3nc4c(N[C@H]5[C@@H](C(N)=O)[C@@H]6C=C[C@H]5C6)c(Br)cnc4[nH]3)cc2)CC1		CHEMBL3218861	=	IC50	nM	40.0	CHEMBL4247	Homo sapiens	IC50	nM	40.0
Not Determined	14529059	CHEMBL3226251	Inhibition of NPM-ALK autophosphorylation in human ALK-positive ALCL SUP-M2 cells	B	NC(=O)[C@H]1[C@@H]2C=C[C@@H](C2)[C@H]1Nc1ccnc2[nH]c(-c3ccc(N4CCOCC4)cc3)nc12		CHEMBL3218862		IC50			CHEMBL4247	Homo sapiens	IC50		
Not Determined	14529060	CHEMBL3226251	Inhibition of NPM-ALK autophosphorylation in human ALK-positive ALCL SUP-M2 cells	B	CN1CCN(c2ccc(-c3nc4c(N[C@H]5[C@@H](C(N)=O)[C@@H]6C=C[C@H]5C6)ccnc4[nH]3)cc2)CC1		CHEMBL3218863		IC50			CHEMBL4247	Homo sapiens	IC50		
	14553659	CHEMBL3223952	Inhibition of ALK (unknown origin) at 10 uM assessed as residual enzyme activity	B	COc1ccc(-c2n[nH]c3ncc(-c4ccc(Cl)cc4N)cc23)cc1		CHEMBL3220823	=	Activity	%	96.5	CHEMBL4247	Homo sapiens	Activity	%	96.5
	14582433	CHEMBL3240216	Inhibition of human ALK assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	103.5	CHEMBL4247	Homo sapiens	Activity	%	103.5
	14593755	CHEMBL3242880	Inhibition of human ALK1	B	Oc1cccc(Nc2ccnc3[nH]c4ccccc4c23)c1		CHEMBL3133821	=	IC50	nM	2200.0	CHEMBL4247	Homo sapiens	IC50	uM	2.2
	14645522	CHEMBL3269109	Inhibition of ALK (unknown origin)	B	N[C@H]1CCCC[C@H]1Nc1cc2nc[nH]c(=O)c2c(Nc2cccc3cc[nH]c23)n1		CHEMBL3262356	=	IC50	nM	70.0	CHEMBL4247	Homo sapiens	IC50	nM	70.0
	14653590	CHEMBL3267809	Ratio of crizotinib IC50 to compound IC50 for purified recombinant ALK (unknown origin) after 60 mins by ELISA	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)C(c2ccccc2)CN(C)CC3)ncc1Cl		CHEMBL3263970	=	Ratio IC50		2.0	CHEMBL4247	Homo sapiens	Ratio IC50		2.0
	14653621	CHEMBL3267806	Inhibition of purified recombinant ALK (unknown origin) after 60 mins by ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	28.0	CHEMBL4247	Homo sapiens	IC50	nM	28.0
	14653622	CHEMBL3267806	Inhibition of purified recombinant ALK (unknown origin) after 60 mins by ELISA	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	IC50	nM	1.6	CHEMBL4247	Homo sapiens	IC50	nM	1.6
	14653623	CHEMBL3267806	Inhibition of purified recombinant ALK (unknown origin) after 60 mins by ELISA	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)C(c2ccccc2)CN(C)CC3)ncc1Cl		CHEMBL3263970	=	IC50	nM	14.0	CHEMBL4247	Homo sapiens	IC50	nM	14.0
	14653624	CHEMBL3267806	Inhibition of purified recombinant ALK (unknown origin) after 60 mins by ELISA	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)C(C)CN(C)CC3)ncc1Cl		CHEMBL3263971	=	IC50	nM	9.0	CHEMBL4247	Homo sapiens	IC50	nM	9.0
	14653625	CHEMBL3267806	Inhibition of purified recombinant ALK (unknown origin) after 60 mins by ELISA	B	CCCCC1CN(C)CCc2ccc(Nc3ncc(Cl)c(Nc4ccccc4C(=O)NC)n3)cc21		CHEMBL3263972	=	IC50	nM	7.7	CHEMBL4247	Homo sapiens	IC50	nM	7.7
	14653626	CHEMBL3267806	Inhibition of purified recombinant ALK (unknown origin) after 60 mins by ELISA	B	C=C1CNCCc2ccc(Nc3ncc(Cl)c(Nc4ccccc4C(=O)NC)n3)cc21		CHEMBL3263973	=	IC50	nM	19.0	CHEMBL4247	Homo sapiens	IC50	nM	19.0
	14653627	CHEMBL3267806	Inhibition of purified recombinant ALK (unknown origin) after 60 mins by ELISA	B	C=C1CN(C)CCc2ccc(Nc3ncc(Cl)c(Nc4ccccc4C(=O)NC)n3)cc21		CHEMBL3263974	=	IC50	nM	60.0	CHEMBL4247	Homo sapiens	IC50	nM	60.0
	14653628	CHEMBL3267806	Inhibition of purified recombinant ALK (unknown origin) after 60 mins by ELISA	B	C/C=C1\CN(C)CCc2ccc(Nc3ncc(Cl)c(Nc4ccccc4C(=O)NC)n3)cc21		CHEMBL3263975	=	IC50	nM	17.0	CHEMBL4247	Homo sapiens	IC50	nM	17.0
	14653629	CHEMBL3267806	Inhibition of purified recombinant ALK (unknown origin) after 60 mins by ELISA	B	C/C=C1/CN(C)CCc2ccc(Nc3ncc(Cl)c(Nc4ccccc4C(=O)NC)n3)cc21		CHEMBL3263976	=	IC50	nM	13.0	CHEMBL4247	Homo sapiens	IC50	nM	13.0
	14653630	CHEMBL3267806	Inhibition of purified recombinant ALK (unknown origin) after 60 mins by ELISA	B	CNC(=O)c1ccccc1Nc1nc(Nc2cc3c(cc2OC)CCN(C)CCCCC3)ncc1Cl		CHEMBL3263977	=	IC50	nM	17.0	CHEMBL4247	Homo sapiens	IC50	nM	17.0
	14653631	CHEMBL3267806	Inhibition of purified recombinant ALK (unknown origin) after 60 mins by ELISA	B	CNC(=O)c1ccccc1Nc1nc(Nc2cc3c(cc2OC)CCN(C)CCCC3)ncc1Cl		CHEMBL3263978	=	IC50	nM	36.0	CHEMBL4247	Homo sapiens	IC50	nM	36.0
	14653632	CHEMBL3267806	Inhibition of purified recombinant ALK (unknown origin) after 60 mins by ELISA	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)C(C)CNCC3)ncc1Cl		CHEMBL3263979	=	IC50	nM	7.9	CHEMBL4247	Homo sapiens	IC50	nM	7.9
	14653633	CHEMBL3267806	Inhibition of purified recombinant ALK (unknown origin) after 60 mins by ELISA	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)C(C)CN(CC(=O)N(C)C)CC3)ncc1Cl		CHEMBL3263980	=	IC50	nM	38.0	CHEMBL4247	Homo sapiens	IC50	nM	38.0
	14653634	CHEMBL3267806	Inhibition of purified recombinant ALK (unknown origin) after 60 mins by ELISA	B	CCC(=O)N1CCc2ccc(Nc3ncc(Cl)c(Nc4ccccc4C(=O)NC)n3)cc2C(C)C1		CHEMBL3263981	=	IC50	nM	50.0	CHEMBL4247	Homo sapiens	IC50	nM	50.0
	14653635	CHEMBL3267806	Inhibition of purified recombinant ALK (unknown origin) after 60 mins by ELISA	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)C(C)CN(C(C)=O)CC3)ncc1Cl		CHEMBL3263982	=	IC50	nM	53.0	CHEMBL4247	Homo sapiens	IC50	nM	53.0
	14653636	CHEMBL3267806	Inhibition of purified recombinant ALK (unknown origin) after 60 mins by ELISA	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)C(C)CN(C)CC3)nc(F)c1Cl		CHEMBL3263983	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	14653637	CHEMBL3267806	Inhibition of purified recombinant ALK (unknown origin) after 60 mins by ELISA	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)C(C)CN(C)CC3)nc(NC)c1Cl		CHEMBL3263984	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	14653638	CHEMBL3267806	Inhibition of purified recombinant ALK (unknown origin) after 60 mins by ELISA	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)C(C)CN(C)CC3)nc(N2CCOCC2)c1Cl		CHEMBL3263985	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	14653639	CHEMBL3267806	Inhibition of purified recombinant ALK (unknown origin) after 60 mins by ELISA	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)C(C)CN(C)CC3)nc2sccc12		CHEMBL3263986	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	14653640	CHEMBL3267806	Inhibition of purified recombinant ALK (unknown origin) after 60 mins by ELISA	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)C(C)CN(C)CC3)nc2cccnc12		CHEMBL3263987	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	14653641	CHEMBL3267806	Inhibition of purified recombinant ALK (unknown origin) after 60 mins by ELISA	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)C(C)CN(C)CC3)nc2ccccc12		CHEMBL3263988	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	14653642	CHEMBL3267806	Inhibition of purified recombinant ALK (unknown origin) after 60 mins by ELISA	B	CC1CN(C)CCc2ccc(Nc3ncc(Cl)c(Nc4ccccc4C(=O)N4CCOCC4)n3)cc21		CHEMBL3263989	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	14653643	CHEMBL3267806	Inhibition of purified recombinant ALK (unknown origin) after 60 mins by ELISA	B	CC1CN(C)CCc2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc21		CHEMBL3263990	=	IC50	nM	3.5	CHEMBL4247	Homo sapiens	IC50	nM	3.5
	14653644	CHEMBL3267806	Inhibition of purified recombinant ALK (unknown origin) after 60 mins by ELISA	B	CC1CN(C)CCc2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C4CC4)n3)cc21		CHEMBL3263991	=	IC50	nM	7.1	CHEMBL4247	Homo sapiens	IC50	nM	7.1
	14653645	CHEMBL3267806	Inhibition of purified recombinant ALK (unknown origin) after 60 mins by ELISA	B	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)C(C)CN(C)CC3)ncc1Cl		CHEMBL3263992	=	IC50	nM	1.3	CHEMBL4247	Homo sapiens	IC50	nM	1.3
	14653646	CHEMBL3267806	Inhibition of purified recombinant ALK (unknown origin) after 60 mins by ELISA	B	CC1CN(C)CCc2ccc(Nc3ncc(Cl)c(N[C@H]4[C@@H](C(N)=O)[C@@H]5C=C[C@H]4C5)n3)cc21		CHEMBL3263993	=	IC50	nM	49.0	CHEMBL4247	Homo sapiens	IC50	nM	49.0
	14653647	CHEMBL3267806	Inhibition of purified recombinant ALK (unknown origin) after 60 mins by ELISA	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)C(c2ccccc2)CN(C)CC3)ncc1Cl		CHEMBL3263970	=	IC50	nM	39.0	CHEMBL4247	Homo sapiens	IC50	nM	39.0
	14653648	CHEMBL3267806	Inhibition of purified recombinant ALK (unknown origin) after 60 mins by ELISA	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)C(c2ccccc2)CN(C)CC3)ncc1Cl		CHEMBL3263970	=	IC50	nM	14.0	CHEMBL4247	Homo sapiens	IC50	nM	14.0
	14653649	CHEMBL3267806	Inhibition of purified recombinant ALK (unknown origin) after 60 mins by ELISA	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)C(C)CN(C)CC3)ncc1Cl		CHEMBL3263971	=	IC50	nM	24.0	CHEMBL4247	Homo sapiens	IC50	nM	24.0
	14653650	CHEMBL3267806	Inhibition of purified recombinant ALK (unknown origin) after 60 mins by ELISA	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)C(C)CN(C)CC3)ncc1Cl		CHEMBL3263971	=	IC50	nM	15.0	CHEMBL4247	Homo sapiens	IC50	nM	15.0
Active	14653678	CHEMBL3267816	Inhibition of ALK L1196M mutant (unknown origin) at > 1 uM	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)C(c2ccccc2)CN(C)CC3)ncc1Cl		CHEMBL3263970		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	14653679	CHEMBL3267816	Inhibition of ALK L1196M mutant (unknown origin) at > 1 uM	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)C(C)CN(C)CC3)ncc1Cl		CHEMBL3263971		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	14653680	CHEMBL3267817	Inhibition of ALK C1156Y mutant (unknown origin) at > 1 uM	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)C(c2ccccc2)CN(C)CC3)ncc1Cl		CHEMBL3263970		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	14653681	CHEMBL3267817	Inhibition of ALK C1156Y mutant (unknown origin) at > 1 uM	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2)C(C)CN(C)CC3)ncc1Cl		CHEMBL3263971		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	14663202	CHEMBL3268843	Inhibition of ALK (unknown origin) at 1 uM relative to control	B	CCOC(=O)c1sc(-c2ccncc2)nc1O		CHEMBL3261228	=	Inhibition	%	86.0	CHEMBL4247	Homo sapiens	INH	%	86.0
	14663203	CHEMBL3268843	Inhibition of ALK (unknown origin) at 1 uM relative to control	B	NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl		CHEMBL3261514	=	Inhibition	%	100.0	CHEMBL4247	Homo sapiens	INH	%	100.0
	14663204	CHEMBL3268843	Inhibition of ALK (unknown origin) at 1 uM relative to control	B	COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1		CHEMBL3261517	=	Inhibition	%	63.0	CHEMBL4247	Homo sapiens	INH	%	63.0
	14713699	CHEMBL3296764	Binding affinity to ALK (unknown origin)	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)CCN1CCN(C)CC1		CHEMBL3288854	=	Ki	nM	95.0	CHEMBL4247	Homo sapiens	Ki	uM	0.095
	14713742	CHEMBL3296853	Inhibition of ALK (unknown origin) at 1 uM relative to control	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)CCN1CCN(C)CC1		CHEMBL3288854	=	Inhibition	%	87.0	CHEMBL4247	Homo sapiens	INH	%	87.0
Not Determined	14713757	CHEMBL3296764	Binding affinity to ALK (unknown origin)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Ki			CHEMBL4247	Homo sapiens	Ki		
	14722318	CHEMBL3293161	Inhibition of wild type human recombinant ALK kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Ki	nM	0.74	CHEMBL4247	Homo sapiens	Ki	nM	0.74
	14722319	CHEMBL3293161	Inhibition of wild type human recombinant ALK kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	Cc1nc([C@](C)(O)CO)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128069	<	Ki	nM	0.1	CHEMBL4247	Homo sapiens	Ki	nM	0.1
	14722320	CHEMBL3293161	Inhibition of wild type human recombinant ALK kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	COc1ccc(F)cc1[C@@H](C)Oc1cc(-c2cnnn2C)cnc1N		CHEMBL3286808	=	Ki	nM	4.0	CHEMBL4247	Homo sapiens	Ki	nM	4.0
	14722321	CHEMBL3293161	Inhibition of wild type human recombinant ALK kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	C[C@@H](Oc1cc(-c2cnnn2C)cnc1N)c1cc(F)ccc1-n1nccn1		CHEMBL3128060	=	Ki	nM	9.0	CHEMBL4247	Homo sapiens	Ki	nM	9.0
	14722322	CHEMBL3293161	Inhibition of wild type human recombinant ALK kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	Cc1nn(C)cc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128075	<	Ki	nM	0.2	CHEMBL4247	Homo sapiens	Ki	nM	0.2
	14722323	CHEMBL3293161	Inhibition of wild type human recombinant ALK kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	CNC(=O)c1ccc(F)cc1[C@@H](C)Oc1cc(-c2cn(C)nc2C)cnc1N		CHEMBL3286809	=	Ki	nM	2.8	CHEMBL4247	Homo sapiens	Ki	nM	2.8
	14722324	CHEMBL3293161	Inhibition of wild type human recombinant ALK kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	Cc1nn(C)cc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2C(=O)N(C)C)c1		CHEMBL3286810	=	Ki	nM	22.0	CHEMBL4247	Homo sapiens	Ki	nM	22.0
	14722325	CHEMBL3293161	Inhibition of wild type human recombinant ALK kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	COc1ncccc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)n1		CHEMBL3286811	<	Ki	nM	0.2	CHEMBL4247	Homo sapiens	Ki	nM	0.2
	14722326	CHEMBL3293161	Inhibition of wild type human recombinant ALK kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	CNC(=O)c1ccc(F)cc1[C@@H](C)Oc1nc(-c2cccnc2OC)cnc1N		CHEMBL3286812	=	Ki	nM	0.85	CHEMBL4247	Homo sapiens	Ki	nM	0.85
	14722327	CHEMBL3293161	Inhibition of wild type human recombinant ALK kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	C[C@@H](Oc1cc(-c2cccc(S(C)(=O)=O)c2)cnc1N)c1cc(F)ccc1-n1nccn1		CHEMBL3286813	<	Ki	nM	0.2	CHEMBL4247	Homo sapiens	Ki	nM	0.2
	14722328	CHEMBL3293161	Inhibition of wild type human recombinant ALK kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	N#Cc1[nH]nc2c1-c1cnc(N)c(c1)OCc1cc(F)ccc1OCC2		CHEMBL3286814	=	Ki	nM	0.36	CHEMBL4247	Homo sapiens	Ki	nM	0.36
	14722329	CHEMBL3293161	Inhibition of wild type human recombinant ALK kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	N#Cc1[nH]nc2c1-c1cnc(N)c(c1)OCc1cc(F)ccc1OCCC2		CHEMBL3286815	=	Ki	nM	0.22	CHEMBL4247	Homo sapiens	Ki	nM	0.22
	14722330	CHEMBL3293161	Inhibition of wild type human recombinant ALK kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	Cn1ncc2c1-c1cnc(N)c(c1)OCc1cc(F)ccc1OCCC2		CHEMBL3286816	=	Ki	nM	0.38	CHEMBL4247	Homo sapiens	Ki	nM	0.38
	14722331	CHEMBL3293161	Inhibition of wild type human recombinant ALK kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	Cn1ncc2c1-c1cnc(N)c(c1)OCc1cc(F)ccc1OCCCC2		CHEMBL3286817	=	Ki	nM	5.0	CHEMBL4247	Homo sapiens	Ki	nM	5.0
	14722332	CHEMBL3293161	Inhibition of wild type human recombinant ALK kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CCOc2ccc(F)cc21		CHEMBL3286818	<	Ki	nM	0.1	CHEMBL4247	Homo sapiens	Ki	nM	0.1
	14722333	CHEMBL3293161	Inhibition of wild type human recombinant ALK kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CCCOc2ccc(F)cc21		CHEMBL3286819	<	Ki	nM	0.1	CHEMBL4247	Homo sapiens	Ki	nM	0.1
	14722334	CHEMBL3293161	Inhibition of wild type human recombinant ALK kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	Cc1nn(C)c2c1-c1cnc(N)c(c1)O[C@H](C)c1cc(F)ccc1C(=O)N(C)C2		CHEMBL3286820	<	Ki	nM	0.2	CHEMBL4247	Homo sapiens	Ki	nM	0.2
	14722335	CHEMBL3293161	Inhibition of wild type human recombinant ALK kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	Cc1nn(C)c2c1-c1cnc(N)c(c1)O[C@@H](C)c1cc(F)ccc1C(=O)N(C)C2		CHEMBL3286821	=	Ki	nM	17.0	CHEMBL4247	Homo sapiens	Ki	nM	17.0
	14722336	CHEMBL3293161	Inhibition of wild type human recombinant ALK kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	Cc1nn(C)c2c1-c1cnc(N)c(c1)OCc1cc(F)ccc1C(=O)N(C)C2		CHEMBL3286822	<	Ki	nM	0.2	CHEMBL4247	Homo sapiens	Ki	nM	0.2
	14722337	CHEMBL3293161	Inhibition of wild type human recombinant ALK kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	Cc1nn(C)c2c1-c1cnc(N)c(n1)O[C@H](C)c1cc(F)ccc1C(=O)N(C)C2		CHEMBL3286823	<	Ki	nM	0.2	CHEMBL4247	Homo sapiens	Ki	nM	0.2
	14722338	CHEMBL3293161	Inhibition of wild type human recombinant ALK kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	Cc1nn(C)c2c1-c1cnc(N)c(n1)O[C@@H](C)c1cc(F)ccc1C(=O)N(C)C2		CHEMBL3286824	=	Ki	nM	17.0	CHEMBL4247	Homo sapiens	Ki	nM	17.0
	14722339	CHEMBL3293161	Inhibition of wild type human recombinant ALK kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	COc1nn(C)c2c1-c1cnc(N)c(c1)O[C@H](C)c1cc(F)ccc1C(=O)N(C)C2		CHEMBL3286825	<	Ki	nM	0.2	CHEMBL4247	Homo sapiens	Ki	nM	0.2
	14722340	CHEMBL3293161	Inhibition of wild type human recombinant ALK kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	COc1nn(C)c2c1-c1cnc(N)c(n1)O[C@H](C)c1cc(F)ccc1C(=O)N(C)C2		CHEMBL3286826	<	Ki	nM	0.08	CHEMBL4247	Homo sapiens	Ki	nM	0.08
	14722341	CHEMBL3293161	Inhibition of wild type human recombinant ALK kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	C[C@H]1Oc2cc(cnc2N)-c2cc(S(C)(=O)=O)ccc2CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286827	<	Ki	nM	0.07	CHEMBL4247	Homo sapiens	Ki	nM	0.07
	14722342	CHEMBL3293161	Inhibition of wild type human recombinant ALK kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	C[C@H]1Oc2nc(cnc2N)-c2cc(S(C)(=O)=O)ccc2CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286828	<	Ki	nM	0.1	CHEMBL4247	Homo sapiens	Ki	nM	0.1
	14722343	CHEMBL3293162	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Ki	nM	8.2	CHEMBL4247	Homo sapiens	Ki	nM	8.2
	14722344	CHEMBL3293162	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	Cc1nc([C@](C)(O)CO)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128069	=	Ki	nM	0.2	CHEMBL4247	Homo sapiens	Ki	nM	0.2
	14722345	CHEMBL3293162	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	COc1ccc(F)cc1[C@@H](C)Oc1cc(-c2cnnn2C)cnc1N		CHEMBL3286808	=	Ki	nM	38.0	CHEMBL4247	Homo sapiens	Ki	nM	38.0
	14722346	CHEMBL3293162	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	C[C@@H](Oc1cc(-c2cnnn2C)cnc1N)c1cc(F)ccc1-n1nccn1		CHEMBL3128060	=	Ki	nM	70.0	CHEMBL4247	Homo sapiens	Ki	nM	70.0
	14722347	CHEMBL3293162	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	Cc1nn(C)cc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128075	=	Ki	nM	2.6	CHEMBL4247	Homo sapiens	Ki	nM	2.6
	14722348	CHEMBL3293162	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	CNC(=O)c1ccc(F)cc1[C@@H](C)Oc1cc(-c2cn(C)nc2C)cnc1N		CHEMBL3286809	=	Ki	nM	35.0	CHEMBL4247	Homo sapiens	Ki	nM	35.0
	14722349	CHEMBL3293162	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	Cc1nn(C)cc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2C(=O)N(C)C)c1		CHEMBL3286810	=	Ki	nM	310.0	CHEMBL4247	Homo sapiens	Ki	nM	310.0
	14722350	CHEMBL3293162	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	COc1ncccc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)n1		CHEMBL3286811	=	Ki	nM	0.7	CHEMBL4247	Homo sapiens	Ki	nM	0.7
	14722351	CHEMBL3293162	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	CNC(=O)c1ccc(F)cc1[C@@H](C)Oc1nc(-c2cccnc2OC)cnc1N		CHEMBL3286812	=	Ki	nM	8.2	CHEMBL4247	Homo sapiens	Ki	nM	8.2
	14722352	CHEMBL3293162	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	C[C@@H](Oc1cc(-c2cccc(S(C)(=O)=O)c2)cnc1N)c1cc(F)ccc1-n1nccn1		CHEMBL3286813	=	Ki	nM	1.4	CHEMBL4247	Homo sapiens	Ki	nM	1.4
	14722353	CHEMBL3293162	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	N#Cc1[nH]nc2c1-c1cnc(N)c(c1)OCc1cc(F)ccc1OCC2		CHEMBL3286814	=	Ki	nM	1.6	CHEMBL4247	Homo sapiens	Ki	nM	1.6
	14722354	CHEMBL3293162	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	N#Cc1[nH]nc2c1-c1cnc(N)c(c1)OCc1cc(F)ccc1OCCC2		CHEMBL3286815	<	Ki	nM	0.1	CHEMBL4247	Homo sapiens	Ki	nM	0.1
	14722355	CHEMBL3293162	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	Cn1ncc2c1-c1cnc(N)c(c1)OCc1cc(F)ccc1OCCC2		CHEMBL3286816	=	Ki	nM	29.0	CHEMBL4247	Homo sapiens	Ki	nM	29.0
	14722356	CHEMBL3293162	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	Cn1ncc2c1-c1cnc(N)c(c1)OCc1cc(F)ccc1OCCCC2		CHEMBL3286817	=	Ki	nM	36.0	CHEMBL4247	Homo sapiens	Ki	nM	36.0
	14722357	CHEMBL3293162	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CCOc2ccc(F)cc21		CHEMBL3286818	=	Ki	nM	0.57	CHEMBL4247	Homo sapiens	Ki	nM	0.57
	14722358	CHEMBL3293162	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CCCOc2ccc(F)cc21		CHEMBL3286819	=	Ki	nM	0.62	CHEMBL4247	Homo sapiens	Ki	nM	0.62
	14722359	CHEMBL3293162	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	Cc1nn(C)c2c1-c1cnc(N)c(c1)O[C@H](C)c1cc(F)ccc1C(=O)N(C)C2		CHEMBL3286820	=	Ki	nM	0.29	CHEMBL4247	Homo sapiens	Ki	nM	0.29
	14722360	CHEMBL3293162	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	Cc1nn(C)c2c1-c1cnc(N)c(c1)O[C@@H](C)c1cc(F)ccc1C(=O)N(C)C2		CHEMBL3286821	=	Ki	nM	61.0	CHEMBL4247	Homo sapiens	Ki	nM	61.0
	14722361	CHEMBL3293162	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	Cc1nn(C)c2c1-c1cnc(N)c(c1)OCc1cc(F)ccc1C(=O)N(C)C2		CHEMBL3286822	=	Ki	nM	1.9	CHEMBL4247	Homo sapiens	Ki	nM	1.9
	14722362	CHEMBL3293162	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	Cc1nn(C)c2c1-c1cnc(N)c(n1)O[C@H](C)c1cc(F)ccc1C(=O)N(C)C2		CHEMBL3286823	=	Ki	nM	0.1	CHEMBL4247	Homo sapiens	Ki	nM	0.1
	14722363	CHEMBL3293162	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	Cc1nn(C)c2c1-c1cnc(N)c(n1)O[C@@H](C)c1cc(F)ccc1C(=O)N(C)C2		CHEMBL3286824	=	Ki	nM	61.0	CHEMBL4247	Homo sapiens	Ki	nM	61.0
	14722364	CHEMBL3293162	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	COc1nn(C)c2c1-c1cnc(N)c(c1)O[C@H](C)c1cc(F)ccc1C(=O)N(C)C2		CHEMBL3286825	=	Ki	nM	0.1	CHEMBL4247	Homo sapiens	Ki	nM	0.1
	14722365	CHEMBL3293162	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	COc1nn(C)c2c1-c1cnc(N)c(n1)O[C@H](C)c1cc(F)ccc1C(=O)N(C)C2		CHEMBL3286826	<	Ki	nM	0.02	CHEMBL4247	Homo sapiens	Ki	nM	0.02
	14722366	CHEMBL3293162	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	C[C@H]1Oc2cc(cnc2N)-c2cc(S(C)(=O)=O)ccc2CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286827	=	Ki	nM	0.4	CHEMBL4247	Homo sapiens	Ki	nM	0.4
	14722367	CHEMBL3293162	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	C[C@H]1Oc2nc(cnc2N)-c2cc(S(C)(=O)=O)ccc2CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286828	=	Ki	nM	0.12	CHEMBL4247	Homo sapiens	Ki	nM	0.12
	14722368	CHEMBL3293162	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	C[C@H]1Oc2cc(cnc2N)-c2c(C3CC3)nn(C)c2CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286829	<	Ki	nM	0.1	CHEMBL4247	Homo sapiens	Ki	nM	0.1
	14722369	CHEMBL3293162	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286830	=	Ki	nM	0.7	CHEMBL4247	Homo sapiens	Ki	nM	0.7
	14722370	CHEMBL3293162	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	Cc1cnc2nc3c(n2c1)-c1cnc(N)c(c1)O[C@H](C)c1cc(F)ccc1C(=O)N(C)C3		CHEMBL3286831	=	Ki	nM	2.0	CHEMBL4247	Homo sapiens	Ki	nM	2.0
	14722371	CHEMBL3293162	Inhibition of human recombinant ALK L1196M mutant kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	C[C@H]1Oc2nc(cnc2N)-c2c(nc3ccc(C#N)cn23)CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286832	=	Ki	nM	0.56	CHEMBL4247	Homo sapiens	Ki	nM	0.56
	14722372	CHEMBL3293163	Inhibition of wild type human EML4-fused ALK expressed in mouse NIH-3T3 cells assessed as phosphorylated ALK level after 1 hr by sandwich ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	80.0	CHEMBL4247	Homo sapiens	IC50	nM	80.0
	14722373	CHEMBL3293163	Inhibition of wild type human EML4-fused ALK expressed in mouse NIH-3T3 cells assessed as phosphorylated ALK level after 1 hr by sandwich ELISA	B	Cc1nc([C@](C)(O)CO)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128069	=	IC50	nM	0.76	CHEMBL4247	Homo sapiens	IC50	nM	0.76
	14722374	CHEMBL3293163	Inhibition of wild type human EML4-fused ALK expressed in mouse NIH-3T3 cells assessed as phosphorylated ALK level after 1 hr by sandwich ELISA	B	COc1ccc(F)cc1[C@@H](C)Oc1cc(-c2cnnn2C)cnc1N		CHEMBL3286808	=	IC50	nM	95.0	CHEMBL4247	Homo sapiens	IC50	nM	95.0
	14722375	CHEMBL3293163	Inhibition of wild type human EML4-fused ALK expressed in mouse NIH-3T3 cells assessed as phosphorylated ALK level after 1 hr by sandwich ELISA	B	C[C@@H](Oc1cc(-c2cnnn2C)cnc1N)c1cc(F)ccc1-n1nccn1		CHEMBL3128060	=	IC50	nM	249.0	CHEMBL4247	Homo sapiens	IC50	nM	249.0
	14722376	CHEMBL3293163	Inhibition of wild type human EML4-fused ALK expressed in mouse NIH-3T3 cells assessed as phosphorylated ALK level after 1 hr by sandwich ELISA	B	Cc1nn(C)cc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128075	=	IC50	nM	14.0	CHEMBL4247	Homo sapiens	IC50	nM	14.0
	14722377	CHEMBL3293163	Inhibition of wild type human EML4-fused ALK expressed in mouse NIH-3T3 cells assessed as phosphorylated ALK level after 1 hr by sandwich ELISA	B	CNC(=O)c1ccc(F)cc1[C@@H](C)Oc1cc(-c2cn(C)nc2C)cnc1N		CHEMBL3286809	=	IC50	nM	116.0	CHEMBL4247	Homo sapiens	IC50	nM	116.0
	14722378	CHEMBL3293163	Inhibition of wild type human EML4-fused ALK expressed in mouse NIH-3T3 cells assessed as phosphorylated ALK level after 1 hr by sandwich ELISA	B	COc1ncccc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)n1		CHEMBL3286811	=	IC50	nM	9.7	CHEMBL4247	Homo sapiens	IC50	nM	9.7
	14722379	CHEMBL3293163	Inhibition of wild type human EML4-fused ALK expressed in mouse NIH-3T3 cells assessed as phosphorylated ALK level after 1 hr by sandwich ELISA	B	CNC(=O)c1ccc(F)cc1[C@@H](C)Oc1nc(-c2cccnc2OC)cnc1N		CHEMBL3286812	=	IC50	nM	16.0	CHEMBL4247	Homo sapiens	IC50	nM	16.0
	14722380	CHEMBL3293163	Inhibition of wild type human EML4-fused ALK expressed in mouse NIH-3T3 cells assessed as phosphorylated ALK level after 1 hr by sandwich ELISA	B	C[C@@H](Oc1cc(-c2cccc(S(C)(=O)=O)c2)cnc1N)c1cc(F)ccc1-n1nccn1		CHEMBL3286813	=	IC50	nM	4.6	CHEMBL4247	Homo sapiens	IC50	nM	4.6
	14722381	CHEMBL3293163	Inhibition of wild type human EML4-fused ALK expressed in mouse NIH-3T3 cells assessed as phosphorylated ALK level after 1 hr by sandwich ELISA	B	N#Cc1[nH]nc2c1-c1cnc(N)c(c1)OCc1cc(F)ccc1OCC2		CHEMBL3286814	=	IC50	nM	22.0	CHEMBL4247	Homo sapiens	IC50	nM	22.0
	14722382	CHEMBL3293163	Inhibition of wild type human EML4-fused ALK expressed in mouse NIH-3T3 cells assessed as phosphorylated ALK level after 1 hr by sandwich ELISA	B	N#Cc1[nH]nc2c1-c1cnc(N)c(c1)OCc1cc(F)ccc1OCCC2		CHEMBL3286815	=	IC50	nM	15.0	CHEMBL4247	Homo sapiens	IC50	nM	15.0
	14722383	CHEMBL3293163	Inhibition of wild type human EML4-fused ALK expressed in mouse NIH-3T3 cells assessed as phosphorylated ALK level after 1 hr by sandwich ELISA	B	Cn1ncc2c1-c1cnc(N)c(c1)OCc1cc(F)ccc1OCCC2		CHEMBL3286816	=	IC50	nM	86.0	CHEMBL4247	Homo sapiens	IC50	nM	86.0
	14722384	CHEMBL3293163	Inhibition of wild type human EML4-fused ALK expressed in mouse NIH-3T3 cells assessed as phosphorylated ALK level after 1 hr by sandwich ELISA	B	Cn1ncc2c1-c1cnc(N)c(c1)OCc1cc(F)ccc1OCCCC2		CHEMBL3286817	=	IC50	nM	524.0	CHEMBL4247	Homo sapiens	IC50	nM	524.0
	14722385	CHEMBL3293163	Inhibition of wild type human EML4-fused ALK expressed in mouse NIH-3T3 cells assessed as phosphorylated ALK level after 1 hr by sandwich ELISA	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CCOc2ccc(F)cc21		CHEMBL3286818	=	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	nM	1.0
	14722386	CHEMBL3293163	Inhibition of wild type human EML4-fused ALK expressed in mouse NIH-3T3 cells assessed as phosphorylated ALK level after 1 hr by sandwich ELISA	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CCCOc2ccc(F)cc21		CHEMBL3286819	=	IC50	nM	0.9	CHEMBL4247	Homo sapiens	IC50	nM	0.9
	14722387	CHEMBL3293163	Inhibition of wild type human EML4-fused ALK expressed in mouse NIH-3T3 cells assessed as phosphorylated ALK level after 1 hr by sandwich ELISA	B	Cc1nn(C)c2c1-c1cnc(N)c(c1)O[C@H](C)c1cc(F)ccc1C(=O)N(C)C2		CHEMBL3286820	=	IC50	nM	0.7	CHEMBL4247	Homo sapiens	IC50	nM	0.7
	14722388	CHEMBL3293163	Inhibition of wild type human EML4-fused ALK expressed in mouse NIH-3T3 cells assessed as phosphorylated ALK level after 1 hr by sandwich ELISA	B	Cc1nn(C)c2c1-c1cnc(N)c(c1)OCc1cc(F)ccc1C(=O)N(C)C2		CHEMBL3286822	=	IC50	nM	6.4	CHEMBL4247	Homo sapiens	IC50	nM	6.4
	14722389	CHEMBL3293163	Inhibition of wild type human EML4-fused ALK expressed in mouse NIH-3T3 cells assessed as phosphorylated ALK level after 1 hr by sandwich ELISA	B	Cc1nn(C)c2c1-c1cnc(N)c(n1)O[C@H](C)c1cc(F)ccc1C(=O)N(C)C2		CHEMBL3286823	=	IC50	nM	0.21	CHEMBL4247	Homo sapiens	IC50	nM	0.21
	14722390	CHEMBL3293163	Inhibition of wild type human EML4-fused ALK expressed in mouse NIH-3T3 cells assessed as phosphorylated ALK level after 1 hr by sandwich ELISA	B	Cc1nn(C)c2c1-c1cnc(N)c(n1)O[C@@H](C)c1cc(F)ccc1C(=O)N(C)C2		CHEMBL3286824	=	IC50	nM	156.0	CHEMBL4247	Homo sapiens	IC50	nM	156.0
	14722391	CHEMBL3293163	Inhibition of wild type human EML4-fused ALK expressed in mouse NIH-3T3 cells assessed as phosphorylated ALK level after 1 hr by sandwich ELISA	B	COc1nn(C)c2c1-c1cnc(N)c(c1)O[C@H](C)c1cc(F)ccc1C(=O)N(C)C2		CHEMBL3286825	=	IC50	nM	0.18	CHEMBL4247	Homo sapiens	IC50	nM	0.18
	14722392	CHEMBL3293163	Inhibition of wild type human EML4-fused ALK expressed in mouse NIH-3T3 cells assessed as phosphorylated ALK level after 1 hr by sandwich ELISA	B	COc1nn(C)c2c1-c1cnc(N)c(n1)O[C@H](C)c1cc(F)ccc1C(=O)N(C)C2		CHEMBL3286826	=	IC50	nM	0.11	CHEMBL4247	Homo sapiens	IC50	nM	0.11
	14722393	CHEMBL3293163	Inhibition of wild type human EML4-fused ALK expressed in mouse NIH-3T3 cells assessed as phosphorylated ALK level after 1 hr by sandwich ELISA	B	C[C@H]1Oc2cc(cnc2N)-c2cc(S(C)(=O)=O)ccc2CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286827	=	IC50	nM	1.3	CHEMBL4247	Homo sapiens	IC50	nM	1.3
	14722394	CHEMBL3293163	Inhibition of wild type human EML4-fused ALK expressed in mouse NIH-3T3 cells assessed as phosphorylated ALK level after 1 hr by sandwich ELISA	B	C[C@H]1Oc2nc(cnc2N)-c2cc(S(C)(=O)=O)ccc2CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286828	=	IC50	nM	0.34	CHEMBL4247	Homo sapiens	IC50	nM	0.34
	14722395	CHEMBL3293164	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	843.0	CHEMBL4247	Homo sapiens	IC50	nM	843.0
	14722396	CHEMBL3293164	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	Cc1nc([C@](C)(O)CO)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128069	=	IC50	nM	6.6	CHEMBL4247	Homo sapiens	IC50	nM	6.6
	14722397	CHEMBL3293164	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	COc1ccc(F)cc1[C@@H](C)Oc1cc(-c2cnnn2C)cnc1N		CHEMBL3286808	=	IC50	nM	3200.0	CHEMBL4247	Homo sapiens	IC50	nM	3200.0
	14722398	CHEMBL3293164	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@@H](Oc1cc(-c2cnnn2C)cnc1N)c1cc(F)ccc1-n1nccn1		CHEMBL3128060	=	IC50	nM	2650.0	CHEMBL4247	Homo sapiens	IC50	nM	2650.0
	14722399	CHEMBL3293164	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	Cc1nn(C)cc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128075	=	IC50	nM	176.0	CHEMBL4247	Homo sapiens	IC50	nM	176.0
	14722400	CHEMBL3293164	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	CNC(=O)c1ccc(F)cc1[C@@H](C)Oc1cc(-c2cn(C)nc2C)cnc1N		CHEMBL3286809	=	IC50	nM	1665.0	CHEMBL4247	Homo sapiens	IC50	nM	1665.0
	14722401	CHEMBL3293164	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	COc1ncccc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)n1		CHEMBL3286811	=	IC50	nM	53.0	CHEMBL4247	Homo sapiens	IC50	nM	53.0
	14722402	CHEMBL3293164	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	CNC(=O)c1ccc(F)cc1[C@@H](C)Oc1nc(-c2cccnc2OC)cnc1N		CHEMBL3286812	=	IC50	nM	312.0	CHEMBL4247	Homo sapiens	IC50	nM	312.0
	14722403	CHEMBL3293164	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@@H](Oc1cc(-c2cccc(S(C)(=O)=O)c2)cnc1N)c1cc(F)ccc1-n1nccn1		CHEMBL3286813	=	IC50	nM	54.0	CHEMBL4247	Homo sapiens	IC50	nM	54.0
	14722404	CHEMBL3293164	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	N#Cc1[nH]nc2c1-c1cnc(N)c(c1)OCc1cc(F)ccc1OCC2		CHEMBL3286814	=	IC50	nM	101.0	CHEMBL4247	Homo sapiens	IC50	nM	101.0
	14722405	CHEMBL3293164	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	N#Cc1[nH]nc2c1-c1cnc(N)c(c1)OCc1cc(F)ccc1OCCC2		CHEMBL3286815	=	IC50	nM	112.0	CHEMBL4247	Homo sapiens	IC50	nM	112.0
	14722406	CHEMBL3293164	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	Cn1ncc2c1-c1cnc(N)c(c1)OCc1cc(F)ccc1OCCC2		CHEMBL3286816	=	IC50	nM	654.0	CHEMBL4247	Homo sapiens	IC50	nM	654.0
	14722407	CHEMBL3293164	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	Cn1ncc2c1-c1cnc(N)c(c1)OCc1cc(F)ccc1OCCCC2		CHEMBL3286817	=	IC50	nM	3655.0	CHEMBL4247	Homo sapiens	IC50	nM	3655.0
	14722408	CHEMBL3293164	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CCOc2ccc(F)cc21		CHEMBL3286818	=	IC50	nM	20.0	CHEMBL4247	Homo sapiens	IC50	nM	20.0
	14722409	CHEMBL3293164	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CCCOc2ccc(F)cc21		CHEMBL3286819	=	IC50	nM	21.0	CHEMBL4247	Homo sapiens	IC50	nM	21.0
	14722410	CHEMBL3293164	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	Cc1nn(C)c2c1-c1cnc(N)c(c1)O[C@H](C)c1cc(F)ccc1C(=O)N(C)C2		CHEMBL3286820	=	IC50	nM	14.0	CHEMBL4247	Homo sapiens	IC50	nM	14.0
	14722411	CHEMBL3293164	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	Cc1nn(C)c2c1-c1cnc(N)c(c1)OCc1cc(F)ccc1C(=O)N(C)C2		CHEMBL3286822	=	IC50	nM	97.0	CHEMBL4247	Homo sapiens	IC50	nM	97.0
	14722412	CHEMBL3293164	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	Cc1nn(C)c2c1-c1cnc(N)c(n1)O[C@H](C)c1cc(F)ccc1C(=O)N(C)C2		CHEMBL3286823	=	IC50	nM	1.4	CHEMBL4247	Homo sapiens	IC50	nM	1.4
	14722413	CHEMBL3293164	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	Cc1nn(C)c2c1-c1cnc(N)c(n1)O[C@@H](C)c1cc(F)ccc1C(=O)N(C)C2		CHEMBL3286824	=	IC50	nM	1230.0	CHEMBL4247	Homo sapiens	IC50	nM	1230.0
	14722414	CHEMBL3293164	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	COc1nn(C)c2c1-c1cnc(N)c(c1)O[C@H](C)c1cc(F)ccc1C(=O)N(C)C2		CHEMBL3286825	=	IC50	nM	2.1	CHEMBL4247	Homo sapiens	IC50	nM	2.1
	14722415	CHEMBL3293164	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	COc1nn(C)c2c1-c1cnc(N)c(n1)O[C@H](C)c1cc(F)ccc1C(=O)N(C)C2		CHEMBL3286826	=	IC50	nM	0.75	CHEMBL4247	Homo sapiens	IC50	nM	0.75
	14722416	CHEMBL3293164	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@H]1Oc2cc(cnc2N)-c2cc(S(C)(=O)=O)ccc2CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286827	=	IC50	nM	21.0	CHEMBL4247	Homo sapiens	IC50	nM	21.0
	14722417	CHEMBL3293164	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@H]1Oc2nc(cnc2N)-c2cc(S(C)(=O)=O)ccc2CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286828	=	IC50	nM	1.9	CHEMBL4247	Homo sapiens	IC50	nM	1.9
	14722418	CHEMBL3293164	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@H]1Oc2cc(cnc2N)-c2c(C3CC3)nn(C)c2CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286829	=	IC50	nM	5.8	CHEMBL4247	Homo sapiens	IC50	nM	5.8
	14722419	CHEMBL3293164	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286830	=	IC50	nM	21.0	CHEMBL4247	Homo sapiens	IC50	nM	21.0
	14722420	CHEMBL3293164	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	Cc1cnc2nc3c(n2c1)-c1cnc(N)c(c1)O[C@H](C)c1cc(F)ccc1C(=O)N(C)C3		CHEMBL3286831	=	IC50	nM	365.0	CHEMBL4247	Homo sapiens	IC50	nM	365.0
	14722421	CHEMBL3293164	Inhibition of human EML4-fused ALK L1196M mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@H]1Oc2nc(cnc2N)-c2c(nc3ccc(C#N)cn23)CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286832	=	IC50	nM	45.0	CHEMBL4247	Homo sapiens	IC50	nM	45.0
	14722504	CHEMBL3293395	Inhibition of human EML4-fused ALK F1174L mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	165.0	CHEMBL4247	Homo sapiens	IC50	nM	165.0
	14722505	CHEMBL3293395	Inhibition of human EML4-fused ALK F1174L mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286830	=	IC50	nM	0.2	CHEMBL4247	Homo sapiens	IC50	nM	0.2
	14722506	CHEMBL3293396	Inhibition of human EML4-fused ALK C1156Y mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	478.0	CHEMBL4247	Homo sapiens	IC50	nM	478.0
	14722507	CHEMBL3293396	Inhibition of human EML4-fused ALK C1156Y mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286830	=	IC50	nM	1.6	CHEMBL4247	Homo sapiens	IC50	nM	1.6
	14722508	CHEMBL3293397	Inhibition of human EML4-fused ALK G1269A mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	605.0	CHEMBL4247	Homo sapiens	IC50	nM	605.0
	14722509	CHEMBL3293397	Inhibition of human EML4-fused ALK G1269A mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286830	=	IC50	nM	15.0	CHEMBL4247	Homo sapiens	IC50	nM	15.0
	14722510	CHEMBL3293398	Inhibition of human EML4-fused ALK S1206Y mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	626.0	CHEMBL4247	Homo sapiens	IC50	nM	626.0
	14722511	CHEMBL3293398	Inhibition of human EML4-fused ALK S1206Y mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286830	=	IC50	nM	4.2	CHEMBL4247	Homo sapiens	IC50	nM	4.2
	14722512	CHEMBL3293399	Inhibition of human EML4-fused ALK L1152R mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	1026.0	CHEMBL4247	Homo sapiens	IC50	nM	1026.0
	14722513	CHEMBL3293399	Inhibition of human EML4-fused ALK L1152R mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286830	=	IC50	nM	9.0	CHEMBL4247	Homo sapiens	IC50	nM	9.0
	14722514	CHEMBL3293400	Inhibition of human EML4-fused ALK G1202R mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	1148.0	CHEMBL4247	Homo sapiens	IC50	nM	1148.0
	14722515	CHEMBL3293400	Inhibition of human EML4-fused ALK G1202R mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286830	=	IC50	nM	77.0	CHEMBL4247	Homo sapiens	IC50	nM	77.0
	14722516	CHEMBL3293401	Inhibition of human EML4-fused ALK 1151Tins mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	3039.0	CHEMBL4247	Homo sapiens	IC50	nM	3039.0
	14722517	CHEMBL3293401	Inhibition of human EML4-fused ALK 1151Tins mutant expressed in mouse NIH-3T3 cells assessed as phospho-ALK level after 1 hr by sandwich ELISA	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286830	=	IC50	nM	38.0	CHEMBL4247	Homo sapiens	IC50	nM	38.0
	14722559	CHEMBL3293161	Inhibition of wild type human recombinant ALK kinase domain (amino acids 1093 to 1141) expressed in baculovirus system using 5'FAM-KKSRGDYMTMQIG-CONH2 as substrate incubated for 15 mins prior to ATP addition measured after 1 hr by microfluidic mobility shift assay	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286830	<	Ki	nM	0.07	CHEMBL4247	Homo sapiens	Ki	nM	0.07
	14722560	CHEMBL3293163	Inhibition of wild type human EML4-fused ALK expressed in mouse NIH-3T3 cells assessed as phosphorylated ALK level after 1 hr by sandwich ELISA	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286830	=	IC50	nM	1.3	CHEMBL4247	Homo sapiens	IC50	nM	1.3
	14751165	CHEMBL3301292	Inhibition of ALK (unknown origin)	B	CC(C)(C)CNC(=O)CC1CNC(=O)c2cc(-c3ccsc3)cn21		CHEMBL3298400	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	14751166	CHEMBL3301292	Inhibition of ALK (unknown origin)	B	CN1CCN(C[C@@H](NC(=O)C[C@H]2CNC(=O)c3cc(-c4cccc(Cl)c4)cn32)C2CCCCC2)CC1		CHEMBL3297762	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	14992051	CHEMBL3374153	Inhibition of ALK (unknown origin) at 1 uM by ELISA method	B	O=C(Nc1ccc(F)cc1)C1(C(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c(F)c2)CC1		CHEMBL3360678	=	Inhibition	%	2.5	CHEMBL4247	Homo sapiens	INH	%	2.5
	15000973	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CNC(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CN)c2)ncc1Cl		CHEMBL3356906	=	IC50	nM	32.8	CHEMBL4247	Homo sapiens	IC50	nM	32.8
	15000974	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2cccc(NC(=O)CNC(=O)OC(C)(C)C)c2)ncc1Cl		CHEMBL3356907	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	15000975	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CNC(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CNC(=O)N3CCCC3)c2)ncc1Cl		CHEMBL3356908	=	IC50	nM	280.0	CHEMBL4247	Homo sapiens	IC50	nM	280.0
	15000976	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CNC(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CNC(=O)C3CCCN3)c2)ncc1Cl		CHEMBL3357437	=	IC50	nM	80.3	CHEMBL4247	Homo sapiens	IC50	nM	80.3
	15000977	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2cccc(NC(=O)CNC(=O)NC(C)(C)C)c2)ncc1Cl		CHEMBL3357438	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	15000978	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CN)c2)ncc1Cl		CHEMBL3357439	=	IC50	nM	2.7	CHEMBL4247	Homo sapiens	IC50	nM	2.7
	15000979	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CNC(=O)[C@H]1[C@@H]2C=C[C@@H](C2)[C@H]1Nc1nc(Nc2cccc(NC(=O)CN)c2)ncc1Cl		CHEMBL3357440	=	IC50	nM	111.0	CHEMBL4247	Homo sapiens	IC50	nM	111.0
	15000980	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CS(=O)(=O)Nc1ccccc1Nc1nc(Nc2cccc(NC(=O)CN)c2)ncc1Cl		CHEMBL3357441	=	IC50	nM	94.5	CHEMBL4247	Homo sapiens	IC50	nM	94.5
	15000981	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CN(c1ccccc1Nc1nc(Nc2cccc(NC(=O)CN)c2)ncc1Cl)S(C)(=O)=O		CHEMBL3357442	=	IC50	nM	7.7	CHEMBL4247	Homo sapiens	IC50	nM	7.7
	15000982	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CS(=O)(=O)N1CCN(c2nc(Nc3cccc(NC(=O)CN)c3)ncc2Cl)c2ccccc21		CHEMBL3357443	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	15000983	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)[C@H](C)N)c2)ncc1Cl		CHEMBL3357444	=	IC50	nM	1.8	CHEMBL4247	Homo sapiens	IC50	nM	1.8
	15000984	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CC(C)[C@H](N)C(=O)Nc1cccc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c1		CHEMBL3357445	=	IC50	nM	14.9	CHEMBL4247	Homo sapiens	IC50	nM	14.9
	15000985	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)C3(N)CC3)c2)ncc1Cl		CHEMBL3357446	=	IC50	nM	50.8	CHEMBL4247	Homo sapiens	IC50	nM	50.8
	15000986	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)C(C)(C)N)c2)ncc1Cl		CHEMBL3357447	=	IC50	nM	5.5	CHEMBL4247	Homo sapiens	IC50	nM	5.5
	15000987	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)[C@@H](N)Cc3c[nH]cn3)c2)ncc1Cl		CHEMBL3357448	=	IC50	nM	28.0	CHEMBL4247	Homo sapiens	IC50	nM	28.0
	15000988	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CCN)c2)ncc1Cl		CHEMBL3357449	=	IC50	nM	3.1	CHEMBL4247	Homo sapiens	IC50	nM	3.1
	15000989	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CCCN)c2)ncc1Cl		CHEMBL3357450	=	IC50	nM	19.1	CHEMBL4247	Homo sapiens	IC50	nM	19.1
	15000990	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)C3CCN3)c2)ncc1Cl		CHEMBL3357451	=	IC50	nM	44.2	CHEMBL4247	Homo sapiens	IC50	nM	44.2
	15000991	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)C3CNC3)c2)ncc1Cl		CHEMBL3352867	=	IC50	nM	20.7	CHEMBL4247	Homo sapiens	IC50	nM	20.7
	15000992	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)C3CN(C(=O)CCCN(C)C)C3)c2)ncc1Cl		CHEMBL3357452	=	IC50	nM	0.8	CHEMBL4247	Homo sapiens	IC50	nM	0.8
	15000993	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CN3CCOCC3)c2)ncc1Cl		CHEMBL3357453	=	IC50	nM	17.8	CHEMBL4247	Homo sapiens	IC50	nM	17.8
	15000994	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CN3C[C@H](C)O[C@H](C)C3)c2)ncc1Cl		CHEMBL3357454	=	IC50	nM	25.5	CHEMBL4247	Homo sapiens	IC50	nM	25.5
	15000995	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CN3CCNCC3)c2)ncc1Cl		CHEMBL3357455	=	IC50	nM	2.5	CHEMBL4247	Homo sapiens	IC50	nM	2.5
	15000996	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CN3CCN(C)CC3)c2)ncc1Cl		CHEMBL3357456	=	IC50	nM	1.7	CHEMBL4247	Homo sapiens	IC50	nM	1.7
	15000997	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CN3CCN(C4COC4)CC3)c2)ncc1Cl		CHEMBL3357457	=	IC50	nM	4.9	CHEMBL4247	Homo sapiens	IC50	nM	4.9
	15000998	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CN3CCN(C(=O)/C=C/CN(C)C)CC3)c2)ncc1Cl		CHEMBL3357458	=	IC50	nM	0.7	CHEMBL4247	Homo sapiens	IC50	nM	0.7
	15000999	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CN3CCN(C(=O)CO)CC3)c2)ncc1Cl		CHEMBL3357459	=	IC50	nM	9.0	CHEMBL4247	Homo sapiens	IC50	nM	9.0
	15001000	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CN3CC4CC3CN4)c2)ncc1Cl		CHEMBL3357460	=	IC50	nM	2.3	CHEMBL4247	Homo sapiens	IC50	nM	2.3
	15001001	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CN3CC4CCC(C3)O4)c2)ncc1Cl		CHEMBL3357461	=	IC50	nM	51.3	CHEMBL4247	Homo sapiens	IC50	nM	51.3
	15002488	CHEMBL3366564	Inhibition of ALK (unknown origin) assessed as residual activity at 20 uM relative to control	B	Cc1cc(O)cc(-c2nn(C)cc2-c2cc(N3CCOCC3)nc(-c3cccnc3)n2)c1		CHEMBL3310332	=	Activity	%	31.0	CHEMBL4247	Homo sapiens	Activity	%	31.0
	15005056	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CN3CC4CC3CC4O)c2)ncc1Cl		CHEMBL3357462	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
	15005057	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CN3CCC4CNCC43)c2)ncc1Cl		CHEMBL3357463	=	IC50	nM	2.3	CHEMBL4247	Homo sapiens	IC50	nM	2.3
	15005058	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CN3CC4CNCC4C3)c2)ncc1Cl		CHEMBL3357464	=	IC50	nM	5.5	CHEMBL4247	Homo sapiens	IC50	nM	5.5
	15005059	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)Cc3ccco3)c2)ncc1Cl		CHEMBL3357465	=	IC50	nM	31.9	CHEMBL4247	Homo sapiens	IC50	nM	31.9
	15005060	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)Cc3cc4ccccc4[nH]3)c2)ncc1Cl		CHEMBL3357466	=	IC50	nM	95.3	CHEMBL4247	Homo sapiens	IC50	nM	95.3
	15005061	CHEMBL3364272	Inhibition of ALK (unknown origin) after 60 mins by ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	13.7	CHEMBL4247	Homo sapiens	IC50	nM	13.7
	15005093	CHEMBL3366502	Inhibition of ALK L1196M mutant (unknown origin) after 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CN)c2)ncc1Cl		CHEMBL3357439	=	IC50	nM	15.3	CHEMBL4247	Homo sapiens	IC50	nM	15.3
	15005094	CHEMBL3366502	Inhibition of ALK L1196M mutant (unknown origin) after 60 mins by ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	122.0	CHEMBL4247	Homo sapiens	IC50	nM	122.0
	15009790	CHEMBL3363737	Inhibition of ALK (unknown origin) at 10 uM	B	C[C@H](O)CNc1nccc(-n2ccnc2Cc2cccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c2)n1		CHEMBL3309549	=	Inhibition	%	4.9	CHEMBL4247	Homo sapiens	INH	%	4.9
	15014101	CHEMBL3361856	Inhibition of ALK (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	1.2	CHEMBL4247	Homo sapiens	INH	%	1.2
	15036718	CHEMBL3381059	Inhibition of ALK (unknown origin)	B	Nc1nc2c3c(F)cccc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309990	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	15036719	CHEMBL3381059	Inhibition of ALK (unknown origin)	B	Nc1ccc2c(c1)nc(Cc1ccc3c(c1)OCO3)n1nc(N)nc21		CHEMBL3309995	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	15036720	CHEMBL3381059	Inhibition of ALK (unknown origin)	B	OCCCNc1ccc2c(c1)nc(-c1ccc3c(c1)OCO3)n1ncnc21		CHEMBL3309997	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	15036721	CHEMBL3381059	Inhibition of ALK (unknown origin)	B	Nc1nc2c3ccc(NCCO)cc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309998	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	15036722	CHEMBL3381059	Inhibition of ALK (unknown origin)	B	CN1CCN(c2cc(F)c3c(c2)nc(Cc2ccc4c(c2)OCO4)n2nc(N)nc32)CC1		CHEMBL3310151	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	15037101	CHEMBL3368323	Inhibition of ALK (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2cnc3[nH]cc(-c4ccc(OC)c(OC)c4)c3c2)cc1OC		CHEMBL3102948	=	Inhibition	%	43.0	CHEMBL4247	Homo sapiens	INH	%	43.0
	15037102	CHEMBL3368323	Inhibition of ALK (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1cc(-c2c[nH]c3ncc(-c4cccc(N)c4)cc23)cc(OC)c1OC		CHEMBL3319457	=	Inhibition	%	33.0	CHEMBL4247	Homo sapiens	INH	%	33.0
	15037103	CHEMBL3368323	Inhibition of ALK (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2c[nH]c3ncc(-c4ccc(C(=O)N5CCOCC5)c(N)c4)cc23)cc1OC		CHEMBL3319467	=	Inhibition	%	76.0	CHEMBL4247	Homo sapiens	INH	%	76.0
	15037104	CHEMBL3368323	Inhibition of ALK (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2c[nH]c3ncc(-c4cc(OC)c(OC)c(OC)c4)cc23)cc1OC		CHEMBL3319468	=	Inhibition	%	40.0	CHEMBL4247	Homo sapiens	INH	%	40.0
	15037105	CHEMBL3368323	Inhibition of ALK (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2cnc3[nH]cc(-c4ccc(OC)c(OC)c4)c3c2)cc1N		CHEMBL3319470	=	Inhibition	%	51.0	CHEMBL4247	Homo sapiens	INH	%	51.0
	15085848	CHEMBL3383506	Inhibition of purified ALK L1196M mutant (unknown origin) after 60 mins by ELISA kinase assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2nc3c(s2)CCN(C(=O)C2CCOCC2)CC3)ncc1Cl		CHEMBL3330859	=	IC50	nM	24.0	CHEMBL4247	Homo sapiens	IC50	nM	24.0
	15085849	CHEMBL3383505	Inhibition of purified ALK (unknown origin) after 60 mins by ELISA kinase assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ncc(C(=O)N3C[C@@H]4CN(C)C[C@@H]4C3)s2)ncc1Cl		CHEMBL3330878	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	15085850	CHEMBL3383505	Inhibition of purified ALK (unknown origin) after 60 mins by ELISA kinase assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2nc(CC(=O)N3C[C@@H]4CN(C)C[C@@H]4C3)cs2)ncc1Cl		CHEMBL3330877	=	IC50	nM	243.0	CHEMBL4247	Homo sapiens	IC50	nM	243.0
	15085851	CHEMBL3383505	Inhibition of purified ALK (unknown origin) after 60 mins by ELISA kinase assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2nc(C(=O)N3C[C@@H]4CN(C)C[C@@H]4C3)cs2)ncc1Cl		CHEMBL3330876	=	IC50	nM	134.0	CHEMBL4247	Homo sapiens	IC50	nM	134.0
	15085852	CHEMBL3383505	Inhibition of purified ALK (unknown origin) after 60 mins by ELISA kinase assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2nc(C(=O)N3CC4(CCNCC4)C3)cs2)ncc1Cl		CHEMBL3330875	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	15085853	CHEMBL3383505	Inhibition of purified ALK (unknown origin) after 60 mins by ELISA kinase assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2nc(C(=O)N3CC4CCC(C3)O4)cs2)ncc1Cl		CHEMBL3330874	=	IC50	nM	144.0	CHEMBL4247	Homo sapiens	IC50	nM	144.0
	15085854	CHEMBL3383505	Inhibition of purified ALK (unknown origin) after 60 mins by ELISA kinase assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2nc(C(=O)N3CCOCC3)cs2)ncc1Cl		CHEMBL3330873	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	15085855	CHEMBL3383505	Inhibition of purified ALK (unknown origin) after 60 mins by ELISA kinase assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2nc(C(=O)N3CCCCC3)cs2)ncc1Cl		CHEMBL3330872	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	15085856	CHEMBL3383505	Inhibition of purified ALK (unknown origin) after 60 mins by ELISA kinase assay	B	CCN(CC)C(=O)c1csc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)n1		CHEMBL3330871	=	IC50	nM	471.0	CHEMBL4247	Homo sapiens	IC50	nM	471.0
	15085857	CHEMBL3383505	Inhibition of purified ALK (unknown origin) after 60 mins by ELISA kinase assay	B	COc1cc(NC(=O)c2csc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)n2)cc(OC)c1OC		CHEMBL3330870	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	15085858	CHEMBL3383505	Inhibition of purified ALK (unknown origin) after 60 mins by ELISA kinase assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2nc(C(=O)NCCN3CCOCC3)cs2)ncc1Cl		CHEMBL3330869	=	IC50	nM	121.0	CHEMBL4247	Homo sapiens	IC50	nM	121.0
	15085859	CHEMBL3383505	Inhibition of purified ALK (unknown origin) after 60 mins by ELISA kinase assay	B	CNC(=O)c1csc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)n1		CHEMBL3330868	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	15085860	CHEMBL3383505	Inhibition of purified ALK (unknown origin) after 60 mins by ELISA kinase assay	B	CCCCOC(=O)c1csc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)n1		CHEMBL3330867	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	15085861	CHEMBL3383505	Inhibition of purified ALK (unknown origin) after 60 mins by ELISA kinase assay	B	COC(=O)c1csc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)n1		CHEMBL3330866	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	15085862	CHEMBL3383505	Inhibition of purified ALK (unknown origin) after 60 mins by ELISA kinase assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2nc(C(=O)O)cs2)ncc1Cl		CHEMBL3330865	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	15085863	CHEMBL3383505	Inhibition of purified ALK (unknown origin) after 60 mins by ELISA kinase assay	B	CCOC(=O)c1csc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)n1		CHEMBL3330864	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	15085864	CHEMBL3383505	Inhibition of purified ALK (unknown origin) after 60 mins by ELISA kinase assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2nc3c(s2)CN(CC(=O)N2CCOCC2)CC3)ncc1Cl		CHEMBL3330863	=	IC50	nM	775.0	CHEMBL4247	Homo sapiens	IC50	nM	775.0
	15085865	CHEMBL3383505	Inhibition of purified ALK (unknown origin) after 60 mins by ELISA kinase assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2nc3c(s2)CN(C)CC3)ncc1Cl		CHEMBL3330862	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	15085866	CHEMBL3383505	Inhibition of purified ALK (unknown origin) after 60 mins by ELISA kinase assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2nc3c(s2)CNCC3)ncc1Cl		CHEMBL3330861	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	15085867	CHEMBL3383505	Inhibition of purified ALK (unknown origin) after 60 mins by ELISA kinase assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2nc3c(s2)CCN(CCN2CCOCC2)CC3)ncc1Cl		CHEMBL3330860	=	IC50	nM	67.8	CHEMBL4247	Homo sapiens	IC50	nM	67.8
	15085868	CHEMBL3383505	Inhibition of purified ALK (unknown origin) after 60 mins by ELISA kinase assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2nc3c(s2)CCN(C(=O)C2CCOCC2)CC3)ncc1Cl		CHEMBL3330859	=	IC50	nM	12.4	CHEMBL4247	Homo sapiens	IC50	nM	12.4
	15085869	CHEMBL3383505	Inhibition of purified ALK (unknown origin) after 60 mins by ELISA kinase assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2nc3c(s2)CCN(CC2CCOCC2)CC3)ncc1Cl		CHEMBL3330858	=	IC50	nM	18.0	CHEMBL4247	Homo sapiens	IC50	nM	18.0
	15085870	CHEMBL3383505	Inhibition of purified ALK (unknown origin) after 60 mins by ELISA kinase assay	B	CNC(=O)c1ccccc1Nc1nc(Nc2nc3c(s2)CCN(C2COC2)CC3)ncc1Cl	Outside typical range	CHEMBL3330857	>	IC50	nM	1000000.0	CHEMBL4247	Homo sapiens	IC50	mM	1.0
	15085871	CHEMBL3383505	Inhibition of purified ALK (unknown origin) after 60 mins by ELISA kinase assay	B	CNC(=O)c1ccccc1Nc1nc(Nc2nc3c(s2)CCN(C2=COC2)CC3)ncc1Cl	Outside typical range	CHEMBL3330856	>	IC50	nM	1000000.0	CHEMBL4247	Homo sapiens	IC50	mM	1.0
	15085872	CHEMBL3383505	Inhibition of purified ALK (unknown origin) after 60 mins by ELISA kinase assay	B	CCOC(=O)N1CCc2nc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)sc2CC1		CHEMBL3330855	=	IC50	nM	178.0	CHEMBL4247	Homo sapiens	IC50	nM	178.0
	15085873	CHEMBL3383505	Inhibition of purified ALK (unknown origin) after 60 mins by ELISA kinase assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2nc3c(s2)CCN(C(=O)CO)CC3)ncc1Cl		CHEMBL3330854	=	IC50	nM	171.0	CHEMBL4247	Homo sapiens	IC50	nM	171.0
	15085874	CHEMBL3383505	Inhibition of purified ALK (unknown origin) after 60 mins by ELISA kinase assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2nc3c(s2)CCN(C)CC3)ncc1Cl		CHEMBL3330853	=	IC50	nM	773.0	CHEMBL4247	Homo sapiens	IC50	nM	773.0
	15085875	CHEMBL3383505	Inhibition of purified ALK (unknown origin) after 60 mins by ELISA kinase assay	B	CC(=O)N1CCc2nc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)sc2CC1		CHEMBL3330852	=	IC50	nM	99.0	CHEMBL4247	Homo sapiens	IC50	nM	99.0
	15085876	CHEMBL3383505	Inhibition of purified ALK (unknown origin) after 60 mins by ELISA kinase assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2nc3c(s2)CCNCC3)ncc1Cl	Outside typical range	CHEMBL3330851	>	IC50	nM	1000000.0	CHEMBL4247	Homo sapiens	IC50	mM	1.0
	15085877	CHEMBL3383505	Inhibition of purified ALK (unknown origin) after 60 mins by ELISA kinase assay	B	CNC(=O)c1ccccc1Nc1nc(Nc2nc3c(s2)CCNCC3)ncc1Cl		CHEMBL3330850	=	IC50	nM	61.8	CHEMBL4247	Homo sapiens	IC50	nM	61.8
	15085878	CHEMBL3383505	Inhibition of purified ALK (unknown origin) after 60 mins by ELISA kinase assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	3.4	CHEMBL4247	Homo sapiens	IC50	nM	3.4
Dose-dependent effect	15085891	CHEMBL3384766	Inhibition of ALK-mediated AKT phosphorylation in human H3122 cells	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2nc3c(s2)CCN(C(=O)C2CCOCC2)CC3)ncc1Cl		CHEMBL3330859		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-dependent effect	15085892	CHEMBL3384767	Inhibition of ALK-mediated ERK phosphorylation in human H3122 cells	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2nc3c(s2)CCN(C(=O)C2CCOCC2)CC3)ncc1Cl		CHEMBL3330859		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-dependent effect	15085893	CHEMBL3384768	Inhibition of ALK-mediated STAT3 phosphorylation in human H3122 cells	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2nc3c(s2)CCN(C(=O)C2CCOCC2)CC3)ncc1Cl		CHEMBL3330859		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-dependent effect	15085894	CHEMBL3384769	Inhibition of ALK phosphorylation in human H3122 cells	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2nc3c(s2)CCN(C(=O)C2CCOCC2)CC3)ncc1Cl		CHEMBL3330859		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	15085904	CHEMBL3384771	Inhibition of purified ALK (unknown origin) at 1 uM after 60 mins by ELISA kinase assay	B	CNC(=O)c1ccccc1Nc1nc(Nc2nc3c(s2)CCNCC3)ncc1Cl		CHEMBL3330850	=	Inhibition	%	96.0	CHEMBL4247	Homo sapiens	INH	%	96.0
	15107868	CHEMBL3385202	Inhibition of wild type ALK (unknown origin) incubated for 5 mins by HTRF assay	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C(F)=C/CN(C)C		CHEMBL3357634	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
	15143824	CHEMBL3396127	Inhibition of purified ALK (unknown origin) at 1 uM after 60 mins by ELISA	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12		CHEMBL3394469	=	Inhibition	%	64.9	CHEMBL4247	Homo sapiens	INH	%	64.9
	15143839	CHEMBL3396225	Inhibition of purified ALK (unknown origin) at 0.1 uM after 60 mins by ELISA	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12		CHEMBL3394469	=	Inhibition	%	36.2	CHEMBL4247	Homo sapiens	INH	%	36.2
Not Determined	15143854	CHEMBL3396240	Inhibition of purified ALK (unknown origin) at 0.01 uM after 60 mins by ELISA	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12		CHEMBL3394469		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	15149912	CHEMBL3395788	Inhibition of ALK (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2CC2CCCO2)ccn1		CHEMBL3394108	<	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	15149913	CHEMBL3395788	Inhibition of ALK (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CCCCC2)ccn1		CHEMBL3394105	<	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	15149922	CHEMBL3395788	Inhibition of ALK (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(Sc3cccc(I)n3)n2C2CCCCC2)ccn1		CHEMBL3394118	<	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	15149923	CHEMBL3395788	Inhibition of ALK (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	COC(Cn1c(SC2CCC(C(=O)O)CC2O)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1)OC		CHEMBL3394112	<	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	15149924	CHEMBL3395788	Inhibition of ALK (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CC2)ccn1		CHEMBL3394102	<	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	15156269	CHEMBL3399437	Inhibition of ALK (unknown origin)	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
	15156270	CHEMBL3399437	Inhibition of ALK (unknown origin)	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	24.0	CHEMBL4247	Homo sapiens	IC50	nM	24.0
	15156271	CHEMBL3399437	Inhibition of ALK (unknown origin)	B	COc1cc(N2CCC(N(C)C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3397300	=	IC50	nM	0.62	CHEMBL4247	Homo sapiens	IC50	nM	0.62
Not Determined	15156292	CHEMBL3399441	Inhibition of ALK (unknown origin) incubated for 20 mins followed by [33P]ATP addition measured after 120 mins by HotSpot assay	B	COc1cc(C)cc(-c2nn(CC#N)cc2-c2cc(NCC(C)C)nc(-c3cccnc3)n2)c1		CHEMBL3397284		IC50			CHEMBL4247	Homo sapiens	IC50		
	15156293	CHEMBL3399441	Inhibition of ALK (unknown origin) incubated for 20 mins followed by [33P]ATP addition measured after 120 mins by HotSpot assay	B	COc1cc(C)cc(-c2nn(CC#N)cc2-c2cc(NCCCO)nc(-c3cccnc3)n2)c1		CHEMBL3397285	=	IC50	nM	4320.0	CHEMBL4247	Homo sapiens	IC50	uM	4.32
	15156294	CHEMBL3399441	Inhibition of ALK (unknown origin) incubated for 20 mins followed by [33P]ATP addition measured after 120 mins by HotSpot assay	B	COc1cc(C)cc(-c2nn(CC#N)cc2-c2cc(NCCCCO)nc(-c3cccnc3)n2)c1		CHEMBL3397286	=	IC50	nM	1920.0	CHEMBL4247	Homo sapiens	IC50	uM	1.92
	15156295	CHEMBL3399441	Inhibition of ALK (unknown origin) incubated for 20 mins followed by [33P]ATP addition measured after 120 mins by HotSpot assay	B	COc1cc(C)cc(-c2nn(CC#N)cc2-c2cc(NCCN3CCOCC3)nc(-c3cccnc3)n2)c1		CHEMBL3397287	=	IC50	nM	10200.0	CHEMBL4247	Homo sapiens	IC50	uM	10.2
	15156296	CHEMBL3399441	Inhibition of ALK (unknown origin) incubated for 20 mins followed by [33P]ATP addition measured after 120 mins by HotSpot assay	B	COc1cc(C)cc(-c2nn(CC#N)cc2-c2cc(NCCCN3CCOCC3)nc(-c3cccnc3)n2)c1		CHEMBL3397288	=	IC50	nM	6220.0	CHEMBL4247	Homo sapiens	IC50	uM	6.22
Not Determined	15156297	CHEMBL3399441	Inhibition of ALK (unknown origin) incubated for 20 mins followed by [33P]ATP addition measured after 120 mins by HotSpot assay	B	Cc1cc(O)cc(-c2nn(CC#N)cc2-c2cc(NCC(C)C)nc(-c3cccnc3)n2)c1		CHEMBL3397289		IC50			CHEMBL4247	Homo sapiens	IC50		
	15156298	CHEMBL3399441	Inhibition of ALK (unknown origin) incubated for 20 mins followed by [33P]ATP addition measured after 120 mins by HotSpot assay	B	Cc1cc(O)cc(-c2nn(CC#N)cc2-c2cc(NCCCO)nc(-c3cccnc3)n2)c1		CHEMBL3397290	=	IC50	nM	9720.0	CHEMBL4247	Homo sapiens	IC50	uM	9.72
	15156299	CHEMBL3399441	Inhibition of ALK (unknown origin) incubated for 20 mins followed by [33P]ATP addition measured after 120 mins by HotSpot assay	B	Cc1cc(O)cc(-c2nn(CC#N)cc2-c2cc(NCCCCO)nc(-c3cccnc3)n2)c1		CHEMBL3397291	=	IC50	nM	4150.0	CHEMBL4247	Homo sapiens	IC50	uM	4.15
	15156300	CHEMBL3399441	Inhibition of ALK (unknown origin) incubated for 20 mins followed by [33P]ATP addition measured after 120 mins by HotSpot assay	B	Cc1cc(O)cc(-c2nn(CC#N)cc2-c2cc(NCCN3CCOCC3)nc(-c3cccnc3)n2)c1		CHEMBL3397292	=	IC50	nM	20000.0	CHEMBL4247	Homo sapiens	IC50	uM	20.0
	15156301	CHEMBL3399441	Inhibition of ALK (unknown origin) incubated for 20 mins followed by [33P]ATP addition measured after 120 mins by HotSpot assay	B	Cc1cc(O)cc(-c2nn(CC#N)cc2-c2cc(NCCCN3CCOCC3)nc(-c3cccnc3)n2)c1		CHEMBL3397293	=	IC50	nM	17600.0	CHEMBL4247	Homo sapiens	IC50	uM	17.6
Not Active	15156302	CHEMBL3399441	Inhibition of ALK (unknown origin) incubated for 20 mins followed by [33P]ATP addition measured after 120 mins by HotSpot assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719		IC50			CHEMBL4247	Homo sapiens	IC50		
	15156303	CHEMBL3399441	Inhibition of ALK (unknown origin) incubated for 20 mins followed by [33P]ATP addition measured after 120 mins by HotSpot assay	B	Cc1cc(O)cc(-c2nn(CC#N)cc2-c2cc(NC[C@H](C)O)nc(-c3cccnc3)n2)c1		CHEMBL560733	=	IC50	nM	0.6	CHEMBL4247	Homo sapiens	IC50	uM	0.0006
Active	15160103	CHEMBL3398706	Inhibition of ALK (unknown origin) by cellular assay	B	COc1cc([C@H]2CCN(CCO)C[C@@H]2O)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL3398175		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	15160104	CHEMBL3398706	Inhibition of ALK (unknown origin) by cellular assay	B	COc1cc(C2CCN(CCO)CC2O)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL3398176		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	15160105	CHEMBL3398706	Inhibition of ALK (unknown origin) by cellular assay	B	COc1cc([C@H]2CCN(CCO)C[C@@H]2O)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL3398175	=	IC50	nM	50.0	CHEMBL4247	Homo sapiens	IC50	nM	50.0
	15160106	CHEMBL3398706	Inhibition of ALK (unknown origin) by cellular assay	B	COc1cc([C@@H]2CCN(CCO)C[C@@H]2O)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL3398174	=	IC50	nM	60.0	CHEMBL4247	Homo sapiens	IC50	nM	60.0
Not Determined	15160107	CHEMBL3398706	Inhibition of ALK (unknown origin) by cellular assay	B	COc1cc([C@@H]2CCN(CC(N)=O)C[C@@H]2O)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL3398173		IC50			CHEMBL4247	Homo sapiens	IC50		
	15160108	CHEMBL3398706	Inhibition of ALK (unknown origin) by cellular assay	B	COc1cc([C@@H]2CCNC[C@@H]2O)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL3397057	=	IC50	nM	120.0	CHEMBL4247	Homo sapiens	IC50	nM	120.0
	15160109	CHEMBL3398706	Inhibition of ALK (unknown origin) by cellular assay	B	COc1cc(C2CCN(C)CC2O)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL3398172	=	IC50	nM	30.0	CHEMBL4247	Homo sapiens	IC50	nM	30.0
	15160110	CHEMBL3398706	Inhibition of ALK (unknown origin) by cellular assay	B	COc1cc([C@@]2(O)CCN(CC(N)=O)C[C@@H]2O)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL3398171	=	IC50	nM	60.0	CHEMBL4247	Homo sapiens	IC50	nM	60.0
	15160111	CHEMBL3398706	Inhibition of ALK (unknown origin) by cellular assay	B	COc1cc([C@@]2(O)CCN(CC(N)=O)C[C@@H]2O)ccc1Nc1ncc2ccc(-c3ccccc3N(C)S(C)(=O)=O)n2n1		CHEMBL3398170	=	IC50	nM	200.0	CHEMBL4247	Homo sapiens	IC50	nM	200.0
	15160112	CHEMBL3398706	Inhibition of ALK (unknown origin) by cellular assay	B	COc1cc([C@@]2(O)CCNC[C@@H]2O)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL3398169	=	IC50	nM	40.0	CHEMBL4247	Homo sapiens	IC50	nM	40.0
	15160113	CHEMBL3398706	Inhibition of ALK (unknown origin) by cellular assay	B	COc1cc([C@@]2(O)CCNC[C@@H]2O)ccc1Nc1ncc2ccc(-c3ccccc3N(C)S(C)(=O)=O)n2n1		CHEMBL3398168	=	IC50	nM	500.0	CHEMBL4247	Homo sapiens	IC50	nM	500.0
Not Determined	15160114	CHEMBL3398706	Inhibition of ALK (unknown origin) by cellular assay	B	COc1cc([C@@]2(O)CCN(C(=O)OC(C)(C)C)C[C@@H]2O)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL3398167		IC50			CHEMBL4247	Homo sapiens	IC50		
	15160115	CHEMBL3398706	Inhibition of ALK (unknown origin) by cellular assay	B	COc1cc([C@@]2(O)CCN(C)C[C@@H]2O)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL3398166	=	IC50	nM	30.0	CHEMBL4247	Homo sapiens	IC50	nM	30.0
Active	15160116	CHEMBL3398705	Inhibition of ALK (unknown origin) by enzymatic assay	B	COc1cc([C@H]2CCN(CCO)C[C@@H]2O)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL3398175		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	15160117	CHEMBL3398705	Inhibition of ALK (unknown origin) by enzymatic assay	B	COc1cc(C2CCN(CCO)CC2O)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL3398176		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	15160118	CHEMBL3398705	Inhibition of ALK (unknown origin) by enzymatic assay	B	COc1cc([C@H]2CCN(CCO)C[C@@H]2O)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL3398175	=	IC50	nM	5.0	CHEMBL4247	Homo sapiens	IC50	nM	5.0
	15160119	CHEMBL3398705	Inhibition of ALK (unknown origin) by enzymatic assay	B	COc1cc([C@@H]2CCN(CCO)C[C@@H]2O)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL3398174	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
	15160120	CHEMBL3398705	Inhibition of ALK (unknown origin) by enzymatic assay	B	COc1cc([C@@H]2CCN(CC(N)=O)C[C@@H]2O)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL3398173	=	IC50	nM	15.0	CHEMBL4247	Homo sapiens	IC50	nM	15.0
	15160121	CHEMBL3398705	Inhibition of ALK (unknown origin) by enzymatic assay	B	COc1cc([C@@H]2CCNC[C@@H]2O)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL3397057	=	IC50	nM	8.0	CHEMBL4247	Homo sapiens	IC50	nM	8.0
	15160122	CHEMBL3398705	Inhibition of ALK (unknown origin) by enzymatic assay	B	COc1cc(C2CCN(C)CC2O)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL3398172	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
	15160123	CHEMBL3398705	Inhibition of ALK (unknown origin) by enzymatic assay	B	COc1cc([C@@]2(O)CCN(CC(N)=O)C[C@@H]2O)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL3398171	=	IC50	nM	6.0	CHEMBL4247	Homo sapiens	IC50	nM	6.0
	15160124	CHEMBL3398705	Inhibition of ALK (unknown origin) by enzymatic assay	B	COc1cc([C@@]2(O)CCN(CC(N)=O)C[C@@H]2O)ccc1Nc1ncc2ccc(-c3ccccc3N(C)S(C)(=O)=O)n2n1		CHEMBL3398170	=	IC50	nM	15.0	CHEMBL4247	Homo sapiens	IC50	nM	15.0
	15160125	CHEMBL3398705	Inhibition of ALK (unknown origin) by enzymatic assay	B	COc1cc([C@@]2(O)CCNC[C@@H]2O)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL3398169	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
	15160126	CHEMBL3398705	Inhibition of ALK (unknown origin) by enzymatic assay	B	COc1cc([C@@]2(O)CCNC[C@@H]2O)ccc1Nc1ncc2ccc(-c3ccccc3N(C)S(C)(=O)=O)n2n1		CHEMBL3398168	=	IC50	nM	6.0	CHEMBL4247	Homo sapiens	IC50	nM	6.0
	15160127	CHEMBL3398705	Inhibition of ALK (unknown origin) by enzymatic assay	B	COc1cc([C@@]2(O)CCN(C(=O)OC(C)(C)C)C[C@@H]2O)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL3398167	=	IC50	nM	57.0	CHEMBL4247	Homo sapiens	IC50	nM	57.0
	15160128	CHEMBL3398705	Inhibition of ALK (unknown origin) by enzymatic assay	B	COc1cc([C@@]2(O)CCN(C)C[C@@H]2O)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL3398166	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
	15160176	CHEMBL3398757	Inhibition of NPM-ALK autophosphorylation in subcutaneous ALK-driven human SUP-M2 cells xenografted in SCID mouse at 30 mg/kg, po administered as single dose measured up to 24 hrs	F	COc1cc([C@@H]2CCN(CCO)C[C@@H]2O)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL3398174	<	Inhibition	%	75.0	CHEMBL4247	Homo sapiens	INH	%	75.0
	15160177	CHEMBL3398758	Inhibition of NPM-ALK autophosphorylation in subcutaneous ALK-driven human SUP-M2 cells xenografted in SCID mouse at 30 mg/kg, po administered as single dose measured up to 12 hrs	F	COc1cc([C@H]2CCN(CCO)C[C@@H]2O)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL3398175	=	Inhibition	%	75.0	CHEMBL4247	Homo sapiens	INH	%	75.0
	15160178	CHEMBL3398759	Inhibition of NPM-ALK autophosphorylation in subcutaneous ALK-driven human SUP-M2 cells xenografted in SCID mouse at 30 mg/kg, po administered as single dose measured up to 16 hrs	F	COc1cc(C2CCN(CCO)CC2O)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL3398176	=	Inhibition	%	40.0	CHEMBL4247	Homo sapiens	INH	%	40.0
	15160179	CHEMBL3398759	Inhibition of NPM-ALK autophosphorylation in subcutaneous ALK-driven human SUP-M2 cells xenografted in SCID mouse at 30 mg/kg, po administered as single dose measured up to 16 hrs	F	COc1cc([C@H]2CCN(CCO)C[C@@H]2O)ccc1Nc1ncc2ccc(-c3ccccc3OC)n2n1		CHEMBL3398175	=	Inhibition	%	80.0	CHEMBL4247	Homo sapiens	INH	%	80.0
	15223346	CHEMBL3420302	Inhibition of ALK (unknown origin)	B	O=c1ccc(-n2ccc3ccc(F)cc32)nn1CCOc1ccnc2cc(OCCCN3CCOCC3)ccc12		CHEMBL3417489	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	15249270	CHEMBL3428300	Inhibition of human ALK using poly[Glu:Tyr] (4:1) peptide substrate at 1 uM by 33P Hotspot assay	B	CN1CCN(c2ccc(Nc3ncc(Cl)c(NC[C@H]4CCCO4)n3)cc2)CC1		CHEMBL3426891	=	Inhibition	%	86.0	CHEMBL4247	Homo sapiens	INH	%	86.0
	15250048	CHEMBL3429149	Inhibition of human ALK using poly[Glu:Tyr] (4:1) peptide substrate by 33P Hotspot assay	B	CN1CCN(c2ccc(Nc3ncc(Cl)c(NC[C@H]4CCCO4)n3)cc2)CC1		CHEMBL3426891	=	IC50	nM	143.0	CHEMBL4247	Homo sapiens	IC50	nM	143.0
	15616286	CHEMBL3583120	Inhibition of Tel-fused ALK (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3	B	OC1CCN(c2cc(-c3cnc4ccc(N5CCC[C@@H]5c5cccc(F)c5)nn34)ccn2)CC1		CHEMBL3582442	=	IC50	nM	3900.0	CHEMBL4247	Homo sapiens	IC50	uM	3.9
	15616287	CHEMBL3583120	Inhibition of Tel-fused ALK (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3	B	O=C(O)CN1CCN(c2cc(-c3cnc4ccc(N5CCC[C@@H]5c5cccc(F)c5)nn34)ccn2)CC1		CHEMBL3582441	=	IC50	nM	2200.0	CHEMBL4247	Homo sapiens	IC50	uM	2.2
	15616288	CHEMBL3583120	Inhibition of Tel-fused ALK (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3	B	N#Cc1ccc(-c2cnc3ccc(NCc4ccccc4)nn23)cc1		CHEMBL3582427	=	IC50	nM	3100.0	CHEMBL4247	Homo sapiens	IC50	uM	3.1
	15616289	CHEMBL3583119	Inhibition of NMP-fused ALK (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3	B	OC1CCN(c2cc(-c3cnc4ccc(N5CCC[C@@H]5c5cccc(F)c5)nn34)ccn2)CC1		CHEMBL3582442	=	IC50	nM	3000.0	CHEMBL4247	Homo sapiens	IC50	uM	3.0
	15616290	CHEMBL3583119	Inhibition of NMP-fused ALK (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3	B	O=C(O)CN1CCN(c2cc(-c3cnc4ccc(N5CCC[C@@H]5c5cccc(F)c5)nn34)ccn2)CC1		CHEMBL3582441	=	IC50	nM	1200.0	CHEMBL4247	Homo sapiens	IC50	uM	1.2
	15616291	CHEMBL3583119	Inhibition of NMP-fused ALK (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3	B	Fc1cccc([C@H]2CCCN2c2ccc3ncc(-c4ccccn4)n3n2)c1		CHEMBL3582439	=	IC50	nM	6300.0	CHEMBL4247	Homo sapiens	IC50	uM	6.3
	15616292	CHEMBL3583119	Inhibition of NMP-fused ALK (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3	B	N#Cc1ccc(-c2cnc3ccc(NCc4ccccc4)nn23)cc1		CHEMBL3582427	=	IC50	nM	4800.0	CHEMBL4247	Homo sapiens	IC50	uM	4.8
	15680051	CHEMBL3607641	Inhibition of ALK L1196M mutant (unknown origin) using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1C1CCCN(C)C1		CHEMBL3604656	=	IC50	nM	7.0	CHEMBL4247	Homo sapiens	IC50	nM	7.0
	15680052	CHEMBL3607641	Inhibition of ALK L1196M mutant (unknown origin) using TK substrate-biotin incubated for 30 mins by HTRF assay	B	CCNC(=O)c1cc(OC2CC2)c(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)cc1C		CHEMBL3604655	=	IC50	nM	6.0	CHEMBL4247	Homo sapiens	IC50	nM	6.0
	15680053	CHEMBL3607641	Inhibition of ALK L1196M mutant (unknown origin) using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1S(C)(=O)=O		CHEMBL3604654	=	IC50	nM	11.0	CHEMBL4247	Homo sapiens	IC50	nM	11.0
	15680054	CHEMBL3607641	Inhibition of ALK L1196M mutant (unknown origin) using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1C(=O)C(C)C		CHEMBL3604653	=	IC50	nM	29.0	CHEMBL4247	Homo sapiens	IC50	nM	29.0
	15680055	CHEMBL3607641	Inhibition of ALK L1196M mutant (unknown origin) using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1CCN(C)C		CHEMBL3604652	=	IC50	nM	5.0	CHEMBL4247	Homo sapiens	IC50	nM	5.0
	15680056	CHEMBL3607641	Inhibition of ALK L1196M mutant (unknown origin) using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1C1COC1		CHEMBL3604651	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
	15680057	CHEMBL3607641	Inhibition of ALK L1196M mutant (unknown origin) using TK substrate-biotin incubated for 30 mins by HTRF assay	B	COCCc1cc(OC2CC2)c(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)cc1C		CHEMBL3604650	=	IC50	nM	7.0	CHEMBL4247	Homo sapiens	IC50	nM	7.0
	15680058	CHEMBL3607641	Inhibition of ALK L1196M mutant (unknown origin) using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1C1CCN(C(C)C)CC1		CHEMBL3604649	=	IC50	nM	5.0	CHEMBL4247	Homo sapiens	IC50	nM	5.0
	15680059	CHEMBL3607641	Inhibition of ALK L1196M mutant (unknown origin) using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(C)C1		CHEMBL3604648	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
	15680060	CHEMBL3607641	Inhibition of ALK L1196M mutant (unknown origin) using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNC1		CHEMBL3604647	=	IC50	nM	5.0	CHEMBL4247	Homo sapiens	IC50	nM	5.0
	15680061	CHEMBL3607641	Inhibition of ALK L1196M mutant (unknown origin) using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CN(C)C1		CHEMBL3604646	=	IC50	nM	5.0	CHEMBL4247	Homo sapiens	IC50	nM	5.0
	15680062	CHEMBL3607641	Inhibition of ALK L1196M mutant (unknown origin) using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CNC1		CHEMBL3604645	=	IC50	nM	13.0	CHEMBL4247	Homo sapiens	IC50	nM	13.0
	15680063	CHEMBL3607641	Inhibition of ALK L1196M mutant (unknown origin) using TK substrate-biotin incubated for 30 mins by HTRF assay	B	CC(C)S(=O)(=O)c1nn(C)cc1Nc1nc(Nc2cc(C#N)c(C3CCN(C)CC3)cc2OC2CC2)ncc1Cl		CHEMBL3604644	=	IC50	nM	13.0	CHEMBL4247	Homo sapiens	IC50	nM	13.0
	15680064	CHEMBL3607641	Inhibition of ALK L1196M mutant (unknown origin) using TK substrate-biotin incubated for 30 mins by HTRF assay	B	CC(C)S(=O)(=O)c1nn(C)cc1Nc1nc(Nc2cc(Cl)c(C3CCN(C)CC3)cc2OC2CC2)ncc1Cl		CHEMBL3604643	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
	15680065	CHEMBL3607641	Inhibition of ALK L1196M mutant (unknown origin) using TK substrate-biotin incubated for 30 mins by HTRF assay	B	CC(C)S(=O)(=O)c1nn(C)cc1Nc1nc(Nc2cc(F)c(C3CCN(C)CC3)cc2OC2CC2)ncc1Cl		CHEMBL3604642	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
	15680066	CHEMBL3607641	Inhibition of ALK L1196M mutant (unknown origin) using TK substrate-biotin incubated for 30 mins by HTRF assay	B	CC(C)S(=O)(=O)c1nn(C)cc1Nc1nc(Nc2ccc(C3CCN(C)CC3)cc2OC2CC2)ncc1Cl		CHEMBL3604641	=	IC50	nM	5.0	CHEMBL4247	Homo sapiens	IC50	nM	5.0
	15680067	CHEMBL3607641	Inhibition of ALK L1196M mutant (unknown origin) using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(C(C)C)cc1C1CCN(C)CC1		CHEMBL3604640	=	IC50	nM	28.0	CHEMBL4247	Homo sapiens	IC50	nM	28.0
	15680068	CHEMBL3607641	Inhibition of ALK L1196M mutant (unknown origin) using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(C(F)(F)F)cc1C1CCN(C)CC1		CHEMBL3604639	=	IC50	nM	49.0	CHEMBL4247	Homo sapiens	IC50	nM	49.0
	15680069	CHEMBL3607641	Inhibition of ALK L1196M mutant (unknown origin) using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC(F)(F)F)cc1C1CCN(C)CC1		CHEMBL3604638	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
	15680070	CHEMBL3607641	Inhibition of ALK L1196M mutant (unknown origin) using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC(CF)CF)cc1C1CCN(C)CC1		CHEMBL3604637	=	IC50	nM	23.0	CHEMBL4247	Homo sapiens	IC50	nM	23.0
	15680071	CHEMBL3607641	Inhibition of ALK L1196M mutant (unknown origin) using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OCC2CC2)cc1C1CCN(C)CC1		CHEMBL3604636	=	IC50	nM	48.0	CHEMBL4247	Homo sapiens	IC50	nM	48.0
	15680072	CHEMBL3607641	Inhibition of ALK L1196M mutant (unknown origin) using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OCC2CC2)cc1C1CCNCC1		CHEMBL3604635	=	IC50	nM	17.0	CHEMBL4247	Homo sapiens	IC50	nM	17.0
	15680073	CHEMBL3607641	Inhibition of ALK L1196M mutant (unknown origin) using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1C1CCN(C)CC1		CHEMBL3604634	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
	15680074	CHEMBL3607641	Inhibition of ALK L1196M mutant (unknown origin) using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1C1CCNCC1		CHEMBL3604633	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
	15680075	CHEMBL3607641	Inhibition of ALK L1196M mutant (unknown origin) using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(C)CC1		CHEMBL3604632	=	IC50	nM	8.0	CHEMBL4247	Homo sapiens	IC50	nM	8.0
	15680076	CHEMBL3607641	Inhibition of ALK L1196M mutant (unknown origin) using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL3604631	=	IC50	nM	20.0	CHEMBL4247	Homo sapiens	IC50	nM	20.0
	15680077	CHEMBL3607640	Inhibition of wild type human recombinant ALK using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1C1CCCN(C)C1		CHEMBL3604656	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
	15680078	CHEMBL3607640	Inhibition of wild type human recombinant ALK using TK substrate-biotin incubated for 30 mins by HTRF assay	B	CCNC(=O)c1cc(OC2CC2)c(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)cc1C		CHEMBL3604655	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
	15680079	CHEMBL3607640	Inhibition of wild type human recombinant ALK using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1S(C)(=O)=O		CHEMBL3604654	=	IC50	nM	9.0	CHEMBL4247	Homo sapiens	IC50	nM	9.0
	15680080	CHEMBL3607640	Inhibition of wild type human recombinant ALK using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1C(=O)C(C)C		CHEMBL3604653	=	IC50	nM	26.0	CHEMBL4247	Homo sapiens	IC50	nM	26.0
	15680081	CHEMBL3607640	Inhibition of wild type human recombinant ALK using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1CCN(C)C		CHEMBL3604652	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	nM	2.0
	15680082	CHEMBL3607640	Inhibition of wild type human recombinant ALK using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1C1COC1		CHEMBL3604651	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
	15680083	CHEMBL3607640	Inhibition of wild type human recombinant ALK using TK substrate-biotin incubated for 30 mins by HTRF assay	B	COCCc1cc(OC2CC2)c(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)cc1C		CHEMBL3604650	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
	15680084	CHEMBL3607640	Inhibition of wild type human recombinant ALK using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(C)CC1		CHEMBL3604632	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
	15680085	CHEMBL3607640	Inhibition of wild type human recombinant ALK using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1C1CCNCC1		CHEMBL3604633	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	nM	2.0
	15680086	CHEMBL3607640	Inhibition of wild type human recombinant ALK using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1C1CCN(C)CC1		CHEMBL3604634	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	nM	2.0
	15680087	CHEMBL3607640	Inhibition of wild type human recombinant ALK using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OCC2CC2)cc1C1CCNCC1		CHEMBL3604635	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
	15680088	CHEMBL3607640	Inhibition of wild type human recombinant ALK using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OCC2CC2)cc1C1CCN(C)CC1		CHEMBL3604636	=	IC50	nM	15.0	CHEMBL4247	Homo sapiens	IC50	nM	15.0
	15680089	CHEMBL3607640	Inhibition of wild type human recombinant ALK using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC(CF)CF)cc1C1CCN(C)CC1		CHEMBL3604637	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
	15680090	CHEMBL3607640	Inhibition of wild type human recombinant ALK using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC(F)(F)F)cc1C1CCN(C)CC1		CHEMBL3604638	=	IC50	nM	6.0	CHEMBL4247	Homo sapiens	IC50	nM	6.0
	15680091	CHEMBL3607640	Inhibition of wild type human recombinant ALK using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(C(F)(F)F)cc1C1CCN(C)CC1		CHEMBL3604639	=	IC50	nM	22.0	CHEMBL4247	Homo sapiens	IC50	nM	22.0
	15680092	CHEMBL3607640	Inhibition of wild type human recombinant ALK using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(C(C)C)cc1C1CCN(C)CC1		CHEMBL3604640	=	IC50	nM	12.0	CHEMBL4247	Homo sapiens	IC50	nM	12.0
	15680093	CHEMBL3607640	Inhibition of wild type human recombinant ALK using TK substrate-biotin incubated for 30 mins by HTRF assay	B	CC(C)S(=O)(=O)c1nn(C)cc1Nc1nc(Nc2ccc(C3CCN(C)CC3)cc2OC2CC2)ncc1Cl		CHEMBL3604641	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
	15680094	CHEMBL3607640	Inhibition of wild type human recombinant ALK using TK substrate-biotin incubated for 30 mins by HTRF assay	B	CC(C)S(=O)(=O)c1nn(C)cc1Nc1nc(Nc2cc(F)c(C3CCN(C)CC3)cc2OC2CC2)ncc1Cl		CHEMBL3604642	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
	15680095	CHEMBL3607640	Inhibition of wild type human recombinant ALK using TK substrate-biotin incubated for 30 mins by HTRF assay	B	CC(C)S(=O)(=O)c1nn(C)cc1Nc1nc(Nc2cc(Cl)c(C3CCN(C)CC3)cc2OC2CC2)ncc1Cl		CHEMBL3604643	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
	15680096	CHEMBL3607640	Inhibition of wild type human recombinant ALK using TK substrate-biotin incubated for 30 mins by HTRF assay	B	CC(C)S(=O)(=O)c1nn(C)cc1Nc1nc(Nc2cc(C#N)c(C3CCN(C)CC3)cc2OC2CC2)ncc1Cl		CHEMBL3604644	=	IC50	nM	8.0	CHEMBL4247	Homo sapiens	IC50	nM	8.0
	15680097	CHEMBL3607640	Inhibition of wild type human recombinant ALK using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CNC1		CHEMBL3604645	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
	15680098	CHEMBL3607640	Inhibition of wild type human recombinant ALK using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CN(C)C1		CHEMBL3604646	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	nM	2.0
	15680099	CHEMBL3607640	Inhibition of wild type human recombinant ALK using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNC1		CHEMBL3604647	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
	15680100	CHEMBL3607640	Inhibition of wild type human recombinant ALK using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(C)C1		CHEMBL3604648	=	IC50	nM	7.0	CHEMBL4247	Homo sapiens	IC50	nM	7.0
	15680101	CHEMBL3607640	Inhibition of wild type human recombinant ALK using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1C1CCN(C(C)C)CC1		CHEMBL3604649	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	nM	2.0
	15680102	CHEMBL3607640	Inhibition of wild type human recombinant ALK using TK substrate-biotin incubated for 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL3604631	=	IC50	nM	8.0	CHEMBL4247	Homo sapiens	IC50	nM	8.0
	15685871	CHEMBL3607947	Inhibition of human ALK	B	NC(=O)c1cc(F)cc2c1C(=O)N(C1CCN(C3CCC(F)(F)CC3)CC1)C2		CHEMBL3606021	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	15690151	CHEMBL3610966	Inhibition of wild type ALK (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCCN(C1CCNCC1)C2		CHEMBL3608642	=	IC50	nM	700.0	CHEMBL4247	Homo sapiens	IC50	uM	0.7
	15690152	CHEMBL3610966	Inhibition of wild type ALK (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCN(CCO)CC2		CHEMBL3608641	=	IC50	nM	3200.0	CHEMBL4247	Homo sapiens	IC50	uM	3.2
	15690153	CHEMBL3610966	Inhibition of wild type ALK (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CN(CCO)CCC2		CHEMBL3608535	=	IC50	nM	1700.0	CHEMBL4247	Homo sapiens	IC50	uM	1.7
	15690154	CHEMBL3610966	Inhibition of wild type ALK (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCCN(CCO)C2		CHEMBL3608534	=	IC50	nM	600.0	CHEMBL4247	Homo sapiens	IC50	uM	0.6
	15690155	CHEMBL3610966	Inhibition of wild type ALK (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCN(C(=O)CO)CC2		CHEMBL3608533	=	IC50	nM	2100.0	CHEMBL4247	Homo sapiens	IC50	uM	2.1
	15690156	CHEMBL3610966	Inhibition of wild type ALK (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CN(C(=O)CO)CCC2		CHEMBL3608532	=	IC50	nM	4500.0	CHEMBL4247	Homo sapiens	IC50	uM	4.5
	15690157	CHEMBL3610966	Inhibition of wild type ALK (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCCN(C(=O)CO)C2		CHEMBL3608531	=	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	uM	1.0
	15690158	CHEMBL3610966	Inhibition of wild type ALK (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CN(C(C)=O)CCC2		CHEMBL3608530	=	IC50	nM	800.0	CHEMBL4247	Homo sapiens	IC50	uM	0.8
	15690159	CHEMBL3610966	Inhibition of wild type ALK (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCCN(C(C)=O)C2		CHEMBL3608529	=	IC50	nM	1900.0	CHEMBL4247	Homo sapiens	IC50	uM	1.9
	15690160	CHEMBL3610966	Inhibition of wild type ALK (unknown origin) by homogeneous time resolved fluorescence assay	B	CCN1CCc2cc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)c(OC)cc2CC1		CHEMBL3608528	=	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	uM	1.0
	15690161	CHEMBL3610966	Inhibition of wild type ALK (unknown origin) by homogeneous time resolved fluorescence assay	B	CCN1CCCc2cc(OC)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C1		CHEMBL3608527	=	IC50	nM	2000.0	CHEMBL4247	Homo sapiens	IC50	uM	2.0
	15690162	CHEMBL3610966	Inhibition of wild type ALK (unknown origin) by homogeneous time resolved fluorescence assay	B	CCN1CCCc2cc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)c(OC)cc2C1		CHEMBL3608526	=	IC50	nM	390.0	CHEMBL4247	Homo sapiens	IC50	uM	0.39
	15690163	CHEMBL3610966	Inhibition of wild type ALK (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CNCCO2		CHEMBL3608525	=	IC50	nM	1.5	CHEMBL4247	Homo sapiens	IC50	nM	1.5
	15690164	CHEMBL3610966	Inhibition of wild type ALK (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNCC2		CHEMBL3608524	=	IC50	nM	1.8	CHEMBL4247	Homo sapiens	IC50	nM	1.8
	15690165	CHEMBL3610966	Inhibition of wild type ALK (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CNCCC2		CHEMBL3608523	=	IC50	nM	1.6	CHEMBL4247	Homo sapiens	IC50	nM	1.6
	15690166	CHEMBL3610966	Inhibition of wild type ALK (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCCNC2		CHEMBL3608522	=	IC50	nM	1.7	CHEMBL4247	Homo sapiens	IC50	nM	1.7
	15690167	CHEMBL3610966	Inhibition of wild type ALK (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC(=O)C2		CHEMBL3608521	=	IC50	nM	5.2	CHEMBL4247	Homo sapiens	IC50	nM	5.2
	15690168	CHEMBL3610966	Inhibition of wild type ALK (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C(=O)NCCC2		CHEMBL3608520	=	IC50	nM	4.4	CHEMBL4247	Homo sapiens	IC50	nM	4.4
	15690169	CHEMBL3610966	Inhibition of wild type ALK (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCCNC2=O		CHEMBL3608519	=	IC50	nM	2.7	CHEMBL4247	Homo sapiens	IC50	nM	2.7
	15690170	CHEMBL3610966	Inhibition of wild type ALK (unknown origin) by homogeneous time resolved fluorescence assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	14.0	CHEMBL4247	Homo sapiens	IC50	nM	14.0
	15690171	CHEMBL3610966	Inhibition of wild type ALK (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CN(C1CCNCC1)CCC2		CHEMBL3608643	=	IC50	nM	2500.0	CHEMBL4247	Homo sapiens	IC50	uM	2.5
	15690172	CHEMBL3610966	Inhibition of wild type ALK (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCCN(C1CCOCC1)C2		CHEMBL3608644	=	IC50	nM	800.0	CHEMBL4247	Homo sapiens	IC50	uM	0.8
	15690173	CHEMBL3610966	Inhibition of wild type ALK (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CN(C1CCOCC1)CCC2		CHEMBL3608313	=	IC50	nM	1500.0	CHEMBL4247	Homo sapiens	IC50	uM	1.5
	15690174	CHEMBL3610966	Inhibition of wild type ALK (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCCN(C1COC1)C2		CHEMBL3608645	=	IC50	nM	2000.0	CHEMBL4247	Homo sapiens	IC50	uM	2.0
	15690175	CHEMBL3610966	Inhibition of wild type ALK (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CN(C1COC1)CCC2		CHEMBL3608646	=	IC50	nM	3600.0	CHEMBL4247	Homo sapiens	IC50	uM	3.6
	15690176	CHEMBL3610967	Inhibition of ALK L1196M mutant (unknown origin) by homogeneous time resolved fluorescence assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	29.0	CHEMBL4247	Homo sapiens	IC50	nM	29.0
	15690177	CHEMBL3610967	Inhibition of ALK L1196M mutant (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCCNC2=O		CHEMBL3608519	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
	15690178	CHEMBL3610967	Inhibition of ALK L1196M mutant (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C(=O)NCCC2		CHEMBL3608520	=	IC50	nM	12.0	CHEMBL4247	Homo sapiens	IC50	nM	12.0
	15690179	CHEMBL3610967	Inhibition of ALK L1196M mutant (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC(=O)C2		CHEMBL3608521	=	IC50	nM	15.0	CHEMBL4247	Homo sapiens	IC50	nM	15.0
	15690180	CHEMBL3610967	Inhibition of ALK L1196M mutant (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCCNC2		CHEMBL3608522	=	IC50	nM	2.7	CHEMBL4247	Homo sapiens	IC50	nM	2.7
	15690181	CHEMBL3610967	Inhibition of ALK L1196M mutant (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CNCCC2		CHEMBL3608523	=	IC50	nM	3.4	CHEMBL4247	Homo sapiens	IC50	nM	3.4
	15690182	CHEMBL3610967	Inhibition of ALK L1196M mutant (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNCC2		CHEMBL3608524	=	IC50	nM	1.6	CHEMBL4247	Homo sapiens	IC50	nM	1.6
	15690183	CHEMBL3610967	Inhibition of ALK L1196M mutant (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CNCCO2		CHEMBL3608525	=	IC50	nM	5.8	CHEMBL4247	Homo sapiens	IC50	nM	5.8
	15690184	CHEMBL3610967	Inhibition of ALK L1196M mutant (unknown origin) by homogeneous time resolved fluorescence assay	B	CCN1CCCc2cc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)c(OC)cc2C1		CHEMBL3608526	=	IC50	nM	1400.0	CHEMBL4247	Homo sapiens	IC50	uM	1.4
	15690185	CHEMBL3610967	Inhibition of ALK L1196M mutant (unknown origin) by homogeneous time resolved fluorescence assay	B	CCN1CCCc2cc(OC)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C1		CHEMBL3608527	=	IC50	nM	7200.0	CHEMBL4247	Homo sapiens	IC50	uM	7.2
	15690186	CHEMBL3610967	Inhibition of ALK L1196M mutant (unknown origin) by homogeneous time resolved fluorescence assay	B	CCN1CCc2cc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)c(OC)cc2CC1		CHEMBL3608528	=	IC50	nM	6100.0	CHEMBL4247	Homo sapiens	IC50	uM	6.1
	15690187	CHEMBL3610967	Inhibition of ALK L1196M mutant (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCCN(C(C)=O)C2		CHEMBL3608529	=	IC50	nM	2700.0	CHEMBL4247	Homo sapiens	IC50	uM	2.7
	15690188	CHEMBL3610967	Inhibition of ALK L1196M mutant (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CN(C(C)=O)CCC2		CHEMBL3608530	=	IC50	nM	7600.0	CHEMBL4247	Homo sapiens	IC50	uM	7.6
	15690189	CHEMBL3610967	Inhibition of ALK L1196M mutant (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCCN(C(=O)CO)C2		CHEMBL3608531	=	IC50	nM	1300.0	CHEMBL4247	Homo sapiens	IC50	uM	1.3
	15690190	CHEMBL3610967	Inhibition of ALK L1196M mutant (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CN(C(=O)CO)CCC2		CHEMBL3608532	=	IC50	nM	34000.0	CHEMBL4247	Homo sapiens	IC50	uM	34.0
	15690191	CHEMBL3610967	Inhibition of ALK L1196M mutant (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCN(C(=O)CO)CC2		CHEMBL3608533	=	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	15690192	CHEMBL3610967	Inhibition of ALK L1196M mutant (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCCN(CCO)C2		CHEMBL3608534	=	IC50	nM	700.0	CHEMBL4247	Homo sapiens	IC50	uM	0.7
	15690193	CHEMBL3610967	Inhibition of ALK L1196M mutant (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CN(CCO)CCC2		CHEMBL3608535	=	IC50	nM	35000.0	CHEMBL4247	Homo sapiens	IC50	uM	35.0
	15690194	CHEMBL3610967	Inhibition of ALK L1196M mutant (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCN(CCO)CC2		CHEMBL3608641	=	IC50	nM	11000.0	CHEMBL4247	Homo sapiens	IC50	uM	11.0
	15690195	CHEMBL3610967	Inhibition of ALK L1196M mutant (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCCN(C1CCNCC1)C2		CHEMBL3608642	=	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	uM	1.0
	15690196	CHEMBL3610967	Inhibition of ALK L1196M mutant (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CN(C1CCNCC1)CCC2		CHEMBL3608643	=	IC50	nM	4400.0	CHEMBL4247	Homo sapiens	IC50	uM	4.4
	15690197	CHEMBL3610967	Inhibition of ALK L1196M mutant (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCCN(C1CCOCC1)C2		CHEMBL3608644	=	IC50	nM	1200.0	CHEMBL4247	Homo sapiens	IC50	uM	1.2
	15690198	CHEMBL3610967	Inhibition of ALK L1196M mutant (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CN(C1CCOCC1)CCC2		CHEMBL3608313	=	IC50	nM	7300.0	CHEMBL4247	Homo sapiens	IC50	uM	7.3
	15690199	CHEMBL3610967	Inhibition of ALK L1196M mutant (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCCN(C1COC1)C2		CHEMBL3608645	=	IC50	nM	2400.0	CHEMBL4247	Homo sapiens	IC50	uM	2.4
	15690200	CHEMBL3610967	Inhibition of ALK L1196M mutant (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CN(C1COC1)CCC2		CHEMBL3608646	=	IC50	nM	3400.0	CHEMBL4247	Homo sapiens	IC50	uM	3.4
	15690259	CHEMBL3610971	Ratio of LDK378 IC50 to compound IC50 for wild type ALK (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCCNC2		CHEMBL3608522	=	Ratio IC50		7.0	CHEMBL4247	Homo sapiens	Ratio IC50		7.0
	15690260	CHEMBL3610971	Ratio of LDK378 IC50 to compound IC50 for wild type ALK (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CNCCC2		CHEMBL3608523	=	Ratio IC50		7.0	CHEMBL4247	Homo sapiens	Ratio IC50		7.0
	15690261	CHEMBL3610971	Ratio of LDK378 IC50 to compound IC50 for wild type ALK (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNCC2		CHEMBL3608524	=	Ratio IC50		7.0	CHEMBL4247	Homo sapiens	Ratio IC50		7.0
	15690262	CHEMBL3610971	Ratio of LDK378 IC50 to compound IC50 for wild type ALK (unknown origin) by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CNCCO2		CHEMBL3608525	=	Ratio IC50		7.0	CHEMBL4247	Homo sapiens	Ratio IC50		7.0
	15690285	CHEMBL3611081	Inhibition of wild type ALK (unknown origin) at 100 nM by homogeneous time resolved fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNCC2		CHEMBL3608524	=	Inhibition	%	100.0	CHEMBL4247	Homo sapiens	INH	%	100.0
	15723363	CHEMBL3619881	Inhibition of ALK (unknown origin) at 10 uM after 40 mins by scintillation counting analysis	B	Cc1ccc(NC(=O)c2cc(N3CCN(C)CC3)cc(C(F)(F)F)c2)cc1NC(=O)c1cnoc1C		CHEMBL3616960	=	Inhibition	%	0.0	CHEMBL4247	Homo sapiens	INH	%	0.0
Not Active	15723364	CHEMBL3619881	Inhibition of ALK (unknown origin) at 10 uM after 40 mins by scintillation counting analysis	B	Cc1ccccc1C(=O)Nc1cnoc1C		CHEMBL3616990		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	15723422	CHEMBL3620016	Inhibition of ALK (unknown origin) after 40 mins by scintillation counting analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	nM	1.0
	15755845	CHEMBL3630631	Inhibition of ALK (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control	B	O=C1c2ccccc2-c2c1oc1ccccc1c2=O		CHEMBL3629616	=	Activity	%	48.0	CHEMBL4247	Homo sapiens	Activity	%	48.0
	15756116	CHEMBL3631718	Inhibition of ALK (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	6.1	CHEMBL4247	Homo sapiens	INH	%	6.1
	15757711	CHEMBL3631718	Inhibition of ALK (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	17.45	CHEMBL4247	Homo sapiens	INH	%	17.45
	15757983	CHEMBL3631718	Inhibition of ALK (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	0.02	CHEMBL4247	Homo sapiens	INH	%	0.02
	16378460	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	=	IC50	nM	11.5	CHEMBL4247	Homo sapiens	IC50	nM	11.5
	16378461	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1N1CCN(C(=O)C3CNC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3735650	=	IC50	nM	2.8	CHEMBL4247	Homo sapiens	IC50	nM	2.8
	16378462	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1N1CCN(C(=O)C3COCCN3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3734938	=	IC50	nM	0.8	CHEMBL4247	Homo sapiens	IC50	nM	0.8
	16378463	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1C1=CCN(C(=O)C3COCCN3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3735314	=	IC50	nM	2.1	CHEMBL4247	Homo sapiens	IC50	nM	2.1
	16378464	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1C1=CCN(C(=O)C3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3736388	=	IC50	nM	1.7	CHEMBL4247	Homo sapiens	IC50	nM	1.7
	16378465	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1C1=CCN(C(=O)C3CNC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3736182	=	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	nM	1.0
	16378466	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1N1CCN(C[C@@H]3CCC(=O)N3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3735794	=	IC50	nM	1.3	CHEMBL4247	Homo sapiens	IC50	nM	1.3
	16378467	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1N1CCN(CC3(CO)COC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3736021	=	IC50	nM	6.9	CHEMBL4247	Homo sapiens	IC50	nM	6.9
	16378468	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1N1CC3CC1CN3CC1CCOCC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3734855	=	IC50	nM	6.6	CHEMBL4247	Homo sapiens	IC50	nM	6.6
	16378469	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1N1CCN(CC3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3735384	=	IC50	nM	2.1	CHEMBL4247	Homo sapiens	IC50	nM	2.1
	16378470	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1C1=CCN(CC3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3735386	=	IC50	nM	2.3	CHEMBL4247	Homo sapiens	IC50	nM	2.3
	16378471	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CC1(C)c2cc(N3CCN(C(=O)C4CNC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735113	=	IC50	nM	10.4	CHEMBL4247	Homo sapiens	IC50	nM	10.4
	16378472	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CC1(C)c2cc(C3CCN(C(=O)C4COCCN4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735587	=	IC50	nM	15.5	CHEMBL4247	Homo sapiens	IC50	nM	15.5
	16378473	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CC1(C)c2cc(C3CCN(CC4CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735648	=	IC50	nM	3.4	CHEMBL4247	Homo sapiens	IC50	nM	3.4
	16378474	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CC1(C)c2cc(C3CCN(CC4(O)CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3736267	=	IC50	nM	16.4	CHEMBL4247	Homo sapiens	IC50	nM	16.4
	16378475	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CC1(C)c2cc(C3CCN(CC4COC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735064	=	IC50	nM	8.1	CHEMBL4247	Homo sapiens	IC50	nM	8.1
	16378476	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CC1(C)c2cc(C3CCN(CC4CCOC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735988	=	IC50	nM	33.0	CHEMBL4247	Homo sapiens	IC50	nM	33.0
	16378477	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1N1CCC(N(C)C3COC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3735531	=	IC50	nM	9.5	CHEMBL4247	Homo sapiens	IC50	nM	9.5
	16378478	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CC1(C)c2cc(-c3cnn(C4CCOCC4)c3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735784	=	IC50	nM	40.3	CHEMBL4247	Homo sapiens	IC50	nM	40.3
	16378479	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1-c1cnn(C3CCOCC3)c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3734844	=	IC50	nM	11.2	CHEMBL4247	Homo sapiens	IC50	nM	11.2
	16378480	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1-c1cnn(C3CCOC3)c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3735859	=	IC50	nM	11.8	CHEMBL4247	Homo sapiens	IC50	nM	11.8
	16378481	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CC1(C)c2cc(-c3cnn(C4CCNCC4)c3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735349	=	IC50	nM	53.0	CHEMBL4247	Homo sapiens	IC50	nM	53.0
	16378482	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1-c1cnn(C3CCNCC3)c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3736273	=	IC50	nM	0.9	CHEMBL4247	Homo sapiens	IC50	nM	0.9
	16378483	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1-c1cnn(CC(=O)N(C)C)c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3735401	=	IC50	nM	8.1	CHEMBL4247	Homo sapiens	IC50	nM	8.1
	16378484	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1-c1cnn(CC(N)=O)c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3735980	=	IC50	nM	7.1	CHEMBL4247	Homo sapiens	IC50	nM	7.1
	16378485	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1-c1cnn(CC(O)CO)c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3735510	=	IC50	nM	4.6	CHEMBL4247	Homo sapiens	IC50	nM	4.6
	16378486	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1ccc(C(C)(C)c2cc3ccc(C#N)cc3[nH]2)cc1-c1cnn(C2CCN(C(C)=O)CC2)c1		CHEMBL3735040	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
	16378487	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1ccc(C(C)(C)c2cc3ccc(C#N)cc3[nH]2)cc1C1=CCN(C(C)=O)CC1		CHEMBL3735272	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
	16378488	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1ccc(C(C)(C)c2cc3ccc(C#N)cc3[nH]2)cc1N1CCC(N2CCOCC2)CC1		CHEMBL3735763	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
	16378489	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1ccc(C(C)(C)c2cc3ccc(C#N)cc3[nH]2)cc1-c1cnn(CC(=O)N(C)C)c1		CHEMBL3734966	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
	16378490	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1ccc(C(C)(C)c2[nH]c3cc(C#N)ccc3c2C(=O)OC(C)(C)C)cc1-c1cnn(CC(=O)N(C)C)c1		CHEMBL3736015	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
	16378491	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1ccc(C(C)(C)c2[nH]c3cc(C#N)ccc3c2C(=O)O)cc1-c1cnn(CC(=O)N(C)C)c1		CHEMBL3735932	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
	16378492	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1NC(=O)N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3736073	=	IC50	nM	32.0	CHEMBL4247	Homo sapiens	IC50	nM	32.0
	16378493	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1NC(=O)N1CCC(C(C)(C)O)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3735811	=	IC50	nM	21.0	CHEMBL4247	Homo sapiens	IC50	nM	21.0
	16378494	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1NC(=O)C1CCn3c(nnc3C(F)(F)F)C1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3735581	=	IC50	nM	38.0	CHEMBL4247	Homo sapiens	IC50	nM	38.0
	16378495	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1NC(=O)N1CC(N3CCOCC3)C1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3735414	=	IC50	nM	381.0	CHEMBL4247	Homo sapiens	IC50	nM	381.0
	16378496	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1NC(=O)N1C[C@@H]3C(CO)[C@@H]3C1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3735452	=	IC50	nM	182.0	CHEMBL4247	Homo sapiens	IC50	nM	182.0
	16378497	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1NC(=O)CN1C[C@@H]3C(CO)[C@@H]3C1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3735241	=	IC50	nM	23.0	CHEMBL4247	Homo sapiens	IC50	nM	23.0
	16378498	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1NC(=O)CN1CC3CN(C)CC3C1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3735802	=	IC50	nM	24.0	CHEMBL4247	Homo sapiens	IC50	nM	24.0
	16378499	CHEMBL3738493	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	23.6	CHEMBL4247	Homo sapiens	IC50	nM	23.6
	16378500	CHEMBL3738494	Inhibition of gatekeeper ALK L1196M mutant (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	=	IC50	nM	15.2	CHEMBL4247	Homo sapiens	IC50	nM	15.2
	16378501	CHEMBL3738494	Inhibition of gatekeeper ALK L1196M mutant (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1N1CCN(C(=O)C3CNC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3735650	=	IC50	nM	4.1	CHEMBL4247	Homo sapiens	IC50	nM	4.1
	16378502	CHEMBL3738494	Inhibition of gatekeeper ALK L1196M mutant (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1N1CCN(C(=O)C3COCCN3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3734938	=	IC50	nM	4.3	CHEMBL4247	Homo sapiens	IC50	nM	4.3
	16378503	CHEMBL3738494	Inhibition of gatekeeper ALK L1196M mutant (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1C1=CCN(C(=O)C3COCCN3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3735314	=	IC50	nM	3.8	CHEMBL4247	Homo sapiens	IC50	nM	3.8
	16378504	CHEMBL3738494	Inhibition of gatekeeper ALK L1196M mutant (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1C1=CCN(C(=O)C3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3736388	=	IC50	nM	18.0	CHEMBL4247	Homo sapiens	IC50	nM	18.0
	16378505	CHEMBL3738494	Inhibition of gatekeeper ALK L1196M mutant (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1C1=CCN(C(=O)C3CNC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3736182	=	IC50	nM	3.1	CHEMBL4247	Homo sapiens	IC50	nM	3.1
	16378506	CHEMBL3738494	Inhibition of gatekeeper ALK L1196M mutant (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1N1CCN(C[C@@H]3CCC(=O)N3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3735794	=	IC50	nM	4.5	CHEMBL4247	Homo sapiens	IC50	nM	4.5
	16378507	CHEMBL3738494	Inhibition of gatekeeper ALK L1196M mutant (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1N1CCN(CC3(CO)COC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3736021	=	IC50	nM	1.8	CHEMBL4247	Homo sapiens	IC50	nM	1.8
	16378508	CHEMBL3738494	Inhibition of gatekeeper ALK L1196M mutant (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1N1CC3CC1CN3CC1CCOCC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3734855	=	IC50	nM	4.7	CHEMBL4247	Homo sapiens	IC50	nM	4.7
	16378509	CHEMBL3738494	Inhibition of gatekeeper ALK L1196M mutant (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1N1CCN(CC3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3735384	=	IC50	nM	4.5	CHEMBL4247	Homo sapiens	IC50	nM	4.5
	16378510	CHEMBL3738494	Inhibition of gatekeeper ALK L1196M mutant (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1C1=CCN(CC3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3735386	=	IC50	nM	11.2	CHEMBL4247	Homo sapiens	IC50	nM	11.2
	16378511	CHEMBL3738494	Inhibition of gatekeeper ALK L1196M mutant (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CC1(C)c2cc(C3CCN(C(=O)C4COCCN4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735587	=	IC50	nM	16.8	CHEMBL4247	Homo sapiens	IC50	nM	16.8
	16378512	CHEMBL3738494	Inhibition of gatekeeper ALK L1196M mutant (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CC1(C)c2cc(C3CCN(CC4CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735648	=	IC50	nM	3.9	CHEMBL4247	Homo sapiens	IC50	nM	3.9
	16378513	CHEMBL3738494	Inhibition of gatekeeper ALK L1196M mutant (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CC1(C)c2cc(C3CCN(CC4(O)CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3736267	>	IC50	nM	100.0	CHEMBL4247	Homo sapiens	IC50	nM	100.0
	16378514	CHEMBL3738494	Inhibition of gatekeeper ALK L1196M mutant (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CC1(C)c2cc(C3CCN(CC4COC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735064	=	IC50	nM	5.6	CHEMBL4247	Homo sapiens	IC50	nM	5.6
	16378515	CHEMBL3738494	Inhibition of gatekeeper ALK L1196M mutant (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1N1CCC(N(C)C3COC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3735531	>	IC50	nM	100.0	CHEMBL4247	Homo sapiens	IC50	nM	100.0
	16378516	CHEMBL3738494	Inhibition of gatekeeper ALK L1196M mutant (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1-c1cnn(C3CCNCC3)c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3736273	=	IC50	nM	15.5	CHEMBL4247	Homo sapiens	IC50	nM	15.5
	16378517	CHEMBL3738494	Inhibition of gatekeeper ALK L1196M mutant (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1-c1cnn(CC(=O)N(C)C)c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3735401	=	IC50	nM	17.3	CHEMBL4247	Homo sapiens	IC50	nM	17.3
	16378518	CHEMBL3738494	Inhibition of gatekeeper ALK L1196M mutant (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1-c1cnn(CC(N)=O)c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3735980	=	IC50	nM	27.1	CHEMBL4247	Homo sapiens	IC50	nM	27.1
	16378519	CHEMBL3738494	Inhibition of gatekeeper ALK L1196M mutant (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	CCc1cc2c(cc1-c1cnn(CC(O)CO)c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3735510	=	IC50	nM	53.2	CHEMBL4247	Homo sapiens	IC50	nM	53.2
	16378520	CHEMBL3738494	Inhibition of gatekeeper ALK L1196M mutant (unknown origin) using poly (Glu, Tyr)4:1 substrate incubated for 60 mins by ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	972.0	CHEMBL4247	Homo sapiens	IC50	nM	972.0
	16413405	CHEMBL3743739	Inhibition of ALK (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	16421896	CHEMBL3750238	Inhibition of ALK (unknown origin)	B	C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1		CHEMBL3651966	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	16431726	CHEMBL3749734	Inhibition of human ALK using [KGSGSGRPRTSSFAEG] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	16433827	CHEMBL3756750	Inhibition of human ALK using IGF-1Rtide as substrate at 10 uM after 2 hrs in presence of 30 uM ATP	B	CN1CCN(c2ccc(NC(=O)c3ccc(-c4cc(Cl)ccc4Cl)o3)cc2)CC1		CHEMBL3754324	=	Inhibition	%	17.4	CHEMBL4247	Homo sapiens	INH	%	17.4
	16433828	CHEMBL3756750	Inhibition of human ALK using IGF-1Rtide as substrate at 10 uM after 2 hrs in presence of 30 uM ATP	B	Cc1c(Cl)cccc1-c1ccc(C(=O)Nc2ccc(S(N)(=O)=O)cc2)o1		CHEMBL3752265	=	Inhibition	%	18.4	CHEMBL4247	Homo sapiens	INH	%	18.4
	16435498	CHEMBL3757893	Inhibition of human ALK assessed as enzyme activity using pEY as substrate at 5 uM incubated for 120 mins in presence of 33-P ATP by kinase phosphorylation assay	B	Cc1nc2[nH]n(-c3ccccc3)c(=O)c2c2c1c(=O)oc1ccc(Br)cc12		CHEMBL3752476	=	Activity	%	87.0	CHEMBL4247	Homo sapiens	Activity	%	87.0
	16465844	CHEMBL3768033	Inhibition of human ALK at 10 uM	B	Cc1cncn1-c1cc(C(=O)Nc2cccc(CNc3ccc4c(C(=O)N[C@@H](C)C(N)=O)[nH]nc4c3)c2)cc(C(F)(F)F)c1		CHEMBL3764798	=	Inhibition	%	0.0	CHEMBL4247	Homo sapiens	INH	%	0.0
	16485699	CHEMBL3773980	Inhibition of human recombinant ALK assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	Cc1c(Cl)cccc1NC(=O)c1sc2nc3c(cc2c1N)C(=O)CC3		CHEMBL3771285	=	Activity	%	100.0	CHEMBL4247	Homo sapiens	Activity	%	100.0
	16495331	CHEMBL3776644	Inhibition of N-terminal His6-tagged recombinant human ALK expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-35.0	CHEMBL4247	Homo sapiens	Activity	%	-35.0
	16508100	CHEMBL3776644	Inhibition of N-terminal His6-tagged recombinant human ALK expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-19.0	CHEMBL4247	Homo sapiens	Activity	%	-19.0
	16509077	CHEMBL3776644	Inhibition of N-terminal His6-tagged recombinant human ALK expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-24.0	CHEMBL4247	Homo sapiens	Activity	%	-24.0
Not Active	16514098	CHEMBL3782146	Inhibition of partial length human ALK expressed in mammalian system at 1 uM	B	Cc1cnc(N)nc1OCC(C)(C)CO		CHEMBL3780032		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	16534417	CHEMBL3789283	Inhibition of human ALK at 1 uM after 30 mins by fluorescence assay in presence of ATP	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCC(N)C2(C)C		CHEMBL3786892	=	Inhibition	%	100.0	CHEMBL4247	Homo sapiens	INH	%	100.0
	16534431	CHEMBL3791603	Inhibition of wild type ALK (unknown origin) after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	14.0	CHEMBL4247	Homo sapiens	IC50	nM	14.0
	16534432	CHEMBL3791603	Inhibition of wild type ALK (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C(C)(C)C(=O)CC2		CHEMBL3787367	=	IC50	nM	342.0	CHEMBL4247	Homo sapiens	IC50	nM	342.0
	16534433	CHEMBL3791603	Inhibition of wild type ALK (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCC(=O)C2(C)C		CHEMBL3787539	=	IC50	nM	43.0	CHEMBL4247	Homo sapiens	IC50	nM	43.0
	16534434	CHEMBL3791603	Inhibition of wild type ALK (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C(C)(C)C(O)CC2		CHEMBL3785322	=	IC50	nM	34.0	CHEMBL4247	Homo sapiens	IC50	nM	34.0
	16534435	CHEMBL3791603	Inhibition of wild type ALK (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCC(O)C2(C)C		CHEMBL3786270	=	IC50	nM	21.0	CHEMBL4247	Homo sapiens	IC50	nM	21.0
	16534436	CHEMBL3791603	Inhibition of wild type ALK (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C(C)(C)/C(=N/O)CC2		CHEMBL3786831	=	IC50	nM	424.0	CHEMBL4247	Homo sapiens	IC50	nM	424.0
	16534437	CHEMBL3791603	Inhibition of wild type ALK (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C(C)(C)/C(=N/NC(C)=O)CC2		CHEMBL3787262	=	IC50	nM	52.0	CHEMBL4247	Homo sapiens	IC50	nM	52.0
	16534438	CHEMBL3791603	Inhibition of wild type ALK (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C(C)(C)/C(=N/NC(N)=O)CC2		CHEMBL3785115	=	IC50	nM	16.0	CHEMBL4247	Homo sapiens	IC50	nM	16.0
	16534439	CHEMBL3791603	Inhibition of wild type ALK (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C(C)(C)/C(=N/NC(=N)N)CC2		CHEMBL3785093	=	IC50	nM	16.0	CHEMBL4247	Homo sapiens	IC50	nM	16.0
	16534440	CHEMBL3791603	Inhibition of wild type ALK (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C(C)(C)/C(=N/N1CCN(C)CC1)CC2		CHEMBL3786792	=	IC50	nM	44.0	CHEMBL4247	Homo sapiens	IC50	nM	44.0
	16534441	CHEMBL3791603	Inhibition of wild type ALK (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C(C)(C)/C(=N/N1CCOCC1)CC2		CHEMBL3785384	=	IC50	nM	122.0	CHEMBL4247	Homo sapiens	IC50	nM	122.0
	16534442	CHEMBL3791603	Inhibition of wild type ALK (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CC/C(=N\O)C2(C)C		CHEMBL3785480	=	IC50	nM	212.0	CHEMBL4247	Homo sapiens	IC50	nM	212.0
	16534443	CHEMBL3791603	Inhibition of wild type ALK (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CC/C(=N\NC(C)=O)C2(C)C		CHEMBL3785497	=	IC50	nM	21.0	CHEMBL4247	Homo sapiens	IC50	nM	21.0
	16534444	CHEMBL3791603	Inhibition of wild type ALK (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CC/C(=N\NC(N)=O)C2(C)C		CHEMBL3786127	=	IC50	nM	29.0	CHEMBL4247	Homo sapiens	IC50	nM	29.0
	16534445	CHEMBL3791603	Inhibition of wild type ALK (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CC/C(=N\NC(=N)N)C2(C)C		CHEMBL3786763	=	IC50	nM	18.0	CHEMBL4247	Homo sapiens	IC50	nM	18.0
	16534446	CHEMBL3791603	Inhibition of wild type ALK (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CC/C(=N\N1CCN(C)CC1)C2(C)C		CHEMBL3785774	=	IC50	nM	0.5	CHEMBL4247	Homo sapiens	IC50	nM	0.5
	16534447	CHEMBL3791603	Inhibition of wild type ALK (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CC/C(=N\N1CCOCC1)C2(C)C		CHEMBL3785538	=	IC50	nM	40.0	CHEMBL4247	Homo sapiens	IC50	nM	40.0
	16534448	CHEMBL3791603	Inhibition of wild type ALK (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C(C)(C)C(N)CC2		CHEMBL3786431	=	IC50	nM	27.0	CHEMBL4247	Homo sapiens	IC50	nM	27.0
	16534449	CHEMBL3791603	Inhibition of wild type ALK (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCC(N)C2(C)C		CHEMBL3786892	=	IC50	nM	0.7	CHEMBL4247	Homo sapiens	IC50	nM	0.7
	16534450	CHEMBL3791603	Inhibition of wild type ALK (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCC(NC(=O)CO)C2(C)C		CHEMBL3786402	=	IC50	nM	6.1	CHEMBL4247	Homo sapiens	IC50	nM	6.1
	16534451	CHEMBL3791603	Inhibition of wild type ALK (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCC(NC(=O)CN(C)C)C2(C)C		CHEMBL3785299	=	IC50	nM	4.2	CHEMBL4247	Homo sapiens	IC50	nM	4.2
	16534452	CHEMBL3791604	Inhibition of ALK L1196M mutant (unknown origin) after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	29.0	CHEMBL4247	Homo sapiens	IC50	nM	29.0
	16534453	CHEMBL3791604	Inhibition of ALK L1196M mutant (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C(C)(C)C(=O)CC2		CHEMBL3787367	=	IC50	nM	1376.0	CHEMBL4247	Homo sapiens	IC50	nM	1376.0
	16534454	CHEMBL3791604	Inhibition of ALK L1196M mutant (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCC(=O)C2(C)C		CHEMBL3787539	=	IC50	nM	207.0	CHEMBL4247	Homo sapiens	IC50	nM	207.0
	16534455	CHEMBL3791604	Inhibition of ALK L1196M mutant (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C(C)(C)C(O)CC2		CHEMBL3785322	=	IC50	nM	109.0	CHEMBL4247	Homo sapiens	IC50	nM	109.0
	16534456	CHEMBL3791604	Inhibition of ALK L1196M mutant (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCC(O)C2(C)C		CHEMBL3786270	=	IC50	nM	56.0	CHEMBL4247	Homo sapiens	IC50	nM	56.0
	16534457	CHEMBL3791604	Inhibition of ALK L1196M mutant (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C(C)(C)/C(=N/O)CC2		CHEMBL3786831	=	IC50	nM	600.0	CHEMBL4247	Homo sapiens	IC50	nM	600.0
	16534458	CHEMBL3791604	Inhibition of ALK L1196M mutant (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C(C)(C)/C(=N/NC(C)=O)CC2		CHEMBL3787262	=	IC50	nM	201.0	CHEMBL4247	Homo sapiens	IC50	nM	201.0
	16534459	CHEMBL3791604	Inhibition of ALK L1196M mutant (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C(C)(C)/C(=N/NC(N)=O)CC2		CHEMBL3785115	=	IC50	nM	97.0	CHEMBL4247	Homo sapiens	IC50	nM	97.0
	16534460	CHEMBL3791604	Inhibition of ALK L1196M mutant (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C(C)(C)/C(=N/NC(=N)N)CC2		CHEMBL3785093	=	IC50	nM	100.0	CHEMBL4247	Homo sapiens	IC50	nM	100.0
	16534461	CHEMBL3791604	Inhibition of ALK L1196M mutant (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C(C)(C)/C(=N/N1CCN(C)CC1)CC2		CHEMBL3786792	=	IC50	nM	200.0	CHEMBL4247	Homo sapiens	IC50	nM	200.0
	16534462	CHEMBL3791604	Inhibition of ALK L1196M mutant (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C(C)(C)/C(=N/N1CCOCC1)CC2		CHEMBL3785384	=	IC50	nM	222.0	CHEMBL4247	Homo sapiens	IC50	nM	222.0
Not Determined	16534463	CHEMBL3791604	Inhibition of ALK L1196M mutant (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CC/C(=N\O)C2(C)C		CHEMBL3785480		IC50			CHEMBL4247	Homo sapiens	IC50		
	16535015	CHEMBL3791604	Inhibition of ALK L1196M mutant (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CC/C(=N\NC(C)=O)C2(C)C		CHEMBL3785497	=	IC50	nM	40.0	CHEMBL4247	Homo sapiens	IC50	nM	40.0
	16535016	CHEMBL3791604	Inhibition of ALK L1196M mutant (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CC/C(=N\NC(N)=O)C2(C)C		CHEMBL3786127	=	IC50	nM	42.0	CHEMBL4247	Homo sapiens	IC50	nM	42.0
	16535017	CHEMBL3791604	Inhibition of ALK L1196M mutant (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CC/C(=N\NC(=N)N)C2(C)C		CHEMBL3786763	=	IC50	nM	37.0	CHEMBL4247	Homo sapiens	IC50	nM	37.0
	16535018	CHEMBL3791604	Inhibition of ALK L1196M mutant (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CC/C(=N\N1CCN(C)CC1)C2(C)C		CHEMBL3785774	=	IC50	nM	8.4	CHEMBL4247	Homo sapiens	IC50	nM	8.4
	16535019	CHEMBL3791604	Inhibition of ALK L1196M mutant (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CC/C(=N\N1CCOCC1)C2(C)C		CHEMBL3785538	=	IC50	nM	40.0	CHEMBL4247	Homo sapiens	IC50	nM	40.0
	16535020	CHEMBL3791604	Inhibition of ALK L1196M mutant (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C(C)(C)C(N)CC2		CHEMBL3786431	=	IC50	nM	94.0	CHEMBL4247	Homo sapiens	IC50	nM	94.0
	16535021	CHEMBL3791604	Inhibition of ALK L1196M mutant (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCC(N)C2(C)C		CHEMBL3786892	=	IC50	nM	1.5	CHEMBL4247	Homo sapiens	IC50	nM	1.5
	16535022	CHEMBL3791604	Inhibition of ALK L1196M mutant (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCC(NC(=O)CO)C2(C)C		CHEMBL3786402	=	IC50	nM	9.9	CHEMBL4247	Homo sapiens	IC50	nM	9.9
	16535023	CHEMBL3791604	Inhibition of ALK L1196M mutant (unknown origin) after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCC(NC(=O)CN(C)C)C2(C)C		CHEMBL3785299	=	IC50	nM	3.6	CHEMBL4247	Homo sapiens	IC50	nM	3.6
	16537411	CHEMBL3791911	Inhibition of recombinant human ALK L1196M mutant using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1[C@H]1CC[C@H](NS(C)(=O)=O)CC1		CHEMBL3787494	=	IC50	nM	20.0	CHEMBL4247	Homo sapiens	IC50	nM	20.0
	16537412	CHEMBL3791911	Inhibition of recombinant human ALK L1196M mutant using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	CC(=O)N1CCN([C@H]2CC[C@H](c3cc(OC4CC4)c(Nc4ncc(Cl)c(Nc5cn(C)nc5S(=O)(=O)C(C)C)n4)cc3C)CC2)CC1		CHEMBL3787658	=	IC50	nM	18.0	CHEMBL4247	Homo sapiens	IC50	nM	18.0
	16537413	CHEMBL3791911	Inhibition of recombinant human ALK L1196M mutant using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	CCN(CC)[C@H]1CC[C@H](c2cc(OC3CC3)c(Nc3ncc(Cl)c(Nc4cn(C)nc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL3785934	=	IC50	nM	12.0	CHEMBL4247	Homo sapiens	IC50	nM	12.0
	16537414	CHEMBL3791911	Inhibition of recombinant human ALK L1196M mutant using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	CCN(CC)[C@H]1CC[C@@H](c2cc(OC3CC3)c(Nc3ncc(Cl)c(Nc4cn(C)nc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL3786173	=	IC50	nM	17.0	CHEMBL4247	Homo sapiens	IC50	nM	17.0
	16537415	CHEMBL3791911	Inhibition of recombinant human ALK L1196M mutant using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1[C@H]1CC[C@H](NC2CC2)CC1		CHEMBL3785665	=	IC50	nM	18.0	CHEMBL4247	Homo sapiens	IC50	nM	18.0
	16537416	CHEMBL3791911	Inhibition of recombinant human ALK L1196M mutant using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1[C@H]1CC[C@@H](NC2CC2)CC1		CHEMBL3786818	=	IC50	nM	20.0	CHEMBL4247	Homo sapiens	IC50	nM	20.0
	16537417	CHEMBL3791911	Inhibition of recombinant human ALK L1196M mutant using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1[C@H]1CC[C@H](NC(C)C)CC1		CHEMBL3785928	=	IC50	nM	9.0	CHEMBL4247	Homo sapiens	IC50	nM	9.0
	16537418	CHEMBL3791911	Inhibition of recombinant human ALK L1196M mutant using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1[C@H]1CC[C@@H](NC(C)C)CC1		CHEMBL3785825	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
	16537419	CHEMBL3791911	Inhibition of recombinant human ALK L1196M mutant using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1C1CCS(=O)(=O)CC1		CHEMBL3785607	=	IC50	nM	9.0	CHEMBL4247	Homo sapiens	IC50	nM	9.0
	16537420	CHEMBL3791911	Inhibition of recombinant human ALK L1196M mutant using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1C1CCOCC1		CHEMBL3786171	=	IC50	nM	19.0	CHEMBL4247	Homo sapiens	IC50	nM	19.0
	16537421	CHEMBL3791911	Inhibition of recombinant human ALK L1196M mutant using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncnc(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1C1CCN(C)CC1		CHEMBL3785304	=	IC50	nM	111.0	CHEMBL4247	Homo sapiens	IC50	nM	111.0
	16537422	CHEMBL3791911	Inhibition of recombinant human ALK L1196M mutant using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(C#N)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1C1CCN(C)CC1		CHEMBL3785890	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
	16537423	CHEMBL3791911	Inhibition of recombinant human ALK L1196M mutant using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(C)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1C1CCN(C)CC1		CHEMBL3785722	=	IC50	nM	6.0	CHEMBL4247	Homo sapiens	IC50	nM	6.0
	16537424	CHEMBL3791911	Inhibition of recombinant human ALK L1196M mutant using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1C1CCN(C)CC1		CHEMBL3604634	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
	16537425	CHEMBL3791911	Inhibition of recombinant human ALK L1196M mutant using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(F)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1C1CCN(C)CC1		CHEMBL3787598	=	IC50	nM	18.0	CHEMBL4247	Homo sapiens	IC50	nM	18.0
	16537426	CHEMBL3791911	Inhibition of recombinant human ALK L1196M mutant using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	CCC(C)S(=O)(=O)c1nn(C)cc1Nc1nc(Nc2cc(C)c(C3CCNCC3)cc2OC(C)C)ncc1Cl		CHEMBL3785232	=	IC50	nM	12.0	CHEMBL4247	Homo sapiens	IC50	nM	12.0
	16537427	CHEMBL3791911	Inhibition of recombinant human ALK L1196M mutant using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)CC(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL3785711	=	IC50	nM	7.0	CHEMBL4247	Homo sapiens	IC50	nM	7.0
	16537428	CHEMBL3791911	Inhibition of recombinant human ALK L1196M mutant using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(C)(=O)=O)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL3785999	=	IC50	nM	94.0	CHEMBL4247	Homo sapiens	IC50	nM	94.0
	16537429	CHEMBL3791911	Inhibition of recombinant human ALK L1196M mutant using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3c[nH]nc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL3786006	=	IC50	nM	28.0	CHEMBL4247	Homo sapiens	IC50	nM	28.0
	16537430	CHEMBL3791911	Inhibition of recombinant human ALK L1196M mutant using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	COc1ccc(Cn2cc(Nc3nc(Nc4cc(C)c(C5CCNCC5)cc4OC(C)C)ncc3Cl)c(S(=O)(=O)C(C)C)n2)cc1		CHEMBL3787422	=	IC50	nM	157.0	CHEMBL4247	Homo sapiens	IC50	nM	157.0
	16537431	CHEMBL3791911	Inhibition of recombinant human ALK L1196M mutant using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C4CC4)nc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL3786976	=	IC50	nM	12.0	CHEMBL4247	Homo sapiens	IC50	nM	12.0
	16537432	CHEMBL3791911	Inhibition of recombinant human ALK L1196M mutant using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	CCn1cc(Nc2nc(Nc3cc(C)c(C4CCNCC4)cc3OC(C)C)ncc2Cl)c(S(=O)(=O)C(C)C)n1		CHEMBL3787103	=	IC50	nM	28.0	CHEMBL4247	Homo sapiens	IC50	nM	28.0
	16537433	CHEMBL3791911	Inhibition of recombinant human ALK L1196M mutant using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL3604631	=	IC50	nM	16.0	CHEMBL4247	Homo sapiens	IC50	nM	16.0
	16537434	CHEMBL3791910	Inhibition of recombinant human wild type ALK using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1[C@H]1CC[C@H](NS(C)(=O)=O)CC1		CHEMBL3787494	=	IC50	nM	16.0	CHEMBL4247	Homo sapiens	IC50	nM	16.0
	16537435	CHEMBL3791910	Inhibition of recombinant human wild type ALK using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	CC(=O)N1CCN([C@H]2CC[C@H](c3cc(OC4CC4)c(Nc4ncc(Cl)c(Nc5cn(C)nc5S(=O)(=O)C(C)C)n4)cc3C)CC2)CC1		CHEMBL3787658	=	IC50	nM	7.0	CHEMBL4247	Homo sapiens	IC50	nM	7.0
	16537436	CHEMBL3791910	Inhibition of recombinant human wild type ALK using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	CCN(CC)[C@H]1CC[C@H](c2cc(OC3CC3)c(Nc3ncc(Cl)c(Nc4cn(C)nc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL3785934	=	IC50	nM	9.0	CHEMBL4247	Homo sapiens	IC50	nM	9.0
	16537437	CHEMBL3791910	Inhibition of recombinant human wild type ALK using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	CCN(CC)[C@H]1CC[C@@H](c2cc(OC3CC3)c(Nc3ncc(Cl)c(Nc4cn(C)nc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL3786173	=	IC50	nM	8.0	CHEMBL4247	Homo sapiens	IC50	nM	8.0
	16537438	CHEMBL3791910	Inhibition of recombinant human wild type ALK using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1[C@H]1CC[C@H](NC2CC2)CC1		CHEMBL3785665	=	IC50	nM	9.0	CHEMBL4247	Homo sapiens	IC50	nM	9.0
	16537439	CHEMBL3791910	Inhibition of recombinant human wild type ALK using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1[C@H]1CC[C@@H](NC2CC2)CC1		CHEMBL3786818	=	IC50	nM	8.0	CHEMBL4247	Homo sapiens	IC50	nM	8.0
	16537440	CHEMBL3791910	Inhibition of recombinant human wild type ALK using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1[C@H]1CC[C@H](NC(C)C)CC1		CHEMBL3785928	=	IC50	nM	5.0	CHEMBL4247	Homo sapiens	IC50	nM	5.0
	16537441	CHEMBL3791910	Inhibition of recombinant human wild type ALK using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1[C@H]1CC[C@@H](NC(C)C)CC1		CHEMBL3785825	=	IC50	nM	5.0	CHEMBL4247	Homo sapiens	IC50	nM	5.0
	16537442	CHEMBL3791910	Inhibition of recombinant human wild type ALK using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1C1CCS(=O)(=O)CC1		CHEMBL3785607	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
	16537443	CHEMBL3791910	Inhibition of recombinant human wild type ALK using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1C1CCOCC1		CHEMBL3786171	=	IC50	nM	9.0	CHEMBL4247	Homo sapiens	IC50	nM	9.0
	16537444	CHEMBL3791910	Inhibition of recombinant human wild type ALK using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncnc(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1C1CCN(C)CC1		CHEMBL3785304	=	IC50	nM	36.0	CHEMBL4247	Homo sapiens	IC50	nM	36.0
	16537445	CHEMBL3791910	Inhibition of recombinant human wild type ALK using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(C#N)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1C1CCN(C)CC1		CHEMBL3785890	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	nM	2.0
	16537446	CHEMBL3791910	Inhibition of recombinant human wild type ALK using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(C)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1C1CCN(C)CC1		CHEMBL3785722	=	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	nM	1.0
	16537447	CHEMBL3791910	Inhibition of recombinant human wild type ALK using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(F)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1C1CCN(C)CC1		CHEMBL3787598	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	nM	2.0
	16537448	CHEMBL3791910	Inhibition of recombinant human wild type ALK using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC2CC2)cc1C1CCN(C)CC1		CHEMBL3604634	=	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	nM	1.0
	16537449	CHEMBL3791910	Inhibition of recombinant human wild type ALK using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1nc(S(=O)(=O)C(C)C)c(Nc2nc(Nc3cc(C)c(C4CCN(C)CC4)cc3OC3CC3)ncc2Cl)s1		CHEMBL3787297	=	IC50	nM	6.0	CHEMBL4247	Homo sapiens	IC50	nM	6.0
	16537450	CHEMBL3791910	Inhibition of recombinant human wild type ALK using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1nc(Nc2nc(Nc3cc(C)c(C4CCN(C)CC4)cc3OC3CC3)ncc2Cl)c(S(=O)(=O)C(C)C)s1		CHEMBL3786916	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
	16537451	CHEMBL3791910	Inhibition of recombinant human wild type ALK using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3C#N)n2)c(OC2CC2)cc1C1CCN(C)CC1		CHEMBL3786148	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
	16537452	CHEMBL3791911	Inhibition of recombinant human ALK L1196M mutant using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL3786002	=	IC50	nM	3905.0	CHEMBL4247	Homo sapiens	IC50	nM	3905.0
	16537453	CHEMBL3791911	Inhibition of recombinant human ALK L1196M mutant using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C3CC3)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL3786714	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
	16537454	CHEMBL3791911	Inhibition of recombinant human ALK L1196M mutant using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)N(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL3787638	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
	16537455	CHEMBL3791911	Inhibition of recombinant human ALK L1196M mutant using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	CNC(=O)c1nn(C)cc1Nc1nc(Nc2cc(C)c(C3CCN(C)CC3)cc2OC2CC2)ncc1Cl		CHEMBL3786830	=	IC50	nM	24.0	CHEMBL4247	Homo sapiens	IC50	nM	24.0
	16537456	CHEMBL3791911	Inhibition of recombinant human ALK L1196M mutant using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3C#N)n2)c(OC2CC2)cc1C1CCN(C)CC1		CHEMBL3786148	=	IC50	nM	11.0	CHEMBL4247	Homo sapiens	IC50	nM	11.0
	16537457	CHEMBL3791911	Inhibition of recombinant human ALK L1196M mutant using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1nc(Nc2nc(Nc3cc(C)c(C4CCN(C)CC4)cc3OC3CC3)ncc2Cl)c(S(=O)(=O)C(C)C)s1		CHEMBL3786916	=	IC50	nM	19.0	CHEMBL4247	Homo sapiens	IC50	nM	19.0
	16537458	CHEMBL3791911	Inhibition of recombinant human ALK L1196M mutant using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1nc(S(=O)(=O)C(C)C)c(Nc2nc(Nc3cc(C)c(C4CCN(C)CC4)cc3OC3CC3)ncc2Cl)s1		CHEMBL3787297	=	IC50	nM	22.0	CHEMBL4247	Homo sapiens	IC50	nM	22.0
	16537459	CHEMBL3791910	Inhibition of recombinant human wild type ALK using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	CNC(=O)c1nn(C)cc1Nc1nc(Nc2cc(C)c(C3CCN(C)CC3)cc2OC2CC2)ncc1Cl		CHEMBL3786830	=	IC50	nM	12.0	CHEMBL4247	Homo sapiens	IC50	nM	12.0
	16537460	CHEMBL3791910	Inhibition of recombinant human wild type ALK using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)N(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL3787638	=	IC50	nM	6683.0	CHEMBL4247	Homo sapiens	IC50	nM	6683.0
	16537461	CHEMBL3791910	Inhibition of recombinant human wild type ALK using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C3CC3)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL3786714	=	IC50	nM	400.0	CHEMBL4247	Homo sapiens	IC50	nM	400.0
	16537462	CHEMBL3791910	Inhibition of recombinant human wild type ALK using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL3786002	=	IC50	nM	753.0	CHEMBL4247	Homo sapiens	IC50	nM	753.0
	16537463	CHEMBL3791910	Inhibition of recombinant human wild type ALK using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	CCC(C)S(=O)(=O)c1nn(C)cc1Nc1nc(Nc2cc(C)c(C3CCNCC3)cc2OC(C)C)ncc1Cl		CHEMBL3785232	=	IC50	nM	8.0	CHEMBL4247	Homo sapiens	IC50	nM	8.0
	16537464	CHEMBL3791910	Inhibition of recombinant human wild type ALK using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)CC(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL3785711	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
	16537465	CHEMBL3791910	Inhibition of recombinant human wild type ALK using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(C)(=O)=O)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL3785999	=	IC50	nM	56.0	CHEMBL4247	Homo sapiens	IC50	nM	56.0
	16537466	CHEMBL3791910	Inhibition of recombinant human wild type ALK using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3c[nH]nc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL3786006	=	IC50	nM	22.0	CHEMBL4247	Homo sapiens	IC50	nM	22.0
	16537467	CHEMBL3791910	Inhibition of recombinant human wild type ALK using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	COc1ccc(Cn2cc(Nc3nc(Nc4cc(C)c(C5CCNCC5)cc4OC(C)C)ncc3Cl)c(S(=O)(=O)C(C)C)n2)cc1		CHEMBL3787422	=	IC50	nM	129.0	CHEMBL4247	Homo sapiens	IC50	nM	129.0
	16537468	CHEMBL3791910	Inhibition of recombinant human wild type ALK using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C4CC4)nc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL3786976	=	IC50	nM	6.0	CHEMBL4247	Homo sapiens	IC50	nM	6.0
	16537469	CHEMBL3791910	Inhibition of recombinant human wild type ALK using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	CCn1cc(Nc2nc(Nc3cc(C)c(C4CCNCC4)cc3OC(C)C)ncc2Cl)c(S(=O)(=O)C(C)C)n1		CHEMBL3787103	=	IC50	nM	20.0	CHEMBL4247	Homo sapiens	IC50	nM	20.0
	16537470	CHEMBL3791910	Inhibition of recombinant human wild type ALK using tyrosine kinase substrate-biotin after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3cn(C)nc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL3604631	=	IC50	nM	6.0	CHEMBL4247	Homo sapiens	IC50	nM	6.0
	16540720	CHEMBL3789970	Inhibition of ALK (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL1614712	>	IC50	nM	5500.0	CHEMBL4247	Homo sapiens	IC50	uM	5.5
	16540721	CHEMBL3789970	Inhibition of ALK (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OC[C@@H]3CCCO3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787614	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	16540722	CHEMBL3789970	Inhibition of ALK (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787112	=	IC50	nM	760.0	CHEMBL4247	Homo sapiens	IC50	uM	0.76
	16540723	CHEMBL3789970	Inhibition of ALK (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCC34CCC(CC3)O4)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3785500	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	16540724	CHEMBL3789970	Inhibition of ALK (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cccc(OC[C@@H]5CCCO5)c4F)c4c(N)ncnc43)C2)CC1		CHEMBL3786167	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	16540725	CHEMBL3789970	Inhibition of ALK (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(OC[C@@H]5CCCO5)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL3785951	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	16562732	CHEMBL3802279	Inhibition of ALK (unknown origin) using peptide substrate incubated for 30 mins by europium donor dye-based plate reader analysis	B	CC(C)(C)C(=O)Nc1ccc2c(c1)/C(=C1/Nc3ccccc3/C1=N\O)C(=O)N2		CHEMBL513703	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	16562733	CHEMBL3802279	Inhibition of ALK (unknown origin) using peptide substrate incubated for 30 mins by europium donor dye-based plate reader analysis	B	CCCCC(=O)Nc1ccc2c(c1)/C(=C1/Nc3ccccc3/C1=N\O)C(=O)N2		CHEMBL3797480	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	16562734	CHEMBL3802279	Inhibition of ALK (unknown origin) using peptide substrate incubated for 30 mins by europium donor dye-based plate reader analysis	B	CCCC(=O)Nc1ccc2c(c1)/C(=C1/Nc3ccccc3/C1=N\O)C(=O)N2		CHEMBL3799585	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	16563781	CHEMBL3802291	Inhibition of ALK (unknown origin) by Z-LYTE assay	B	CC(NC(=O)c1ccc2[nH]nc(-c3ccncc3)c2c1)c1cccc(Cl)c1		CHEMBL3798631	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	16563782	CHEMBL3802291	Inhibition of ALK (unknown origin) by Z-LYTE assay	B	Cc1cc(-c2n[nH]c3ccc(C(=O)NC(C)c4c(Cl)cncc4Cl)cc23)ccn1		CHEMBL3798257	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	16574817	CHEMBL3801254	Inhibition of recombinant ALK (unknown origin) using poly (Glu, Tyr) 4:1 as substrate at 1000 nM incubated for 60 mins by ELISA relative to control	B	Fc1ccc(-c2cnc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cc1		CHEMBL3797579	=	Inhibition	%	2.1	CHEMBL4247	Homo sapiens	INH	%	2.1
	16578377	CHEMBL3802249	Inhibition of partial length wild type human ALK expressed in mammalian system assessed as enzyme activity at 1 uM relative to control	B	CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F		CHEMBL3798256	=	Activity	%	96.0	CHEMBL4247	Homo sapiens	Activity	%	96.0
	16586434	CHEMBL3806916	Inhibition of recombinant ALK (unknown origin) in presence of gamma33-ATP	B	COCCNc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL3672895	=	IC50	nM	210.0	CHEMBL4247	Homo sapiens	IC50	uM	0.21
	16586435	CHEMBL3806916	Inhibition of recombinant ALK (unknown origin) in presence of gamma33-ATP	B	COC[C@@H](C)Nc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL3805786	=	IC50	nM	72.0	CHEMBL4247	Homo sapiens	IC50	uM	0.072
	16586436	CHEMBL3806916	Inhibition of recombinant ALK (unknown origin) in presence of gamma33-ATP	B	COCCCNc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL3806013	=	IC50	nM	135.0	CHEMBL4247	Homo sapiens	IC50	uM	0.135
	16586437	CHEMBL3806916	Inhibition of recombinant ALK (unknown origin) in presence of gamma33-ATP	B	COCC(COC)Nc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL3805254	=	IC50	nM	99.0	CHEMBL4247	Homo sapiens	IC50	uM	0.099
	16586438	CHEMBL3806916	Inhibition of recombinant ALK (unknown origin) in presence of gamma33-ATP	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NCCF)c2)CC1		CHEMBL3805899	=	IC50	nM	14.0	CHEMBL4247	Homo sapiens	IC50	uM	0.014
	16586439	CHEMBL3806916	Inhibition of recombinant ALK (unknown origin) in presence of gamma33-ATP	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NCCO)c2)CC1		CHEMBL3805749	=	IC50	nM	26.0	CHEMBL4247	Homo sapiens	IC50	uM	0.026
	16586440	CHEMBL3806916	Inhibition of recombinant ALK (unknown origin) in presence of gamma33-ATP	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NCC3CN(C)C3)c2)CC1		CHEMBL3806280	=	IC50	nM	67.0	CHEMBL4247	Homo sapiens	IC50	uM	0.067
	16586441	CHEMBL3806916	Inhibition of recombinant ALK (unknown origin) in presence of gamma33-ATP	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NCc3ccccc3)c2)CC1		CHEMBL3806043	=	IC50	nM	378.0	CHEMBL4247	Homo sapiens	IC50	uM	0.378
	16586442	CHEMBL3806916	Inhibition of recombinant ALK (unknown origin) in presence of gamma33-ATP	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(Nc3ccccc3)c2)CC1		CHEMBL3805009	=	IC50	nM	684.0	CHEMBL4247	Homo sapiens	IC50	uM	0.684
	16586443	CHEMBL3806916	Inhibition of recombinant ALK (unknown origin) in presence of gamma33-ATP	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCCCC3)c2)CC1		CHEMBL3672896	=	IC50	nM	560.0	CHEMBL4247	Homo sapiens	IC50	uM	0.56
	16586444	CHEMBL3806916	Inhibition of recombinant ALK (unknown origin) in presence of gamma33-ATP	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(N[C@H]3CC[C@H](O)CC3)c2)CC1		CHEMBL3805123	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	uM	0.01
	16586445	CHEMBL3806916	Inhibition of recombinant ALK (unknown origin) in presence of gamma33-ATP	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(N[C@H]3CC[C@@H](O)CC3)c2)CC1		CHEMBL3805129	=	IC50	nM	98.0	CHEMBL4247	Homo sapiens	IC50	uM	0.098
	16586446	CHEMBL3806916	Inhibition of recombinant ALK (unknown origin) in presence of gamma33-ATP	B	CN1CCC(Nc2cc(N3CCN(C)CC3)ccc2C(=O)Nc2n[nH]c3ccc(Cc4cc(F)cc(F)c4)cc23)CC1		CHEMBL3805020	=	IC50	nM	15.0	CHEMBL4247	Homo sapiens	IC50	uM	0.015
	16586447	CHEMBL3806916	Inhibition of recombinant ALK (unknown origin) in presence of gamma33-ATP	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	=	IC50	nM	12.0	CHEMBL4247	Homo sapiens	IC50	uM	0.012
	16586448	CHEMBL3806916	Inhibition of recombinant ALK (unknown origin) in presence of gamma33-ATP	B	C[C@H](c1cc(F)cc(F)c1)c1ccc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3NC3CCOCC3)c2c1		CHEMBL3804988	=	IC50	nM	59.0	CHEMBL4247	Homo sapiens	IC50	uM	0.059
	16586449	CHEMBL3806916	Inhibition of recombinant ALK (unknown origin) in presence of gamma33-ATP	B	C[C@@H](c1cc(F)cc(F)c1)c1ccc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3NC3CCOCC3)c2c1		CHEMBL3805214	=	IC50	nM	19.0	CHEMBL4247	Homo sapiens	IC50	uM	0.019
	16586450	CHEMBL3806916	Inhibition of recombinant ALK (unknown origin) in presence of gamma33-ATP	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5ccccc5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL3806196	=	IC50	nM	106.0	CHEMBL4247	Homo sapiens	IC50	uM	0.106
	16586451	CHEMBL3806916	Inhibition of recombinant ALK (unknown origin) in presence of gamma33-ATP	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cccc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL3805002	=	IC50	nM	30.0	CHEMBL4247	Homo sapiens	IC50	uM	0.03
	16586452	CHEMBL3806916	Inhibition of recombinant ALK (unknown origin) in presence of gamma33-ATP	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)ccc5F)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL3805462	=	IC50	nM	38.0	CHEMBL4247	Homo sapiens	IC50	uM	0.038
	16586453	CHEMBL3806916	Inhibition of recombinant ALK (unknown origin) in presence of gamma33-ATP	B	Cc1ccc(F)cc1Cc1ccc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3NC3CCOCC3)c2c1		CHEMBL3806045	=	IC50	nM	181.0	CHEMBL4247	Homo sapiens	IC50	uM	0.181
	16586454	CHEMBL3806916	Inhibition of recombinant ALK (unknown origin) in presence of gamma33-ATP	B	CN(C)CCN(C)C(=O)c1ccc(C(=O)Nc2n[nH]c3ccc(Cc4cc(F)cc(F)c4)cc23)c(NC2CCOCC2)c1		CHEMBL3805741	=	IC50	nM	15.0	CHEMBL4247	Homo sapiens	IC50	uM	0.015
	16586455	CHEMBL3806916	Inhibition of recombinant ALK (unknown origin) in presence of gamma33-ATP	B	O=C(Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12)c1ccc(N2CCNCC2)cc1NC1CCOCC1		CHEMBL3805643	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	uM	0.003
	16586456	CHEMBL3806916	Inhibition of recombinant ALK (unknown origin) in presence of gamma33-ATP	B	O=C(Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12)c1ccc(CN2CCCCC2)cc1NC1CCOCC1		CHEMBL3806112	=	IC50	nM	18.0	CHEMBL4247	Homo sapiens	IC50	uM	0.018
	16586457	CHEMBL3806916	Inhibition of recombinant ALK (unknown origin) in presence of gamma33-ATP	B	CN1CCC(Oc2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL3806122	=	IC50	nM	9.0	CHEMBL4247	Homo sapiens	IC50	uM	0.009
	16586458	CHEMBL3806916	Inhibition of recombinant ALK (unknown origin) in presence of gamma33-ATP	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(N)c2)CC1		CHEMBL3805516	=	IC50	nM	67.0	CHEMBL4247	Homo sapiens	IC50	uM	0.067
	16586459	CHEMBL3806916	Inhibition of recombinant ALK (unknown origin) in presence of gamma33-ATP	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)cc2)CC1		CHEMBL3672894	=	IC50	nM	73.0	CHEMBL4247	Homo sapiens	IC50	uM	0.073
	16587065	CHEMBL3807876	Inhibition of recombinant ALK (unknown origin)	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	=	Ki	nM	6.2	CHEMBL4247	Homo sapiens	Ki	nM	6.2
	16589181	CHEMBL3807589	Inhibition of ALK (unknown origin) at 10 uM by mobility shift assay	B	Cn1ncc(Cl)c1-c1cc(C(=O)NC2(c3ccc(Cl)c(Cl)c3)CCNCC2)oc1Cl		CHEMBL3805228	=	Inhibition	%	65.9	CHEMBL4247	Homo sapiens	INH	%	65.9
	16589697	CHEMBL3807609	Inhibition of ALK (unknown origin) at 0.5 uM by mobility shift assay	B	Cn1ncc(Cl)c1-c1cc(C(=O)NC2(c3ccc(Cl)c(Cl)c3)CCNCC2)oc1Cl		CHEMBL3805228	=	Inhibition	%	20.8	CHEMBL4247	Homo sapiens	INH	%	20.8
	16589716	CHEMBL3807904	Inhibition of ALK (unknown origin) by mobility shift assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	7.1	CHEMBL4247	Homo sapiens	IC50	nM	7.1
	16594827	CHEMBL3813079	Inhibition of human ALK (1088 to 1409 amino acid residues) assessed as enzyme activity at 10 uM by KINOMEScan assay	B	O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2		CHEMBL1987813	=	Activity	%	100.0	CHEMBL4247	Homo sapiens	Activity	%	100.0
Not Active	16600564	CHEMBL3810900	Induction of conformational changes in human ALK (1084 to 1410 residues) expressed in baculovirus infected Sf21 insect cells	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Active	16600565	CHEMBL3810899	Binding affinity to human ALK (1084 to 1410 residues) expressed in baculovirus infected Sf21 insect cells assessed as protein conformational changes	B	COc1cc2nccc(Oc3ccc4oc(Nc5ccc(Cl)cc5)nc4c3)c2cc1OC		CHEMBL3809422		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	16600566	CHEMBL3810899	Binding affinity to human ALK (1084 to 1410 residues) expressed in baculovirus infected Sf21 insect cells assessed as protein conformational changes	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1N		CHEMBL3809012		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	16600567	CHEMBL3810898	Binding affinity to human ALK (1084 to 1410 residues) expressed in baculovirus infected Sf21 insect cells by surface plasmon resonance assay	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1N		CHEMBL3809012		Activity			CHEMBL4247	Homo sapiens	Activity		
	16600568	CHEMBL3810897	Binding affinity to human ALK (1084 to 1410 residues) expressed in baculovirus infected Sf21 insect cells assessed as dissociation rate constant by surface plasmon resonance assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl	Non standard unit for type	CHEMBL601719	=	Kd	10'-2/s	3.55	CHEMBL4247	Homo sapiens	Kd	10'-2/s	3.55
	16600569	CHEMBL3810897	Binding affinity to human ALK (1084 to 1410 residues) expressed in baculovirus infected Sf21 insect cells assessed as dissociation rate constant by surface plasmon resonance assay	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1	Non standard unit for type	CHEMBL2386796	=	Kd	10'-3/s	2.4	CHEMBL4247	Homo sapiens	Kd	10'-3/s	2.4
	16600570	CHEMBL3812108	Binding affinity to human ALK (1084 to 1410 residues) expressed in baculovirus infected Sf21 insect cells assessed as association rate constant by surface plasmon resonance assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Ka	10'7/Ms	1.17	CHEMBL4247	Homo sapiens	Ka	10'7/Ms	1.17
	16600571	CHEMBL3812108	Binding affinity to human ALK (1084 to 1410 residues) expressed in baculovirus infected Sf21 insect cells assessed as association rate constant by surface plasmon resonance assay	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1		CHEMBL2386796	=	Ka	10'4/Ms	5.17	CHEMBL4247	Homo sapiens	Ka	10'4/Ms	5.17
Active	16600572	CHEMBL3812106	Binding affinity to human ALK (1084 to 1410 residues) expressed in baculovirus infected Sf21 insect cells assessed as conformational change of juxtamembrane domain	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1		CHEMBL2386796		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	16600573	CHEMBL3812105	Binding affinity to human ALK (1084 to 1410 residues) expressed in baculovirus infected Sf21 insect cells assessed as rearrangement of activation loop/alphaC-helix	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1		CHEMBL2386796		Activity			CHEMBL4247	Homo sapiens	Activity		
	16600574	CHEMBL3812107	Inhibition of human ALK (1084 to 1410 residues) expressed in baculovirus infected Sf21 insect cells using polyGlu4:Tyr peptide as substrate after 1 hr by kinase-Glo luminescence assay	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccc(NC(=O)Nc5cc(C(C)(C)C)on5)cc4)n[nH]3)cc2)CC1		CHEMBL2386789	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
	16600575	CHEMBL3812107	Inhibition of human ALK (1084 to 1410 residues) expressed in baculovirus infected Sf21 insect cells using polyGlu4:Tyr peptide as substrate after 1 hr by kinase-Glo luminescence assay	B	Cc1cc(-c2cc(NC(=O)c3ccc(OCCN4CCOCC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1		CHEMBL2386795	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
	16600576	CHEMBL3812107	Inhibition of human ALK (1084 to 1410 residues) expressed in baculovirus infected Sf21 insect cells using polyGlu4:Tyr peptide as substrate after 1 hr by kinase-Glo luminescence assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cc(NC(=O)c4ccc(OCCCN5CCCC5)cc4)[nH]n3)cc2)no1		CHEMBL3809934	=	IC50	nM	1200.0	CHEMBL4247	Homo sapiens	IC50	nM	1200.0
	16600577	CHEMBL3812107	Inhibition of human ALK (1084 to 1410 residues) expressed in baculovirus infected Sf21 insect cells using polyGlu4:Tyr peptide as substrate after 1 hr by kinase-Glo luminescence assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cc(NC(=O)c4ccc(OCCN5CCCC5)cc4)[nH]n3)cc2)no1		CHEMBL2386792	=	IC50	nM	559.0	CHEMBL4247	Homo sapiens	IC50	nM	559.0
	16600578	CHEMBL3812107	Inhibition of human ALK (1084 to 1410 residues) expressed in baculovirus infected Sf21 insect cells using polyGlu4:Tyr peptide as substrate after 1 hr by kinase-Glo luminescence assay	B	CC(C)c1cc(NC(=O)Nc2ccc(-c3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)[nH]n3)cc2)no1		CHEMBL3810070	=	IC50	nM	855.0	CHEMBL4247	Homo sapiens	IC50	nM	855.0
	16600579	CHEMBL3812107	Inhibition of human ALK (1084 to 1410 residues) expressed in baculovirus infected Sf21 insect cells using polyGlu4:Tyr peptide as substrate after 1 hr by kinase-Glo luminescence assay	B	CN1CCN(Cc2ccc(C(=O)Nc3cc(-c4ccc(NC(=O)Nc5cc(C(C)(C)C)on5)cc4)n[nH]3)cc2)CC1		CHEMBL2386794	=	IC50	nM	860.0	CHEMBL4247	Homo sapiens	IC50	nM	860.0
	16600580	CHEMBL3812107	Inhibition of human ALK (1084 to 1410 residues) expressed in baculovirus infected Sf21 insect cells using polyGlu4:Tyr peptide as substrate after 1 hr by kinase-Glo luminescence assay	B	Cc1cc(NC(=O)Nc2ccc(-c3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)[nH]n3)cc2C)no1		CHEMBL3808520	=	IC50	nM	5642.0	CHEMBL4247	Homo sapiens	IC50	nM	5642.0
	16600581	CHEMBL3812107	Inhibition of human ALK (1084 to 1410 residues) expressed in baculovirus infected Sf21 insect cells using polyGlu4:Tyr peptide as substrate after 1 hr by kinase-Glo luminescence assay	B	CCc1cc(NC(=O)Nc2ccc(-c3cc(NC(=O)c4ccc(CN5CCN(C)CC5)cc4)[nH]n3)cc2C)no1		CHEMBL3808519	=	IC50	nM	805.0	CHEMBL4247	Homo sapiens	IC50	nM	805.0
	16600582	CHEMBL3812107	Inhibition of human ALK (1084 to 1410 residues) expressed in baculovirus infected Sf21 insect cells using polyGlu4:Tyr peptide as substrate after 1 hr by kinase-Glo luminescence assay	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)C)on1		CHEMBL3810133	=	IC50	nM	402.0	CHEMBL4247	Homo sapiens	IC50	nM	402.0
	16600583	CHEMBL3812107	Inhibition of human ALK (1084 to 1410 residues) expressed in baculovirus infected Sf21 insect cells using polyGlu4:Tyr peptide as substrate after 1 hr by kinase-Glo luminescence assay	B	CN1CCN(Cc2ccc(C(=O)Nc3cc(-c4ccc(CNC(=O)Nc5cc(C(C)(C)C)on5)cc4)n[nH]3)cc2)CC1		CHEMBL2386803	=	IC50	nM	4500.0	CHEMBL4247	Homo sapiens	IC50	nM	4500.0
	16600584	CHEMBL3812107	Inhibition of human ALK (1084 to 1410 residues) expressed in baculovirus infected Sf21 insect cells using polyGlu4:Tyr peptide as substrate after 1 hr by kinase-Glo luminescence assay	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cccc(F)c1		CHEMBL3809888	=	IC50	nM	6203.0	CHEMBL4247	Homo sapiens	IC50	nM	6203.0
	16600585	CHEMBL3812107	Inhibition of human ALK (1084 to 1410 residues) expressed in baculovirus infected Sf21 insect cells using polyGlu4:Tyr peptide as substrate after 1 hr by kinase-Glo luminescence assay	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1		CHEMBL2386796	=	IC50	nM	177.0	CHEMBL4247	Homo sapiens	IC50	nM	177.0
	16600586	CHEMBL3812107	Inhibition of human ALK (1084 to 1410 residues) expressed in baculovirus infected Sf21 insect cells using polyGlu4:Tyr peptide as substrate after 1 hr by kinase-Glo luminescence assay	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1N		CHEMBL3809012	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
	16613764	CHEMBL3816557	Inhibition of human ALK at 1 uM using poly[Glu:Tyr] (4:1) as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	-8.0	CHEMBL4247	Homo sapiens	INH	%	-8.0
	16618683	CHEMBL3816105	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	16621476	CHEMBL3820469	Inhibition of ALK (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN1C(=O)COc2c1cnc1ccc(Sc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc21		CHEMBL3818247	>	IC50	nM	30000.0	CHEMBL4247	Homo sapiens	IC50	nM	30000.0
	16622191	CHEMBL3820469	Inhibition of ALK (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	6.7	CHEMBL4247	Homo sapiens	IC50	nM	6.7
	16635313	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	IC50	nM	0.15	CHEMBL4247	Homo sapiens	IC50	nM	0.15
	16635314	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(C)(=O)=O)n1		CHEMBL3822475	=	IC50	nM	0.59	CHEMBL4247	Homo sapiens	IC50	nM	0.59
	16635863	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2C(C)O)n1		CHEMBL3822499	=	IC50	nM	0.99	CHEMBL4247	Homo sapiens	IC50	nM	0.99
	16635864	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2C(C)=O)n1		CHEMBL3824301	=	IC50	nM	1.59	CHEMBL4247	Homo sapiens	IC50	nM	1.59
	16635865	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)N(C)C)n1		CHEMBL3822672	=	IC50	nM	0.75	CHEMBL4247	Homo sapiens	IC50	nM	0.75
	16635866	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2C(=O)N(C)C)n1		CHEMBL3823016	=	IC50	nM	4.77	CHEMBL4247	Homo sapiens	IC50	nM	4.77
	16635867	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2C(N)=O)n1		CHEMBL3824246	=	IC50	nM	0.8	CHEMBL4247	Homo sapiens	IC50	nM	0.8
	16635868	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2OC)n1		CHEMBL3823045	=	IC50	nM	1.88	CHEMBL4247	Homo sapiens	IC50	nM	1.88
	16635869	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2C#N)n1		CHEMBL3823864	=	IC50	nM	1.86	CHEMBL4247	Homo sapiens	IC50	nM	1.86
	16635870	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2I)n1		CHEMBL3822664	=	IC50	nM	1.36	CHEMBL4247	Homo sapiens	IC50	nM	1.36
	16635871	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2)n1		CHEMBL3824185	=	IC50	nM	9.9	CHEMBL4247	Homo sapiens	IC50	nM	9.9
	16635872	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	CC(C)Oc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3823224	=	IC50	nM	0.68	CHEMBL4247	Homo sapiens	IC50	nM	0.68
	16635873	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	CCOc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3824318	=	IC50	nM	0.75	CHEMBL4247	Homo sapiens	IC50	nM	0.75
	16635874	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3823836	=	IC50	nM	0.86	CHEMBL4247	Homo sapiens	IC50	nM	0.86
	16635875	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)c(F)cc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3823078	=	IC50	nM	1.03	CHEMBL4247	Homo sapiens	IC50	nM	1.03
	16635876	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	CCP(=O)(CC)c1ccccc1Nc1nc(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)cc2OC)ncc1Cl		CHEMBL3824308	=	IC50	nM	0.12	CHEMBL4247	Homo sapiens	IC50	nM	0.12
	16635877	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(C(C)=O)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3822589	=	IC50	nM	291.0	CHEMBL4247	Homo sapiens	IC50	nM	291.0
	16635878	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(C)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3823577	=	IC50	nM	0.42	CHEMBL4247	Homo sapiens	IC50	nM	0.42
	16635879	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(F)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3823296	=	IC50	nM	0.39	CHEMBL4247	Homo sapiens	IC50	nM	0.39
	16635880	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(OC)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3823198	=	IC50	nM	1.19	CHEMBL4247	Homo sapiens	IC50	nM	1.19
	16635881	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(C2CC2)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3822524	=	IC50	nM	3.23	CHEMBL4247	Homo sapiens	IC50	nM	3.23
	16635882	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(C2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3823190	=	IC50	nM	0.38	CHEMBL4247	Homo sapiens	IC50	nM	0.38
	16635883	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(-c2cnn(C3CCNCC3)c2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3822645	=	IC50	nM	0.76	CHEMBL4247	Homo sapiens	IC50	nM	0.76
	16635884	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(N2CCC(N3CCCCC3)C2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3823243	=	IC50	nM	0.88	CHEMBL4247	Homo sapiens	IC50	nM	0.88
	16635885	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(N2CCC(N3CCCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3824290	=	IC50	nM	0.49	CHEMBL4247	Homo sapiens	IC50	nM	0.49
	16635886	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3545311	=	IC50	nM	0.37	CHEMBL4247	Homo sapiens	IC50	nM	0.37
	16635887	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(N2CCC(N3CCOCC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3822557	=	IC50	nM	0.49	CHEMBL4247	Homo sapiens	IC50	nM	0.49
	16635888	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(N2CCN(C3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3824327	=	IC50	nM	0.28	CHEMBL4247	Homo sapiens	IC50	nM	0.28
	16635889	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(N2CCC(N3CCCC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3823031	=	IC50	nM	0.53	CHEMBL4247	Homo sapiens	IC50	nM	0.53
	16635890	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(N2CCC(CN3CCC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3823218	=	IC50	nM	0.88	CHEMBL4247	Homo sapiens	IC50	nM	0.88
	16635891	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(N2CCC(N(C)C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3397300	=	IC50	nM	0.07	CHEMBL4247	Homo sapiens	IC50	nM	0.07
	16635892	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(N2CC[C@@H](N(C)C)C2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3823107	=	IC50	nM	0.33	CHEMBL4247	Homo sapiens	IC50	nM	0.33
	16635893	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(N2CCCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3824130	=	IC50	nM	0.72	CHEMBL4247	Homo sapiens	IC50	nM	0.72
	16635894	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(N2CCN(CCO)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3823235	=	IC50	nM	0.18	CHEMBL4247	Homo sapiens	IC50	nM	0.18
	16635895	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	CNC(=O)CN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccccc4P(C)(C)=O)n3)c(OC)c2)CC1		CHEMBL3823872	=	IC50	nM	3.1	CHEMBL4247	Homo sapiens	IC50	nM	3.1
	16635896	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(N2CCC(O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3823017	=	IC50	nM	0.36	CHEMBL4247	Homo sapiens	IC50	nM	0.36
	16635897	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3824007	=	IC50	nM	0.59	CHEMBL4247	Homo sapiens	IC50	nM	0.59
	16635898	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3822611	=	IC50	nM	0.18	CHEMBL4247	Homo sapiens	IC50	nM	0.18
	16635899	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(N2CCOCC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3823416	=	IC50	nM	0.24	CHEMBL4247	Homo sapiens	IC50	nM	0.24
	16635900	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(OC2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3823916	=	IC50	nM	0.54	CHEMBL4247	Homo sapiens	IC50	nM	0.54
	16635901	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(OC2CCN(C)C2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3823603	=	IC50	nM	0.33	CHEMBL4247	Homo sapiens	IC50	nM	0.33
	16635902	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(OCCCN2CCCC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3823549	=	IC50	nM	0.22	CHEMBL4247	Homo sapiens	IC50	nM	0.22
	16635903	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1ccccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3822973	=	IC50	nM	2.1	CHEMBL4247	Homo sapiens	IC50	nM	2.1
	16635904	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(P(C)(C)=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3823165	=	IC50	nM	1.06	CHEMBL4247	Homo sapiens	IC50	nM	1.06
	16635905	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(P(C)(C)=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(C)(=O)=O)n1		CHEMBL3823256	=	IC50	nM	0.33	CHEMBL4247	Homo sapiens	IC50	nM	0.33
	16635906	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(P(C)(C)=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2C(N)=O)n1		CHEMBL3823268	=	IC50	nM	0.68	CHEMBL4247	Homo sapiens	IC50	nM	0.68
	16635907	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(P(C)(C)=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2C(C)=O)n1		CHEMBL3824326	=	IC50	nM	0.79	CHEMBL4247	Homo sapiens	IC50	nM	0.79
	16635908	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(P(C)(C)=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2OC)n1		CHEMBL3822982	=	IC50	nM	0.96	CHEMBL4247	Homo sapiens	IC50	nM	0.96
	16635909	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	COc1cc(P(C)(C)=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3824304	=	IC50	nM	0.31	CHEMBL4247	Homo sapiens	IC50	nM	0.31
	16635910	CHEMBL3824709	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	0.64	CHEMBL4247	Homo sapiens	IC50	nM	0.64
	16636080	CHEMBL3824726	Inhibition of ALK phosphorylation in mouse xenografted with human KARPAS299 cells assessed as p-ALK level at 25 mg/kg, po administered as single dose measured after 10 hrs relative to 2 hrs vehicle-treated tumor	B	COc1cc(OC2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3823916	=	Activity	%	23.0	CHEMBL4247	Homo sapiens	Activity	%	23.0
	16636081	CHEMBL3824726	Inhibition of ALK phosphorylation in mouse xenografted with human KARPAS299 cells assessed as p-ALK level at 25 mg/kg, po administered as single dose measured after 10 hrs relative to 2 hrs vehicle-treated tumor	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3822611	=	Activity	%	2.0	CHEMBL4247	Homo sapiens	Activity	%	2.0
	16636082	CHEMBL3824726	Inhibition of ALK phosphorylation in mouse xenografted with human KARPAS299 cells assessed as p-ALK level at 25 mg/kg, po administered as single dose measured after 10 hrs relative to 2 hrs vehicle-treated tumor	B	COc1cc(N2CCC(CN3CCC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3823218	=	Activity	%	13.0	CHEMBL4247	Homo sapiens	Activity	%	13.0
	16636083	CHEMBL3824726	Inhibition of ALK phosphorylation in mouse xenografted with human KARPAS299 cells assessed as p-ALK level at 25 mg/kg, po administered as single dose measured after 10 hrs relative to 2 hrs vehicle-treated tumor	B	COc1cc(N2CCC(N3CCCC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3823031	=	Activity	%	2.0	CHEMBL4247	Homo sapiens	Activity	%	2.0
	16636084	CHEMBL3824726	Inhibition of ALK phosphorylation in mouse xenografted with human KARPAS299 cells assessed as p-ALK level at 25 mg/kg, po administered as single dose measured after 10 hrs relative to 2 hrs vehicle-treated tumor	B	COc1cc(N2CCC(N3CCOCC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3822557	=	Activity	%	15.0	CHEMBL4247	Homo sapiens	Activity	%	15.0
	16636085	CHEMBL3824726	Inhibition of ALK phosphorylation in mouse xenografted with human KARPAS299 cells assessed as p-ALK level at 25 mg/kg, po administered as single dose measured after 10 hrs relative to 2 hrs vehicle-treated tumor	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3545311	=	Activity	%	1.0	CHEMBL4247	Homo sapiens	Activity	%	1.0
	16636086	CHEMBL3824726	Inhibition of ALK phosphorylation in mouse xenografted with human KARPAS299 cells assessed as p-ALK level at 25 mg/kg, po administered as single dose measured after 10 hrs relative to 2 hrs vehicle-treated tumor	B	COc1cc(C2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3823190	=	Activity	%	1.0	CHEMBL4247	Homo sapiens	Activity	%	1.0
	16636087	CHEMBL3824727	Inhibition of ALK phosphorylation in mouse xenografted with human KARPAS299 cells assessed as p-ALK level at 25 mg/kg, po administered as single dose measured after 16 hrs relative to 2 hrs vehicle-treated tumor	B	COc1cc(OC2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3823916	=	Activity	%	125.0	CHEMBL4247	Homo sapiens	Activity	%	125.0
	16636088	CHEMBL3824727	Inhibition of ALK phosphorylation in mouse xenografted with human KARPAS299 cells assessed as p-ALK level at 25 mg/kg, po administered as single dose measured after 16 hrs relative to 2 hrs vehicle-treated tumor	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3822611	=	Activity	%	14.0	CHEMBL4247	Homo sapiens	Activity	%	14.0
	16636089	CHEMBL3824727	Inhibition of ALK phosphorylation in mouse xenografted with human KARPAS299 cells assessed as p-ALK level at 25 mg/kg, po administered as single dose measured after 16 hrs relative to 2 hrs vehicle-treated tumor	B	COc1cc(N2CCC(O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3823017	=	Activity	%	25.0	CHEMBL4247	Homo sapiens	Activity	%	25.0
	16636090	CHEMBL3824727	Inhibition of ALK phosphorylation in mouse xenografted with human KARPAS299 cells assessed as p-ALK level at 25 mg/kg, po administered as single dose measured after 16 hrs relative to 2 hrs vehicle-treated tumor	B	COc1cc(N2CCC(CN3CCC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3823218	=	Activity	%	60.0	CHEMBL4247	Homo sapiens	Activity	%	60.0
	16636091	CHEMBL3824727	Inhibition of ALK phosphorylation in mouse xenografted with human KARPAS299 cells assessed as p-ALK level at 25 mg/kg, po administered as single dose measured after 16 hrs relative to 2 hrs vehicle-treated tumor	B	COc1cc(N2CCC(N3CCCC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3823031	=	Activity	%	39.0	CHEMBL4247	Homo sapiens	Activity	%	39.0
	16636092	CHEMBL3824727	Inhibition of ALK phosphorylation in mouse xenografted with human KARPAS299 cells assessed as p-ALK level at 25 mg/kg, po administered as single dose measured after 16 hrs relative to 2 hrs vehicle-treated tumor	B	COc1cc(N2CCC(N3CCOCC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3822557	=	Activity	%	52.0	CHEMBL4247	Homo sapiens	Activity	%	52.0
	16636093	CHEMBL3824727	Inhibition of ALK phosphorylation in mouse xenografted with human KARPAS299 cells assessed as p-ALK level at 25 mg/kg, po administered as single dose measured after 16 hrs relative to 2 hrs vehicle-treated tumor	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3545311	=	Activity	%	7.0	CHEMBL4247	Homo sapiens	Activity	%	7.0
	16636094	CHEMBL3824727	Inhibition of ALK phosphorylation in mouse xenografted with human KARPAS299 cells assessed as p-ALK level at 25 mg/kg, po administered as single dose measured after 16 hrs relative to 2 hrs vehicle-treated tumor	B	COc1cc(C2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3823190	=	Activity	%	69.0	CHEMBL4247	Homo sapiens	Activity	%	69.0
	16636095	CHEMBL3824728	Inhibition of ALK phosphorylation in mouse xenografted with human KARPAS299 cells assessed as p-ALK level at 25 mg/kg, po administered as single dose measured after 24 hrs relative to 2 hrs vehicle-treated tumor	B	COc1cc(OC2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3823916	=	Activity	%	160.0	CHEMBL4247	Homo sapiens	Activity	%	160.0
	16636096	CHEMBL3824728	Inhibition of ALK phosphorylation in mouse xenografted with human KARPAS299 cells assessed as p-ALK level at 25 mg/kg, po administered as single dose measured after 24 hrs relative to 2 hrs vehicle-treated tumor	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3822611	=	Activity	%	94.0	CHEMBL4247	Homo sapiens	Activity	%	94.0
	16636097	CHEMBL3824728	Inhibition of ALK phosphorylation in mouse xenografted with human KARPAS299 cells assessed as p-ALK level at 25 mg/kg, po administered as single dose measured after 24 hrs relative to 2 hrs vehicle-treated tumor	B	COc1cc(N2CCC(O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3823017	=	Activity	%	168.0	CHEMBL4247	Homo sapiens	Activity	%	168.0
	16636098	CHEMBL3824728	Inhibition of ALK phosphorylation in mouse xenografted with human KARPAS299 cells assessed as p-ALK level at 25 mg/kg, po administered as single dose measured after 24 hrs relative to 2 hrs vehicle-treated tumor	B	COc1cc(N2CCC(CN3CCC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3823218	=	Activity	%	104.0	CHEMBL4247	Homo sapiens	Activity	%	104.0
	16636099	CHEMBL3824728	Inhibition of ALK phosphorylation in mouse xenografted with human KARPAS299 cells assessed as p-ALK level at 25 mg/kg, po administered as single dose measured after 24 hrs relative to 2 hrs vehicle-treated tumor	B	COc1cc(N2CCC(N3CCCC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3823031	=	Activity	%	51.0	CHEMBL4247	Homo sapiens	Activity	%	51.0
	16636100	CHEMBL3824728	Inhibition of ALK phosphorylation in mouse xenografted with human KARPAS299 cells assessed as p-ALK level at 25 mg/kg, po administered as single dose measured after 24 hrs relative to 2 hrs vehicle-treated tumor	B	COc1cc(N2CCC(N3CCOCC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3822557	=	Activity	%	50.0	CHEMBL4247	Homo sapiens	Activity	%	50.0
	16636101	CHEMBL3824728	Inhibition of ALK phosphorylation in mouse xenografted with human KARPAS299 cells assessed as p-ALK level at 25 mg/kg, po administered as single dose measured after 24 hrs relative to 2 hrs vehicle-treated tumor	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3545311	=	Activity	%	39.0	CHEMBL4247	Homo sapiens	Activity	%	39.0
	16636102	CHEMBL3824728	Inhibition of ALK phosphorylation in mouse xenografted with human KARPAS299 cells assessed as p-ALK level at 25 mg/kg, po administered as single dose measured after 24 hrs relative to 2 hrs vehicle-treated tumor	B	COc1cc(C2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3823190	=	Activity	%	118.0	CHEMBL4247	Homo sapiens	Activity	%	118.0
	16636103	CHEMBL3824729	Inhibition of ALK phosphorylation in mouse xenografted with human KARPAS299 cells assessed as p-ALK level at 25 mg/kg, po administered as single dose measured after 8 hrs relative to 2 hrs vehicle-treated tumor	B	COc1cc(N2CCC(O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3823017	=	Activity	%	41.0	CHEMBL4247	Homo sapiens	Activity	%	41.0
	16655100	CHEMBL3831013	Inhibition of ALK expressed in human NCI-H3122 cells assessed as cell growth inhibition after 72 hrs by SRB/CCK-8 assay	B	CCc1cc2c(cc1C1=CCN(C(=O)C3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3736388	=	IC50	nM	126.0	CHEMBL4247	Homo sapiens	IC50	nM	126.0
	16655101	CHEMBL3831013	Inhibition of ALK expressed in human NCI-H3122 cells assessed as cell growth inhibition after 72 hrs by SRB/CCK-8 assay	B	CCc1cc2c(cc1C1=CCN(CC3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3735386	=	IC50	nM	49.0	CHEMBL4247	Homo sapiens	IC50	nM	49.0
	16655108	CHEMBL3830306	Inhibition of N-terminal His6-tagged recombinant human ALK (1058 residues) expressed in insect Sf21 cells using poly(Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CC1(C)c2cc(C3CCN(CC4CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735648	=	IC50	nM	3.4	CHEMBL4247	Homo sapiens	IC50	nM	3.4
Dose-dependent effect	16655128	CHEMBL3830899	Inhibition of ALK phosphorylation at Y1604 residue in human Karpas299 cells after 1 hr by Western blot analysis	B	CC1(C)c2cc(C3CCN(CC4CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735648		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-dependent effect	16655129	CHEMBL3830898	Inhibition of ALK in human Karpas299 cells assessed as suppression of STAT3 phosphorylation at Y705 residue after 1 hr by Western blot analysis	B	CC1(C)c2cc(C3CCN(CC4CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735648		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-dependent effect	16655130	CHEMBL3830897	Inhibition of ALK in human Karpas299 cells assessed as suppression of ERK phosphorylation at T202/Y204 residue after 1 hr by Western blot analysis	B	CC1(C)c2cc(C3CCN(CC4CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735648		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-dependent effect	16655131	CHEMBL3830900	Inhibition of ALK phosphorylation at Y1604 residue in human NCI-H3122 cells after 1 hr by Western blot analysis	B	CC1(C)c2cc(C3CCN(CC4CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735648		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-dependent effect	16655132	CHEMBL3830901	Inhibition of ALK in human NCI-H3122 cells assessed as suppression of STAT3 phosphorylation at Y705 residue after 1 hr by Western blot analysis	B	CC1(C)c2cc(C3CCN(CC4CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735648		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-dependent effect	16655133	CHEMBL3830902	Inhibition of ALK in human NCI-H3122 cells assessed as suppression of ERK phosphorylation at T202/Y204 residue after 1 hr by Western blot analysis	B	CC1(C)c2cc(C3CCN(CC4CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735648		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	16655140	CHEMBL3831013	Inhibition of ALK expressed in human NCI-H3122 cells assessed as cell growth inhibition after 72 hrs by SRB/CCK-8 assay	B	CC1(C)c2cc(C3CCN(CC4CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735648	=	IC50	nM	17.9	CHEMBL4247	Homo sapiens	IC50	nM	17.9
	16655141	CHEMBL3831015	Inhibition of recombinant ALK L1196M mutant (unknown origin) using poly(Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CC1(C)c2cc(C3CCN(CC4CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735648	=	IC50	nM	3.9	CHEMBL4247	Homo sapiens	IC50	nM	3.9
	16655142	CHEMBL3831016	Inhibition of recombinant ALK C1156Y mutant (unknown origin) using poly(Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CC1(C)c2cc(C3CCN(CC4CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735648	=	IC50	nM	3.7	CHEMBL4247	Homo sapiens	IC50	nM	3.7
	16655143	CHEMBL3831017	Inhibition of recombinant ALK F1174L mutant (unknown origin) using poly(Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CC1(C)c2cc(C3CCN(CC4CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735648	=	IC50	nM	8.5	CHEMBL4247	Homo sapiens	IC50	nM	8.5
	16655144	CHEMBL3831018	Inhibition of recombinant ALK G1269A mutant (unknown origin) using poly(Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CC1(C)c2cc(C3CCN(CC4CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735648	=	IC50	nM	8.1	CHEMBL4247	Homo sapiens	IC50	nM	8.1
	16655145	CHEMBL3831019	Inhibition of recombinant ALK R1275Q mutant (unknown origin) using poly(Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CC1(C)c2cc(C3CCN(CC4CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735648	=	IC50	nM	7.6	CHEMBL4247	Homo sapiens	IC50	nM	7.6
	16655146	CHEMBL3831020	Inhibition of recombinant ALK T1151ins mutant (unknown origin) using poly(Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CC1(C)c2cc(C3CCN(CC4CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735648	=	IC50	nM	38.1	CHEMBL4247	Homo sapiens	IC50	nM	38.1
	16655162	CHEMBL3831013	Inhibition of ALK expressed in human NCI-H3122 cells assessed as cell growth inhibition after 72 hrs by SRB/CCK-8 assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	261.0	CHEMBL4247	Homo sapiens	IC50	nM	261.0
	16655173	CHEMBL3831013	Inhibition of ALK expressed in human NCI-H3122 cells assessed as cell growth inhibition after 72 hrs by SRB/CCK-8 assay	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	=	IC50	nM	19.0	CHEMBL4247	Homo sapiens	IC50	nM	19.0
	16744043	CHEMBL3858239	Inhibition of human ALK expressed in baculovirus using recombinant GST PLC-gamma as substrate assessed as phosphorylation of the substrate after 15 mins by TRF assay	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CC[C@@H](N1CCOCC1)CC2		CHEMBL2064666	=	IC50	nM	1.9	CHEMBL4247	Homo sapiens	IC50	nM	1.9
	16744044	CHEMBL3858239	Inhibition of human ALK expressed in baculovirus using recombinant GST PLC-gamma as substrate assessed as phosphorylation of the substrate after 15 mins by TRF assay	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CC(N1CCOCC1)CCC2		CHEMBL3917455	=	IC50	nM	39.0	CHEMBL4247	Homo sapiens	IC50	nM	39.0
	16744045	CHEMBL3858239	Inhibition of human ALK expressed in baculovirus using recombinant GST PLC-gamma as substrate assessed as phosphorylation of the substrate after 15 mins by TRF assay	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CCC[C@H](N1CCOCC1)C2		CHEMBL3945332	=	IC50	nM	7.0	CHEMBL4247	Homo sapiens	IC50	nM	7.0
	16744046	CHEMBL3858239	Inhibition of human ALK expressed in baculovirus using recombinant GST PLC-gamma as substrate assessed as phosphorylation of the substrate after 15 mins by TRF assay	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CCC[C@@H](N1CCOCC1)C2		CHEMBL3908493	=	IC50	nM	1.5	CHEMBL4247	Homo sapiens	IC50	nM	1.5
	16744047	CHEMBL3858239	Inhibition of human ALK expressed in baculovirus using recombinant GST PLC-gamma as substrate assessed as phosphorylation of the substrate after 15 mins by TRF assay	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CCC[C@H](N1CCN(C)CC1)C2		CHEMBL3936443	=	IC50	nM	9.0	CHEMBL4247	Homo sapiens	IC50	nM	9.0
	16744048	CHEMBL3858239	Inhibition of human ALK expressed in baculovirus using recombinant GST PLC-gamma as substrate assessed as phosphorylation of the substrate after 15 mins by TRF assay	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CCC[C@@H](N1CCN(C)CC1)C2		CHEMBL3980825	=	IC50	nM	9.0	CHEMBL4247	Homo sapiens	IC50	nM	9.0
	16744049	CHEMBL3858239	Inhibition of human ALK expressed in baculovirus using recombinant GST PLC-gamma as substrate assessed as phosphorylation of the substrate after 15 mins by TRF assay	B	COCCNC1CCCc2c(ccc(Nc3ncc(Cl)c(N[C@H]4[C@@H](C(N)=O)[C@@H]5C=C[C@H]4C5)n3)c2OC)C1		CHEMBL3951972	=	IC50	nM	7.0	CHEMBL4247	Homo sapiens	IC50	nM	7.0
	16744050	CHEMBL3858239	Inhibition of human ALK expressed in baculovirus using recombinant GST PLC-gamma as substrate assessed as phosphorylation of the substrate after 15 mins by TRF assay	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CCC[C@H](N1CCN(CCO)CC1)C2		CHEMBL3972807	=	IC50	nM	5.8	CHEMBL4247	Homo sapiens	IC50	nM	5.8
	16744051	CHEMBL3858239	Inhibition of human ALK expressed in baculovirus using recombinant GST PLC-gamma as substrate assessed as phosphorylation of the substrate after 15 mins by TRF assay	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CCC[C@@H](N1CCN(CCO)CC1)C2		CHEMBL3943236	=	IC50	nM	6.3	CHEMBL4247	Homo sapiens	IC50	nM	6.3
	16744052	CHEMBL3858239	Inhibition of human ALK expressed in baculovirus using recombinant GST PLC-gamma as substrate assessed as phosphorylation of the substrate after 15 mins by TRF assay	B	COc1c(Nc2ncc(Cl)c(Nc3ccccc3N(C)S(C)(=O)=O)n2)ccc2c1CCCC(N1CCN(C)CC1)C2		CHEMBL3961771	=	IC50	nM	2.3	CHEMBL4247	Homo sapiens	IC50	nM	2.3
	16744053	CHEMBL3858239	Inhibition of human ALK expressed in baculovirus using recombinant GST PLC-gamma as substrate assessed as phosphorylation of the substrate after 15 mins by TRF assay	B	COc1c(Nc2ncc(Cl)c(Nc3ccccc3N(C)S(C)(=O)=O)n2)ccc2c1CCCC(N1CCN(CCO)CC1)C2		CHEMBL3934268	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	nM	2.0
	16744054	CHEMBL3858239	Inhibition of human ALK expressed in baculovirus using recombinant GST PLC-gamma as substrate assessed as phosphorylation of the substrate after 15 mins by TRF assay	B	COc1c(Nc2ncc(Cl)c(Nc3ccccc3NS(C)(=O)=O)n2)ccc2c1CCCC(N1CCN(CCO)CC1)C2		CHEMBL3953048	=	IC50	nM	18.0	CHEMBL4247	Homo sapiens	IC50	nM	18.0
	16744055	CHEMBL3858239	Inhibition of human ALK expressed in baculovirus using recombinant GST PLC-gamma as substrate assessed as phosphorylation of the substrate after 15 mins by TRF assay	B	COc1c(Nc2ncc(Cl)c(Nc3ccccc3N3CCCS3(=O)=O)n2)ccc2c1CCCC(N1CCN(CCO)CC1)C2		CHEMBL3925372	=	IC50	nM	6.1	CHEMBL4247	Homo sapiens	IC50	nM	6.1
	16744056	CHEMBL3858239	Inhibition of human ALK expressed in baculovirus using recombinant GST PLC-gamma as substrate assessed as phosphorylation of the substrate after 15 mins by TRF assay	B	COc1c(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)N(C)C)n2)ccc2c1CCCC(N1CCN(CCO)CC1)C2		CHEMBL3918616	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
	16744057	CHEMBL3858239	Inhibition of human ALK expressed in baculovirus using recombinant GST PLC-gamma as substrate assessed as phosphorylation of the substrate after 15 mins by TRF assay	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2OC)CCCC(N2CCN(CCO)CC2)C3)ncc1Cl		CHEMBL3890564	=	IC50	nM	3.4	CHEMBL4247	Homo sapiens	IC50	nM	3.4
	16744058	CHEMBL3858239	Inhibition of human ALK expressed in baculovirus using recombinant GST PLC-gamma as substrate assessed as phosphorylation of the substrate after 15 mins by TRF assay	B	COc1c(Nc2ncc(Cl)c(Nc3ccccc3-n3cccn3)n2)ccc2c1CCCC(N1CCN(CCO)CC1)C2		CHEMBL3934099	=	IC50	nM	2.3	CHEMBL4247	Homo sapiens	IC50	nM	2.3
	16744059	CHEMBL3858239	Inhibition of human ALK expressed in baculovirus using recombinant GST PLC-gamma as substrate assessed as phosphorylation of the substrate after 15 mins by TRF assay	B	COc1c(Nc2ncc(Cl)c(Nc3ccccc3-c3nccn3C)n2)ccc2c1CCCC(N1CCN(CCO)CC1)C2		CHEMBL3961598	=	IC50	nM	5.0	CHEMBL4247	Homo sapiens	IC50	nM	5.0
	16744060	CHEMBL3858239	Inhibition of human ALK expressed in baculovirus using recombinant GST PLC-gamma as substrate assessed as phosphorylation of the substrate after 15 mins by TRF assay	B	COc1ccccc1Nc1nc(Nc2ccc3c(c2OC)CCCC(N2CCN(CCO)CC2)C3)ncc1Cl		CHEMBL3943066	=	IC50	nM	44.0	CHEMBL4247	Homo sapiens	IC50	nM	44.0
	16744061	CHEMBL3858239	Inhibition of human ALK expressed in baculovirus using recombinant GST PLC-gamma as substrate assessed as phosphorylation of the substrate after 15 mins by TRF assay	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2OC)CCC[C@@H](N2CCN(CCO)CC2)C3)ncc1Cl		CHEMBL3972653	=	IC50	nM	5.7	CHEMBL4247	Homo sapiens	IC50	nM	5.7
	16744062	CHEMBL3858239	Inhibition of human ALK expressed in baculovirus using recombinant GST PLC-gamma as substrate assessed as phosphorylation of the substrate after 15 mins by TRF assay	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2OC)CCC[C@H](N2CCN(CCO)CC2)C3)ncc1Cl		CHEMBL3951811	=	IC50	nM	3.1	CHEMBL4247	Homo sapiens	IC50	nM	3.1
	16744119	CHEMBL3858243	Inhibition of NPM-ALK phosphorylation in human SUP-M2 cells after 2 to 3 hrs by ELISA	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CC[C@@H](N1CCOCC1)CC2		CHEMBL2064666	=	IC50	nM	20.0	CHEMBL4247	Homo sapiens	IC50	nM	20.0
	16744120	CHEMBL3858243	Inhibition of NPM-ALK phosphorylation in human SUP-M2 cells after 2 to 3 hrs by ELISA	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CCC[C@H](N1CCN(C)CC1)C2		CHEMBL3936443	=	IC50	nM	200.0	CHEMBL4247	Homo sapiens	IC50	nM	200.0
	16744121	CHEMBL3858243	Inhibition of NPM-ALK phosphorylation in human SUP-M2 cells after 2 to 3 hrs by ELISA	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CCC[C@@H](N1CCN(C)CC1)C2		CHEMBL3980825	=	IC50	nM	200.0	CHEMBL4247	Homo sapiens	IC50	nM	200.0
	16744122	CHEMBL3858243	Inhibition of NPM-ALK phosphorylation in human SUP-M2 cells after 2 to 3 hrs by ELISA	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CCC[C@H](N1CCN(CCO)CC1)C2		CHEMBL3972807	=	IC50	nM	30.0	CHEMBL4247	Homo sapiens	IC50	nM	30.0
	16744123	CHEMBL3858243	Inhibition of NPM-ALK phosphorylation in human SUP-M2 cells after 2 to 3 hrs by ELISA	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CCC[C@@H](N1CCN(CCO)CC1)C2		CHEMBL3943236	=	IC50	nM	50.0	CHEMBL4247	Homo sapiens	IC50	nM	50.0
	16744124	CHEMBL3858243	Inhibition of NPM-ALK phosphorylation in human SUP-M2 cells after 2 to 3 hrs by ELISA	B	COc1c(Nc2ncc(Cl)c(Nc3ccccc3N(C)S(C)(=O)=O)n2)ccc2c1CCCC(N1CCN(C)CC1)C2		CHEMBL3961771	=	IC50	nM	40.0	CHEMBL4247	Homo sapiens	IC50	nM	40.0
	16744125	CHEMBL3858243	Inhibition of NPM-ALK phosphorylation in human SUP-M2 cells after 2 to 3 hrs by ELISA	B	COc1c(Nc2ncc(Cl)c(Nc3ccccc3N(C)S(C)(=O)=O)n2)ccc2c1CCCC(N1CCN(CCO)CC1)C2		CHEMBL3934268	=	IC50	nM	30.0	CHEMBL4247	Homo sapiens	IC50	nM	30.0
	16744126	CHEMBL3858243	Inhibition of NPM-ALK phosphorylation in human SUP-M2 cells after 2 to 3 hrs by ELISA	B	COc1c(Nc2ncc(Cl)c(Nc3ccccc3N3CCCS3(=O)=O)n2)ccc2c1CCCC(N1CCN(CCO)CC1)C2		CHEMBL3925372	=	IC50	nM	60.0	CHEMBL4247	Homo sapiens	IC50	nM	60.0
	16744127	CHEMBL3858243	Inhibition of NPM-ALK phosphorylation in human SUP-M2 cells after 2 to 3 hrs by ELISA	B	COc1c(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)N(C)C)n2)ccc2c1CCCC(N1CCN(CCO)CC1)C2		CHEMBL3918616	=	IC50	nM	40.0	CHEMBL4247	Homo sapiens	IC50	nM	40.0
	16744128	CHEMBL3858243	Inhibition of NPM-ALK phosphorylation in human SUP-M2 cells after 2 to 3 hrs by ELISA	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2OC)CCCC(N2CCN(CCO)CC2)C3)ncc1Cl		CHEMBL3890564	=	IC50	nM	40.0	CHEMBL4247	Homo sapiens	IC50	nM	40.0
	16744129	CHEMBL3858243	Inhibition of NPM-ALK phosphorylation in human SUP-M2 cells after 2 to 3 hrs by ELISA	B	COc1c(Nc2ncc(Cl)c(Nc3ccccc3-n3cccn3)n2)ccc2c1CCCC(N1CCN(CCO)CC1)C2		CHEMBL3934099	=	IC50	nM	20.0	CHEMBL4247	Homo sapiens	IC50	nM	20.0
	16744130	CHEMBL3858243	Inhibition of NPM-ALK phosphorylation in human SUP-M2 cells after 2 to 3 hrs by ELISA	B	COc1c(Nc2ncc(Cl)c(Nc3ccccc3-c3nccn3C)n2)ccc2c1CCCC(N1CCN(CCO)CC1)C2		CHEMBL3961598	=	IC50	nM	50.0	CHEMBL4247	Homo sapiens	IC50	nM	50.0
	16744131	CHEMBL3858243	Inhibition of NPM-ALK phosphorylation in human SUP-M2 cells after 2 to 3 hrs by ELISA	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2OC)CCC[C@@H](N2CCN(CCO)CC2)C3)ncc1Cl		CHEMBL3972653	=	IC50	nM	50.0	CHEMBL4247	Homo sapiens	IC50	nM	50.0
	16744132	CHEMBL3858243	Inhibition of NPM-ALK phosphorylation in human SUP-M2 cells after 2 to 3 hrs by ELISA	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2OC)CCC[C@H](N2CCN(CCO)CC2)C3)ncc1Cl		CHEMBL3951811	=	IC50	nM	22.0	CHEMBL4247	Homo sapiens	IC50	nM	22.0
	16744223	CHEMBL3858266	Binding affinity to human ALK (1088 to 1409 residues) expressed in mammalian system by KINOMEscan assay	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2OC)CCC[C@H](N2CCN(CCO)CC2)C3)ncc1Cl		CHEMBL3951811	=	Kd	nM	2.3	CHEMBL4247	Homo sapiens	Kd	nM	2.3
	16744224	CHEMBL3858267	Inhibition of human ALK (1088 to 1409 residues) expressed in mammalian system at 1 uM by KINOMEscan assay	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2OC)CCC[C@H](N2CCN(CCO)CC2)C3)ncc1Cl		CHEMBL3951811	>	Inhibition	%	90.0	CHEMBL4247	Homo sapiens	INH	%	90.0
	16744235	CHEMBL3858278	Binding affinity to human ALK (1088 to 1409 residues) C1156Y mutant expressed in mammalian system by KINOMEscan assay	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2OC)CCC[C@H](N2CCN(CCO)CC2)C3)ncc1Cl		CHEMBL3951811	=	Kd	nM	1.6	CHEMBL4247	Homo sapiens	Kd	nM	1.6
	16744236	CHEMBL3858221	Binding affinity to human ALK (1088 to 1409 residues) F1174L mutant expressed in mammalian system by KINOMEscan assay	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2OC)CCC[C@H](N2CCN(CCO)CC2)C3)ncc1Cl		CHEMBL3951811	=	Kd	nM	1.1	CHEMBL4247	Homo sapiens	Kd	nM	1.1
	16744237	CHEMBL3858279	Binding affinity to human ALK (1088 to 1409 residues) L1196M mutant expressed in mammalian system by KINOMEscan assay	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2OC)CCC[C@H](N2CCN(CCO)CC2)C3)ncc1Cl		CHEMBL3951811	=	Kd	nM	3.3	CHEMBL4247	Homo sapiens	Kd	nM	3.3
	16744276	CHEMBL3858315	Inhibition of EML4-ALK tyrosine phosphorylation in human NCI-H2228 cells	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2OC)CCC[C@H](N2CCN(CCO)CC2)C3)ncc1Cl		CHEMBL3951811	=	IC50	nM	175.0	CHEMBL4247	Homo sapiens	IC50	nM	175.0
	16744277	CHEMBL3858316	Inhibition of EML4-ALK tyrosine phosphorylation in human NCI-H3122 cells	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc3c(c2OC)CCC[C@H](N2CCN(CCO)CC2)C3)ncc1Cl		CHEMBL3951811	=	IC50	nM	85.0	CHEMBL4247	Homo sapiens	IC50	nM	85.0
	16777234	CHEMBL3864889	Inhibition of recombinant wild type ALK (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	CCc1cc2c(cc1N1CCN(CC3(O)CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3958173	=	IC50	nM	1.5	CHEMBL4247	Homo sapiens	IC50	nM	1.5
	16777235	CHEMBL3864890	Inhibition of recombinant ALK L1196M mutant (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	CCc1cc2c(cc1N1CCN(CC3(O)CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3958173	=	IC50	nM	4.2	CHEMBL4247	Homo sapiens	IC50	nM	4.2
Dose-dependent effect	16777239	CHEMBL3864895	Inhibition of ALK phosphorylation in human NCI-H3122 cells after 1 hr by Western blot method	B	CCc1cc2c(cc1N1CCN(CC3(O)CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3958173		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-dependent effect	16777240	CHEMBL3864896	Inhibition of ALK in human NCI-H3122 cells assessed as decrease in STAT3 phosphorylation after 1 hr by Western blot method	B	CCc1cc2c(cc1N1CCN(CC3(O)CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3958173		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-dependent effect	16777241	CHEMBL3864897	Inhibition of ALK in human NCI-H3122 cells assessed as decrease in Akt phosphorylation after 1 hr by Western blot method	B	CCc1cc2c(cc1N1CCN(CC3(O)CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3958173		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-dependent effect	16777242	CHEMBL3864898	Inhibition of ALK in human NCI-H3122 cells assessed as decrease in ERK phosphorylation after 1 hr by Western blot method	B	CCc1cc2c(cc1N1CCN(CC3(O)CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3958173		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	16777265	CHEMBL3864889	Inhibition of recombinant wild type ALK (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	CC1(C)c2cc(C3CCN(CC4(O)CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3736267	=	IC50	nM	16.4	CHEMBL4247	Homo sapiens	IC50	nM	16.4
	16777266	CHEMBL3864890	Inhibition of recombinant ALK L1196M mutant (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	CC1(C)c2cc(C3CCN(CC4(O)CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3736267	>	IC50	nM	100.0	CHEMBL4247	Homo sapiens	IC50	nM	100.0
	16777269	CHEMBL3864889	Inhibition of recombinant wild type ALK (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	CCc1cc2c(cc1N1CCN(CC3(O)CCCCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3913823	=	IC50	nM	7.0	CHEMBL4247	Homo sapiens	IC50	nM	7.0
	16777271	CHEMBL3864889	Inhibition of recombinant wild type ALK (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	CCc1cc2c(cc1N1CCN(CC3(O)CCNCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3925858	=	IC50	nM	1.4	CHEMBL4247	Homo sapiens	IC50	nM	1.4
	16777273	CHEMBL3864889	Inhibition of recombinant wild type ALK (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	CCc1cc2c(cc1N1CCN(CC3(O)CC(C)OC(C)C3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3897774	=	IC50	nM	2.4	CHEMBL4247	Homo sapiens	IC50	nM	2.4
	16777275	CHEMBL3864889	Inhibition of recombinant wild type ALK (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	CCc1cc2c(cc1N1CCN(CC(O)(CCC(=O)O)CC(=O)O)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3934754	=	IC50	nM	17.1	CHEMBL4247	Homo sapiens	IC50	nM	17.1
	16808321	CHEMBL3870414	Inhibition of ALK (unknown origin) using peptide as substrate after 60 mins by HTRF assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(N/N=C/c2ccc(F)cc2)ncc1Cl		CHEMBL3921664	=	IC50	nM	2.3	CHEMBL4247	Homo sapiens	IC50	nmol/L	2.3
	16808322	CHEMBL3870414	Inhibition of ALK (unknown origin) using peptide as substrate after 60 mins by HTRF assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(N/N=C/c2ccc(C(F)(F)F)cc2)ncc1Cl		CHEMBL3893810	=	IC50	nM	3.6	CHEMBL4247	Homo sapiens	IC50	nmol/L	3.6
	16808323	CHEMBL3870414	Inhibition of ALK (unknown origin) using peptide as substrate after 60 mins by HTRF assay	B	COc1ccc(/C=N/Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)cc1		CHEMBL3894726	=	IC50	nM	4.8	CHEMBL4247	Homo sapiens	IC50	nmol/L	4.8
	16808324	CHEMBL3870414	Inhibition of ALK (unknown origin) using peptide as substrate after 60 mins by HTRF assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(N/N=C/c2ccc(OC(F)(F)F)cc2)ncc1Cl		CHEMBL3913728	=	IC50	nM	5.5	CHEMBL4247	Homo sapiens	IC50	nmol/L	5.5
	16808325	CHEMBL3870414	Inhibition of ALK (unknown origin) using peptide as substrate after 60 mins by HTRF assay	B	COc1cccc(/C=N/Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c1		CHEMBL3905284	=	IC50	nM	6.2	CHEMBL4247	Homo sapiens	IC50	nmol/L	6.2
	16808326	CHEMBL3870414	Inhibition of ALK (unknown origin) using peptide as substrate after 60 mins by HTRF assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(N/N=C/c2cccc(C(F)(F)F)c2)ncc1Cl		CHEMBL3934594	=	IC50	nM	5.5	CHEMBL4247	Homo sapiens	IC50	nmol/L	5.5
	16808327	CHEMBL3870414	Inhibition of ALK (unknown origin) using peptide as substrate after 60 mins by HTRF assay	B	COc1ccc(/C(C)=N/Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)cc1		CHEMBL3950479	=	IC50	nM	4.9	CHEMBL4247	Homo sapiens	IC50	nmol/L	4.9
	16808328	CHEMBL3870414	Inhibition of ALK (unknown origin) using peptide as substrate after 60 mins by HTRF assay	B	C/C(=N\Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1)c1ccc(F)cc1		CHEMBL3922762	=	IC50	nM	2.5	CHEMBL4247	Homo sapiens	IC50	nmol/L	2.5
	16808329	CHEMBL3870414	Inhibition of ALK (unknown origin) using peptide as substrate after 60 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	2.3	CHEMBL4247	Homo sapiens	IC50	nmol/L	2.3
	16808330	CHEMBL3870414	Inhibition of ALK (unknown origin) using peptide as substrate after 60 mins by HTRF assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	25.0	CHEMBL4247	Homo sapiens	IC50	nmol/L	25.0
	16808331	CHEMBL3870415	Inhibition of ALK L1196M mutant (unknown origin) using peptide as substrate after 60 mins by HTRF assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(N/N=C/c2ccc(F)cc2)ncc1Cl		CHEMBL3921664	=	IC50	nM	45.0	CHEMBL4247	Homo sapiens	IC50	nmol/L	45.0
	16808332	CHEMBL3870415	Inhibition of ALK L1196M mutant (unknown origin) using peptide as substrate after 60 mins by HTRF assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(N/N=C/c2ccc(C(F)(F)F)cc2)ncc1Cl		CHEMBL3893810	=	IC50	nM	73.0	CHEMBL4247	Homo sapiens	IC50	nmol/L	73.0
	16808333	CHEMBL3870415	Inhibition of ALK L1196M mutant (unknown origin) using peptide as substrate after 60 mins by HTRF assay	B	COc1ccc(/C=N/Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)cc1		CHEMBL3894726	=	IC50	nM	82.0	CHEMBL4247	Homo sapiens	IC50	nmol/L	82.0
	16808334	CHEMBL3870415	Inhibition of ALK L1196M mutant (unknown origin) using peptide as substrate after 60 mins by HTRF assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(N/N=C/c2ccc(OC(F)(F)F)cc2)ncc1Cl		CHEMBL3913728	=	IC50	nM	79.0	CHEMBL4247	Homo sapiens	IC50	nmol/L	79.0
	16808335	CHEMBL3870415	Inhibition of ALK L1196M mutant (unknown origin) using peptide as substrate after 60 mins by HTRF assay	B	COc1cccc(/C=N/Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c1		CHEMBL3905284	=	IC50	nM	86.0	CHEMBL4247	Homo sapiens	IC50	nmol/L	86.0
	16808336	CHEMBL3870415	Inhibition of ALK L1196M mutant (unknown origin) using peptide as substrate after 60 mins by HTRF assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(N/N=C/c2cccc(C(F)(F)F)c2)ncc1Cl		CHEMBL3934594	=	IC50	nM	69.0	CHEMBL4247	Homo sapiens	IC50	nmol/L	69.0
	16808337	CHEMBL3870415	Inhibition of ALK L1196M mutant (unknown origin) using peptide as substrate after 60 mins by HTRF assay	B	COc1ccc(/C(C)=N/Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)cc1		CHEMBL3950479	=	IC50	nM	80.0	CHEMBL4247	Homo sapiens	IC50	nmol/L	80.0
	16808338	CHEMBL3870415	Inhibition of ALK L1196M mutant (unknown origin) using peptide as substrate after 60 mins by HTRF assay	B	C/C(=N\Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1)c1ccc(F)cc1		CHEMBL3922762	=	IC50	nM	67.0	CHEMBL4247	Homo sapiens	IC50	nmol/L	67.0
	16808339	CHEMBL3870415	Inhibition of ALK L1196M mutant (unknown origin) using peptide as substrate after 60 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	64.0	CHEMBL4247	Homo sapiens	IC50	nmol/L	64.0
	16808340	CHEMBL3870415	Inhibition of ALK L1196M mutant (unknown origin) using peptide as substrate after 60 mins by HTRF assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	980.0	CHEMBL4247	Homo sapiens	IC50	nmol/L	980.0
	16808371	CHEMBL3870419	Potency index, ratio of crizotinib IC50 to compound IC50 for ALK (unknown origin)	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(N/N=C/c2ccc(F)cc2)ncc1Cl		CHEMBL3921664	=	Ratio IC50		9.0	CHEMBL4247	Homo sapiens	Ratio IC50		9.0
	16808372	CHEMBL3870419	Potency index, ratio of crizotinib IC50 to compound IC50 for ALK (unknown origin)	B	C/C(=N\Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1)c1ccc(F)cc1		CHEMBL3922762	=	Ratio IC50		9.0	CHEMBL4247	Homo sapiens	Ratio IC50		9.0
	16808373	CHEMBL3870420	Potency index, ratio of crizotinib IC50 to compound IC50 for ALK L1196M mutant (unknown origin)	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(N/N=C/c2ccc(F)cc2)ncc1Cl		CHEMBL3921664	=	Ratio IC50		20.0	CHEMBL4247	Homo sapiens	Ratio IC50		20.0
	16808374	CHEMBL3870420	Potency index, ratio of crizotinib IC50 to compound IC50 for ALK L1196M mutant (unknown origin)	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(N/N=C/c2ccc(C(F)(F)F)cc2)ncc1Cl		CHEMBL3893810	=	Ratio IC50		20.0	CHEMBL4247	Homo sapiens	Ratio IC50		20.0
	16808375	CHEMBL3870420	Potency index, ratio of crizotinib IC50 to compound IC50 for ALK L1196M mutant (unknown origin)	B	COc1ccc(/C=N/Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)cc1		CHEMBL3894726	=	Ratio IC50		20.0	CHEMBL4247	Homo sapiens	Ratio IC50		20.0
	16808376	CHEMBL3870420	Potency index, ratio of crizotinib IC50 to compound IC50 for ALK L1196M mutant (unknown origin)	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(N/N=C/c2ccc(OC(F)(F)F)cc2)ncc1Cl		CHEMBL3913728	=	Ratio IC50		20.0	CHEMBL4247	Homo sapiens	Ratio IC50		20.0
	16808377	CHEMBL3870420	Potency index, ratio of crizotinib IC50 to compound IC50 for ALK L1196M mutant (unknown origin)	B	COc1cccc(/C=N/Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c1		CHEMBL3905284	=	Ratio IC50		20.0	CHEMBL4247	Homo sapiens	Ratio IC50		20.0
	16808378	CHEMBL3870420	Potency index, ratio of crizotinib IC50 to compound IC50 for ALK L1196M mutant (unknown origin)	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(N/N=C/c2cccc(C(F)(F)F)c2)ncc1Cl		CHEMBL3934594	=	Ratio IC50		20.0	CHEMBL4247	Homo sapiens	Ratio IC50		20.0
	16808379	CHEMBL3870420	Potency index, ratio of crizotinib IC50 to compound IC50 for ALK L1196M mutant (unknown origin)	B	COc1ccc(/C(C)=N/Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)cc1		CHEMBL3950479	=	Ratio IC50		20.0	CHEMBL4247	Homo sapiens	Ratio IC50		20.0
	16808380	CHEMBL3870420	Potency index, ratio of crizotinib IC50 to compound IC50 for ALK L1196M mutant (unknown origin)	B	C/C(=N\Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1)c1ccc(F)cc1		CHEMBL3922762	=	Ratio IC50		20.0	CHEMBL4247	Homo sapiens	Ratio IC50		20.0
	16829737	CHEMBL3874957	Inhibition of ALK (unknown origin)	B	COc1cc2c(Oc3ccc(NC(=O)c4cn(-c5ccccc5OC)cn4)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL3931223	>	IC50	nM	3333.0	CHEMBL4247	Homo sapiens	IC50	nM	3333.0
	16844123	CHEMBL3877180	Binding affinity to ALK (unknown origin)	B	C[C@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825141	=	Kd	nM	525.0	CHEMBL4247	Homo sapiens	Kd	nM	525.0
	16844124	CHEMBL3877180	Binding affinity to ALK (unknown origin)	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	4.4	CHEMBL4247	Homo sapiens	Kd	nM	4.4
226241	17614678	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(C(=O)CN(C)C)CC1		CHEMBL2403842	=	IC50	nM	26.0	CHEMBL4247	Homo sapiens	IC50	nM	26.0
226242	17614679	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	COc1cc(C2CCN(C(=O)CN(C)C)CC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3651827	=	IC50	nM	8.0	CHEMBL4247	Homo sapiens	IC50	nM	8.0
226243	17614680	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(F)F)n2)c(OC(C)C)cc1C1CCN(C(=O)CN(C)C)CC1		CHEMBL3651828	=	IC50	nM	77.0	CHEMBL4247	Homo sapiens	IC50	nM	77.0
226244	17614681	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(C[C@@H](O)C(F)(F)F)CC1		CHEMBL3651829	=	IC50	nM	88.0	CHEMBL4247	Homo sapiens	IC50	nM	88.0
226245	17614682	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(C[C@H](O)C(F)(F)F)CC1		CHEMBL3651830	=	IC50	nM	43.0	CHEMBL4247	Homo sapiens	IC50	nM	43.0
226246	17614683	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(C(=O)[C@@H]2CCCN2)CC1		CHEMBL3651831	=	IC50	nM	13.0	CHEMBL4247	Homo sapiens	IC50	nM	13.0
226247	17614684	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(F)F)n2)c(OC(C)C)cc1C1CCN(C(=O)[C@@H]2CCCN2)CC1		CHEMBL3651832	=	IC50	nM	34.0	CHEMBL4247	Homo sapiens	IC50	nM	34.0
226248	17614685	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	CC(C)Oc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C(=O)N(C1CCN(C(=O)CN(C)C)CC1)C2		CHEMBL3651833	=	IC50	nM	6.0	CHEMBL4247	Homo sapiens	IC50	nM	6.0
226249	17614686	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	CC(C)Oc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C3CCCCC3)n1)C(=O)N(C1CCN(C(=O)CN(C)C)CC1)C2		CHEMBL3651834	=	IC50	nM	33.0	CHEMBL4247	Homo sapiens	IC50	nM	33.0
226250	17614687	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	CC(C)Oc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C3CCC3)n1)C(=O)N(C1CCN(C(=O)CN(C)C)CC1)C2		CHEMBL3651835	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	nM	2.0
226251	17614688	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	CC(C)Oc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C(=O)N(C1CCN(C(=O)[C@@H]3CCCN3)CC1)C2		CHEMBL3651836	=	IC50	nM	29.0	CHEMBL4247	Homo sapiens	IC50	nM	29.0
226252	17614689	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	CC(C)Oc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C(=O)N(C1CCN(C(=O)C3CCCN3C)CC1)C2		CHEMBL3651837	=	IC50	nM	5.0	CHEMBL4247	Homo sapiens	IC50	nM	5.0
226253	17614690	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	CC(C)Oc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C(=O)N(C1CCN(C(=O)[C@@H]3CCCN3C)CC1)C2		CHEMBL3651838	=	IC50	nM	23.0	CHEMBL4247	Homo sapiens	IC50	nM	23.0
226254	17614691	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	CC(C)Oc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C(=O)N(C1CCN(C(=O)C3CNC3)CC1)C2		CHEMBL3651839	=	IC50	nM	87.0	CHEMBL4247	Homo sapiens	IC50	nM	87.0
226255	17614692	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	CC(C)Oc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C(=O)N(C1CCN(C(=O)C3CN(C)C3)CC1)C2		CHEMBL3651840	=	IC50	nM	12.0	CHEMBL4247	Homo sapiens	IC50	nM	12.0
226256	17614693	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C(=O)N(C1CN(C(=O)CN(C)C)C1)C2		CHEMBL3651841	=	IC50	nM	6.0	CHEMBL4247	Homo sapiens	IC50	nM	6.0
226257	17614694	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C(=O)N(C1CN(C(=O)[C@@H]3CCCN3)C1)C2		CHEMBL3651842	=	IC50	nM	12.0	CHEMBL4247	Homo sapiens	IC50	nM	12.0
226258	17614695	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C(=O)N(C1CN(C(=O)[C@@H]3CCCN3C)C1)C2		CHEMBL3651843	=	IC50	nM	5.0	CHEMBL4247	Homo sapiens	IC50	nM	5.0
226259	17614696	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c[nH]nc3n2)c(OC(C)C)cc1C1CCN(C(=O)CN(C)C)CC1		CHEMBL3651844	=	IC50	nM	13.0	CHEMBL4247	Homo sapiens	IC50	nM	13.0
226260	17614697	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c[nH]nc3n2)c(OC(C)C)cc1C1CCN(C[C@@H](O)C(F)(F)F)CC1		CHEMBL3651845	=	IC50	nM	29.0	CHEMBL4247	Homo sapiens	IC50	nM	29.0
226261	17614698	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	COc1cc(C2CCN(C[C@H](O)C(F)(F)F)CC2)c(C)cc1Nc1nc(Nc2ccccc2S(=O)(=O)C(C)C)c2c[nH]nc2n1		CHEMBL3651846	=	IC50	nM	48.0	CHEMBL4247	Homo sapiens	IC50	nM	48.0
226262	17614699	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	COc1cc(C2CCN(C(=O)CN(C)C)CC2)c(C)cc1Nc1nc(Nc2ccccc2S(=O)(=O)C(C)C)c2c(C)[nH]nc2n1		CHEMBL3651847	=	IC50	nM	5.0	CHEMBL4247	Homo sapiens	IC50	nM	5.0
226263	17614700	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)[nH]nc3n2)c(OC(C)C)cc1C1CCN(C(=O)CN(C)C)CC1		CHEMBL3651848	=	IC50	nM	7.0	CHEMBL4247	Homo sapiens	IC50	nM	7.0
226264	17614701	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)[nH]nc3n2)c(OC(C)C)cc1C1CCN(C(=O)Cn2cccn2)CC1		CHEMBL3651849	=	IC50	nM	22.0	CHEMBL4247	Homo sapiens	IC50	nM	22.0
226265	17614702	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)[nH]nc3n2)c(OC(C)C)cc1C1CCN(C(=O)Cn2ccnc2)CC1		CHEMBL3651850	=	IC50	nM	29.0	CHEMBL4247	Homo sapiens	IC50	nM	29.0
226266	17614703	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)[nH]nc3n2)c(OC(C)C)cc1C1CCN(C(=O)CN2CCOCC2)CC1		CHEMBL3651851	=	IC50	nM	41.0	CHEMBL4247	Homo sapiens	IC50	nM	41.0
226267	17614704	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)[nH]nc3n2)c(OC(C)C)cc1C1CCN(C(=O)C2CCNCC2)CC1		CHEMBL3651852	=	IC50	nM	113.0	CHEMBL4247	Homo sapiens	IC50	nM	113.0
226268	17614705	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2cc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)n[nH]c3c2)c(OC(C)C)cc1C1CCNCC1		CHEMBL3651853	=	IC50	nM	38.0	CHEMBL4247	Homo sapiens	IC50	nM	38.0
226269	17614706	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)[nH]nc3n2)c(OC(C)C)cc1C1CCN(C)CC1		CHEMBL3651854	=	IC50	nM	20.0	CHEMBL4247	Homo sapiens	IC50	nM	20.0
226270	17614707	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)[nH]nc3n2)c(OC(C)C)cc1C1CCN(CC(N)=O)CC1		CHEMBL3651855	=	IC50	nM	14.0	CHEMBL4247	Homo sapiens	IC50	nM	14.0
226271	17614708	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	CNC(=O)CN1CCC(c2cc(OC(C)C)c(Nc3nc(Nc4ccccc4S(=O)(=O)C(C)C)c4c(C)[nH]nc4n3)cc2C)CC1		CHEMBL3651856	=	IC50	nM	21.0	CHEMBL4247	Homo sapiens	IC50	nM	21.0
226272	17614709	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)[nH]nc3n2)c(OC(C)C)cc1C1CCN(CCO)CC1		CHEMBL3651857	=	IC50	nM	11.0	CHEMBL4247	Homo sapiens	IC50	nM	11.0
226273	17614710	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	COCCN1CCC(c2cc(OC(C)C)c(Nc3nc(Nc4ccccc4S(=O)(=O)C(C)C)c4c(C)[nH]nc4n3)cc2C)CC1		CHEMBL3651858	=	IC50	nM	12.0	CHEMBL4247	Homo sapiens	IC50	nM	12.0
226274	17614711	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	COCCN1CCC(c2cc(OC(C)C)c(Nc3nc(Nc4ccccc4S(=O)(=O)C(C)C)c4c(-c5ccccc5)[nH]nc4n3)cc2C)CC1		CHEMBL3651859	=	IC50	nM	579.0	CHEMBL4247	Homo sapiens	IC50	nM	579.0
226275	17614712	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	CCc1[nH]nc2nc(Nc3cc(C)c(C4CCN(CCOC)CC4)cc3OC(C)C)nc(Nc3ccccc3S(=O)(=O)C(C)C)c12		CHEMBL3651860	=	IC50	nM	181.0	CHEMBL4247	Homo sapiens	IC50	nM	181.0
226276	17614713	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)[nH]nc3n2)c(OC(C)C)cc1C1CCN(CCS(C)(=O)=O)CC1		CHEMBL3651861	=	IC50	nM	23.0	CHEMBL4247	Homo sapiens	IC50	nM	23.0
226277	17614714	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	COc1cc(C2CCN(C)CC2)c(C)cc1Nc1nc(Nc2ccccc2S(=O)(=O)C(C)C)c2c(C)[nH]nc2n1		CHEMBL3651862	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	nM	2.0
226278	17614715	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	COc1cc(C2CCNCC2)c(C)cc1Nc1nc(Nc2ccccc2S(=O)(=O)C(C)C)c2c(C)[nH]nc2n1		CHEMBL3651863	=	IC50	nM	12.0	CHEMBL4247	Homo sapiens	IC50	nM	12.0
226279	17614716	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)[nH]nc3n2)c(OC(C)C)cc1C1CCN(CCC(N)=O)CC1		CHEMBL3651864	=	IC50	nM	18.0	CHEMBL4247	Homo sapiens	IC50	nM	18.0
226280	17614717	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)[nH]nc3n2)c(OC(C)C)cc1C1CCN(CCC(=O)N2CCC2)CC1		CHEMBL3651865	=	IC50	nM	21.0	CHEMBL4247	Homo sapiens	IC50	nM	21.0
226281	17614718	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)[nH]nc3n2)c(OC(C)C)cc1C1CCN(CCC(=O)N(C)C)CC1		CHEMBL3651866	=	IC50	nM	15.0	CHEMBL4247	Homo sapiens	IC50	nM	15.0
226282	17614719	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	CNC(=O)CCN1CCC(c2cc(OC(C)C)c(Nc3nc(Nc4ccccc4S(=O)(=O)C(C)C)c4c(C)[nH]nc4n3)cc2C)CC1		CHEMBL3651867	=	IC50	nM	25.0	CHEMBL4247	Homo sapiens	IC50	nM	25.0
226283	17614720	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)[nH]nc3n2)c(OC(C)C)cc1C1CCN(C[C@@H](O)C(F)(F)F)CC1		CHEMBL3651868	=	IC50	nM	105.0	CHEMBL4247	Homo sapiens	IC50	nM	105.0
226284	17614721	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)[nH]nc3n2)c(OC(C)C)cc1C1CCN(C[C@H](O)C(F)(F)F)CC1		CHEMBL3651869	=	IC50	nM	87.0	CHEMBL4247	Homo sapiens	IC50	nM	87.0
226285	17614722	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1[nH]nc2nc(Nc3ccc(C4CCNCC4)cc3)nc(Nc3ccccc3S(=O)(=O)C(C)C)c12		CHEMBL3651870	=	IC50	nM	17.0	CHEMBL4247	Homo sapiens	IC50	nM	17.0
226286	17614723	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	COc1cc(C2CCN(CCS(C)(=O)=O)CC2)c(C)cc1Nc1nc(Nc2ccccc2S(=O)(=O)C(C)C)c2c(C)[nH]nc2n1		CHEMBL3651871	=	IC50	nM	43.0	CHEMBL4247	Homo sapiens	IC50	nM	43.0
226287	17614724	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	CCN1CCC(c2ccc(Nc3nc(Nc4ccccc4S(=O)(=O)C(C)C)c4c(C)[nH]nc4n3)cc2)C1		CHEMBL3651872	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
226288	17614725	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)[nH]nc3n2)c(OC(C)C)cc1C1CCN([C@H]2CCS(=O)(=O)C2)CC1		CHEMBL3651873	=	IC50	nM	19.0	CHEMBL4247	Homo sapiens	IC50	nM	19.0
226289	17614726	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)[nH]nc3n2)c(OC(C)C)cc1C1CCN([C@@H]2CCS(=O)(=O)C2)CC1		CHEMBL3651874	=	IC50	nM	18.0	CHEMBL4247	Homo sapiens	IC50	nM	18.0
226290	17614727	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	COc1cc(C2CCOCC2)c(C)cc1Nc1nc(Nc2ccccc2S(=O)(=O)C(C)C)c2c(C)[nH]nc2n1		CHEMBL3651875	=	IC50	nM	6.0	CHEMBL4247	Homo sapiens	IC50	nM	6.0
226291	17614728	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)[nH]nc3n2)c(OC(C)C)cc1C1CCN(C(=O)CCN(C)C)CC1		CHEMBL3651876	=	IC50	nM	18.0	CHEMBL4247	Homo sapiens	IC50	nM	18.0
226292	17614729	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)[nH]nc3n2)c(OC(C)C)cc1C1CCN(C(=O)CCN2CCC2)CC1		CHEMBL3651877	=	IC50	nM	46.0	CHEMBL4247	Homo sapiens	IC50	nM	46.0
226293	17614730	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	CCS(=O)(=O)N1CCC(c2cc(OC(C)C)c(Nc3nc(Nc4ccccc4S(=O)(=O)C(C)C)c4c(C)[nH]nc4n3)cc2C)CC1		CHEMBL3651878	=	IC50	nM	92.0	CHEMBL4247	Homo sapiens	IC50	nM	92.0
226294	17614731	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)c[nH]c3n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL3651879	=	IC50	nM	155.0	CHEMBL4247	Homo sapiens	IC50	nM	155.0
226295	17614732	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)c[nH]c3n2)c(OC(C)C)cc1C1CCN(CC(N)=O)CC1		CHEMBL3651880	=	IC50	nM	7.0	CHEMBL4247	Homo sapiens	IC50	nM	7.0
226296	17614733	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)c[nH]c3n2)c(OC(C)C)cc1C1CCN(C)CC1		CHEMBL3651881	=	IC50	nM	9.0	CHEMBL4247	Homo sapiens	IC50	nM	9.0
226297	17614734	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)c[nH]c3n2)c(OC(C)C)cc1C1CCN(CCO)CC1		CHEMBL3651882	=	IC50	nM	6.0	CHEMBL4247	Homo sapiens	IC50	nM	6.0
226298	17614735	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)c[nH]c3n2)c(OC(C)C)cc1C1CCN(C[C@@H](O)C(F)(F)F)CC1		CHEMBL3651883	=	IC50	nM	163.0	CHEMBL4247	Homo sapiens	IC50	nM	163.0
226299	17614736	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)c[nH]c3n2)c(OC(C)C)cc1C1CCN(C[C@H](O)C(F)(F)F)CC1		CHEMBL3651884	=	IC50	nM	102.0	CHEMBL4247	Homo sapiens	IC50	nM	102.0
226300	17614737	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3[nH]nnc3n2)c(OC(C)C)cc1C1CCN(C)CC1		CHEMBL3651885	=	IC50	nM	48.0	CHEMBL4247	Homo sapiens	IC50	nM	48.0
226301	17614738	CHEMBL3705165	Enzyme Assay: The inhibition of ALK tyrosine kinase activity may be demonstrated using known methods, for example using the recombinant kinase domain of the ALK in analogy to the VEGF-R kinase assay described in J. Wood et al. Cancer Res. 60, 2178-2189 (2000).	B	CCN1CCC(c2cc(OC(C)C)c(Nc3nc(Nc4ccccc4S(=O)(=O)C(C)C)c4[nH]nnc4n3)cc2C)CC1		CHEMBL3651886	=	IC50	nM	39.0	CHEMBL4247	Homo sapiens	IC50	nM	39.0
235370	17623333	CHEMBL3887055	In Vitro Inhibition Assay: The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0.01% (Sigma S8032), BSA at 0.005% (Sigma A2153), 0.05 mM sodium orthovanadate (Calbiochem 567540). Detection buffer (DB): 50 mM HEPES (pH: 7.0), BSA at 0.1%, 0.8 M KF (Fluka 60239), 20 mM EDTA (Sigma E5134).The peptide used is the one described in Biochemistry, 2005, 44, 8533-8542; A-21-K(biotin)NH.sub.2, obtained from NeoMPS (reference SP081233). All the HTRF reagents Mab PT66-K (61T66KLB) and streptavidin-XL665 (610SAXLB), and the SEB reagent, are purchased from Cisbio.The test is carried out in a 384-well plate (Greiner 784076). The serial dilutions are carried out in pure DMSO, and then an intermediate one-in-three dilution in water is carried out, with 1 microliter of each concentration being distributed, all these operations being performed using the Zephyr apparatus (Caliper Life Sciences).	B	COc1nc(C)ccc1-c1c(CO)sc2cnc(Nc3cc(C)c(N4CCN(C)CC4)cc3OC(C)C)nc12		CHEMBL3928179	=	IC50	nM	14.0	CHEMBL4247	Homo sapiens	IC50	nM	14.0
255728	17638561	CHEMBL3705231	HTRF Kinase Assay: HTRF kinase assay: 40 L reactions were run in black 384 well polystyrene plates in assay buffer (50 mM Tris, pH 7.8, 100 mM NaCI, 0.1 mg/mL BSA, 5 mM DTT), containing 0.5 M Biotinylated peptide substrate, 10 mM MgCl2, 90 M ATP, and 0.25 nM enzyme for 2 hours at 25 C. Reactions were stopped by addition of 20 L assay buffer supplemented with an additional 50 mM NaCl, 0.4 mg/mL BSA, 45 mM EDTA, 4.5 nM LANCE Eu-W1024 labeled anti-phosphotyrosine antibody and 200 nM streptavidin conjugated SureLight-allophycocyanin. Plates were read in Fusion -FP instrument (Perkin-Elmer).	B	Clc1cnc2nc1NCc1cccc(c1)OCc1cccc(c1)N2		CHEMBL3694577	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
255729	17638562	CHEMBL3705231	HTRF Kinase Assay: HTRF kinase assay: 40 L reactions were run in black 384 well polystyrene plates in assay buffer (50 mM Tris, pH 7.8, 100 mM NaCI, 0.1 mg/mL BSA, 5 mM DTT), containing 0.5 M Biotinylated peptide substrate, 10 mM MgCl2, 90 M ATP, and 0.25 nM enzyme for 2 hours at 25 C. Reactions were stopped by addition of 20 L assay buffer supplemented with an additional 50 mM NaCl, 0.4 mg/mL BSA, 45 mM EDTA, 4.5 nM LANCE Eu-W1024 labeled anti-phosphotyrosine antibody and 200 nM streptavidin conjugated SureLight-allophycocyanin. Plates were read in Fusion -FP instrument (Perkin-Elmer).	B	Clc1cnc2nc1NCc1cccc(c1)OCCc1cccc(c1)N2		CHEMBL3694578	=	IC50	nM	1530.0	CHEMBL4247	Homo sapiens	IC50	nM	1530.0
255730	17638563	CHEMBL3705231	HTRF Kinase Assay: HTRF kinase assay: 40 L reactions were run in black 384 well polystyrene plates in assay buffer (50 mM Tris, pH 7.8, 100 mM NaCI, 0.1 mg/mL BSA, 5 mM DTT), containing 0.5 M Biotinylated peptide substrate, 10 mM MgCl2, 90 M ATP, and 0.25 nM enzyme for 2 hours at 25 C. Reactions were stopped by addition of 20 L assay buffer supplemented with an additional 50 mM NaCl, 0.4 mg/mL BSA, 45 mM EDTA, 4.5 nM LANCE Eu-W1024 labeled anti-phosphotyrosine antibody and 200 nM streptavidin conjugated SureLight-allophycocyanin. Plates were read in Fusion -FP instrument (Perkin-Elmer).	B	O=S1(=O)Nc2cccc(c2)CNc2nc(ncc2Cl)Nc2cccc1c2		CHEMBL3694579	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
255731	17638564	CHEMBL3705231	HTRF Kinase Assay: HTRF kinase assay: 40 L reactions were run in black 384 well polystyrene plates in assay buffer (50 mM Tris, pH 7.8, 100 mM NaCI, 0.1 mg/mL BSA, 5 mM DTT), containing 0.5 M Biotinylated peptide substrate, 10 mM MgCl2, 90 M ATP, and 0.25 nM enzyme for 2 hours at 25 C. Reactions were stopped by addition of 20 L assay buffer supplemented with an additional 50 mM NaCl, 0.4 mg/mL BSA, 45 mM EDTA, 4.5 nM LANCE Eu-W1024 labeled anti-phosphotyrosine antibody and 200 nM streptavidin conjugated SureLight-allophycocyanin. Plates were read in Fusion -FP instrument (Perkin-Elmer).	B	O=C1Nc2cccc(c2)CNc2nc(ncc2Cl)Nc2cccc1c2		CHEMBL3694580	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
255732	17638565	CHEMBL3705231	HTRF Kinase Assay: HTRF kinase assay: 40 L reactions were run in black 384 well polystyrene plates in assay buffer (50 mM Tris, pH 7.8, 100 mM NaCI, 0.1 mg/mL BSA, 5 mM DTT), containing 0.5 M Biotinylated peptide substrate, 10 mM MgCl2, 90 M ATP, and 0.25 nM enzyme for 2 hours at 25 C. Reactions were stopped by addition of 20 L assay buffer supplemented with an additional 50 mM NaCl, 0.4 mg/mL BSA, 45 mM EDTA, 4.5 nM LANCE Eu-W1024 labeled anti-phosphotyrosine antibody and 200 nM streptavidin conjugated SureLight-allophycocyanin. Plates were read in Fusion -FP instrument (Perkin-Elmer).	B	Clc1cnc2nc1NCc1cccc(c1)OCCCc1cccc(c1)N2		CHEMBL3694581	=	IC50	nM	706.0	CHEMBL4247	Homo sapiens	IC50	nM	706.0
255733	17638566	CHEMBL3705231	HTRF Kinase Assay: HTRF kinase assay: 40 L reactions were run in black 384 well polystyrene plates in assay buffer (50 mM Tris, pH 7.8, 100 mM NaCI, 0.1 mg/mL BSA, 5 mM DTT), containing 0.5 M Biotinylated peptide substrate, 10 mM MgCl2, 90 M ATP, and 0.25 nM enzyme for 2 hours at 25 C. Reactions were stopped by addition of 20 L assay buffer supplemented with an additional 50 mM NaCl, 0.4 mg/mL BSA, 45 mM EDTA, 4.5 nM LANCE Eu-W1024 labeled anti-phosphotyrosine antibody and 200 nM streptavidin conjugated SureLight-allophycocyanin. Plates were read in Fusion -FP instrument (Perkin-Elmer).	B	C[C@H]1Nc2nc(ncc2Cl)Nc2cccc(c2)COc2cccc1c2		CHEMBL3694582	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
255734	17638567	CHEMBL3705231	HTRF Kinase Assay: HTRF kinase assay: 40 L reactions were run in black 384 well polystyrene plates in assay buffer (50 mM Tris, pH 7.8, 100 mM NaCI, 0.1 mg/mL BSA, 5 mM DTT), containing 0.5 M Biotinylated peptide substrate, 10 mM MgCl2, 90 M ATP, and 0.25 nM enzyme for 2 hours at 25 C. Reactions were stopped by addition of 20 L assay buffer supplemented with an additional 50 mM NaCl, 0.4 mg/mL BSA, 45 mM EDTA, 4.5 nM LANCE Eu-W1024 labeled anti-phosphotyrosine antibody and 200 nM streptavidin conjugated SureLight-allophycocyanin. Plates were read in Fusion -FP instrument (Perkin-Elmer).	B	Clc1cnc2nc1NCc1cccc(c1)OCCOc1cccc(c1)N2		CHEMBL3694583	=	IC50	nM	2050.0	CHEMBL4247	Homo sapiens	IC50	nM	2050.0
255735	17638568	CHEMBL3705231	HTRF Kinase Assay: HTRF kinase assay: 40 L reactions were run in black 384 well polystyrene plates in assay buffer (50 mM Tris, pH 7.8, 100 mM NaCI, 0.1 mg/mL BSA, 5 mM DTT), containing 0.5 M Biotinylated peptide substrate, 10 mM MgCl2, 90 M ATP, and 0.25 nM enzyme for 2 hours at 25 C. Reactions were stopped by addition of 20 L assay buffer supplemented with an additional 50 mM NaCl, 0.4 mg/mL BSA, 45 mM EDTA, 4.5 nM LANCE Eu-W1024 labeled anti-phosphotyrosine antibody and 200 nM streptavidin conjugated SureLight-allophycocyanin. Plates were read in Fusion -FP instrument (Perkin-Elmer).	B	Clc1cnc2nc1NCCc1cccc(c1)OCc1cccc(c1)N2		CHEMBL3694584	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
255736	17638569	CHEMBL3705231	HTRF Kinase Assay: HTRF kinase assay: 40 L reactions were run in black 384 well polystyrene plates in assay buffer (50 mM Tris, pH 7.8, 100 mM NaCI, 0.1 mg/mL BSA, 5 mM DTT), containing 0.5 M Biotinylated peptide substrate, 10 mM MgCl2, 90 M ATP, and 0.25 nM enzyme for 2 hours at 25 C. Reactions were stopped by addition of 20 L assay buffer supplemented with an additional 50 mM NaCl, 0.4 mg/mL BSA, 45 mM EDTA, 4.5 nM LANCE Eu-W1024 labeled anti-phosphotyrosine antibody and 200 nM streptavidin conjugated SureLight-allophycocyanin. Plates were read in Fusion -FP instrument (Perkin-Elmer).	B	Clc1cnc2nc1NCCc1cccc(c1)OCCc1cccc(c1)N2		CHEMBL3694585	=	IC50	nM	1230.0	CHEMBL4247	Homo sapiens	IC50	nM	1230.0
255737	17638570	CHEMBL3705231	HTRF Kinase Assay: HTRF kinase assay: 40 L reactions were run in black 384 well polystyrene plates in assay buffer (50 mM Tris, pH 7.8, 100 mM NaCI, 0.1 mg/mL BSA, 5 mM DTT), containing 0.5 M Biotinylated peptide substrate, 10 mM MgCl2, 90 M ATP, and 0.25 nM enzyme for 2 hours at 25 C. Reactions were stopped by addition of 20 L assay buffer supplemented with an additional 50 mM NaCl, 0.4 mg/mL BSA, 45 mM EDTA, 4.5 nM LANCE Eu-W1024 labeled anti-phosphotyrosine antibody and 200 nM streptavidin conjugated SureLight-allophycocyanin. Plates were read in Fusion -FP instrument (Perkin-Elmer).	B	Clc1cnc2nc1NCCCc1cccc(c1)OCc1cccc(c1)N2		CHEMBL3694586	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
255738	17638571	CHEMBL3705231	HTRF Kinase Assay: HTRF kinase assay: 40 L reactions were run in black 384 well polystyrene plates in assay buffer (50 mM Tris, pH 7.8, 100 mM NaCI, 0.1 mg/mL BSA, 5 mM DTT), containing 0.5 M Biotinylated peptide substrate, 10 mM MgCl2, 90 M ATP, and 0.25 nM enzyme for 2 hours at 25 C. Reactions were stopped by addition of 20 L assay buffer supplemented with an additional 50 mM NaCl, 0.4 mg/mL BSA, 45 mM EDTA, 4.5 nM LANCE Eu-W1024 labeled anti-phosphotyrosine antibody and 200 nM streptavidin conjugated SureLight-allophycocyanin. Plates were read in Fusion -FP instrument (Perkin-Elmer).	B	C[C@@H]1Nc2nc(ncc2Cl)Nc2cccc(c2)COc2cccc1c2		CHEMBL3694587	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
255739	17638572	CHEMBL3705231	HTRF Kinase Assay: HTRF kinase assay: 40 L reactions were run in black 384 well polystyrene plates in assay buffer (50 mM Tris, pH 7.8, 100 mM NaCI, 0.1 mg/mL BSA, 5 mM DTT), containing 0.5 M Biotinylated peptide substrate, 10 mM MgCl2, 90 M ATP, and 0.25 nM enzyme for 2 hours at 25 C. Reactions were stopped by addition of 20 L assay buffer supplemented with an additional 50 mM NaCl, 0.4 mg/mL BSA, 45 mM EDTA, 4.5 nM LANCE Eu-W1024 labeled anti-phosphotyrosine antibody and 200 nM streptavidin conjugated SureLight-allophycocyanin. Plates were read in Fusion -FP instrument (Perkin-Elmer).	B	Clc1cnc2nc1NCCc1cccc(c1)OCCCc1cccc(c1)N2		CHEMBL3694588	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
255740	17638573	CHEMBL3705231	HTRF Kinase Assay: HTRF kinase assay: 40 L reactions were run in black 384 well polystyrene plates in assay buffer (50 mM Tris, pH 7.8, 100 mM NaCI, 0.1 mg/mL BSA, 5 mM DTT), containing 0.5 M Biotinylated peptide substrate, 10 mM MgCl2, 90 M ATP, and 0.25 nM enzyme for 2 hours at 25 C. Reactions were stopped by addition of 20 L assay buffer supplemented with an additional 50 mM NaCl, 0.4 mg/mL BSA, 45 mM EDTA, 4.5 nM LANCE Eu-W1024 labeled anti-phosphotyrosine antibody and 200 nM streptavidin conjugated SureLight-allophycocyanin. Plates were read in Fusion -FP instrument (Perkin-Elmer).	B	Clc1cnc2nc1NCCCc1cccc(c1)OCCc1cccc(c1)N2		CHEMBL3694589	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
255741	17638574	CHEMBL3705231	HTRF Kinase Assay: HTRF kinase assay: 40 L reactions were run in black 384 well polystyrene plates in assay buffer (50 mM Tris, pH 7.8, 100 mM NaCI, 0.1 mg/mL BSA, 5 mM DTT), containing 0.5 M Biotinylated peptide substrate, 10 mM MgCl2, 90 M ATP, and 0.25 nM enzyme for 2 hours at 25 C. Reactions were stopped by addition of 20 L assay buffer supplemented with an additional 50 mM NaCl, 0.4 mg/mL BSA, 45 mM EDTA, 4.5 nM LANCE Eu-W1024 labeled anti-phosphotyrosine antibody and 200 nM streptavidin conjugated SureLight-allophycocyanin. Plates were read in Fusion -FP instrument (Perkin-Elmer).	B	Clc1cnc2nc1NCc1cc(ccc1Br)OCCCc1cccc(c1)N2		CHEMBL3694590	=	IC50	nM	8200.0	CHEMBL4247	Homo sapiens	IC50	nM	8200.0
255742	17638575	CHEMBL3705231	HTRF Kinase Assay: HTRF kinase assay: 40 L reactions were run in black 384 well polystyrene plates in assay buffer (50 mM Tris, pH 7.8, 100 mM NaCI, 0.1 mg/mL BSA, 5 mM DTT), containing 0.5 M Biotinylated peptide substrate, 10 mM MgCl2, 90 M ATP, and 0.25 nM enzyme for 2 hours at 25 C. Reactions were stopped by addition of 20 L assay buffer supplemented with an additional 50 mM NaCl, 0.4 mg/mL BSA, 45 mM EDTA, 4.5 nM LANCE Eu-W1024 labeled anti-phosphotyrosine antibody and 200 nM streptavidin conjugated SureLight-allophycocyanin. Plates were read in Fusion -FP instrument (Perkin-Elmer).	B	Clc1cnc2nc1NCc1cc(ccc1-c1ccccc1)OCCCc1cccc(c1)N2		CHEMBL3694591	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
255743	17638576	CHEMBL3705231	HTRF Kinase Assay: HTRF kinase assay: 40 L reactions were run in black 384 well polystyrene plates in assay buffer (50 mM Tris, pH 7.8, 100 mM NaCI, 0.1 mg/mL BSA, 5 mM DTT), containing 0.5 M Biotinylated peptide substrate, 10 mM MgCl2, 90 M ATP, and 0.25 nM enzyme for 2 hours at 25 C. Reactions were stopped by addition of 20 L assay buffer supplemented with an additional 50 mM NaCl, 0.4 mg/mL BSA, 45 mM EDTA, 4.5 nM LANCE Eu-W1024 labeled anti-phosphotyrosine antibody and 200 nM streptavidin conjugated SureLight-allophycocyanin. Plates were read in Fusion -FP instrument (Perkin-Elmer).	B	Clc1cnc2nc1NCc1cc(Br)cc(c1)OCCCc1cccc(c1)N2		CHEMBL3694592	=	IC50	nM	280.0	CHEMBL4247	Homo sapiens	IC50	nM	280.0
255744	17638577	CHEMBL3705231	HTRF Kinase Assay: HTRF kinase assay: 40 L reactions were run in black 384 well polystyrene plates in assay buffer (50 mM Tris, pH 7.8, 100 mM NaCI, 0.1 mg/mL BSA, 5 mM DTT), containing 0.5 M Biotinylated peptide substrate, 10 mM MgCl2, 90 M ATP, and 0.25 nM enzyme for 2 hours at 25 C. Reactions were stopped by addition of 20 L assay buffer supplemented with an additional 50 mM NaCl, 0.4 mg/mL BSA, 45 mM EDTA, 4.5 nM LANCE Eu-W1024 labeled anti-phosphotyrosine antibody and 200 nM streptavidin conjugated SureLight-allophycocyanin. Plates were read in Fusion -FP instrument (Perkin-Elmer).	B	Nc1ccc2cc1CCc1cncc(c1)Nc1ncc(Cl)c(n1)NC2		CHEMBL3694593	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
255745	17638578	CHEMBL3705231	HTRF Kinase Assay: HTRF kinase assay: 40 L reactions were run in black 384 well polystyrene plates in assay buffer (50 mM Tris, pH 7.8, 100 mM NaCI, 0.1 mg/mL BSA, 5 mM DTT), containing 0.5 M Biotinylated peptide substrate, 10 mM MgCl2, 90 M ATP, and 0.25 nM enzyme for 2 hours at 25 C. Reactions were stopped by addition of 20 L assay buffer supplemented with an additional 50 mM NaCl, 0.4 mg/mL BSA, 45 mM EDTA, 4.5 nM LANCE Eu-W1024 labeled anti-phosphotyrosine antibody and 200 nM streptavidin conjugated SureLight-allophycocyanin. Plates were read in Fusion -FP instrument (Perkin-Elmer).	B	O=C(Nc1ccc2cc1CCc1cncc(c1)Nc1ncc(Cl)c(n1)NC2)c1ccccc1		CHEMBL3694594	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
255746	17638579	CHEMBL3705231	HTRF Kinase Assay: HTRF kinase assay: 40 L reactions were run in black 384 well polystyrene plates in assay buffer (50 mM Tris, pH 7.8, 100 mM NaCI, 0.1 mg/mL BSA, 5 mM DTT), containing 0.5 M Biotinylated peptide substrate, 10 mM MgCl2, 90 M ATP, and 0.25 nM enzyme for 2 hours at 25 C. Reactions were stopped by addition of 20 L assay buffer supplemented with an additional 50 mM NaCl, 0.4 mg/mL BSA, 45 mM EDTA, 4.5 nM LANCE Eu-W1024 labeled anti-phosphotyrosine antibody and 200 nM streptavidin conjugated SureLight-allophycocyanin. Plates were read in Fusion -FP instrument (Perkin-Elmer).	B	N#Cc1ccccc1S(=O)(=O)Nc1ccc2cc1CCc1cncc(c1)Nc1ncc(Cl)c(n1)NC2		CHEMBL3694595	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
267477	17649796	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCN(CC)CCOc1ccc2c(c1)C(C)(C)c1c(c3ccc(C)cc3n1C)C2=O		CHEMBL3918268	=	IC50	nM	5947.3	CHEMBL4247	Homo sapiens	IC50	nM	5947.3
267668	17649987	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCN(CC)CCOc1ccc2c(c1)C(C)(C)c1c(c3ccc(NC(=O)Cc4ccccc4)cc3n1C)C2=O		CHEMBL3965090	=	IC50	nM	21307.8	CHEMBL4247	Homo sapiens	IC50	nM	21307.8
273501	17655824	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	Cn1c2c(c3ccc(C(=O)Nc4ccccc4)cc31)C(=O)c1ccc(OC[C@@H](O)[C@H](O)CO)cc1C2(C)C		CHEMBL4108699	=	IC50	nM	12951.9	CHEMBL4247	Homo sapiens	IC50	nM	12951.9
273502	17655825	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CN(C)C(=O)c1ccc2c3c(n(C)c2c1)C(C)(C)c1cc(OC[C@@H](O)[C@H](O)CO)ccc1C3=O		CHEMBL4114864	=	IC50	nM	12970.4	CHEMBL4247	Homo sapiens	IC50	nM	12970.4
273503	17655826	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OCCCCCC(=O)O)ccc2C(=O)c2c1oc1ccccc21		CHEMBL3939763	=	IC50	nM	5934.6	CHEMBL4247	Homo sapiens	IC50	nM	5934.6
273504	17655827	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCN(CC)C(=O)COc1ccc2c(c1)C(C)(C)c1oc3ccccc3c1C2=O		CHEMBL3948508	=	IC50	nM	7794.7	CHEMBL4247	Homo sapiens	IC50	nM	7794.7
273505	17655828	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OCC(=O)NCCOCCO)ccc2C(=O)c2c1oc1ccccc21		CHEMBL3934533	=	IC50	nM	7045.1	CHEMBL4247	Homo sapiens	IC50	nM	7045.1
273506	17655829	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC[C@@H](O)CO)ccc2C(=O)c2c1oc1cc(OCC(=O)Nc3ccccc3)ccc21		CHEMBL3939589	=	IC50	nM	17464.1	CHEMBL4247	Homo sapiens	IC50	nM	17464.1
280581	17662926	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2cccc(S(C)(=O)=O)c2)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3687188	=	IC50	nM	17.0	CHEMBL4247	Homo sapiens	IC50	nM	17.0
280582	17662927	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2cccc(S(C)(=O)=O)c2)nc1N[C@H]1CC[C@](C)(O)CC1		CHEMBL3687189	=	IC50	nM	0.99	CHEMBL4247	Homo sapiens	IC50	nM	0.99
280583	17662928	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)cc2OC)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3687190	=	IC50	nM	8.9	CHEMBL4247	Homo sapiens	IC50	nM	8.9
280584	17662929	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCN(C)CC3)cc2)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3687191	=	IC50	nM	5.3	CHEMBL4247	Homo sapiens	IC50	nM	5.3
280585	17662930	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2ccc3cnn(C)c3c2)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3687192	=	IC50	nM	76.0	CHEMBL4247	Homo sapiens	IC50	nM	76.0
280586	17662931	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3687193	=	IC50	nM	0.37	CHEMBL4247	Homo sapiens	IC50	nM	0.37
280587	17662932	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)cc2)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3687194	=	IC50	nM	2.8	CHEMBL4247	Homo sapiens	IC50	nM	2.8
280588	17662933	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CC(C)c1nc(C(N)=O)c(Nc2ccc(N3CCN(C)CC3)cc2)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3687195	=	IC50	nM	2.1	CHEMBL4247	Homo sapiens	IC50	nM	2.1
280589	17662934	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2cccc(N3CCN(C)CC3)c2)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3975354	=	IC50	nM	1.7	CHEMBL4247	Homo sapiens	IC50	nM	1.7
280590	17662935	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCN(C)CC3)c(C(F)(F)F)c2)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3687197	=	IC50	nM	0.77	CHEMBL4247	Homo sapiens	IC50	nM	0.77
280591	17662936	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCN(C)CC3)c(OC)c2)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3687198	=	IC50	nM	0.33	CHEMBL4247	Homo sapiens	IC50	nM	0.33
280592	17662937	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCOCC3)cc2)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3687199	=	IC50	nM	17.0	CHEMBL4247	Homo sapiens	IC50	nM	17.0
280593	17662938	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C(F)(F)F)c2)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3687200	=	IC50	nM	0.65	CHEMBL4247	Homo sapiens	IC50	nM	0.65
280594	17662939	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCN(C)CC3)c(C)c2)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3687201	=	IC50	nM	0.24	CHEMBL4247	Homo sapiens	IC50	nM	0.24
280595	17662940	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C)c2)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3687202	=	IC50	nM	0.26	CHEMBL4247	Homo sapiens	IC50	nM	0.26
280596	17662941	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2ccc(OC)c(N3CCN(C)CC3)c2)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3889838	=	IC50	nM	0.23	CHEMBL4247	Homo sapiens	IC50	nM	0.23
280597	17662942	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2ccc(C3CCN(C)CC3)cc2)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3687204	=	IC50	nM	0.26	CHEMBL4247	Homo sapiens	IC50	nM	0.26
280598	17662943	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CC(C)c1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C(F)(F)F)c2)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3687205	=	IC50	nM	0.17	CHEMBL4247	Homo sapiens	IC50	nM	0.17
280599	17662944	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCN(C)CC3)c(C)c2)nc1N[C@H]1CC[C@@](C)(O)CC1		CHEMBL3687206	=	IC50	nM	0.22	CHEMBL4247	Homo sapiens	IC50	nM	0.22
280600	17662945	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C)c2)nc1N[C@H]1CC[C@@](C)(O)CC1		CHEMBL3687207	=	IC50	nM	0.21	CHEMBL4247	Homo sapiens	IC50	nM	0.21
280601	17662946	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCN(C4CC4)CC3)c(C(F)(F)F)c2)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3687208	=	IC50	nM	0.94	CHEMBL4247	Homo sapiens	IC50	nM	0.94
280602	17662947	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N(C)C)C3)c(C(F)(F)F)c2)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3687209	=	IC50	nM	0.34	CHEMBL4247	Homo sapiens	IC50	nM	0.34
280603	17662948	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCN(C(C)C)CC3)c(C)c2)nc1N[C@H]1CC[C@H](O)CC1		CHEMBL3687210	=	IC50	nM	0.49	CHEMBL4247	Homo sapiens	IC50	nM	0.49
280604	17662949	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCOc1cc(Nc2nc(N[C@H]3CC[C@H](O)CC3)c(CC)nc2C(N)=O)ccc1N1CCC(N2CCN(C)CC2)CC1		CHEMBL3687211	=	IC50	nM	0.26	CHEMBL4247	Homo sapiens	IC50	nM	0.26
280605	17662950	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C)c2)nc1N[C@H]1CC[C@](C)(O)CC1		CHEMBL3687212	=	IC50	nM	0.93	CHEMBL4247	Homo sapiens	IC50	nM	0.93
280606	17662951	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C)c2)nc1NC1CCC(O)(CC)CC1		CHEMBL3687213	=	IC50	nM	3.1	CHEMBL4247	Homo sapiens	IC50	nM	3.1
280607	17662952	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C)c2)nc1NC1CCC(O)(CC)CC1		CHEMBL3687213	=	IC50	nM	2.8	CHEMBL4247	Homo sapiens	IC50	nM	2.8
280608	17662953	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C)c2)nc1NC1CCC(O)(C(C)C)CC1		CHEMBL3687214	=	IC50	nM	2.6	CHEMBL4247	Homo sapiens	IC50	nM	2.6
280609	17662954	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C)c2)nc1NC1CCC(O)(C(C)C)CC1		CHEMBL3687214	=	IC50	nM	4.1	CHEMBL4247	Homo sapiens	IC50	nM	4.1
280610	17662955	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C)c2)nc1NC1CCOCC1		CHEMBL3687215	=	IC50	nM	1.5	CHEMBL4247	Homo sapiens	IC50	nM	1.5
280611	17662956	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C)c2)nc1NC1CCNCC1		CHEMBL3687216	=	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	nM	1.0
280612	17662957	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	Cc1cc(Nc2nc(N[C@H]3CC[C@H](O)CC3)c(Cl)nc2C(N)=O)ccc1N1CCC(N2CCN(C)CC2)CC1		CHEMBL3687217	=	IC50	nM	2.3	CHEMBL4247	Homo sapiens	IC50	nM	2.3
280613	17662958	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C)c2)nc1NC1CCN(C)CC1		CHEMBL3687218	=	IC50	nM	1.9	CHEMBL4247	Homo sapiens	IC50	nM	1.9
280614	17662959	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCN(C)CC3)cc2)nc1NC1CCOCC1		CHEMBL3687219	=	IC50	nM	11.0	CHEMBL4247	Homo sapiens	IC50	nM	11.0
280615	17662960	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)cc2)nc1NC1CCOCC1		CHEMBL3687220	=	IC50	nM	7.8	CHEMBL4247	Homo sapiens	IC50	nM	7.8
280616	17662961	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	=	IC50	nM	1.5	CHEMBL4247	Homo sapiens	IC50	nM	1.5
280617	17662962	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CC(C)c1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)cc2)nc1NC1CCOCC1		CHEMBL3687221	=	IC50	nM	2.1	CHEMBL4247	Homo sapiens	IC50	nM	2.1
280618	17662963	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCN(C)CC3)c(F)c2)nc1NC1CCOCC1		CHEMBL3687222	=	IC50	nM	11.0	CHEMBL4247	Homo sapiens	IC50	nM	11.0
280619	17662964	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	COc1cc(Nc2nc(NC3CCOCC3)c(C(C)C)nc2C(N)=O)ccc1N1CCN(C)CC1		CHEMBL3687223	=	IC50	nM	1.4	CHEMBL4247	Homo sapiens	IC50	nM	1.4
280620	17662965	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CC(C)c1nc(C(N)=O)c(Nc2ccc(N3CCN(C)CC3)cc2)nc1NC1CCOCC1		CHEMBL3687224	=	IC50	nM	4.5	CHEMBL4247	Homo sapiens	IC50	nM	4.5
280621	17662966	CHEMBL3706338	Inhibition Assay: A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated, and injected into mouse lymphoid cell line BA/F3 cells. Using a magnetic bead reagent for cell separation and a purification column (anti-CD8 monoclonal antibody immobilized on magnetic beads and a MiniMACS purification column; both are products of MilteDyi Biotec Inc.), cell surface CD8-expressing cells were purified to establish EML4-ALK fusion protein v1-expressing BA/F3 cells. From the cells, EML4-ALK fusion protein v1 was purified and subjected to kinase activity evaluation. EML4-ALK fusion protein v1 was investigated for its phosphorylation activity toward a peptide substrate by using a kinase activity detection kit (HTRF KinEASE-TK; Cisbio Inc.). Test compounds were each added to a reaction solution containing the enzyme protein to give 8 final concentrations from 1000 nM to 0.3 nM, followed by addition of ATP.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCN(C4CCN(C)CC4)CC3)c(C)c2)nc1NC1CCOCC1		CHEMBL3687225	=	IC50	nM	2.2	CHEMBL4247	Homo sapiens	IC50	nM	2.2
300515	17681345	CHEMBL3705430	Biochemical Assay: ALK enzyme needs pre-activation in order to linearize reaction kinetics.Kinase Buffer (KB) for ALKKinase buffer was composed of 50 mM HEPES pH 7.5 containing 1 mM MnCl.sub.2, 5 mM MgCl.sub.2, 1 mM DTT, 3 microM Na.sub.3VO.sub.4, and 0.2 mg/mL BSA. 3.times.KB is buffer of the same composition and pH as KB, but with three times the concentration of each component.Assay ConditionsThe kinase assay was run with a final enzyme concentration of 20 nM, in the presence of 8 microM ATP, 1 nM .sup.33P-.gamma.-ATP and 2 microM MBP. The MPB was purchased from Sigma-Aldrich, St. Louis, Mo., USA.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	=	IC50	nM	55.0	CHEMBL4247	Homo sapiens	IC50	nM	55.0
300516	17681346	CHEMBL3705430	Biochemical Assay: ALK enzyme needs pre-activation in order to linearize reaction kinetics.Kinase Buffer (KB) for ALKKinase buffer was composed of 50 mM HEPES pH 7.5 containing 1 mM MnCl.sub.2, 5 mM MgCl.sub.2, 1 mM DTT, 3 microM Na.sub.3VO.sub.4, and 0.2 mg/mL BSA. 3.times.KB is buffer of the same composition and pH as KB, but with three times the concentration of each component.Assay ConditionsThe kinase assay was run with a final enzyme concentration of 20 nM, in the presence of 8 microM ATP, 1 nM .sup.33P-.gamma.-ATP and 2 microM MBP. The MPB was purchased from Sigma-Aldrich, St. Louis, Mo., USA.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)cc2)CC1		CHEMBL3672894	=	IC50	nM	207.0	CHEMBL4247	Homo sapiens	IC50	nM	207.0
300517	17681347	CHEMBL3705430	Biochemical Assay: ALK enzyme needs pre-activation in order to linearize reaction kinetics.Kinase Buffer (KB) for ALKKinase buffer was composed of 50 mM HEPES pH 7.5 containing 1 mM MnCl.sub.2, 5 mM MgCl.sub.2, 1 mM DTT, 3 microM Na.sub.3VO.sub.4, and 0.2 mg/mL BSA. 3.times.KB is buffer of the same composition and pH as KB, but with three times the concentration of each component.Assay ConditionsThe kinase assay was run with a final enzyme concentration of 20 nM, in the presence of 8 microM ATP, 1 nM .sup.33P-.gamma.-ATP and 2 microM MBP. The MPB was purchased from Sigma-Aldrich, St. Louis, Mo., USA.	B	COCCNc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL3672895	=	IC50	nM	411.0	CHEMBL4247	Homo sapiens	IC50	nM	411.0
300518	17681348	CHEMBL3705430	Biochemical Assay: ALK enzyme needs pre-activation in order to linearize reaction kinetics.Kinase Buffer (KB) for ALKKinase buffer was composed of 50 mM HEPES pH 7.5 containing 1 mM MnCl.sub.2, 5 mM MgCl.sub.2, 1 mM DTT, 3 microM Na.sub.3VO.sub.4, and 0.2 mg/mL BSA. 3.times.KB is buffer of the same composition and pH as KB, but with three times the concentration of each component.Assay ConditionsThe kinase assay was run with a final enzyme concentration of 20 nM, in the presence of 8 microM ATP, 1 nM .sup.33P-.gamma.-ATP and 2 microM MBP. The MPB was purchased from Sigma-Aldrich, St. Louis, Mo., USA.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCCCC3)c2)CC1		CHEMBL3672896	=	IC50	nM	1771.0	CHEMBL4247	Homo sapiens	IC50	nM	1771.0
312163	17692416	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	36.0	CHEMBL4247	Homo sapiens	IC50	nM	36.0
312164	17692417	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	220.0	CHEMBL4247	Homo sapiens	IC50	nM	220.0
321195	17701087	CHEMBL3705810	In Vitro Inhibition Assay: The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0.01% (Sigma S8032), BSA at 0.005% (Sigma A2153), 0.05 mM sodium orthovanadate (Calbiochem 567540). Detection buffer (DB): 50 mM HEPES (pH: 7.0), BSA at 0.1%, 0.8 M KF (Fluka 60239), 20 mM EDTA (Sigma E5134).The peptide used is the one described in Biochemistry, 2005, 44, 8533-8542; A-21-K(biotin)NH.sub.2, obtained from NeoMPS (reference SP081233). All the HTRF reagents Mab PT66-K (61T66KLB) and streptavidin-XL665 (610SAXLB), and the SEB reagent, are purchased from Cisbio.The test is carried out in a 384-well plate (Greiner 784076). The serial dilutions are carried out in pure DMSO, and then an intermediate one-in-three dilution in water is carried out, with 1 microliter of each concentration being distributed, all these operations being performed using the Zephyr apparatus (Caliper Life Sciences).	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1ncc2sc(C(N)=O)c(-c3ccccc3)c2n1		CHEMBL3669134	=	IC50	nM	28.0	CHEMBL4247	Homo sapiens	IC50	nM	28.0
321196	17701088	CHEMBL3705810	In Vitro Inhibition Assay: The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0.01% (Sigma S8032), BSA at 0.005% (Sigma A2153), 0.05 mM sodium orthovanadate (Calbiochem 567540). Detection buffer (DB): 50 mM HEPES (pH: 7.0), BSA at 0.1%, 0.8 M KF (Fluka 60239), 20 mM EDTA (Sigma E5134).The peptide used is the one described in Biochemistry, 2005, 44, 8533-8542; A-21-K(biotin)NH.sub.2, obtained from NeoMPS (reference SP081233). All the HTRF reagents Mab PT66-K (61T66KLB) and streptavidin-XL665 (610SAXLB), and the SEB reagent, are purchased from Cisbio.The test is carried out in a 384-well plate (Greiner 784076). The serial dilutions are carried out in pure DMSO, and then an intermediate one-in-three dilution in water is carried out, with 1 microliter of each concentration being distributed, all these operations being performed using the Zephyr apparatus (Caliper Life Sciences).	B	COc1cc(C2CCN(C)CC2)c(C)cc1Nc1ncc2sc(C(N)=O)c(-c3ccccc3)c2n1		CHEMBL3669135	=	IC50	nM	14.0	CHEMBL4247	Homo sapiens	IC50	nM	14.0
321197	17701089	CHEMBL3705810	In Vitro Inhibition Assay: The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0.01% (Sigma S8032), BSA at 0.005% (Sigma A2153), 0.05 mM sodium orthovanadate (Calbiochem 567540). Detection buffer (DB): 50 mM HEPES (pH: 7.0), BSA at 0.1%, 0.8 M KF (Fluka 60239), 20 mM EDTA (Sigma E5134).The peptide used is the one described in Biochemistry, 2005, 44, 8533-8542; A-21-K(biotin)NH.sub.2, obtained from NeoMPS (reference SP081233). All the HTRF reagents Mab PT66-K (61T66KLB) and streptavidin-XL665 (610SAXLB), and the SEB reagent, are purchased from Cisbio.The test is carried out in a 384-well plate (Greiner 784076). The serial dilutions are carried out in pure DMSO, and then an intermediate one-in-three dilution in water is carried out, with 1 microliter of each concentration being distributed, all these operations being performed using the Zephyr apparatus (Caliper Life Sciences).	B	COc1ccccc1-c1c(C(N)=O)sc2cnc(Nc3ccc(C4CCN(C)CC4)cc3OC(C)C)nc12		CHEMBL3669136	=	IC50	nM	7.0	CHEMBL4247	Homo sapiens	IC50	nM	7.0
321198	17701090	CHEMBL3705810	In Vitro Inhibition Assay: The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0.01% (Sigma S8032), BSA at 0.005% (Sigma A2153), 0.05 mM sodium orthovanadate (Calbiochem 567540). Detection buffer (DB): 50 mM HEPES (pH: 7.0), BSA at 0.1%, 0.8 M KF (Fluka 60239), 20 mM EDTA (Sigma E5134).The peptide used is the one described in Biochemistry, 2005, 44, 8533-8542; A-21-K(biotin)NH.sub.2, obtained from NeoMPS (reference SP081233). All the HTRF reagents Mab PT66-K (61T66KLB) and streptavidin-XL665 (610SAXLB), and the SEB reagent, are purchased from Cisbio.The test is carried out in a 384-well plate (Greiner 784076). The serial dilutions are carried out in pure DMSO, and then an intermediate one-in-three dilution in water is carried out, with 1 microliter of each concentration being distributed, all these operations being performed using the Zephyr apparatus (Caliper Life Sciences).	B	CC(C)Oc1cc(C2CCN(C)CC2)ccc1Nc1ncc2sc(C(N)=O)c(-c3ccccc3OC(F)(F)F)c2n1		CHEMBL3669137	=	IC50	nM	0.5	CHEMBL4247	Homo sapiens	IC50	nM	0.5
321199	17701091	CHEMBL3705810	In Vitro Inhibition Assay: The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0.01% (Sigma S8032), BSA at 0.005% (Sigma A2153), 0.05 mM sodium orthovanadate (Calbiochem 567540). Detection buffer (DB): 50 mM HEPES (pH: 7.0), BSA at 0.1%, 0.8 M KF (Fluka 60239), 20 mM EDTA (Sigma E5134).The peptide used is the one described in Biochemistry, 2005, 44, 8533-8542; A-21-K(biotin)NH.sub.2, obtained from NeoMPS (reference SP081233). All the HTRF reagents Mab PT66-K (61T66KLB) and streptavidin-XL665 (610SAXLB), and the SEB reagent, are purchased from Cisbio.The test is carried out in a 384-well plate (Greiner 784076). The serial dilutions are carried out in pure DMSO, and then an intermediate one-in-three dilution in water is carried out, with 1 microliter of each concentration being distributed, all these operations being performed using the Zephyr apparatus (Caliper Life Sciences).	B	COc1ccccc1-c1c(C(N)=O)sc2cnc(Nc3cnc(C4CCN(C)CC4)cc3OC(C)C)nc12		CHEMBL3669138	=	IC50	nM	7.0	CHEMBL4247	Homo sapiens	IC50	nM	7.0
321200	17701092	CHEMBL3705810	In Vitro Inhibition Assay: The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0.01% (Sigma S8032), BSA at 0.005% (Sigma A2153), 0.05 mM sodium orthovanadate (Calbiochem 567540). Detection buffer (DB): 50 mM HEPES (pH: 7.0), BSA at 0.1%, 0.8 M KF (Fluka 60239), 20 mM EDTA (Sigma E5134).The peptide used is the one described in Biochemistry, 2005, 44, 8533-8542; A-21-K(biotin)NH.sub.2, obtained from NeoMPS (reference SP081233). All the HTRF reagents Mab PT66-K (61T66KLB) and streptavidin-XL665 (610SAXLB), and the SEB reagent, are purchased from Cisbio.The test is carried out in a 384-well plate (Greiner 784076). The serial dilutions are carried out in pure DMSO, and then an intermediate one-in-three dilution in water is carried out, with 1 microliter of each concentration being distributed, all these operations being performed using the Zephyr apparatus (Caliper Life Sciences).	B	COc1ncccc1-c1c(C(N)=O)sc2cnc(Nc3cc(C)c(N4CCN(C)CC4)cc3OC(C)C)nc12		CHEMBL3669139	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
321201	17701093	CHEMBL3705810	In Vitro Inhibition Assay: The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0.01% (Sigma S8032), BSA at 0.005% (Sigma A2153), 0.05 mM sodium orthovanadate (Calbiochem 567540). Detection buffer (DB): 50 mM HEPES (pH: 7.0), BSA at 0.1%, 0.8 M KF (Fluka 60239), 20 mM EDTA (Sigma E5134).The peptide used is the one described in Biochemistry, 2005, 44, 8533-8542; A-21-K(biotin)NH.sub.2, obtained from NeoMPS (reference SP081233). All the HTRF reagents Mab PT66-K (61T66KLB) and streptavidin-XL665 (610SAXLB), and the SEB reagent, are purchased from Cisbio.The test is carried out in a 384-well plate (Greiner 784076). The serial dilutions are carried out in pure DMSO, and then an intermediate one-in-three dilution in water is carried out, with 1 microliter of each concentration being distributed, all these operations being performed using the Zephyr apparatus (Caliper Life Sciences).	B	Cc1occc1-c1c(C(N)=O)sc2cnc(Nc3ccc(C4CCN(C)CC4)cc3OC(C)C)nc12		CHEMBL3669140	=	IC50	nM	13.0	CHEMBL4247	Homo sapiens	IC50	nM	13.0
321202	17701094	CHEMBL3705810	In Vitro Inhibition Assay: The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0.01% (Sigma S8032), BSA at 0.005% (Sigma A2153), 0.05 mM sodium orthovanadate (Calbiochem 567540). Detection buffer (DB): 50 mM HEPES (pH: 7.0), BSA at 0.1%, 0.8 M KF (Fluka 60239), 20 mM EDTA (Sigma E5134).The peptide used is the one described in Biochemistry, 2005, 44, 8533-8542; A-21-K(biotin)NH.sub.2, obtained from NeoMPS (reference SP081233). All the HTRF reagents Mab PT66-K (61T66KLB) and streptavidin-XL665 (610SAXLB), and the SEB reagent, are purchased from Cisbio.The test is carried out in a 384-well plate (Greiner 784076). The serial dilutions are carried out in pure DMSO, and then an intermediate one-in-three dilution in water is carried out, with 1 microliter of each concentration being distributed, all these operations being performed using the Zephyr apparatus (Caliper Life Sciences).	B	COc1ccccc1-c1c(C(N)=O)sc2cnc(Nc3cc(C)c(N4CCC(N(C)C)C4)cc3OC(C)C)nc12		CHEMBL3669141	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	nM	2.0
321203	17701095	CHEMBL3705810	In Vitro Inhibition Assay: The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0.01% (Sigma S8032), BSA at 0.005% (Sigma A2153), 0.05 mM sodium orthovanadate (Calbiochem 567540). Detection buffer (DB): 50 mM HEPES (pH: 7.0), BSA at 0.1%, 0.8 M KF (Fluka 60239), 20 mM EDTA (Sigma E5134).The peptide used is the one described in Biochemistry, 2005, 44, 8533-8542; A-21-K(biotin)NH.sub.2, obtained from NeoMPS (reference SP081233). All the HTRF reagents Mab PT66-K (61T66KLB) and streptavidin-XL665 (610SAXLB), and the SEB reagent, are purchased from Cisbio.The test is carried out in a 384-well plate (Greiner 784076). The serial dilutions are carried out in pure DMSO, and then an intermediate one-in-three dilution in water is carried out, with 1 microliter of each concentration being distributed, all these operations being performed using the Zephyr apparatus (Caliper Life Sciences).	B	CCN1CCC(c2cc(Nc3ncc4sc(C(N)=O)c(-c5ccccc5OC(F)(F)F)c4n3)n(C(C)C)n2)CC1		CHEMBL3669142	=	IC50	nM	0.5	CHEMBL4247	Homo sapiens	IC50	nM	0.5
321204	17701096	CHEMBL3705810	In Vitro Inhibition Assay: The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0.01% (Sigma S8032), BSA at 0.005% (Sigma A2153), 0.05 mM sodium orthovanadate (Calbiochem 567540). Detection buffer (DB): 50 mM HEPES (pH: 7.0), BSA at 0.1%, 0.8 M KF (Fluka 60239), 20 mM EDTA (Sigma E5134).The peptide used is the one described in Biochemistry, 2005, 44, 8533-8542; A-21-K(biotin)NH.sub.2, obtained from NeoMPS (reference SP081233). All the HTRF reagents Mab PT66-K (61T66KLB) and streptavidin-XL665 (610SAXLB), and the SEB reagent, are purchased from Cisbio.The test is carried out in a 384-well plate (Greiner 784076). The serial dilutions are carried out in pure DMSO, and then an intermediate one-in-three dilution in water is carried out, with 1 microliter of each concentration being distributed, all these operations being performed using the Zephyr apparatus (Caliper Life Sciences).	B	COc1ccccc1-c1c(C(N)=O)sc2cnc(Nc3ccc(-c4cnn(C)c4)cc3OC(C)C)nc12		CHEMBL3669143	=	IC50	nM	43.0	CHEMBL4247	Homo sapiens	IC50	nM	43.0
321205	17701097	CHEMBL3705810	In Vitro Inhibition Assay: The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0.01% (Sigma S8032), BSA at 0.005% (Sigma A2153), 0.05 mM sodium orthovanadate (Calbiochem 567540). Detection buffer (DB): 50 mM HEPES (pH: 7.0), BSA at 0.1%, 0.8 M KF (Fluka 60239), 20 mM EDTA (Sigma E5134).The peptide used is the one described in Biochemistry, 2005, 44, 8533-8542; A-21-K(biotin)NH.sub.2, obtained from NeoMPS (reference SP081233). All the HTRF reagents Mab PT66-K (61T66KLB) and streptavidin-XL665 (610SAXLB), and the SEB reagent, are purchased from Cisbio.The test is carried out in a 384-well plate (Greiner 784076). The serial dilutions are carried out in pure DMSO, and then an intermediate one-in-three dilution in water is carried out, with 1 microliter of each concentration being distributed, all these operations being performed using the Zephyr apparatus (Caliper Life Sciences).	B	COc1ncccc1-c1c(C(N)=O)sc2cnc(Nc3cc(F)c(C4CCN(C)CC4)cc3OC(C)C)nc12		CHEMBL3669144	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
321206	17701098	CHEMBL3705810	In Vitro Inhibition Assay: The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0.01% (Sigma S8032), BSA at 0.005% (Sigma A2153), 0.05 mM sodium orthovanadate (Calbiochem 567540). Detection buffer (DB): 50 mM HEPES (pH: 7.0), BSA at 0.1%, 0.8 M KF (Fluka 60239), 20 mM EDTA (Sigma E5134).The peptide used is the one described in Biochemistry, 2005, 44, 8533-8542; A-21-K(biotin)NH.sub.2, obtained from NeoMPS (reference SP081233). All the HTRF reagents Mab PT66-K (61T66KLB) and streptavidin-XL665 (610SAXLB), and the SEB reagent, are purchased from Cisbio.The test is carried out in a 384-well plate (Greiner 784076). The serial dilutions are carried out in pure DMSO, and then an intermediate one-in-three dilution in water is carried out, with 1 microliter of each concentration being distributed, all these operations being performed using the Zephyr apparatus (Caliper Life Sciences).	B	COc1ncccc1-c1c(C(N)=O)sc2cnc(Nc3cc(C)c(-n4ccnc4C)cc3OC(C)C)nc12		CHEMBL3669145	=	IC50	nM	17.0	CHEMBL4247	Homo sapiens	IC50	nM	17.0
321207	17701099	CHEMBL3705810	In Vitro Inhibition Assay: The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0.01% (Sigma S8032), BSA at 0.005% (Sigma A2153), 0.05 mM sodium orthovanadate (Calbiochem 567540). Detection buffer (DB): 50 mM HEPES (pH: 7.0), BSA at 0.1%, 0.8 M KF (Fluka 60239), 20 mM EDTA (Sigma E5134).The peptide used is the one described in Biochemistry, 2005, 44, 8533-8542; A-21-K(biotin)NH.sub.2, obtained from NeoMPS (reference SP081233). All the HTRF reagents Mab PT66-K (61T66KLB) and streptavidin-XL665 (610SAXLB), and the SEB reagent, are purchased from Cisbio.The test is carried out in a 384-well plate (Greiner 784076). The serial dilutions are carried out in pure DMSO, and then an intermediate one-in-three dilution in water is carried out, with 1 microliter of each concentration being distributed, all these operations being performed using the Zephyr apparatus (Caliper Life Sciences).	B	COc1ccccc1-c1c(C(N)=O)sc2cnc(Nc3ccc(CN4CCN(C)CC4)cc3OC(C)C)nc12		CHEMBL3669146	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
321208	17701100	CHEMBL3705810	In Vitro Inhibition Assay: The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0.01% (Sigma S8032), BSA at 0.005% (Sigma A2153), 0.05 mM sodium orthovanadate (Calbiochem 567540). Detection buffer (DB): 50 mM HEPES (pH: 7.0), BSA at 0.1%, 0.8 M KF (Fluka 60239), 20 mM EDTA (Sigma E5134).The peptide used is the one described in Biochemistry, 2005, 44, 8533-8542; A-21-K(biotin)NH.sub.2, obtained from NeoMPS (reference SP081233). All the HTRF reagents Mab PT66-K (61T66KLB) and streptavidin-XL665 (610SAXLB), and the SEB reagent, are purchased from Cisbio.The test is carried out in a 384-well plate (Greiner 784076). The serial dilutions are carried out in pure DMSO, and then an intermediate one-in-three dilution in water is carried out, with 1 microliter of each concentration being distributed, all these operations being performed using the Zephyr apparatus (Caliper Life Sciences).	B	COc1ccccc1-c1c(C(N)=O)sc2cnc(Nc3ccc(NC4CCOCC4)cc3OC(C)C)nc12		CHEMBL3669147	=	IC50	nM	35.0	CHEMBL4247	Homo sapiens	IC50	nM	35.0
321209	17701101	CHEMBL3705810	In Vitro Inhibition Assay: The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0.01% (Sigma S8032), BSA at 0.005% (Sigma A2153), 0.05 mM sodium orthovanadate (Calbiochem 567540). Detection buffer (DB): 50 mM HEPES (pH: 7.0), BSA at 0.1%, 0.8 M KF (Fluka 60239), 20 mM EDTA (Sigma E5134).The peptide used is the one described in Biochemistry, 2005, 44, 8533-8542; A-21-K(biotin)NH.sub.2, obtained from NeoMPS (reference SP081233). All the HTRF reagents Mab PT66-K (61T66KLB) and streptavidin-XL665 (610SAXLB), and the SEB reagent, are purchased from Cisbio.The test is carried out in a 384-well plate (Greiner 784076). The serial dilutions are carried out in pure DMSO, and then an intermediate one-in-three dilution in water is carried out, with 1 microliter of each concentration being distributed, all these operations being performed using the Zephyr apparatus (Caliper Life Sciences).	B	COc1ncc(F)cc1-c1c(C(N)=O)sc2cnc(Nc3cc(C4CCOCC4)nn3C(C)C)nc12		CHEMBL3669148	=	IC50	nM	8.0	CHEMBL4247	Homo sapiens	IC50	nM	8.0
321210	17701102	CHEMBL3705810	In Vitro Inhibition Assay: The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0.01% (Sigma S8032), BSA at 0.005% (Sigma A2153), 0.05 mM sodium orthovanadate (Calbiochem 567540). Detection buffer (DB): 50 mM HEPES (pH: 7.0), BSA at 0.1%, 0.8 M KF (Fluka 60239), 20 mM EDTA (Sigma E5134).The peptide used is the one described in Biochemistry, 2005, 44, 8533-8542; A-21-K(biotin)NH.sub.2, obtained from NeoMPS (reference SP081233). All the HTRF reagents Mab PT66-K (61T66KLB) and streptavidin-XL665 (610SAXLB), and the SEB reagent, are purchased from Cisbio.The test is carried out in a 384-well plate (Greiner 784076). The serial dilutions are carried out in pure DMSO, and then an intermediate one-in-three dilution in water is carried out, with 1 microliter of each concentration being distributed, all these operations being performed using the Zephyr apparatus (Caliper Life Sciences).	B	COc1ncccc1-c1c(C(N)=O)sc2cnc(Nc3cccc(N4CCN(C)CC4)c3OC(C)C)nc12		CHEMBL3669149	=	IC50	nM	23.0	CHEMBL4247	Homo sapiens	IC50	nM	23.0
321211	17701103	CHEMBL3705810	In Vitro Inhibition Assay: The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0.01% (Sigma S8032), BSA at 0.005% (Sigma A2153), 0.05 mM sodium orthovanadate (Calbiochem 567540). Detection buffer (DB): 50 mM HEPES (pH: 7.0), BSA at 0.1%, 0.8 M KF (Fluka 60239), 20 mM EDTA (Sigma E5134).The peptide used is the one described in Biochemistry, 2005, 44, 8533-8542; A-21-K(biotin)NH.sub.2, obtained from NeoMPS (reference SP081233). All the HTRF reagents Mab PT66-K (61T66KLB) and streptavidin-XL665 (610SAXLB), and the SEB reagent, are purchased from Cisbio.The test is carried out in a 384-well plate (Greiner 784076). The serial dilutions are carried out in pure DMSO, and then an intermediate one-in-three dilution in water is carried out, with 1 microliter of each concentration being distributed, all these operations being performed using the Zephyr apparatus (Caliper Life Sciences).	B	COc1ccccc1-c1c(C(N)=O)sc2cnc(Nc3cc4c(cc3OC(C)C)N(C)C(=O)CCC4)nc12		CHEMBL3669150	=	IC50	nM	310.0	CHEMBL4247	Homo sapiens	IC50	nM	310.0
321212	17701104	CHEMBL3705810	In Vitro Inhibition Assay: The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0.01% (Sigma S8032), BSA at 0.005% (Sigma A2153), 0.05 mM sodium orthovanadate (Calbiochem 567540). Detection buffer (DB): 50 mM HEPES (pH: 7.0), BSA at 0.1%, 0.8 M KF (Fluka 60239), 20 mM EDTA (Sigma E5134).The peptide used is the one described in Biochemistry, 2005, 44, 8533-8542; A-21-K(biotin)NH.sub.2, obtained from NeoMPS (reference SP081233). All the HTRF reagents Mab PT66-K (61T66KLB) and streptavidin-XL665 (610SAXLB), and the SEB reagent, are purchased from Cisbio.The test is carried out in a 384-well plate (Greiner 784076). The serial dilutions are carried out in pure DMSO, and then an intermediate one-in-three dilution in water is carried out, with 1 microliter of each concentration being distributed, all these operations being performed using the Zephyr apparatus (Caliper Life Sciences).	B	COc1ccc(F)cc1-c1c(CO)sc2cnc(Nc3ccc(N4CCN(C)CC4)cc3OC(C)C)nc12		CHEMBL3669151	=	IC50	nM	27.0	CHEMBL4247	Homo sapiens	IC50	nM	27.0
321213	17701105	CHEMBL3705810	In Vitro Inhibition Assay: The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0.01% (Sigma S8032), BSA at 0.005% (Sigma A2153), 0.05 mM sodium orthovanadate (Calbiochem 567540). Detection buffer (DB): 50 mM HEPES (pH: 7.0), BSA at 0.1%, 0.8 M KF (Fluka 60239), 20 mM EDTA (Sigma E5134).The peptide used is the one described in Biochemistry, 2005, 44, 8533-8542; A-21-K(biotin)NH.sub.2, obtained from NeoMPS (reference SP081233). All the HTRF reagents Mab PT66-K (61T66KLB) and streptavidin-XL665 (610SAXLB), and the SEB reagent, are purchased from Cisbio.The test is carried out in a 384-well plate (Greiner 784076). The serial dilutions are carried out in pure DMSO, and then an intermediate one-in-three dilution in water is carried out, with 1 microliter of each concentration being distributed, all these operations being performed using the Zephyr apparatus (Caliper Life Sciences).	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2sc(C(C)(C)O)c(-c3ccccc3OC)c2n1		CHEMBL3669152	=	IC50	nM	130.0	CHEMBL4247	Homo sapiens	IC50	nM	130.0
321214	17701106	CHEMBL3887055	In Vitro Inhibition Assay: The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0.01% (Sigma S8032), BSA at 0.005% (Sigma A2153), 0.05 mM sodium orthovanadate (Calbiochem 567540). Detection buffer (DB): 50 mM HEPES (pH: 7.0), BSA at 0.1%, 0.8 M KF (Fluka 60239), 20 mM EDTA (Sigma E5134).The peptide used is the one described in Biochemistry, 2005, 44, 8533-8542; A-21-K(biotin)NH.sub.2, obtained from NeoMPS (reference SP081233). All the HTRF reagents Mab PT66-K (61T66KLB) and streptavidin-XL665 (610SAXLB), and the SEB reagent, are purchased from Cisbio.The test is carried out in a 384-well plate (Greiner 784076). The serial dilutions are carried out in pure DMSO, and then an intermediate one-in-three dilution in water is carried out, with 1 microliter of each concentration being distributed, all these operations being performed using the Zephyr apparatus (Caliper Life Sciences).	B	COc1ncccc1-c1c(C(N)=O)sc2cnc(Nc3cc(C)c(N4CCN(C)CC4)cc3OC(C)C)nc12		CHEMBL3669139	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
321215	17701107	CHEMBL3887055	In Vitro Inhibition Assay: The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0.01% (Sigma S8032), BSA at 0.005% (Sigma A2153), 0.05 mM sodium orthovanadate (Calbiochem 567540). Detection buffer (DB): 50 mM HEPES (pH: 7.0), BSA at 0.1%, 0.8 M KF (Fluka 60239), 20 mM EDTA (Sigma E5134).The peptide used is the one described in Biochemistry, 2005, 44, 8533-8542; A-21-K(biotin)NH.sub.2, obtained from NeoMPS (reference SP081233). All the HTRF reagents Mab PT66-K (61T66KLB) and streptavidin-XL665 (610SAXLB), and the SEB reagent, are purchased from Cisbio.The test is carried out in a 384-well plate (Greiner 784076). The serial dilutions are carried out in pure DMSO, and then an intermediate one-in-three dilution in water is carried out, with 1 microliter of each concentration being distributed, all these operations being performed using the Zephyr apparatus (Caliper Life Sciences).	B	Cc1occc1-c1c(C(N)=O)sc2cnc(Nc3ccc(C4CCN(C)CC4)cc3OC(C)C)nc12		CHEMBL3669140	=	IC50	nM	17.0	CHEMBL4247	Homo sapiens	IC50	nM	17.0
321216	17701108	CHEMBL3887055	In Vitro Inhibition Assay: The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0.01% (Sigma S8032), BSA at 0.005% (Sigma A2153), 0.05 mM sodium orthovanadate (Calbiochem 567540). Detection buffer (DB): 50 mM HEPES (pH: 7.0), BSA at 0.1%, 0.8 M KF (Fluka 60239), 20 mM EDTA (Sigma E5134).The peptide used is the one described in Biochemistry, 2005, 44, 8533-8542; A-21-K(biotin)NH.sub.2, obtained from NeoMPS (reference SP081233). All the HTRF reagents Mab PT66-K (61T66KLB) and streptavidin-XL665 (610SAXLB), and the SEB reagent, are purchased from Cisbio.The test is carried out in a 384-well plate (Greiner 784076). The serial dilutions are carried out in pure DMSO, and then an intermediate one-in-three dilution in water is carried out, with 1 microliter of each concentration being distributed, all these operations being performed using the Zephyr apparatus (Caliper Life Sciences).	B	COc1ccccc1-c1c(C(N)=O)sc2cnc(Nc3cc(C)c(N4CCC(N(C)C)C4)cc3OC(C)C)nc12		CHEMBL3669141	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	nM	2.0
321217	17701109	CHEMBL3887055	In Vitro Inhibition Assay: The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0.01% (Sigma S8032), BSA at 0.005% (Sigma A2153), 0.05 mM sodium orthovanadate (Calbiochem 567540). Detection buffer (DB): 50 mM HEPES (pH: 7.0), BSA at 0.1%, 0.8 M KF (Fluka 60239), 20 mM EDTA (Sigma E5134).The peptide used is the one described in Biochemistry, 2005, 44, 8533-8542; A-21-K(biotin)NH.sub.2, obtained from NeoMPS (reference SP081233). All the HTRF reagents Mab PT66-K (61T66KLB) and streptavidin-XL665 (610SAXLB), and the SEB reagent, are purchased from Cisbio.The test is carried out in a 384-well plate (Greiner 784076). The serial dilutions are carried out in pure DMSO, and then an intermediate one-in-three dilution in water is carried out, with 1 microliter of each concentration being distributed, all these operations being performed using the Zephyr apparatus (Caliper Life Sciences).	B	CCN1CCC(c2cc(Nc3ncc4sc(C(N)=O)c(-c5ccccc5OC(F)(F)F)c4n3)n(C(C)C)n2)CC1		CHEMBL3669142	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
321218	17701110	CHEMBL3887055	In Vitro Inhibition Assay: The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0.01% (Sigma S8032), BSA at 0.005% (Sigma A2153), 0.05 mM sodium orthovanadate (Calbiochem 567540). Detection buffer (DB): 50 mM HEPES (pH: 7.0), BSA at 0.1%, 0.8 M KF (Fluka 60239), 20 mM EDTA (Sigma E5134).The peptide used is the one described in Biochemistry, 2005, 44, 8533-8542; A-21-K(biotin)NH.sub.2, obtained from NeoMPS (reference SP081233). All the HTRF reagents Mab PT66-K (61T66KLB) and streptavidin-XL665 (610SAXLB), and the SEB reagent, are purchased from Cisbio.The test is carried out in a 384-well plate (Greiner 784076). The serial dilutions are carried out in pure DMSO, and then an intermediate one-in-three dilution in water is carried out, with 1 microliter of each concentration being distributed, all these operations being performed using the Zephyr apparatus (Caliper Life Sciences).	B	COc1ccccc1-c1c(C(N)=O)sc2cnc(Nc3ccc(-c4cnn(C)c4)cc3OC(C)C)nc12		CHEMBL3669143	=	IC50	nM	54.0	CHEMBL4247	Homo sapiens	IC50	nM	54.0
321219	17701111	CHEMBL3887055	In Vitro Inhibition Assay: The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0.01% (Sigma S8032), BSA at 0.005% (Sigma A2153), 0.05 mM sodium orthovanadate (Calbiochem 567540). Detection buffer (DB): 50 mM HEPES (pH: 7.0), BSA at 0.1%, 0.8 M KF (Fluka 60239), 20 mM EDTA (Sigma E5134).The peptide used is the one described in Biochemistry, 2005, 44, 8533-8542; A-21-K(biotin)NH.sub.2, obtained from NeoMPS (reference SP081233). All the HTRF reagents Mab PT66-K (61T66KLB) and streptavidin-XL665 (610SAXLB), and the SEB reagent, are purchased from Cisbio.The test is carried out in a 384-well plate (Greiner 784076). The serial dilutions are carried out in pure DMSO, and then an intermediate one-in-three dilution in water is carried out, with 1 microliter of each concentration being distributed, all these operations being performed using the Zephyr apparatus (Caliper Life Sciences).	B	COc1ncccc1-c1c(C(N)=O)sc2cnc(Nc3cc(F)c(C4CCN(C)CC4)cc3OC(C)C)nc12		CHEMBL3669144	=	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	nM	1.0
321220	17701112	CHEMBL3887055	In Vitro Inhibition Assay: The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0.01% (Sigma S8032), BSA at 0.005% (Sigma A2153), 0.05 mM sodium orthovanadate (Calbiochem 567540). Detection buffer (DB): 50 mM HEPES (pH: 7.0), BSA at 0.1%, 0.8 M KF (Fluka 60239), 20 mM EDTA (Sigma E5134).The peptide used is the one described in Biochemistry, 2005, 44, 8533-8542; A-21-K(biotin)NH.sub.2, obtained from NeoMPS (reference SP081233). All the HTRF reagents Mab PT66-K (61T66KLB) and streptavidin-XL665 (610SAXLB), and the SEB reagent, are purchased from Cisbio.The test is carried out in a 384-well plate (Greiner 784076). The serial dilutions are carried out in pure DMSO, and then an intermediate one-in-three dilution in water is carried out, with 1 microliter of each concentration being distributed, all these operations being performed using the Zephyr apparatus (Caliper Life Sciences).	B	COc1ncccc1-c1c(C(N)=O)sc2cnc(Nc3cc(C)c(-n4ccnc4C)cc3OC(C)C)nc12		CHEMBL3669145	=	IC50	nM	65.0	CHEMBL4247	Homo sapiens	IC50	nM	65.0
321221	17701113	CHEMBL3887055	In Vitro Inhibition Assay: The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0.01% (Sigma S8032), BSA at 0.005% (Sigma A2153), 0.05 mM sodium orthovanadate (Calbiochem 567540). Detection buffer (DB): 50 mM HEPES (pH: 7.0), BSA at 0.1%, 0.8 M KF (Fluka 60239), 20 mM EDTA (Sigma E5134).The peptide used is the one described in Biochemistry, 2005, 44, 8533-8542; A-21-K(biotin)NH.sub.2, obtained from NeoMPS (reference SP081233). All the HTRF reagents Mab PT66-K (61T66KLB) and streptavidin-XL665 (610SAXLB), and the SEB reagent, are purchased from Cisbio.The test is carried out in a 384-well plate (Greiner 784076). The serial dilutions are carried out in pure DMSO, and then an intermediate one-in-three dilution in water is carried out, with 1 microliter of each concentration being distributed, all these operations being performed using the Zephyr apparatus (Caliper Life Sciences).	B	COc1ccccc1-c1c(C(N)=O)sc2cnc(Nc3ccc(CN4CCN(C)CC4)cc3OC(C)C)nc12		CHEMBL3669146	=	IC50	nM	9.0	CHEMBL4247	Homo sapiens	IC50	nM	9.0
321222	17701114	CHEMBL3887055	In Vitro Inhibition Assay: The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0.01% (Sigma S8032), BSA at 0.005% (Sigma A2153), 0.05 mM sodium orthovanadate (Calbiochem 567540). Detection buffer (DB): 50 mM HEPES (pH: 7.0), BSA at 0.1%, 0.8 M KF (Fluka 60239), 20 mM EDTA (Sigma E5134).The peptide used is the one described in Biochemistry, 2005, 44, 8533-8542; A-21-K(biotin)NH.sub.2, obtained from NeoMPS (reference SP081233). All the HTRF reagents Mab PT66-K (61T66KLB) and streptavidin-XL665 (610SAXLB), and the SEB reagent, are purchased from Cisbio.The test is carried out in a 384-well plate (Greiner 784076). The serial dilutions are carried out in pure DMSO, and then an intermediate one-in-three dilution in water is carried out, with 1 microliter of each concentration being distributed, all these operations being performed using the Zephyr apparatus (Caliper Life Sciences).	B	COc1ccccc1-c1c(C(N)=O)sc2cnc(Nc3ccc(NC4CCOCC4)cc3OC(C)C)nc12		CHEMBL3669147	=	IC50	nM	57.0	CHEMBL4247	Homo sapiens	IC50	nM	57.0
321223	17701115	CHEMBL3887055	In Vitro Inhibition Assay: The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0.01% (Sigma S8032), BSA at 0.005% (Sigma A2153), 0.05 mM sodium orthovanadate (Calbiochem 567540). Detection buffer (DB): 50 mM HEPES (pH: 7.0), BSA at 0.1%, 0.8 M KF (Fluka 60239), 20 mM EDTA (Sigma E5134).The peptide used is the one described in Biochemistry, 2005, 44, 8533-8542; A-21-K(biotin)NH.sub.2, obtained from NeoMPS (reference SP081233). All the HTRF reagents Mab PT66-K (61T66KLB) and streptavidin-XL665 (610SAXLB), and the SEB reagent, are purchased from Cisbio.The test is carried out in a 384-well plate (Greiner 784076). The serial dilutions are carried out in pure DMSO, and then an intermediate one-in-three dilution in water is carried out, with 1 microliter of each concentration being distributed, all these operations being performed using the Zephyr apparatus (Caliper Life Sciences).	B	COc1ncc(F)cc1-c1c(C(N)=O)sc2cnc(Nc3cc(C4CCOCC4)nn3C(C)C)nc12		CHEMBL3669148	=	IC50	nM	13.0	CHEMBL4247	Homo sapiens	IC50	nM	13.0
321224	17701116	CHEMBL3887055	In Vitro Inhibition Assay: The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0.01% (Sigma S8032), BSA at 0.005% (Sigma A2153), 0.05 mM sodium orthovanadate (Calbiochem 567540). Detection buffer (DB): 50 mM HEPES (pH: 7.0), BSA at 0.1%, 0.8 M KF (Fluka 60239), 20 mM EDTA (Sigma E5134).The peptide used is the one described in Biochemistry, 2005, 44, 8533-8542; A-21-K(biotin)NH.sub.2, obtained from NeoMPS (reference SP081233). All the HTRF reagents Mab PT66-K (61T66KLB) and streptavidin-XL665 (610SAXLB), and the SEB reagent, are purchased from Cisbio.The test is carried out in a 384-well plate (Greiner 784076). The serial dilutions are carried out in pure DMSO, and then an intermediate one-in-three dilution in water is carried out, with 1 microliter of each concentration being distributed, all these operations being performed using the Zephyr apparatus (Caliper Life Sciences).	B	COc1ncccc1-c1c(C(N)=O)sc2cnc(Nc3cccc(N4CCN(C)CC4)c3OC(C)C)nc12		CHEMBL3669149	=	IC50	nM	43.0	CHEMBL4247	Homo sapiens	IC50	nM	43.0
321225	17701117	CHEMBL3887055	In Vitro Inhibition Assay: The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0.01% (Sigma S8032), BSA at 0.005% (Sigma A2153), 0.05 mM sodium orthovanadate (Calbiochem 567540). Detection buffer (DB): 50 mM HEPES (pH: 7.0), BSA at 0.1%, 0.8 M KF (Fluka 60239), 20 mM EDTA (Sigma E5134).The peptide used is the one described in Biochemistry, 2005, 44, 8533-8542; A-21-K(biotin)NH.sub.2, obtained from NeoMPS (reference SP081233). All the HTRF reagents Mab PT66-K (61T66KLB) and streptavidin-XL665 (610SAXLB), and the SEB reagent, are purchased from Cisbio.The test is carried out in a 384-well plate (Greiner 784076). The serial dilutions are carried out in pure DMSO, and then an intermediate one-in-three dilution in water is carried out, with 1 microliter of each concentration being distributed, all these operations being performed using the Zephyr apparatus (Caliper Life Sciences).	B	COc1ccccc1-c1c(C(N)=O)sc2cnc(Nc3cc4c(cc3OC(C)C)N(C)C(=O)CCC4)nc12		CHEMBL3669150	=	IC50	nM	424.0	CHEMBL4247	Homo sapiens	IC50	nM	424.0
321226	17701118	CHEMBL3887055	In Vitro Inhibition Assay: The reagents used have the following composition: Enzyme buffer (EB): 50 mM HEPES (pH: 7.0) (Sigma H7523), 100 mM NaCl (Sigma S7653), NaN.sub.3 at 0.01% (Sigma S8032), BSA at 0.005% (Sigma A2153), 0.05 mM sodium orthovanadate (Calbiochem 567540). Detection buffer (DB): 50 mM HEPES (pH: 7.0), BSA at 0.1%, 0.8 M KF (Fluka 60239), 20 mM EDTA (Sigma E5134).The peptide used is the one described in Biochemistry, 2005, 44, 8533-8542; A-21-K(biotin)NH.sub.2, obtained from NeoMPS (reference SP081233). All the HTRF reagents Mab PT66-K (61T66KLB) and streptavidin-XL665 (610SAXLB), and the SEB reagent, are purchased from Cisbio.The test is carried out in a 384-well plate (Greiner 784076). The serial dilutions are carried out in pure DMSO, and then an intermediate one-in-three dilution in water is carried out, with 1 microliter of each concentration being distributed, all these operations being performed using the Zephyr apparatus (Caliper Life Sciences).	B	COc1ccc(F)cc1-c1c(CO)sc2cnc(Nc3ccc(N4CCN(C)CC4)cc3OC(C)C)nc12		CHEMBL3669151	=	IC50	nM	29.0	CHEMBL4247	Homo sapiens	IC50	nM	29.0
325603	17704357	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC(C)N1CCC(Cc2ccc3c(c2)C(C)(C)c2[nH]c4cc(C#N)ccc4c2C3=O)CC1		CHEMBL3968909	=	IC50	nM	2.28	CHEMBL4247	Homo sapiens	IC50	nM	2.28
325604	17704358	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC(C)N1CCC(c2ccc3c(c2)C(C)(C)c2[nH]c4cc(C#N)ccc4c2C3=O)CC1		CHEMBL3945000	=	IC50	nM	0.84	CHEMBL4247	Homo sapiens	IC50	nM	0.84
325605	17704359	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(C3CCN(C4COC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL1779202	=	IC50	nM	1.53	CHEMBL4247	Homo sapiens	IC50	nM	1.53
325606	17704360	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	Cn1cc(-c2cc3c(cc2N2CCOCC2)C(C)(C)c2[nH]c4cc(C#N)ccc4c2C3=O)cn1		CHEMBL3929315	=	IC50	nM	0.81	CHEMBL4247	Homo sapiens	IC50	nM	0.81
325607	17704361	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	C#Cc1cc2c(cc1N1CCN(C3CCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3946496	=	IC50	nM	0.32	CHEMBL4247	Homo sapiens	IC50	nM	0.32
325608	17704362	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(N3CCN(C4CCC4)CC3)c(C3CC3)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3951779	=	IC50	nM	10.56	CHEMBL4247	Homo sapiens	IC50	nM	10.56
325609	17704363	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCCc1cc2c(cc1N1CCN(C3CCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3974835	=	IC50	nM	1.77	CHEMBL4247	Homo sapiens	IC50	nM	1.77
325610	17704364	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	=	IC50	nM	5.3	CHEMBL4247	Homo sapiens	IC50	nM	5.3
325611	17704365	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(N3CCC(N4CCCC4)CC3)ccc2C(=O)c2c1[nH]c1ncccc21		CHEMBL3945435	=	IC50	nM	30.74	CHEMBL4247	Homo sapiens	IC50	nM	30.74
325612	17704366	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCN(CC)CCOc1cc2c(cc1C(C)=O)C(=O)c1c([nH]c3cc(C#N)ccc13)C2(C)C		CHEMBL3932266	=	IC50	nM	0.53	CHEMBL4247	Homo sapiens	IC50	nM	0.53
325613	17704367	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2ccc(C3=CCNCC3)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3896252	=	IC50	nM	0.83	CHEMBL4247	Homo sapiens	IC50	nM	0.83
325614	17704368	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC(C)(C)N1CCN(c2cc3c(cc2Br)C(=O)c2c([nH]c4cc(C#N)ccc24)C32CCOCC2)CC1		CHEMBL3915577	=	IC50	nM	0.32	CHEMBL4247	Homo sapiens	IC50	nM	0.32
325615	17704369	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC#Cc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C1(CCOCC1)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3940191	=	IC50	nM	0.9	CHEMBL4247	Homo sapiens	IC50	nM	0.9
325616	17704370	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCN(CC)CCOc1ccc2c(c1)C(C)(C)c1sc3ccccc3c1C2=O		CHEMBL3897963	=	IC50	nM	93.85	CHEMBL4247	Homo sapiens	IC50	nM	93.85
325617	17704371	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	N#Cc1ccc2c3c([nH]c2c1)C1(CCOCC1)c1cc(OC2CCNCC2)ccc1C3=O		CHEMBL3901152	=	IC50	nM	3.907	CHEMBL4247	Homo sapiens	IC50	nM	3.9067
325618	17704372	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCN(CC)CCOc1ccc2c(c1)C1(CCNCC1)c1[nH]c3ccccc3c1C2=O		CHEMBL3935752	=	IC50	nM	687.68	CHEMBL4247	Homo sapiens	IC50	nM	687.6834
325619	17704373	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(N3CCC(N4CCCCC4)CC3)ncc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3969707	=	IC50	nM	0.4938	CHEMBL4247	Homo sapiens	IC50	nM	0.4938
325620	17704374	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCc1cc2c(cc1N1CCN(C3CCC3)CC1)C(C)(C)c1[nH]c3nc(C#N)ccc3c1C2=O		CHEMBL3890509	=	IC50	nM	1.837	CHEMBL4247	Homo sapiens	IC50	nM	1.8367
325621	17704375	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCN(CC)CCOc1ccc2c(n1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3938910	=	IC50	nM	6.473	CHEMBL4247	Homo sapiens	IC50	nM	6.473
325622	17704376	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCN(CC)CCOc1ccc2c(n1)C(C)(C)c1oc3cc(C#N)ccc3c1C2=O		CHEMBL3975852	=	IC50	nM	399.87	CHEMBL4247	Homo sapiens	IC50	nM	399.8653
325623	17704377	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	O=C1c2ccc(OC[C@@H](O)[C@H](O)CO)cc2C2(CCCCC2)c2oc3ccccc3c21		CHEMBL4108907	=	IC50	nM	93.0	CHEMBL4247	Homo sapiens	IC50	nM	93.0
325624	17704378	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC(C)(C)OC(=O)N1CCC(Oc2ccc3c(c2)C(C)(C)c2[nH]c4cc(C#N)ccc4c2C3=O)CC1		CHEMBL3983559	=	IC50	nM	52.71	CHEMBL4247	Homo sapiens	IC50	nM	52.708
325625	17704379	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OCCN3CCNC3=O)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3922741	=	IC50	nM	6.159	CHEMBL4247	Homo sapiens	IC50	nM	6.159
325626	17704380	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OCCNC(N)=O)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL1779195	=	IC50	nM	26.18	CHEMBL4247	Homo sapiens	IC50	nM	26.184
325627	17704381	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC3COC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3921085	=	IC50	nM	17.71	CHEMBL4247	Homo sapiens	IC50	nM	17.714
325628	17704382	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(Oc3ncccn3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3931695	=	IC50	nM	30.43	CHEMBL4247	Homo sapiens	IC50	nM	30.434
325629	17704383	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCOC(=O)COc1ccc2c(c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3934856	=	IC50	nM	29.47	CHEMBL4247	Homo sapiens	IC50	nM	29.47
325630	17704384	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OCCN)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3898277	=	IC50	nM	8.01	CHEMBL4247	Homo sapiens	IC50	nM	8.01
325631	17704385	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	C[S+]([O-])CCOc1ccc2c(c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3929912	=	IC50	nM	10.25	CHEMBL4247	Homo sapiens	IC50	nM	10.253
325632	17704386	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCN(CC)CCOc1ccc2c(c1)C(C)(C)c1[nH]c3cc(C#N)c(Br)cc3c1C2=O		CHEMBL3978315	=	IC50	nM	97.92	CHEMBL4247	Homo sapiens	IC50	nM	97.92
325633	17704387	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OCC(=O)O)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3894226	=	IC50	nM	45.96	CHEMBL4247	Homo sapiens	IC50	nM	45.96
325634	17704388	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC(C)(C)NCCOc1ccc2c(c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3892306	=	IC50	nM	6.73	CHEMBL4247	Homo sapiens	IC50	nM	6.73
325635	17704389	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC(C)(CO)NCCOc1ccc2c(c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3916798	=	IC50	nM	3.595	CHEMBL4247	Homo sapiens	IC50	nM	3.595
325636	17704390	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OCCNS(=O)(=O)N3CCOCC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3962401	=	IC50	nM	16.0	CHEMBL4247	Homo sapiens	IC50	nM	16.005
325637	17704391	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OCC3CCN(C4COC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3893380	=	IC50	nM	2.9	CHEMBL4247	Homo sapiens	IC50	nM	2.9
325638	17704392	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OCCNS(C)(=O)=O)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3893584	=	IC50	nM	4.943	CHEMBL4247	Homo sapiens	IC50	nM	4.943
325639	17704393	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OCCNS(N)(=O)=O)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3902372	=	IC50	nM	7.65	CHEMBL4247	Homo sapiens	IC50	nM	7.65
325640	17704394	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC3CCN(CCO)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3963068	=	IC50	nM	1.398	CHEMBL4247	Homo sapiens	IC50	nM	1.398
325641	17704395	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC3CCN(CCF)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3924288	=	IC50	nM	3.461	CHEMBL4247	Homo sapiens	IC50	nM	3.461
325642	17704396	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OCC(N)=O)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3977837	=	IC50	nM	17.15	CHEMBL4247	Homo sapiens	IC50	nM	17.148
325643	17704397	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)OCC(CNC(=O)COc2ccc3c(c2)C(C)(C)c2[nH]c4cc(C#N)ccc4c2C3=O)O1		CHEMBL3931796	=	IC50	nM	51.12	CHEMBL4247	Homo sapiens	IC50	nM	51.124
325644	17704398	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OCC(=O)NCC(O)CO)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3969437	=	IC50	nM	17.5	CHEMBL4247	Homo sapiens	IC50	nM	17.501
325645	17704399	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OCC(=O)N3CCNCC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3963168	=	IC50	nM	3.5	CHEMBL4247	Homo sapiens	IC50	nM	3.5
325646	17704400	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OCC(=O)NCCC#N)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3903395	=	IC50	nM	84.68	CHEMBL4247	Homo sapiens	IC50	nM	84.68
325647	17704401	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC(C)N1CCN(c2ccc3c(c2)C(C)(C)c2[nH]c4cc(C#N)ccc4c2C3=O)CC1		CHEMBL1779200	=	IC50	nM	33.57	CHEMBL4247	Homo sapiens	IC50	nM	33.572
325648	17704402	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(N3CCC(S(C)(=O)=O)C3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3936470	=	IC50	nM	16.23	CHEMBL4247	Homo sapiens	IC50	nM	16.225
325649	17704403	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(N3CCS(=O)(=O)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3982627	=	IC50	nM	39.43	CHEMBL4247	Homo sapiens	IC50	nM	39.434
325650	17704404	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(N3CCN(C4CCCC4)CC3=O)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3964940	=	IC50	nM	72.61	CHEMBL4247	Homo sapiens	IC50	nM	72.607
325651	17704405	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(N3CCC(N4CCC(F)(F)CC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3943227	=	IC50	nM	1.681	CHEMBL4247	Homo sapiens	IC50	nM	1.681
325652	17704406	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	C[C@H]1CN(C2CCC2)CCN1c1ccc2c(c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3981666	=	IC50	nM	0.981	CHEMBL4247	Homo sapiens	IC50	nM	0.981
325653	17704407	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	Cn1cc(-c2ccc3c(c2)C(C)(C)c2[nH]c4cc(C#N)ccc4c2C3=O)cn1		CHEMBL3951557	=	IC50	nM	5.437	CHEMBL4247	Homo sapiens	IC50	nM	5.437
325654	17704408	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	C=Cc1ccc2c(c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3977388	=	IC50	nM	14.84	CHEMBL4247	Homo sapiens	IC50	nM	14.835
325655	17704409	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(CC3CCN(S(N)(=O)=O)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3939371	=	IC50	nM	7.278	CHEMBL4247	Homo sapiens	IC50	nM	7.278
325656	17704410	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(C(=O)O)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3930379	=	IC50	nM	59.63	CHEMBL4247	Homo sapiens	IC50	nM	59.632
325657	17704411	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(N3CCN(S(N)(=O)=O)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3961322	=	IC50	nM	3.184	CHEMBL4247	Homo sapiens	IC50	nM	3.184
325658	17704412	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CN(C)S(=O)(=O)N1CCN(c2ccc3c(c2)C(C)(C)c2c(c4ccc(C#N)cc4n2C)C3=O)CC1		CHEMBL3924929	=	IC50	nM	63.8	CHEMBL4247	Homo sapiens	IC50	nM	63.798
325659	17704413	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC(C)N(CCS(=O)(=O)c1ccc2c(c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O)C(C)C		CHEMBL3952637	=	IC50	nM	14.92	CHEMBL4247	Homo sapiens	IC50	nM	14.923
325660	17704414	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(S(=O)(=O)CCC(=O)O)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3918298	=	IC50	nM	71.08	CHEMBL4247	Homo sapiens	IC50	nM	71.084
325661	17704415	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(C(O)CO)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3942730	=	IC50	nM	11.89	CHEMBL4247	Homo sapiens	IC50	nM	11.894
325662	17704416	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(C(=O)N3CCOCC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3901433	=	IC50	nM	30.13	CHEMBL4247	Homo sapiens	IC50	nM	30.134
325663	17704417	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(C(=O)N3CCN(S(C)(=O)=O)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3972539	=	IC50	nM	27.32	CHEMBL4247	Homo sapiens	IC50	nM	27.324
325664	17704418	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(C(=O)NCCS(C)(=O)=O)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3910490	=	IC50	nM	10.37	CHEMBL4247	Homo sapiens	IC50	nM	10.369
325665	17704419	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(C(=O)NC3CCS(=O)(=O)C3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3983750	=	IC50	nM	26.85	CHEMBL4247	Homo sapiens	IC50	nM	26.851
325666	17704420	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(C(=O)N(CCO)CCO)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3984781	=	IC50	nM	272.36	CHEMBL4247	Homo sapiens	IC50	nM	272.356
325667	17704421	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(C(=O)NC3COC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3901838	=	IC50	nM	23.09	CHEMBL4247	Homo sapiens	IC50	nM	23.088
325668	17704422	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(C(=O)NOCCO)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3928499	=	IC50	nM	3.611	CHEMBL4247	Homo sapiens	IC50	nM	3.611
325669	17704423	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(C(=O)NCCNS(N)(=O)=O)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3961470	=	IC50	nM	2.115	CHEMBL4247	Homo sapiens	IC50	nM	2.115
325670	17704424	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(C(=O)N3CCN(CCO)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3967160	=	IC50	nM	42.38	CHEMBL4247	Homo sapiens	IC50	nM	42.375
325671	17704425	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(C(=O)N3CCN(C(C)(C)C)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3937469	=	IC50	nM	6.002	CHEMBL4247	Homo sapiens	IC50	nM	6.002
325672	17704426	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(CN3CCS(=O)(=O)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3929985	=	IC50	nM	6.783	CHEMBL4247	Homo sapiens	IC50	nM	6.783
325673	17704427	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(CN3CCN(S(C)(=O)=O)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3965185	=	IC50	nM	3.473	CHEMBL4247	Homo sapiens	IC50	nM	3.473
325674	17704428	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(CNCC(F)(F)F)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3962220	=	IC50	nM	11.86	CHEMBL4247	Homo sapiens	IC50	nM	11.859
325675	17704429	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCNC(=O)N1CCC(c2ccc3c(c2)C(C)(C)c2[nH]c4cc(C#N)ccc4c2C3=O)CC1		CHEMBL3972824	=	IC50	nM	2.001	CHEMBL4247	Homo sapiens	IC50	nM	2.001
325676	17704430	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	COc1cc2c(cc1S(=O)(=O)N1CCN(C)CC1)C(=O)c1c([nH]c3cc(Br)ccc13)C2(C)C		CHEMBL3963805	=	IC50	nM	96.12	CHEMBL4247	Homo sapiens	IC50	nM	96.116
325677	17704431	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CN(C)S(=O)(=O)Oc1ccc2c(c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3934973	=	IC50	nM	51.1	CHEMBL4247	Homo sapiens	IC50	nM	51.102
325678	17704432	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CN(C)S(=O)(=O)c1cc2c(cc1N1CCN(CCO)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3916287	=	IC50	nM	5.101	CHEMBL4247	Homo sapiens	IC50	nM	5.101
325679	17704433	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(N3CCC(N4CCCC4)CC3)c(S(=O)(=O)N3CCCC3)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3909864	=	IC50	nM	8.753	CHEMBL4247	Homo sapiens	IC50	nM	8.753
325680	17704434	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC3CCOCC3)c(S(=O)(=O)N3CCOCC3)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3980776	=	IC50	nM	9.617	CHEMBL4247	Homo sapiens	IC50	nM	9.617
325681	17704435	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CN1CCC(Oc2cc3c(cc2[N+](=O)[O-])C(=O)c2c([nH]c4cc(C#N)ccc24)C3(C)C)CC1		CHEMBL3986775	=	IC50	nM	0.991	CHEMBL4247	Homo sapiens	IC50	nM	0.991
325682	17704436	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CN1CCC(Oc2cc3c(cc2N)C(=O)c2c([nH]c4cc(C#N)ccc24)C3(C)C)CC1		CHEMBL3961537	=	IC50	nM	3.612	CHEMBL4247	Homo sapiens	IC50	nM	3.612
325683	17704437	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CN1CCC(Oc2cc3c(cc2NS(C)(=O)=O)C(=O)c2c([nH]c4cc(C#N)ccc24)C3(C)C)CC1		CHEMBL3978523	=	IC50	nM	6.28	CHEMBL4247	Homo sapiens	IC50	nM	6.28
325684	17704438	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	COc1cc2c(cc1SC(C)C)C(=O)c1c([nH]c3cc(C#N)ccc13)C2(C)C		CHEMBL3949427	=	IC50	nM	9.451	CHEMBL4247	Homo sapiens	IC50	nM	9.451
325685	17704439	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCN(CC)CCS(=O)(=O)c1cc2c(cc1OC)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3897705	=	IC50	nM	1.338	CHEMBL4247	Homo sapiens	IC50	nM	1.338
325686	17704440	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	COc1cc2c(cc1C#CC(=O)O)C(=O)c1c([nH]c3cc(C#N)ccc13)C2(C)C		CHEMBL3912544	=	IC50	nM	6.668	CHEMBL4247	Homo sapiens	IC50	nM	6.668
325687	17704441	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	COc1cc2c(cc1CCC(C)(C)O)C(=O)c1c([nH]c3cc(C#N)ccc13)C2(C)C		CHEMBL3935006	=	IC50	nM	8.113	CHEMBL4247	Homo sapiens	IC50	nM	8.113
325688	17704442	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC3CCN(S(C)(=O)=O)CC3)c(Br)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3907048	=	IC50	nM	5.054	CHEMBL4247	Homo sapiens	IC50	nM	5.054
325689	17704443	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(N3CCC(N)CC3)c(Br)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3892880	=	IC50	nM	0.168	CHEMBL4247	Homo sapiens	IC50	nM	0.168
325690	17704444	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	C#Cc1cc2c(cc1OC1CCN(C3COC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3941123	=	IC50	nM	1.625	CHEMBL4247	Homo sapiens	IC50	nM	1.625
325691	17704445	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(N3CCN(C4COC4)CC3)c(Br)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3981472	=	IC50	nM	0.952	CHEMBL4247	Homo sapiens	IC50	nM	0.952
325692	17704446	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(N3CCN(C4CCS(=O)(=O)CC4)CC3)c(Br)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3914907	=	IC50	nM	1.134	CHEMBL4247	Homo sapiens	IC50	nM	1.134
325693	17704447	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(N3CCN(C4CCC4)CC3)c(Br)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3976640	=	IC50	nM	2.099	CHEMBL4247	Homo sapiens	IC50	nM	2.099
325694	17704448	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	C#Cc1cc2c(cc1N1CCOCC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3905916	=	IC50	nM	2.386	CHEMBL4247	Homo sapiens	IC50	nM	2.386
325695	17704449	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(N3CCOCC3)c(C#CCN3CCOCC3)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3904875	=	IC50	nM	2.575	CHEMBL4247	Homo sapiens	IC50	nM	2.575
325696	17704450	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	C=Cc1cc2c(cc1N1CCOCC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3892424	=	IC50	nM	2.052	CHEMBL4247	Homo sapiens	IC50	nM	2.052
325697	17704451	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(N3CCN(C4COC4)CC3)c(C#CCN3CCN(C4COC4)CC3)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3920411	=	IC50	nM	0.996	CHEMBL4247	Homo sapiens	IC50	nM	0.996
325698	17704452	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(N3CCN(C4COC4)CC3)c(C#CC3CC3)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3919367	=	IC50	nM	0.881	CHEMBL4247	Homo sapiens	IC50	nM	0.881
325699	17704453	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC(C)CCC#Cc1cc2c(cc1N1CCN(C3COC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3922720	=	IC50	nM	12.27	CHEMBL4247	Homo sapiens	IC50	nM	12.271
325700	17704454	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(N3CCC(N4CCCC4)CC3)c(C3=CCNCC3)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3937655	=	IC50	nM	1.778	CHEMBL4247	Homo sapiens	IC50	nM	1.778
325701	17704455	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(N3CCN(C4CC4)CC3)c(-c3ccccc3)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3934077	=	IC50	nM	14.82	CHEMBL4247	Homo sapiens	IC50	nM	14.824
325702	17704456	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(N3CCN(C4CCC4)CC3)c(C#CC3CCC3)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3915056	=	IC50	nM	0.58	CHEMBL4247	Homo sapiens	IC50	nM	0.58
325703	17704457	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	Cc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1940181	=	IC50	nM	2.611	CHEMBL4247	Homo sapiens	IC50	nM	2.611
325704	17704458	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCc1cc2c(cc1N1CCN(C3COC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1823221	=	IC50	nM	7.154	CHEMBL4247	Homo sapiens	IC50	nM	7.154
325705	17704459	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(N3CCN(C4COC4)CC3)c(CCC3CCCC3)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL1823361	=	IC50	nM	20.28	CHEMBL4247	Homo sapiens	IC50	nM	20.277
325706	17704460	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCCc1cc2c(cc1N1CCN(CCCCO)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3924077	=	IC50	nM	1.093	CHEMBL4247	Homo sapiens	IC50	nM	1.093
325707	17704461	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCCCCc1cc2c(cc1N1CCN(C3COC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3960479	=	IC50	nM	15.05	CHEMBL4247	Homo sapiens	IC50	nM	15.048
325708	17704462	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC(C)OCC#Cc1cc2c(cc1N1CCN(C3COC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3936548	=	IC50	nM	0.4	CHEMBL4247	Homo sapiens	IC50	nM	0.4
325709	17704463	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	C#CC(C)(C)N1CCN(c2cc3c(cc2C(C)=O)C(=O)c2c([nH]c4cc(C#N)ccc24)C3(C)C)CC1		CHEMBL3924183	=	IC50	nM	2.622	CHEMBL4247	Homo sapiens	IC50	nM	2.622
325710	17704464	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(N3CCC(N4CCOCC4)CC3)c(Cl)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3944715	=	IC50	nM	0.391	CHEMBL4247	Homo sapiens	IC50	nM	0.391
325711	17704465	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(N3CCC(NS(C)(=O)=O)CC3)c(Cl)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3978878	=	IC50	nM	1.864	CHEMBL4247	Homo sapiens	IC50	nM	1.864
325712	17704466	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2ccc(N3CCC(N4CCCC4)CC3)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3917881	=	IC50	nM	15.29	CHEMBL4247	Homo sapiens	IC50	nM	15.291
325713	17704467	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC(C)N1CCN(c2ccc3c(c2)C(=O)c2c([nH]c4cc(C#N)ccc24)C3(C)C)CC1		CHEMBL3945766	=	IC50	nM	4.631	CHEMBL4247	Homo sapiens	IC50	nM	4.631
325714	17704468	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2ccc(N3CCCC3)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3897451	=	IC50	nM	12.01	CHEMBL4247	Homo sapiens	IC50	nM	12.01
325715	17704469	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2ccc(N3CCC[C@H]3CN3CCCC3)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3891393	=	IC50	nM	1.57	CHEMBL4247	Homo sapiens	IC50	nM	1.57
325716	17704470	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC(C)(O)C#Cc1ccc2c(c1)C(=O)c1c([nH]c3cc(C#N)ccc13)C2(C)C		CHEMBL3967479	=	IC50	nM	1.171	CHEMBL4247	Homo sapiens	IC50	nM	1.171
325717	17704471	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC(C)N1CCC(Cc2ccc3c(c2)C(=O)c2c([nH]c4cc(C#N)ccc24)C3(C)C)CC1		CHEMBL3931742	=	IC50	nM	11.73	CHEMBL4247	Homo sapiens	IC50	nM	11.728
325718	17704472	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2ccc(OCCOCCC(=O)O)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3900241	=	IC50	nM	23.19	CHEMBL4247	Homo sapiens	IC50	nM	23.19
325719	17704473	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2ccc(OCc3cccnc3)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3922786	=	IC50	nM	7.092	CHEMBL4247	Homo sapiens	IC50	nM	7.092
325720	17704474	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2ccc(N3CCN(C4COC4)CC3)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL1940177	=	IC50	nM	12.52	CHEMBL4247	Homo sapiens	IC50	nM	12.518
325721	17704475	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2ccc(C3=CCN(C4CC4)CC3)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3894804	=	IC50	nM	3.96	CHEMBL4247	Homo sapiens	IC50	nM	3.96
325722	17704476	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2ccc(OCC(=O)O)cc2C(=O)c2c1[nH]c1cc(Br)ccc21		CHEMBL3946088	=	IC50	nM	862.94	CHEMBL4247	Homo sapiens	IC50	nM	862.942
325723	17704477	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2ccc(OC[C@@H](O)[C@H](O)CO)cc2C(=O)c2c1[nH]c1cc(Br)ccc21		CHEMBL4106475	=	IC50	nM	28.99	CHEMBL4247	Homo sapiens	IC50	nM	28.994
325724	17704478	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2ccc(OC[C@H](O)CO)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL4107738	=	IC50	nM	4.338	CHEMBL4247	Homo sapiens	IC50	nM	4.338
325725	17704479	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2ccc(OCc3ccccc3)cc2C(=O)c2c1[nH]c1cc(Br)ccc21		CHEMBL3909267	=	IC50	nM	492.73	CHEMBL4247	Homo sapiens	IC50	nM	492.725
325726	17704480	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	COc1cc2c(cc1Br)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3923481	=	IC50	nM	29.29	CHEMBL4247	Homo sapiens	IC50	nM	29.285
325727	17704481	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(N3CCOCC3)c(OC3CCOC3)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3936102	=	IC50	nM	0.59	CHEMBL4247	Homo sapiens	IC50	nM	0.59
325728	17704482	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC(C)Oc1cc2c(cc1O[C@@H]1CCN(C3CCC3)C1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL4106737	=	IC50	nM	1.6	CHEMBL4247	Homo sapiens	IC50	nM	1.6
325729	17704483	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	N#Cc1ccc2c3c([nH]c2c1)C1(CCCC1)c1cc(OC[C@H](O)CO)ccc1C3=O		CHEMBL4111362	=	IC50	nM	6.137	CHEMBL4247	Homo sapiens	IC50	nM	6.137
325730	17704484	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	N#Cc1ccc2c3c([nH]c2c1)C1(CCOCC1)c1cc(OCCN2CCOCC2)ccc1C3=O		CHEMBL3929113	=	IC50	nM	32.73	CHEMBL4247	Homo sapiens	IC50	nM	32.729
325731	17704485	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	N#Cc1ccc2c3c([nH]c2c1)C1(CCOCC1)c1cc(OCCN2CCS(=O)(=O)CC2)ccc1C3=O		CHEMBL3928036	=	IC50	nM	26.85	CHEMBL4247	Homo sapiens	IC50	nM	26.853
325732	17704486	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	N#Cc1ccc2c3c([nH]c2c1)C1(CCOCC1)c1cc(N2CCN(C4CCC4)CC2)c(F)cc1C3=O		CHEMBL3952250	=	IC50	nM	4.31	CHEMBL4247	Homo sapiens	IC50	nM	4.31
325733	17704487	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	N#Cc1ccc2c3c([nH]c2c1)C1(CCOCC1)c1cc(N2CCC(N4CCCC4)CC2)c(C#N)cc1C3=O		CHEMBL3921449	=	IC50	nM	0.86	CHEMBL4247	Homo sapiens	IC50	nM	0.86
325734	17704488	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC3CCNCC3)ccc2C(=O)c2c1[nH]c1cc(C#N)c(F)cc21		CHEMBL3973126	=	IC50	nM	5.719	CHEMBL4247	Homo sapiens	IC50	nM	5.719
325735	17704489	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC(C)N1CCN(c2ccc3c(c2)C(C)(C)c2[nH]c4c(F)c(C#N)ccc4c2C3=O)CC1		CHEMBL3960260	=	IC50	nM	0.77	CHEMBL4247	Homo sapiens	IC50	nM	0.77
325736	17704490	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	Cc1cc2c3c([nH]c2cc1Cl)C(C)(C)c1cc(OC[C@@H](O)[C@H](O)CO)ccc1C3=O		CHEMBL4108355	=	IC50	nM	1664.82	CHEMBL4247	Homo sapiens	IC50	nM	1664.819
325737	17704491	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC[C@H](O)CO)c(O)cc2C(=O)c2c1[nH]c1cc(Cl)ccc21		CHEMBL4111037	=	IC50	nM	40.64	CHEMBL4247	Homo sapiens	IC50	nM	40.64
325738	17704492	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(O)c(-c3nn[nH]n3)cc2C(=O)c2c1[nH]c1cc(Cl)ccc21		CHEMBL3938280	=	IC50	nM	0.456	CHEMBL4247	Homo sapiens	IC50	nM	0.456
325739	17704493	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(O[C@H]3CCOC3)ccc2C(=O)c2c1[nH]c1cc(Br)ccc21		CHEMBL3916238	=	IC50	nM	432.81	CHEMBL4247	Homo sapiens	IC50	nM	432.812
325740	17704494	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC3CCN(C(=O)C(F)(F)F)CC3)ccc2C(=O)c2c1[nH]c1cc(Br)ccc21		CHEMBL3943314	=	IC50	nM	614.08	CHEMBL4247	Homo sapiens	IC50	nM	614.075
325741	17704495	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC(=O)N1CCC(Oc2ccc3c(c2)C(C)(C)c2c(c4ccc(Br)cc4n2C)C3=O)CC1		CHEMBL3984417	=	IC50	nM	341.43	CHEMBL4247	Homo sapiens	IC50	nM	341.433
325742	17704496	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC3COC[C@@H]3O)ccc2C(=O)c2c1[nH]c1cc(Br)ccc21		CHEMBL3959170	=	IC50	nM	271.48	CHEMBL4247	Homo sapiens	IC50	nM	271.479
325743	17704497	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CO[C@H]1O[C@H](COc2ccc3c(c2)C(C)(C)c2[nH]c4cc(Br)ccc4c2C3=O)[C@@H](O)[C@H](O)[C@H]1O		CHEMBL4114282	=	IC50	nM	154.22	CHEMBL4247	Homo sapiens	IC50	nM	154.22
325744	17704498	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCC(O)(CC)CCNC(=O)COc1ccc2c(c1)C(C)(C)c1[nH]c3cc(Br)ccc3c1C2=O		CHEMBL3967916	=	IC50	nM	162.11	CHEMBL4247	Homo sapiens	IC50	nM	162.11
325745	17704499	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC(C)S(=O)(=O)N1CCN(C(=O)COc2ccc3c(c2)C(C)(C)c2[nH]c4cc(Br)ccc4c2C3=O)CC1		CHEMBL3986413	=	IC50	nM	168.21	CHEMBL4247	Homo sapiens	IC50	nM	168.21
325746	17704500	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OCC(=O)N3CCN(C4COC4)CC3)ccc2C(=O)c2c1[nH]c1cc(Br)ccc21		CHEMBL3916650	=	IC50	nM	161.89	CHEMBL4247	Homo sapiens	IC50	nM	161.89
325747	17704501	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OCC3CCN(S(C)(=O)=O)CC3)ccc2C(=O)c2c1[nH]c1cc(Br)ccc21		CHEMBL3894115	=	IC50	nM	413.27	CHEMBL4247	Homo sapiens	IC50	nM	413.27
325748	17704502	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC(=O)N1CC(N2CCC(COc3ccc4c(c3)C(C)(C)c3[nH]c5cc(Br)ccc5c3C4=O)CC2)C1		CHEMBL3964766	=	IC50	nM	189.23	CHEMBL4247	Homo sapiens	IC50	nM	189.23
325749	17704503	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC(C)(C)OC(=O)N1CCC2(CC1)OCCC2Oc1ccc2c(c1)C(C)(C)c1[nH]c3cc(Br)ccc3c1C2=O		CHEMBL3931176	=	IC50	nM	19.51	CHEMBL4247	Homo sapiens	IC50	nM	19.51
325750	17704504	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC3CCOC34CCN(C3COC3)CC4)ccc2C(=O)c2c1[nH]c1cc(Br)ccc21		CHEMBL3958668	=	IC50	nM	79.41	CHEMBL4247	Homo sapiens	IC50	nM	79.41
325751	17704505	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC[C@H](O)CCC(=O)O)ccc2C(=O)c2c1[nH]c1cc(Br)ccc21		CHEMBL4107461	=	IC50	nM	852.1	CHEMBL4247	Homo sapiens	IC50	nM	852.1
325752	17704506	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)O[C@H](CO)[C@@H](COc2ccc3c(c2)C(C)(C)c2[nH]c4cc(Br)ccc4c2C3=O)O1		CHEMBL4113969	=	IC50	nM	151.06	CHEMBL4247	Homo sapiens	IC50	nM	151.062
325753	17704507	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC[C@@H](O)[C@H](O)CO)ccc2C(=O)c2c1n(CC(=O)O)c1cc(Br)ccc21		CHEMBL4112744	=	IC50	nM	2813.5	CHEMBL4247	Homo sapiens	IC50	nM	2813.5
325754	17704508	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	COC(=O)Cn1c2c(c3ccc(Br)cc31)C(=O)c1ccc(OC[C@@H](O)[C@H](O)CO)cc1C2(C)C		CHEMBL4113894	=	IC50	nM	583.0	CHEMBL4247	Homo sapiens	IC50	nM	583.0
325755	17704509	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC[C@@H](O)[C@H](O)CO)ccc2C(=O)c2c1[nH]c1cc(I)ccc21		CHEMBL4115197	=	IC50	nM	83.2	CHEMBL4247	Homo sapiens	IC50	nM	83.2
325756	17704510	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC[C@H](O)CO)ccc2C(=O)c2c1[nH]c1c(C3CC3)c(C#N)ccc21		CHEMBL4110481	=	IC50	nM	2.6	CHEMBL4247	Homo sapiens	IC50	nM	2.6
325757	17704511	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	Cc1c(C#N)ccc2c3c([nH]c12)C(C)(C)c1cc(OC[C@H](O)CO)ccc1C3=O		CHEMBL4109094	=	IC50	nM	6.04	CHEMBL4247	Homo sapiens	IC50	nM	6.04
325758	17704512	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC[C@H](O)CO)ccc2C(=O)c2c1[nH]c1c(C(=O)O)c(C#N)ccc21		CHEMBL4114136	=	IC50	nM	359.76	CHEMBL4247	Homo sapiens	IC50	nM	359.76
325759	17704513	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC[C@H](O)CO)ccc2C(=O)c2c1[nH]c1c(C(N)=O)c(C#N)ccc21		CHEMBL4113977	=	IC50	nM	848.84	CHEMBL4247	Homo sapiens	IC50	nM	848.84
325760	17704514	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	COc1ccc2c(c1)C(C)(C)c1[nH]c3c(OC[C@H](O)CO)c(C#N)ccc3c1C2=O		CHEMBL4111677	=	IC50	nM	552.15	CHEMBL4247	Homo sapiens	IC50	nM	552.15
325761	17704515	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	COc1ccc2c(c1)C(C)(C)c1[nH]c3c(N)c(C#N)ccc3c1C2=O		CHEMBL3948122	=	IC50	nM	1.93	CHEMBL4247	Homo sapiens	IC50	nM	1.93
325762	17704516	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2[nH]c3cc(C#N)ccc3c2C(=O)c2cccc(OC[C@@H](O)CO)c21		CHEMBL3920298	=	IC50	nM	134.45	CHEMBL4247	Homo sapiens	IC50	nM	134.45
325763	17704517	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC[C@@H](O)[C@H](O)CO)ccc2C(=O)c2c1[nH]c1cc(Cl)c(Cl)cc21		CHEMBL4111137	=	IC50	nM	554.74	CHEMBL4247	Homo sapiens	IC50	nM	554.738
325764	17704518	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	COCCOc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1c(c3ccc(C#N)cc3n1CCOC)C2=O		CHEMBL3922510	=	IC50	nM	8.5	CHEMBL4247	Homo sapiens	IC50	nM	8.5
325765	17704519	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCOc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3983337	=	IC50	nM	2.2	CHEMBL4247	Homo sapiens	IC50	nM	2.2
325766	17704520	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCN(CC)CCOc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3913523	=	IC50	nM	11.8	CHEMBL4247	Homo sapiens	IC50	nM	11.8
325767	17704521	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCC(CC)Oc1cc2c(cc1N1CCN(C3CCC3)CC1)C(C)(C)c1c(c3ccc(C#N)cc3n1C)C2=O		CHEMBL3909538	=	IC50	nM	142.2	CHEMBL4247	Homo sapiens	IC50	nM	142.2
325768	17704522	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(N3CCN(C4CCC4)CC3)c(OC3CCOCC3)cc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3908067	=	IC50	nM	1.5	CHEMBL4247	Homo sapiens	IC50	nM	1.5
325769	17704523	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	COCCOc1cc2c(cc1OC(C)C)C(=O)c1c(n(CCOC)c3cc(C#N)ccc13)C2(C)C		CHEMBL3975525	=	IC50	nM	9.9	CHEMBL4247	Homo sapiens	IC50	nM	9.9
325770	17704524	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	C=COc1cc2c(cc1OC(C)C)C(=O)c1c([nH]c3cc(C#N)ccc13)C2(C)C		CHEMBL3899020	=	IC50	nM	23.1	CHEMBL4247	Homo sapiens	IC50	nM	23.1
325771	17704525	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(N3CCN(C(=O)C4CC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3961467	=	IC50	nM	4.2	CHEMBL4247	Homo sapiens	IC50	nM	4.2
325772	17704526	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCc1cc2c(cc1N1CCN(C(=O)CN(C)C)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3986700	=	IC50	nM	0.4	CHEMBL4247	Homo sapiens	IC50	nM	0.4
325773	17704527	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCc1cc2c(cc1N1CCN(C(=O)C3CCCCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3945084	=	IC50	nM	7.5	CHEMBL4247	Homo sapiens	IC50	nM	7.5
325774	17704528	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	C[C@H]1CN(c2cc3c(cc2Br)C(=O)c2c([nH]c4cc(C#N)ccc24)C3(C)C)C[C@@H](C)N1C1CCC1		CHEMBL3917178	=	IC50	nM	0.3	CHEMBL4247	Homo sapiens	IC50	nM	0.3
325775	17704529	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCc1cc2c(cc1N1CCC(N3CCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3953815	=	IC50	nM	0.3	CHEMBL4247	Homo sapiens	IC50	nM	0.3
325776	17704530	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCc1cc2c(cc1N1CCC(N3CCC(O)CC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3929615	=	IC50	nM	0.3	CHEMBL4247	Homo sapiens	IC50	nM	0.3
325777	17704531	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCc1cc2c(cc1N1CCC(O)(C3CC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3930736	=	IC50	nM	14.2	CHEMBL4247	Homo sapiens	IC50	nM	14.2
325778	17704532	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCc1cc2c(cc1N1CCC(N3CCN(C)CC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3902757	=	IC50	nM	0.7	CHEMBL4247	Homo sapiens	IC50	nM	0.7
325779	17704533	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCc1cc2c(cc1N1CCC(NCCCO)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3939751	=	IC50	nM	0.6	CHEMBL4247	Homo sapiens	IC50	nM	0.6
325780	17704534	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCc1cc2c(cc1N1CCC(OCCC3CCCCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3908208	=	IC50	nM	21.74	CHEMBL4247	Homo sapiens	IC50	nM	21.744
325781	17704535	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCc1cc2c(cc1N1CCC(NC3CCCCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3911685	=	IC50	nM	1.891	CHEMBL4247	Homo sapiens	IC50	nM	1.891
325782	17704536	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCc1cc2c(cc1N1CCC(NCC3CC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3981662	=	IC50	nM	0.813	CHEMBL4247	Homo sapiens	IC50	nM	0.813
325783	17704537	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(NC(=O)c4ccccc4)ccc3c1C2=O		CHEMBL3931121	=	IC50	nM	424.84	CHEMBL4247	Homo sapiens	IC50	nM	424.843
325784	17704538	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(NC(C)=O)ccc3c1C2=O		CHEMBL3958614	=	IC50	nM	2398.3	CHEMBL4247	Homo sapiens	IC50	nM	2398.295
325785	17704539	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	C[C@H]1CN(C2CCN(c3cc4c(cn3)C(=O)c3c([nH]c5cc(C(N)=O)ccc35)C4(C)C)CC2)C[C@@H](C)O1		CHEMBL3943601	=	IC50	nM	113.91	CHEMBL4247	Homo sapiens	IC50	nM	113.911
325786	17704540	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC(C)C1(N2CCOCC2)CCN(c2cc3c(cn2)C(=O)c2c([nH]c4cc(C#N)ccc24)C3(C)C)CC1		CHEMBL3916733	=	IC50	nM	9.37	CHEMBL4247	Homo sapiens	IC50	nM	9.37
325787	17704541	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCCC1(N2CCN(c3cc4c(cn3)C(=O)c3c([nH]c5cc(C(N)=O)ccc35)C4(C)C)CC2)CCC1		CHEMBL4107288	=	IC50	nM	142.93	CHEMBL4247	Homo sapiens	IC50	nM	142.934
325788	17704542	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCc1cc2c(cc1N1CCOCC1)C(C)(C)c1[nH]c3nc(C(=O)N4CCOCC4)ccc3c1C2=O		CHEMBL3953362	=	IC50	nM	326.37	CHEMBL4247	Homo sapiens	IC50	nM	326.374
325789	17704543	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCN(CC)CCOc1ccc2c(n1)C(C)(C)c1c(c3ccc(C#N)cc3n1CCN(CC)CC)C2=O		CHEMBL3968459	=	IC50	nM	300.76	CHEMBL4247	Homo sapiens	IC50	nM	300.76
325790	17704544	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCCn1c2c(c3ccccc31)C(=O)c1ccc(OCCN(CC)CC)cc1C2(C)C		CHEMBL3967044	=	IC50	nM	1325.5	CHEMBL4247	Homo sapiens	IC50	nM	1325.5
325791	17704545	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCN(CC)CCOc1ccc2c(c1)C(C)(C)c1c(c3ccccc3n1S(C)(=O)=O)C2=O		CHEMBL3890271	=	IC50	nM	161.7	CHEMBL4247	Homo sapiens	IC50	nM	161.7
325792	17704546	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCN(CC)CCOc1ccc2c(c1)C(C)(C)c1c(c3ccc(C)cc3n1C)C2=O		CHEMBL3918268	=	IC50	nM	5947.3	CHEMBL4247	Homo sapiens	IC50	nM	5947.3
325793	17704547	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCN(CC)CCOc1ccc2c(c1)C(C)(C)c1[nH]c3cc(C(F)(F)F)ccc3c1C2=O		CHEMBL3983398	=	IC50	nM	1082.9	CHEMBL4247	Homo sapiens	IC50	nM	1082.9
325794	17704548	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCN(CC)CCOc1ccc2c(c1)C(C)(C)c1c(c3ccc([N+](=O)[O-])cc3n1CCN(CC)CC)C2=O		CHEMBL3914305	=	IC50	nM	4224.0	CHEMBL4247	Homo sapiens	IC50	nM	4224.0
325795	17704549	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC[C@@H](O)[C@H](O)CO)ccc2C(=O)c2c1[nH]c1ccc(C#N)cc21		CHEMBL4111723	=	IC50	nM	898.1	CHEMBL4247	Homo sapiens	IC50	nM	898.1
325796	17704550	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	COc1ccc2c3c(n(C)c2c1)C(C)(C)c1cc(OC[C@H](O)CO)ccc1C3=O		CHEMBL4108286	=	IC50	nM	1621.4	CHEMBL4247	Homo sapiens	IC50	nM	1621.4
325797	17704551	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC[C@H](O)CO)c(Br)cc2C(=O)c2c1[nH]c1cc(OC(F)(F)F)ccc21		CHEMBL4113691	=	IC50	nM	290.0	CHEMBL4247	Homo sapiens	IC50	nM	290.0
325798	17704552	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC[C@H](O)CO)c(Br)cc2C(=O)c2c1[nH]c1cccc(Cl)c21		CHEMBL4115062	=	IC50	nM	104.0	CHEMBL4247	Homo sapiens	IC50	nM	104.0
325799	17704553	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCN(CC)CCOc1ccc2c(c1)C(C)(C)c1[nH]c3cc(NC(=O)Nc4ccccc4)ccc3c1C2=O		CHEMBL3895149	=	IC50	nM	2974.3	CHEMBL4247	Homo sapiens	IC50	nM	2974.3
325800	17704554	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCN(CC)CCOc1ccc2c(c1)C(C)(C)c1[nH]c3cc(NC(=O)Cc4ccccc4)ccc3c1C2=O		CHEMBL3966467	=	IC50	nM	21307.8	CHEMBL4247	Homo sapiens	IC50	nM	21307.8
325801	17704555	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCN(CC)CCOc1ccc2c(c1)C(C)(C)c1[nH]c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3c1C2=O		CHEMBL3904080	=	IC50	nM	3200.0	CHEMBL4247	Homo sapiens	IC50	nM	3200.0
325802	17704556	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCN(CC)CCOc1ccc2c(c1)C(C)(C)c1[nH]c3cc(NC(=O)Oc4ccccc4)ccc3c1C2=O		CHEMBL3978144	=	IC50	nM	1246.6	CHEMBL4247	Homo sapiens	IC50	nM	1246.6
325803	17704557	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC[C@@H](O)[C@H](O)CO)ccc2C(=O)c2c1[nH]c1cc(C(=O)Nc3ccccc3)ccc21		CHEMBL4110008	=	IC50	nM	12951.9	CHEMBL4247	Homo sapiens	IC50	nM	12951.9
325804	17704558	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CN(C)C(=O)c1ccc2c3c([nH]c2c1)C(C)(C)c1cc(OC[C@@H](O)[C@H](O)CO)ccc1C3=O		CHEMBL4110334	=	IC50	nM	12970.4	CHEMBL4247	Homo sapiens	IC50	nM	12970.4
325805	17704559	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC[C@@H](O)[C@H](O)CO)ccc2C(=O)c2c1[nH]c1cc(C(=O)OCCO)ccc21		CHEMBL4115599	=	IC50	nM	575.0	CHEMBL4247	Homo sapiens	IC50	nM	575.0
325806	17704560	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	COC(=O)N[C@@H](C(=O)N[C@@H](c1ccc([C@H](CO)N(CCC(C)(C)C)S(=O)(=O)c2ccc3[nH]ccc3c2)s1)C(F)(F)F)C(c1ccccc1)c1ccccc1		CHEMBL3943362	=	IC50	nM	4385.5	CHEMBL4247	Homo sapiens	IC50	nM	4385.5
325807	17704561	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	COCCNC(=O)c1ccc2c3c([nH]c2c1)C(C)(C)c1cc(OC[C@@H](O)[C@H](O)CO)ccc1C3=O		CHEMBL4115036	=	IC50	nM	3900.0	CHEMBL4247	Homo sapiens	IC50	nM	3900.0
325808	17704562	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CNC(=O)c1ccc2c3c([nH]c2c1)C(C)(C)c1cc(OC[C@@H](O)[C@H](O)CO)ccc1C3=O		CHEMBL4109150	=	IC50	nM	5400.0	CHEMBL4247	Homo sapiens	IC50	nM	5400.0
325809	17704563	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC[C@@H](O)[C@H](O)CO)ccc2C(=O)c2c1[nH]c1cc(C(=O)NCc3ccccc3)ccc21		CHEMBL4112112	=	IC50	nM	3700.0	CHEMBL4247	Homo sapiens	IC50	nM	3700.0
325810	17704564	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC[C@@H](O)[C@H](O)CO)ccc2C(=O)c2c1[nH]c1cc(C(=O)O)ccc21		CHEMBL4108270	=	IC50	nM	900.0	CHEMBL4247	Homo sapiens	IC50	nM	900.0
325811	17704565	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC[C@@H](O)[C@H](O)CO)ccc2C(=O)c2c1[nH]c1cc(C(=O)Nc3ccccn3)ccc21		CHEMBL4108561	=	IC50	nM	1438.5	CHEMBL4247	Homo sapiens	IC50	nM	1438.5
325812	17704566	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC[C@@H](O)[C@H](O)CO)ccc2C(=O)c2c1[nH]c1cc(C(=O)NCCc3ccccc3)ccc21		CHEMBL4110292	=	IC50	nM	752.6	CHEMBL4247	Homo sapiens	IC50	nM	752.6
325813	17704567	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC[C@@H](O)[C@H](O)CO)ccc2C(=O)c2c1[nH]c1cc(C(=O)NS(=O)(=O)c3ccccc3)ccc21		CHEMBL4113311	=	IC50	nM	4842.9	CHEMBL4247	Homo sapiens	IC50	nM	4842.9
325814	17704568	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	Cn1c2c(c3ccc(OC4COC4)cc31)C(=O)c1ccc(OC[C@H](O)CO)cc1C2(C)C		CHEMBL4115198	=	IC50	nM	930.0	CHEMBL4247	Homo sapiens	IC50	nM	930.0
325815	17704569	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC[C@H](O)CO)ccc2C(=O)c2c1[nH]c1cc(-c3cccs3)ccc21		CHEMBL4112408	=	IC50	nM	378.5	CHEMBL4247	Homo sapiens	IC50	nM	378.5
325816	17704570	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC[C@H](O)CO)ccc2C(=O)c2c1[nH]c1cc(-c3ccn[nH]3)ccc21		CHEMBL4106671	=	IC50	nM	770.0	CHEMBL4247	Homo sapiens	IC50	nM	770.0
325817	17704571	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OCCCCCC(=O)O)ccc2C(=O)c2c1oc1ccccc21		CHEMBL3939763	=	IC50	nM	5934.6	CHEMBL4247	Homo sapiens	IC50	nM	5934.6
325818	17704572	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCN(CC)C(=O)COc1ccc2c(c1)C(C)(C)c1oc3ccccc3c1C2=O		CHEMBL3948508	=	IC50	nM	7794.7	CHEMBL4247	Homo sapiens	IC50	nM	7794.7
325819	17704573	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC[C@@H](O)CO)ccc2C(=O)c2c1oc1ccccc21		CHEMBL3922369	=	IC50	nM	2076.0	CHEMBL4247	Homo sapiens	IC50	nM	2076.0
325820	17704574	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC[C@H](O)CO)ccc2C(=O)c2c1oc1ccccc21		CHEMBL4111072	=	IC50	nM	1627.4	CHEMBL4247	Homo sapiens	IC50	nM	1627.4
325821	17704575	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OCCN3CCCCCC3)ccc2C(=O)c2c1oc1ccccc21		CHEMBL3913363	=	IC50	nM	793.8	CHEMBL4247	Homo sapiens	IC50	nM	793.8
325822	17704576	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OCCN3CCNCC3)ccc2C(=O)c2c1oc1ccccc21		CHEMBL3961889	=	IC50	nM	508.3	CHEMBL4247	Homo sapiens	IC50	nM	508.3
325823	17704577	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OCCN3CCN(S(C)(=O)=O)CC3)ccc2C(=O)c2c1oc1ccccc21		CHEMBL3907916	=	IC50	nM	2282.2	CHEMBL4247	Homo sapiens	IC50	nM	2282.2
325824	17704578	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC(=O)N1CCN(CCOc2ccc3c(c2)C(C)(C)c2oc4ccccc4c2C3=O)CC1		CHEMBL3945738	=	IC50	nM	1903.8	CHEMBL4247	Homo sapiens	IC50	nM	1903.8
325825	17704579	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC(C)(C)OC(=O)N1CCN(C(=O)COc2ccc3c(c2)C(C)(C)c2oc4ccccc4c2C3=O)CC1		CHEMBL3969960	=	IC50	nM	5370.8	CHEMBL4247	Homo sapiens	IC50	nM	5370.8
325826	17704580	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OCCOCCOCCO)ccc2C(=O)c2c1oc1ccccc21		CHEMBL3940406	=	IC50	nM	3281.3	CHEMBL4247	Homo sapiens	IC50	nM	3281.3
325827	17704581	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OCCn3ccnc3)ccc2C(=O)c2c1oc1ccccc21		CHEMBL3955465	=	IC50	nM	1811.0	CHEMBL4247	Homo sapiens	IC50	nM	1811.0
325828	17704582	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OCC(=O)NCCc3ccncc3)ccc2C(=O)c2c1oc1ccccc21		CHEMBL3945830	=	IC50	nM	4093.1	CHEMBL4247	Homo sapiens	IC50	nM	4093.1
325829	17704583	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OCC(=O)NCCOCCO)ccc2C(=O)c2c1oc1ccccc21		CHEMBL3934533	=	IC50	nM	7045.1	CHEMBL4247	Homo sapiens	IC50	nM	7045.1
325830	17704584	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OCCN3CCN(C(=O)CO)CC3)ccc2C(=O)c2c1oc1ccccc21		CHEMBL3948073	=	IC50	nM	2773.9	CHEMBL4247	Homo sapiens	IC50	nM	2773.9
325831	17704585	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC[C@@H](O)CN3CCCCC3)ccc2C(=O)c2c1oc1ccccc21		CHEMBL3925752	=	IC50	nM	1158.7	CHEMBL4247	Homo sapiens	IC50	nM	1158.7
325832	17704586	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OCCNC[C@@H](O)CO)ccc2C(=O)c2c1oc1ccccc21		CHEMBL4111382	=	IC50	nM	1091.4	CHEMBL4247	Homo sapiens	IC50	nM	1091.4
325833	17704587	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OCC(=O)NCCN(CCO)CCO)ccc2C(=O)c2c1oc1ccccc21		CHEMBL3943525	=	IC50	nM	3702.8	CHEMBL4247	Homo sapiens	IC50	nM	3702.8
325834	17704588	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CN(C)CCCNC(=O)COc1ccc2c(c1)C(C)(C)c1oc3ccccc3c1C2=O		CHEMBL3893252	=	IC50	nM	3120.3	CHEMBL4247	Homo sapiens	IC50	nM	3120.3
325835	17704589	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OCC(=O)NCCN3CCNCC3)ccc2C(=O)c2c1oc1ccccc21		CHEMBL3976418	=	IC50	nM	3342.8	CHEMBL4247	Homo sapiens	IC50	nM	3342.8
325836	17704590	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CN(C)CC(=O)NCCOc1ccc2c(c1)C(C)(C)c1oc3ccccc3c1C2=O		CHEMBL3902232	=	IC50	nM	2547.0	CHEMBL4247	Homo sapiens	IC50	nM	2547.0
325837	17704591	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OCCN3CC[N+](C)(C)CC3=O)ccc2C(=O)c2c1oc1ccccc21		CHEMBL3955911	=	IC50	nM	1258.8	CHEMBL4247	Homo sapiens	IC50	nM	1258.8
325838	17704592	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OCCN3CCCC(O)C3)ccc2C(=O)c2c1oc1ccccc21		CHEMBL3912386	=	IC50	nM	1058.6	CHEMBL4247	Homo sapiens	IC50	nM	1058.6
325839	17704593	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCN(CCO)CCOc1ccc2c(c1)C(C)(C)c1oc3ccccc3c1C2=O		CHEMBL3929368	=	IC50	nM	792.8	CHEMBL4247	Homo sapiens	IC50	nM	792.8
325840	17704594	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OCCNC3(CO)CCCC3)ccc2C(=O)c2c1oc1ccccc21		CHEMBL3901426	=	IC50	nM	901.3	CHEMBL4247	Homo sapiens	IC50	nM	901.3
325841	17704595	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OCC3CC(O)CN3)ccc2C(=O)c2c1oc1ccccc21		CHEMBL3938417	=	IC50	nM	312.7	CHEMBL4247	Homo sapiens	IC50	nM	312.7
325842	17704596	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC3CCCNC3)ccc2C(=O)c2c1oc1ccccc21		CHEMBL3906889	=	IC50	nM	206.0	CHEMBL4247	Homo sapiens	IC50	nM	206.0
325843	17704597	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCN(C)CCOc1ccc2c(c1)C(C)(C)C1Oc3cc(F)ccc3C1C2=O		CHEMBL3943814	=	IC50	nM	854.1	CHEMBL4247	Homo sapiens	IC50	nM	854.1
325844	17704598	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCN(CC)CCOc1ccc2c(c1)C(C)(C)c1oc3cccc(F)c3c1C2=O		CHEMBL3915862	=	IC50	nM	5757.1	CHEMBL4247	Homo sapiens	IC50	nM	5757.1
325845	17704599	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC(C)N(CCSc1ccc2c(c1)C(C)(C)c1oc3ccccc3c1C2=O)C(C)C		CHEMBL3952558	=	IC50	nM	420.9	CHEMBL4247	Homo sapiens	IC50	nM	420.9
325846	17704600	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCN(CC)CCOc1ccc2c(c1)C(C)(C)c1oc3cc(O)ccc3c1C2=O		CHEMBL3928314	=	IC50	nM	389.4	CHEMBL4247	Homo sapiens	IC50	nM	389.4
325847	17704601	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC[C@@H](O)[C@H](O)CO)ccc2C(=O)c2c1oc1cc(OCCCCO)ccc21		CHEMBL4109403	=	IC50	nM	157.1	CHEMBL4247	Homo sapiens	IC50	nM	157.1
325848	17704602	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC(C)Oc1ccc2c3c(oc2c1)C(C)(C)c1cc(OC[C@@H](O)[C@H](O)CO)ccc1C3=O		CHEMBL4106507	=	IC50	nM	700.0	CHEMBL4247	Homo sapiens	IC50	nM	700.0
325849	17704603	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	COCCCCOc1ccc2c3c(oc2c1)C(C)(C)c1cc(OC[C@@H](O)[C@H](O)CO)ccc1C3=O		CHEMBL4112041	=	IC50	nM	2200.0	CHEMBL4247	Homo sapiens	IC50	nM	2200.0
325850	17704604	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC[C@@H](O)[C@H](O)CO)ccc2C(=O)c2c1oc1cc(OC[C@@H](O)CO)ccc21		CHEMBL3961544	=	IC50	nM	500.0	CHEMBL4247	Homo sapiens	IC50	nM	500.0
325851	17704605	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC[C@@H](O)[C@H](O)CO)ccc2C(=O)c2c1oc1cc(OC[C@H](O)CO)ccc21		CHEMBL4108197	=	IC50	nM	420.0	CHEMBL4247	Homo sapiens	IC50	nM	420.0
325852	17704606	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC[C@@H](O)[C@H](O)CO)ccc2C(=O)c2c1oc1cc(OC(=O)NCc3ccccc3)ccc21		CHEMBL4107978	=	IC50	nM	28.0	CHEMBL4247	Homo sapiens	IC50	nM	28.0
325853	17704607	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CN(C(=O)Oc1ccc2c3c(oc2c1)C(C)(C)c1cc(OC[C@@H](O)[C@H](O)CO)ccc1C3=O)c1ccccc1		CHEMBL4114111	=	IC50	nM	3064.5	CHEMBL4247	Homo sapiens	IC50	nM	3064.5
325854	17704608	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCN(CC)CCOc1ccc2c3c(oc2c1)C(C)(C)c1cc(OC)ccc1C3=O		CHEMBL3977582	=	IC50	nM	5631.1	CHEMBL4247	Homo sapiens	IC50	nM	5631.1
325855	17704609	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC1(C)c2cc(OC[C@H](O)CO)ccc2C(=O)c2c1oc1cc(OCC(=O)Nc3ccccc3)ccc21		CHEMBL4111292	=	IC50	nM	17464.1	CHEMBL4247	Homo sapiens	IC50	nM	17464.1
325856	17704610	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC(C)(C)c1ccc(NC(=O)Oc2ccc3c4c(oc3c2)C(C)(C)c2cc(OC[C@H](O)CO)ccc2C4=O)cc1		CHEMBL4108305	=	IC50	nM	510.0	CHEMBL4247	Homo sapiens	IC50	nM	510.0
325857	17704611	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CC(C)(C)c1ccccc1NC(=O)Oc1ccc2c3c(oc2c1)C(C)(C)c1cc(OC[C@H](O)CO)ccc1C3=O		CHEMBL4114948	=	IC50	nM	540.0	CHEMBL4247	Homo sapiens	IC50	nM	540.0
325858	17704612	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCN(CC)CCOc1ccc2c(c1)C(=O)c1c(oc3ccccc13)C2(C)C		CHEMBL3898031	=	IC50	nM	414.9	CHEMBL4247	Homo sapiens	IC50	nM	414.9
325859	17704613	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	CCN(CC)CCOc1ccc2c(c1)C1(CCOCC1)c1oc3ccccc3c1C2=O		CHEMBL3939011	=	IC50	nM	752.7	CHEMBL4247	Homo sapiens	IC50	nM	752.7
325860	17704614	CHEMBL3887074	Inhibition Assay: ALK-inhibiting activity was measured by following an activity of inhibiting phosphorylation by biotinylated peptide (EGPWLEEEEEAYGWMDF). For the detection of phosphorylation of the biotinylated peptide, time-resolved fluorescence measurement was performed using an anti-phosphorylated tyrosine antibody labeled with europium cryptate and streptavidin conjugated to XL665, i.e., an allophycocyanin derivative.	B	COCn1ccnc1-c1ccc2c3c([nH]c2c1)C(C)(C)c1cc(OC[C@H](O)CO)ccc1C3=O		CHEMBL4111239	=	IC50	nM	1800.0	CHEMBL4247	Homo sapiens	IC50	nM	1800.0
325937	17704685	CHEMBL3887228	Kinase Assay: Assays were performed as described in Fabian et al. (2005) Nature Biotechnology, vol. 23, p. 329 and in Karaman et al. (2008) Nature Biotechnology, vol. 26, p. 127.For most assays, kinase-tagged T7 phage strains were grown in parallel in 24-well blocks in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase and infected with T7 phage from a frozen stock (multiplicity of infection 0.1) and incubated with shaking at 32 C. until lysis (90 minutes). The lysates were centrifuged (6,000xg) and filtered (0.2 mm) to remove cell debris. The remaining kinases were produced in HEK-293 cells and subsequently tagged with DNA for qPCR detection. Streptavidin-coated magnetic beads were treated with biotinylated small molecule ligands for 30 minutes at room temperature to generate affinity resins for kinase assays. The liganded beads were blocked with excess biotin and washed with blocking buffer (SeaBlock (Pierce), 1% BSA, 0.05% Tween 20, 1 mM DTT) to remove unbound ligand.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	<	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	nM	1.0
325938	17704686	CHEMBL3887228	Kinase Assay: Assays were performed as described in Fabian et al. (2005) Nature Biotechnology, vol. 23, p. 329 and in Karaman et al. (2008) Nature Biotechnology, vol. 26, p. 127.For most assays, kinase-tagged T7 phage strains were grown in parallel in 24-well blocks in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase and infected with T7 phage from a frozen stock (multiplicity of infection 0.1) and incubated with shaking at 32 C. until lysis (90 minutes). The lysates were centrifuged (6,000xg) and filtered (0.2 mm) to remove cell debris. The remaining kinases were produced in HEK-293 cells and subsequently tagged with DNA for qPCR detection. Streptavidin-coated magnetic beads were treated with biotinylated small molecule ligands for 30 minutes at room temperature to generate affinity resins for kinase assays. The liganded beads were blocked with excess biotin and washed with blocking buffer (SeaBlock (Pierce), 1% BSA, 0.05% Tween 20, 1 mM DTT) to remove unbound ligand.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN4CCCC4C3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL4108280	<	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	nM	1.0
325939	17704687	CHEMBL3887228	Kinase Assay: Assays were performed as described in Fabian et al. (2005) Nature Biotechnology, vol. 23, p. 329 and in Karaman et al. (2008) Nature Biotechnology, vol. 26, p. 127.For most assays, kinase-tagged T7 phage strains were grown in parallel in 24-well blocks in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase and infected with T7 phage from a frozen stock (multiplicity of infection 0.1) and incubated with shaking at 32 C. until lysis (90 minutes). The lysates were centrifuged (6,000xg) and filtered (0.2 mm) to remove cell debris. The remaining kinases were produced in HEK-293 cells and subsequently tagged with DNA for qPCR detection. Streptavidin-coated magnetic beads were treated with biotinylated small molecule ligands for 30 minutes at room temperature to generate affinity resins for kinase assays. The liganded beads were blocked with excess biotin and washed with blocking buffer (SeaBlock (Pierce), 1% BSA, 0.05% Tween 20, 1 mM DTT) to remove unbound ligand.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL4110651	<	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	nM	1.0
325940	17704688	CHEMBL3887228	Kinase Assay: Assays were performed as described in Fabian et al. (2005) Nature Biotechnology, vol. 23, p. 329 and in Karaman et al. (2008) Nature Biotechnology, vol. 26, p. 127.For most assays, kinase-tagged T7 phage strains were grown in parallel in 24-well blocks in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase and infected with T7 phage from a frozen stock (multiplicity of infection 0.1) and incubated with shaking at 32 C. until lysis (90 minutes). The lysates were centrifuged (6,000xg) and filtered (0.2 mm) to remove cell debris. The remaining kinases were produced in HEK-293 cells and subsequently tagged with DNA for qPCR detection. Streptavidin-coated magnetic beads were treated with biotinylated small molecule ligands for 30 minutes at room temperature to generate affinity resins for kinase assays. The liganded beads were blocked with excess biotin and washed with blocking buffer (SeaBlock (Pierce), 1% BSA, 0.05% Tween 20, 1 mM DTT) to remove unbound ligand.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCCNCC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL4111113	<	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	nM	1.0
325941	17704689	CHEMBL3887228	Kinase Assay: Assays were performed as described in Fabian et al. (2005) Nature Biotechnology, vol. 23, p. 329 and in Karaman et al. (2008) Nature Biotechnology, vol. 26, p. 127.For most assays, kinase-tagged T7 phage strains were grown in parallel in 24-well blocks in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase and infected with T7 phage from a frozen stock (multiplicity of infection 0.1) and incubated with shaking at 32 C. until lysis (90 minutes). The lysates were centrifuged (6,000xg) and filtered (0.2 mm) to remove cell debris. The remaining kinases were produced in HEK-293 cells and subsequently tagged with DNA for qPCR detection. Streptavidin-coated magnetic beads were treated with biotinylated small molecule ligands for 30 minutes at room temperature to generate affinity resins for kinase assays. The liganded beads were blocked with excess biotin and washed with blocking buffer (SeaBlock (Pierce), 1% BSA, 0.05% Tween 20, 1 mM DTT) to remove unbound ligand.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCNC(C)(C)C3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL4107802	<	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	nM	1.0
325942	17704690	CHEMBL3887228	Kinase Assay: Assays were performed as described in Fabian et al. (2005) Nature Biotechnology, vol. 23, p. 329 and in Karaman et al. (2008) Nature Biotechnology, vol. 26, p. 127.For most assays, kinase-tagged T7 phage strains were grown in parallel in 24-well blocks in an E. coli host derived from the BL21 strain. E. coli were grown to log-phase and infected with T7 phage from a frozen stock (multiplicity of infection 0.1) and incubated with shaking at 32 C. until lysis (90 minutes). The lysates were centrifuged (6,000xg) and filtered (0.2 mm) to remove cell debris. The remaining kinases were produced in HEK-293 cells and subsequently tagged with DNA for qPCR detection. Streptavidin-coated magnetic beads were treated with biotinylated small molecule ligands for 30 minutes at room temperature to generate affinity resins for kinase assays. The liganded beads were blocked with excess biotin and washed with blocking buffer (SeaBlock (Pierce), 1% BSA, 0.05% Tween 20, 1 mM DTT) to remove unbound ligand.	B	C[C@H]1CN(C(=O)c2ccc(NC(=O)c3cc(O[C@H](C)c4c(Cl)ccc(F)c4Cl)c(N)nn3)cc2)C[C@@H](C)N1		CHEMBL4113131	<	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	nM	1.0
342797	17720188	CHEMBL3887553	Kinase Inhibition Assay: This example shows that the inhibitory activity of the compound, N1'-[3-fluoro-4-[[7-[4-(hydroxyamino)-4-oxobutoxy]-6-methoxy-4-quinolyl]oxy]phenyl]-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide prepared in Example 9 in cells against kinases including ALK, AXL, FLT3, VEGFR2, c-KIT, c-MET, PDGFR-beta, RET and SRC (tested by Advanced Cellular Dynamics, 3550 General Atomics Court, Building 2, Room 639, San Diego, CA 92121. www.advancedcelldynamics.com and Carna Biosciences, Inc.(www.carnabio.com)) measured according to the method described in the literature (Reference: Daley, G. Q.; Baltimore, D. Proc. Natl. Acd. Sci. USA 1988, 85(23), 9312). Specific steps were as follows: The compound of the present invention was dissolved in dimethyl sulfoxide (DMSO) to make a stock solution of 2 mM, then the stock solution was diluted with DMSO following a 7 half-log series to concentrations ranging from 2 uM to 600 pM.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCC(=O)NO		CHEMBL3981567	>	IC50	nM	630.0	CHEMBL4247	Homo sapiens	IC50	nM	630.0
345675	17722445	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	CCOc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1nc(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)ncc1Cl		CHEMBL3958866	=	IC50	nM	25.0	CHEMBL4247	Homo sapiens	IC50	nM	25.0
345676	17722446	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	CCCOc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1nc(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)ncc1Cl		CHEMBL3923931	=	IC50	nM	38.0	CHEMBL4247	Homo sapiens	IC50	nM	38.0
345677	17722447	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC(C)C)n1		CHEMBL3927296	=	IC50	nM	33.0	CHEMBL4247	Homo sapiens	IC50	nM	33.0
345678	17722448	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	CCCOc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1nc(Nc2ccc(N3CCN(C(C)=O)CC3)cc2)ncc1Cl		CHEMBL3918496	=	IC50	nM	150.0	CHEMBL4247	Homo sapiens	IC50	nM	150.0
345679	17722449	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(F)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)n1		CHEMBL3946370	=	IC50	nM	29.0	CHEMBL4247	Homo sapiens	IC50	nM	29.0
345680	17722450	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	CCOc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1nc(Nc2ccc(N3CCN(C(C)=O)CC3)cc2)ncc1Cl		CHEMBL3917268	=	IC50	nM	65.0	CHEMBL4247	Homo sapiens	IC50	nM	65.0
345681	17722451	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)n1		CHEMBL3941724	=	IC50	nM	12.0	CHEMBL4247	Homo sapiens	IC50	nM	12.0
345682	17722452	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2)n1		CHEMBL3961414	=	IC50	nM	64.0	CHEMBL4247	Homo sapiens	IC50	nM	64.0
345683	17722453	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	CC(=O)N1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc(N5CCN(C(C)=O)CC5)cc4)n3)cc2)CC1		CHEMBL3953811	=	IC50	nM	300.0	CHEMBL4247	Homo sapiens	IC50	nM	300.0
345684	17722454	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1nc(Nc2ccc(N3CCN(C(C)=O)CC3)cc2)ncc1Cl		CHEMBL3904285	=	IC50	nM	18.0	CHEMBL4247	Homo sapiens	IC50	nM	18.0
345685	17722455	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(C(F)(F)F)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)n1		CHEMBL3919579	=	IC50	nM	9.0	CHEMBL4247	Homo sapiens	IC50	nM	9.0
345686	17722456	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCNCC3)cc2OC)n1		CHEMBL3925957	=	IC50	nM	9.0	CHEMBL4247	Homo sapiens	IC50	nM	9.0
345687	17722457	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(S(C)(=O)=O)CC3)cc2OC)n1		CHEMBL3962445	=	IC50	nM	25.0	CHEMBL4247	Homo sapiens	IC50	nM	25.0
345688	17722458	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(=O)CO)CC3)cc2OC)n1		CHEMBL3895817	=	IC50	nM	16.0	CHEMBL4247	Homo sapiens	IC50	nM	16.0
345689	17722459	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(=O)OC(C)(C)C)CC3)cc2OC)n1		CHEMBL3898320	=	IC50	nM	85.0	CHEMBL4247	Homo sapiens	IC50	nM	85.0
345690	17722460	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(CCO)CC3)cc2OC)n1		CHEMBL3944300	=	IC50	nM	14.0	CHEMBL4247	Homo sapiens	IC50	nM	14.0
345691	17722461	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OCc2ccccc2)n1		CHEMBL3949131	=	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
345692	17722462	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Br)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)n1		CHEMBL3982727	=	IC50	nM	11.0	CHEMBL4247	Homo sapiens	IC50	nM	11.0
345693	17722463	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ccnc(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)n1		CHEMBL3961212	=	IC50	nM	120.0	CHEMBL4247	Homo sapiens	IC50	nM	120.0
345694	17722464	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COC(=O)N1CCN(c2ccc(Nc3nc(Nc4ccc(N5CCN(C(C)=O)CC5)cc4OC)ncc3Cl)c(OC)c2)CC1		CHEMBL3954721	=	IC50	nM	130.0	CHEMBL4247	Homo sapiens	IC50	nM	130.0
345695	17722465	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(S(N)(=O)=O)CC3)cc2OC)n1		CHEMBL3927081	=	IC50	nM	12.0	CHEMBL4247	Homo sapiens	IC50	nM	12.0
345696	17722466	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	CCC(=O)N1CCN(c2ccc(Nc3nc(Nc4ccc(N5CCN(C(C)=O)CC5)cc4OC)ncc3Cl)c(OC)c2)CC1		CHEMBL3942803	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
345697	17722467	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(=O)C(C)(C)C)CC3)cc2OC)n1		CHEMBL3972422	=	IC50	nM	23.0	CHEMBL4247	Homo sapiens	IC50	nM	23.0
345698	17722468	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1nc(Nc2ccc(N3CCN(C(C)=O)CC3)cc2)ncc1F		CHEMBL3948141	=	IC50	nM	67.0	CHEMBL4247	Homo sapiens	IC50	nM	67.0
345699	17722469	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(F)c(Nc2ccc(N3CCNCC3)cc2OC)n1		CHEMBL3980452	=	IC50	nM	15.0	CHEMBL4247	Homo sapiens	IC50	nM	15.0
345700	17722470	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(F)c(Nc2ccc(N3CCN(S(C)(=O)=O)CC3)cc2OC)n1		CHEMBL3956794	=	IC50	nM	22.0	CHEMBL4247	Homo sapiens	IC50	nM	22.0
345701	17722471	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COC(=O)N1CCN(c2ccc(Nc3nc(Nc4ccc(N5CCN(C(C)=O)CC5)cc4OC)ncc3F)c(OC)c2)CC1		CHEMBL3985471	=	IC50	nM	19.0	CHEMBL4247	Homo sapiens	IC50	nM	19.0
345702	17722472	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(F)c(Nc2ccc(N3CCN(CCO)CC3)cc2OC)n1		CHEMBL3971353	=	IC50	nM	11.0	CHEMBL4247	Homo sapiens	IC50	nM	11.0
345703	17722473	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	CCOc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1nc(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)ncc1F		CHEMBL3896672	=	IC50	nM	79.0	CHEMBL4247	Homo sapiens	IC50	nM	79.0
345704	17722474	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(F)c(Nc2ccc(N3CCN(C)CC3)cc2OC)n1		CHEMBL3977453	=	IC50	nM	14.0	CHEMBL4247	Homo sapiens	IC50	nM	14.0
345705	17722475	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	CCNC(=O)N1CCN(c2ccc(Nc3nc(Nc4ccc(N5CCN(C(C)=O)CC5)cc4OC)ncc3F)c(OC)c2)CC1		CHEMBL3906824	=	IC50	nM	31.0	CHEMBL4247	Homo sapiens	IC50	nM	31.0
345706	17722476	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(F)c(Nc2ccc(N3CCN(C(=O)OC(C)(C)C)CC3)cc2OC)n1		CHEMBL3897359	=	IC50	nM	210.0	CHEMBL4247	Homo sapiens	IC50	nM	210.0
345707	17722477	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCNCC3)cc2OC(F)F)n1		CHEMBL3972028	=	IC50	nM	5.0	CHEMBL4247	Homo sapiens	IC50	nM	5.0
345708	17722478	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(=O)OC(C)(C)C)CC3)cc2OC(F)F)n1		CHEMBL3981192	=	IC50	nM	570.0	CHEMBL4247	Homo sapiens	IC50	nM	570.0
345709	17722479	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC(F)F)n1		CHEMBL3957490	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
345710	17722480	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(F)c(Nc2ccc(N3CCN(C(=O)CO)CC3)cc2OC)n1		CHEMBL3981035	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
345711	17722481	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(F)c(Nc2ccc(N3CCNCC3)cc2OC(F)F)n1		CHEMBL3948834	=	IC50	nM	12.0	CHEMBL4247	Homo sapiens	IC50	nM	12.0
345712	17722482	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(F)c(Nc2ccc(N3CCN(C)CC3)cc2OC(F)F)n1		CHEMBL3973022	=	IC50	nM	17.0	CHEMBL4247	Homo sapiens	IC50	nM	17.0
345713	17722483	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(F)c(Nc2ccc(N3CCN(C(=O)OC(C)(C)C)CC3)cc2OC(F)F)n1		CHEMBL3943505	=	IC50	nM	350.0	CHEMBL4247	Homo sapiens	IC50	nM	350.0
345714	17722484	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(F)c(Nc2ccc(N3CCN(S(C)(=O)=O)CC3)cc2OC(F)F)n1		CHEMBL3958376	=	IC50	nM	29.0	CHEMBL4247	Homo sapiens	IC50	nM	29.0
345715	17722485	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COC(=O)N1CCN(c2ccc(Nc3nc(Nc4ccc(N5CCN(C(C)=O)CC5)cc4OC)ncc3F)c(OC(F)F)c2)CC1		CHEMBL3934535	=	IC50	nM	73.0	CHEMBL4247	Homo sapiens	IC50	nM	73.0
345716	17722486	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(F)c(Nc2ccc(N3CCN(CCO)CC3)cc2OC(F)F)n1		CHEMBL3951932	=	IC50	nM	16.0	CHEMBL4247	Homo sapiens	IC50	nM	16.0
345717	17722487	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	CCNC(=O)N1CCN(c2ccc(Nc3nc(Nc4ccc(N5CCN(C(C)=O)CC5)cc4OC)ncc3F)c(OC(F)F)c2)CC1		CHEMBL3977731	=	IC50	nM	32.0	CHEMBL4247	Homo sapiens	IC50	nM	32.0
345718	17722488	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(F)c(Nc2ccc(N3CCN(C(=O)CO)CC3)cc2OC(F)F)n1		CHEMBL3924733	=	IC50	nM	8.0	CHEMBL4247	Homo sapiens	IC50	nM	8.0
345719	17722489	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(F)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC(F)F)n1		CHEMBL3939640	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
345720	17722490	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2NC(C)(C)C)n1		CHEMBL3902647	=	IC50	nM	580.0	CHEMBL4247	Homo sapiens	IC50	nM	580.0
345721	17722491	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2Nc2ccccc2)n1		CHEMBL3934090	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
345722	17722492	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	CCC(=O)N(C)c1cc(N2CCNCC2)ccc1Nc1nc(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)ncc1Cl		CHEMBL3963519	=	IC50	nM	760.0	CHEMBL4247	Homo sapiens	IC50	nM	760.0
345723	17722493	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	CCCC(=O)N(C)c1cc(N2CCNCC2)ccc1Nc1nc(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)ncc1Cl		CHEMBL3925204	=	IC50	nM	1200.0	CHEMBL4247	Homo sapiens	IC50	nM	1200.0
345724	17722494	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	CCC(=O)N(C)c1cc(N2CCN(C(=O)OC(C)(C)C)CC2)ccc1Nc1nc(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)ncc1Cl		CHEMBL3890523	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
345725	17722495	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	CCCC(=O)N(C)c1cc(N2CCN(C(=O)OC(C)(C)C)CC2)ccc1Nc1nc(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)ncc1Cl		CHEMBL3945208	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
345726	17722496	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(=O)OC(C)(C)C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)n1		CHEMBL3913998	=	IC50	nM	25.0	CHEMBL4247	Homo sapiens	IC50	nM	25.0
345727	17722497	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	CCC(=O)N(C)c1cc(N2CCN(C(C)=O)CC2)ccc1Nc1nc(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)ncc1C(F)(F)F		CHEMBL3983806	=	IC50	nM	990.0	CHEMBL4247	Homo sapiens	IC50	nM	990.0
345728	17722498	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	CCCC(=O)N(C)c1cc(N2CCN(C(C)=O)CC2)ccc1Nc1nc(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)ncc1Cl		CHEMBL3950830	=	IC50	nM	4500.0	CHEMBL4247	Homo sapiens	IC50	nM	4500.0
345729	17722499	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(C(F)(F)F)c(Nc2ccc(N3CCN(C(=O)OC(C)(C)C)CC3)cc2OC)n1		CHEMBL3926626	=	IC50	nM	120.0	CHEMBL4247	Homo sapiens	IC50	nM	120.0
345730	17722500	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(C(F)(F)F)c(Nc2ccc(N3CCNCC3)cc2OC)n1		CHEMBL3899531	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
345731	17722501	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	CCNC(=O)N1CCN(c2ccc(Nc3nc(Nc4ccc(N5CCN(C(C)=O)CC5)cc4OC)ncc3C(F)(F)F)c(OC)c2)CC1		CHEMBL3970685	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
345732	17722502	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(C(F)(F)F)c(Nc2ccc(N3CCN(C(=O)CO)CC3)cc2OC)n1		CHEMBL3908581	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
345733	17722503	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(C(F)(F)F)c(Nc2ccc(N3CCN(C)CC3)cc2OC)n1		CHEMBL3975774	=	IC50	nM	7.0	CHEMBL4247	Homo sapiens	IC50	nM	7.0
345734	17722504	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(C(F)(F)F)c(Nc2ccc(N3CCN(S(C)(=O)=O)CC3)cc2OC)n1		CHEMBL3978871	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
345735	17722505	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(C(F)(F)F)c(Nc2ccc(N3CCN(CCO)CC3)cc2OC)n1		CHEMBL3949819	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
345736	17722506	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(=O)OC(C)(C)C)CC2)ccc1Nc1ncc(C(F)(F)F)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)n1		CHEMBL3959706	=	IC50	nM	31.0	CHEMBL4247	Homo sapiens	IC50	nM	31.0
345737	17722507	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCNCC2)ccc1Nc1ncc(C(F)(F)F)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)n1		CHEMBL3890636	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
345738	17722508	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	CCNC(=O)N1CCN(c2ccc(Nc3ncc(C(F)(F)F)c(Nc4ccc(N5CCN(C(C)=O)CC5)cc4OC)n3)c(OC)c2)CC1		CHEMBL3944539	=	IC50	nM	6.0	CHEMBL4247	Homo sapiens	IC50	nM	6.0
345739	17722509	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(=O)CO)CC2)ccc1Nc1ncc(C(F)(F)F)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)n1		CHEMBL3954637	=	IC50	nM	7.0	CHEMBL4247	Homo sapiens	IC50	nM	7.0
345740	17722510	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(C(F)(F)F)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)n1		CHEMBL3934738	=	IC50	nM	6.0	CHEMBL4247	Homo sapiens	IC50	nM	6.0
345741	17722511	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(S(C)(=O)=O)CC2)ccc1Nc1ncc(C(F)(F)F)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)n1		CHEMBL3975069	=	IC50	nM	14.0	CHEMBL4247	Homo sapiens	IC50	nM	14.0
345742	17722512	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(CCO)CC2)ccc1Nc1ncc(C(F)(F)F)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)n1		CHEMBL3950987	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
345743	17722513	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCNCC2)ccc1Nc1ncc(C(F)(F)F)c(Nc2ccc(N3CCNCC3)cc2OC)n1		CHEMBL3892892	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
345744	17722514	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COC(=O)N1CCN(c2ccc(Nc3ncc(C(F)(F)F)c(Nc4ccc(N5CCN(C(=O)OC)CC5)cc4OC)n3)c(OC)c2)CC1		CHEMBL3969585	=	IC50	nM	160.0	CHEMBL4247	Homo sapiens	IC50	nM	160.0
345745	17722515	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	CCNC(=O)N1CCN(c2ccc(Nc3ncc(C(F)(F)F)c(Nc4ccc(N5CCN(C(=O)NCC)CC5)cc4OC)n3)c(OC)c2)CC1		CHEMBL3896263	=	IC50	nM	20.0	CHEMBL4247	Homo sapiens	IC50	nM	20.0
345746	17722516	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(=O)CO)CC2)ccc1Nc1ncc(C(F)(F)F)c(Nc2ccc(N3CCN(C(=O)CO)CC3)cc2OC)n1		CHEMBL3974726	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
345747	17722517	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	CC(=O)N1CCN(c2ccc(Nc3ncc(C(F)(F)F)c(Nc4ccc(N5CCN(C(C)=O)CC5)cc4OC(F)F)n3)c(OC(F)F)c2)CC1		CHEMBL3911373	=	IC50	nM	16.0	CHEMBL4247	Homo sapiens	IC50	nM	16.0
345748	17722518	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2Cl)n1		CHEMBL3916647	=	IC50	nM	7.0	CHEMBL4247	Homo sapiens	IC50	nM	7.0
345749	17722519	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	CC(=O)N1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc(N5CCN(C(C)=O)CC5)cc4Cl)n3)c(Cl)c2)CC1		CHEMBL3985396	=	IC50	nM	40.0	CHEMBL4247	Homo sapiens	IC50	nM	40.0
345750	17722520	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2Oc2ccccc2)n1		CHEMBL3939064	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
345751	17722521	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCNCC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCNCC3)cc2OC)n1		CHEMBL3920829	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
345752	17722522	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	CCNC(=O)N1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc(N5CCN(C(=O)NCC)CC5)cc4OC)n3)c(OC)c2)CC1		CHEMBL3926221	=	IC50	nM	18.0	CHEMBL4247	Homo sapiens	IC50	nM	18.0
345753	17722523	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(S(C)(=O)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(S(C)(=O)=O)CC3)cc2OC)n1		CHEMBL3902089	=	IC50	nM	20.0	CHEMBL4247	Homo sapiens	IC50	nM	20.0
345754	17722524	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(=O)CO)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(=O)CO)CC3)cc2OC)n1		CHEMBL3916883	=	IC50	nM	6.0	CHEMBL4247	Homo sapiens	IC50	nM	6.0
345755	17722525	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCNCC3)cc2F)n1		CHEMBL3983190	=	IC50	nM	17.0	CHEMBL4247	Homo sapiens	IC50	nM	17.0
345756	17722526	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2F)n1		CHEMBL3959161	=	IC50	nM	11.0	CHEMBL4247	Homo sapiens	IC50	nM	11.0
345757	17722527	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(=O)CO)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)n1		CHEMBL3931692	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
345758	17722528	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COC(=O)N1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc(N5CCN(C(C)=O)CC5)cc4OC)n3)c(OC)c2)CC1		CHEMBL3899182	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
345759	17722529	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(CCO)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)n1		CHEMBL3973750	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	nM	2.0
345760	17722530	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(S(N)(=O)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)n1		CHEMBL3945192	=	IC50	nM	9.0	CHEMBL4247	Homo sapiens	IC50	nM	9.0
345761	17722531	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(S(C)(=O)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)n1		CHEMBL3917284	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
345762	17722532	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(=O)CO)CC3)cc2OC(F)F)n1		CHEMBL3953919	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
345763	17722533	CHEMBL3887132	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCNCC2)ccc1Nc1ncc(F)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC(F)F)n1		CHEMBL3922740	=	IC50	nM	13.0	CHEMBL4247	Homo sapiens	IC50	nM	13.0
345764	17722534	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	CCOc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1nc(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)ncc1Cl		CHEMBL3958866	=	IC50	nM	23.4	CHEMBL4247	Homo sapiens	IC50	nM	23.4
345765	17722535	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	CCCOc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1nc(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)ncc1Cl		CHEMBL3923931	=	IC50	nM	364.0	CHEMBL4247	Homo sapiens	IC50	nM	364.0
345766	17722536	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC(C)C)n1		CHEMBL3927296	=	IC50	nM	361.0	CHEMBL4247	Homo sapiens	IC50	nM	361.0
345767	17722537	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(F)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)n1		CHEMBL3946370	=	IC50	nM	305.0	CHEMBL4247	Homo sapiens	IC50	nM	305.0
345768	17722538	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	CCOc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1nc(Nc2ccc(N3CCN(C(C)=O)CC3)cc2)ncc1Cl		CHEMBL3917268	=	IC50	nM	247.0	CHEMBL4247	Homo sapiens	IC50	nM	247.0
345769	17722539	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)n1		CHEMBL3941724	=	IC50	nM	75.0	CHEMBL4247	Homo sapiens	IC50	nM	75.0
345770	17722540	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2)n1		CHEMBL3961414	=	IC50	nM	326.6	CHEMBL4247	Homo sapiens	IC50	nM	326.6
345771	17722541	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1nc(Nc2ccc(N3CCN(C(C)=O)CC3)cc2)ncc1Cl		CHEMBL3904285	=	IC50	nM	207.0	CHEMBL4247	Homo sapiens	IC50	nM	207.0
345772	17722542	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(C(F)(F)F)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)n1		CHEMBL3919579	=	IC50	nM	49.0	CHEMBL4247	Homo sapiens	IC50	nM	49.0
345773	17722543	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCNCC3)cc2OC)n1		CHEMBL3925957	=	IC50	nM	43.0	CHEMBL4247	Homo sapiens	IC50	nM	43.0
345774	17722544	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(S(C)(=O)=O)CC3)cc2OC)n1		CHEMBL3962445	=	IC50	nM	113.0	CHEMBL4247	Homo sapiens	IC50	nM	113.0
345775	17722545	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(=O)CO)CC3)cc2OC)n1		CHEMBL3895817	=	IC50	nM	63.0	CHEMBL4247	Homo sapiens	IC50	nM	63.0
345776	17722546	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(=O)OC(C)(C)C)CC3)cc2OC)n1		CHEMBL3898320	=	IC50	nM	301.0	CHEMBL4247	Homo sapiens	IC50	nM	301.0
345777	17722547	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(CCO)CC3)cc2OC)n1		CHEMBL3944300	=	IC50	nM	56.0	CHEMBL4247	Homo sapiens	IC50	nM	56.0
345778	17722548	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Br)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)n1		CHEMBL3982727	=	IC50	nM	86.0	CHEMBL4247	Homo sapiens	IC50	nM	86.0
345779	17722549	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ccnc(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)n1		CHEMBL3961212	=	IC50	nM	751.0	CHEMBL4247	Homo sapiens	IC50	nM	751.0
345780	17722550	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COC(=O)N1CCN(c2ccc(Nc3nc(Nc4ccc(N5CCN(C(C)=O)CC5)cc4OC)ncc3Cl)c(OC)c2)CC1		CHEMBL3954721	=	IC50	nM	1101.0	CHEMBL4247	Homo sapiens	IC50	nM	1101.0
345781	17722551	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(S(N)(=O)=O)CC3)cc2OC)n1		CHEMBL3927081	=	IC50	nM	43.0	CHEMBL4247	Homo sapiens	IC50	nM	43.0
345782	17722552	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	CCC(=O)N1CCN(c2ccc(Nc3nc(Nc4ccc(N5CCN(C(C)=O)CC5)cc4OC)ncc3Cl)c(OC)c2)CC1		CHEMBL3942803	=	IC50	nM	257.0	CHEMBL4247	Homo sapiens	IC50	nM	257.0
345783	17722553	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(=O)C(C)(C)C)CC3)cc2OC)n1		CHEMBL3972422	=	IC50	nM	183.0	CHEMBL4247	Homo sapiens	IC50	nM	183.0
345784	17722554	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1nc(Nc2ccc(N3CCN(C(C)=O)CC3)cc2)ncc1F		CHEMBL3948141	=	IC50	nM	846.0	CHEMBL4247	Homo sapiens	IC50	nM	846.0
345785	17722555	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(F)c(Nc2ccc(N3CCN(S(C)(=O)=O)CC3)cc2OC)n1		CHEMBL3956794	=	IC50	nM	235.0	CHEMBL4247	Homo sapiens	IC50	nM	235.0
345786	17722556	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COC(=O)N1CCN(c2ccc(Nc3nc(Nc4ccc(N5CCN(C(C)=O)CC5)cc4OC)ncc3F)c(OC)c2)CC1		CHEMBL3985471	=	IC50	nM	567.0	CHEMBL4247	Homo sapiens	IC50	nM	567.0
345787	17722557	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(F)c(Nc2ccc(N3CCN(CCO)CC3)cc2OC)n1		CHEMBL3971353	=	IC50	nM	169.0	CHEMBL4247	Homo sapiens	IC50	nM	169.0
345788	17722558	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	CCOc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1nc(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)ncc1F		CHEMBL3896672	=	IC50	nM	698.0	CHEMBL4247	Homo sapiens	IC50	nM	698.0
345789	17722559	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(F)c(Nc2ccc(N3CCN(C)CC3)cc2OC)n1		CHEMBL3977453	=	IC50	nM	265.0	CHEMBL4247	Homo sapiens	IC50	nM	265.0
345790	17722560	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	CCNC(=O)N1CCN(c2ccc(Nc3nc(Nc4ccc(N5CCN(C(C)=O)CC5)cc4OC)ncc3F)c(OC)c2)CC1		CHEMBL3906824	=	IC50	nM	394.0	CHEMBL4247	Homo sapiens	IC50	nM	394.0
345791	17722561	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCNCC3)cc2OC(F)F)n1		CHEMBL3972028	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
345792	17722562	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC(F)F)n1		CHEMBL3957490	=	IC50	nM	41.0	CHEMBL4247	Homo sapiens	IC50	nM	41.0
345793	17722563	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(F)c(Nc2ccc(N3CCN(C(=O)CO)CC3)cc2OC)n1		CHEMBL3981035	=	IC50	nM	31.0	CHEMBL4247	Homo sapiens	IC50	nM	31.0
345794	17722564	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(F)c(Nc2ccc(N3CCNCC3)cc2OC(F)F)n1		CHEMBL3948834	=	IC50	nM	49.0	CHEMBL4247	Homo sapiens	IC50	nM	49.0
345795	17722565	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(F)c(Nc2ccc(N3CCN(C)CC3)cc2OC(F)F)n1		CHEMBL3973022	=	IC50	nM	110.0	CHEMBL4247	Homo sapiens	IC50	nM	110.0
345796	17722566	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(F)c(Nc2ccc(N3CCN(CCO)CC3)cc2OC(F)F)n1		CHEMBL3951932	=	IC50	nM	140.0	CHEMBL4247	Homo sapiens	IC50	nM	140.0
345797	17722567	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(F)c(Nc2ccc(N3CCN(C(=O)CO)CC3)cc2OC(F)F)n1		CHEMBL3924733	=	IC50	nM	36.0	CHEMBL4247	Homo sapiens	IC50	nM	36.0
345798	17722568	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(=O)OC(C)(C)C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)n1		CHEMBL3913998	=	IC50	nM	550.0	CHEMBL4247	Homo sapiens	IC50	nM	550.0
345799	17722569	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(C(F)(F)F)c(Nc2ccc(N3CCNCC3)cc2OC)n1		CHEMBL3899531	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
345800	17722570	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	CCNC(=O)N1CCN(c2ccc(Nc3nc(Nc4ccc(N5CCN(C(C)=O)CC5)cc4OC)ncc3C(F)(F)F)c(OC)c2)CC1		CHEMBL3970685	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	nM	2.0
345801	17722571	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(C(F)(F)F)c(Nc2ccc(N3CCN(C(=O)CO)CC3)cc2OC)n1		CHEMBL3908581	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	nM	2.0
345802	17722572	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(C(F)(F)F)c(Nc2ccc(N3CCN(C)CC3)cc2OC)n1		CHEMBL3975774	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
345803	17722573	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(C(F)(F)F)c(Nc2ccc(N3CCN(S(C)(=O)=O)CC3)cc2OC)n1		CHEMBL3978871	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
345804	17722574	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(C(F)(F)F)c(Nc2ccc(N3CCN(CCO)CC3)cc2OC)n1		CHEMBL3949819	=	IC50	nM	11.0	CHEMBL4247	Homo sapiens	IC50	nM	11.0
345805	17722575	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(=O)OC(C)(C)C)CC2)ccc1Nc1ncc(C(F)(F)F)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)n1		CHEMBL3959706	=	IC50	nM	33.0	CHEMBL4247	Homo sapiens	IC50	nM	33.0
345806	17722576	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCNCC2)ccc1Nc1ncc(C(F)(F)F)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)n1		CHEMBL3890636	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
345807	17722577	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	CCNC(=O)N1CCN(c2ccc(Nc3ncc(C(F)(F)F)c(Nc4ccc(N5CCN(C(C)=O)CC5)cc4OC)n3)c(OC)c2)CC1		CHEMBL3944539	=	IC50	nM	8.0	CHEMBL4247	Homo sapiens	IC50	nM	8.0
345808	17722578	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(=O)CO)CC2)ccc1Nc1ncc(C(F)(F)F)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)n1		CHEMBL3954637	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
345809	17722579	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc(C(F)(F)F)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)n1		CHEMBL3934738	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
345810	17722580	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(S(C)(=O)=O)CC2)ccc1Nc1ncc(C(F)(F)F)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)n1		CHEMBL3975069	=	IC50	nM	39.0	CHEMBL4247	Homo sapiens	IC50	nM	39.0
345811	17722581	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(CCO)CC2)ccc1Nc1ncc(C(F)(F)F)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)n1		CHEMBL3950987	=	IC50	nM	5.0	CHEMBL4247	Homo sapiens	IC50	nM	5.0
345812	17722582	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCNCC2)ccc1Nc1ncc(C(F)(F)F)c(Nc2ccc(N3CCNCC3)cc2OC)n1		CHEMBL3892892	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
345813	17722583	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	CCNC(=O)N1CCN(c2ccc(Nc3ncc(C(F)(F)F)c(Nc4ccc(N5CCN(C(=O)NCC)CC5)cc4OC)n3)c(OC)c2)CC1		CHEMBL3896263	=	IC50	nM	46.0	CHEMBL4247	Homo sapiens	IC50	nM	46.0
345814	17722584	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(=O)CO)CC2)ccc1Nc1ncc(C(F)(F)F)c(Nc2ccc(N3CCN(C(=O)CO)CC3)cc2OC)n1		CHEMBL3974726	=	IC50	nM	5.0	CHEMBL4247	Homo sapiens	IC50	nM	5.0
345815	17722585	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	CC(=O)N1CCN(c2ccc(Nc3ncc(C(F)(F)F)c(Nc4ccc(N5CCN(C(C)=O)CC5)cc4OC(F)F)n3)c(OC(F)F)c2)CC1		CHEMBL3911373	=	IC50	nM	58.0	CHEMBL4247	Homo sapiens	IC50	nM	58.0
345816	17722586	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2Cl)n1		CHEMBL3916647	=	IC50	nM	44.0	CHEMBL4247	Homo sapiens	IC50	nM	44.0
345817	17722587	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	CC(=O)N1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc(N5CCN(C(C)=O)CC5)cc4Cl)n3)c(Cl)c2)CC1		CHEMBL3985396	=	IC50	nM	260.0	CHEMBL4247	Homo sapiens	IC50	nM	260.0
345818	17722588	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCNCC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCNCC3)cc2OC)n1		CHEMBL3920829	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
345819	17722589	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(S(C)(=O)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(S(C)(=O)=O)CC3)cc2OC)n1		CHEMBL3902089	=	IC50	nM	64.0	CHEMBL4247	Homo sapiens	IC50	nM	64.0
345820	17722590	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(=O)CO)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(=O)CO)CC3)cc2OC)n1		CHEMBL3916883	=	IC50	nM	11.0	CHEMBL4247	Homo sapiens	IC50	nM	11.0
345821	17722591	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCNCC3)cc2F)n1		CHEMBL3983190	=	IC50	nM	130.0	CHEMBL4247	Homo sapiens	IC50	nM	130.0
345822	17722592	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2F)n1		CHEMBL3959161	=	IC50	nM	280.0	CHEMBL4247	Homo sapiens	IC50	nM	280.0
345823	17722593	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(=O)CO)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)n1		CHEMBL3931692	=	IC50	nM	27.0	CHEMBL4247	Homo sapiens	IC50	nM	27.0
345824	17722594	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COC(=O)N1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc(N5CCN(C(C)=O)CC5)cc4OC)n3)c(OC)c2)CC1		CHEMBL3899182	=	IC50	nM	94.0	CHEMBL4247	Homo sapiens	IC50	nM	94.0
345825	17722595	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(CCO)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)n1		CHEMBL3973750	=	IC50	nM	21.0	CHEMBL4247	Homo sapiens	IC50	nM	21.0
345826	17722596	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(S(N)(=O)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)n1		CHEMBL3945192	=	IC50	nM	91.0	CHEMBL4247	Homo sapiens	IC50	nM	91.0
345827	17722597	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(S(C)(=O)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC)n1		CHEMBL3917284	=	IC50	nM	53.0	CHEMBL4247	Homo sapiens	IC50	nM	53.0
345828	17722598	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCN(C(C)=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C(=O)CO)CC3)cc2OC(F)F)n1		CHEMBL3953919	=	IC50	nM	27.0	CHEMBL4247	Homo sapiens	IC50	nM	27.0
345829	17722599	CHEMBL3887133	Homogeneous Time-resolved fluorescence (HTRF) Assay: In order to measure the inhibitory activity against ALK, a Grainer 96-well round type bottom plate was added with the compounds (2 l) prepared in Examples 1 to 89, and mixed with ALK enzyme (1 ul) and a peptide substrate (2 l) with biotin attached thereto for 15 minutes and cultured thereafter. Here, ATP solution (5 l) was added thereto and kinase reaction was performed at room temperature for 30 minutes. XL 665 (5 l), to which Streptavidin dissolved in ethylenediaminetetraacetic acid solution was attached, anti-phosphotyrosine antibody (5 l), to which europium (Eu3+) was attached, were added to a reaction solution to stop the reaction, cultured for 1 hour, and analyzed using Homogeneous Time-resolved fluorescence (HTRF, Cisbio). The result was read by a Wallac Envision 2103 device at the wavelength range of 615/665 nm.	B	COc1cc(N2CCNCC2)ccc1Nc1ncc(F)c(Nc2ccc(N3CCN(C(C)=O)CC3)cc2OC(F)F)n1		CHEMBL3922740	=	IC50	nM	170.0	CHEMBL4247	Homo sapiens	IC50	nM	170.0
349838	17726087	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	COc1cc(C(=O)N2CCOCC2)ccc1Nc1nc(Cc2c(Cl)cccc2Cl)n2ccnc2c1C(N)=O		CHEMBL3956713	=	Ki	nM	5.0	CHEMBL4247	Homo sapiens	Ki	nM	5.0
349839	17726088	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	COc1cc(C(=O)NCCN2CCCCC2)ccc1Nc1nc(Cc2c(Cl)cccc2Cl)n2cnnc2c1C(N)=O		CHEMBL3974089	=	Ki	nM	1100.0	CHEMBL4247	Homo sapiens	Ki	nM	1100.0
349840	17726089	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	COc1cc(C(=O)NCCN(C)C)ccc1Nc1nc(Cc2c(Cl)cccc2Cl)n2ccnc2c1C(N)=O		CHEMBL3949172	=	Ki	nM	1.0	CHEMBL4247	Homo sapiens	Ki	nM	1.0
349841	17726090	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	COc1cc(N2CCNCC2)ccc1Nc1nc(N2CCCC2)n2ccnc2c1C(N)=O		CHEMBL3903868	=	Ki	nM	79.0	CHEMBL4247	Homo sapiens	Ki	nM	79.0
349842	17726091	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	C[S+]([O-])c1cc(N2CCNCC2)ccc1Nc1nc(Cc2c(Cl)cccc2Cl)n2ccnc2c1C(N)=O		CHEMBL3953217	=	Ki	nM	65.0	CHEMBL4247	Homo sapiens	Ki	nM	65.0
349843	17726092	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	NC(=O)c1c(Nc2cc(F)c(N3CCNCC3)cc2F)nc(Cc2c(Cl)cccc2Cl)n2cnnc12		CHEMBL3943494	<	Ki	nM	1.0	CHEMBL4247	Homo sapiens	Ki	nM	1.0
349844	17726093	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	NC(=O)c1c(Nc2c(F)cc(N3CCNCC3)cc2F)nc(Cc2c(Cl)cccc2Cl)n2cnnc12		CHEMBL3934342	=	Ki	nM	13.0	CHEMBL4247	Homo sapiens	Ki	nM	13.0
349845	17726094	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	Cc1cc(Nc2nc(Cc3c(Cl)cccc3Cl)n3cnnc3c2C(N)=O)ccc1N1CCNCC1		CHEMBL3911901	<	Ki	nM	1.0	CHEMBL4247	Homo sapiens	Ki	nM	1.0
349846	17726095	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	NC(=O)c1c(Nc2ccc(N3CCNCC3)c(Cl)c2)nc(Cc2c(Cl)cccc2Cl)c2nc[nH]c12		CHEMBL3939879	<	Ki	nM	1.0	CHEMBL4247	Homo sapiens	Ki	nM	1.0
349847	17726096	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	COc1cc(N2CCNCC2)ccc1Nc1nc(Cc2ccccc2Cl)n2ccnc2c1C(N)=O		CHEMBL3924329	=	Ki	nM	2.0	CHEMBL4247	Homo sapiens	Ki	nM	2.0
349848	17726097	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	NC(=O)c1c(Nc2cc(F)c(N3CCNCC3)cc2F)nc(Cc2c(Cl)cccc2Cl)c2nc[nH]c12		CHEMBL3948640	<	Ki	nM	1.0	CHEMBL4247	Homo sapiens	Ki	nM	1.0
349849	17726098	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	COc1cc(N2CCNCC2)ccc1Nc1nc(N2CCNCC2)n2ccnc2c1C(N)=O		CHEMBL3889662	=	Ki	nM	180.0	CHEMBL4247	Homo sapiens	Ki	nM	180.0
349850	17726099	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	NC(=O)c1c(Nc2ccc(N3CCNCC3)cc2C(F)(F)F)nc(Cc2c(Cl)cccc2Cl)c2nc[nH]c12		CHEMBL3965445	=	Ki	nM	8.0	CHEMBL4247	Homo sapiens	Ki	nM	8.0
349851	17726100	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	COc1cc(C(=O)N2CCN(C)CC2)ccc1Nc1nc(Cc2c(Cl)cccc2Cl)n2ccnc2c1C(N)=O		CHEMBL3912006	=	Ki	nM	5.0	CHEMBL4247	Homo sapiens	Ki	nM	5.0
349852	17726101	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	COc1cc(C(=O)NCCN2CCN(C)CC2)ccc1Nc1nc(Cc2c(Cl)cccc2Cl)n2ccnc2c1C(N)=O		CHEMBL3900693	=	Ki	nM	7.0	CHEMBL4247	Homo sapiens	Ki	nM	7.0
349853	17726102	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	NC(=O)c1c(Nc2cc(Cl)c(N3CCNCC3)c(Cl)c2)nc(Cc2c(Cl)cccc2Cl)n2cnnc12		CHEMBL3971274	<	Ki	nM	1.0	CHEMBL4247	Homo sapiens	Ki	nM	1.0
349854	17726103	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	Cc1cc(N2CCNCC2)ccc1Nc1nc(Cc2c(Cl)cccc2Cl)c2nc[nH]c2c1C(N)=O		CHEMBL3931291	<	Ki	nM	1.0	CHEMBL4247	Homo sapiens	Ki	nM	1.0
349855	17726104	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	NC(=O)c1c(Nc2ccc(N3CCNCC3)c(Cl)c2)nc(Cc2c(Cl)cccc2Cl)n2cnnc12		CHEMBL3897487	<	Ki	nM	1.0	CHEMBL4247	Homo sapiens	Ki	nM	1.0
349856	17726105	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	NC(=O)c1c(Nc2ccc(N3CCNCC3)cc2F)nc(Cc2c(Cl)cccc2Cl)n2cnnc12		CHEMBL3966675	<	Ki	nM	1.0	CHEMBL4247	Homo sapiens	Ki	nM	1.0
349857	17726106	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	Cc1cc(Nc2nc(Cc3c(Cl)cccc3Cl)c3nc[nH]c3c2C(N)=O)ccc1N1CCNCC1		CHEMBL3906481	<	Ki	nM	1.0	CHEMBL4247	Homo sapiens	Ki	nM	1.0
349858	17726107	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	COc1cc(CC(=O)N2CCCC2)ccc1Nc1nc(Cc2c(Cl)cccc2Cl)c2nc[nH]c2c1C(N)=O		CHEMBL3900093	=	Ki	nM	180.0	CHEMBL4247	Homo sapiens	Ki	nM	180.0
349859	17726108	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	COc1cc(C(=O)NCCN(C)C)ccc1Nc1nc(Cc2c(Cl)cccc2Cl)c2nc[nH]c2c1C(N)=O		CHEMBL3919748	=	Ki	nM	1.0	CHEMBL4247	Homo sapiens	Ki	nM	1.0
349860	17726109	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	COc1cc(C(=O)NCCN2CCCC2)ccc1Nc1nc(Cc2c(Cl)cccc2Cl)n2ccnc2c1C(N)=O		CHEMBL3891699	=	Ki	nM	1.0	CHEMBL4247	Homo sapiens	Ki	nM	1.0
349861	17726110	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	COc1cc(C(=O)NCCN2CCCCC2)ccc1Nc1nc(Cc2c(Cl)cccc2Cl)n2ccnc2c1C(N)=O		CHEMBL3961811	=	Ki	nM	1.0	CHEMBL4247	Homo sapiens	Ki	nM	1.0
349862	17726111	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	COc1cc(C(=O)NCCCCN(C)C)ccc1Nc1nc(Cc2c(Cl)cccc2Cl)n2ccnc2c1C(N)=O		CHEMBL3986050	=	Ki	nM	3.0	CHEMBL4247	Homo sapiens	Ki	nM	3.0
349863	17726112	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	COc1cc(C(=O)NCCCN2CCOCC2)ccc1Nc1nc(Cc2c(Cl)cccc2Cl)n2ccnc2c1C(N)=O		CHEMBL3949679	=	Ki	nM	4.0	CHEMBL4247	Homo sapiens	Ki	nM	4.0
349864	17726113	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	COc1cc(C(=O)N2CCNCC2)ccc1Nc1nc(Cc2c(Cl)cccc2Cl)n2ccnc2c1C(N)=O		CHEMBL3978742	=	Ki	nM	1.0	CHEMBL4247	Homo sapiens	Ki	nM	1.0
349865	17726114	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	COc1cc(C(=O)N2CCN(C)CC2)ccc1Nc1nc(Cc2c(Cl)cccc2Cl)c2nc[nH]c2c1C(N)=O		CHEMBL3905248	=	Ki	nM	4.0	CHEMBL4247	Homo sapiens	Ki	nM	4.0
349866	17726115	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	NC(=O)c1c(Nc2ccc(N3CCNCC3)cc2F)nc(Cc2c(Cl)cccc2Cl)c2nc[nH]c12		CHEMBL3898303	<	Ki	nM	1.0	CHEMBL4247	Homo sapiens	Ki	nM	1.0
349867	17726116	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	COc1cc(C(=O)N2CCNCC2)ccc1Nc1nc(Cc2c(Cl)cccc2Cl)c2nc[nH]c2c1C(N)=O		CHEMBL3935393	=	Ki	nM	2.0	CHEMBL4247	Homo sapiens	Ki	nM	2.0
349868	17726117	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	NC(=O)c1c(Nc2cc(Cl)c(N3CCNCC3)c(Cl)c2)nc(Cc2c(Cl)cccc2Cl)c2nc[nH]c12		CHEMBL3962852	<	Ki	nM	1.0	CHEMBL4247	Homo sapiens	Ki	nM	1.0
349869	17726118	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	NC(=O)c1c(Nc2cc(F)c(N3CCNCC3)c(F)c2)nc(Cc2c(Cl)cccc2Cl)c2nc[nH]c12		CHEMBL3983346	<	Ki	nM	1.0	CHEMBL4247	Homo sapiens	Ki	nM	1.0
349870	17726119	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	NC(=O)c1c(Nc2ccc(N3CCNCC3)cc2Cl)nc(Cc2c(Cl)cccc2Cl)c2nc[nH]c12		CHEMBL3897008	<	Ki	nM	1.0	CHEMBL4247	Homo sapiens	Ki	nM	1.0
349871	17726120	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	COc1c(Nc2nc(Cc3c(Cl)cccc3Cl)c3nc[nH]c3c2C(N)=O)ccc(N2CCNCC2)c1F		CHEMBL3950416	=	Ki	nM	1.5	CHEMBL4247	Homo sapiens	Ki	nM	1.5
349872	17726121	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	NC(=O)c1c(Nc2ccc(N3CCNCC3)c(C(F)(F)F)c2)nc(Cc2c(Cl)cccc2Cl)c2nc[nH]c12		CHEMBL3891022	<	Ki	nM	1.0	CHEMBL4247	Homo sapiens	Ki	nM	1.0
349873	17726122	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	NC(=O)c1c(Nc2ccc(N3CCNCC3)cc2OC(F)(F)F)nc(Cc2c(Cl)cccc2Cl)c2nc[nH]c12		CHEMBL3913589	=	Ki	nM	4.0	CHEMBL4247	Homo sapiens	Ki	nM	4.0
349874	17726123	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	COc1ccc(N2CCNCC2)cc1Nc1nc(Cc2c(Cl)cccc2Cl)c2nc[nH]c2c1C(N)=O		CHEMBL3983410	=	Ki	nM	15.0	CHEMBL4247	Homo sapiens	Ki	nM	15.0
349875	17726124	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	COc1cc(N2CCN3CCCC3C2)ccc1Nc1nc(Cc2c(Cl)cccc2Cl)c2nc[nH]c2c1C(N)=O		CHEMBL3966854	=	Ki	nM	2.0	CHEMBL4247	Homo sapiens	Ki	nM	2.0
349876	17726125	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	Cc1c(Nc2nc(Cc3c(Cl)cccc3Cl)c3nc[nH]c3c2C(N)=O)ccc(N2CCNCC2)c1C		CHEMBL3940654	<	Ki	nM	1.0	CHEMBL4247	Homo sapiens	Ki	nM	1.0
349877	17726126	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	COc1cc(CN2CCCC2)ccc1Nc1nc(Cc2c(Cl)cccc2Cl)c2nc[nH]c2c1C(N)=O		CHEMBL3955742	=	Ki	nM	1.0	CHEMBL4247	Homo sapiens	Ki	nM	1.0
349878	17726127	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	NC(=O)c1c(Nc2ccc(N3CCNCC3)cc2Br)nc(Cc2c(Cl)cccc2Cl)n2cnnc12		CHEMBL3928116	<	Ki	nM	1.0	CHEMBL4247	Homo sapiens	Ki	nM	1.0
349879	17726128	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	Cc1cc(Nc2nc(Cc3c(Cl)cccc3Cl)c3nc[nH]c3c2C(N)=O)c(F)cc1N1CCNCC1		CHEMBL3984443	<	Ki	nM	1.0	CHEMBL4247	Homo sapiens	Ki	nM	1.0
349880	17726129	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	COc1c(Nc2nc(Cc3c(Cl)cccc3Cl)c3nc[nH]c3c2C(N)=O)cc(F)c(N2CCNCC2)c1F		CHEMBL3952424	=	Ki	nM	57.0	CHEMBL4247	Homo sapiens	Ki	nM	57.0
349881	17726130	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	COc1cc2c(cc1Nc1nc(Cc3c(Cl)cccc3Cl)c3nc[nH]c3c1C(N)=O)CNCC2		CHEMBL3914113	=	Ki	nM	1.0	CHEMBL4247	Homo sapiens	Ki	nM	1.0
349882	17726131	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	NC(=O)c1c(Nc2ccc(C3CCNCC3)cc2Cl)nc(Cc2c(Cl)cccc2Cl)c2nc[nH]c12		CHEMBL3942108	<	Ki	nM	1.0	CHEMBL4247	Homo sapiens	Ki	nM	1.0
349883	17726132	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	CCc1nnc2c(C(N)=O)c(Nc3ccc(C4CCNCC4)cc3Cl)nc(Cc3ccccc3Cl)n12		CHEMBL3926619	=	Ki	nM	2.0	CHEMBL4247	Homo sapiens	Ki	nM	2.0
349884	17726133	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	COc1cc(N2CCNCC2)ccc1Nc1nc(Cc2c(Cl)cccc2Cl)n2c(C)nnc2c1C(N)=O		CHEMBL3950825	=	Ki	nM	2.0	CHEMBL4247	Homo sapiens	Ki	nM	2.0
349885	17726134	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	CCc1nnc2c(C(N)=O)c(Nc3ccc(N4CCNCC4)cc3OC)nc(Cc3c(Cl)cccc3Cl)n12		CHEMBL3899654	=	Ki	nM	2.0	CHEMBL4247	Homo sapiens	Ki	nM	2.0
349886	17726135	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	CCc1cn2c(Cc3ccccc3Cl)nc(Nc3ccc(N4CCNCC4)cc3OC)c(C(N)=O)c2n1		CHEMBL3927674	=	Ki	nM	18.0	CHEMBL4247	Homo sapiens	Ki	nM	18.0
349887	17726136	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	CCc1cn2c(Cc3ccccc3Cl)nc(Nc3ccc(C4CCNCC4)cc3Cl)c(C(N)=O)c2n1		CHEMBL3905111	=	Ki	nM	2.0	CHEMBL4247	Homo sapiens	Ki	nM	2.0
349888	17726137	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	NC(=O)c1c(Nc2ccc(C3CCNCC3)cc2Cl)nc(Cc2ccccc2Cl)n2cnnc12		CHEMBL3936641	=	Ki	nM	1.0	CHEMBL4247	Homo sapiens	Ki	nM	1.0
349889	17726138	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	CCc1nnc2c(C(N)=O)c(Nc3ccc(N4CCNCC4)cc3OC)nc(Cc3ccccc3Cl)n12		CHEMBL3978977	=	Ki	nM	11.0	CHEMBL4247	Homo sapiens	Ki	nM	11.0
349890	17726139	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	COc1cc(C2CCNCC2)ccc1Nc1nc(Cc2cccc(Cl)c2Cl)n2cnnc2c1C(N)=O		CHEMBL3908626	=	Ki	nM	2.0	CHEMBL4247	Homo sapiens	Ki	nM	2.0
349891	17726140	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	COc1cc(C2CCNCC2)ccc1Nc1nc(Cc2ccccc2F)n2cnnc2c1C(N)=O		CHEMBL3941424	=	Ki	nM	8.0	CHEMBL4247	Homo sapiens	Ki	nM	8.0
349892	17726141	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	COc1cc(C2CCNCC2)ccc1Nc1nc(Cc2cccc(F)c2F)n2cnnc2c1C(N)=O		CHEMBL3964023	=	Ki	nM	6.0	CHEMBL4247	Homo sapiens	Ki	nM	6.0
349893	17726142	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	COc1cc(N2CCNCC2)ccc1Nc1nc(Cc2c(Cl)cccc2Cl)n2cc(CN3CCOCC3)nc2c1C(N)=O		CHEMBL3984690	=	Ki	nM	77.0	CHEMBL4247	Homo sapiens	Ki	nM	77.0
349894	17726143	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	CCOC(=O)c1cn2c(Cc3c(Cl)cccc3Cl)nc(Nc3ccc(N4CCNCC4)cc3OC)c(C(N)=O)c2n1		CHEMBL3965838	=	Ki	nM	1.0	CHEMBL4247	Homo sapiens	Ki	nM	1.0
349895	17726144	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	CCNC(=O)c1cn2c(Cc3c(Cl)cccc3Cl)nc(Nc3ccc(N4CCNCC4)cc3OC)c(C(N)=O)c2n1		CHEMBL3962374	=	Ki	nM	13.0	CHEMBL4247	Homo sapiens	Ki	nM	13.0
349896	17726145	CHEMBL3887723	Enzyme Inhibition Assay: ALK kinase assays were conducted with the indicated final concentrations unless otherwise specified. In 384 well black plates (Axygen), 8 ul of compound (2% DMSO) was incubated with 8 ul Lck-peptide substrate (0.5 uM, biotin-Ahx-GAEEEIYAAFFA-COOH) and 8 ul of a mixture of ALK (3 nM, Millipore) and ATP (50 uM) in reaction buffer (50 mM Hepes, pH 7.4; 10 mM MgCl2; 2 mM MnCl2; 0.1 mM sodium orthovanadate; 0.01% BSA and 1 mM DTT (added fresh before assay) for 1 h at room temperature. Reactions were then quenched by the addition of 30 ul quench solution (streptavidin-allophycocyanin and Europium-cryptate PT66 monoclonal antibody in 40 mM Hepes, pH 7.4; 480 mM KF; 66 mM EDTA; 0.01% Tween-20; and 0.1% BSA) at room temperature. Plates were read 1 h after quenching on an Envision Multilaber Reader and IC50 values were calculated using a sigmoidal fit of the concentration/inhibition response curves. These values were converted to apparent Ki values.	B	COc1cc(N2CCNCC2)ccc1Nc1nc(Cc2c(Cl)cccc2Cl)n2cc(C(=O)NCC(F)(F)F)nc2c1C(N)=O		CHEMBL3889819	=	Ki	nM	120.0	CHEMBL4247	Homo sapiens	Ki	nM	120.0
355490	17731321	CHEMBL3887797	Inhibition Assay: The inhibitory activities of compounds of Formula I were assay at Reaction Biology Corporation, One Great Valley Parkway, Malvern, Pa., USA. Human ALK and cMet enzymes were used and the substrate was a peptide substrate, poly[Glu:Tyr] (4:1) at a concentration of 0.2 mg/ml. The ATP concentration for the assay was 10 uM and Staurosporine was used as a standardwith an IC50 of 2.3 nM, and 75 nM, respectively for ALK and cMet.	B	C[C@@H](Oc1cc(-c2cnn(C3CC4(CNC4)C3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL4111854	=	IC50	nM	2.21	CHEMBL4247	Homo sapiens	IC50	nM	2.21
355491	17731322	CHEMBL3887797	Inhibition Assay: The inhibitory activities of compounds of Formula I were assay at Reaction Biology Corporation, One Great Valley Parkway, Malvern, Pa., USA. Human ALK and cMet enzymes were used and the substrate was a peptide substrate, poly[Glu:Tyr] (4:1) at a concentration of 0.2 mg/ml. The ATP concentration for the assay was 10 uM and Staurosporine was used as a standardwith an IC50 of 2.3 nM, and 75 nM, respectively for ALK and cMet.	B	C[C@@H](Oc1cc(-c2cnn(C3CC4(CCNCC4)C3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL4113696	=	IC50	nM	1.2	CHEMBL4247	Homo sapiens	IC50	nM	1.2
355492	17731323	CHEMBL3887797	Inhibition Assay: The inhibitory activities of compounds of Formula I were assay at Reaction Biology Corporation, One Great Valley Parkway, Malvern, Pa., USA. Human ALK and cMet enzymes were used and the substrate was a peptide substrate, poly[Glu:Tyr] (4:1) at a concentration of 0.2 mg/ml. The ATP concentration for the assay was 10 uM and Staurosporine was used as a standardwith an IC50 of 2.3 nM, and 75 nM, respectively for ALK and cMet.	B	C[C@@H](Oc1cc(-c2cnn(C3CCC4(CC3)CNC4)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL4109336	=	IC50	nM	4.31	CHEMBL4247	Homo sapiens	IC50	nM	4.31
355493	17731324	CHEMBL3887797	Inhibition Assay: The inhibitory activities of compounds of Formula I were assay at Reaction Biology Corporation, One Great Valley Parkway, Malvern, Pa., USA. Human ALK and cMet enzymes were used and the substrate was a peptide substrate, poly[Glu:Tyr] (4:1) at a concentration of 0.2 mg/ml. The ATP concentration for the assay was 10 uM and Staurosporine was used as a standardwith an IC50 of 2.3 nM, and 75 nM, respectively for ALK and cMet.	B	C[C@@H](Oc1cc(-c2cnn(C3CC4(CCCNC4)C3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL4114311	=	IC50	nM	1.92	CHEMBL4247	Homo sapiens	IC50	nM	1.92
355494	17731325	CHEMBL3887797	Inhibition Assay: The inhibitory activities of compounds of Formula I were assay at Reaction Biology Corporation, One Great Valley Parkway, Malvern, Pa., USA. Human ALK and cMet enzymes were used and the substrate was a peptide substrate, poly[Glu:Tyr] (4:1) at a concentration of 0.2 mg/ml. The ATP concentration for the assay was 10 uM and Staurosporine was used as a standardwith an IC50 of 2.3 nM, and 75 nM, respectively for ALK and cMet.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	2.3	CHEMBL4247	Homo sapiens	IC50	nM	2.3
355500	17731331	CHEMBL3887799	Inhibition Assay: The inhibitory activities of compounds of Formula I were assay at Reaction Biology Corporation, One Great Valley Parkway, Malvern, Pa., USA. Human ALK and cMet enzymes were used and the substrate was a peptide substrate, poly[Glu:Tyr] (4:1) at a concentration of 0.2 mg/ml. The ATP concentration for the assay was 10 uM and Staurosporine was used as a standardwith an IC50 of 2.3 nM, and 75 nM, respectively for ALK and cMet.	B	C[C@@H](Oc1cc(-c2cnn(C3CC4(CCNCC4)C3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL4113696	<	IC50	nM	1.2	CHEMBL4247	Homo sapiens	IC50	nM	1.2
355501	17731332	CHEMBL3887800	Inhibition Assay: The inhibitory activities of compounds of Formula I were assay at Reaction Biology Corporation, One Great Valley Parkway, Malvern, Pa., USA. Human ALK and cMet enzymes were used and the substrate was a peptide substrate, poly[Glu:Tyr] (4:1) at a concentration of 0.2 mg/ml. The ATP concentration for the assay was 10 uM and Staurosporine was used as a standardwith an IC50 of 2.3 nM, and 75 nM, respectively for ALK and cMet.	B	C[C@@H](Oc1cc(-c2cnn(C3CC4(CCNCC4)C3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL4113696	=	IC50	nM	1.4	CHEMBL4247	Homo sapiens	IC50	nM	1.4
355502	17731333	CHEMBL3887801	Inhibition Assay: The inhibitory activities of compounds of Formula I were assay at Reaction Biology Corporation, One Great Valley Parkway, Malvern, Pa., USA. Human ALK and cMet enzymes were used and the substrate was a peptide substrate, poly[Glu:Tyr] (4:1) at a concentration of 0.2 mg/ml. The ATP concentration for the assay was 10 uM and Staurosporine was used as a standardwith an IC50 of 2.3 nM, and 75 nM, respectively for ALK and cMet.	B	C[C@@H](Oc1cc(-c2cnn(C3CC4(CCNCC4)C3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL4113696	=	IC50	nM	1.8	CHEMBL4247	Homo sapiens	IC50	nM	1.8
355503	17731334	CHEMBL3887802	Inhibition Assay: The inhibitory activities of compounds of Formula I were assay at Reaction Biology Corporation, One Great Valley Parkway, Malvern, Pa., USA. Human ALK and cMet enzymes were used and the substrate was a peptide substrate, poly[Glu:Tyr] (4:1) at a concentration of 0.2 mg/ml. The ATP concentration for the assay was 10 uM and Staurosporine was used as a standardwith an IC50 of 2.3 nM, and 75 nM, respectively for ALK and cMet.	B	C[C@@H](Oc1cc(-c2cnn(C3CC4(CCNCC4)C3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL4113696	=	IC50	nM	1.5	CHEMBL4247	Homo sapiens	IC50	nM	1.5
355504	17731335	CHEMBL3887797	Inhibition Assay: The inhibitory activities of compounds of Formula I were assay at Reaction Biology Corporation, One Great Valley Parkway, Malvern, Pa., USA. Human ALK and cMet enzymes were used and the substrate was a peptide substrate, poly[Glu:Tyr] (4:1) at a concentration of 0.2 mg/ml. The ATP concentration for the assay was 10 uM and Staurosporine was used as a standardwith an IC50 of 2.3 nM, and 75 nM, respectively for ALK and cMet.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	2.1	CHEMBL4247	Homo sapiens	IC50	nM	2.1
355505	17731336	CHEMBL3887799	Inhibition Assay: The inhibitory activities of compounds of Formula I were assay at Reaction Biology Corporation, One Great Valley Parkway, Malvern, Pa., USA. Human ALK and cMet enzymes were used and the substrate was a peptide substrate, poly[Glu:Tyr] (4:1) at a concentration of 0.2 mg/ml. The ATP concentration for the assay was 10 uM and Staurosporine was used as a standardwith an IC50 of 2.3 nM, and 75 nM, respectively for ALK and cMet.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	<	IC50	nM	1.2	CHEMBL4247	Homo sapiens	IC50	nM	1.2
355506	17731337	CHEMBL3887800	Inhibition Assay: The inhibitory activities of compounds of Formula I were assay at Reaction Biology Corporation, One Great Valley Parkway, Malvern, Pa., USA. Human ALK and cMet enzymes were used and the substrate was a peptide substrate, poly[Glu:Tyr] (4:1) at a concentration of 0.2 mg/ml. The ATP concentration for the assay was 10 uM and Staurosporine was used as a standardwith an IC50 of 2.3 nM, and 75 nM, respectively for ALK and cMet.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	2.7	CHEMBL4247	Homo sapiens	IC50	nM	2.7
355507	17731338	CHEMBL3887801	Inhibition Assay: The inhibitory activities of compounds of Formula I were assay at Reaction Biology Corporation, One Great Valley Parkway, Malvern, Pa., USA. Human ALK and cMet enzymes were used and the substrate was a peptide substrate, poly[Glu:Tyr] (4:1) at a concentration of 0.2 mg/ml. The ATP concentration for the assay was 10 uM and Staurosporine was used as a standardwith an IC50 of 2.3 nM, and 75 nM, respectively for ALK and cMet.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	7.4	CHEMBL4247	Homo sapiens	IC50	nM	7.4
355508	17731339	CHEMBL3887802	Inhibition Assay: The inhibitory activities of compounds of Formula I were assay at Reaction Biology Corporation, One Great Valley Parkway, Malvern, Pa., USA. Human ALK and cMet enzymes were used and the substrate was a peptide substrate, poly[Glu:Tyr] (4:1) at a concentration of 0.2 mg/ml. The ATP concentration for the assay was 10 uM and Staurosporine was used as a standardwith an IC50 of 2.3 nM, and 75 nM, respectively for ALK and cMet.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	2.9	CHEMBL4247	Homo sapiens	IC50	nM	2.9
363840	17739214	CHEMBL3887925	ALK Kinase Biochemical Assay: BioKinase buffer was composed of 50 mM HEPES pH 7.5 containing 1 mM MnCl2, 5 mM MgCl2, 1 mM DTT, 3 microM Na3VO4, and 0.2 mg/mL BSA. 3x KB is buffer of the same composition and pH as KB, but with three times the concentration of each component. The kinase assay was run with a final enzyme concentration of 20 nM, in the presence of 8 microM ATP, 1 nM 33P--ATP and 2 microM MBP. The MPB was purchased from Sigma-Aldrich, St. Louis, Mo., USA.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	=	IC50	nM	55.0	CHEMBL4247	Homo sapiens	IC50	nM	55.0
363841	17739215	CHEMBL3887925	ALK Kinase Biochemical Assay: BioKinase buffer was composed of 50 mM HEPES pH 7.5 containing 1 mM MnCl2, 5 mM MgCl2, 1 mM DTT, 3 microM Na3VO4, and 0.2 mg/mL BSA. 3x KB is buffer of the same composition and pH as KB, but with three times the concentration of each component. The kinase assay was run with a final enzyme concentration of 20 nM, in the presence of 8 microM ATP, 1 nM 33P--ATP and 2 microM MBP. The MPB was purchased from Sigma-Aldrich, St. Louis, Mo., USA.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)cc2)CC1		CHEMBL3672894	=	IC50	nM	207.0	CHEMBL4247	Homo sapiens	IC50	nM	207.0
363842	17739216	CHEMBL3887925	ALK Kinase Biochemical Assay: BioKinase buffer was composed of 50 mM HEPES pH 7.5 containing 1 mM MnCl2, 5 mM MgCl2, 1 mM DTT, 3 microM Na3VO4, and 0.2 mg/mL BSA. 3x KB is buffer of the same composition and pH as KB, but with three times the concentration of each component. The kinase assay was run with a final enzyme concentration of 20 nM, in the presence of 8 microM ATP, 1 nM 33P--ATP and 2 microM MBP. The MPB was purchased from Sigma-Aldrich, St. Louis, Mo., USA.	B	COCCNc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL3672895	=	IC50	nM	411.0	CHEMBL4247	Homo sapiens	IC50	nM	411.0
363843	17739217	CHEMBL3887925	ALK Kinase Biochemical Assay: BioKinase buffer was composed of 50 mM HEPES pH 7.5 containing 1 mM MnCl2, 5 mM MgCl2, 1 mM DTT, 3 microM Na3VO4, and 0.2 mg/mL BSA. 3x KB is buffer of the same composition and pH as KB, but with three times the concentration of each component. The kinase assay was run with a final enzyme concentration of 20 nM, in the presence of 8 microM ATP, 1 nM 33P--ATP and 2 microM MBP. The MPB was purchased from Sigma-Aldrich, St. Louis, Mo., USA.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCCCC3)c2)CC1		CHEMBL3672896	=	IC50	nM	1771.0	CHEMBL4247	Homo sapiens	IC50	nM	1771.0
412003	17776718	CHEMBL3888647	Mobility Shift Assay: Agents: 1-fold kinase buffer without MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 2 mM DTT. 1-fold kinase buffer with MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 10 mM MnCl2, 2 mM DTT. Termination solution: 100 mM HEPES, pH 7.5, 0.0015% Brij-35, 0.2% Coating Reagent#3, 50 mM EDTA. 2.5-fold kinase solution: The kinase was added to the 1-fold kinase buffer to form a 2.5-fold kinase solution. 2.5-fold substrate solution: FAM fluorescence-labelled polypeptide and ATP were added to the 1-fold kinase buffer to form a 2.5-fold substrate solution. Compounds: The final test concentration of the compound was 10 M at maximum. Firstly, a 50-fold concentration (i.e. 500 M) was prepared with 100% DMSO. The compound was diluted with 100% DMSO by 5 folds at 5 concentrations (successively 500 M, 100 M, 20 M, 4 M, and 0.8 M). After diluting with 1-fold kinase buffer by 10 folds, 5 l of the samples were transferred to a 384-well reaction plate. Two negative control wells and two positive control wells were set at each line respectively. Replication was made in a 96-well plate in five concentrations of 5-fold compound. 10% DMSO was added to the positive control well, and 5 l of EDTA (250 mM) was added to the negative control well. Procedure: To the 384-well reaction plate was added 5-fold compound dissolved in 10% DMSO at 5 l/well. To the 384-well reaction plate was added 2.5-fold kinase solution at 10 l/well. The plate was incubated at room temperature for 10 mins. To the 384-well reaction plate was added 2.5-fold substrate solution at 10 l/well. The plate was incubated at 28 C. for a certain period. 25 l termination solution was added to terminate the reaction.	B	Nc1ccc(-c2ccc3ncc4c(=O)[nH]c(=O)n(-c5cccc(C(F)(F)F)c5)c4c3n2)cn1		CHEMBL3903725	=	IC50	nM	1170.0	CHEMBL4247	Homo sapiens	IC50	nM	1170.0
427332	17789002	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(Cl)c5c4c3)cc2)CC1		CHEMBL3952772	=	IC50	nM	2100.0	CHEMBL4247	Homo sapiens	IC50	nM	2100.0
427333	17789003	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(/C=C/c6ccccc6)c5c4c3)cc2)CC1		CHEMBL3937542	=	IC50	nM	500.0	CHEMBL4247	Homo sapiens	IC50	nM	500.0
427334	17789004	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	C/C(=C\c1ccccc1C(F)(F)F)c1ccnc2[nH]c3ccc(-c4ccc(N5CCN(C)CC5)cc4)cc3c12		CHEMBL3967225	=	IC50	nM	7600.0	CHEMBL4247	Homo sapiens	IC50	nM	7600.0
427335	17789005	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(/C=C/c6ccccc6)c5c4c3)cn2)CC1		CHEMBL3986372	=	IC50	nM	350.0	CHEMBL4247	Homo sapiens	IC50	nM	350.0
427336	17789006	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(-c6ccc(-c7ccccc7)cc6)c5c4c3)cc2)CC1		CHEMBL3907560	=	IC50	nM	660.0	CHEMBL4247	Homo sapiens	IC50	nM	660.0
427337	17789007	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(/C=C/c6cccc(F)c6)c5c4c3)cc2)CC1		CHEMBL3904008	=	IC50	nM	250.0	CHEMBL4247	Homo sapiens	IC50	nM	250.0
427338	17789008	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	COc1ccc(/C=C/c2ccnc3[nH]c4ccc(-c5ccc(N6CCN(C)CC6)cc5)cc4c23)cc1		CHEMBL3933100	=	IC50	nM	1200.0	CHEMBL4247	Homo sapiens	IC50	nM	1200.0
427339	17789009	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(-c6ccc(OCc7ccccc7)cc6)c5c4c3)cc2)CC1		CHEMBL3953243	=	IC50	nM	2200.0	CHEMBL4247	Homo sapiens	IC50	nM	2200.0
427340	17789010	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(-c6ccc(COc7cccc(C(F)(F)F)c7)cc6)c5c4c3)cc2)CC1		CHEMBL3920297	=	IC50	nM	1700.0	CHEMBL4247	Homo sapiens	IC50	nM	1700.0
427341	17789011	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	COc1ccccc1/C=C/c1ccnc2[nH]c3ccc(-c4ccc(N5CCN(C)CC5)cc4)cc3c12		CHEMBL3916988	=	IC50	nM	320.0	CHEMBL4247	Homo sapiens	IC50	nM	320.0
427342	17789012	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(/C=C/c6ccccc6C(F)(F)F)c5c4c3)cc2)CC1		CHEMBL3916480	=	IC50	nM	260.0	CHEMBL4247	Homo sapiens	IC50	nM	260.0
427343	17789013	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	Cc1cc(OCc2ccc(-c3ccnc4[nH]c5ccc(-c6ccc(N7CCN(C)CC7)cc6)cc5c34)cc2)ccc1Cl		CHEMBL3975258	=	IC50	nM	110.0	CHEMBL4247	Homo sapiens	IC50	nM	110.0
427344	17789014	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(/C=C/c6ccc(F)cc6)c5c4c3)cc2)CC1		CHEMBL3949340	=	IC50	nM	370.0	CHEMBL4247	Homo sapiens	IC50	nM	370.0
427345	17789015	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(/C=C/c6ccc(C(F)(F)F)cc6)c5c4c3)cc2)CC1		CHEMBL3961294	=	IC50	nM	280.0	CHEMBL4247	Homo sapiens	IC50	nM	280.0
427346	17789016	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(-c6ccc(-c7ccccc7)cc6F)c5c4c3)cc2)CC1		CHEMBL3913624	=	IC50	nM	970.0	CHEMBL4247	Homo sapiens	IC50	nM	970.0
427347	17789017	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(-c6ccc(Cc7ccccc7)cc6)c5c4c3)cc2)CC1		CHEMBL3924528	=	IC50	nM	200.0	CHEMBL4247	Homo sapiens	IC50	nM	200.0
427348	17789018	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(-c6cccc(-c7ccccc7)c6)c5c4c3)cc2)CC1		CHEMBL3982473	=	IC50	nM	210.0	CHEMBL4247	Homo sapiens	IC50	nM	210.0
427349	17789019	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(/C=C/c6ccccc6F)c5c4c3)cc2)CC1		CHEMBL3956515	=	IC50	nM	460.0	CHEMBL4247	Homo sapiens	IC50	nM	460.0
427350	17789020	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(/C=C/c6ccccc6Cl)c5c4c3)cc2)CC1		CHEMBL3977662	=	IC50	nM	880.0	CHEMBL4247	Homo sapiens	IC50	nM	880.0
427351	17789021	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(-c6ccc(N7CCN(C)CC7)cc6)c5c4c3)cc2)CC1		CHEMBL3923844	=	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
427352	17789022	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCC(N2CCN(c3ccc(-c4ccc5[nH]c6nccc(-c7ccc(Cc8ccccc8)cc7)c6c5c4)cc3)CC2)CC1		CHEMBL3939548	=	IC50	nM	1500.0	CHEMBL4247	Homo sapiens	IC50	nM	1500.0
427353	17789023	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCC(N2CCN(c3ccc(-c4ccc5[nH]c6nccc(/C=C/c7ccccc7C(F)(F)F)c6c5c4)cc3)CC2)CC1		CHEMBL3902568	=	IC50	nM	2900.0	CHEMBL4247	Homo sapiens	IC50	nM	2900.0
427354	17789024	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(-c6ccc(C(=O)c7ccccc7)cc6)c5c4c3)cc2)CC1		CHEMBL3927036	=	IC50	nM	610.0	CHEMBL4247	Homo sapiens	IC50	nM	610.0
427355	17789025	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(-c6ccc(-c7cccc8ccccc78)cc6)c5c4c3)cc2)CC1		CHEMBL3964686	=	IC50	nM	52.0	CHEMBL4247	Homo sapiens	IC50	nM	52.0
427356	17789026	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(/C(=C/c6ccccc6)c6ccccc6)c5c4c3)cc2)CC1		CHEMBL3975454	=	IC50	nM	1200.0	CHEMBL4247	Homo sapiens	IC50	nM	1200.0
427357	17789027	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	COc1ccc(Cc2ccc(-c3ccnc4[nH]c5ccc(-c6ccc(N7CCN(C)CC7)cc6)cc5c34)cc2)c(OC)c1		CHEMBL3913619	=	IC50	nM	520.0	CHEMBL4247	Homo sapiens	IC50	nM	520.0
427358	17789028	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	COc1ccccc1/C=C(\C)c1ccnc2[nH]c3ccc(-c4ccc(N5CCN(C)CC5)cc4)cc3c12		CHEMBL3966723	=	IC50	nM	1500.0	CHEMBL4247	Homo sapiens	IC50	nM	1500.0
427359	17789029	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	C/C(=C\c1ccccc1)c1ccnc2[nH]c3ccc(-c4ccc(N5CCN(C)CC5)cc4)cc3c12		CHEMBL3920323	=	IC50	nM	270.0	CHEMBL4247	Homo sapiens	IC50	nM	270.0
427360	17789030	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(/C=C/c6ccccc6NS(C)(=O)=O)c5c4c3)cc2)CC1		CHEMBL3947279	=	IC50	nM	160.0	CHEMBL4247	Homo sapiens	IC50	nM	160.0
427361	17789031	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CC/C=C(\c1ccccc1)c1ccnc2[nH]c3ccc(-c4ccc(N5CCN(C)CC5)cc4)cc3c12		CHEMBL3963627	=	IC50	nM	1400.0	CHEMBL4247	Homo sapiens	IC50	nM	1400.0
427362	17789032	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CC/C=C(\c1ccccc1)c1ccnc2[nH]c3ccc(-c4ccc(N5CCN(C)CC5)cc4)cc3c12		CHEMBL3963627	=	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
427363	17789033	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CC(C)[Si](/C=C/c1ccnc2[nH]c3ccc(-c4ccc(N5CCN(C)CC5)cc4)cc3c12)(C(C)C)C(C)C		CHEMBL3938221	=	IC50	nM	3200.0	CHEMBL4247	Homo sapiens	IC50	nM	3200.0
427364	17789034	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(-c6ccc(C(O)c7ccccc7)cc6)c5c4c3)cc2)CC1		CHEMBL3910295	=	IC50	nM	1400.0	CHEMBL4247	Homo sapiens	IC50	nM	1400.0
427365	17789035	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(Nc6ccccc6[N+](=O)[O-])c5c4c3)cc2)CC1		CHEMBL3972466	=	IC50	nM	560.0	CHEMBL4247	Homo sapiens	IC50	nM	560.0
427366	17789036	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(Nc6ccccc6[N+](=O)[O-])c5c4c3)cc2)CC1		CHEMBL3972466	=	IC50	nM	3300.0	CHEMBL4247	Homo sapiens	IC50	nM	3300.0
427367	17789037	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCC(N2CCN(c3ccc(-c4ccc5[nH]c6nccc(Nc7ccccc7[N+](=O)[O-])c6c5c4)cc3)CC2)CC1		CHEMBL3983644	=	IC50	nM	8500.0	CHEMBL4247	Homo sapiens	IC50	nM	8500.0
427368	17789038	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(C#Cc6ccccc6)c5c4c3)cc2)CC1		CHEMBL3910396	=	IC50	nM	170.0	CHEMBL4247	Homo sapiens	IC50	nM	170.0
427369	17789039	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	COc1ccccc1C#Cc1ccnc2[nH]c3ccc(-c4ccc(N5CCN(C)CC5)cc4)cc3c12		CHEMBL3956055	=	IC50	nM	750.0	CHEMBL4247	Homo sapiens	IC50	nM	750.0
427370	17789040	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(C#Cc6ccccc6C(F)(F)F)c5c4c3)cc2)CC1		CHEMBL3984671	=	IC50	nM	1100.0	CHEMBL4247	Homo sapiens	IC50	nM	1100.0
427371	17789041	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(C#Cc6ccc(F)cc6)c5c4c3)cc2)CC1		CHEMBL3961377	=	IC50	nM	890.0	CHEMBL4247	Homo sapiens	IC50	nM	890.0
427372	17789042	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(C#Cc6ccccc6F)c5c4c3)cc2)CC1		CHEMBL3895881	=	IC50	nM	1100.0	CHEMBL4247	Homo sapiens	IC50	nM	1100.0
427373	17789043	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(C#Cc6ccccc6Cl)c5c4c3)cc2)CC1		CHEMBL3937361	=	IC50	nM	1200.0	CHEMBL4247	Homo sapiens	IC50	nM	1200.0
427374	17789044	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CC(C)[Si](C#Cc1ccnc2[nH]c3ccc(-c4ccc(N5CCN(C)CC5)cc4)cc3c12)(C(C)C)C(C)C		CHEMBL3967080	=	IC50	nM	4900.0	CHEMBL4247	Homo sapiens	IC50	nM	4900.0
427375	17789045	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	C#Cc1ccnc2[nH]c3ccc(-c4ccc(N5CCN(C)CC5)cc4)cc3c12		CHEMBL3944913	=	IC50	nM	29000.0	CHEMBL4247	Homo sapiens	IC50	nM	29000.0
427376	17789046	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	COc1ccccc1C#Cc1ccnc2c1c1cc(-c3ccc(N4CCN(C)CC4)cc3)ccc1n2C		CHEMBL3983174	=	IC50	nM	3800.0	CHEMBL4247	Homo sapiens	IC50	nM	3800.0
427377	17789047	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	COc1ccc(Sc2ccnc3[nH]c4ccc(-c5ccc(N6CCN(C)CC6)cc5)cc4c23)cc1		CHEMBL3907871	=	IC50	nM	5700.0	CHEMBL4247	Homo sapiens	IC50	nM	5700.0
427378	17789048	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	Cc1ccc(Cn2cc(-c3ccnc4[nH]c5ccc(-c6ccc(N7CCN(C)CC7)cc6)cc5c34)nn2)cc1		CHEMBL3978376	=	IC50	nM	6800.0	CHEMBL4247	Homo sapiens	IC50	nM	6800.0
427379	17789049	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(-c6ccc(Oc7ccccc7)cc6)c5c4c3)cc2)CC1		CHEMBL3958885	=	IC50	nM	840.0	CHEMBL4247	Homo sapiens	IC50	nM	840.0
427380	17789050	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(-c6ccc(-c7ccc(F)cc7)nc6)c5c4c3)cc2)CC1		CHEMBL3934879	=	IC50	nM	1800.0	CHEMBL4247	Homo sapiens	IC50	nM	1800.0
427381	17789051	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	COc1cc(-c2ccnc3[nH]c4ccc(-c5ccc(N6CCN(C)CC6)cc5)cc4c23)c(OC)cc1C(=O)c1ccccc1		CHEMBL3950181	=	IC50	nM	8200.0	CHEMBL4247	Homo sapiens	IC50	nM	8200.0
427382	17789052	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	COc1cc(C(=O)c2ccccc2)c(O)cc1-c1ccnc2[nH]c3ccc(-c4ccc(N5CCN(C)CC5)cc4)cc3c12		CHEMBL3922458	=	IC50	nM	2800.0	CHEMBL4247	Homo sapiens	IC50	nM	2800.0
427383	17789053	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	COc1cc(-c2ccnc3[nH]c4ccc(-c5ccc(N6CCN(C)CC6)cc5)cc4c23)c(OC)cc1Cc1ccccc1		CHEMBL3979310	=	IC50	nM	310.0	CHEMBL4247	Homo sapiens	IC50	nM	310.0
427384	17789054	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	COc1cc(Cc2ccccc2)c(O)cc1-c1ccnc2[nH]c3ccc(-c4ccc(N5CCN(C)CC5)cc4)cc3c12		CHEMBL3946847	=	IC50	nM	4300.0	CHEMBL4247	Homo sapiens	IC50	nM	4300.0
427385	17789055	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(-c6ccc(Cc7ccccc7)c(C(F)(F)F)c6)c5c4c3)cc2)CC1		CHEMBL3891424	=	IC50	nM	2200.0	CHEMBL4247	Homo sapiens	IC50	nM	2200.0
427386	17789056	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(-c6ccc(Cc7ccccc7)cc6C(F)(F)F)c5c4c3)cc2)CC1		CHEMBL3923002	=	IC50	nM	7900.0	CHEMBL4247	Homo sapiens	IC50	nM	7900.0
427387	17789057	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	COc1cc(-c2ccnc3[nH]c4ccc(-c5ccc(N6CCN(C)CC6)cc5)cc4c23)cc(OC)c1Cc1ccccc1		CHEMBL3983825	=	IC50	nM	7900.0	CHEMBL4247	Homo sapiens	IC50	nM	7900.0
427388	17789058	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	COc1cc(C(O)c2ccccc2)c(OC)cc1-c1ccnc2[nH]c3ccc(-c4ccc(N5CCN(C)CC5)cc4)cc3c12		CHEMBL3931540	=	IC50	nM	18000.0	CHEMBL4247	Homo sapiens	IC50	nM	18000.0
427389	17789059	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(N6CCC(Cc7ccccc7)CC6)c5c4c3)cc2)CC1		CHEMBL3912968	=	IC50	nM	200.0	CHEMBL4247	Homo sapiens	IC50	nM	200.0
427390	17789060	CHEMBL3888984	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(N6CCN(Cc7ccccc7)CC6)c5c4c3)cc2)CC1		CHEMBL3937418	=	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
427391	17789061	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(Cl)c5c4c3)cc2)CC1		CHEMBL3952772	=	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
427392	17789062	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	C/C(=C\c1ccccc1C(F)(F)F)c1ccnc2[nH]c3ccc(-c4ccc(N5CCN(C)CC5)cc4)cc3c12		CHEMBL3967225	=	IC50	nM	6400.0	CHEMBL4247	Homo sapiens	IC50	nM	6400.0
427393	17789063	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(/C=C/c6ccccc6)c5c4c3)cn2)CC1		CHEMBL3986372	=	IC50	nM	350.0	CHEMBL4247	Homo sapiens	IC50	nM	350.0
427394	17789064	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(-c6ccc(-c7ccccc7)cc6)c5c4c3)cc2)CC1		CHEMBL3907560	=	IC50	nM	680.0	CHEMBL4247	Homo sapiens	IC50	nM	680.0
427395	17789065	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(/C=C/c6cccc(F)c6)c5c4c3)cc2)CC1		CHEMBL3904008	=	IC50	nM	320.0	CHEMBL4247	Homo sapiens	IC50	nM	320.0
427396	17789066	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	COc1ccc(/C=C/c2ccnc3[nH]c4ccc(-c5ccc(N6CCN(C)CC6)cc5)cc4c23)cc1		CHEMBL3933100	=	IC50	nM	170.0	CHEMBL4247	Homo sapiens	IC50	nM	170.0
427397	17789067	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(-c6ccc(OCc7ccccc7)cc6)c5c4c3)cc2)CC1		CHEMBL3953243	=	IC50	nM	900.0	CHEMBL4247	Homo sapiens	IC50	nM	900.0
427398	17789068	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(-c6ccc(COc7cccc(C(F)(F)F)c7)cc6)c5c4c3)cc2)CC1		CHEMBL3920297	=	IC50	nM	350.0	CHEMBL4247	Homo sapiens	IC50	nM	350.0
427399	17789069	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	COc1ccccc1/C=C/c1ccnc2[nH]c3ccc(-c4ccc(N5CCN(C)CC5)cc4)cc3c12		CHEMBL3916988	=	IC50	nM	110.0	CHEMBL4247	Homo sapiens	IC50	nM	110.0
427400	17789070	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(/C=C/c6ccccc6C(F)(F)F)c5c4c3)cc2)CC1		CHEMBL3916480	=	IC50	nM	160.0	CHEMBL4247	Homo sapiens	IC50	nM	160.0
427401	17789071	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	Cc1cc(OCc2ccc(-c3ccnc4[nH]c5ccc(-c6ccc(N7CCN(C)CC7)cc6)cc5c34)cc2)ccc1Cl		CHEMBL3975258	=	IC50	nM	52.0	CHEMBL4247	Homo sapiens	IC50	nM	52.0
427402	17789072	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(/C=C/c6ccc(F)cc6)c5c4c3)cc2)CC1		CHEMBL3949340	=	IC50	nM	91.0	CHEMBL4247	Homo sapiens	IC50	nM	91.0
427403	17789073	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(/C=C/c6ccc(C(F)(F)F)cc6)c5c4c3)cc2)CC1		CHEMBL3961294	=	IC50	nM	120.0	CHEMBL4247	Homo sapiens	IC50	nM	120.0
427404	17789074	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(-c6ccc(-c7ccccc7)cc6F)c5c4c3)cc2)CC1		CHEMBL3913624	=	IC50	nM	390.0	CHEMBL4247	Homo sapiens	IC50	nM	390.0
427405	17789075	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(-c6ccc(Cc7ccccc7)cc6)c5c4c3)cc2)CC1		CHEMBL3924528	=	IC50	nM	40.0	CHEMBL4247	Homo sapiens	IC50	nM	40.0
427406	17789076	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(-c6cccc(-c7ccccc7)c6)c5c4c3)cc2)CC1		CHEMBL3982473	=	IC50	nM	140.0	CHEMBL4247	Homo sapiens	IC50	nM	140.0
427407	17789077	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(/C=C/c6ccccc6F)c5c4c3)cc2)CC1		CHEMBL3956515	=	IC50	nM	150.0	CHEMBL4247	Homo sapiens	IC50	nM	150.0
427408	17789078	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(/C=C/c6ccccc6Cl)c5c4c3)cc2)CC1		CHEMBL3977662	=	IC50	nM	320.0	CHEMBL4247	Homo sapiens	IC50	nM	320.0
427409	17789079	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(-c6ccc(N7CCN(C)CC7)cc6)c5c4c3)cc2)CC1		CHEMBL3923844	=	IC50	nM	900.0	CHEMBL4247	Homo sapiens	IC50	nM	900.0
427410	17789080	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCC(N2CCN(c3ccc(-c4ccc5[nH]c6nccc(-c7ccc(Cc8ccccc8)cc7)c6c5c4)cc3)CC2)CC1		CHEMBL3939548	=	IC50	nM	700.0	CHEMBL4247	Homo sapiens	IC50	nM	700.0
427411	17789081	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCC(N2CCN(c3ccc(-c4ccc5[nH]c6nccc(/C=C/c7ccccc7C(F)(F)F)c6c5c4)cc3)CC2)CC1		CHEMBL3902568	=	IC50	nM	880.0	CHEMBL4247	Homo sapiens	IC50	nM	880.0
427412	17789082	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(-c6ccc(C(=O)c7ccccc7)cc6)c5c4c3)cc2)CC1		CHEMBL3927036	=	IC50	nM	150.0	CHEMBL4247	Homo sapiens	IC50	nM	150.0
427413	17789083	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(-c6ccc(-c7cccc8ccccc78)cc6)c5c4c3)cc2)CC1		CHEMBL3964686	=	IC50	nM	52.0	CHEMBL4247	Homo sapiens	IC50	nM	52.0
427414	17789084	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(/C(=C/c6ccccc6)c6ccccc6)c5c4c3)cc2)CC1		CHEMBL3975454	=	IC50	nM	1600.0	CHEMBL4247	Homo sapiens	IC50	nM	1600.0
427415	17789085	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	COc1ccc(Cc2ccc(-c3ccnc4[nH]c5ccc(-c6ccc(N7CCN(C)CC7)cc6)cc5c34)cc2)c(OC)c1		CHEMBL3913619	=	IC50	nM	590.0	CHEMBL4247	Homo sapiens	IC50	nM	590.0
427416	17789086	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	COc1ccccc1/C=C(\C)c1ccnc2[nH]c3ccc(-c4ccc(N5CCN(C)CC5)cc4)cc3c12		CHEMBL3966723	=	IC50	nM	1800.0	CHEMBL4247	Homo sapiens	IC50	nM	1800.0
427417	17789087	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	C/C(=C\c1ccccc1)c1ccnc2[nH]c3ccc(-c4ccc(N5CCN(C)CC5)cc4)cc3c12		CHEMBL3920323	=	IC50	nM	160.0	CHEMBL4247	Homo sapiens	IC50	nM	160.0
427418	17789088	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(/C=C/c6ccccc6NS(C)(=O)=O)c5c4c3)cc2)CC1		CHEMBL3947279	=	IC50	nM	280.0	CHEMBL4247	Homo sapiens	IC50	nM	280.0
427419	17789089	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CC/C=C(\c1ccccc1)c1ccnc2[nH]c3ccc(-c4ccc(N5CCN(C)CC5)cc4)cc3c12		CHEMBL3963627	=	IC50	nM	1500.0	CHEMBL4247	Homo sapiens	IC50	nM	1500.0
427420	17789090	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CC/C=C(\c1ccccc1)c1ccnc2[nH]c3ccc(-c4ccc(N5CCN(C)CC5)cc4)cc3c12		CHEMBL3963627	=	IC50	nM	2300.0	CHEMBL4247	Homo sapiens	IC50	nM	2300.0
427421	17789091	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CC(C)[Si](/C=C/c1ccnc2[nH]c3ccc(-c4ccc(N5CCN(C)CC5)cc4)cc3c12)(C(C)C)C(C)C		CHEMBL3938221	=	IC50	nM	7100.0	CHEMBL4247	Homo sapiens	IC50	nM	7100.0
427422	17789092	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(-c6ccc(C(O)c7ccccc7)cc6)c5c4c3)cc2)CC1		CHEMBL3910295	=	IC50	nM	230.0	CHEMBL4247	Homo sapiens	IC50	nM	230.0
427423	17789093	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(Nc6ccccc6[N+](=O)[O-])c5c4c3)cc2)CC1		CHEMBL3972466	=	IC50	nM	180.0	CHEMBL4247	Homo sapiens	IC50	nM	180.0
427424	17789094	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(Nc6ccccc6[N+](=O)[O-])c5c4c3)cc2)CC1		CHEMBL3972466	=	IC50	nM	1900.0	CHEMBL4247	Homo sapiens	IC50	nM	1900.0
427425	17789095	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCC(N2CCN(c3ccc(-c4ccc5[nH]c6nccc(Nc7ccccc7[N+](=O)[O-])c6c5c4)cc3)CC2)CC1		CHEMBL3983644	=	IC50	nM	890.0	CHEMBL4247	Homo sapiens	IC50	nM	890.0
427426	17789096	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(C#Cc6ccccc6)c5c4c3)cc2)CC1		CHEMBL3910396	=	IC50	nM	130.0	CHEMBL4247	Homo sapiens	IC50	nM	130.0
427427	17789097	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	COc1ccccc1C#Cc1ccnc2[nH]c3ccc(-c4ccc(N5CCN(C)CC5)cc4)cc3c12		CHEMBL3956055	=	IC50	nM	290.0	CHEMBL4247	Homo sapiens	IC50	nM	290.0
427428	17789098	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(C#Cc6ccccc6C(F)(F)F)c5c4c3)cc2)CC1		CHEMBL3984671	=	IC50	nM	270.0	CHEMBL4247	Homo sapiens	IC50	nM	270.0
427429	17789099	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(C#Cc6ccc(F)cc6)c5c4c3)cc2)CC1		CHEMBL3961377	=	IC50	nM	130.0	CHEMBL4247	Homo sapiens	IC50	nM	130.0
427430	17789100	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(C#Cc6ccccc6F)c5c4c3)cc2)CC1		CHEMBL3895881	=	IC50	nM	140.0	CHEMBL4247	Homo sapiens	IC50	nM	140.0
427431	17789101	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(C#Cc6ccccc6Cl)c5c4c3)cc2)CC1		CHEMBL3937361	=	IC50	nM	290.0	CHEMBL4247	Homo sapiens	IC50	nM	290.0
427432	17789102	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CC(C)[Si](C#Cc1ccnc2[nH]c3ccc(-c4ccc(N5CCN(C)CC5)cc4)cc3c12)(C(C)C)C(C)C		CHEMBL3967080	=	IC50	nM	6200.0	CHEMBL4247	Homo sapiens	IC50	nM	6200.0
427433	17789103	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	C#Cc1ccnc2[nH]c3ccc(-c4ccc(N5CCN(C)CC5)cc4)cc3c12		CHEMBL3944913	=	IC50	nM	43000.0	CHEMBL4247	Homo sapiens	IC50	nM	43000.0
427434	17789104	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	COc1ccccc1C#Cc1ccnc2c1c1cc(-c3ccc(N4CCN(C)CC4)cc3)ccc1n2C		CHEMBL3983174	=	IC50	nM	910.0	CHEMBL4247	Homo sapiens	IC50	nM	910.0
427435	17789105	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	COc1ccc(Sc2ccnc3[nH]c4ccc(-c5ccc(N6CCN(C)CC6)cc5)cc4c23)cc1		CHEMBL3907871	=	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
427436	17789106	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	Cc1ccc(Cn2cc(-c3ccnc4[nH]c5ccc(-c6ccc(N7CCN(C)CC7)cc6)cc5c34)nn2)cc1		CHEMBL3978376	=	IC50	nM	2200.0	CHEMBL4247	Homo sapiens	IC50	nM	2200.0
427437	17789107	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(-c6ccc(Oc7ccccc7)cc6)c5c4c3)cc2)CC1		CHEMBL3958885	=	IC50	nM	7200.0	CHEMBL4247	Homo sapiens	IC50	nM	7200.0
427438	17789108	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(-c6ccc(-c7ccc(F)cc7)nc6)c5c4c3)cc2)CC1		CHEMBL3934879	=	IC50	nM	920.0	CHEMBL4247	Homo sapiens	IC50	nM	920.0
427439	17789109	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	COc1cc(-c2ccnc3[nH]c4ccc(-c5ccc(N6CCN(C)CC6)cc5)cc4c23)c(OC)cc1C(=O)c1ccccc1		CHEMBL3950181	=	IC50	nM	2300.0	CHEMBL4247	Homo sapiens	IC50	nM	2300.0
427440	17789110	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	COc1cc(C(=O)c2ccccc2)c(O)cc1-c1ccnc2[nH]c3ccc(-c4ccc(N5CCN(C)CC5)cc4)cc3c12		CHEMBL3922458	=	IC50	nM	830.0	CHEMBL4247	Homo sapiens	IC50	nM	830.0
427441	17789111	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	COc1cc(-c2ccnc3[nH]c4ccc(-c5ccc(N6CCN(C)CC6)cc5)cc4c23)c(OC)cc1Cc1ccccc1		CHEMBL3979310	=	IC50	nM	22.0	CHEMBL4247	Homo sapiens	IC50	nM	22.0
427442	17789112	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	COc1cc(Cc2ccccc2)c(O)cc1-c1ccnc2[nH]c3ccc(-c4ccc(N5CCN(C)CC5)cc4)cc3c12		CHEMBL3946847	=	IC50	nM	1300.0	CHEMBL4247	Homo sapiens	IC50	nM	1300.0
427443	17789113	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(-c6ccc(Cc7ccccc7)c(C(F)(F)F)c6)c5c4c3)cc2)CC1		CHEMBL3891424	=	IC50	nM	2100.0	CHEMBL4247	Homo sapiens	IC50	nM	2100.0
427444	17789114	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(-c6ccc(Cc7ccccc7)cc6C(F)(F)F)c5c4c3)cc2)CC1		CHEMBL3923002	=	IC50	nM	3200.0	CHEMBL4247	Homo sapiens	IC50	nM	3200.0
427445	17789115	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	COc1cc(-c2ccnc3[nH]c4ccc(-c5ccc(N6CCN(C)CC6)cc5)cc4c23)cc(OC)c1Cc1ccccc1		CHEMBL3983825	=	IC50	nM	19000.0	CHEMBL4247	Homo sapiens	IC50	nM	19000.0
427446	17789116	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	COc1cc(C(O)c2ccccc2)c(OC)cc1-c1ccnc2[nH]c3ccc(-c4ccc(N5CCN(C)CC5)cc4)cc3c12		CHEMBL3931540	=	IC50	nM	8700.0	CHEMBL4247	Homo sapiens	IC50	nM	8700.0
427447	17789117	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(N6CCC(Cc7ccccc7)CC6)c5c4c3)cc2)CC1		CHEMBL3912968	=	IC50	nM	32.0	CHEMBL4247	Homo sapiens	IC50	nM	32.0
427448	17789118	CHEMBL3888985	ELISA-Based In Vitro Kinase Assay: GST-tagged recombinant wild-type or L1196M mutated ALK kinase (rALK) was expressed in Sf9 insect cells using the pBacPAK baculovirus vector system (Clontech) and purified using Glutathione Sepharose 4B affinity beads (GE Healthcare). Recombinant 3C protease was used to remove the GST tag. Purified ALK was used to screen inhibitors in the ELISA-based kinase assay, as follows: Nunc-Immuno 96-well plates were incubated overnight at 30 C. with coating solution containing 2 g of a specific ALK peptide substrate (ARDIYRASFFRKGGCAMLPVK) in PBS. Wells were then washed with 200 L of wash buffer (PBS-Tween 0.05%) and incubated with 4% BSA in PBS for at least 2 h at 30 C. The kinase reaction was performed in the presence of 50 mM Tris pH 7.5, 5 mM MnCl2, 5 mM MgCl2, 0.3 mM ATP and purified rALK in a total volume of 100 L/well at 30 C. for 15 min. For inhibitor testing the reaction mix was preincubated with inhibitor or vehicle for 10 min at room temperature before transferring to the ELISA plate. After the reaction, the wells were washed 5 times with 200 L of wash buffer. Phosphorylated peptide was detected using 100 L/well of a mouse monoclonal anti-phosphotyrosine antibody (clone 4G10 UpstateBiotech Ltd) diluted 1:2000 in PBS+4% BSA. After 30 min incubation at room temperature the antibody was removed and wells were washed as described above. 100 L of a secondary antibody (anti-mouse IgG, Horseradish Peroxidase linked whole antibody, Amersham Pharmacia Biotech) diluted 1:1000 in PBS+4% BSA was added to each well and the plate was incubated again for 30 min at room temperature before washing as above. The plate was developed using 100 L/well TMB Substrate Solution (Pierce) and the reaction was stopped by adding an equal volume of 1M H2SO4. Finally, the absorbance was read at 450 nm using an ELISA plate reader (Bio-Rad).	B	CN1CCN(c2ccc(-c3ccc4[nH]c5nccc(N6CCN(Cc7ccccc7)CC6)c5c4c3)cc2)CC1		CHEMBL3937418	=	IC50	nM	690.0	CHEMBL4247	Homo sapiens	IC50	nM	690.0
Inactive	17883439	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883440	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883441	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883442	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883443	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883444	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883445	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883446	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883447	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883448	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883449	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883450	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883451	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883452	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883453	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883454	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883455	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883456	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883457	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883458	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883459	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883460	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883461	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883462	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883463	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883464	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883465	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17883466	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	=	Kd	nM	2.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	2.0
Inactive	17883467	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883468	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883469	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883470	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883471	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883472	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883473	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883474	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883475	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883476	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883477	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883478	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17883479	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	3.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	3.0
Inactive	17883480	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883481	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883482	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883483	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17883484	CHEMBL3991626	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL4247	Homo sapiens	Kd apparent	nM	30000.0
	17952478	CHEMBL3993014	Inhibition of wild-type ALK (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	14.0	CHEMBL4247	Homo sapiens	IC50	nM	14.0
	17952479	CHEMBL3993014	Inhibition of wild-type ALK (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	COc1cc(CC#N)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4089527	=	IC50	nM	21.0	CHEMBL4247	Homo sapiens	IC50	nM	21.0
	17952480	CHEMBL3993014	Inhibition of wild-type ALK (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	COc1cc(C(C)(C)C#N)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4061375	=	IC50	nM	200.0	CHEMBL4247	Homo sapiens	IC50	nM	200.0
	17952481	CHEMBL3993014	Inhibition of wild-type ALK (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	COc1cc(CCN)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4081656	=	IC50	nM	2.7	CHEMBL4247	Homo sapiens	IC50	nM	2.7
	17952482	CHEMBL3993014	Inhibition of wild-type ALK (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	COc1cc(CCN(C)C)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4099660	=	IC50	nM	1.4	CHEMBL4247	Homo sapiens	IC50	nM	1.4
	17952483	CHEMBL3993014	Inhibition of wild-type ALK (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	COc1cc(CCNC=O)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4071105	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
	17952484	CHEMBL3993014	Inhibition of wild-type ALK (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	CNCCc1cc(OC)c(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)cc1C		CHEMBL4091928	=	IC50	nM	1.5	CHEMBL4247	Homo sapiens	IC50	nM	1.5
	17952485	CHEMBL3993014	Inhibition of wild-type ALK (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	COc1cc(C(C)(C)CN)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4062466	=	IC50	nM	4.9	CHEMBL4247	Homo sapiens	IC50	nM	4.9
	17952486	CHEMBL3993014	Inhibition of wild-type ALK (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	COc1cc(C(C)(C)CN(C)C)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4084168	=	IC50	nM	2.2	CHEMBL4247	Homo sapiens	IC50	nM	2.2
	17952487	CHEMBL3993014	Inhibition of wild-type ALK (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	COc1cc(C(C)(C)CNC=O)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4061549	=	IC50	nM	7.8	CHEMBL4247	Homo sapiens	IC50	nM	7.8
	17952488	CHEMBL3993014	Inhibition of wild-type ALK (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	CNCC(C)(C)c1cc(OC)c(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)cc1C		CHEMBL4089672	=	IC50	nM	1.5	CHEMBL4247	Homo sapiens	IC50	nM	1.5
	17952489	CHEMBL3993014	Inhibition of wild-type ALK (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	COc1cc(CN)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4070217	=	IC50	nM	1.9	CHEMBL4247	Homo sapiens	IC50	nM	1.9
	17952490	CHEMBL3993014	Inhibition of wild-type ALK (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	COc1cc(CN(C)C)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4097392	=	IC50	nM	3.4	CHEMBL4247	Homo sapiens	IC50	nM	3.4
	17952491	CHEMBL3993014	Inhibition of wild-type ALK (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	COc1cc(C(C)(C)N)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4080869	=	IC50	nM	1.5	CHEMBL4247	Homo sapiens	IC50	nM	1.5
	17952492	CHEMBL3993014	Inhibition of wild-type ALK (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	COc1cc(C(C)(C)N(C)C)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4105099	=	IC50	nM	2.8	CHEMBL4247	Homo sapiens	IC50	nM	2.8
	17952493	CHEMBL3993014	Inhibition of wild-type ALK (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	COc1cc(CNC=O)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4088751	=	IC50	nM	4.7	CHEMBL4247	Homo sapiens	IC50	nM	4.7
	17952494	CHEMBL3993014	Inhibition of wild-type ALK (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	CNCc1cc(OC)c(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)cc1C		CHEMBL4067503	=	IC50	nM	1.7	CHEMBL4247	Homo sapiens	IC50	nM	1.7
	17952495	CHEMBL3993014	Inhibition of wild-type ALK (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	COc1cc(C(C)(C)NC=O)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4096452	=	IC50	nM	2.1	CHEMBL4247	Homo sapiens	IC50	nM	2.1
	17952496	CHEMBL3993014	Inhibition of wild-type ALK (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	CNC(C)(C)c1cc(OC)c(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)cc1C		CHEMBL4078406	=	IC50	nM	1.2	CHEMBL4247	Homo sapiens	IC50	nM	1.2
	17952497	CHEMBL3993015	Inhibition of ALK L1196M mutant (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	29.0	CHEMBL4247	Homo sapiens	IC50	nM	29.0
	17952498	CHEMBL3993015	Inhibition of ALK L1196M mutant (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	COc1cc(CC#N)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4089527	=	IC50	nM	36.0	CHEMBL4247	Homo sapiens	IC50	nM	36.0
	17952499	CHEMBL3993015	Inhibition of ALK L1196M mutant (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	COc1cc(C(C)(C)C#N)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4061375	=	IC50	nM	570.0	CHEMBL4247	Homo sapiens	IC50	nM	570.0
	17952500	CHEMBL3993015	Inhibition of ALK L1196M mutant (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	COc1cc(CCN)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4081656	=	IC50	nM	1.7	CHEMBL4247	Homo sapiens	IC50	nM	1.7
	17952501	CHEMBL3993015	Inhibition of ALK L1196M mutant (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	COc1cc(CCN(C)C)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4099660	=	IC50	nM	1.3	CHEMBL4247	Homo sapiens	IC50	nM	1.3
	17952502	CHEMBL3993015	Inhibition of ALK L1196M mutant (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	COc1cc(CCNC=O)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4071105	=	IC50	nM	4.4	CHEMBL4247	Homo sapiens	IC50	nM	4.4
	17952503	CHEMBL3993015	Inhibition of ALK L1196M mutant (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	CNCCc1cc(OC)c(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)cc1C		CHEMBL4091928	=	IC50	nM	1.9	CHEMBL4247	Homo sapiens	IC50	nM	1.9
	17952504	CHEMBL3993015	Inhibition of ALK L1196M mutant (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	COc1cc(C(C)(C)CN)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4062466	=	IC50	nM	3.4	CHEMBL4247	Homo sapiens	IC50	nM	3.4
	17952505	CHEMBL3993015	Inhibition of ALK L1196M mutant (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	COc1cc(C(C)(C)CN(C)C)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4084168	=	IC50	nM	3.6	CHEMBL4247	Homo sapiens	IC50	nM	3.6
	17952506	CHEMBL3993015	Inhibition of ALK L1196M mutant (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	COc1cc(C(C)(C)CNC=O)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4061549	=	IC50	nM	6.1	CHEMBL4247	Homo sapiens	IC50	nM	6.1
	17952507	CHEMBL3993015	Inhibition of ALK L1196M mutant (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	CNCC(C)(C)c1cc(OC)c(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)cc1C		CHEMBL4089672	=	IC50	nM	1.7	CHEMBL4247	Homo sapiens	IC50	nM	1.7
	17952508	CHEMBL3993015	Inhibition of ALK L1196M mutant (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	COc1cc(CN)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4070217	=	IC50	nM	2.1	CHEMBL4247	Homo sapiens	IC50	nM	2.1
	17952509	CHEMBL3993015	Inhibition of ALK L1196M mutant (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	COc1cc(CN(C)C)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4097392	=	IC50	nM	2.1	CHEMBL4247	Homo sapiens	IC50	nM	2.1
	17952510	CHEMBL3993015	Inhibition of ALK L1196M mutant (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	COc1cc(C(C)(C)N)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4080869	=	IC50	nM	1.6	CHEMBL4247	Homo sapiens	IC50	nM	1.6
	17952511	CHEMBL3993015	Inhibition of ALK L1196M mutant (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	COc1cc(C(C)(C)N(C)C)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4105099	=	IC50	nM	1.5	CHEMBL4247	Homo sapiens	IC50	nM	1.5
	17952512	CHEMBL3993015	Inhibition of ALK L1196M mutant (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	COc1cc(CNC=O)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4088751	=	IC50	nM	2.8	CHEMBL4247	Homo sapiens	IC50	nM	2.8
	17952513	CHEMBL3993015	Inhibition of ALK L1196M mutant (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	CNCc1cc(OC)c(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)cc1C		CHEMBL4067503	=	IC50	nM	2.2	CHEMBL4247	Homo sapiens	IC50	nM	2.2
	17952514	CHEMBL3993015	Inhibition of ALK L1196M mutant (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	COc1cc(C(C)(C)NC=O)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4096452	=	IC50	nM	2.5	CHEMBL4247	Homo sapiens	IC50	nM	2.5
	17952515	CHEMBL3993015	Inhibition of ALK L1196M mutant (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	CNC(C)(C)c1cc(OC)c(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)cc1C		CHEMBL4078406	=	IC50	nM	1.4	CHEMBL4247	Homo sapiens	IC50	nM	1.4
	17952516	CHEMBL3993016	Inhibition of EML4 fused ALK in human NCI-H3122 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	CC50	nM	25.0	CHEMBL4247	Homo sapiens	CC50	nM	25.0
	17952517	CHEMBL3993016	Inhibition of EML4 fused ALK in human NCI-H3122 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(CC#N)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4089527	=	CC50	nM	74.0	CHEMBL4247	Homo sapiens	CC50	nM	74.0
	17952518	CHEMBL3993016	Inhibition of EML4 fused ALK in human NCI-H3122 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(C(C)(C)C#N)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4061375	=	CC50	nM	250.0	CHEMBL4247	Homo sapiens	CC50	nM	250.0
	17952519	CHEMBL3993016	Inhibition of EML4 fused ALK in human NCI-H3122 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(CCN)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4081656	=	CC50	nM	60.0	CHEMBL4247	Homo sapiens	CC50	nM	60.0
	17952520	CHEMBL3993016	Inhibition of EML4 fused ALK in human NCI-H3122 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(CCN(C)C)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4099660	=	CC50	nM	13.0	CHEMBL4247	Homo sapiens	CC50	nM	13.0
	17952521	CHEMBL3993016	Inhibition of EML4 fused ALK in human NCI-H3122 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(CCNC=O)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4071105	=	CC50	nM	68.0	CHEMBL4247	Homo sapiens	CC50	nM	68.0
	17952522	CHEMBL3993016	Inhibition of EML4 fused ALK in human NCI-H3122 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	CNCCc1cc(OC)c(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)cc1C		CHEMBL4091928	=	CC50	nM	20.0	CHEMBL4247	Homo sapiens	CC50	nM	20.0
	17952523	CHEMBL3993016	Inhibition of EML4 fused ALK in human NCI-H3122 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(C(C)(C)CN)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4062466	=	CC50	nM	53.0	CHEMBL4247	Homo sapiens	CC50	nM	53.0
	17952524	CHEMBL3993016	Inhibition of EML4 fused ALK in human NCI-H3122 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(C(C)(C)CN(C)C)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4084168	=	CC50	nM	26.0	CHEMBL4247	Homo sapiens	CC50	nM	26.0
	17952525	CHEMBL3993016	Inhibition of EML4 fused ALK in human NCI-H3122 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(C(C)(C)CNC=O)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4061549	=	CC50	nM	63.0	CHEMBL4247	Homo sapiens	CC50	nM	63.0
	17952526	CHEMBL3993016	Inhibition of EML4 fused ALK in human NCI-H3122 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	CNCC(C)(C)c1cc(OC)c(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)cc1C		CHEMBL4089672	=	CC50	nM	41.0	CHEMBL4247	Homo sapiens	CC50	nM	41.0
	17952527	CHEMBL3993016	Inhibition of EML4 fused ALK in human NCI-H3122 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(CN)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4070217	=	CC50	nM	110.0	CHEMBL4247	Homo sapiens	CC50	nM	110.0
	17952528	CHEMBL3993016	Inhibition of EML4 fused ALK in human NCI-H3122 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(CN(C)C)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4097392	=	CC50	nM	37.0	CHEMBL4247	Homo sapiens	CC50	nM	37.0
	17952529	CHEMBL3993016	Inhibition of EML4 fused ALK in human NCI-H3122 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(C(C)(C)N)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4080869	=	CC50	nM	12.0	CHEMBL4247	Homo sapiens	CC50	nM	12.0
	17952530	CHEMBL3993016	Inhibition of EML4 fused ALK in human NCI-H3122 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(C(C)(C)N(C)C)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4105099	=	CC50	nM	35.0	CHEMBL4247	Homo sapiens	CC50	nM	35.0
	17952531	CHEMBL3993016	Inhibition of EML4 fused ALK in human NCI-H3122 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(CNC=O)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4088751	=	CC50	nM	28.0	CHEMBL4247	Homo sapiens	CC50	nM	28.0
	17952532	CHEMBL3993016	Inhibition of EML4 fused ALK in human NCI-H3122 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	CNCc1cc(OC)c(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)cc1C		CHEMBL4067503	=	CC50	nM	25.0	CHEMBL4247	Homo sapiens	CC50	nM	25.0
	17952533	CHEMBL3993016	Inhibition of EML4 fused ALK in human NCI-H3122 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(C(C)(C)NC=O)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4096452	=	CC50	nM	52.0	CHEMBL4247	Homo sapiens	CC50	nM	52.0
	17952534	CHEMBL3993016	Inhibition of EML4 fused ALK in human NCI-H3122 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	CNC(C)(C)c1cc(OC)c(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)cc1C		CHEMBL4078406	=	CC50	nM	29.0	CHEMBL4247	Homo sapiens	CC50	nM	29.0
	17952535	CHEMBL3993017	Inhibition of EML4 fused ALK L1196M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	CC50	nM	75.0	CHEMBL4247	Homo sapiens	CC50	nM	75.0
	17952536	CHEMBL3993017	Inhibition of EML4 fused ALK L1196M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(CC#N)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4089527	=	CC50	nM	190.0	CHEMBL4247	Homo sapiens	CC50	nM	190.0
	17952537	CHEMBL3993017	Inhibition of EML4 fused ALK L1196M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(C(C)(C)C#N)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4061375	=	CC50	nM	440.0	CHEMBL4247	Homo sapiens	CC50	nM	440.0
	17952538	CHEMBL3993017	Inhibition of EML4 fused ALK L1196M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(CCN)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4081656	=	CC50	nM	300.0	CHEMBL4247	Homo sapiens	CC50	nM	300.0
	17952539	CHEMBL3993017	Inhibition of EML4 fused ALK L1196M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(CCN(C)C)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4099660	=	CC50	nM	35.0	CHEMBL4247	Homo sapiens	CC50	nM	35.0
	17952540	CHEMBL3993017	Inhibition of EML4 fused ALK L1196M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(CCNC=O)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4071105	=	CC50	nM	260.0	CHEMBL4247	Homo sapiens	CC50	nM	260.0
	17952541	CHEMBL3993017	Inhibition of EML4 fused ALK L1196M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	CNCCc1cc(OC)c(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)cc1C		CHEMBL4091928	=	CC50	nM	58.0	CHEMBL4247	Homo sapiens	CC50	nM	58.0
	17952542	CHEMBL3993017	Inhibition of EML4 fused ALK L1196M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(C(C)(C)CN)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4062466	=	CC50	nM	96.0	CHEMBL4247	Homo sapiens	CC50	nM	96.0
	17952543	CHEMBL3993017	Inhibition of EML4 fused ALK L1196M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(C(C)(C)CN(C)C)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4084168	=	CC50	nM	66.0	CHEMBL4247	Homo sapiens	CC50	nM	66.0
	17952544	CHEMBL3993017	Inhibition of EML4 fused ALK L1196M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(C(C)(C)CNC=O)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4061549	=	CC50	nM	99.0	CHEMBL4247	Homo sapiens	CC50	nM	99.0
	17952545	CHEMBL3993017	Inhibition of EML4 fused ALK L1196M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	CNCC(C)(C)c1cc(OC)c(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)cc1C		CHEMBL4089672	=	CC50	nM	68.0	CHEMBL4247	Homo sapiens	CC50	nM	68.0
	17952546	CHEMBL3993017	Inhibition of EML4 fused ALK L1196M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(CN)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4070217	=	CC50	nM	39.0	CHEMBL4247	Homo sapiens	CC50	nM	39.0
	17952547	CHEMBL3993017	Inhibition of EML4 fused ALK L1196M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(CN(C)C)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4097392	=	CC50	nM	66.0	CHEMBL4247	Homo sapiens	CC50	nM	66.0
	17952548	CHEMBL3993017	Inhibition of EML4 fused ALK L1196M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(C(C)(C)N)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4080869	=	CC50	nM	55.0	CHEMBL4247	Homo sapiens	CC50	nM	55.0
	17952549	CHEMBL3993017	Inhibition of EML4 fused ALK L1196M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(C(C)(C)N(C)C)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4105099	=	CC50	nM	91.0	CHEMBL4247	Homo sapiens	CC50	nM	91.0
	17952550	CHEMBL3993017	Inhibition of EML4 fused ALK L1196M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(CNC=O)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4088751	=	CC50	nM	62.0	CHEMBL4247	Homo sapiens	CC50	nM	62.0
	17952551	CHEMBL3993017	Inhibition of EML4 fused ALK L1196M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	CNCc1cc(OC)c(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)cc1C		CHEMBL4067503	=	CC50	nM	54.0	CHEMBL4247	Homo sapiens	CC50	nM	54.0
	17952552	CHEMBL3993017	Inhibition of EML4 fused ALK L1196M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(C(C)(C)NC=O)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4096452	=	CC50	nM	81.0	CHEMBL4247	Homo sapiens	CC50	nM	81.0
	17952553	CHEMBL3993017	Inhibition of EML4 fused ALK L1196M mutant (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	CNC(C)(C)c1cc(OC)c(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)cc1C		CHEMBL4078406	=	CC50	nM	66.0	CHEMBL4247	Homo sapiens	CC50	nM	66.0
	17952554	CHEMBL3993018	Inhibition of EML4 fused ALK (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	CC50	nM	75.0	CHEMBL4247	Homo sapiens	CC50	nM	75.0
	17952555	CHEMBL3993018	Inhibition of EML4 fused ALK (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(CC#N)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4089527	=	CC50	nM	61.0	CHEMBL4247	Homo sapiens	CC50	nM	61.0
	17952556	CHEMBL3993018	Inhibition of EML4 fused ALK (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(C(C)(C)C#N)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4061375	=	CC50	nM	250.0	CHEMBL4247	Homo sapiens	CC50	nM	250.0
	17952557	CHEMBL3993018	Inhibition of EML4 fused ALK (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(CCN)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4081656	=	CC50	nM	68.0	CHEMBL4247	Homo sapiens	CC50	nM	68.0
	17952558	CHEMBL3993018	Inhibition of EML4 fused ALK (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(CCN(C)C)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4099660	=	CC50	nM	10.0	CHEMBL4247	Homo sapiens	CC50	nM	10.0
	17952559	CHEMBL3993018	Inhibition of EML4 fused ALK (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(CCNC=O)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4071105	=	CC50	nM	60.0	CHEMBL4247	Homo sapiens	CC50	nM	60.0
	17952560	CHEMBL3993018	Inhibition of EML4 fused ALK (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	CNCCc1cc(OC)c(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)cc1C		CHEMBL4091928	=	CC50	nM	13.0	CHEMBL4247	Homo sapiens	CC50	nM	13.0
	17952561	CHEMBL3993018	Inhibition of EML4 fused ALK (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(C(C)(C)CN)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4062466	=	CC50	nM	36.0	CHEMBL4247	Homo sapiens	CC50	nM	36.0
	17952562	CHEMBL3993018	Inhibition of EML4 fused ALK (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(C(C)(C)CN(C)C)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4084168	=	CC50	nM	14.0	CHEMBL4247	Homo sapiens	CC50	nM	14.0
	17952563	CHEMBL3993018	Inhibition of EML4 fused ALK (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(C(C)(C)CNC=O)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4061549	=	CC50	nM	38.0	CHEMBL4247	Homo sapiens	CC50	nM	38.0
	17952564	CHEMBL3993018	Inhibition of EML4 fused ALK (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	CNCC(C)(C)c1cc(OC)c(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)cc1C		CHEMBL4089672	=	CC50	nM	19.0	CHEMBL4247	Homo sapiens	CC50	nM	19.0
	17952565	CHEMBL3993018	Inhibition of EML4 fused ALK (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(CN)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4070217	=	CC50	nM	120.0	CHEMBL4247	Homo sapiens	CC50	nM	120.0
	17952566	CHEMBL3993018	Inhibition of EML4 fused ALK (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(CN(C)C)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4097392	=	CC50	nM	21.0	CHEMBL4247	Homo sapiens	CC50	nM	21.0
	17952567	CHEMBL3993018	Inhibition of EML4 fused ALK (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(C(C)(C)N)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4080869	=	CC50	nM	12.0	CHEMBL4247	Homo sapiens	CC50	nM	12.0
	17952568	CHEMBL3993018	Inhibition of EML4 fused ALK (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(C(C)(C)N(C)C)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4105099	=	CC50	nM	20.0	CHEMBL4247	Homo sapiens	CC50	nM	20.0
	17952569	CHEMBL3993018	Inhibition of EML4 fused ALK (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(CNC=O)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4088751	=	CC50	nM	15.0	CHEMBL4247	Homo sapiens	CC50	nM	15.0
	17952570	CHEMBL3993018	Inhibition of EML4 fused ALK (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	CNCc1cc(OC)c(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)cc1C		CHEMBL4067503	=	CC50	nM	15.0	CHEMBL4247	Homo sapiens	CC50	nM	15.0
	17952571	CHEMBL3993018	Inhibition of EML4 fused ALK (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	COc1cc(C(C)(C)NC=O)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4096452	=	CC50	nM	24.0	CHEMBL4247	Homo sapiens	CC50	nM	24.0
	17952572	CHEMBL3993018	Inhibition of EML4 fused ALK (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition measured after 72 hrs by SRB assay	B	CNC(C)(C)c1cc(OC)c(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)cc1C		CHEMBL4078406	=	CC50	nM	15.0	CHEMBL4247	Homo sapiens	CC50	nM	15.0
	17952573	CHEMBL3993019	Inhibition of ALK G1202R mutant (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	13.0	CHEMBL4247	Homo sapiens	IC50	nM	13.0
	17952574	CHEMBL3993019	Inhibition of ALK G1202R mutant (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	COc1cc(CCN(C)C)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4099660	=	IC50	nM	1.8	CHEMBL4247	Homo sapiens	IC50	nM	1.8
	17952575	CHEMBL3993020	Inhibition of ALK G1269A mutant (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	1.4	CHEMBL4247	Homo sapiens	IC50	nM	1.4
	17952576	CHEMBL3993020	Inhibition of ALK G1269A mutant (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	COc1cc(CCN(C)C)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4099660	=	IC50	nM	0.4	CHEMBL4247	Homo sapiens	IC50	nM	0.4
	17952579	CHEMBL3993022	Inhibition of ALK F1174L mutant (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	1.5	CHEMBL4247	Homo sapiens	IC50	nM	1.5
	17952580	CHEMBL3993022	Inhibition of ALK F1174L mutant (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	COc1cc(CCN(C)C)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4099660	=	IC50	nM	0.56	CHEMBL4247	Homo sapiens	IC50	nM	0.56
	17952581	CHEMBL3993023	Inhibition of ALK C1156Y mutant (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	nM	2.0
	17952582	CHEMBL3993023	Inhibition of ALK C1156Y mutant (unknown origin) using peptide as substrate measured after 30 mins by fluorescence assay	B	COc1cc(CCN(C)C)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4099660	=	IC50	nM	1.1	CHEMBL4247	Homo sapiens	IC50	nM	1.1
	17952583	CHEMBL3993024	Potency index, ratio of ceritinib CC50 to compound CC50 for inhibition of EML4 fused ALK in human NCI-H3122 cells assessed as cell growth inhibition	B	COc1cc(CCN(C)C)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4099660	=	Ratio		2.0	CHEMBL4247	Homo sapiens	Ratio		2.0
	17952584	CHEMBL3993025	Potency index, ratio of ceritinib CC50 to compound CC50 for inhibition of EML4 fused ALK L1196M mutant (unknown origin) expressed in mouse BA/F3 cells	B	COc1cc(CCN(C)C)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4099660	=	Ratio		2.0	CHEMBL4247	Homo sapiens	Ratio		2.0
	17952585	CHEMBL3993026	Potency index, ratio of ceritinib CC50 to compound CC50 for inhibition of EML4 fused ALK (unknown origin) expressed in mouse BA/F3 cells assessed as cell growth inhibition	B	COc1cc(CCN(C)C)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4099660	=	Ratio		2.0	CHEMBL4247	Homo sapiens	Ratio		2.0
	17952586	CHEMBL3993027	Potency index, ratio of ceritinib IC50 to compound IC50 for inhibition of ALK G1202R mutant (unknown origin)	B	COc1cc(CCN(C)C)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4099660	=	Ratio IC50		7.0	CHEMBL4247	Homo sapiens	Ratio IC50		7.0
	17952587	CHEMBL3993028	Potency index, ratio of ceritinib IC50 to compound IC50 for inhibition of ALK G1269A mutant (unknown origin)	B	COc1cc(CCN(C)C)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4099660	=	Ratio IC50		3.0	CHEMBL4247	Homo sapiens	Ratio IC50		3.0
	17964873	CHEMBL3994982	Inhibition of human ALK (I1088 to E1409 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control	B	CNc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)c(C)c2)ncn1		CHEMBL4060295	=	Activity	%	100.0	CHEMBL4247	Homo sapiens	Activity	%	100.0
	18008662	CHEMBL4003777	Inhibition of human ALK using casein as substrate in presence of [gamma-33P]ATP at 1 uM after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CCCC[C@@H]3N)nc21		CHEMBL4088144	=	Inhibition	%	7.0	CHEMBL4247	Homo sapiens	INH	%	7.0
	18008663	CHEMBL4003777	Inhibition of human ALK using casein as substrate in presence of [gamma-33P]ATP at 1 uM after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL4066861	=	Inhibition	%	-2.0	CHEMBL4247	Homo sapiens	INH	%	-2.0
	18008664	CHEMBL4003777	Inhibition of human ALK using casein as substrate in presence of [gamma-33P]ATP at 1 uM after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cc(N)cc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL4078898	=	Inhibition	%	10.0	CHEMBL4247	Homo sapiens	INH	%	10.0
	18031600	CHEMBL4007683	Inhibition of ALK (unknown origin) after 60 mins by TR-FRET assay	B	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	=	IC50	nM	266.0	CHEMBL4247	Homo sapiens	IC50	uM	0.266
	18031601	CHEMBL4007683	Inhibition of ALK (unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2ccoc12		CHEMBL4078893	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	18031602	CHEMBL4007683	Inhibition of ALK (unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc3cn[nH]c3c2)nc2ccoc12		CHEMBL4066664	=	IC50	nM	7630.0	CHEMBL4247	Homo sapiens	IC50	uM	7.63
	18031603	CHEMBL4007683	Inhibition of ALK (unknown origin) after 60 mins by TR-FRET assay	B	CC1(C)OCC(=O)Nc2cc(Nc3nc(NCC(F)(F)F)c4occc4n3)ccc21		CHEMBL4069365	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	18031604	CHEMBL4007683	Inhibition of ALK (unknown origin) after 60 mins by TR-FRET assay	B	Cc1n[nH]c2cc(Nc3nc(NC4CC4)c4occc4n3)ccc12		CHEMBL4062803	=	IC50	nM	5940.0	CHEMBL4247	Homo sapiens	IC50	uM	5.94
	18033106	CHEMBL4007922	Inhibition of human ALK at 0.1 uM relative to control	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)[C@H]1CCCN1.Cl		CHEMBL4093614	=	Inhibition	%	63.0	CHEMBL4247	Homo sapiens	INH	%	63.0
	18052994	CHEMBL4011829	Inhibition of ALK (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	1.9	CHEMBL4247	Homo sapiens	INH	%	1.9
	18052995	CHEMBL4011830	Inhibition of ALK C1156Y mutant (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	-5.0	CHEMBL4247	Homo sapiens	INH	%	-5.0
	18052996	CHEMBL4011831	Inhibition of ALK F1174L mutant (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	-0.5	CHEMBL4247	Homo sapiens	INH	%	-0.5
	18052997	CHEMBL4011832	Inhibition of ALK G1202R mutant (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	-2.5	CHEMBL4247	Homo sapiens	INH	%	-2.5
	18052998	CHEMBL4011833	Inhibition of ALK L1196M mutant (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	-3.9	CHEMBL4247	Homo sapiens	INH	%	-3.9
	18082260	CHEMBL4017792	Inhibition of ALK L1196M mutant (unknown origin) using TK as substrate after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C1CNCCN1CC2		CHEMBL4084421	=	IC50	nM	4.8	CHEMBL4247	Homo sapiens	IC50	nM	4.8
	18082261	CHEMBL4017792	Inhibition of ALK L1196M mutant (unknown origin) using TK as substrate after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C1CNCC(=O)N1CC2		CHEMBL4071384	=	IC50	nM	5.3	CHEMBL4247	Homo sapiens	IC50	nM	5.3
	18082262	CHEMBL4017792	Inhibition of ALK L1196M mutant (unknown origin) using TK as substrate after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCN1CCNCC21		CHEMBL4092174	=	IC50	nM	1.9	CHEMBL4247	Homo sapiens	IC50	nM	1.9
	18082263	CHEMBL4017792	Inhibition of ALK L1196M mutant (unknown origin) using TK as substrate after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCN1C(=O)CNCC21		CHEMBL4081925	=	IC50	nM	5.2	CHEMBL4247	Homo sapiens	IC50	nM	5.2
	18082264	CHEMBL4017792	Inhibition of ALK L1196M mutant (unknown origin) using TK as substrate after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCC1=NN(C)CCN12		CHEMBL4099922	=	IC50	nM	8.1	CHEMBL4247	Homo sapiens	IC50	nM	8.1
	18082265	CHEMBL4017792	Inhibition of ALK L1196M mutant (unknown origin) using TK as substrate after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCC1=NNCCN12		CHEMBL4101954	=	IC50	nM	8.3	CHEMBL4247	Homo sapiens	IC50	nM	8.3
	18082266	CHEMBL4017792	Inhibition of ALK L1196M mutant (unknown origin) using TK as substrate after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCN1C(N)=NCC21		CHEMBL4083964	=	IC50	nM	11.0	CHEMBL4247	Homo sapiens	IC50	nM	11.0
	18082267	CHEMBL4017792	Inhibition of ALK L1196M mutant (unknown origin) using TK as substrate after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCc1nn(C(=O)CO)c(C)c1-2		CHEMBL4063965	=	IC50	nM	130.0	CHEMBL4247	Homo sapiens	IC50	nM	130.0
	18082268	CHEMBL4017792	Inhibition of ALK L1196M mutant (unknown origin) using TK as substrate after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCc1n[nH]c(C)c1-2		CHEMBL4091729	=	IC50	nM	170.0	CHEMBL4247	Homo sapiens	IC50	nM	170.0
	18082269	CHEMBL4017791	Inhibition of wild type ALK (unknown origin) using TK as substrate after 30 mins by HTRF assay	B	COc1cc2c(cnc3ccccc32)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4100875	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
	18082270	CHEMBL4017791	Inhibition of wild type ALK (unknown origin) using TK as substrate after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)c(=O)[nH]c1ccccc12		CHEMBL4074115	=	IC50	nM	310.0	CHEMBL4247	Homo sapiens	IC50	nM	310.0
	18082271	CHEMBL4017791	Inhibition of wild type ALK (unknown origin) using TK as substrate after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)c(=O)n(OC)c1ccccc21		CHEMBL4062738	=	IC50	nM	190.0	CHEMBL4247	Homo sapiens	IC50	nM	190.0
	18082272	CHEMBL4017791	Inhibition of wild type ALK (unknown origin) using TK as substrate after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C1CNCCN1CC2		CHEMBL4084421	=	IC50	nM	12.0	CHEMBL4247	Homo sapiens	IC50	nM	12.0
	18082273	CHEMBL4017791	Inhibition of wild type ALK (unknown origin) using TK as substrate after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C1CNCC(=O)N1CC2		CHEMBL4071384	=	IC50	nM	4.3	CHEMBL4247	Homo sapiens	IC50	nM	4.3
	18082274	CHEMBL4017791	Inhibition of wild type ALK (unknown origin) using TK as substrate after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCN1CCNCC21		CHEMBL4092174	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	nM	2.0
	18082275	CHEMBL4017791	Inhibition of wild type ALK (unknown origin) using TK as substrate after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCN1C(=O)CNCC21		CHEMBL4081925	=	IC50	nM	3.7	CHEMBL4247	Homo sapiens	IC50	nM	3.7
	18082276	CHEMBL4017791	Inhibition of wild type ALK (unknown origin) using TK as substrate after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCC1=NN(C)CCN12		CHEMBL4099922	=	IC50	nM	1.7	CHEMBL4247	Homo sapiens	IC50	nM	1.7
	18082277	CHEMBL4017791	Inhibition of wild type ALK (unknown origin) using TK as substrate after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCC1=NNCCN12		CHEMBL4101954	=	IC50	nM	0.33	CHEMBL4247	Homo sapiens	IC50	nM	0.33
	18082278	CHEMBL4017791	Inhibition of wild type ALK (unknown origin) using TK as substrate after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCN1C(N)=NCC21		CHEMBL4083964	=	IC50	nM	5.3	CHEMBL4247	Homo sapiens	IC50	nM	5.3
	18082279	CHEMBL4017791	Inhibition of wild type ALK (unknown origin) using TK as substrate after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCc1nn(C(=O)CO)c(C)c1-2		CHEMBL4063965	=	IC50	nM	21.0	CHEMBL4247	Homo sapiens	IC50	nM	21.0
	18082280	CHEMBL4017791	Inhibition of wild type ALK (unknown origin) using TK as substrate after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCc1n[nH]c(C)c1-2		CHEMBL4091729	=	IC50	nM	29.0	CHEMBL4247	Homo sapiens	IC50	nM	29.0
	18082281	CHEMBL4017792	Inhibition of ALK L1196M mutant (unknown origin) using TK as substrate after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)c(=O)n(OC)c1ccccc21		CHEMBL4062738	=	IC50	nM	380.0	CHEMBL4247	Homo sapiens	IC50	nM	380.0
	18082282	CHEMBL4017792	Inhibition of ALK L1196M mutant (unknown origin) using TK as substrate after 30 mins by HTRF assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)c(=O)[nH]c1ccccc12		CHEMBL4074115	=	IC50	nM	530.0	CHEMBL4247	Homo sapiens	IC50	nM	530.0
	18082283	CHEMBL4017792	Inhibition of ALK L1196M mutant (unknown origin) using TK as substrate after 30 mins by HTRF assay	B	COc1cc2c(cnc3ccccc32)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4100875	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
	18082296	CHEMBL4017794	Inhibition of EML4 fused ALK in human NCI-H3122 cells assessed as cell growth inhibition after 72 hrs by SRB assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCc1n[nH]c(C)c1-2		CHEMBL4091729	=	CC50	nM	140.0	CHEMBL4247	Homo sapiens	CC50	nM	140.0
	18082297	CHEMBL4017794	Inhibition of EML4 fused ALK in human NCI-H3122 cells assessed as cell growth inhibition after 72 hrs by SRB assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCc1nn(C(=O)CO)c(C)c1-2		CHEMBL4063965	=	CC50	nM	100.0	CHEMBL4247	Homo sapiens	CC50	nM	100.0
	18082298	CHEMBL4017794	Inhibition of EML4 fused ALK in human NCI-H3122 cells assessed as cell growth inhibition after 72 hrs by SRB assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCN1C(N)=NCC21		CHEMBL4083964	=	CC50	nM	380.0	CHEMBL4247	Homo sapiens	CC50	nM	380.0
	18082299	CHEMBL4017794	Inhibition of EML4 fused ALK in human NCI-H3122 cells assessed as cell growth inhibition after 72 hrs by SRB assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCC1=NNCCN12		CHEMBL4101954	=	CC50	nM	38.0	CHEMBL4247	Homo sapiens	CC50	nM	38.0
	18082300	CHEMBL4017794	Inhibition of EML4 fused ALK in human NCI-H3122 cells assessed as cell growth inhibition after 72 hrs by SRB assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCC1=NN(C)CCN12		CHEMBL4099922	=	CC50	nM	36.0	CHEMBL4247	Homo sapiens	CC50	nM	36.0
	18082301	CHEMBL4017794	Inhibition of EML4 fused ALK in human NCI-H3122 cells assessed as cell growth inhibition after 72 hrs by SRB assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCN1C(=O)CNCC21		CHEMBL4081925	=	CC50	nM	30.0	CHEMBL4247	Homo sapiens	CC50	nM	30.0
	18082302	CHEMBL4017794	Inhibition of EML4 fused ALK in human NCI-H3122 cells assessed as cell growth inhibition after 72 hrs by SRB assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCN1CCNCC21		CHEMBL4092174	=	CC50	nM	36.0	CHEMBL4247	Homo sapiens	CC50	nM	36.0
	18082303	CHEMBL4017794	Inhibition of EML4 fused ALK in human NCI-H3122 cells assessed as cell growth inhibition after 72 hrs by SRB assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C1CNCC(=O)N1CC2		CHEMBL4071384	=	CC50	nM	770.0	CHEMBL4247	Homo sapiens	CC50	nM	770.0
	18082304	CHEMBL4017794	Inhibition of EML4 fused ALK in human NCI-H3122 cells assessed as cell growth inhibition after 72 hrs by SRB assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C1CNCCN1CC2		CHEMBL4084421	=	CC50	nM	240.0	CHEMBL4247	Homo sapiens	CC50	nM	240.0
	18082305	CHEMBL4017794	Inhibition of EML4 fused ALK in human NCI-H3122 cells assessed as cell growth inhibition after 72 hrs by SRB assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)c(=O)n(OC)c1ccccc21		CHEMBL4062738	=	CC50	nM	160.0	CHEMBL4247	Homo sapiens	CC50	nM	160.0
	18082306	CHEMBL4017794	Inhibition of EML4 fused ALK in human NCI-H3122 cells assessed as cell growth inhibition after 72 hrs by SRB assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)c(=O)[nH]c1ccccc12		CHEMBL4074115	=	CC50	nM	760.0	CHEMBL4247	Homo sapiens	CC50	nM	760.0
	18082307	CHEMBL4017794	Inhibition of EML4 fused ALK in human NCI-H3122 cells assessed as cell growth inhibition after 72 hrs by SRB assay	B	COc1cc2c(cnc3ccccc32)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4100875	=	CC50	nM	410.0	CHEMBL4247	Homo sapiens	CC50	nM	410.0
	18082308	CHEMBL4017795	Inhibition of ALK L1196M mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by WST-1 assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCc1n[nH]c(C)c1-2		CHEMBL4091729	=	CC50	nM	700.0	CHEMBL4247	Homo sapiens	CC50	nM	700.0
	18082309	CHEMBL4017795	Inhibition of ALK L1196M mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by WST-1 assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCc1nn(C(=O)CO)c(C)c1-2		CHEMBL4063965	=	CC50	nM	500.0	CHEMBL4247	Homo sapiens	CC50	nM	500.0
	18082310	CHEMBL4017795	Inhibition of ALK L1196M mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by WST-1 assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCN1C(N)=NCC21		CHEMBL4083964	=	CC50	nM	1300.0	CHEMBL4247	Homo sapiens	CC50	nM	1300.0
	18082311	CHEMBL4017795	Inhibition of ALK L1196M mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by WST-1 assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCC1=NNCCN12		CHEMBL4101954	=	CC50	nM	260.0	CHEMBL4247	Homo sapiens	CC50	nM	260.0
	18082312	CHEMBL4017795	Inhibition of ALK L1196M mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by WST-1 assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCC1=NN(C)CCN12		CHEMBL4099922	=	CC50	nM	120.0	CHEMBL4247	Homo sapiens	CC50	nM	120.0
	18082313	CHEMBL4017795	Inhibition of ALK L1196M mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by WST-1 assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCN1C(=O)CNCC21		CHEMBL4081925	=	CC50	nM	93.0	CHEMBL4247	Homo sapiens	CC50	nM	93.0
	18082314	CHEMBL4017795	Inhibition of ALK L1196M mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by WST-1 assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCN1CCNCC21		CHEMBL4092174	=	CC50	nM	75.0	CHEMBL4247	Homo sapiens	CC50	nM	75.0
	18082315	CHEMBL4017795	Inhibition of ALK L1196M mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by WST-1 assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C1CNCC(=O)N1CC2		CHEMBL4071384	=	CC50	nM	310.0	CHEMBL4247	Homo sapiens	CC50	nM	310.0
	18082316	CHEMBL4017795	Inhibition of ALK L1196M mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by WST-1 assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)C1CNCCN1CC2		CHEMBL4084421	=	CC50	nM	790.0	CHEMBL4247	Homo sapiens	CC50	nM	790.0
	18082317	CHEMBL4017795	Inhibition of ALK L1196M mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by WST-1 assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)c(=O)n(OC)c1ccccc21		CHEMBL4062738	=	CC50	nM	2600.0	CHEMBL4247	Homo sapiens	CC50	nM	2600.0
	18082318	CHEMBL4017795	Inhibition of ALK L1196M mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by WST-1 assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)c(=O)[nH]c1ccccc12		CHEMBL4074115	>	CC50	nM	10000.0	CHEMBL4247	Homo sapiens	CC50	nM	10000.0
	18082319	CHEMBL4017795	Inhibition of ALK L1196M mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by WST-1 assay	B	COc1cc2c(cnc3ccccc32)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4100875	>	CC50	nM	10000.0	CHEMBL4247	Homo sapiens	CC50	nM	10000.0
	18082325	CHEMBL4017791	Inhibition of wild type ALK (unknown origin) using TK as substrate after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	14.0	CHEMBL4247	Homo sapiens	IC50	nM	14.0
	18082326	CHEMBL4017792	Inhibition of ALK L1196M mutant (unknown origin) using TK as substrate after 30 mins by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	29.0	CHEMBL4247	Homo sapiens	IC50	nM	29.0
	18082328	CHEMBL4017794	Inhibition of EML4 fused ALK in human NCI-H3122 cells assessed as cell growth inhibition after 72 hrs by SRB assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	CC50	nM	38.0	CHEMBL4247	Homo sapiens	CC50	nM	38.0
	18082329	CHEMBL4017795	Inhibition of ALK L1196M mutant (unknown origin) expressed in mouse BAF3 cells assessed as cell growth inhibition after 72 hrs by WST-1 assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	CC50	nM	75.0	CHEMBL4247	Homo sapiens	CC50	nM	75.0
	18085997	CHEMBL4018644	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(Cl)ccc3O)cc12		CHEMBL4105329	=	IC50	nM	231.1	CHEMBL4247	Homo sapiens	IC50	nM	231.1
	18085998	CHEMBL4018644	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	OC[C@H](Nc1cnc(-c2cc(Cl)ccc2O)c(-c2ccc3cnccc3c2)c1)c1ccccc1		CHEMBL4067871	=	IC50	nM	93.9	CHEMBL4247	Homo sapiens	IC50	nM	93.9
	18085999	CHEMBL4018644	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877	=	IC50	nM	101.1	CHEMBL4247	Homo sapiens	IC50	nM	101.1
	18086000	CHEMBL4018644	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccc(F)cc3O)cc12		CHEMBL4075917	=	IC50	nM	155.5	CHEMBL4247	Homo sapiens	IC50	nM	155.5
	18096335	CHEMBL4021222	Inhibition of ALK (unknown origin) using FAM-labeled peptide as substrate preincubated for 5 to 10 mins followed by substrate/ATP addition measured after 30 to 60 mins by mobility shift assay	B	CC(c1cc2cc(-c3cnn(C)c3)cnc2cc1F)n1nnc2ncc(-c3cnn(CCO)c3)nc21		CHEMBL4074262	>	IC50	nM	30000.0	CHEMBL4247	Homo sapiens	IC50	nM	30000.0
	18114483	CHEMBL4025011	Inhibition of wild-type human partial length ALK L1196M mutant (I1088 to E1409 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	96.0	CHEMBL4247	Homo sapiens	Activity	%	96.0
	18114484	CHEMBL4025010	Inhibition of wild-type human partial length ALK C1156Y mutant (I1088 to E1409 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	94.0	CHEMBL4247	Homo sapiens	Activity	%	94.0
	18114485	CHEMBL4025009	Inhibition of wild-type human partial length ALK (I1088 to E1409 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	94.0	CHEMBL4247	Homo sapiens	Activity	%	94.0
	18121100	CHEMBL4026800	Inhibition of recombinant human ALK G1269A mutant (1093 to 1411 residues) expressed in baculovirus expression system using 5'FAM-KKSRGDYMTMQIG-CONH as substrate preincubated for 15 mins followed by addition of ATP measured after 1 hr by microfluidic mobility shift assay	B	Oc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4065208	=	IC50	nM	16.2	CHEMBL4247	Homo sapiens	IC50	uM	0.0162
	18121101	CHEMBL4026798	Inhibition of recombinant human ALK C1156Y mutant (1093 to 1411 residues) expressed in baculovirus expression system using 5'FAM-KKSRGDYMTMQIG-CONH as substrate preincubated for 15 mins followed by addition of ATP measured after 1 hr by microfluidic mobility shift assay	B	Oc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4065208	=	IC50	nM	11.5	CHEMBL4247	Homo sapiens	IC50	uM	0.0115
	18121102	CHEMBL4026799	Inhibition of recombinant human ALK F1174L mutant (1093 to 1411 residues) expressed in baculovirus expression system using 5'FAM-KKSRGDYMTMQIG-CONH as substrate preincubated for 15 mins followed by addition of ATP measured after 1 hr by microfluidic mobility shift assay	B	Oc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4065208	=	IC50	nM	9.3	CHEMBL4247	Homo sapiens	IC50	uM	0.0093
	18121103	CHEMBL4026802	Inhibition of recombinant human ALK G1202R mutant (1093 to 1411 residues) expressed in baculovirus expression system using 5'FAM-KKSRGDYMTMQIG-CONH as substrate preincubated for 15 mins followed by addition of ATP measured after 1 hr by microfluidic mobility shift assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	3.8	CHEMBL4247	Homo sapiens	IC50	uM	0.0038
	18121104	CHEMBL4026801	Inhibition of recombinant human ALK L1152R mutant (1093 to 1411 residues) expressed in baculovirus expression system using 5'FAM-KKSRGDYMTMQIG-CONH as substrate preincubated for 15 mins followed by addition of ATP measured after 1 hr by microfluidic mobility shift assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	2.9	CHEMBL4247	Homo sapiens	IC50	uM	0.0029
	18121105	CHEMBL4026798	Inhibition of recombinant human ALK C1156Y mutant (1093 to 1411 residues) expressed in baculovirus expression system using 5'FAM-KKSRGDYMTMQIG-CONH as substrate preincubated for 15 mins followed by addition of ATP measured after 1 hr by microfluidic mobility shift assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.7	CHEMBL4247	Homo sapiens	IC50	uM	0.0017
	18121106	CHEMBL4026799	Inhibition of recombinant human ALK F1174L mutant (1093 to 1411 residues) expressed in baculovirus expression system using 5'FAM-KKSRGDYMTMQIG-CONH as substrate preincubated for 15 mins followed by addition of ATP measured after 1 hr by microfluidic mobility shift assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.6	CHEMBL4247	Homo sapiens	IC50	uM	0.0016
	18121108	CHEMBL4026800	Inhibition of recombinant human ALK G1269A mutant (1093 to 1411 residues) expressed in baculovirus expression system using 5'FAM-KKSRGDYMTMQIG-CONH as substrate preincubated for 15 mins followed by addition of ATP measured after 1 hr by microfluidic mobility shift assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.74	CHEMBL4247	Homo sapiens	IC50	uM	0.00074
Not Active	18121109	CHEMBL4026838	Time-dependant inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition measured for 2 hrs	B	Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4091441		TDI			CHEMBL4247	Homo sapiens	TDI		
	18121110	CHEMBL4026801	Inhibition of recombinant human ALK L1152R mutant (1093 to 1411 residues) expressed in baculovirus expression system using 5'FAM-KKSRGDYMTMQIG-CONH as substrate preincubated for 15 mins followed by addition of ATP measured after 1 hr by microfluidic mobility shift assay	B	Oc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4065208	=	IC50	nM	29.6	CHEMBL4247	Homo sapiens	IC50	uM	0.0296
	18121111	CHEMBL4026800	Inhibition of recombinant human ALK G1269A mutant (1093 to 1411 residues) expressed in baculovirus expression system using 5'FAM-KKSRGDYMTMQIG-CONH as substrate preincubated for 15 mins followed by addition of ATP measured after 1 hr by microfluidic mobility shift assay	B	Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4091441	=	IC50	nM	35.1	CHEMBL4247	Homo sapiens	IC50	uM	0.0351
	18121112	CHEMBL4026800	Inhibition of recombinant human ALK G1269A mutant (1093 to 1411 residues) expressed in baculovirus expression system using 5'FAM-KKSRGDYMTMQIG-CONH as substrate preincubated for 15 mins followed by addition of ATP measured after 1 hr by microfluidic mobility shift assay	B	COc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4087615	=	IC50	nM	38.4	CHEMBL4247	Homo sapiens	IC50	uM	0.0384
	18121113	CHEMBL4026798	Inhibition of recombinant human ALK C1156Y mutant (1093 to 1411 residues) expressed in baculovirus expression system using 5'FAM-KKSRGDYMTMQIG-CONH as substrate preincubated for 15 mins followed by addition of ATP measured after 1 hr by microfluidic mobility shift assay	B	Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4091441	=	IC50	nM	40.9	CHEMBL4247	Homo sapiens	IC50	uM	0.0409
	18121114	CHEMBL4026785	Competitive inhibition of human ALK L1196M mutant assessed as enzyme Vmax at 41.2 nM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by Michaelis-Menten plot analysis (Rvb = 0.04230 microM/min)	B	Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4091441	=	Vmax	microM/min	0.04195	CHEMBL4247	Homo sapiens	Vmax	microM/min	0.04195
	18121115	CHEMBL4026798	Inhibition of recombinant human ALK C1156Y mutant (1093 to 1411 residues) expressed in baculovirus expression system using 5'FAM-KKSRGDYMTMQIG-CONH as substrate preincubated for 15 mins followed by addition of ATP measured after 1 hr by microfluidic mobility shift assay	B	COc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4087615	=	IC50	nM	42.2	CHEMBL4247	Homo sapiens	IC50	uM	0.0422
	18121116	CHEMBL4026794	Competitive inhibition of human ALK L1196M mutant assessed as enzyme Vmax at 13.7 to 370 nM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by Michaelis-Menten plot analysis	B	Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4091441	=	Vmax	microM/min	0.0427	CHEMBL4247	Homo sapiens	Vmax	microM/min	0.0427
	18121117	CHEMBL4026784	Competitive inhibition of human ALK L1196M mutant assessed as enzyme Vmax at 13.7 nM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by Michaelis-Menten plot analysis (Rvb = 0.04230 microM/min)	B	Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4091441	=	Vmax	microM/min	0.04401	CHEMBL4247	Homo sapiens	Vmax	microM/min	0.04401
	18121118	CHEMBL4026787	Competitive inhibition of human ALK L1196M mutant assessed as enzyme Vmax at 370 nM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by Michaelis-Menten plot analysis (Rvb = 0.04230 microM/min)	B	Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4091441	=	Vmax	microM/min	0.05458	CHEMBL4247	Homo sapiens	Vmax	microM/min	0.05458
	18121119	CHEMBL4026786	Competitive inhibition of human ALK L1196M mutant assessed as enzyme Vmax at 123 nM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by Michaelis-Menten plot analysis (Rvb = 0.04230 microM/min)	B	Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4091441	=	Vmax	microM/min	0.0581	CHEMBL4247	Homo sapiens	Vmax	microM/min	0.0581
	18121123	CHEMBL4026799	Inhibition of recombinant human ALK F1174L mutant (1093 to 1411 residues) expressed in baculovirus expression system using 5'FAM-KKSRGDYMTMQIG-CONH as substrate preincubated for 15 mins followed by addition of ATP measured after 1 hr by microfluidic mobility shift assay	B	Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4091441	=	IC50	nM	141.0	CHEMBL4247	Homo sapiens	IC50	uM	0.141
	18121124	CHEMBL4026799	Inhibition of recombinant human ALK F1174L mutant (1093 to 1411 residues) expressed in baculovirus expression system using 5'FAM-KKSRGDYMTMQIG-CONH as substrate preincubated for 15 mins followed by addition of ATP measured after 1 hr by microfluidic mobility shift assay	B	COc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4087615	=	IC50	nM	154.0	CHEMBL4247	Homo sapiens	IC50	uM	0.154
	18121125	CHEMBL4026801	Inhibition of recombinant human ALK L1152R mutant (1093 to 1411 residues) expressed in baculovirus expression system using 5'FAM-KKSRGDYMTMQIG-CONH as substrate preincubated for 15 mins followed by addition of ATP measured after 1 hr by microfluidic mobility shift assay	B	COc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4087615	=	IC50	nM	155.0	CHEMBL4247	Homo sapiens	IC50	uM	0.155
	18121126	CHEMBL4026801	Inhibition of recombinant human ALK L1152R mutant (1093 to 1411 residues) expressed in baculovirus expression system using 5'FAM-KKSRGDYMTMQIG-CONH as substrate preincubated for 15 mins followed by addition of ATP measured after 1 hr by microfluidic mobility shift assay	B	Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4091441	=	IC50	nM	159.0	CHEMBL4247	Homo sapiens	IC50	uM	0.159
	18121127	CHEMBL4026783	Inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.67	CHEMBL4247	Homo sapiens	IC50	nM	0.67
	18121128	CHEMBL4026797	Competitive inhibition of human ALK L1196M mutant assessed as enzyme/ATP complex using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by Michaelis-Menten plot analysis	B	Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1	Outside typical range	CHEMBL4091441	=	Ki	nM	729046655.0	CHEMBL4247	Homo sapiens	Ki	M	0.729046655
	18121129	CHEMBL4026783	Inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	c1ccc(Nc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4103197	=	IC50	nM	1180.0	CHEMBL4247	Homo sapiens	IC50	uM	1.18
	18121130	CHEMBL4026782	Inhibition of human wild type ALK using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	c1ccc(Nc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4103197	=	IC50	nM	1800.0	CHEMBL4247	Homo sapiens	IC50	uM	1.8
	18121131	CHEMBL4026782	Inhibition of human wild type ALK using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.7	CHEMBL4247	Homo sapiens	IC50	nM	1.7
	18121132	CHEMBL4026803	Inhibition of human ALK (I1088 to E1409 residues) expressed in mammalian expression system assessed as percent enzyme activity at 1 uM relative to control	B	Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4091441	=	Activity	%	2.3	CHEMBL4247	Homo sapiens	Activity	%	2.3
	18121136	CHEMBL4026783	Inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	c1ccc(Nc2ccnc3cc(-c4ccccc4)ccc23)cc1		CHEMBL4067168	=	IC50	nM	2680.0	CHEMBL4247	Homo sapiens	IC50	uM	2.68
	18121137	CHEMBL4026783	Inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	Nc1ccc(-c2ccc3c(Nc4ccccc4)ccnc3c2)cn1		CHEMBL4079865	=	IC50	nM	2700.0	CHEMBL4247	Homo sapiens	IC50	uM	2.7
	18121138	CHEMBL4026782	Inhibition of human wild type ALK using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	c1ccc(Nc2ccnc3cc(-c4cnn(C5CCOCC5)c4)ccc23)cc1		CHEMBL4085274	=	IC50	nM	2710.0	CHEMBL4247	Homo sapiens	IC50	uM	2.71
	18121140	CHEMBL4026782	Inhibition of human wild type ALK using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	c1ccc(Nc2ccnc3cc(-c4ccncc4)ccc23)cc1		CHEMBL4088426	=	IC50	nM	2860.0	CHEMBL4247	Homo sapiens	IC50	uM	2.86
	18121141	CHEMBL4026782	Inhibition of human wild type ALK using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	Nc1ccc(-c2ccc3c(Nc4ccccc4)ccnc3c2)cn1		CHEMBL4079865	=	IC50	nM	2990.0	CHEMBL4247	Homo sapiens	IC50	uM	2.99
	18121143	CHEMBL4026783	Inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4091441	=	IC50	nM	3.3	CHEMBL4247	Homo sapiens	IC50	nM	3.3
	18121146	CHEMBL4026783	Inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	c1ccc(Nc2ccnc3cc(-c4cnn(C5CCOCC5)c4)ccc23)cc1		CHEMBL4085274	=	IC50	nM	3460.0	CHEMBL4247	Homo sapiens	IC50	uM	3.46
	18121148	CHEMBL4026782	Inhibition of human wild type ALK using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	c1ccc(Nc2ccnc3cc(-c4ccccc4)ccc23)cc1		CHEMBL4067168	=	IC50	nM	3690.0	CHEMBL4247	Homo sapiens	IC50	uM	3.69
	18121149	CHEMBL4026783	Inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	c1ccc(Nc2ccnc3cc(-c4cccs4)ccc23)cc1		CHEMBL4087745	=	IC50	nM	3810.0	CHEMBL4247	Homo sapiens	IC50	uM	3.81
	18121152	CHEMBL4026782	Inhibition of human wild type ALK using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	c1ccc(Nc2ccnc3cc(-c4cccs4)ccc23)cc1		CHEMBL4087745	=	IC50	nM	4230.0	CHEMBL4247	Homo sapiens	IC50	uM	4.23
	18121154	CHEMBL4026802	Inhibition of recombinant human ALK G1202R mutant (1093 to 1411 residues) expressed in baculovirus expression system using 5'FAM-KKSRGDYMTMQIG-CONH as substrate preincubated for 15 mins followed by addition of ATP measured after 1 hr by microfluidic mobility shift assay	B	Oc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4065208	=	IC50	nM	4450.0	CHEMBL4247	Homo sapiens	IC50	uM	4.45
	18121155	CHEMBL4026782	Inhibition of human wild type ALK using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	Cn1cc(-c2ccc3c(Nc4ccccc4)ccnc3c2)cn1		CHEMBL4095442	=	IC50	nM	4740.0	CHEMBL4247	Homo sapiens	IC50	uM	4.74
	18121157	CHEMBL4026782	Inhibition of human wild type ALK using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	Oc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4065208	=	IC50	nM	5.2	CHEMBL4247	Homo sapiens	IC50	nM	5.2
	18121160	CHEMBL4026783	Inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	Cn1cc(-c2ccc3c(Nc4ccccc4)ccnc3c2)cn1		CHEMBL4095442	=	IC50	nM	6080.0	CHEMBL4247	Homo sapiens	IC50	uM	6.08
	18121161	CHEMBL4026783	Inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	c1ccc(Nc2ccnc3cc(-c4ccncc4)ccc23)cc1		CHEMBL4088426	=	IC50	nM	6590.0	CHEMBL4247	Homo sapiens	IC50	uM	6.59
	18121162	CHEMBL4026783	Inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	Oc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4065208	=	IC50	nM	7.1	CHEMBL4247	Homo sapiens	IC50	nM	7.1
	18121163	CHEMBL4026783	Inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	c1ccc(Nc2ccnc3cc(-c4ccco4)ccc23)cc1		CHEMBL4104111	=	IC50	nM	7130.0	CHEMBL4247	Homo sapiens	IC50	uM	7.13
	18121164	CHEMBL4026782	Inhibition of human wild type ALK using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	c1ccc(Nc2ccnc3cc(-c4ccco4)ccc23)cc1		CHEMBL4104111	=	IC50	nM	7390.0	CHEMBL4247	Homo sapiens	IC50	uM	7.39
	18121165	CHEMBL4026782	Inhibition of human wild type ALK using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	c1ccc(Nc2ccnc3cc(-c4cn[nH]c4)ccc23)cc1		CHEMBL4066413	=	IC50	nM	8810.0	CHEMBL4247	Homo sapiens	IC50	uM	8.81
	18121166	CHEMBL4026802	Inhibition of recombinant human ALK G1202R mutant (1093 to 1411 residues) expressed in baculovirus expression system using 5'FAM-KKSRGDYMTMQIG-CONH as substrate preincubated for 15 mins followed by addition of ATP measured after 1 hr by microfluidic mobility shift assay	B	COc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4087615	=	IC50	nM	8910.0	CHEMBL4247	Homo sapiens	IC50	uM	8.91
	18121168	CHEMBL4026802	Inhibition of recombinant human ALK G1202R mutant (1093 to 1411 residues) expressed in baculovirus expression system using 5'FAM-KKSRGDYMTMQIG-CONH as substrate preincubated for 15 mins followed by addition of ATP measured after 1 hr by microfluidic mobility shift assay	B	Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4091441	=	IC50	nM	9430.0	CHEMBL4247	Homo sapiens	IC50	uM	9.43
	18121170	CHEMBL4026783	Inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	c1ccc(Nc2ccnc3cc(-c4cn[nH]c4)ccc23)cc1		CHEMBL4066413	=	IC50	nM	10300.0	CHEMBL4247	Homo sapiens	IC50	uM	10.3
	18121177	CHEMBL4026796	Competitive inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by Michaelis-Menten plot analysis	B	Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4091441	=	Ki	nM	21.99	CHEMBL4247	Homo sapiens	Ki	nM	21.9872
	18121178	CHEMBL4026782	Inhibition of human wild type ALK using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	CCn1nccc1-c1ccc2c(Nc3ccccc3)ccnc2c1		CHEMBL4075012	=	IC50	nM	23200.0	CHEMBL4247	Homo sapiens	IC50	uM	23.2
	18121180	CHEMBL4026783	Inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	Fc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1F		CHEMBL4083663	=	IC50	nM	26.3	CHEMBL4247	Homo sapiens	IC50	nM	26.3
	18121181	CHEMBL4026782	Inhibition of human wild type ALK using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	Oc1ccc(Nc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4086648	=	IC50	nM	26.4	CHEMBL4247	Homo sapiens	IC50	nM	26.4
	18121182	CHEMBL4026783	Inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	CCn1nccc1-c1ccc2c(Nc3ccccc3)ccnc2c1		CHEMBL4075012	=	IC50	nM	28400.0	CHEMBL4247	Homo sapiens	IC50	uM	28.4
	18121183	CHEMBL4026783	Inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	COc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4087615	=	IC50	nM	28.4	CHEMBL4247	Homo sapiens	IC50	nM	28.4
	18121184	CHEMBL4026783	Inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	Fc1ccccc1Oc1ccnc2cc(-c3cnn(C4CCNCC4)c3)ccc12		CHEMBL4102556	=	IC50	nM	30.7	CHEMBL4247	Homo sapiens	IC50	nM	30.7
	18121185	CHEMBL4026795	Competitive inhibition of human ALK L1196M mutant assessed as substrate Km at 13.7 to 370 nM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by Michaelis-Menten plot analysis	B	Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4091441	=	Km	nM	32568.4	CHEMBL4247	Homo sapiens	Km	uM	32.5684
	18121186	CHEMBL4026782	Inhibition of human wild type ALK using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	COc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4087615	=	IC50	nM	33.6	CHEMBL4247	Homo sapiens	IC50	nM	33.6
	18121187	CHEMBL4026782	Inhibition of human wild type ALK using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	Fc1ccccc1Oc1ccnc2cc(-c3cnn(C4CCNCC4)c3)ccc12		CHEMBL4102556	=	IC50	nM	35.4	CHEMBL4247	Homo sapiens	IC50	nM	35.4
	18121188	CHEMBL4026783	Inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	Fc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4073257	=	IC50	nM	41.5	CHEMBL4247	Homo sapiens	IC50	nM	41.5
	18121192	CHEMBL4026782	Inhibition of human wild type ALK using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4091441	=	IC50	nM	50.2	CHEMBL4247	Homo sapiens	IC50	nM	50.2
	18121193	CHEMBL4026783	Inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	Oc1ccc(Nc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4086648	=	IC50	nM	50.9	CHEMBL4247	Homo sapiens	IC50	nM	50.9
	18121194	CHEMBL4026783	Inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	Fc1ccc(Nc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1F		CHEMBL4073990	=	IC50	nM	58.0	CHEMBL4247	Homo sapiens	IC50	nM	58.0
	18121195	CHEMBL4026788	Competitive inhibition of human ALK L1196M mutant assessed as substrate Km at 13.7 nM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by Michaelis-Menten plot analysis (Rvb = 30.94 microM)	B	Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4091441	=	Km	nM	58760.0	CHEMBL4247	Homo sapiens	Km(app)	uM	58.76
	18121196	CHEMBL4026783	Inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	Fc1cccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)c1		CHEMBL4064669	=	IC50	nM	58.8	CHEMBL4247	Homo sapiens	IC50	nM	58.8
	18121197	CHEMBL4026783	Inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	Brc1ccc2c(Nc3ccccc3)ccnc2c1		CHEMBL4073635	=	IC50	nM	59100.0	CHEMBL4247	Homo sapiens	IC50	uM	59.1
	18121198	CHEMBL4026783	Inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	Fc1ccccc1Nc1ccnc2cc(-c3cnn(C4CCNCC4)c3)ccc12		CHEMBL4084608	=	IC50	nM	62.0	CHEMBL4247	Homo sapiens	IC50	nM	62.0
	18121199	CHEMBL4026782	Inhibition of human wild type ALK using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	Brc1ccc2c(Nc3ccccc3)ccnc2c1		CHEMBL4073635	=	IC50	nM	65700.0	CHEMBL4247	Homo sapiens	IC50	uM	65.7
	18121203	CHEMBL4026783	Inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	N#Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4095317	=	IC50	nM	93.5	CHEMBL4247	Homo sapiens	IC50	nM	93.5
	18121205	CHEMBL4026789	Competitive inhibition of human ALK L1196M mutant assessed as substrate Km at 41.2 nM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by Michaelis-Menten plot analysis (Rvb = 30.94 microM)	B	Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4091441	=	Km	nM	94600.0	CHEMBL4247	Homo sapiens	Km(app)	uM	94.6
	18121207	CHEMBL4026783	Inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	c1ccc(Nc2ccnc3ccccc23)cc1	Outside typical range	CHEMBL1644358	=	IC50	nM	112000.0	CHEMBL4247	Homo sapiens	IC50	uM	112.0
	18121208	CHEMBL4026783	Inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	c1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4070113	=	IC50	nM	118.0	CHEMBL4247	Homo sapiens	IC50	nM	118.0
	18121209	CHEMBL4026782	Inhibition of human wild type ALK using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	c1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4070113	=	IC50	nM	126.0	CHEMBL4247	Homo sapiens	IC50	nM	126.0
	18121210	CHEMBL4026783	Inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	Cc1ccc(Nc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4076799	=	IC50	nM	129.0	CHEMBL4247	Homo sapiens	IC50	nM	129.0
	18121212	CHEMBL4026782	Inhibition of human wild type ALK using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	c1ccc(Nc2ccnc3ccccc23)cc1	Outside typical range	CHEMBL1644358	=	IC50	nM	147000.0	CHEMBL4247	Homo sapiens	IC50	uM	147.0
	18121213	CHEMBL4026782	Inhibition of human wild type ALK using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	Fc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1F		CHEMBL4083663	=	IC50	nM	148.0	CHEMBL4247	Homo sapiens	IC50	nM	148.0
	18121214	CHEMBL4026782	Inhibition of human wild type ALK using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	Fc1cccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)c1		CHEMBL4064669	=	IC50	nM	155.0	CHEMBL4247	Homo sapiens	IC50	nM	155.0
	18121217	CHEMBL4026782	Inhibition of human wild type ALK using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	Fc1ccc(Nc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1F		CHEMBL4073990	=	IC50	nM	181.0	CHEMBL4247	Homo sapiens	IC50	nM	181.0
	18121218	CHEMBL4026782	Inhibition of human wild type ALK using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	Cc1ccc(Nc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4076799	=	IC50	nM	201.0	CHEMBL4247	Homo sapiens	IC50	nM	201.0
	18121219	CHEMBL4026782	Inhibition of human wild type ALK using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	Fc1ccccc1Nc1ccnc2cc(-c3cnn(C4CCNCC4)c3)ccc12		CHEMBL4084608	=	IC50	nM	219.0	CHEMBL4247	Homo sapiens	IC50	nM	219.0
	18121220	CHEMBL4026782	Inhibition of human wild type ALK using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	N#Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4095317	=	IC50	nM	231.0	CHEMBL4247	Homo sapiens	IC50	nM	231.0
	18121221	CHEMBL4026783	Inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	c1ccc(Cc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4091078	=	IC50	nM	242.0	CHEMBL4247	Homo sapiens	IC50	nM	242.0
	18121222	CHEMBL4026782	Inhibition of human wild type ALK using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	Fc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4073257	=	IC50	nM	256.0	CHEMBL4247	Homo sapiens	IC50	nM	256.0
	18121223	CHEMBL4026782	Inhibition of human wild type ALK using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	c1ccc(Cc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4091078	=	IC50	nM	288.0	CHEMBL4247	Homo sapiens	IC50	nM	288.0
	18121224	CHEMBL4026790	Competitive inhibition of human ALK L1196M mutant assessed as substrate Km at 123 nM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by Michaelis-Menten plot analysis (Rvb = 30.94 microM)	B	Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4091441	=	Km	nM	298000.0	CHEMBL4247	Homo sapiens	Km(app)	uM	298.0
	18121225	CHEMBL4026782	Inhibition of human wild type ALK using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	Fc1cccc(Nc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)c1		CHEMBL4092349	=	IC50	nM	377.0	CHEMBL4247	Homo sapiens	IC50	nM	377.0
	18121228	CHEMBL4026783	Inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	Fc1cccc(Nc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)c1		CHEMBL4092349	=	IC50	nM	504.0	CHEMBL4247	Homo sapiens	IC50	nM	504.0
	18121229	CHEMBL4026783	Inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	COc1ccc(Nc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4105497	=	IC50	nM	547.0	CHEMBL4247	Homo sapiens	IC50	nM	547.0
	18121231	CHEMBL4026791	Competitive inhibition of human ALK L1196M mutant assessed as substrate Km at 370 nM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by Michaelis-Menten plot analysis (Rvb = 30.94 microM)	B	Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4091441	=	Km	nM	859800.0	CHEMBL4247	Homo sapiens	Km(app)	uM	859.8
	18121232	CHEMBL4026783	Inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	N#Cc1ccc(Nc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4067908	=	IC50	nM	926.0	CHEMBL4247	Homo sapiens	IC50	nM	926.0
	18121233	CHEMBL4026782	Inhibition of human wild type ALK using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	COc1ccc(Nc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4105497	=	IC50	nM	1064.0	CHEMBL4247	Homo sapiens	IC50	nM	1064.0
	18121234	CHEMBL4026783	Inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	Fc1ccc(Nc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4100102	=	IC50	nM	1075.0	CHEMBL4247	Homo sapiens	IC50	nM	1075.0
	18121235	CHEMBL4026782	Inhibition of human wild type ALK using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	Fc1ccc(Nc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4100102	=	IC50	nM	1483.0	CHEMBL4247	Homo sapiens	IC50	nM	1483.0
	18121236	CHEMBL4026782	Inhibition of human wild type ALK using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding assay	B	N#Cc1ccc(Nc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4067908	=	IC50	nM	1664.0	CHEMBL4247	Homo sapiens	IC50	nM	1664.0
Active	18121237	CHEMBL4026792	Competitive inhibition of human ALK L1196M mutant at 13.7 to 370 nM using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by Lineweaver-Burk plot analysis	B	Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4091441		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18121238	CHEMBL4026793	Competitive inhibition of human ALK L1196M mutant using YRRAAVPPSPSLSRHSSPHQ(pS)EDEEE as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition after 2 hrs by filter binding method	B	Cc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4091441		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-dependent effect	18121239	CHEMBL4026815	Inhibition of human wild type EML4 fused ALK expressed in mouse Ba/F3 cells assessed as decrease in cell proliferation preincubated for 72 hrs followed by methyl-3H-thymidine incorporation measured after 8 hrs by filter scintillation counter method	B	Oc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4065208		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-dependent effect	18121240	CHEMBL4026816	Inhibition of human EML4 fused ALK L1196M mutant expressed in mouse Ba/F3 cells assessed as decrease in cell proliferation preincubated for 72 hrs followed by methyl-3H-thymidine incorporation measured after 8 hrs by filter scintillation counter method	B	Oc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4065208		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18121247	CHEMBL4026818	Inhibition of ALK in human H2228 cells assessed as decrease in AKT phosphorylation at 0.5 uM after 3 hrs by Western blot method	B	Oc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4065208		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18121248	CHEMBL4026818	Inhibition of ALK in human H2228 cells assessed as decrease in AKT phosphorylation at 0.5 uM after 3 hrs by Western blot method	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Not Active	18121249	CHEMBL4026819	Inhibition of ALK in human H2228 cells assessed as effect on ERK phosphorylation at 0.5 uM after 3 hrs by Western blot method	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18121250	CHEMBL4026820	Inhibition of ALK in human H2228 cells assessed as decrease in AKT phosphorylation at 5 uM after 3 hrs by Western blot method	B	Oc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4065208		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18121251	CHEMBL4026821	Inhibition of ALK in human H2228 cells assessed as decrease in ERK phosphorylation at 0.5 uM after 3 hrs by Western blot method	B	Oc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4065208		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18121252	CHEMBL4026822	Inhibition of ALK in human H2228 cells assessed as decrease in ERK phosphorylation at 5 uM after 3 hrs by Western blot method	B	Oc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4065208		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18121253	CHEMBL4026823	Inhibition of ALK L1196M mutant in human H2228/CR cells assessed as decrease in AKT phosphorylation at 0.5 uM after 3 hrs by Western blot method	B	Oc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4065208		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18121254	CHEMBL4026824	Inhibition of ALK L1196M mutant in human H2228/CR cells assessed as decrease in AKT phosphorylation at 5 uM after 3 hrs by Western blot method	B	Oc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4065208		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18121255	CHEMBL4026825	Inhibition of ALK L1196M mutant in human H2228/CR cells assessed as decrease in ERK phosphorylation at 0.5 uM after 3 hrs by Western blot method	B	Oc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4065208		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18121256	CHEMBL4026826	Inhibition of ALK L1196M mutant in human H2228/CR cells assessed as decrease in ERK phosphorylation at 5 uM after 3 hrs by Western blot method	B	Oc1ccc(Oc2ccnc3cc(-c4cnn(C5CCNCC5)c4)ccc23)cc1		CHEMBL4065208		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18121257	CHEMBL4026836	Inhibition of human wild type EML4 fused ALK expressed in mouse Ba/F3 cells assessed as decrease in cell proliferation at 0.1 to 1 uM preincubated for 72 hrs followed by methyl-3H-thymidine incorporation measured after 8 hrs by filter scintillation counter method	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Not Active	18121258	CHEMBL4026837	Inhibition of human wild type EML4 fused ALK L1196M mutant expressed in mouse Ba/F3 cells assessed as decrease in cell proliferation at 0.1 to 1 uM preincubated for 72 hrs followed by methyl-3H-thymidine incorporation measured after 8 hrs by filter scintillation counter method	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	18203399	CHEMBL4043820	Inhibition of wild-type human partial length ALK (I1088 to E1409 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL4247	Homo sapiens	Activity	%	100.0
	18203400	CHEMBL4043821	Inhibition of wild-type human partial length ALK C1156Y mutant (I1088 to E1409 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	68.0	CHEMBL4247	Homo sapiens	Activity	%	68.0
	18203401	CHEMBL4043822	Inhibition of wild-type human partial length ALK L1196M mutant (I1088 to E1409 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	92.0	CHEMBL4247	Homo sapiens	Activity	%	92.0
	18212125	CHEMBL4046143	Inhibition of ALK (unknown origin) at 1 uM relative to control	B	Cc1c(-c2ccncc2)c[nH]c1C(N)=O		CHEMBL4100387	<	Inhibition	%	20.0	CHEMBL4247	Homo sapiens	INH	%	20.0
	18248573	CHEMBL4053856	Inhibition of ALK (unknown origin) at 1 uM relative to control	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn4c5c(cccc35)CCC4)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4104658	=	Inhibition	%	84.0	CHEMBL4247	Homo sapiens	INH	%	84.0
	18250469	CHEMBL4054286	Inhibition of ALK (unknown origin) using poly (Glu, Tyr) 4:1 as substrate at 100 uM after 1 hr by ELISA relative to control	B	CCCCCCCCCCCCCCC(=O)NC1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4081419	=	Inhibition	%	-1.7	CHEMBL4247	Homo sapiens	INH	%	-1.7
	18250470	CHEMBL4054287	Inhibition of ALK (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	10.5	CHEMBL4247	Homo sapiens	IC50	nM	10.5
	18253727	CHEMBL4055148	Inhibition of wild-type human partial length ALK (I1088 to E1409 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL4247	Homo sapiens	Activity	%	100.0
	18253728	CHEMBL4055148	Inhibition of wild-type human partial length ALK (I1088 to E1409 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	94.0	CHEMBL4247	Homo sapiens	Activity	%	94.0
	18265923	CHEMBL4057373	Inhibition of ALK (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	26.0	CHEMBL4247	Homo sapiens	INH	%	26.0
	18266128	CHEMBL4057578	Inhibition of ALK (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	0.3	CHEMBL4247	Homo sapiens	INH	%	0.3
	18267651	CHEMBL4057895	Inhibition of ALK (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 30 mins by HTRF assay	B	COc1cc2c(Oc3ccc(NC(=O)c4nc5ccccc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4082724	=	IC50	nM	2840.72	CHEMBL4247	Homo sapiens	IC50	nM	2840.72
	18267695	CHEMBL4057895	Inhibition of ALK (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 30 mins by HTRF assay	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	IC50	nM	3000.0	CHEMBL4247	Homo sapiens	IC50	nM	3000.0
	18273761	CHEMBL4059199	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition measure after 120 mins by filter binding method	B	CN1CCN(Cc2ccc(NC(=O)c3n[nH]cc3Nc3ncnc4sccc34)cc2)CC1		CHEMBL4075720	=	IC50	nM	94.1	CHEMBL4247	Homo sapiens	IC50	nM	94.1
	18282846	CHEMBL4120431	Inhibition of ALK (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	26.0	CHEMBL4247	Homo sapiens	INH	%	26.0
	18283066	CHEMBL4120651	Inhibition of ALK (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	6.7	CHEMBL4247	Homo sapiens	INH	%	6.7
	18283286	CHEMBL4120871	Inhibition of ALK (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	4.3	CHEMBL4247	Homo sapiens	INH	%	4.3
	18285544	CHEMBL4121235	Inhibition of ALK L1196M mutant (unknown origin)	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccccc21		CHEMBL4130209	=	Ki	nM	4.0	CHEMBL4247	Homo sapiens	Ki	nM	4.0
	18285545	CHEMBL4121235	Inhibition of ALK L1196M mutant (unknown origin)	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286830	=	Ki	nM	0.7	CHEMBL4247	Homo sapiens	Ki	nM	0.7
	18309614	CHEMBL4131870	Inhibition of human GST-tagged ALK at 3 uM preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by Hot-SpotSM kinase assay	B	CN1CCC(Nc2ccc(-c3n[nH]c4c3CN(S(=O)(=O)c3c(Cl)cccc3Cl)CC4)cc2)CC1		CHEMBL4168618	=	Inhibition	%	55.6	CHEMBL4247	Homo sapiens	INH	%	55.6
	18330837	CHEMBL4136266	Inhibition of recombinant ALK (unknown origin) at 1 uM by off-chip mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Inhibition	%	92.0	CHEMBL4247	Homo sapiens	INH	%	92.0
	18332181	CHEMBL4136448	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using peptide substrate after 1 hr by mobility shift assay	B	COc1cc(-c2nc(CN3CCC(C)CC3)cs2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4159161	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
	18332182	CHEMBL4136448	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using peptide substrate after 1 hr by mobility shift assay	B	COc1cc(-c2nc(CN3CCN(C)CC3)cs2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4167072	=	IC50	nM	2.3	CHEMBL4247	Homo sapiens	IC50	nM	2.3
	18332183	CHEMBL4136448	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using peptide substrate after 1 hr by mobility shift assay	B	CC(C)Oc1cc(-c2nc(CN3CCN(C)CC3)cs2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4163707	=	IC50	nM	3.4	CHEMBL4247	Homo sapiens	IC50	nM	3.4
	18332184	CHEMBL4136448	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using peptide substrate after 1 hr by mobility shift assay	B	CC(C)Oc1cc(-c2nc(CN3CCN(CCO)CC3)cs2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4160581	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
	18332185	CHEMBL4136448	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using peptide substrate after 1 hr by mobility shift assay	B	COc1cc(-n2cc(CN3CCC(C)CC3)nn2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4168473	=	IC50	nM	3.9	CHEMBL4247	Homo sapiens	IC50	nM	3.9
	18332186	CHEMBL4136448	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using peptide substrate after 1 hr by mobility shift assay	B	COc1cc(-n2cc(CN3CCN(C)CC3)nn2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4174347	=	IC50	nM	1.4	CHEMBL4247	Homo sapiens	IC50	nM	1.4
	18332187	CHEMBL4136448	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using peptide substrate after 1 hr by mobility shift assay	B	COc1cc(-n2cc(CN3C[C@H](C)N[C@H](C)C3)nn2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4166436	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
	18332188	CHEMBL4136448	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using peptide substrate after 1 hr by mobility shift assay	B	COc1cc(-n2cc(CN3CCNCC3)nn2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4166038	=	IC50	nM	4.3	CHEMBL4247	Homo sapiens	IC50	nM	4.3
	18332189	CHEMBL4136448	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using peptide substrate after 1 hr by mobility shift assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	32.2	CHEMBL4247	Homo sapiens	IC50	nM	32.2
	18332190	CHEMBL4136448	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using peptide substrate after 1 hr by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	2.9	CHEMBL4247	Homo sapiens	IC50	nM	2.9
	18332221	CHEMBL4136452	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) L1196M mutant expressed in baculovirus expression system using peptide substrate after 1 hr by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	35.0	CHEMBL4247	Homo sapiens	IC50	nM	35.0
	18332222	CHEMBL4136452	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) L1196M mutant expressed in baculovirus expression system using peptide substrate after 1 hr by mobility shift assay	B	COc1cc(-n2cc(CN3CCN(C)CC3)nn2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4174347	=	IC50	nM	3.1	CHEMBL4247	Homo sapiens	IC50	nM	3.1
	18332223	CHEMBL4136453	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) G1269A mutant expressed in baculovirus expression system using peptide substrate after 1 hr by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	3.4	CHEMBL4247	Homo sapiens	IC50	nM	3.4
	18332224	CHEMBL4136453	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) G1269A mutant expressed in baculovirus expression system using peptide substrate after 1 hr by mobility shift assay	B	COc1cc(-n2cc(CN3CCN(C)CC3)nn2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4174347	=	IC50	nM	2.8	CHEMBL4247	Homo sapiens	IC50	nM	2.8
	18332225	CHEMBL4136454	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) C1156Y mutant expressed in baculovirus expression system using peptide substrate after 1 hr by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	2.9	CHEMBL4247	Homo sapiens	IC50	nM	2.9
	18332226	CHEMBL4136454	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) C1156Y mutant expressed in baculovirus expression system using peptide substrate after 1 hr by mobility shift assay	B	COc1cc(-n2cc(CN3CCN(C)CC3)nn2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4174347	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
	18332227	CHEMBL4136455	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) T1151 insertion mutant expressed in baculovirus expression system using peptide substrate after 1 hr by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	2.5	CHEMBL4247	Homo sapiens	IC50	nM	2.5
	18332228	CHEMBL4136455	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) T1151 insertion mutant expressed in baculovirus expression system using peptide substrate after 1 hr by mobility shift assay	B	COc1cc(-n2cc(CN3CCN(C)CC3)nn2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4174347	=	IC50	nM	2.3	CHEMBL4247	Homo sapiens	IC50	nM	2.3
	18332229	CHEMBL4136456	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) G1202R mutant expressed in baculovirus expression system using peptide substrate after 1 hr by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1	Potential transcription error	CHEMBL2403108	=	IC50	nM	91.0	CHEMBL4247	Homo sapiens	IC50	nM	91.0
	18332230	CHEMBL4136456	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) G1202R mutant expressed in baculovirus expression system using peptide substrate after 1 hr by mobility shift assay	B	COc1cc(-n2cc(CN3CCN(C)CC3)nn2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4174347	=	IC50	nM	8.7	CHEMBL4247	Homo sapiens	IC50	nM	8.7
	18332231	CHEMBL4136457	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) S1206Y mutant expressed in baculovirus expression system using peptide substrate after 1 hr by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	4.6	CHEMBL4247	Homo sapiens	IC50	nM	4.6
	18332232	CHEMBL4136457	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) S1206Y mutant expressed in baculovirus expression system using peptide substrate after 1 hr by mobility shift assay	B	COc1cc(-n2cc(CN3CCN(C)CC3)nn2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4174347	=	IC50	nM	4.6	CHEMBL4247	Homo sapiens	IC50	nM	4.6
	18332233	CHEMBL4136458	Potency index, ratio of ceritinib IC50 to compound IC50 for recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) L1196M mutant expressed in baculovirus expression system	B	COc1cc(-n2cc(CN3CCN(C)CC3)nn2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4174347	=	Ratio IC50		11.0	CHEMBL4247	Homo sapiens	Ratio IC50		11.0
	18332234	CHEMBL4136459	Potency index, ratio of ceritinib IC50 to compound IC50 for recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) G1202R mutant expressed in baculovirus expression system	B	COc1cc(-n2cc(CN3CCN(C)CC3)nn2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4174347	=	Ratio IC50		10.0	CHEMBL4247	Homo sapiens	Ratio IC50		10.0
Dose-dependent effect	18332238	CHEMBL4136463	Inhibition of ALK phosphorylation in human KARPAS299 cells after 6 hrs by Western blot method	B	COc1cc(-n2cc(CN3CCN(C)CC3)nn2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4174347		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	18366622	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	CC(Oc1ccnc(Nc2cnn(C)c2)c1)c1cccc(C(=O)NCc2ccc(C#N)cc2)c1		CHEMBL4177227	=	IC50	nM	6700.0	CHEMBL4247	Homo sapiens	IC50	uM	6.7
	18366623	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	CC(Oc1ccnc(Nc2cnn(C)c2)c1)c1cccc(C(=O)NCc2cc(C(F)(F)F)cc(C(F)(F)F)c2)c1		CHEMBL4170808	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	18366624	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	CC(Oc1ccnc(Nc2cnn(C)c2)c1)c1cccc(C(=O)NCc2cc(F)cc(F)c2)c1		CHEMBL4160169	=	IC50	nM	4700.0	CHEMBL4247	Homo sapiens	IC50	uM	4.7
	18366625	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	CC(Oc1ccnc(Nc2cnn(C3CCN(C)CC3)c2)c1)c1cccc(C(=O)NCc2ccc(Cl)c(C(F)(F)F)c2)c1		CHEMBL4165486	=	IC50	nM	9200.0	CHEMBL4247	Homo sapiens	IC50	uM	9.2
	18366626	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	Cc1ccc(CNC(=O)c2cccc(C(C)Oc3ccnc(Nc4cnn(C5CCN(C)CC5)c4)c3)c2)cc1		CHEMBL4173409	=	IC50	nM	3100.0	CHEMBL4247	Homo sapiens	IC50	uM	3.1
	18366627	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	COc1cc(CNC(=O)c2cccc(C(C)Oc3ccnc(Nc4cnn(C)c4)c3)c2)cc(OC)c1OC		CHEMBL4168903	=	IC50	nM	2300.0	CHEMBL4247	Homo sapiens	IC50	uM	2.3
	18366628	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	COc1ccc(CNC(=O)c2cccc(C(C)Oc3ccnc(Nc4cnn(C)c4)c3)c2)cc1OC		CHEMBL4176767	=	IC50	nM	3600.0	CHEMBL4247	Homo sapiens	IC50	uM	3.6
	18366629	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	COc1cccc(CNC(=O)c2cccc(C(C)Oc3ccnc(Nc4cnn(C)c4)c3)c2)c1		CHEMBL4172265	=	IC50	nM	6100.0	CHEMBL4247	Homo sapiens	IC50	uM	6.1
	18366630	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	Cc1cnc(Nc2ncccc2OC(C)c2cccc(C(=O)NCc3ccc(F)c(Cl)c3)c2)s1		CHEMBL4161643	=	IC50	nM	8600.0	CHEMBL4247	Homo sapiens	IC50	uM	8.6
	18366631	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	Cc1ccc(CNC(=O)c2cccc(C(C)Oc3cccnc3Nc3nncs3)c2)cc1		CHEMBL4175678	=	IC50	nM	7600.0	CHEMBL4247	Homo sapiens	IC50	uM	7.6
	18366632	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	Cc1ccc(CNC(=O)c2cccc(C(C)Oc3cccnc3Nn3cnnc3)c2)cc1		CHEMBL4165058	=	IC50	nM	8700.0	CHEMBL4247	Homo sapiens	IC50	uM	8.7
	18366633	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	Cc1ccc(CNC(=O)c2cccc(C(C)Oc3cccnc3Nc3ncc(C)s3)c2)cc1		CHEMBL4169356	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	18366634	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	Cc1ccc(CNC(=O)c2cccc(C(C)Oc3cccnc3Nc3cnn(CC#N)c3)c2)cc1		CHEMBL4177198	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	18366635	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	Cc1ccc(CNC(=O)c2cccc(C(C)Oc3cccnc3Nc3nccs3)c2)cc1		CHEMBL4159094	=	IC50	nM	8000.0	CHEMBL4247	Homo sapiens	IC50	uM	8.0
	18366636	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	Cc1ccc(CNC(=O)c2cccc(C(C)Oc3cccnc3Nc3cnn(CC(C)(C)O)c3)c2)cc1		CHEMBL4166996	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	18366637	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	Cc1ccc(CNC(=O)c2cccc(C(C)Oc3cccnc3Nc3ncccn3)c2)cc1		CHEMBL4162485	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	18366638	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	CC(Oc1cccnc1Nc1cnn(C)c1)c1cccc(C(=O)NCc2ccccc2S(=O)(=O)C(C)C)c1		CHEMBL4170404	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	18366639	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	CC(Oc1cccnc1Nc1cnn(C)c1)c1cccc(C(=O)NCc2ccc(Cl)c(C(F)(F)F)c2)c1		CHEMBL4170816	=	IC50	nM	5900.0	CHEMBL4247	Homo sapiens	IC50	uM	5.9
	18366640	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	CC(Oc1cccnc1Nc1cnn(C)c1)c1cccc(C(=O)NCc2ccc(F)c(Cl)c2)c1		CHEMBL4160182	=	IC50	nM	9500.0	CHEMBL4247	Homo sapiens	IC50	uM	9.5
	18366641	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	CC(Oc1cccnc1Nc1cnn(C)c1)c1cccc(C(=O)NCc2ccc(OC(F)(F)F)cc2)c1		CHEMBL4174239	=	IC50	nM	8900.0	CHEMBL4247	Homo sapiens	IC50	uM	8.9
	18366642	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	COc1cccc(CNC(=O)c2cccc(C(C)Oc3cccnc3Nc3cnn(C)c3)c2)c1		CHEMBL4163543	=	IC50	nM	8600.0	CHEMBL4247	Homo sapiens	IC50	uM	8.6
	18366643	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	CC(Oc1cccnc1Nc1cnn(C)c1)c1cccc(C(=O)NCc2ccc(F)cc2)c1		CHEMBL4168623	=	IC50	nM	8100.0	CHEMBL4247	Homo sapiens	IC50	uM	8.1
	18366659	CHEMBL4142801	Inhibition of ALK (unknown origin) by radiometric assay	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	=	IC50	nM	12.0	CHEMBL4247	Homo sapiens	IC50	nM	12.0
Not Determined	18366780	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719		IC50			CHEMBL4247	Homo sapiens	IC50		
	18366781	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	COc1ccc(CNC(=O)c2cccc(C(C)Oc3ccnc(Nc4cnn(C5CCNCC5)c4)c3)c2)cc1OC		CHEMBL4166182	=	IC50	nM	4500.0	CHEMBL4247	Homo sapiens	IC50	uM	4.5
	18366782	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	COc1ccc(CNC(=O)c2cccc(C(C)Oc3ccnc(Nc4ncccn4)c3)c2)cc1OC		CHEMBL4174101	=	IC50	nM	2800.0	CHEMBL4247	Homo sapiens	IC50	uM	2.8
	18366783	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	COc1ccc(CNC(=O)c2cccc(C(C)Oc3ccnc(Nc4cnn(C5CCN(C)CC5)c4)c3)c2)cc1OC		CHEMBL4162738	=	IC50	nM	1800.0	CHEMBL4247	Homo sapiens	IC50	uM	1.8
	18366784	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	COc1cc(Nc2cc(OC(C)c3cccc(C(=O)NCc4ccc(C)cc4)c3)ccn2)cc(OC)c1OC		CHEMBL4170674	=	IC50	nM	8700.0	CHEMBL4247	Homo sapiens	IC50	uM	8.7
	18366785	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	Cc1ccc(CNC(=O)c2cccc(C(C)Oc3ccnc(NN4CCCCC4)c3)c2)cc1		CHEMBL4171478	=	IC50	nM	4700.0	CHEMBL4247	Homo sapiens	IC50	uM	4.7
	18366786	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	Cc1ccc(CNC(=O)c2cccc(C(C)Oc3ccnc(Nc4nc5ccccc5[nH]4)c3)c2)cc1		CHEMBL4163582	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	18366787	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	CC(Oc1ccnc(Nc2cnn(CC(C)(C)O)c2)c1)c1cccc(C(=O)NCc2ccc(Cl)c(C(F)(F)F)c2)c1		CHEMBL4176820	=	IC50	nM	9600.0	CHEMBL4247	Homo sapiens	IC50	uM	9.6
	18366788	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	Cc1ccc(CNC(=O)c2cccc(C(C)Oc3ccnc(Nc4cnn(CC(C)(C)O)c4)c3)c2)cc1		CHEMBL4168963	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	18366789	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	CC(Oc1ccnc(NN2CCN(C)CC2)c1)c1cccc(C(=O)NCc2ccc(Cl)c(C(F)(F)F)c2)c1		CHEMBL4173466	=	IC50	nM	9700.0	CHEMBL4247	Homo sapiens	IC50	uM	9.7
	18366790	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	Cc1ccc(CNC(=O)c2cccc(C(C)Oc3ccnc(NN4CCN(C)CC4)c3)c2)cc1		CHEMBL4165540	=	IC50	nM	7000.0	CHEMBL4247	Homo sapiens	IC50	uM	7.0
	18366791	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	Cc1ccc(CNC(=O)c2cccc(C(C)Oc3ccnc(NN4CCOCC4)c3)c2)cc1		CHEMBL4170026	=	IC50	nM	6800.0	CHEMBL4247	Homo sapiens	IC50	uM	6.8
	18366792	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	Cc1ccc(CNC(=O)c2cccc(C(C)Oc3ccnc(Nc4cn(C)nc4C)c3)c2)cc1		CHEMBL4162098	=	IC50	nM	3500.0	CHEMBL4247	Homo sapiens	IC50	uM	3.5
	18366793	CHEMBL4142784	Inhibition of recombinant human GST-tagged ALK expressed in baculovirus expression system by Z'LYTE assay	B	Cc1ccc(CNC(=O)c2cccc(C(C)Oc3ccnc(Nc4cnn(C)c4)c3)c2)cc1		CHEMBL4166604	=	IC50	nM	6700.0	CHEMBL4247	Homo sapiens	IC50	uM	6.7
	18379691	CHEMBL4145708	Inhibition of recombinant human N-terminal GST/His6-fused ALK C1156Y mutant expressed in Sf9 insect cells using Tyr 1 peptide as substrate after 1 hr by Z-LYTE assay	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N1CCCN(C)CC1		CHEMBL4159909	=	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	nM	1.0
	18379692	CHEMBL4145707	Inhibition of recombinant human N-terminal GST/His6-fused ALK F1174L mutant expressed in Sf9 insect cells using Tyr 1 peptide as substrate after 1 hr by Z-LYTE assay	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N1CCCN(C)CC1		CHEMBL4159909	=	IC50	nM	0.92	CHEMBL4247	Homo sapiens	IC50	nM	0.92
	18379693	CHEMBL4145706	Inhibition of recombinant human N-terminal GST/His6-fused ALK L1196M mutant expressed in Sf9 insect cells using Tyr 1 peptide as substrate after 1 hr by Z-LYTE assay	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N1CCCN(C)CC1		CHEMBL4159909	=	IC50	nM	0.59	CHEMBL4247	Homo sapiens	IC50	nM	0.59
	18379694	CHEMBL4145705	Inhibition of recombinant human N-terminal GST/His6-fused ALK R1275Q mutant expressed in Sf9 insect cells using Tyr 1 peptide as substrate after 1 hr by Z-LYTE assay	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N1CCCN(C)CC1		CHEMBL4159909	=	IC50	nM	0.82	CHEMBL4247	Homo sapiens	IC50	nM	0.82
	18379695	CHEMBL4145704	Inhibition of recombinant human wild-type GST-tagged ALK expressed in Baculovirus expression system using Tyr 1 peptide as substrate after 1 hr by Z-LYTE assay	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N1CCCN(C)CC1		CHEMBL4159909	=	IC50	nM	9.8	CHEMBL4247	Homo sapiens	IC50	nM	9.8
	18379786	CHEMBL4145715	Inhibition of NPM-fused ALK (unknown origin) expressed in mouse BAF3 cells assessed as decrease in cell proliferation after 72 hrs by CellTiter-Glo assay	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N1CCCN(C)CC1		CHEMBL4159909	=	GI50	nM	1.0	CHEMBL4247	Homo sapiens	GI50	uM	0.001
	18379787	CHEMBL4145715	Inhibition of NPM-fused ALK (unknown origin) expressed in mouse BAF3 cells assessed as decrease in cell proliferation after 72 hrs by CellTiter-Glo assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl	Outside typical range	CHEMBL601719	<	GI50	nM	0.3	CHEMBL4247	Homo sapiens	GI50	uM	0.0003
	18379788	CHEMBL4145720	Inhibition of EML4-fused ALK (unknown origin) expressed in mouse BAF3 cells assessed as decrease in cell proliferation after 72 hrs by CellTiter-Glo assay	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N1CCCN(C)CC1	Outside typical range	CHEMBL4159909	<	GI50	nM	0.3	CHEMBL4247	Homo sapiens	GI50	uM	0.0003
	18379789	CHEMBL4145720	Inhibition of EML4-fused ALK (unknown origin) expressed in mouse BAF3 cells assessed as decrease in cell proliferation after 72 hrs by CellTiter-Glo assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl	Outside typical range	CHEMBL601719	<	GI50	nM	0.3	CHEMBL4247	Homo sapiens	GI50	uM	0.0003
	18379790	CHEMBL4145721	Inhibition of TEL-fused ALK (unknown origin) expressed in mouse BAF3 cells assessed as decrease in cell proliferation after 72 hrs by CellTiter-Glo assay	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N1CCCN(C)CC1	Outside typical range	CHEMBL4159909	<	GI50	nM	0.3	CHEMBL4247	Homo sapiens	GI50	uM	0.0003
	18379791	CHEMBL4145721	Inhibition of TEL-fused ALK (unknown origin) expressed in mouse BAF3 cells assessed as decrease in cell proliferation after 72 hrs by CellTiter-Glo assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl	Outside typical range	CHEMBL601719	<	GI50	nM	0.3	CHEMBL4247	Homo sapiens	GI50	uM	0.0003
	18379792	CHEMBL4145722	Inhibition of full length ALK F1174L mutant (unknown origin) expressed in mouse BAF3 cells assessed as decrease in cell proliferation after 72 hrs by CellTiter-Glo assay	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N1CCCN(C)CC1		CHEMBL4159909	=	GI50	nM	29.0	CHEMBL4247	Homo sapiens	GI50	uM	0.029
	18379793	CHEMBL4145722	Inhibition of full length ALK F1174L mutant (unknown origin) expressed in mouse BAF3 cells assessed as decrease in cell proliferation after 72 hrs by CellTiter-Glo assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	GI50	nM	320.0	CHEMBL4247	Homo sapiens	GI50	uM	0.32
	18379794	CHEMBL4145723	Inhibition of TEL-fused ALK C1156Y mutant (unknown origin) expressed in mouse BAF3 cells assessed as decrease in cell proliferation after 72 hrs by CellTiter-Glo assay	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N1CCCN(C)CC1		CHEMBL4159909	=	GI50	nM	6.9	CHEMBL4247	Homo sapiens	GI50	uM	0.0069
	18379795	CHEMBL4145723	Inhibition of TEL-fused ALK C1156Y mutant (unknown origin) expressed in mouse BAF3 cells assessed as decrease in cell proliferation after 72 hrs by CellTiter-Glo assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	GI50	nM	150.0	CHEMBL4247	Homo sapiens	GI50	uM	0.15
	18379796	CHEMBL4145724	Inhibition of TEL-fused ALK L1196M mutant (unknown origin) expressed in mouse BAF3 cells assessed as decrease in cell proliferation after 72 hrs by CellTiter-Glo assay	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N1CCCN(C)CC1	Outside typical range	CHEMBL4159909	<	GI50	nM	0.3	CHEMBL4247	Homo sapiens	GI50	uM	0.0003
	18379797	CHEMBL4145724	Inhibition of TEL-fused ALK L1196M mutant (unknown origin) expressed in mouse BAF3 cells assessed as decrease in cell proliferation after 72 hrs by CellTiter-Glo assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	GI50	nM	590.0	CHEMBL4247	Homo sapiens	GI50	uM	0.59
	18379798	CHEMBL4145725	Inhibition of TEL-fused ALK G1202R mutant (unknown origin) expressed in mouse BAF3 cells assessed as decrease in cell proliferation after 72 hrs by CellTiter-Glo assay	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N1CCCN(C)CC1		CHEMBL4159909	=	GI50	nM	460.0	CHEMBL4247	Homo sapiens	GI50	uM	0.46
	18379799	CHEMBL4145725	Inhibition of TEL-fused ALK G1202R mutant (unknown origin) expressed in mouse BAF3 cells assessed as decrease in cell proliferation after 72 hrs by CellTiter-Glo assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	GI50	nM	430.0	CHEMBL4247	Homo sapiens	GI50	uM	0.43
Active	18379860	CHEMBL4145762	Inhibition of ALK phosphorylation at Tyr1604 residue in human NCI-H3122 cells harboring EML4-fused ALK at 100 nM after 2 hrs by immunoblot method	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N1CCCN(C)CC1		CHEMBL4159909		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18379861	CHEMBL4145763	Inhibition of ALK in human NCI-H3122 cells harboring EML4-fused ALK assessed as reduction in ALK-induced AKT phosphorylation at Ser473 residue up to 3 uM after 2 hrs by immunoblot method	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N1CCCN(C)CC1		CHEMBL4159909		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18379862	CHEMBL4145764	Inhibition of ALK in human NCI-H3122 cells harboring EML4-fused ALK assessed as reduction in ALK-induced ERK phosphorylation at Thr202/Tyr204 residues up to 3 uM after 2 hrs by immunoblot method	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N1CCCN(C)CC1		CHEMBL4159909		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18379895	CHEMBL4145795	Reversible inhibition of ALK phosphorylation at Tyr1604 residue in human NCI-H3122 cells at 30 to 300 nM measured 1 to 24 hrs post compound wash out by immunoblotting method	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N1CCCN(C)CC1		CHEMBL4159909		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	18382395	CHEMBL4146207	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	COc1ccc(NC(=O)CNC(=O)c2cc(C(C)C)c(O)cc2O)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4168868	=	IC50	nM	1.7	CHEMBL4247	Homo sapiens	IC50	nM	1.7
	18382396	CHEMBL4146210	Inhibition of recombinant ALK G1202R mutant (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	CC(C)c1cc(C(=O)NCC(=O)Nc2ccc(F)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)c2)c(O)cc1O		CHEMBL4177038	=	IC50	nM	15.5	CHEMBL4247	Homo sapiens	IC50	nM	15.5
	18382397	CHEMBL4146209	Inhibition of recombinant ALK L1196M mutant (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	CC(C)c1cc(C(=O)NCC(=O)Nc2ccc(F)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)c2)c(O)cc1O		CHEMBL4177038	=	IC50	nM	14.0	CHEMBL4247	Homo sapiens	IC50	nM	14.0
	18382399	CHEMBL4146207	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	CC(C)c1cc(C(=O)NCC(=O)Nc2ccc(F)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)c2)c(O)cc1O		CHEMBL4177038	=	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	nM	1.0
	18382401	CHEMBL4146207	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	CC(C)Oc1ccc(NC(=O)CNC(=O)c2cc(C(C)C)c(O)cc2O)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4170213	=	IC50	nM	3.3	CHEMBL4247	Homo sapiens	IC50	nM	3.3
	18382403	CHEMBL4146207	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	CC(C)c1cc(C(=O)NCC(=O)Nc2cccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)c2)c(O)cc1O		CHEMBL4162295	=	IC50	nM	0.8	CHEMBL4247	Homo sapiens	IC50	nM	0.8
	18382405	CHEMBL4146207	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CN)c2)ncc1Cl		CHEMBL3357439	=	IC50	nM	2.7	CHEMBL4247	Homo sapiens	IC50	nM	2.7
Active	18382415	CHEMBL4146238	Inhibition of ALK in human NCI-H3122 cells assessed as reduction in ERK phosphorylation at T202//Y204 residues at 20 to 80 nM after 1 hr by Western blot analysis	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286830		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18382416	CHEMBL4146237	Inhibition of ALK in human NCI-H3122 cells assessed as reduction in Akt phosphorylation at S473 residue at 20 to 80 nM after 1 hr by Western blot analysis	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286830		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18382417	CHEMBL4146236	Inhibition of ALK in human NCI-H3122 cells assessed as reduction in STAT3 phosphorylation at Y705 residue at 20 to 80 nM after 1 hr by Western blot analysis	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286830		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18382418	CHEMBL4146235	Inhibition of ALK phosphorylation at Y1278 residue in human NCI-H3122 cells at 20 to 80 nM after 1 hr by Western blot analysis	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286830		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18382419	CHEMBL4146234	Inhibition of ALK in human SU-DHL1 cells assessed as reduction in ERK phosphorylation at T202//Y204 residues at 20 to 80 nM after 1 hr by Western blot analysis	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286830		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18382420	CHEMBL4146233	Inhibition of ALK in human SU-DHL1 cells assessed as reduction in Akt phosphorylation at S473 residue at 20 to 80 nM after 1 hr by Western blot analysis	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286830		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18382421	CHEMBL4146232	Inhibition of ALK in human SU-DHL1 cells assessed as reduction in STAT3 phosphorylation at Y705 residue at 20 to 80 nM after 1 hr by Western blot analysis	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286830		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18382422	CHEMBL4146231	Inhibition of ALK phosphorylation at Y1278 residue in human SU-DHL1 cells at 20 to 80 nM after 1 hr by Western blot analysis	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286830		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18382433	CHEMBL4146230	Inhibition of ALK in human NCI-H3122 cells assessed as reduction in ERK phosphorylation at T202//Y204 residues at 20 to 200 nM after 1 hr by Western blot analysis	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18382434	CHEMBL4146229	Inhibition of ALK in human NCI-H3122 cells assessed as reduction in Akt phosphorylation at S473 residue at 20 to 200 nM after 1 hr by Western blot analysis	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18382435	CHEMBL4146228	Inhibition of ALK in human NCI-H3122 cells assessed as reduction in STAT3 phosphorylation at Y705 residue at 20 to 200 nM after 1 hr by Western blot analysis	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18382436	CHEMBL4146227	Inhibition of ALK phosphorylation at Y1278 residue in human NCI-H3122 cells at 20 to 200 nM after 1 hr by Western blot analysis	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18382437	CHEMBL4146226	Inhibition of ALK in human SU-DHL1 cells assessed as reduction in ERK phosphorylation at T202//Y204 residues at 20 to 200 nM after 1 hr by Western blot analysis	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18382438	CHEMBL4146225	Inhibition of ALK in human SU-DHL1 cells assessed as reduction in Akt phosphorylation at S473 residue at 20 to 200 nM after 1 hr by Western blot analysis	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18382439	CHEMBL4146224	Inhibition of ALK in human SU-DHL1 cells assessed as reduction in STAT3 phosphorylation at Y705 residue at 20 to 200 nM after 1 hr by Western blot analysis	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18382440	CHEMBL4146223	Inhibition of ALK phosphorylation at Y1278 residue in human SU-DHL1 cells at 20 to 200 nM after 1 hr by Western blot analysis	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	18382442	CHEMBL4146207	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	3.4	CHEMBL4247	Homo sapiens	IC50	nM	3.4
	18382452	CHEMBL4146214	Inhibition of recombinant ALK L1152R mutant (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	148.0	CHEMBL4247	Homo sapiens	IC50	nM	148.0
	18382453	CHEMBL4146213	Inhibition of recombinant ALK R1275Q mutant (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	71.6	CHEMBL4247	Homo sapiens	IC50	nM	71.6
	18382454	CHEMBL4146212	Inhibition of recombinant ALK S1206Y mutant (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	353.0	CHEMBL4247	Homo sapiens	IC50	nM	353.0
	18382455	CHEMBL4146211	Inhibition of recombinant ALK T1151M mutant (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	77.8	CHEMBL4247	Homo sapiens	IC50	nM	77.8
	18382456	CHEMBL4146210	Inhibition of recombinant ALK G1202R mutant (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	IC50	nM	9000.0	CHEMBL4247	Homo sapiens	IC50	nM	9000.0
	18382457	CHEMBL4146209	Inhibition of recombinant ALK L1196M mutant (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	355.0	CHEMBL4247	Homo sapiens	IC50	nM	355.0
	18382460	CHEMBL4146209	Inhibition of recombinant ALK L1196M mutant (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	COc1ccc(NC(=O)CNC(=O)c2cc(C(C)C)c(O)cc2O)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4168868	=	IC50	nM	3.5	CHEMBL4247	Homo sapiens	IC50	nM	3.5
	18382461	CHEMBL4146210	Inhibition of recombinant ALK G1202R mutant (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	COc1ccc(NC(=O)CNC(=O)c2cc(C(C)C)c(O)cc2O)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4168868	=	IC50	nM	1.8	CHEMBL4247	Homo sapiens	IC50	nM	1.8
	18382462	CHEMBL4146211	Inhibition of recombinant ALK T1151M mutant (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	COc1ccc(NC(=O)CNC(=O)c2cc(C(C)C)c(O)cc2O)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4168868	=	IC50	nM	2.2	CHEMBL4247	Homo sapiens	IC50	nM	2.2
	18382463	CHEMBL4146212	Inhibition of recombinant ALK S1206Y mutant (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	COc1ccc(NC(=O)CNC(=O)c2cc(C(C)C)c(O)cc2O)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4168868	=	IC50	nM	5.1	CHEMBL4247	Homo sapiens	IC50	nM	5.1
	18382464	CHEMBL4146213	Inhibition of recombinant ALK R1275Q mutant (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	COc1ccc(NC(=O)CNC(=O)c2cc(C(C)C)c(O)cc2O)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4168868	=	IC50	nM	2.7	CHEMBL4247	Homo sapiens	IC50	nM	2.7
	18382465	CHEMBL4146214	Inhibition of recombinant ALK L1152R mutant (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	COc1ccc(NC(=O)CNC(=O)c2cc(C(C)C)c(O)cc2O)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4168868	=	IC50	nM	10.6	CHEMBL4247	Homo sapiens	IC50	nM	10.6
Dose-dependent effect	18382466	CHEMBL4146215	Inhibition of ALK phosphorylation at Y1278 residue in human NCI-H3122 cells after 1 hr by Western blot analysis	B	COc1ccc(NC(=O)CNC(=O)c2cc(C(C)C)c(O)cc2O)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4168868		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-dependent effect	18382467	CHEMBL4146216	Inhibition of ALK in human NCI-H3122 cells assessed as reduction in STAT3 phosphorylation at Y705 residue after 1 hr by Western blot analysis	B	COc1ccc(NC(=O)CNC(=O)c2cc(C(C)C)c(O)cc2O)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4168868		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-dependent effect	18382468	CHEMBL4146217	Inhibition of ALK in human NCI-H3122 cells assessed as reduction in Akt phosphorylation at S473 residue after 1 hr by Western blot analysis	B	COc1ccc(NC(=O)CNC(=O)c2cc(C(C)C)c(O)cc2O)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4168868		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-dependent effect	18382469	CHEMBL4146218	Inhibition of ALK in human NCI-H3122 cells assessed as reduction in ERK phosphorylation at T202//Y204 residues after 1 hr by Western blot analysis	B	COc1ccc(NC(=O)CNC(=O)c2cc(C(C)C)c(O)cc2O)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4168868		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-dependent effect	18382470	CHEMBL4146219	Inhibition of ALK phosphorylation at Y1278 residue in human SU-DHL1 cells after 1 hr by Western blot analysis	B	COc1ccc(NC(=O)CNC(=O)c2cc(C(C)C)c(O)cc2O)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4168868		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-dependent effect	18382471	CHEMBL4146220	Inhibition of ALK in human SU-DHL1 cells assessed as reduction in STAT3 phosphorylation at Y705 residue after 1 hr by Western blot analysis	B	COc1ccc(NC(=O)CNC(=O)c2cc(C(C)C)c(O)cc2O)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4168868		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-dependent effect	18382472	CHEMBL4146221	Inhibition of ALK in human SU-DHL1 cells assessed as reduction in Akt phosphorylation at S473 residue after 1 hr by Western blot analysis	B	COc1ccc(NC(=O)CNC(=O)c2cc(C(C)C)c(O)cc2O)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4168868		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-dependent effect	18382473	CHEMBL4146222	Inhibition of ALK in human SU-DHL1 cells assessed as reduction in ERK phosphorylation at T202//Y204 residues after 1 hr by Western blot analysis	B	COc1ccc(NC(=O)CNC(=O)c2cc(C(C)C)c(O)cc2O)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4168868		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	18382485	CHEMBL4146207	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	COc1ccc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)cc1NC(=O)CNC(=O)c1cc(C(C)C)c(O)cc1O		CHEMBL4162252	=	IC50	nM	2.6	CHEMBL4247	Homo sapiens	IC50	nM	2.6
	18382487	CHEMBL4146207	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	COc1ccc(NC(=O)C(C)NC(=O)c2cc(C(C)C)c(O)cc2O)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4172925	=	IC50	nM	0.7	CHEMBL4247	Homo sapiens	IC50	nM	0.7
	18382489	CHEMBL4146207	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	COc1ccc(NC(=O)C(NC(=O)c2cc(C(C)C)c(O)cc2O)C(C)C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4177392	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	18382491	CHEMBL4146207	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	COc1ccc(NC(=O)C2(NC(=O)c3cc(C(C)C)c(O)cc3O)CC2)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4169529	=	IC50	nM	130.0	CHEMBL4247	Homo sapiens	IC50	nM	130.0
	18382493	CHEMBL4146207	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	COc1ccc(NC(=O)C(Cc2ccccc2)NC(=O)c2cc(C(C)C)c(O)cc2O)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4174031	=	IC50	nM	7.8	CHEMBL4247	Homo sapiens	IC50	nM	7.8
	18382495	CHEMBL4146209	Inhibition of recombinant ALK L1196M mutant (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	COc1ccc(NC(=O)C(Cc2ccccc2)NC(=O)c2cc(C(C)C)c(O)cc2O)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4174031	=	IC50	nM	81.0	CHEMBL4247	Homo sapiens	IC50	nM	81.0
	18382496	CHEMBL4146210	Inhibition of recombinant ALK G1202R mutant (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	COc1ccc(NC(=O)C(Cc2ccccc2)NC(=O)c2cc(C(C)C)c(O)cc2O)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4174031	=	IC50	nM	65.0	CHEMBL4247	Homo sapiens	IC50	nM	65.0
	18382497	CHEMBL4146207	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	COc1cc(OC)c(C(C)C)cc1C(=O)NCC(=O)Nc1cccc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c1		CHEMBL4166111	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	18382499	CHEMBL4146207	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	COc1ccc(NC(=O)CNC(=O)c2cc(C(C)C)c(OC)cc2O)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4170592	=	IC50	nM	10.5	CHEMBL4247	Homo sapiens	IC50	nM	10.5
	18382501	CHEMBL4146207	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	COc1ccc(NC(=O)CNC(=O)c2cc(C(C)C)c(O)cc2OC)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4162661	=	IC50	nM	48.0	CHEMBL4247	Homo sapiens	IC50	nM	48.0
	18382503	CHEMBL4146207	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	COc1ccc(NC(=O)CNC(=O)c2ccc(O)c(C(C)C)c2)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4175908	=	IC50	nM	1.4	CHEMBL4247	Homo sapiens	IC50	nM	1.4
	18382505	CHEMBL4146210	Inhibition of recombinant ALK G1202R mutant (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	COc1ccc(NC(=O)CNC(=O)c2ccc(O)c(C(C)C)c2)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4175908	=	IC50	nM	6.1	CHEMBL4247	Homo sapiens	IC50	nM	6.1
	18382506	CHEMBL4146207	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	COc1ccc(NC(=O)CNC(=O)c2cc(C(C)C)ccc2O)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4168049	=	IC50	nM	0.7	CHEMBL4247	Homo sapiens	IC50	nM	0.7
	18382508	CHEMBL4146210	Inhibition of recombinant ALK G1202R mutant (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	COc1ccc(NC(=O)CNC(=O)c2cc(C(C)C)ccc2O)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4168049	=	IC50	nM	15.3	CHEMBL4247	Homo sapiens	IC50	nM	15.3
	18382509	CHEMBL4146207	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	COc1ccc(NC(=O)CNC(=O)c2cc(C(C)C)c(O)cc2O)cc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4168701	=	IC50	nM	1.3	CHEMBL4247	Homo sapiens	IC50	nM	1.3
	18382511	CHEMBL4146207	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	CC(C)Oc1ccc(NC(=O)CNC(=O)c2cc(C(C)C)c(O)cc2O)cc1Nc1nccc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4176561	=	IC50	nM	4.2	CHEMBL4247	Homo sapiens	IC50	nM	4.2
	18382513	CHEMBL4146207	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	COc1ccc(NC(=O)CNC(=O)c2cc(C(C)C)c(O)cc2O)cc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL4172048	=	IC50	nM	1.5	CHEMBL4247	Homo sapiens	IC50	nM	1.5
	18382515	CHEMBL4146209	Inhibition of recombinant ALK L1196M mutant (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	COc1ccc(NC(=O)CNC(=O)c2cc(C(C)C)c(O)cc2O)cc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL4172048	=	IC50	nM	5.0	CHEMBL4247	Homo sapiens	IC50	nM	5.0
	18382516	CHEMBL4146210	Inhibition of recombinant ALK G1202R mutant (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	COc1ccc(NC(=O)CNC(=O)c2cc(C(C)C)c(O)cc2O)cc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL4172048	=	IC50	nM	7.8	CHEMBL4247	Homo sapiens	IC50	nM	7.8
	18382517	CHEMBL4146207	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 60 mins by ELISA	B	CC(C)c1cc(C(=O)NCC(=O)Nc2cccc(Nc3ncc(Cl)c(Nc4cc(S(=O)(=O)C(C)C)nn4C)n3)c2)c(O)cc1O		CHEMBL4161453	=	IC50	nM	262.0	CHEMBL4247	Homo sapiens	IC50	nM	262.0
	18415014	CHEMBL4152830	Binding affinity to wild-type human partial length ALK (I1088 to E1409 residues) expressed in mammalian expression system by KINOMEscan assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CC(=O)NCCOCCOCCOCCOCCOCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4165519	=	Kd	nM	37.0	CHEMBL4247	Homo sapiens	Kd	nM	37.0
	18415015	CHEMBL4152830	Binding affinity to wild-type human partial length ALK (I1088 to E1409 residues) expressed in mammalian expression system by KINOMEscan assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CC(=O)NCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4161454	=	Kd	nM	19.0	CHEMBL4247	Homo sapiens	Kd	nM	19.0
	18415016	CHEMBL4152830	Binding affinity to wild-type human partial length ALK (I1088 to E1409 residues) expressed in mammalian expression system by KINOMEscan assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CC(=O)NCCOCCOCCOCCOCCOCCNc2cccc3c2C(=O)N(C2CCC(=O)N(C)C2=O)C3=O)CC1		CHEMBL4159122	=	Kd	nM	54.0	CHEMBL4247	Homo sapiens	Kd	nM	54.0
	18415017	CHEMBL4152830	Binding affinity to wild-type human partial length ALK (I1088 to E1409 residues) expressed in mammalian expression system by KINOMEscan assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CC(=O)NCCNc2cccc3c2C(=O)N(C2CCC(=O)N(C)C2=O)C3=O)CC1		CHEMBL4169769	=	Kd	nM	78.0	CHEMBL4247	Homo sapiens	Kd	nM	78.0
	18415018	CHEMBL4152830	Binding affinity to wild-type human partial length ALK (I1088 to E1409 residues) expressed in mammalian expression system by KINOMEscan assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Kd	nM	1.3	CHEMBL4247	Homo sapiens	Kd	nM	1.3
Dose-dependent effect	18415019	CHEMBL4152831	Inhibition of ALK autophosphorylation at Y1507 residue in human SU-DHL1 cells after 16 hrs by Western blot analysis	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CC(=O)NCCOCCOCCOCCOCCOCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4165519		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-dependent effect	18415020	CHEMBL4152831	Inhibition of ALK autophosphorylation at Y1507 residue in human SU-DHL1 cells after 16 hrs by Western blot analysis	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CC(=O)NCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4161454		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-dependent effect	18415021	CHEMBL4152832	Inhibition of ALK autophosphorylation at Y1507 residue in human NCI-H2228 cells after 16 hrs by Western blot analysis	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CC(=O)NCCOCCOCCOCCOCCOCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4165519		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-dependent effect	18415022	CHEMBL4152832	Inhibition of ALK autophosphorylation at Y1507 residue in human NCI-H2228 cells after 16 hrs by Western blot analysis	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CC(=O)NCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4161454		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	18415031	CHEMBL4152837	Inhibition of ALK autophosphorylation at Y1507 residue in human SU-DHL1 cells at 100 nM after 16 hrs by Western blot analysis	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CC(=O)NCCOCCOCCOCCOCCOCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4165519	>	Inhibition	%	90.0	CHEMBL4247	Homo sapiens	INH	%	90.0
	18415032	CHEMBL4152837	Inhibition of ALK autophosphorylation at Y1507 residue in human SU-DHL1 cells at 100 nM after 16 hrs by Western blot analysis	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CC(=O)NCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4161454	>	Inhibition	%	90.0	CHEMBL4247	Homo sapiens	INH	%	90.0
	18415033	CHEMBL4152838	Inhibition of ALK in human SU-DHL1 cells assessed as reduction in STAT3 phosphorylation at Y705 residue at 100 nM after 16 hrs by Western blot analysis	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CC(=O)NCCOCCOCCOCCOCCOCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4165519	>	Inhibition	%	90.0	CHEMBL4247	Homo sapiens	INH	%	90.0
	18415034	CHEMBL4152838	Inhibition of ALK in human SU-DHL1 cells assessed as reduction in STAT3 phosphorylation at Y705 residue at 100 nM after 16 hrs by Western blot analysis	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CC(=O)NCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4161454	>	Inhibition	%	90.0	CHEMBL4247	Homo sapiens	INH	%	90.0
Not Active	18415040	CHEMBL4152841	Inhibition of ALK autophosphorylation at Y1507 residue in human SU-DHL1 cells at 30 nM after 16 hrs by Western blot analysis	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CC(=O)NCCOCCOCCOCCOCCOCCNc2cccc3c2C(=O)N(C2CCC(=O)N(C)C2=O)C3=O)CC1		CHEMBL4159122		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Not Active	18415041	CHEMBL4152841	Inhibition of ALK autophosphorylation at Y1507 residue in human SU-DHL1 cells at 30 nM after 16 hrs by Western blot analysis	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CC(=O)NCCNc2cccc3c2C(=O)N(C2CCC(=O)N(C)C2=O)C3=O)CC1		CHEMBL4169769		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18415042	CHEMBL4152841	Inhibition of ALK autophosphorylation at Y1507 residue in human SU-DHL1 cells at 30 nM after 16 hrs by Western blot analysis	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Not Active	18415043	CHEMBL4152842	Inhibition of ALK in human SU-DHL1 cells assessed as reduction in STAT3 phosphorylation at Y705 residue at 30 nM after 16 hrs by Western blot analysis	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CC(=O)NCCOCCOCCOCCOCCOCCNc2cccc3c2C(=O)N(C2CCC(=O)N(C)C2=O)C3=O)CC1		CHEMBL4159122		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Not Active	18415044	CHEMBL4152842	Inhibition of ALK in human SU-DHL1 cells assessed as reduction in STAT3 phosphorylation at Y705 residue at 30 nM after 16 hrs by Western blot analysis	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CC(=O)NCCNc2cccc3c2C(=O)N(C2CCC(=O)N(C)C2=O)C3=O)CC1		CHEMBL4169769		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18415045	CHEMBL4152842	Inhibition of ALK in human SU-DHL1 cells assessed as reduction in STAT3 phosphorylation at Y705 residue at 30 nM after 16 hrs by Western blot analysis	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18415069	CHEMBL4152853	Inhibition of ALK autophosphorylation at Y1507 residue in human SU-DHL1 cells pretreated with MG-132 for 2 hrs followed by compound addition at 100 nM and measured after 6 hrs by Western blot analysis	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CC(=O)NCCOCCOCCOCCOCCOCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4165519		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18415070	CHEMBL4152853	Inhibition of ALK autophosphorylation at Y1507 residue in human SU-DHL1 cells pretreated with MG-132 for 2 hrs followed by compound addition at 100 nM and measured after 6 hrs by Western blot analysis	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CC(=O)NCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4161454		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18415071	CHEMBL4152854	Inhibition of ALK autophosphorylation at Y1507 residue in human SU-DHL1 cells pretreated with MLN4924 for 2 hrs followed by compound addition at 100 nM and measured after 6 hrs by Western blot analysis	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CC(=O)NCCOCCOCCOCCOCCOCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4165519		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18415072	CHEMBL4152854	Inhibition of ALK autophosphorylation at Y1507 residue in human SU-DHL1 cells pretreated with MLN4924 for 2 hrs followed by compound addition at 100 nM and measured after 6 hrs by Western blot analysis	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CC(=O)NCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4161454		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18415073	CHEMBL4152855	Inhibition of ALK autophosphorylation at Y1507 residue in human SU-DHL1 cells pretreated with pomalidomide for 2 hrs followed by compound addition at 100 nM and measured after 6 hrs by Western blot analysis	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CC(=O)NCCOCCOCCOCCOCCOCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4165519		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18415074	CHEMBL4152855	Inhibition of ALK autophosphorylation at Y1507 residue in human SU-DHL1 cells pretreated with pomalidomide for 2 hrs followed by compound addition at 100 nM and measured after 6 hrs by Western blot analysis	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CC(=O)NCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4161454		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	18420973	CHEMBL4153932	Inhibition of DNA-tagged ALK (unknown origin) expressed in HEK293 cells at 10 uM after 1 hr by real-time fluorescent quantitative PCR analysis	B	Fc1ccc(Nc2nc(N3CCOCC3)c3nc[nH]c3n2)cc1		CHEMBL4175978	=	Inhibition	%	1.0	CHEMBL4247	Homo sapiens	INH	%	1.0
	18421244	CHEMBL4153979	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CN)c2)ncc1Cl		CHEMBL3357439	=	IC50	nM	2.7	CHEMBL4247	Homo sapiens	IC50	nM	2.7
	18421258	CHEMBL4153979	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	CC(C)c1cc(-c2onc(C(=O)NCC(=O)Nc3cccc(Nc4ncc(Cl)c(Nc5ccccc5S(=O)(=O)C(C)C)n4)c3)c2-c2ccc(CN3CCOCC3)cc2)c(O)cc1O		CHEMBL4162888	=	IC50	nM	53.7	CHEMBL4247	Homo sapiens	IC50	nM	53.7
	18421261	CHEMBL4153979	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	COc1ccc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)cc1NC(=O)CNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCOCC2)cc1		CHEMBL4166575	=	IC50	nM	958.0	CHEMBL4247	Homo sapiens	IC50	nM	958.0
	18421264	CHEMBL4153979	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	COc1ccc(NC(=O)CNC(=O)c2noc(-c3cc(C(C)C)c(O)cc3O)c2-c2ccc(CN3CCOCC3)cc2)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4177203	=	IC50	nM	108.0	CHEMBL4247	Homo sapiens	IC50	nM	108.0
	18421267	CHEMBL4153979	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(C(=O)NCC(=O)Nc2ccc(OC)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)c2)cc1		CHEMBL4169998	=	IC50	nM	83.2	CHEMBL4247	Homo sapiens	IC50	nM	83.2
	18421270	CHEMBL4153979	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(C(=O)N2CCN(CC(=O)Nc3cccc(Nc4ncc(Cl)c(Nc5ccccc5S(=O)(=O)C(C)C)n4)c3)CC2)cc1		CHEMBL4162078	=	IC50	nM	22.9	CHEMBL4247	Homo sapiens	IC50	nM	22.9
	18421273	CHEMBL4153979	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CNCC(=O)Nc2cccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)c2)cc1		CHEMBL4159769	=	IC50	nM	10.3	CHEMBL4247	Homo sapiens	IC50	nM	10.3
	18421276	CHEMBL4153979	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CNCC(=O)Nc2ccc(OC)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)c2)cc1		CHEMBL4170411	=	IC50	nM	24.2	CHEMBL4247	Homo sapiens	IC50	nM	24.2
	18421279	CHEMBL4153979	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCN(CC(=O)Nc3ccc(OC)c(Nc4ncc(Cl)c(Nc5ccccc5S(=O)(=O)C(C)C)n4)c3)CC2)cc1		CHEMBL4159104	=	IC50	nM	17.3	CHEMBL4247	Homo sapiens	IC50	nM	17.3
	18421282	CHEMBL4153982	Inhibition of ALK L1196M mutant (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCN(CC(=O)Nc3ccc(OC)c(Nc4ncc(Cl)c(Nc5ccccc5S(=O)(=O)C(C)C)n4)c3)CC2)cc1		CHEMBL4159104	=	IC50	nM	6.2	CHEMBL4247	Homo sapiens	IC50	nM	6.2
	18421283	CHEMBL4153983	Inhibition of ALK G1202R mutant (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCN(CC(=O)Nc3ccc(OC)c(Nc4ncc(Cl)c(Nc5ccccc5S(=O)(=O)C(C)C)n4)c3)CC2)cc1		CHEMBL4159104	=	IC50	nM	85.5	CHEMBL4247	Homo sapiens	IC50	nM	85.5
	18421298	CHEMBL4153979	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCN(CC(=O)NCC(=O)Nc3ccc(OC)c(Nc4ncc(Cl)c(Nc5ccccc5S(=O)(=O)C(C)C)n4)c3)CC2)cc1		CHEMBL4169444	=	IC50	nM	6.9	CHEMBL4247	Homo sapiens	IC50	nM	6.9
	18421301	CHEMBL4153982	Inhibition of ALK L1196M mutant (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCN(CC(=O)NCC(=O)Nc3ccc(OC)c(Nc4ncc(Cl)c(Nc5ccccc5S(=O)(=O)C(C)C)n4)c3)CC2)cc1		CHEMBL4169444	=	IC50	nM	8.7	CHEMBL4247	Homo sapiens	IC50	nM	8.7
	18421302	CHEMBL4153983	Inhibition of ALK G1202R mutant (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	CCNC(=O)c1noc(-c2cc(C(C)C)c(O)cc2O)c1-c1ccc(CN2CCN(CC(=O)NCC(=O)Nc3ccc(OC)c(Nc4ncc(Cl)c(Nc5ccccc5S(=O)(=O)C(C)C)n4)c3)CC2)cc1		CHEMBL4169444	=	IC50	nM	36.4	CHEMBL4247	Homo sapiens	IC50	nM	36.4
	18421313	CHEMBL4153979	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	COc1ccc(NC(=O)CN2CCN(Cc3ccc4c(c3)CN(C(=O)c3cc(C(C)C)c(O)cc3O)C4)CC2)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4167999	=	IC50	nM	9.8	CHEMBL4247	Homo sapiens	IC50	nM	9.8
	18421316	CHEMBL4153982	Inhibition of ALK L1196M mutant (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	COc1ccc(NC(=O)CN2CCN(Cc3ccc4c(c3)CN(C(=O)c3cc(C(C)C)c(O)cc3O)C4)CC2)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4167999	=	IC50	nM	6.0	CHEMBL4247	Homo sapiens	IC50	nM	6.0
Not Determined	18421317	CHEMBL4153983	Inhibition of ALK G1202R mutant (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	COc1ccc(NC(=O)CN2CCN(Cc3ccc4c(c3)CN(C(=O)c3cc(C(C)C)c(O)cc3O)C4)CC2)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4167999		IC50			CHEMBL4247	Homo sapiens	IC50		
	18421322	CHEMBL4153979	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	COc1ccc(NC(=O)CNC(=O)CN2CCN(Cc3ccc4c(c3)CN(C(=O)c3cc(C(C)C)c(O)cc3O)C4)CC2)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4175858	=	IC50	nM	4.1	CHEMBL4247	Homo sapiens	IC50	nM	4.1
	18431046	CHEMBL4155727	Inhibition of recombinant GST-tagged human ALK expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control	B	O=C1Nc2ccc(C(=O)N[C@H](CO)c3ccccc3)cc2/C1=C(\c1ccccc1)c1ncc[nH]1		CHEMBL4160587	=	Inhibition	%	57.0	CHEMBL4247	Homo sapiens	INH	%	57.0
	18431338	CHEMBL4155790	Inhibition of ALK (unknown origin) at 1 uM relative to control	B	Cn1ncc2c(Oc3ccc4c(c3)nc(Nc3ccc(OC(F)(F)F)cc3)n4C)ncnc21	Outside typical range	CHEMBL4170025	=	Inhibition	%	-11.7	CHEMBL4247	Homo sapiens	INH	%	-11.7
	18440075	CHEMBL4156899	Binding affinity to wild-type human partial length ALK (I1088 to E1409 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	93.0	CHEMBL4247	Homo sapiens	Activity	%	93.0
	18440076	CHEMBL4156900	Binding affinity to wild-type human partial length ALK C1156Y mutant (I1088 to E1409 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL4247	Homo sapiens	Activity	%	100.0
	18440077	CHEMBL4156901	Binding affinity to wild-type human partial length ALK L1196M mutant (I1088 to E1409 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL4247	Homo sapiens	Activity	%	100.0
	18463715	CHEMBL4181131	Inhibition of recombinant human N-terminal His6-tagged ALK (1058 to end residues) expressed in baculovirus Sf21 insect cells at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	16.0	CHEMBL4247	Homo sapiens	INH	%	16.0
Active	18476688	CHEMBL4183660	Inhibition of N-terminal GST-tagged human ALK (1058 to 1620 residues) expressed in baculovirus expression system using biotinylated gastrin peptide as substrate after 1 hr by TR-FRET assay	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18476689	CHEMBL4183660	Inhibition of N-terminal GST-tagged human ALK (1058 to 1620 residues) expressed in baculovirus expression system using biotinylated gastrin peptide as substrate after 1 hr by TR-FRET assay	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18476690	CHEMBL4183660	Inhibition of N-terminal GST-tagged human ALK (1058 to 1620 residues) expressed in baculovirus expression system using biotinylated gastrin peptide as substrate after 1 hr by TR-FRET assay	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCCNC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217930		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18476691	CHEMBL4183660	Inhibition of N-terminal GST-tagged human ALK (1058 to 1620 residues) expressed in baculovirus expression system using biotinylated gastrin peptide as substrate after 1 hr by TR-FRET assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18476692	CHEMBL4183660	Inhibition of N-terminal GST-tagged human ALK (1058 to 1620 residues) expressed in baculovirus expression system using biotinylated gastrin peptide as substrate after 1 hr by TR-FRET assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18476693	CHEMBL4183660	Inhibition of N-terminal GST-tagged human ALK (1058 to 1620 residues) expressed in baculovirus expression system using biotinylated gastrin peptide as substrate after 1 hr by TR-FRET assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCCNC2=O)C3=O)CC1		CHEMBL4207108		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	18476712	CHEMBL4183664	Induction of ALK degradation in human NCI-H3122 cells after 16 hrs by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
	18476713	CHEMBL4183664	Induction of ALK degradation in human NCI-H3122 cells after 16 hrs by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
	18476714	CHEMBL4183665	Induction of ALK degradation in human KARPAS299 cells after 16 hrs by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325	=	IC50	nM	180.0	CHEMBL4247	Homo sapiens	IC50	nM	180.0
	18476715	CHEMBL4183665	Induction of ALK degradation in human KARPAS299 cells after 16 hrs by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986	=	IC50	nM	40.0	CHEMBL4247	Homo sapiens	IC50	nM	40.0
Active	18476716	CHEMBL4183666	Induction of ALK degradation in human NCI-H3122 cells at 250 nM after 4 hrs by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476717	CHEMBL4183666	Induction of ALK degradation in human NCI-H3122 cells at 250 nM after 4 hrs by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476718	CHEMBL4183667	Induction of ALK degradation in human KARPAS299 cells at 250 nM after 8 hrs by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476719	CHEMBL4183667	Induction of ALK degradation in human KARPAS299 cells at 250 nM after 8 hrs by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Active	18476720	CHEMBL4183668	Induction of ALK degradation in human NCI-H3122 cells at 250 nM after 16 hrs in presence of proteasome inhibitor carfilzomib by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Active	18476721	CHEMBL4183668	Induction of ALK degradation in human NCI-H3122 cells at 250 nM after 16 hrs in presence of proteasome inhibitor carfilzomib by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Active	18476722	CHEMBL4183669	Induction of ALK degradation in human KARPAS299 cells at 250 nM after 16 hrs in presence of proteasome inhibitor carfilzomib by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Active	18476723	CHEMBL4183669	Induction of ALK degradation in human KARPAS299 cells at 250 nM after 16 hrs in presence of proteasome inhibitor carfilzomib by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Active	18476728	CHEMBL4183672	Induction of ALK degradation in human NCI-H3122 cells at 250 nM after 16 hrs in presence of cereblon E3 ligase inhibitor MLN4924 by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Active	18476729	CHEMBL4183672	Induction of ALK degradation in human NCI-H3122 cells at 250 nM after 16 hrs in presence of cereblon E3 ligase inhibitor MLN4924 by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Active	18476730	CHEMBL4183673	Induction of ALK degradation in human KARPAS299 cells at 250 nM after 16 hrs in presence of cereblon E3 ligase inhibitor MLN4924 by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Active	18476731	CHEMBL4183673	Induction of ALK degradation in human KARPAS299 cells at 250 nM after 16 hrs in presence of cereblon E3 ligase inhibitor MLN4924 by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Active	18476736	CHEMBL4183676	Induction of ALK degradation in human NCI-H3122 cells at 250 nM after 16 hrs in presence of pomalidomide by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Active	18476737	CHEMBL4183676	Induction of ALK degradation in human NCI-H3122 cells at 250 nM after 16 hrs in presence of pomalidomide by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Active	18476738	CHEMBL4183677	Induction of ALK degradation in human KARPAS299 cells at 250 nM after 16 hrs in presence of pomalidomide by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Active	18476739	CHEMBL4183677	Induction of ALK degradation in human KARPAS299 cells at 250 nM after 16 hrs in presence of pomalidomide by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Active	18476740	CHEMBL4183678	Induction of ALK degradation in human NCI-H3122 cells at 250 nM after 16 hrs in presence of ALK inhibitor TAE684 by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Active	18476741	CHEMBL4183678	Induction of ALK degradation in human NCI-H3122 cells at 250 nM after 16 hrs in presence of ALK inhibitor TAE684 by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Active	18476742	CHEMBL4183679	Induction of ALK degradation in human KARPAS299 cells at 250 nM after 16 hrs in presence of ALK inhibitor TAE684 by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Active	18476743	CHEMBL4183679	Induction of ALK degradation in human KARPAS299 cells at 250 nM after 16 hrs in presence of ALK inhibitor TAE684 by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476744	CHEMBL4183680	Induction of ALK degradation in human NCI-H3122 cells at 250 nM after 16 hrs in presence of ALK inhibitor LDK378 by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476745	CHEMBL4183680	Induction of ALK degradation in human NCI-H3122 cells at 250 nM after 16 hrs in presence of ALK inhibitor LDK378 by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Active	18476746	CHEMBL4183681	Induction of ALK degradation in human KARPAS299 cells at 250 nM after 16 hrs in presence of ALK inhibitor LDK378 by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Active	18476747	CHEMBL4183681	Induction of ALK degradation in human KARPAS299 cells at 250 nM after 16 hrs in presence of ALK inhibitor LDK378 by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476748	CHEMBL4183682	Induction of ALK degradation in human NCI-H3122 cells assessed as decrease in ALK phosphorylation at Y1604 at 50 to 250 nM after 16 hrs by immunoblot method	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476749	CHEMBL4183682	Induction of ALK degradation in human NCI-H3122 cells assessed as decrease in ALK phosphorylation at Y1604 at 50 to 250 nM after 16 hrs by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476750	CHEMBL4183682	Induction of ALK degradation in human NCI-H3122 cells assessed as decrease in ALK phosphorylation at Y1604 at 50 to 250 nM after 16 hrs by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476751	CHEMBL4183682	Induction of ALK degradation in human NCI-H3122 cells assessed as decrease in ALK phosphorylation at Y1604 at 50 to 250 nM after 16 hrs by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476752	CHEMBL4183683	Induction of ALK degradation in human KARPAS299 cells assessed as decrease in ALK phosphorylation at Y1604 at 50 to 250 nM after 16 hrs by immunoblot method	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476753	CHEMBL4183683	Induction of ALK degradation in human KARPAS299 cells assessed as decrease in ALK phosphorylation at Y1604 at 50 to 250 nM after 16 hrs by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476754	CHEMBL4183683	Induction of ALK degradation in human KARPAS299 cells assessed as decrease in ALK phosphorylation at Y1604 at 50 to 250 nM after 16 hrs by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476755	CHEMBL4183683	Induction of ALK degradation in human KARPAS299 cells assessed as decrease in ALK phosphorylation at Y1604 at 50 to 250 nM after 16 hrs by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476756	CHEMBL4183684	Induction of ALK degradation in human NCI-H3122 cells assessed as decrease in ALK phosphorylation at Y1604 at 250 nM measured over 6 to 48 hrs by immunoblot method	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476757	CHEMBL4183684	Induction of ALK degradation in human NCI-H3122 cells assessed as decrease in ALK phosphorylation at Y1604 at 250 nM measured over 6 to 48 hrs by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476758	CHEMBL4183684	Induction of ALK degradation in human NCI-H3122 cells assessed as decrease in ALK phosphorylation at Y1604 at 250 nM measured over 6 to 48 hrs by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476759	CHEMBL4183685	Induction of ALK degradation in human NCI-H3122 cells assessed as decrease in STAT3 phosphorylation at Y705 at 250 nM measured over 6 to 48 hrs by immunoblot method	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476760	CHEMBL4183685	Induction of ALK degradation in human NCI-H3122 cells assessed as decrease in STAT3 phosphorylation at Y705 at 250 nM measured over 6 to 48 hrs by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476761	CHEMBL4183685	Induction of ALK degradation in human NCI-H3122 cells assessed as decrease in STAT3 phosphorylation at Y705 at 250 nM measured over 6 to 48 hrs by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476788	CHEMBL4183691	Induction of ALK degradation in human CHLA20 cells at 100 nM after 16 hrs in presence of ABCB1 shRNA by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476789	CHEMBL4183691	Induction of ALK degradation in human CHLA20 cells at 100 nM after 16 hrs in presence of ABCB1 shRNA by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4247	Homo sapiens	Activity		
	18476790	CHEMBL4183692	Induction of ALK degradation in human Kelly cells after 16 hrs by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325	=	IC50	nM	50.0	CHEMBL4247	Homo sapiens	IC50	nM	50.0
	18476791	CHEMBL4183692	Induction of ALK degradation in human Kelly cells after 16 hrs by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986	=	IC50	nM	50.0	CHEMBL4247	Homo sapiens	IC50	nM	50.0
Active	18476796	CHEMBL4183697	Induction of ALK degradation in human Kelly cells at 100 nM after 8 hrs by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476797	CHEMBL4183697	Induction of ALK degradation in human Kelly cells at 100 nM after 8 hrs by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCCNC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217930		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476798	CHEMBL4183697	Induction of ALK degradation in human Kelly cells at 100 nM after 8 hrs by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476799	CHEMBL4183697	Induction of ALK degradation in human Kelly cells at 100 nM after 8 hrs by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCCNC2=O)C3=O)CC1		CHEMBL4207108		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476800	CHEMBL4183698	Induction of ALK degradation in human CHLA20 cells at 100 nM after 4 hrs in presence of ABCB1 inhibitor tariquidar by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476801	CHEMBL4183698	Induction of ALK degradation in human CHLA20 cells at 100 nM after 4 hrs in presence of ABCB1 inhibitor tariquidar by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCCNC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217930		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476802	CHEMBL4183698	Induction of ALK degradation in human CHLA20 cells at 100 nM after 4 hrs in presence of ABCB1 inhibitor tariquidar by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476803	CHEMBL4183698	Induction of ALK degradation in human CHLA20 cells at 100 nM after 4 hrs in presence of ABCB1 inhibitor tariquidar by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCCNC2=O)C3=O)CC1		CHEMBL4207108		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Active	18476816	CHEMBL4183705	Induction of ALK degradation in human Kelly cells at 100 nM after 16 hrs in presence of pomalidomide by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Active	18476817	CHEMBL4183705	Induction of ALK degradation in human Kelly cells at 100 nM after 16 hrs in presence of pomalidomide by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Active	18476818	CHEMBL4183706	Induction of ALK degradation in human CHLA20 cells at 100 nM after 16 hrs in presence of pomalidomide and ABCB1 inhibitor tariquidar by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Active	18476819	CHEMBL4183706	Induction of ALK degradation in human CHLA20 cells at 100 nM after 16 hrs in presence of pomalidomide and ABCB1 inhibitor tariquidar by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Active	18476820	CHEMBL4183707	Induction of ALK degradation in human Kelly cells at 100 nM after 16 hrs in presence of ALK inhibitor TAE684 by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Active	18476821	CHEMBL4183707	Induction of ALK degradation in human Kelly cells at 100 nM after 16 hrs in presence of ALK inhibitor TAE684 by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Active	18476822	CHEMBL4183708	Induction of ALK degradation in human CHLA20 cells at 100 nM after 16 hrs in presence of ALK inhibitor TAE684 and ABCB1 inhibitor tariquidar by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Active	18476823	CHEMBL4183708	Induction of ALK degradation in human CHLA20 cells at 100 nM after 16 hrs in presence of ALK inhibitor TAE684 and ABCB1 inhibitor tariquidar by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Active	18476824	CHEMBL4183709	Induction of ALK degradation in human Kelly cells at 100 nM after 16 hrs in presence of ALK inhibitor LDK378 by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Active	18476825	CHEMBL4183709	Induction of ALK degradation in human Kelly cells at 100 nM after 16 hrs in presence of ALK inhibitor LDK378 by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Active	18476826	CHEMBL4183710	Induction of ALK degradation in human CHLA20 cells at 100 nM after 16 hrs in presence of ALK inhibitor LDK378 and ABCB1 inhibitor tariquidar by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Active	18476827	CHEMBL4183710	Induction of ALK degradation in human CHLA20 cells at 100 nM after 16 hrs in presence of ALK inhibitor LDK378 and ABCB1 inhibitor tariquidar by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476828	CHEMBL4183711	Induction of ALK degradation in human Kelly cells assessed as decrease in ALK phosphorylation at Y1507 at 50 to 250 nM after 16 hrs by immunoblot method	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476829	CHEMBL4183711	Induction of ALK degradation in human Kelly cells assessed as decrease in ALK phosphorylation at Y1507 at 50 to 250 nM after 16 hrs by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476830	CHEMBL4183711	Induction of ALK degradation in human Kelly cells assessed as decrease in ALK phosphorylation at Y1507 at 50 to 250 nM after 16 hrs by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476831	CHEMBL4183712	Induction of ALK degradation in human CHLA20 cells assessed as decrease in ALK phosphorylation at Y1507 at 50 to 250 nM after 16 hrs in presence of ABCB1 inhibitor tariquidar by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476832	CHEMBL4183712	Induction of ALK degradation in human CHLA20 cells assessed as decrease in ALK phosphorylation at Y1507 at 50 to 250 nM after 16 hrs in presence of ABCB1 inhibitor tariquidar by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476833	CHEMBL4183713	Induction of ALK degradation in human Kelly cells assessed as decrease in ALK phosphorylation at Y1507 at 250 nM after 6 to 48 hrs by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4247	Homo sapiens	Activity		
Active	18476834	CHEMBL4183714	Induction of ALK degradation in human CHLA20 cells assessed as decrease in ALK phosphorylation at Y1507 at 250 nM after 6 to 48 hrs in presence of ABCB1 inhibitor tariquidar by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Active	18476839	CHEMBL4183717	Induction of ALK degradation in human Kelly cells at 100 nM after 4 hrs by immunoblot method	B	COc1cc(N2CCN(CCOCCOCCNC(=O)CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4217325		Activity			CHEMBL4247	Homo sapiens	Activity		
Not Active	18476840	CHEMBL4183717	Induction of ALK degradation in human Kelly cells at 100 nM after 4 hrs by immunoblot method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCOCCOCCNC(=O)CNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4213986		Activity			CHEMBL4247	Homo sapiens	Activity		
	18481853	CHEMBL4185095	Inhibition of ALK (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 30 mins in presence of ATP by HTRF assay	B	CCCNC(=O)c1cc(Oc2ccc(NC(=O)c3cc4cccnc4n(-c4ccc(F)cc4)c3=O)cc2)ccn1		CHEMBL4204920	=	IC50	nM	186.2	CHEMBL4247	Homo sapiens	IC50	nM	186.2
	18484515	CHEMBL4185678	Binding affinity to wild-type human partial length ALK (I1088 to E1409 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	83.0	CHEMBL4247	Homo sapiens	Activity	%	83.0
	18484516	CHEMBL4185679	Binding affinity to wild-type human partial length ALK C1156Y mutant (I1088 to E1409 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	100.0	CHEMBL4247	Homo sapiens	Activity	%	100.0
	18484517	CHEMBL4185680	Binding affinity to wild-type human partial length ALK L1196M mutant (I1088 to E1409 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	96.0	CHEMBL4247	Homo sapiens	Activity	%	96.0
	18485104	CHEMBL4185680	Binding affinity to wild-type human partial length ALK L1196M mutant (I1088 to E1409 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	94.0	CHEMBL4247	Homo sapiens	Activity	%	94.0
	18485105	CHEMBL4185679	Binding affinity to wild-type human partial length ALK C1156Y mutant (I1088 to E1409 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	94.0	CHEMBL4247	Homo sapiens	Activity	%	94.0
	18485106	CHEMBL4185678	Binding affinity to wild-type human partial length ALK (I1088 to E1409 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	100.0	CHEMBL4247	Homo sapiens	Activity	%	100.0
	18489488	CHEMBL4187229	Inhibition of wild-type human partial length ALK (I1088 to E1409 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Fc1cc(F)cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4207079	=	Activity	%	95.0	CHEMBL4247	Homo sapiens	Activity	%	95.0
Not Determined	18499375	CHEMBL4188982	Inhibition of wild-type human partial length ALK (I1088 to E1409 residues) expressed in mammalian expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCN(C(=O)C(C)(C)C)CC4)nc3)nn(CC3CCCC3)c2n1		CHEMBL4204515		IC50			CHEMBL4247	Homo sapiens	IC50		
Not Determined	18499376	CHEMBL4188982	Inhibition of wild-type human partial length ALK (I1088 to E1409 residues) expressed in mammalian expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CCN1CCN(c2ccc(-c3nn(CC4CCCC4)c4nc(NC)ncc34)cn2)CC1		CHEMBL4213775		IC50			CHEMBL4247	Homo sapiens	IC50		
	18499377	CHEMBL4188982	Inhibition of wild-type human partial length ALK (I1088 to E1409 residues) expressed in mammalian expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCN(C)CC4)nc3)nn(CC3CCCC3)c2n1		CHEMBL4208852	=	IC50	nM	190.0	CHEMBL4247	Homo sapiens	IC50	uM	0.19
	18499378	CHEMBL4188982	Inhibition of wild-type human partial length ALK (I1088 to E1409 residues) expressed in mammalian expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCN(C)CC4)cc3)nn(CC3CCCC3)c2n1		CHEMBL4218175	=	IC50	nM	50.0	CHEMBL4247	Homo sapiens	IC50	uM	0.05
	18499379	CHEMBL4188982	Inhibition of wild-type human partial length ALK (I1088 to E1409 residues) expressed in mammalian expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	Nc1nc(Nc2ccc3c(c2)CC[C@@H](N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2		CHEMBL3809489	=	IC50	nM	530.0	CHEMBL4247	Homo sapiens	IC50	uM	0.53
	18507907	CHEMBL4190855	Inhibition of recombinant human ALK (1058 to end residues) at 1 uM using KKKSPGEYVNIEFG as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	-4.0	CHEMBL4247	Homo sapiens	INH	%	-4.0
	18580286	CHEMBL4222686	Inhibition of ALK (unknown origin)	B	CC(C)Nc1ccc2cnn(-c3cncc(-c4ccc(C(=O)O)cc4)n3)c2c1		CHEMBL4228654	>	IC50	nM	30000.0	CHEMBL4247	Homo sapiens	IC50	uM	30.0
	18580313	CHEMBL4222707	Inhibition of ALK (unknown origin) at 1 uM	B	CC(C)Nc1ccc2cnn(-c3cncc(-c4ccc(C(=O)O)cc4)n3)c2c1		CHEMBL4228654	>	Inhibition	%	70.0	CHEMBL4247	Homo sapiens	INH	%	70.0
	18653773	CHEMBL4230017	Inhibition of ALK (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	6.0	CHEMBL4247	Homo sapiens	INH	%	6.0
	18653774	CHEMBL4230017	Inhibition of ALK (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	1.0	CHEMBL4247	Homo sapiens	INH	%	1.0
	18655640	CHEMBL4230580	Binding affinity to wild-type human partial length ALK L1196M mutant (I1088 to E1409 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL4247	Homo sapiens	Activity	%	100.0
	18655641	CHEMBL4230579	Binding affinity to wild-type human partial length ALK C1156Y mutant (I1088 to E1409 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL4247	Homo sapiens	Activity	%	100.0
	18655642	CHEMBL4230578	Binding affinity to wild-type human partial length ALK (I1088 to E1409 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL4247	Homo sapiens	Activity	%	100.0
	18658982	CHEMBL4231725	Inhibition of GST-tagged human ALK at 5 uM preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by Hot-Spot kinase assay	B	COc1ccc2c(OCc3nnc4sc(-c5cnn(C)c5)nn34)ccnc2c1		CHEMBL4249147	=	Inhibition	%	-1.59	CHEMBL4247	Homo sapiens	INH	%	-1.59
	18663901	CHEMBL4232867	Inhibition of human ALK (I1088 to E1409 residues) expressed in mammalian expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	=	Activity	%	65.0	CHEMBL4247	Homo sapiens	Activity	%	65.0
	18663980	CHEMBL4232964	Binding affinity to human ALK (I1088 to E1409 residues) expressed in mammalian expression system by KINOMEscan assay	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	>=	Kd	nM	5000.0	CHEMBL4247	Homo sapiens	Kd	uM	5.0
	18693960	CHEMBL4253413	Inhibition of recombinant N-terminal GST-tagged human ALK cytoplasmic domain (1058 to 1620 residues) C1156Y mutant expressed in baculovirus expression system at 0.1 uM by TR-FRET assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2	Outside typical range	CHEMBL4277900	=	Inhibition	%	-18.0	CHEMBL4247	Homo sapiens	INH	%	-18.0
	18693961	CHEMBL4253414	Inhibition of recombinant N-terminal GST-tagged human ALK cytoplasmic domain (1058 to 1620 residues) L1196M mutant expressed in baculovirus expression system at 0.1 uM by TR-FRET assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2	Outside typical range	CHEMBL4277900	=	Inhibition	%	-14.0	CHEMBL4247	Homo sapiens	INH	%	-14.0
	18693962	CHEMBL4253415	Inhibition of recombinant N-terminal GST-tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system at 0.1 uM by TR-FRET assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	7.0	CHEMBL4247	Homo sapiens	INH	%	7.0
	18694042	CHEMBL4253495	Inhibition of recombinant N-terminal GST-tagged human ALK cytoplasmic domain (1058 to 1620 residues) C1156Y mutant expressed in baculovirus expression system at 1 uM by TR-FRET assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	28.0	CHEMBL4247	Homo sapiens	INH	%	28.0
	18694043	CHEMBL4253496	Inhibition of recombinant N-terminal GST-tagged human ALK cytoplasmic domain (1058 to 1620 residues) L1196M mutant expressed in baculovirus expression system at 1 uM by TR-FRET assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	34.0	CHEMBL4247	Homo sapiens	INH	%	34.0
	18694044	CHEMBL4253497	Inhibition of recombinant N-terminal GST-tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system at 1 uM by TR-FRET assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	89.0	CHEMBL4247	Homo sapiens	INH	%	89.0
	18697609	CHEMBL4254282	Inhibition of wild-type human partial length ALK (I1088 to E1409 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2C(F)(F)F)ccn1		CHEMBL4281348	=	Activity	%	88.0	CHEMBL4247	Homo sapiens	Activity	%	88.0
	18706742	CHEMBL4256132	Inhibition of ALK (unknown origin) by mobility shift assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	7.1	CHEMBL4247	Homo sapiens	IC50	nM	7.1
	18706767	CHEMBL4256119	Inhibition of ALK (unknown origin) at 50 ug/ml by mobility shift assay relative to control	B	CC(C)c1ccc2c(c1)CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(=O)O		CHEMBL12850	=	Inhibition	%	17.6	CHEMBL4247	Homo sapiens	INH	%	17.6
Dose-dependent effect	18746615	CHEMBL4263078	Inhibition of EML4-fused ALK in human NCI-H2228 cells assessed as suppression of AKT phosphorylation after 48 hrs by Western blot method	B	CC1=C(C)C2C(=O)N3N=C(NCCCN(C)C)c4ccccc4C3=NC2S1		CHEMBL4278474		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-dependent effect	18746616	CHEMBL4263077	Inhibition of EML4-fused ALK in human NCI-H2228 cells assessed as suppression of STAT3 phosphorylation after 48 hrs by Western blot method	B	CC1=C(C)C2C(=O)N3N=C(NCCCN(C)C)c4ccccc4C3=NC2S1		CHEMBL4278474		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-dependent effect	18746617	CHEMBL4263076	Inhibition of EML4-fused ALK in human NCI-H2228 cells assessed as suppression of ERK1/2 phosphorylation after 48 hrs by Western blot method	B	CC1=C(C)C2C(=O)N3N=C(NCCCN(C)C)c4ccccc4C3=NC2S1		CHEMBL4278474		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18746618	CHEMBL4263075	Inhibition of EML4-fused ALK autophosphorylation at Tyr1282/1283 in human NCI-H2228 cells at 2.5 uM after 48 hrs by Western blot method	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	18746619	CHEMBL4263074	Inhibition of EML4-fused ALK autophosphorylation at Tyr1282/1283 in human NCI-H2228 cells at 2.5 to 10 uM after 48 hrs by Western blot method	B	CC1=C(C)C2C(=O)N3N=C(NCCCN(C)C)c4ccccc4C3=NC2S1		CHEMBL4278474		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	18746624	CHEMBL4263067	Inhibition of recombinant ALK (unknown origin) after 1 hr by fluorescence assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	EC50	nM	0.47	CHEMBL4247	Homo sapiens	EC50	nM	0.47
	18746625	CHEMBL4263067	Inhibition of recombinant ALK (unknown origin) after 1 hr by fluorescence assay	B	CC1=C(C)C2C(=O)N3N=C(NCCCN(C)C)c4ccccc4C3=NC2S1		CHEMBL4278474	=	EC50	nM	19630.0	CHEMBL4247	Homo sapiens	EC50	uM	19.63
	18751076	CHEMBL4263729	Inhibition of ALK (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	21.0	CHEMBL4247	Homo sapiens	INH	%	21.0
	18752045	CHEMBL4264169	Binding affinity to wild-type human partial length ALK L1196M mutant (I1088 to E1409 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	78.0	CHEMBL4247	Homo sapiens	Activity	%	78.0
	18752046	CHEMBL4264168	Binding affinity to wild-type human partial length ALK C1156Y mutant (I1088 to E1409 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	86.0	CHEMBL4247	Homo sapiens	Activity	%	86.0
	18752047	CHEMBL4264167	Binding affinity to wild-type human partial length ALK (I1088 to E1409 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	96.0	CHEMBL4247	Homo sapiens	Activity	%	96.0
	18761118	CHEMBL4266256	Inhibition of ALK (unknown origin)	B	Cc1[nH][n+](C)c2c1-c1cnc(N)c(c1)O[C@H](C)c1cc(F)ccc1C(=O)N(C)C2		CHEMBL4286522	<	Ki	nM	0.2	CHEMBL4247	Homo sapiens	Ki	nM	0.2
	18761119	CHEMBL4266257	Inhibition of L1196M mutant (unknown origin)	B	Cc1[nH][n+](C)c2c1-c1cnc(N)c(c1)O[C@H](C)c1cc(F)ccc1C(=O)N(C)C2		CHEMBL4286522	=	Ki	nM	0.29	CHEMBL4247	Homo sapiens	Ki	nM	0.29
	18761137	CHEMBL4266256	Inhibition of ALK (unknown origin)	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Ki	nM	0.74	CHEMBL4247	Homo sapiens	Ki	nM	0.74
	18761138	CHEMBL4266257	Inhibition of L1196M mutant (unknown origin)	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Ki	nM	8.2	CHEMBL4247	Homo sapiens	Ki	nM	8.2
	18761156	CHEMBL4266256	Inhibition of ALK (unknown origin)	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286830	=	Ki	nM	0.7	CHEMBL4247	Homo sapiens	Ki	nM	0.7
	18761157	CHEMBL4266257	Inhibition of L1196M mutant (unknown origin)	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286830	=	Ki	nM	8.2	CHEMBL4247	Homo sapiens	Ki	nM	8.2
	18761503	CHEMBL4266519	Inhibition of recombinant human N-terminal His6-tagged ALK (1058 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	12.0	CHEMBL4247	Homo sapiens	INH	%	12.0
	18761739	CHEMBL4266519	Inhibition of recombinant human N-terminal His6-tagged ALK (1058 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	41.0	CHEMBL4247	Homo sapiens	INH	%	41.0
	18761902	CHEMBL4266519	Inhibition of recombinant human N-terminal His6-tagged ALK (1058 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1	Outside typical range	CHEMBL4290222	=	Inhibition	%	-13.0	CHEMBL4247	Homo sapiens	INH	%	-13.0
	18768306	CHEMBL4267755	Inhibition of ALK (unknown origin) using FAM-labeled peptide as substrate incubated for 10 mins followed by substrate addition by HTRF assay	B	COc1cc2c(Oc3ccc(NC(=O)c4cc5cccnc5n(-c5ccc(F)cc5)c4=O)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4279457	=	IC50	nM	199.7	CHEMBL4247	Homo sapiens	IC50	nM	199.7
	18769007	CHEMBL4267883	Inhibition of human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system after 1 hr by mobility shift assay	B	COc1nc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4277936	=	IC50	nM	2100.0	CHEMBL4247	Homo sapiens	IC50	uM	2.1
	18769008	CHEMBL4267883	Inhibition of human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system after 1 hr by mobility shift assay	B	COc1nc(N2CCSCC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4284800	=	IC50	nM	2800.0	CHEMBL4247	Homo sapiens	IC50	uM	2.8
	18769009	CHEMBL4267883	Inhibition of human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system after 1 hr by mobility shift assay	B	COc1nc(N2CC(O)C2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4281394	=	IC50	nM	1400.0	CHEMBL4247	Homo sapiens	IC50	uM	1.4
	18769010	CHEMBL4267883	Inhibition of human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system after 1 hr by mobility shift assay	B	COc1nc(N2CCN(CCO)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4291608	=	IC50	nM	3200.0	CHEMBL4247	Homo sapiens	IC50	uM	3.2
	18769011	CHEMBL4267883	Inhibition of human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system after 1 hr by mobility shift assay	B	COc1nc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(=O)(=O)C2CC2)n1		CHEMBL4285785	=	IC50	nM	3900.0	CHEMBL4247	Homo sapiens	IC50	uM	3.9
	18769012	CHEMBL4267883	Inhibition of human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system after 1 hr by mobility shift assay	B	CC(C)Oc1nc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4279793	=	IC50	nM	4200.0	CHEMBL4247	Homo sapiens	IC50	uM	4.2
	18769013	CHEMBL4267883	Inhibition of human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system after 1 hr by mobility shift assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl	Potential transcription error	CHEMBL601719	=	IC50	nM	32200.0	CHEMBL4247	Homo sapiens	IC50	uM	32.2
	18769014	CHEMBL4267883	Inhibition of human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system after 1 hr by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1	Potential transcription error	CHEMBL2403108	=	IC50	nM	2900.0	CHEMBL4247	Homo sapiens	IC50	uM	2.9
	18769015	CHEMBL4267882	Inhibition of human N-terminal GST-tagged ALK L1196M mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system after 1 hr by mobility shift assay	B	COc1nc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4277936	=	IC50	nM	1300.0	CHEMBL4247	Homo sapiens	IC50	uM	1.3
	18769016	CHEMBL4267882	Inhibition of human N-terminal GST-tagged ALK L1196M mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system after 1 hr by mobility shift assay	B	COc1nc(N2CCSCC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4284800	=	IC50	nM	1600.0	CHEMBL4247	Homo sapiens	IC50	uM	1.6
	18769017	CHEMBL4267882	Inhibition of human N-terminal GST-tagged ALK L1196M mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system after 1 hr by mobility shift assay	B	COc1nc(N2CC(O)C2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4281394	=	IC50	nM	2000.0	CHEMBL4247	Homo sapiens	IC50	uM	2.0
	18769018	CHEMBL4267882	Inhibition of human N-terminal GST-tagged ALK L1196M mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system after 1 hr by mobility shift assay	B	COc1nc(N2CCN(CCO)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4291608	=	IC50	nM	2200.0	CHEMBL4247	Homo sapiens	IC50	uM	2.2
	18769019	CHEMBL4267882	Inhibition of human N-terminal GST-tagged ALK L1196M mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system after 1 hr by mobility shift assay	B	COc1nc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(=O)(=O)C2CC2)n1		CHEMBL4285785	=	IC50	nM	3900.0	CHEMBL4247	Homo sapiens	IC50	uM	3.9
	18769020	CHEMBL4267882	Inhibition of human N-terminal GST-tagged ALK L1196M mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system after 1 hr by mobility shift assay	B	CC(C)Oc1nc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4279793	=	IC50	nM	4800.0	CHEMBL4247	Homo sapiens	IC50	uM	4.8
	18769021	CHEMBL4267882	Inhibition of human N-terminal GST-tagged ALK L1196M mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system after 1 hr by mobility shift assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl	Outside typical range	CHEMBL601719	=	IC50	nM	380000.0	CHEMBL4247	Homo sapiens	IC50	uM	380.0
	18769022	CHEMBL4267882	Inhibition of human N-terminal GST-tagged ALK L1196M mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system after 1 hr by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1	Potential transcription error	CHEMBL2403108	=	IC50	nM	35000.0	CHEMBL4247	Homo sapiens	IC50	uM	35.0
	18769023	CHEMBL4267884	Inhibition of human N-terminal GST-tagged ALK G1202R mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system after 1 hr by mobility shift assay	B	COc1nc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4277936	=	IC50	nM	3900.0	CHEMBL4247	Homo sapiens	IC50	uM	3.9
	18769024	CHEMBL4267884	Inhibition of human N-terminal GST-tagged ALK G1202R mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system after 1 hr by mobility shift assay	B	COc1nc(N2CCSCC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4284800	=	IC50	nM	7900.0	CHEMBL4247	Homo sapiens	IC50	uM	7.9
	18769025	CHEMBL4267884	Inhibition of human N-terminal GST-tagged ALK G1202R mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system after 1 hr by mobility shift assay	B	COc1nc(N2CC(O)C2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4281394	=	IC50	nM	5200.0	CHEMBL4247	Homo sapiens	IC50	uM	5.2
	18769026	CHEMBL4267884	Inhibition of human N-terminal GST-tagged ALK G1202R mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system after 1 hr by mobility shift assay	B	COc1nc(N2CCN(CCO)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4291608	=	IC50	nM	7800.0	CHEMBL4247	Homo sapiens	IC50	uM	7.8
	18769027	CHEMBL4267884	Inhibition of human N-terminal GST-tagged ALK G1202R mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system after 1 hr by mobility shift assay	B	COc1nc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(=O)(=O)C2CC2)n1		CHEMBL4285785	=	IC50	nM	6000.0	CHEMBL4247	Homo sapiens	IC50	uM	6.0
	18769028	CHEMBL4267884	Inhibition of human N-terminal GST-tagged ALK G1202R mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system after 1 hr by mobility shift assay	B	CC(C)Oc1nc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4279793	=	IC50	nM	9400.0	CHEMBL4247	Homo sapiens	IC50	uM	9.4
	18769029	CHEMBL4267884	Inhibition of human N-terminal GST-tagged ALK G1202R mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system after 1 hr by mobility shift assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl	Potential transcription error	CHEMBL601719	>	IC50	nM	1000000.0	CHEMBL4247	Homo sapiens	IC50	uM	1000.0
	18769030	CHEMBL4267884	Inhibition of human N-terminal GST-tagged ALK G1202R mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system after 1 hr by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	91000.0	CHEMBL4247	Homo sapiens	IC50	uM	91.0
	18769047	CHEMBL4267887	Potency index, ratio of ceritinib IC50 to compound IC50 for human N-terminal GST-tagged ALK L1196M mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system	B	COc1nc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4277936	=	Ratio IC50		11.0	CHEMBL4247	Homo sapiens	Ratio IC50		11.0
	18769048	CHEMBL4267888	Potency index, ratio of ceritinib IC50 to compound IC50 for human N-terminal GST-tagged ALK G1202R mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system	B	COc1nc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4277936	=	Ratio IC50		11.0	CHEMBL4247	Homo sapiens	Ratio IC50		11.0
Dose-dependent effect	18769049	CHEMBL4267889	Inhibition of ALK phosphorylation in human KARPAS299 cells after 24 hrs by Western blot analysis	B	COc1nc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4277936		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-dependent effect	18769050	CHEMBL4267890	Inhibition of ALK in human KARPAS299 cells assessed as decrease in Akt phosphorylation after 24 hrs by Western blot analysis	B	COc1nc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4277936		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-dependent effect	18769051	CHEMBL4267891	Inhibition of ALK in human KARPAS299 cells assessed as decrease in STAT3 phosphorylation after 24 hrs by Western blot analysis	B	COc1nc(N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4277936		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Not Active	18847344	CHEMBL4304876	Inhibition of wild-type human partial length ALK (I1088 to E1409 residues) expressed in mammalian expression system at 1 uM by Kinomescan method	B	O=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl		CHEMBL4517719		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	18849482	CHEMBL4305548	Inhibition of recombinant N-terminal GST-fusion protein tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system assessed as decrease in fluorescence labelled Srctide phosphorylation at 200 nM by off-chip mobility shift assay relative to control	B	Cc1cccc(Nc2nc(N[C@@H]3CCCC[C@@H]3N)c(C#N)c3cn[nH]c(=O)c23)c1		CHEMBL4461851	>	Inhibition	%	90.0	CHEMBL4247	Homo sapiens	INH	%	90.0
	18857782	CHEMBL4307684	Binding affinity to wild-type human partial length ALK (I1088 to E1409 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	100.0	CHEMBL4247	Homo sapiens	Activity	%	100.0
	18857839	CHEMBL4307685	Binding affinity to wild-type human partial length ALK C1156Y mutant (I1088 to E1409 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	90.0	CHEMBL4247	Homo sapiens	Activity	%	90.0
	18857840	CHEMBL4307686	Binding affinity to wild-type human partial length ALK L1196M mutant (I1088 to E1409 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	90.0	CHEMBL4247	Homo sapiens	Activity	%	90.0
	18864253	CHEMBL4309576	Inhibition of human ALK at 10 uM using poly[Glu:Tyr] (4:1) as substrate after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	COc1cc(Cl)cc(-c2nn(-c3cccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)c3)cc2-c2ccncc2)c1		CHEMBL4436746	=	Inhibition	%	-3.77	CHEMBL4247	Homo sapiens	INH	%	-3.77
	18885104	CHEMBL4313077	Inhibition of human ALK using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA relative to control	A	C=CC(=O)Nc1ccc(-n2nc3c(=O)[nH]nc(N)c3c2-c2oc3ccc(C)cc3c2C)cc1		CHEMBL4446835	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	18885105	CHEMBL4313077	Inhibition of human ALK using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA relative to control	A	C=CC(=O)NCc1ccc(-n2nc3c(=O)[nH]nc(N)c3c2-c2oc3ccc(C)cc3c2C)cc1		CHEMBL4541330	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	18886114	CHEMBL4313437	Inhibition of human ALK at 10 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	COc1ccc(-c2nn(-c3cccc(NC(=O)c4cccc(C(F)(F)F)c4)c3)cc2-c2ccncc2)cc1Cl		CHEMBL4553144	=	Inhibition	%	3.5	CHEMBL4247	Homo sapiens	INH	%	3.5
	18886199	CHEMBL4313437	Inhibition of human ALK at 10 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	COc1ccc(-c2nn(-c3cccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)c3)cc2-c2ccncc2)cc1Cl		CHEMBL4559825	=	Inhibition	%	-3.13	CHEMBL4247	Homo sapiens	INH	%	-3.13
	18890188	CHEMBL4314037	Inhibition of recombinant human GST-tagged ALK (1058 to 1620 residues) expressed in baculovirus at 0.5 uM using tyr 01 as substrate as substrate in presence of ATP at Km concentration after 1 hr by Z'-LYTE assay relative to control	B	COc1cc(C(=O)NC2CCNCC2)ccc1Nc1nc(Nc2ccccc2P(C)(C)=O)c2cc[nH]c2n1		CHEMBL4448754	=	Inhibition	%	98.0	CHEMBL4247	Homo sapiens	INH	%	98.0
	18892553	CHEMBL4314719	Inhibition of recombinant human ALK (1058 to end residues) assessed as residual activity at 10 uM using KKKSPGEYVNIEF as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	112.5	CHEMBL4247	Homo sapiens	Activity	%	112.5
	18916454	CHEMBL4322136	Inhibition of ALK (unknown origin)	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Ki	nM	3700.0	CHEMBL4247	Homo sapiens	Ki	uM	3.7
	18916455	CHEMBL4322136	Inhibition of ALK (unknown origin)	B	Cn1cc(-c2cnc3[nH]cc(-c4cnn(Cc5cc(F)ccc5F)c4)c3c2)cn1		CHEMBL2418761	=	IC50	nM	29.0	CHEMBL4247	Homo sapiens	IC50	nM	29.0
	18916456	CHEMBL4322136	Inhibition of ALK (unknown origin)	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)C)on1		CHEMBL3810133	=	IC50	nM	402.0	CHEMBL4247	Homo sapiens	IC50	nM	402.0
	18919520	CHEMBL4322876	Binding affinity to recombinant human full length N-terminal GST-tagged ALK (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	230.0	CHEMBL4247	Homo sapiens	Kd	nM	230.0
	18919708	CHEMBL4322876	Binding affinity to recombinant human full length N-terminal GST-tagged ALK (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	172.0	CHEMBL4247	Homo sapiens	Kd	nM	172.0
	18934068	CHEMBL4326600	Inhibition of human ALK at 10 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	CC(=O)N1CCN(c2ccc(Nc3ncc(C(F)(F)F)c(N4Cc5cccc(N(C)S(C)(=O)=O)c5C4)n3)cc2)CC1		CHEMBL4476226	=	Inhibition	%	71.3	CHEMBL4247	Homo sapiens	INH	%	71.3
	18937697	CHEMBL4327578	Inhibition of human ALK assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	97.11	CHEMBL4247	Homo sapiens	Activity	%	97.11
	18937698	CHEMBL4327578	Inhibition of human ALK assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	97.26	CHEMBL4247	Homo sapiens	Activity	%	97.26
	18938419	CHEMBL4327939	Inhibition of human ALK assessed as residual activity at 100 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL4247	Homo sapiens	Activity	%	65.0
	18938784	CHEMBL4328303	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	2.98	CHEMBL4247	Homo sapiens	IC50	10'-9M	2.98
	18946705	CHEMBL4330188	Inhibition of human ALK cytoplasmic domain (1060 to 1620 residues) expressed in sf9 cells using H-ARDIYRASFFRKGGCAMLPVK-CONH2 peptide as substrate after 1 hr in presence of [gamma-33ATP] by top count analysis	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4c3CN(C(=O)[C@H](O)c3ccccc3)C4)cc2)CC1		CHEMBL385872	=	IC50	nM	91.0	CHEMBL4247	Homo sapiens	IC50	uM	0.091
	18948038	CHEMBL4330450	Inhibition of ALK (unknown origin) using FAM-labelled peptide and ATP incubated for 10 mins by mobility shift assay	B	CCN1CCN(CCCOc2cc3nccc(Oc4c(F)cc(NC(=O)NN5C(=O)CSC5c5c(F)cccc5F)cc4F)c3cc2OC)CC1		CHEMBL4587222	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	18950208	CHEMBL4331060	Inhibition of human ALK assessed as residual activity at 10 uM using poly[Glu:Tyr] (4:1) as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by Hotspot assay relative to control	B	CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4cc(C#N)cs4)n[nH]3)cc2)CC1		CHEMBL4473820	=	Activity	%	22.99	CHEMBL4247	Homo sapiens	Activity	%	22.99
	18950282	CHEMBL4331129	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by Hotspot assay	B	CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4cc(C#N)cs4)n[nH]3)cc2)CC1		CHEMBL4473820	=	IC50	nM	5138.0	CHEMBL4247	Homo sapiens	IC50	nM	5138.0
	18950353	CHEMBL4331129	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by Hotspot assay	B	CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4cc(C#N)cs4)n[nH]3)cc2)CC1		CHEMBL4473820	=	IC50	nM	5011.87	CHEMBL4247	Homo sapiens	pIC50		5.3
	18958685	CHEMBL4333278	Binding affinity to wild-type human partial length ALK (I1088 to E1409 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	100.0	CHEMBL4247	Homo sapiens	Activity	%	100.0
	18964052	CHEMBL4334960	Inhibition of human ALK (1058 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	98.0	CHEMBL4247	Homo sapiens	Activity	%	98.0
	18964053	CHEMBL4334960	Inhibition of human ALK (1058 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	90.0	CHEMBL4247	Homo sapiens	Activity	%	90.0
	18971777	CHEMBL4336787	Inhibition of human ALK (1058 to end residues) assessed as residual activity at 10 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	28.0	CHEMBL4247	Homo sapiens	Activity	%	28.0
	18985713	CHEMBL4340012	Inhibition of ALK (unknown origin)	B	COC[C@@H](C)Nc1cc(NC(=O)N2CCCc3cc(CN4CCCCOC4=O)c(C=O)nc32)ncc1C#N		CHEMBL4475216	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
	18994678	CHEMBL4342020	Inhibition of ALK (unknown origin) using poly (Glu, Tyr) 4:1 substrate incubated for 30 mins by HTRF assay	B	COc1cc2c(Oc3ccc(NC(=O)NS(=O)(=O)Cc4ccc(F)cc4)cc3F)ccnc2cc1OCCCN1CCCC1		CHEMBL4533153	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
	18994679	CHEMBL4342020	Inhibition of ALK (unknown origin) using poly (Glu, Tyr) 4:1 substrate incubated for 30 mins by HTRF assay	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	IC50	nM	3180.0	CHEMBL4247	Homo sapiens	IC50	nM	3180.0
Active	19008741	CHEMBL4345073	Inhibition of ALK-mediated STAT3 phosphorylation in EML4-ALK-positive human CCL185IG cells at 500 nM measured after 24 hrs by Western blot analysis	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	19008742	CHEMBL4345063	Inhibition of ALK-mediated STAT3 phosphorylation in EML4-ALK-positive human CCL185IG cells at 500 nM measured after 24 hrs in presence of pictilisib by Western blot analysis	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	19021446	CHEMBL4347666	Inhibition of recombinant human ALK at 20 nM using Ulight-CKKSRGDYMTMQIG as substrate measured after 60 mins by LANCE assay relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO	Outside typical range	CHEMBL4526274	=	Inhibition	%	-15.0	CHEMBL4247	Homo sapiens	INH	%	-15.0
	19021447	CHEMBL4347667	Inhibition of recombinant human ALK at 200 nM using Ulight-CKKSRGDYMTMQIG as substrate measured after 60 mins by LANCE assay relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	35.0	CHEMBL4247	Homo sapiens	INH	%	35.0
	19026251	CHEMBL4348490	Inhibition of N-terminal GST-tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in Baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(N2CCNC2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4465558	=	IC50	nM	7.3	CHEMBL4247	Homo sapiens	IC50	nM	7.3
	19026252	CHEMBL4348490	Inhibition of N-terminal GST-tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in Baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(N2CCN(CCN(C)C)C2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4470529	=	IC50	nM	1.2	CHEMBL4247	Homo sapiens	IC50	nM	1.2
	19026253	CHEMBL4348490	Inhibition of N-terminal GST-tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in Baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(N2CCN(CCCN)C2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4466920	=	IC50	nM	4.7	CHEMBL4247	Homo sapiens	IC50	nM	4.7
	19026254	CHEMBL4348490	Inhibition of N-terminal GST-tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in Baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	10.3	CHEMBL4247	Homo sapiens	IC50	nM	10.3
	19026255	CHEMBL4348490	Inhibition of N-terminal GST-tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in Baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	2.3	CHEMBL4247	Homo sapiens	IC50	nM	2.3
	19026256	CHEMBL4348490	Inhibition of N-terminal GST-tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in Baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(N2CCN(CC(N)=O)C2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4573193	=	IC50	nM	2.7	CHEMBL4247	Homo sapiens	IC50	nM	2.7
	19026257	CHEMBL4348490	Inhibition of N-terminal GST-tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in Baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(N2CCN(CC(=O)N(C)C)C2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4519408	=	IC50	nM	6.7	CHEMBL4247	Homo sapiens	IC50	nM	6.7
	19026258	CHEMBL4348490	Inhibition of N-terminal GST-tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in Baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(N2CCN(CC(=O)N3CCN(C)CC3)C2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4447747	=	IC50	nM	2.1	CHEMBL4247	Homo sapiens	IC50	nM	2.1
	19026259	CHEMBL4348490	Inhibition of N-terminal GST-tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in Baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(N2CCN(CC(=O)N3CCC(=O)CC3)C2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4464571	=	IC50	nM	5.3	CHEMBL4247	Homo sapiens	IC50	nM	5.3
	19026260	CHEMBL4348491	Inhibition of N-terminal GST-tagged human ALK L1196M mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(N2CCNC2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4465558	=	IC50	nM	4.2	CHEMBL4247	Homo sapiens	IC50	nM	4.2
	19026261	CHEMBL4348491	Inhibition of N-terminal GST-tagged human ALK L1196M mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(N2CCN(CCN(C)C)C2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4470529	=	IC50	nM	0.73	CHEMBL4247	Homo sapiens	IC50	nM	0.73
	19026262	CHEMBL4348491	Inhibition of N-terminal GST-tagged human ALK L1196M mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(N2CCN(CCCN)C2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4466920	=	IC50	nM	5.1	CHEMBL4247	Homo sapiens	IC50	nM	5.1
	19026263	CHEMBL4348491	Inhibition of N-terminal GST-tagged human ALK L1196M mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	117.0	CHEMBL4247	Homo sapiens	IC50	nM	117.0
	19026264	CHEMBL4348491	Inhibition of N-terminal GST-tagged human ALK L1196M mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	nM	2.0
	19026265	CHEMBL4348491	Inhibition of N-terminal GST-tagged human ALK L1196M mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(N2CCN(CC(N)=O)C2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4573193	=	IC50	nM	0.95	CHEMBL4247	Homo sapiens	IC50	nM	0.95
	19026266	CHEMBL4348491	Inhibition of N-terminal GST-tagged human ALK L1196M mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(N2CCN(CC(=O)N(C)C)C2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4519408	=	IC50	nM	3.7	CHEMBL4247	Homo sapiens	IC50	nM	3.7
	19026267	CHEMBL4348491	Inhibition of N-terminal GST-tagged human ALK L1196M mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(N2CCN(CC(=O)N3CCN(C)CC3)C2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4447747	=	IC50	nM	0.87	CHEMBL4247	Homo sapiens	IC50	nM	0.87
	19026268	CHEMBL4348491	Inhibition of N-terminal GST-tagged human ALK L1196M mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(N2CCN(CC(=O)N3CCC(=O)CC3)C2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4464571	=	IC50	nM	2.7	CHEMBL4247	Homo sapiens	IC50	nM	2.7
	19026287	CHEMBL4348492	Inhibition of N-terminal GST-tagged human ALK G1202R mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(N2CCNC2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4465558	=	IC50	nM	20.1	CHEMBL4247	Homo sapiens	IC50	nM	20.1
	19026288	CHEMBL4348492	Inhibition of N-terminal GST-tagged human ALK G1202R mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(N2CCN(CCN(C)C)C2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4470529	=	IC50	nM	6.7	CHEMBL4247	Homo sapiens	IC50	nM	6.7
	19026289	CHEMBL4348492	Inhibition of N-terminal GST-tagged human ALK G1202R mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(N2CCN(CCCN)C2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4466920	=	IC50	nM	11.9	CHEMBL4247	Homo sapiens	IC50	nM	11.9
	19026290	CHEMBL4348492	Inhibition of N-terminal GST-tagged human ALK G1202R mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	19026291	CHEMBL4348492	Inhibition of N-terminal GST-tagged human ALK G1202R mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	201.0	CHEMBL4247	Homo sapiens	IC50	nM	201.0
	19026292	CHEMBL4348492	Inhibition of N-terminal GST-tagged human ALK G1202R mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(N2CCN(CC(N)=O)C2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4573193	=	IC50	nM	8.5	CHEMBL4247	Homo sapiens	IC50	nM	8.5
	19026293	CHEMBL4348492	Inhibition of N-terminal GST-tagged human ALK G1202R mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(N2CCN(CC(=O)N(C)C)C2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4519408	=	IC50	nM	23.4	CHEMBL4247	Homo sapiens	IC50	nM	23.4
	19026294	CHEMBL4348492	Inhibition of N-terminal GST-tagged human ALK G1202R mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(N2CCN(CC(=O)N3CCN(C)CC3)C2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4447747	=	IC50	nM	10.3	CHEMBL4247	Homo sapiens	IC50	nM	10.3
	19026295	CHEMBL4348492	Inhibition of N-terminal GST-tagged human ALK G1202R mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(N2CCN(CC(=O)N3CCC(=O)CC3)C2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4464571	=	IC50	nM	15.6	CHEMBL4247	Homo sapiens	IC50	nM	15.6
	19026297	CHEMBL4348493	Potency index, ratio of IC50 for ceritinib to IC50 for test compound for inhibition of N-terminal GST-tagged human ALK G1202R mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(N2CCN(CCN(C)C)C2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4470529	=	Ratio IC50		30.0	CHEMBL4247	Homo sapiens	Ratio IC50		30.0
Dose-dependent effect	19026310	CHEMBL4348505	Inhibition of ALK phosphorylation in human H2228 cells incubated for 24 hrs by Western blot analysis	B	COc1cc(N2CCN(CCN(C)C)C2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4470529		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	19026311	CHEMBL4348506	Inhibition of ALK phosphorylation in human H2228 cells at 100 uM incubated for 24 hrs by Western blot analysis	B	COc1cc(N2CCN(CCN(C)C)C2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4470529		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	19036772	CHEMBL4351070	Inhibition of ALK (unknown origin) by TR-FRET assay	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	=	IC50	nM	1.9	CHEMBL4247	Homo sapiens	IC50	nM	1.9
	19036773	CHEMBL4351070	Inhibition of ALK (unknown origin) by TR-FRET assay	B	CCc1cc2c(cc1-c1cccc(S(=O)(=O)F)c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL4468747	=	IC50	nM	11.0	CHEMBL4247	Homo sapiens	IC50	nM	11.0
Not Active	19039905	CHEMBL4351717	Inhibition of recombinant human ALK (1058 to end residues) at 10 uM using KKKSPGEYVNIEF as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	19041004	CHEMBL4352265	Inhibition of human ALK at 10 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	19043736	CHEMBL4353205	Inhibition of human ALK using poly (Glu,Tyr) 4:1 as substrate at 0.1 uM in presence of 33P-gamma ATP by hotspot kinase assay relative to control	B	CN1CCC(Nc2ccc(C(=O)Nc3cc(-c4ccc5c(c4)OCO5)n[nH]3)cc2)CC1		CHEMBL4456471	=	Inhibition	%	65.64	CHEMBL4247	Homo sapiens	INH	%	65.64
	19048646	CHEMBL4354245	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate preincubated with enzyme for 30 mins followed by substrate addition by HTRF method	B	COc1cc(Nc2cc(N3CCC[C@H](C(=O)NCc4ccc(C)cc4)C3)ccn2)cc(OC)c1OC		CHEMBL4518526	=	IC50	nM	4340.0	CHEMBL4247	Homo sapiens	IC50	uM	4.34
Not Active	19048647	CHEMBL4354245	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate preincubated with enzyme for 30 mins followed by substrate addition by HTRF method	B	Cc1ccc(CNC(=O)[C@H]2CCCN(c3ccnc(Nc4cn(C)nc4C)c3)C2)cc1		CHEMBL4517108		IC50			CHEMBL4247	Homo sapiens	IC50		
Not Active	19048648	CHEMBL4354245	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate preincubated with enzyme for 30 mins followed by substrate addition by HTRF method	B	CN1CCC(n2cc(Nc3cc(N4CCC[C@H](C(=O)NCc5ccc(C#N)cc5)C4)ccn3)cn2)CC1		CHEMBL4563380		IC50			CHEMBL4247	Homo sapiens	IC50		
Not Active	19048649	CHEMBL4354245	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate preincubated with enzyme for 30 mins followed by substrate addition by HTRF method	B	COc1ccc(CNC(=O)[C@H]2CCCN(c3ccnc(Nc4cnn(C5CCN(C)CC5)c4)c3)C2)cc1OC		CHEMBL4540437		IC50			CHEMBL4247	Homo sapiens	IC50		
Not Active	19048650	CHEMBL4354245	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate preincubated with enzyme for 30 mins followed by substrate addition by HTRF method	B	COc1ccc(CNC(=O)[C@H]2CCCN(c3ccnc(Nc4cnn(C5CCNCC5)c4)c3)C2)cc1OC		CHEMBL4459539		IC50			CHEMBL4247	Homo sapiens	IC50		
Not Active	19048651	CHEMBL4354245	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate preincubated with enzyme for 30 mins followed by substrate addition by HTRF method	B	COc1ccc(CNC(=O)[C@H]2CCCN(c3ccnc(Nc4cn(C)nc4C)c3)C2)cc1OC		CHEMBL4588373		IC50			CHEMBL4247	Homo sapiens	IC50		
Not Active	19048652	CHEMBL4354245	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate preincubated with enzyme for 30 mins followed by substrate addition by HTRF method	B	COc1ccc(CNC(=O)[C@H]2CCCN(c3ccnc(Nc4cnn(C)c4)c3)C2)cc1OC		CHEMBL4557265		IC50			CHEMBL4247	Homo sapiens	IC50		
	19048653	CHEMBL4354245	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate preincubated with enzyme for 30 mins followed by substrate addition by HTRF method	B	Cc1nn(C)cc1Nc1cc(N2CCC[C@H](C(=O)NCc3ccc(OC(F)(F)F)cc3)C2)ccn1		CHEMBL4441874	=	IC50	nM	800.0	CHEMBL4247	Homo sapiens	IC50	uM	0.8
Not Active	19048654	CHEMBL4354245	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate preincubated with enzyme for 30 mins followed by substrate addition by HTRF method	B	O=C(NCc1ccc(OC(F)(F)F)cc1)[C@H]1CCCN(c2ccnc(Nc3ncccn3)c2)C1		CHEMBL4451098		IC50			CHEMBL4247	Homo sapiens	IC50		
	19048655	CHEMBL4354245	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate preincubated with enzyme for 30 mins followed by substrate addition by HTRF method	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1cc(N2CCC[C@H](C(=O)NCc3ccc(OC(F)(F)F)cc3)C2)ccn1		CHEMBL4470301	=	IC50	nM	413.0	CHEMBL4247	Homo sapiens	IC50	uM	0.413
	19048656	CHEMBL4354245	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate preincubated with enzyme for 30 mins followed by substrate addition by HTRF method	B	COc1cc(N2CCC(N3CCOCC3)CC2)ccc1Nc1cc(N2CCC[C@H](C(=O)NCc3ccc(OC(F)(F)F)cc3)C2)ccn1		CHEMBL4455502	=	IC50	nM	558.0	CHEMBL4247	Homo sapiens	IC50	uM	0.558
	19048657	CHEMBL4354245	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate preincubated with enzyme for 30 mins followed by substrate addition by HTRF method	B	COc1cc(N2CCN(C)CC2)ccc1Nc1cc(N2CCC[C@H](C(=O)NCc3ccc(OC(F)(F)F)cc3)C2)ccn1		CHEMBL4470581	=	IC50	nM	492.0	CHEMBL4247	Homo sapiens	IC50	uM	0.492
	19048658	CHEMBL4354245	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate preincubated with enzyme for 30 mins followed by substrate addition by HTRF method	B	COc1cc(N2CCNCC2)ccc1Nc1cc(N2CCC[C@H](C(=O)NCc3ccc(OC(F)(F)F)cc3)C2)ccn1		CHEMBL4523063	=	IC50	nM	174.0	CHEMBL4247	Homo sapiens	IC50	uM	0.174
	19048659	CHEMBL4354245	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate preincubated with enzyme for 30 mins followed by substrate addition by HTRF method	B	Cc1cc(Nc2cc(N3CCC[C@H](C(=O)NCc4ccc(OC(F)(F)F)cc4)C3)ccn2)ccc1NC1CCN(C)CC1		CHEMBL4574554	=	IC50	nM	2010.0	CHEMBL4247	Homo sapiens	IC50	uM	2.01
Not Active	19048660	CHEMBL4354245	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate preincubated with enzyme for 30 mins followed by substrate addition by HTRF method	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719		IC50			CHEMBL4247	Homo sapiens	IC50		
	19048661	CHEMBL4354245	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate preincubated with enzyme for 30 mins followed by substrate addition by HTRF method	B	Cc1nn(C)cc1Nc1cc(N2CCC[C@@H](C(=O)NCc3ccc(OC(F)(F)F)cc3)C2)ccn1		CHEMBL4459365	=	IC50	nM	2480.0	CHEMBL4247	Homo sapiens	IC50	uM	2.48
	19048662	CHEMBL4354245	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate preincubated with enzyme for 30 mins followed by substrate addition by HTRF method	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1cc(N2CCC[C@@H](C(=O)NCc3ccc(OC(F)(F)F)cc3)C2)ccn1		CHEMBL4453984	=	IC50	nM	2150.0	CHEMBL4247	Homo sapiens	IC50	uM	2.15
	19048663	CHEMBL4354245	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate preincubated with enzyme for 30 mins followed by substrate addition by HTRF method	B	COc1cc(N2CCC(N3CCOCC3)CC2)ccc1Nc1cc(N2CCC[C@@H](C(=O)NCc3ccc(OC(F)(F)F)cc3)C2)ccn1		CHEMBL4518092	=	IC50	nM	3210.0	CHEMBL4247	Homo sapiens	IC50	uM	3.21
	19048664	CHEMBL4354245	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate preincubated with enzyme for 30 mins followed by substrate addition by HTRF method	B	Cc1cc(Nc2cc(N3CCC[C@@H](C(=O)NCc4ccc(OC(F)(F)F)cc4)C3)ccn2)ccc1NC1CCN(C)CC1		CHEMBL4476002	=	IC50	nM	4260.0	CHEMBL4247	Homo sapiens	IC50	uM	4.26
	19048665	CHEMBL4354245	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate preincubated with enzyme for 30 mins followed by substrate addition by HTRF method	B	COc1cc(N2CCNCC2)ccc1Nc1cc(N2CCC[C@@H](C(=O)NCc3ccc(OC(F)(F)F)cc3)C2)ccn1		CHEMBL4459183	=	IC50	nM	560.0	CHEMBL4247	Homo sapiens	IC50	uM	0.56
	19048686	CHEMBL4354246	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate at 1 uM preincubated with enzyme for 30 mins followed by substrate addition by HTRF method relative to control	B	COc1cc(Nc2cc(N3CCC[C@H](C(=O)NCc4ccc(C)cc4)C3)ccn2)cc(OC)c1OC		CHEMBL4518526	=	Inhibition	%	14.0	CHEMBL4247	Homo sapiens	INH	%	14.0
	19048687	CHEMBL4354246	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate at 1 uM preincubated with enzyme for 30 mins followed by substrate addition by HTRF method relative to control	B	Cc1ccc(CNC(=O)[C@H]2CCCN(c3ccnc(Nc4cn(C)nc4C)c3)C2)cc1		CHEMBL4517108	=	Inhibition	%	12.0	CHEMBL4247	Homo sapiens	INH	%	12.0
	19048688	CHEMBL4354246	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate at 1 uM preincubated with enzyme for 30 mins followed by substrate addition by HTRF method relative to control	B	CN1CCC(n2cc(Nc3cc(N4CCC[C@H](C(=O)NCc5ccc(C#N)cc5)C4)ccn3)cn2)CC1		CHEMBL4563380	=	Inhibition	%	5.0	CHEMBL4247	Homo sapiens	INH	%	5.0
	19048689	CHEMBL4354246	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate at 1 uM preincubated with enzyme for 30 mins followed by substrate addition by HTRF method relative to control	B	COc1ccc(CNC(=O)[C@H]2CCCN(c3ccnc(Nc4cnn(C5CCN(C)CC5)c4)c3)C2)cc1OC		CHEMBL4540437	=	Inhibition	%	6.0	CHEMBL4247	Homo sapiens	INH	%	6.0
	19048690	CHEMBL4354246	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate at 1 uM preincubated with enzyme for 30 mins followed by substrate addition by HTRF method relative to control	B	COc1ccc(CNC(=O)[C@H]2CCCN(c3ccnc(Nc4cnn(C5CCNCC5)c4)c3)C2)cc1OC		CHEMBL4459539	=	Inhibition	%	3.0	CHEMBL4247	Homo sapiens	INH	%	3.0
	19048691	CHEMBL4354246	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate at 1 uM preincubated with enzyme for 30 mins followed by substrate addition by HTRF method relative to control	B	COc1ccc(CNC(=O)[C@H]2CCCN(c3ccnc(Nc4cn(C)nc4C)c3)C2)cc1OC		CHEMBL4588373	=	Inhibition	%	12.0	CHEMBL4247	Homo sapiens	INH	%	12.0
	19048692	CHEMBL4354246	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate at 1 uM preincubated with enzyme for 30 mins followed by substrate addition by HTRF method relative to control	B	COc1ccc(CNC(=O)[C@H]2CCCN(c3ccnc(Nc4cnn(C)c4)c3)C2)cc1OC		CHEMBL4557265	=	Inhibition	%	8.0	CHEMBL4247	Homo sapiens	INH	%	8.0
	19048693	CHEMBL4354246	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate at 1 uM preincubated with enzyme for 30 mins followed by substrate addition by HTRF method relative to control	B	Cc1nn(C)cc1Nc1cc(N2CCC[C@H](C(=O)NCc3ccc(OC(F)(F)F)cc3)C2)ccn1		CHEMBL4441874	=	Inhibition	%	52.0	CHEMBL4247	Homo sapiens	INH	%	52.0
	19048694	CHEMBL4354246	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate at 1 uM preincubated with enzyme for 30 mins followed by substrate addition by HTRF method relative to control	B	O=C(NCc1ccc(OC(F)(F)F)cc1)[C@H]1CCCN(c2ccnc(Nc3ncccn3)c2)C1		CHEMBL4451098	=	Inhibition	%	20.0	CHEMBL4247	Homo sapiens	INH	%	20.0
	19048695	CHEMBL4354246	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate at 1 uM preincubated with enzyme for 30 mins followed by substrate addition by HTRF method relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1cc(N2CCC[C@H](C(=O)NCc3ccc(OC(F)(F)F)cc3)C2)ccn1		CHEMBL4470301	=	Inhibition	%	92.0	CHEMBL4247	Homo sapiens	INH	%	92.0
	19048696	CHEMBL4354246	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate at 1 uM preincubated with enzyme for 30 mins followed by substrate addition by HTRF method relative to control	B	COc1cc(N2CCC(N3CCOCC3)CC2)ccc1Nc1cc(N2CCC[C@H](C(=O)NCc3ccc(OC(F)(F)F)cc3)C2)ccn1		CHEMBL4455502	=	Inhibition	%	82.0	CHEMBL4247	Homo sapiens	INH	%	82.0
	19048697	CHEMBL4354246	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate at 1 uM preincubated with enzyme for 30 mins followed by substrate addition by HTRF method relative to control	B	COc1cc(N2CCN(C)CC2)ccc1Nc1cc(N2CCC[C@H](C(=O)NCc3ccc(OC(F)(F)F)cc3)C2)ccn1		CHEMBL4470581	=	Inhibition	%	90.0	CHEMBL4247	Homo sapiens	INH	%	90.0
	19048698	CHEMBL4354246	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate at 1 uM preincubated with enzyme for 30 mins followed by substrate addition by HTRF method relative to control	B	COc1cc(N2CCNCC2)ccc1Nc1cc(N2CCC[C@H](C(=O)NCc3ccc(OC(F)(F)F)cc3)C2)ccn1		CHEMBL4523063	=	Inhibition	%	95.0	CHEMBL4247	Homo sapiens	INH	%	95.0
	19048699	CHEMBL4354246	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate at 1 uM preincubated with enzyme for 30 mins followed by substrate addition by HTRF method relative to control	B	Cc1cc(Nc2cc(N3CCC[C@H](C(=O)NCc4ccc(OC(F)(F)F)cc4)C3)ccn2)ccc1NC1CCN(C)CC1		CHEMBL4574554	=	Inhibition	%	43.0	CHEMBL4247	Homo sapiens	INH	%	43.0
Not Active	19048700	CHEMBL4354246	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate at 1 uM preincubated with enzyme for 30 mins followed by substrate addition by HTRF method relative to control	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	19048701	CHEMBL4354246	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate at 1 uM preincubated with enzyme for 30 mins followed by substrate addition by HTRF method relative to control	B	Cc1nn(C)cc1Nc1cc(N2CCC[C@@H](C(=O)NCc3ccc(OC(F)(F)F)cc3)C2)ccn1		CHEMBL4459365	=	Inhibition	%	24.0	CHEMBL4247	Homo sapiens	INH	%	24.0
	19048702	CHEMBL4354246	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate at 1 uM preincubated with enzyme for 30 mins followed by substrate addition by HTRF method relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1cc(N2CCC[C@@H](C(=O)NCc3ccc(OC(F)(F)F)cc3)C2)ccn1		CHEMBL4453984	=	Inhibition	%	44.0	CHEMBL4247	Homo sapiens	INH	%	44.0
	19048703	CHEMBL4354246	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate at 1 uM preincubated with enzyme for 30 mins followed by substrate addition by HTRF method relative to control	B	COc1cc(N2CCC(N3CCOCC3)CC2)ccc1Nc1cc(N2CCC[C@@H](C(=O)NCc3ccc(OC(F)(F)F)cc3)C2)ccn1		CHEMBL4518092	=	Inhibition	%	39.0	CHEMBL4247	Homo sapiens	INH	%	39.0
	19048704	CHEMBL4354246	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate at 1 uM preincubated with enzyme for 30 mins followed by substrate addition by HTRF method relative to control	B	Cc1cc(Nc2cc(N3CCC[C@@H](C(=O)NCc4ccc(OC(F)(F)F)cc4)C3)ccn2)ccc1NC1CCN(C)CC1		CHEMBL4476002	=	Inhibition	%	11.0	CHEMBL4247	Homo sapiens	INH	%	11.0
	19048705	CHEMBL4354246	Inhibition of recombinant human N-terminal GST-tagged ALK (catalytic domain 1058 - 1620 residues) expressed in baculovirus system assessed as decrease in substrate phosphorylation using TK peptide as substrate at 1 uM preincubated with enzyme for 30 mins followed by substrate addition by HTRF method relative to control	B	COc1cc(N2CCNCC2)ccc1Nc1cc(N2CCC[C@@H](C(=O)NCc3ccc(OC(F)(F)F)cc3)C2)ccn1		CHEMBL4459183	=	Inhibition	%	76.0	CHEMBL4247	Homo sapiens	INH	%	76.0
	19048781	CHEMBL4354266	Inhibition of ALK L1196M mutant (unknown origin) at 1 uM relative to control	B	COc1cc(N2CCNCC2)ccc1Nc1cc(N2CCC[C@H](C(=O)NCc3ccc(OC(F)(F)F)cc3)C2)ccn1		CHEMBL4523063	=	Inhibition	%	93.0	CHEMBL4247	Homo sapiens	INH	%	93.0
	19048782	CHEMBL4354266	Inhibition of ALK L1196M mutant (unknown origin) at 1 uM relative to control	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Inhibition	%	99.0	CHEMBL4247	Homo sapiens	INH	%	99.0
	19048783	CHEMBL4354268	Inhibition of ALK L1196M mutant (unknown origin) at 1 uM	B	COc1cc(N2CCNCC2)ccc1Nc1cc(N2CCC[C@H](C(=O)NCc3ccc(OC(F)(F)F)cc3)C2)ccn1		CHEMBL4523063	=	IC50	nM	41.3	CHEMBL4247	Homo sapiens	IC50	nM	41.3
	19048784	CHEMBL4354268	Inhibition of ALK L1196M mutant (unknown origin) at 1 uM	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	73.6	CHEMBL4247	Homo sapiens	IC50	nM	73.6
	19048785	CHEMBL4354269	Inhibition of ALK C1156Y mutant (unknown origin) at 1 uM	B	COc1cc(N2CCNCC2)ccc1Nc1cc(N2CCC[C@H](C(=O)NCc3ccc(OC(F)(F)F)cc3)C2)ccn1		CHEMBL4523063	=	Inhibition	%	100.0	CHEMBL4247	Homo sapiens	INH	%	100.0
Not Active	19048786	CHEMBL4354269	Inhibition of ALK C1156Y mutant (unknown origin) at 1 uM	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	19048787	CHEMBL4354267	Inhibition of ALK F1174L mutant (unknown origin) at 1 uM	B	COc1cc(N2CCNCC2)ccc1Nc1cc(N2CCC[C@H](C(=O)NCc3ccc(OC(F)(F)F)cc3)C2)ccn1		CHEMBL4523063	=	Inhibition	%	80.0	CHEMBL4247	Homo sapiens	INH	%	80.0
Not Active	19048788	CHEMBL4354267	Inhibition of ALK F1174L mutant (unknown origin) at 1 uM	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	19048789	CHEMBL4354270	Inhibition of ALK R1275Q mutant (unknown origin) at 1 uM	B	COc1cc(N2CCNCC2)ccc1Nc1cc(N2CCC[C@H](C(=O)NCc3ccc(OC(F)(F)F)cc3)C2)ccn1		CHEMBL4523063	=	Inhibition	%	92.0	CHEMBL4247	Homo sapiens	INH	%	92.0
Not Active	19048790	CHEMBL4354270	Inhibition of ALK R1275Q mutant (unknown origin) at 1 uM	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	19048791	CHEMBL4354271	Potency index, ratio of crizotinib IC50 to compound IC50 for ALK L1196M mutant (unknown origin) at 1 uM	B	COc1cc(N2CCNCC2)ccc1Nc1cc(N2CCC[C@H](C(=O)NCc3ccc(OC(F)(F)F)cc3)C2)ccn1		CHEMBL4523063	=	Ratio IC50		2.0	CHEMBL4247	Homo sapiens	Ratio IC50		2.0
	19059455	CHEMBL4357756	Binding affinity to wild-type human partial length ALK (I1088 to E1409 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL4247	Homo sapiens	Activity	%	100.0
	19059456	CHEMBL4357757	Binding affinity to wild-type human partial length ALK C1156Y mutant (I1088 to E1409 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	99.0	CHEMBL4247	Homo sapiens	Activity	%	99.0
	19059457	CHEMBL4357758	Binding affinity to wild-type human partial length ALK L1196M mutant (I1088 to E1409 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	90.0	CHEMBL4247	Homo sapiens	Activity	%	90.0
Dose-dependent effect	19085610	CHEMBL4364830	Inhibition of ALK in human KARPAS299 cells assessed as reduction in ALK phosphorylation incubated for 2 hrs by Western blot analysis	B	COc1cc(NC(=O)NCc2cccnc2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCOCC3)c(OC)c2)n1		CHEMBL4514156		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	19085611	CHEMBL4364831	Inhibition of ALK in human KARPAS299 cells assessed as reduction in STAT3 phosphorylation at 0.05 to 5 uM incubated for 2 hrs by Western blot analysis	B	COc1cc(NC(=O)NCc2cccnc2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCOCC3)c(OC)c2)n1		CHEMBL4514156		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	19085612	CHEMBL4364832	Inhibition of ALK in human KARPAS299 cells assessed as reduction in ERK phosphorylation at 0.05 to 5 uM incubated for 2 hrs by Western blot analysis	B	COc1cc(NC(=O)NCc2cccnc2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCOCC3)c(OC)c2)n1		CHEMBL4514156		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	19085613	CHEMBL4364833	Inhibition of recombinant human N-terminal His-tagged ALK expressed in baculovirus expression system using polyGlu4:Tyr peptide as substrate incubated for 1 hr by kinase-Glo plus assay	B	COc1cc(NC(=O)NCc2cccnc2)ccc1Nc1ncc(Cl)c(Nc2cc(OC)c(OC)c(OC)c2)n1		CHEMBL4470277	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	19085614	CHEMBL4364833	Inhibition of recombinant human N-terminal His-tagged ALK expressed in baculovirus expression system using polyGlu4:Tyr peptide as substrate incubated for 1 hr by kinase-Glo plus assay	B	COc1cc(NC(=O)NCc2cccnc2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCOCC3)c(OC)c2)n1		CHEMBL4514156	=	IC50	nM	661.0	CHEMBL4247	Homo sapiens	IC50	uM	0.661
	19085615	CHEMBL4364833	Inhibition of recombinant human N-terminal His-tagged ALK expressed in baculovirus expression system using polyGlu4:Tyr peptide as substrate incubated for 1 hr by kinase-Glo plus assay	B	COc1cc(NC(=O)NCc2cccnc2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCN(C)CC3)cc2)n1		CHEMBL4445283	=	IC50	nM	757.0	CHEMBL4247	Homo sapiens	IC50	uM	0.757
	19085616	CHEMBL4364833	Inhibition of recombinant human N-terminal His-tagged ALK expressed in baculovirus expression system using polyGlu4:Tyr peptide as substrate incubated for 1 hr by kinase-Glo plus assay	B	COc1cc(NC(=O)NCCc2cccnc2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCOCC3)c(OC)c2)n1		CHEMBL4443942	=	IC50	nM	1046.0	CHEMBL4247	Homo sapiens	IC50	uM	1.046
Active	19085617	CHEMBL4364834	Inhibition of ALK phosphorylation in human KARPAS299 cells at 10 uM incubated for 3 hrs by mass spectrometry-based global phospho-proteomic analysis	B	COc1cc(NC(=O)NCc2cccnc2)ccc1Nc1ncc(Cl)c(Nc2ccc(N3CCOCC3)c(OC)c2)n1		CHEMBL4514156		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	19090028	CHEMBL4365602	Inhibition of wild-type human partial length ALK (I1088 to E1409 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	61.0	CHEMBL4247	Homo sapiens	Activity	%	61.0
	19090029	CHEMBL4365603	Inhibition of wild-type human partial length ALK C1156Y mutant (I1088 to E1409 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	52.0	CHEMBL4247	Homo sapiens	Activity	%	52.0
	19090030	CHEMBL4365604	Inhibition of wild-type human partial length ALK L1196M mutant (I1088 to E1409 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	63.0	CHEMBL4247	Homo sapiens	Activity	%	63.0
	19091807	CHEMBL4366281	Inhibition of human ALK at 100 nM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	2.94	CHEMBL4247	Homo sapiens	INH	%	2.94
	19113519	CHEMBL4370936	Inhibition of recombinant ALK (unknown origin) using peptide substrate measured after 1 hr by LanthaScreen assay	B	Oc1ccc(-c2ccc3c(-c4cnn(C5CCNCC5)c4)n[nH]c3n2)cc1F		CHEMBL4586635	=	IC50	nM	39.64	CHEMBL4247	Homo sapiens	IC50	nM	39.64
	19113520	CHEMBL4370936	Inhibition of recombinant ALK (unknown origin) using peptide substrate measured after 1 hr by LanthaScreen assay	B	Oc1ccc(-c2ccc3c(-c4cnn(C5CCNCC5)c4)n[nH]c3n2)cc1		CHEMBL4455547	=	IC50	nM	13.76	CHEMBL4247	Homo sapiens	IC50	nM	13.76
	19113521	CHEMBL4370936	Inhibition of recombinant ALK (unknown origin) using peptide substrate measured after 1 hr by LanthaScreen assay	B	COc1cc(N2CCN(C(C)C)CC2)ccc1-c1n[nH]c2nc(-c3ccc(O)c(F)c3)ccc12		CHEMBL4551774	=	IC50	nM	53.08	CHEMBL4247	Homo sapiens	IC50	nM	53.08
	19113522	CHEMBL4370936	Inhibition of recombinant ALK (unknown origin) using peptide substrate measured after 1 hr by LanthaScreen assay	B	COc1cc(N2CCN(C(C)C)CC2)ccc1-c1n[nH]c2nc(-c3ccc(O)cc3)ccc12		CHEMBL4584172	=	IC50	nM	27.05	CHEMBL4247	Homo sapiens	IC50	nM	27.05
	19113523	CHEMBL4370936	Inhibition of recombinant ALK (unknown origin) using peptide substrate measured after 1 hr by LanthaScreen assay	B	CC(C)N1CCN(c2ccc(-c3n[nH]c4nc(-c5cc(F)c(O)c(F)c5)ccc34)cc2)CC1		CHEMBL4472747	=	IC50	nM	648.59	CHEMBL4247	Homo sapiens	IC50	nM	648.59
	19113524	CHEMBL4370936	Inhibition of recombinant ALK (unknown origin) using peptide substrate measured after 1 hr by LanthaScreen assay	B	CC(C)N1CCN(c2ccc(-c3n[nH]c4nc(-c5ccc(O)c(F)c5)ccc34)cc2)CC1		CHEMBL4577227	=	IC50	nM	1.58	CHEMBL4247	Homo sapiens	IC50	nM	1.58
	19113525	CHEMBL4370936	Inhibition of recombinant ALK (unknown origin) using peptide substrate measured after 1 hr by LanthaScreen assay	B	CC(C)N1CCN(c2ccc(-c3n[nH]c4nc(-c5ccc(C(C)(C)O)cc5)ccc34)cc2)CC1		CHEMBL4462189	>	IC50	nM	2000.0	CHEMBL4247	Homo sapiens	IC50	nM	2000.0
	19113526	CHEMBL4370936	Inhibition of recombinant ALK (unknown origin) using peptide substrate measured after 1 hr by LanthaScreen assay	B	CC(C)N1CCN(c2ccc(-c3n[nH]c4nc(-c5ccc(N)cc5)ccc34)cc2)CC1		CHEMBL4588073	=	IC50	nM	218.45	CHEMBL4247	Homo sapiens	IC50	nM	218.45
	19113527	CHEMBL4370936	Inhibition of recombinant ALK (unknown origin) using peptide substrate measured after 1 hr by LanthaScreen assay	B	CC(C)N1CCN(c2ccc(-c3n[nH]c4nc(-c5ccc(C#N)cc5)ccc34)cc2)CC1		CHEMBL4466808	>	IC50	nM	2000.0	CHEMBL4247	Homo sapiens	IC50	nM	2000.0
	19113528	CHEMBL4370936	Inhibition of recombinant ALK (unknown origin) using peptide substrate measured after 1 hr by LanthaScreen assay	B	CC(C)N1CCN(c2ccc(-c3n[nH]c4nc(-c5ccc(Cl)cc5)ccc34)cc2)CC1		CHEMBL4461143	>	IC50	nM	2000.0	CHEMBL4247	Homo sapiens	IC50	nM	2000.0
	19113529	CHEMBL4370936	Inhibition of recombinant ALK (unknown origin) using peptide substrate measured after 1 hr by LanthaScreen assay	B	CC(C)N1CCN(c2ccc(-c3n[nH]c4nc(-c5ccc(F)cc5)ccc34)cc2)CC1		CHEMBL4578001	>	IC50	nM	2000.0	CHEMBL4247	Homo sapiens	IC50	nM	2000.0
	19113530	CHEMBL4370936	Inhibition of recombinant ALK (unknown origin) using peptide substrate measured after 1 hr by LanthaScreen assay	B	CN(CCO)Cc1ccc(-c2n[nH]c3nc(-c4ccc(O)cc4)ccc23)o1		CHEMBL4524160	=	IC50	nM	83.15	CHEMBL4247	Homo sapiens	IC50	nM	83.15
	19113531	CHEMBL4370936	Inhibition of recombinant ALK (unknown origin) using peptide substrate measured after 1 hr by LanthaScreen assay	B	OCC1CCCCN1Cc1ccc(-c2n[nH]c3nc(-c4ccc(O)cc4)ccc23)o1		CHEMBL4444118	=	IC50	nM	567.92	CHEMBL4247	Homo sapiens	IC50	nM	567.92
	19113532	CHEMBL4370936	Inhibition of recombinant ALK (unknown origin) using peptide substrate measured after 1 hr by LanthaScreen assay	B	CC(C)N1CCN(Cc2ccc(-c3n[nH]c4nc(-c5ccc(O)cc5)ccc34)o2)CC1		CHEMBL4550250	=	IC50	nM	103.47	CHEMBL4247	Homo sapiens	IC50	nM	103.47
	19113533	CHEMBL4370936	Inhibition of recombinant ALK (unknown origin) using peptide substrate measured after 1 hr by LanthaScreen assay	B	CN1CCN(Cc2ccc(-c3n[nH]c4nc(-c5ccc(O)cc5)ccc34)o2)CC1		CHEMBL4536896	=	IC50	nM	194.38	CHEMBL4247	Homo sapiens	IC50	nM	194.38
	19113534	CHEMBL4370936	Inhibition of recombinant ALK (unknown origin) using peptide substrate measured after 1 hr by LanthaScreen assay	B	Oc1ccc(-c2ccc3c(-c4ccc(CN5CCOCC5)o4)n[nH]c3n2)cc1		CHEMBL4483645	=	IC50	nM	94.05	CHEMBL4247	Homo sapiens	IC50	nM	94.05
	19113535	CHEMBL4370936	Inhibition of recombinant ALK (unknown origin) using peptide substrate measured after 1 hr by LanthaScreen assay	B	Oc1ccc(-c2ccc3c(-c4ccc(CN5CCCCC5)o4)n[nH]c3n2)cc1		CHEMBL4456479	=	IC50	nM	394.19	CHEMBL4247	Homo sapiens	IC50	nM	394.19
	19113536	CHEMBL4370936	Inhibition of recombinant ALK (unknown origin) using peptide substrate measured after 1 hr by LanthaScreen assay	B	Oc1ccc(-c2ccc3c(-c4ccc(CN5CCCC5)o4)n[nH]c3n2)cc1		CHEMBL4514558	=	IC50	nM	253.18	CHEMBL4247	Homo sapiens	IC50	nM	253.18
	19113537	CHEMBL4370936	Inhibition of recombinant ALK (unknown origin) using peptide substrate measured after 1 hr by LanthaScreen assay	B	Cc1ccc(-c2n[nH]c3nc(-c4ccc(O)cc4)ccc23)o1		CHEMBL4472823	=	IC50	nM	53.95	CHEMBL4247	Homo sapiens	IC50	nM	53.95
	19113538	CHEMBL4370936	Inhibition of recombinant ALK (unknown origin) using peptide substrate measured after 1 hr by LanthaScreen assay	B	CC(C)N1CCN(c2ccc(-c3n[nH]c4nc(-c5ccc(O)cc5)ccc34)cc2)CC1		CHEMBL4461630	=	IC50	nM	47.4	CHEMBL4247	Homo sapiens	IC50	nM	47.4
	19113539	CHEMBL4370936	Inhibition of recombinant ALK (unknown origin) using peptide substrate measured after 1 hr by LanthaScreen assay	B	Oc1ccc(-c2ccc3c(-c4ccc(N5CCOCC5)cc4)n[nH]c3n2)cc1		CHEMBL4448493	=	IC50	nM	425.33	CHEMBL4247	Homo sapiens	IC50	nM	425.33
	19113540	CHEMBL4370936	Inhibition of recombinant ALK (unknown origin) using peptide substrate measured after 1 hr by LanthaScreen assay	B	Oc1ccc(-c2ccc3c(-c4ccc(N5CCCCC5)cc4)n[nH]c3n2)cc1		CHEMBL4443507	=	IC50	nM	338.51	CHEMBL4247	Homo sapiens	IC50	nM	338.51
	19113541	CHEMBL4370936	Inhibition of recombinant ALK (unknown origin) using peptide substrate measured after 1 hr by LanthaScreen assay	B	Oc1ccc(-c2ccc3c(-c4ccc(O)cc4)n[nH]c3n2)cc1		CHEMBL4539723	=	IC50	nM	129.9	CHEMBL4247	Homo sapiens	IC50	nM	129.9
	19113542	CHEMBL4370936	Inhibition of recombinant ALK (unknown origin) using peptide substrate measured after 1 hr by LanthaScreen assay	B	COc1ccc(-c2n[nH]c3nc(-c4ccc(O)cc4)ccc23)cc1		CHEMBL4539309	=	IC50	nM	239.49	CHEMBL4247	Homo sapiens	IC50	nM	239.49
	19113543	CHEMBL4370936	Inhibition of recombinant ALK (unknown origin) using peptide substrate measured after 1 hr by LanthaScreen assay	B	Oc1ccc(-c2ccc3c(-c4ccc(Cl)cc4)n[nH]c3n2)cc1		CHEMBL4513978	>	IC50	nM	2000.0	CHEMBL4247	Homo sapiens	IC50	nM	2000.0
	19113544	CHEMBL4370936	Inhibition of recombinant ALK (unknown origin) using peptide substrate measured after 1 hr by LanthaScreen assay	B	Oc1ccc(-c2ccc3c(-c4ccc(F)cc4)n[nH]c3n2)cc1		CHEMBL4518979	=	IC50	nM	336.38	CHEMBL4247	Homo sapiens	IC50	nM	336.38
	19113545	CHEMBL4370936	Inhibition of recombinant ALK (unknown origin) using peptide substrate measured after 1 hr by LanthaScreen assay	B	Oc1ccc(-c2ccc3c(-c4ccccc4)n[nH]c3n2)cc1		CHEMBL4538313	=	IC50	nM	250.94	CHEMBL4247	Homo sapiens	IC50	nM	250.94
	19113546	CHEMBL4370936	Inhibition of recombinant ALK (unknown origin) using peptide substrate measured after 1 hr by LanthaScreen assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	3.33	CHEMBL4247	Homo sapiens	IC50	nM	3.33
	19140803	CHEMBL4376567	Inhibition of human GST-tagged ALK cytoplasmic domain (1060 to end residues) expressed in sf9 cells at 1 uM using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins in presence of ATP by HTRF assay relative to control	B	Cn1cc(-c2ccc(F)cc2)c(=O)c2c(Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)nccc21		CHEMBL4584949	<	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	19144608	CHEMBL4377624	Inhibition of recombinant human ALK (1058 to end residues) at 1 uM using KKKSPGEYVNIEF as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	-3.0	CHEMBL4247	Homo sapiens	INH	%	-3.0
	19145425	CHEMBL4378233	Inhibition of ALK (unknown origin)	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	20.0	CHEMBL4247	Homo sapiens	IC50	nM	20.0
	19145426	CHEMBL4378233	Inhibition of ALK (unknown origin)	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	=	IC50	nM	1.9	CHEMBL4247	Homo sapiens	IC50	nM	1.9
	19145427	CHEMBL4378233	Inhibition of ALK (unknown origin)	B	C[C@H]1Oc2cc(cnc2N)Cc2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21		CHEMBL4436406	=	IC50	nM	1.01	CHEMBL4247	Homo sapiens	IC50	nM	1.01
	19145428	CHEMBL4378233	Inhibition of ALK (unknown origin)	B	C[C@H]1Oc2cc(cnc2N)Cc2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21		CHEMBL4436406	<	Ki	nM	0.02	CHEMBL4247	Homo sapiens	Ki	nM	0.02
	19145429	CHEMBL4378233	Inhibition of ALK (unknown origin)	B	C[C@H]1CNC(=O)c2cnn3ccc(nc23)N[C@H](C)c2cc(F)ccc2O1		CHEMBL4298138	=	IC50	nM	1.01	CHEMBL4247	Homo sapiens	IC50	nM	1.01
	19145430	CHEMBL4378233	Inhibition of ALK (unknown origin)	B	CCOc1ccc2c3c(oc2c1)C(C)(C)c1cc(OCCN(CC)CC)ccc1C3=O		CHEMBL1779097	=	IC50	nM	1336.0	CHEMBL4247	Homo sapiens	IC50	nM	1336.0
	19145431	CHEMBL4378233	Inhibition of ALK (unknown origin)	B	CCN(CC)CCOc1ccc2c(c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1779192	=	IC50	nM	7.6	CHEMBL4247	Homo sapiens	IC50	nM	7.6
	19145432	CHEMBL4378233	Inhibition of ALK (unknown origin)	B	CC1(C)c2cc(C3CCN(C4COC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL1779202	=	IC50	nM	1.5	CHEMBL4247	Homo sapiens	IC50	nM	1.5
	19145433	CHEMBL4378233	Inhibition of ALK (unknown origin)	B	CCc1cc2c(cc1N1CCN(C3COC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1823221	=	IC50	nM	2.9	CHEMBL4247	Homo sapiens	IC50	nM	2.9
	19145434	CHEMBL4378233	Inhibition of ALK (unknown origin)	B	CCN1C(=O)CCCc2c1ccc(Nc1ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n1)c2OC		CHEMBL2042829	=	IC50	nM	14.0	CHEMBL4247	Homo sapiens	IC50	nM	14.0
	19145435	CHEMBL4378233	Inhibition of ALK (unknown origin)	B	COc1cc(N2CCC(N)CC2)ccc1Nc1ncc(Cl)c(-c2c[nH]c3ccccc23)n1		CHEMBL4203266	=	Ki	nM	0.75	CHEMBL4247	Homo sapiens	Ki	nM	0.75
	19145436	CHEMBL4378233	Inhibition of ALK (unknown origin)	B	COC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccccc3)[nH]c3ccc(CN4CCCCC4)cc32)CC1		CHEMBL2172323	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
	19145437	CHEMBL4378233	Inhibition of ALK (unknown origin)	B	CNC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccccc3)[nH]c3ccc(CN4CCCCC4)cc32)CC1		CHEMBL4476742	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	nM	2.0
	19145438	CHEMBL4378233	Inhibition of ALK (unknown origin)	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3ccc(F)cc3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1		CHEMBL2172308	=	IC50	nM	1.2	CHEMBL4247	Homo sapiens	IC50	nM	1.2
	19145439	CHEMBL4378233	Inhibition of ALK (unknown origin)	B	CC(C)NC(=O)[C@H]1CC[C@@H](n2/c(=N/C(=O)c3cc(F)cc(F)c3)[nH]c3ccc(CN4CCC(C(C)(C)O)CC4)cc32)CC1		CHEMBL2172315	=	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	nM	1.0
	19145440	CHEMBL4378233	Inhibition of ALK (unknown origin)	B	CCc1cc2c(cc1-c1cnn(CC(=O)N(C)C)c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3735401	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	nM	2.0
	19145441	CHEMBL4378233	Inhibition of ALK (unknown origin)	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	=	IC50	nM	0.5	CHEMBL4247	Homo sapiens	IC50	nM	0.5
	19145442	CHEMBL4378234	Inhibition of ALK in human KARPAS299 cells assessed as reduction in NPM-ALK phosphorylation after 1 hrs by ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	32.0	CHEMBL4247	Homo sapiens	IC50	nM	32.0
	19145443	CHEMBL4378235	Inhibition of ALK in human SUDHL1 cells assessed as reduction in NPM-ALK phosphorylation after 1 hrs by ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	43.0	CHEMBL4247	Homo sapiens	IC50	nM	43.0
	19145458	CHEMBL4378241	Inhibition of ALK L1196M mutant in mouse NIH-3T3 cells	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	843.0	CHEMBL4247	Homo sapiens	IC50	nM	843.0
	19145459	CHEMBL4378241	Inhibition of ALK L1196M mutant in mouse NIH-3T3 cells	B	C[C@H]1Oc2cc(cnc2N)Cc2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21		CHEMBL4436406	=	IC50	nM	21.0	CHEMBL4247	Homo sapiens	IC50	nM	21.0
	19145460	CHEMBL4378241	Inhibition of ALK L1196M mutant in mouse NIH-3T3 cells	B	Cc1n[nH]cc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128074	=	IC50	nM	60.0	CHEMBL4247	Homo sapiens	IC50	nM	60.0
	19145461	CHEMBL4378241	Inhibition of ALK L1196M mutant in mouse NIH-3T3 cells	B	Cc1nc(C(C)(C)O)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128064	=	IC50	nM	27.0	CHEMBL4247	Homo sapiens	IC50	nM	27.0
	19145462	CHEMBL4378241	Inhibition of ALK L1196M mutant in mouse NIH-3T3 cells	B	Cc1nc([C@](C)(O)CO)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128069	=	IC50	nM	0.8	CHEMBL4247	Homo sapiens	IC50	nM	0.8
	19145463	CHEMBL4378241	Inhibition of ALK L1196M mutant in mouse NIH-3T3 cells	B	Cc1nn(C)c2c1Cc1cnc(N)c(c1)O[C@H](C)c1cc(F)ccc1C(=O)N(C)C2		CHEMBL4573293	=	IC50	nM	6.6	CHEMBL4247	Homo sapiens	IC50	nM	6.6
	19145470	CHEMBL4378243	Inhibition of ALK L1196M (unknown origin)	B	C[C@H]1Oc2cc(cnc2N)Cc2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21		CHEMBL4436406	=	Ki	nM	0.7	CHEMBL4247	Homo sapiens	Ki	nM	0.7
	19145471	CHEMBL4378243	Inhibition of ALK L1196M (unknown origin)	B	C[C@H]1Oc2cc(cnc2N)Cc2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21		CHEMBL4436406	=	IC50	nM	0.7	CHEMBL4247	Homo sapiens	IC50	nM	0.7
	19145472	CHEMBL4378243	Inhibition of ALK L1196M (unknown origin)	B	C[C@H]1CNC(=O)c2cnn3ccc(nc23)N[C@H](C)c2cc(F)ccc2O1		CHEMBL4298138	=	IC50	nM	1.08	CHEMBL4247	Homo sapiens	IC50	nM	1.08
	19145473	CHEMBL4378243	Inhibition of ALK L1196M (unknown origin)	B	Cc1nc([C@](C)(O)CO)sc1-c1cnc(N)c(O[C@H](C)c2cc(F)ccc2-n2nccn2)c1		CHEMBL3128069	=	IC50	nM	0.2	CHEMBL4247	Homo sapiens	IC50	nM	0.2
	19145474	CHEMBL4378243	Inhibition of ALK L1196M (unknown origin)	B	Cc1nn(C)c2c1Cc1cnc(N)c(c1)O[C@H](C)c1cc(F)ccc1C(=O)N(C)C2		CHEMBL4573293	=	IC50	nM	14.0	CHEMBL4247	Homo sapiens	IC50	nM	14.0
	19145475	CHEMBL4378244	Inhibition of ALK G1202R (unknown origin)	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	=	IC50	nM	2.07	CHEMBL4247	Homo sapiens	IC50	nM	2.07
	19145476	CHEMBL4378244	Inhibition of ALK G1202R (unknown origin)	B	C[C@H]1Oc2cc(cnc2N)Cc2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21		CHEMBL4436406	=	IC50	nM	77.0	CHEMBL4247	Homo sapiens	IC50	nM	77.0
	19145477	CHEMBL4378244	Inhibition of ALK G1202R (unknown origin)	B	C[C@H]1CNC(=O)c2cnn3ccc(nc23)N[C@H](C)c2cc(F)ccc2O1		CHEMBL4298138	=	IC50	nM	1.26	CHEMBL4247	Homo sapiens	IC50	nM	1.26
	19145478	CHEMBL4378244	Inhibition of ALK G1202R (unknown origin)	B	CCc1cc2c(cc1-c1cnn(C)c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3747406	=	IC50	nM	21.0	CHEMBL4247	Homo sapiens	IC50	nM	21.0
	19145479	CHEMBL4378244	Inhibition of ALK G1202R (unknown origin)	B	CCc1cc2c(cc1-c1cnn(CC(=O)N(C)C)c1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL3735401	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	nM	2.0
	19145484	CHEMBL4378231	Inhibition of ALK (unknown origin) by kinome scan-based assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	4.5	CHEMBL4247	Homo sapiens	IC50	nM	4.5
	19145485	CHEMBL4378231	Inhibition of ALK (unknown origin) by kinome scan-based assay	B	C[C@H]1CN(C(=O)c2ccc(NC(=O)c3cc(O[C@H](C)c4c(Cl)ccc(F)c4Cl)c(N)nn3)cc2)C[C@@H](C)N1		CHEMBL4113131	<	IC50	nM	0.4	CHEMBL4247	Homo sapiens	IC50	nM	0.4
	19145497	CHEMBL4378261	Inhibition of ALK (unknown origin) by TR-FRET assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	4.66	CHEMBL4247	Homo sapiens	IC50	nM	4.66
	19145498	CHEMBL4378261	Inhibition of ALK (unknown origin) by TR-FRET assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	3.94	CHEMBL4247	Homo sapiens	IC50	nM	3.94
	19145499	CHEMBL4378261	Inhibition of ALK (unknown origin) by TR-FRET assay	B	CN1CCN(C(=O)c2ccc(-c3cc4c(N5CCC[C@H](C(=O)NCc6ccc(OC(F)(F)F)cc6)C5)ncnc4[nH]3)cc2)CC1		CHEMBL4461100	=	IC50	nM	0.6	CHEMBL4247	Homo sapiens	IC50	nM	0.6
	19145500	CHEMBL4378261	Inhibition of ALK (unknown origin) by TR-FRET assay	B	Cc1cc(NC2CCN(C)CC2)ccc1-c1cc2c(N3CCC[C@H](C(=O)NCc4ccc(Cl)cc4)C3)ncnc2[nH]1		CHEMBL4466561	=	IC50	nM	0.86	CHEMBL4247	Homo sapiens	IC50	nM	0.86
	19145501	CHEMBL4378261	Inhibition of ALK (unknown origin) by TR-FRET assay	B	Cc1cc(NC2CCN(C)CC2)ccc1-c1cc2c(N3CCC[C@H](C(=O)NCc4cccc(OC(F)(F)F)c4)C3)ncnc2[nH]1		CHEMBL4537938	=	IC50	nM	0.64	CHEMBL4247	Homo sapiens	IC50	nM	0.64
	19145502	CHEMBL4378261	Inhibition of ALK (unknown origin) by TR-FRET assay	B	Cc1cc(NC2CCN(C)CC2)ccc1-c1cc2c(N3CCC[C@H](C(=O)NCc4ccc(S(F)(F)F)cc4)C3)ncnc2[nH]1		CHEMBL4588120	=	IC50	nM	0.6	CHEMBL4247	Homo sapiens	IC50	nM	0.6
	19145503	CHEMBL4378261	Inhibition of ALK (unknown origin) by TR-FRET assay	B	Cc1cc(NC2CCN(C)CC2)ccc1-c1cc2c(N3CCC[C@H](C(=O)NCc4ccc(OC(F)(F)F)cc4)C3)ncnc2[nH]1		CHEMBL4522012	=	IC50	nM	0.27	CHEMBL4247	Homo sapiens	IC50	nM	0.27
	19145504	CHEMBL4378260	Inhibition of ALK L1196M mutant (unknown origin) by TR-FRET assay	B	Cc1cc(NC2CCN(C)CC2)ccc1-c1cc2c(N3CCC[C@H](C(=O)NCc4ccc(OC(F)(F)F)cc4)C3)ncnc2[nH]1		CHEMBL4522012	=	IC50	nM	7.51	CHEMBL4247	Homo sapiens	IC50	nM	7.51
	19145505	CHEMBL4378259	Inhibition of ALK C1156Y mutant (unknown origin) by TR-FRET assay	B	Cc1cc(NC2CCN(C)CC2)ccc1-c1cc2c(N3CCC[C@H](C(=O)NCc4ccc(OC(F)(F)F)cc4)C3)ncnc2[nH]1		CHEMBL4522012	=	IC50	nM	4.71	CHEMBL4247	Homo sapiens	IC50	nM	4.71
	19145506	CHEMBL4378258	Inhibition of ALK R1275Q mutant (unknown origin) by TR-FRET assay	B	Cc1cc(NC2CCN(C)CC2)ccc1-c1cc2c(N3CCC[C@H](C(=O)NCc4ccc(OC(F)(F)F)cc4)C3)ncnc2[nH]1		CHEMBL4522012	=	IC50	nM	2.69	CHEMBL4247	Homo sapiens	IC50	nM	2.69
	19145507	CHEMBL4378257	Inhibition of ALK F1174L mutant (unknown origin) by TR-FRET assay	B	Cc1cc(NC2CCN(C)CC2)ccc1-c1cc2c(N3CCC[C@H](C(=O)NCc4ccc(OC(F)(F)F)cc4)C3)ncnc2[nH]1		CHEMBL4522012	=	IC50	nM	9.81	CHEMBL4247	Homo sapiens	IC50	nM	9.81
	19146818	CHEMBL4378974	Inhibition of recombinant human ALK (1058 to end residues) at 10 uM using KKKSPGEYVNIEF as substrate after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	0.0	CHEMBL4247	Homo sapiens	INH	%	0.0
	19147738	CHEMBL4379134	Inhibition of human recombinant ALK (1058 to end residues) using KKKSPGEYVNIEF as substrate incubated for 40 mins in presence of [gamma-33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	uM	10.0
	19158971	CHEMBL4382297	Inhibition of GST-tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay	B	C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1		CHEMBL1229592	=	IC50	nM	990.0	CHEMBL4247	Homo sapiens	IC50	nM	990.0
	19158972	CHEMBL4382297	Inhibition of GST-tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	=	IC50	nM	177.0	CHEMBL4247	Homo sapiens	IC50	nM	177.0
	19158973	CHEMBL4382297	Inhibition of GST-tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	20.0	CHEMBL4247	Homo sapiens	IC50	nM	20.0
	19158974	CHEMBL4382297	Inhibition of GST-tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay	B	C=CC(=O)Nc1cc(Nc2ncc(I)c(Nc3ccccc3S(=O)(=O)N(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4467561	=	IC50	nM	38.0	CHEMBL4247	Homo sapiens	IC50	nM	38.0
	19158975	CHEMBL4382297	Inhibition of GST-tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)N(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4449391	=	IC50	nM	17.0	CHEMBL4247	Homo sapiens	IC50	nM	17.0
	19158976	CHEMBL4382297	Inhibition of GST-tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay	B	C=CC(=O)Nc1cc(Nc2ncc(F)c(Nc3ccccc3S(=O)(=O)N(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4565984	=	IC50	nM	15.0	CHEMBL4247	Homo sapiens	IC50	nM	15.0
	19158977	CHEMBL4382297	Inhibition of GST-tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay	B	C=CC(=O)Nc1cc(Nc2nccc(Nc3ccccc3S(=O)(=O)N(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4540442	=	IC50	nM	31.0	CHEMBL4247	Homo sapiens	IC50	nM	31.0
	19158978	CHEMBL4382297	Inhibition of GST-tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay	B	C=CC(=O)Nc1cc(Nc2ncc(I)c(Nc3ccccc3P(C)(C)=O)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4581316	=	IC50	nM	41.0	CHEMBL4247	Homo sapiens	IC50	nM	41.0
	19158979	CHEMBL4382297	Inhibition of GST-tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3P(C)(C)=O)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4520341	=	IC50	nM	40.0	CHEMBL4247	Homo sapiens	IC50	nM	40.0
	19158980	CHEMBL4382297	Inhibition of GST-tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay	B	C=CC(=O)Nc1cc(Nc2ncc(F)c(Nc3ccccc3P(C)(C)=O)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4558227	=	IC50	nM	123.0	CHEMBL4247	Homo sapiens	IC50	nM	123.0
	19158981	CHEMBL4382297	Inhibition of GST-tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay	B	C=CC(=O)Nc1cc(Nc2nccc(Nc3ccccc3P(C)(C)=O)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4465103	=	IC50	nM	695.0	CHEMBL4247	Homo sapiens	IC50	nM	695.0
	19158982	CHEMBL4382297	Inhibition of GST-tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay	B	C=CC(=O)Nc1cc(Nc2ncc(I)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4531697	=	IC50	nM	91.0	CHEMBL4247	Homo sapiens	IC50	nM	91.0
	19158983	CHEMBL4382297	Inhibition of GST-tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	IC50	nM	18.0	CHEMBL4247	Homo sapiens	IC50	nM	18.0
	19158984	CHEMBL4382297	Inhibition of GST-tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay	B	C=CC(=O)Nc1cc(Nc2ncc(F)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4448107	=	IC50	nM	17.0	CHEMBL4247	Homo sapiens	IC50	nM	17.0
	19158985	CHEMBL4382297	Inhibition of GST-tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay	B	C=CC(=O)Nc1cc(Nc2nccc(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4516287	=	IC50	nM	103.0	CHEMBL4247	Homo sapiens	IC50	nM	103.0
	19159111	CHEMBL4382318	Inhibition of ALK L1152R mutant in human DFCI076 cells assessed as reduction in cell viability after 72 hrs by MTS assay in presence of osimertinib	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	EC50	nM	3210.0	CHEMBL4247	Homo sapiens	EC50	uM	3.21
	19159129	CHEMBL4382333	Inhibition of ALK L1152R mutant in human DFCI076 cells assessed as reduction in cell viability after 72 hrs by MTS assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	EC50	nM	3490.0	CHEMBL4247	Homo sapiens	EC50	uM	3.49
	19159283	CHEMBL4382387	Binding affinity to wild-type human partial length ALK (I1088 to E1409 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	0.0	CHEMBL4247	Homo sapiens	Activity	%	0.0
	19159284	CHEMBL4382388	Binding affinity to wild-type human partial length ALK C1156Y mutant (I1088 to E1409 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	0.2	CHEMBL4247	Homo sapiens	Activity	%	0.2
	19159285	CHEMBL4382389	Binding affinity to wild-type human partial length ALK L1196M mutant (I1088 to E1409 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	0.0	CHEMBL4247	Homo sapiens	Activity	%	0.0
	19159839	CHEMBL4382851	Inhibition of recombinant ALK (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=CC(=O)N1CC[C@H](n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)ncnc32)C1		CHEMBL4475243	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	19187430	CHEMBL4388503	Inhibition of wild-type ALK (unknown origin)	B	[2H]C([2H])([2H])Oc1cc(C2CCNCC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4464582	=	IC50	nM	71.0	CHEMBL4247	Homo sapiens	IC50	nM	71.0
	19187431	CHEMBL4388503	Inhibition of wild-type ALK (unknown origin)	B	[2H]C([2H])([2H])C([2H])([2H])Oc1cc(C2CCNCC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4451829	=	IC50	nM	106.3	CHEMBL4247	Homo sapiens	IC50	nM	106.3
	19187432	CHEMBL4388503	Inhibition of wild-type ALK (unknown origin)	B	[2H]C([2H])([2H])C([2H])(Oc1cc(C2CCNCC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1)C([2H])([2H])[2H]		CHEMBL4476089	=	IC50	nM	169.8	CHEMBL4247	Homo sapiens	IC50	nM	169.8
	19187433	CHEMBL4388503	Inhibition of wild-type ALK (unknown origin)	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	198.0	CHEMBL4247	Homo sapiens	IC50	nM	198.0
	19187434	CHEMBL4388504	Inhibition of ALK L1196M mutant (unknown origin)	B	[2H]C([2H])([2H])Oc1cc(C2CCNCC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4464582	=	IC50	nM	18.72	CHEMBL4247	Homo sapiens	IC50	nM	18.72
	19187435	CHEMBL4388504	Inhibition of ALK L1196M mutant (unknown origin)	B	[2H]C([2H])([2H])C([2H])([2H])Oc1cc(C2CCNCC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4451829	=	IC50	nM	36.98	CHEMBL4247	Homo sapiens	IC50	nM	36.98
	19187436	CHEMBL4388504	Inhibition of ALK L1196M mutant (unknown origin)	B	[2H]C([2H])([2H])C([2H])(Oc1cc(C2CCNCC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1)C([2H])([2H])[2H]		CHEMBL4476089	=	IC50	nM	63.42	CHEMBL4247	Homo sapiens	IC50	nM	63.42
	19187437	CHEMBL4388504	Inhibition of ALK L1196M mutant (unknown origin)	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	47.65	CHEMBL4247	Homo sapiens	IC50	nM	47.65
	19187438	CHEMBL4388505	Inhibition of ALK F1174L mutant (unknown origin)	B	[2H]C([2H])([2H])Oc1cc(C2CCNCC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4464582	=	IC50	nM	36.81	CHEMBL4247	Homo sapiens	IC50	nM	36.81
	19187439	CHEMBL4388505	Inhibition of ALK F1174L mutant (unknown origin)	B	[2H]C([2H])([2H])C([2H])([2H])Oc1cc(C2CCNCC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4451829	=	IC50	nM	51.62	CHEMBL4247	Homo sapiens	IC50	nM	51.62
	19187440	CHEMBL4388505	Inhibition of ALK F1174L mutant (unknown origin)	B	[2H]C([2H])([2H])C([2H])(Oc1cc(C2CCNCC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1)C([2H])([2H])[2H]		CHEMBL4476089	=	IC50	nM	109.3	CHEMBL4247	Homo sapiens	IC50	nM	109.3
	19187441	CHEMBL4388505	Inhibition of ALK F1174L mutant (unknown origin)	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	114.3	CHEMBL4247	Homo sapiens	IC50	nM	114.3
	19191240	CHEMBL4389585	Inhibition of wild-type human partial length ALK L1196M mutant (I1088 to E1409 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	74.0	CHEMBL4247	Homo sapiens	INH	%	74.0
	19191241	CHEMBL4389584	Inhibition of wild-type human partial length ALK C1156Y mutant (I1088 to E1409 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	70.0	CHEMBL4247	Homo sapiens	INH	%	70.0
	19191242	CHEMBL4389583	Inhibition of wild-type human partial length ALK (I1088 to E1409 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	98.0	CHEMBL4247	Homo sapiens	INH	%	98.0
	19191722	CHEMBL4389108	Inhibition of wild-type human partial length ALK L1196M mutant (I1088 to E1409 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	63.0	CHEMBL4247	Homo sapiens	INH	%	63.0
	19191723	CHEMBL4389107	Inhibition of wild-type human partial length ALK C1156Y mutant (I1088 to E1409 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	57.0	CHEMBL4247	Homo sapiens	INH	%	57.0
	19191724	CHEMBL4389106	Inhibition of wild-type human partial length ALK (I1088 to E1409 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	80.0	CHEMBL4247	Homo sapiens	INH	%	80.0
	19200011	CHEMBL4391211	Binding affinity to wild-type human partial length ALK L1196M mutant (I1088 to E1409 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	100.0	CHEMBL4247	Homo sapiens	Activity	%	100.0
	19200012	CHEMBL4391210	Binding affinity to wild-type human partial length ALK C1156Y mutant (I1088 to E1409 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	100.0	CHEMBL4247	Homo sapiens	Activity	%	100.0
	19200013	CHEMBL4391209	Binding affinity to wild-type human partial length ALK (I1088 to E1409 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	100.0	CHEMBL4247	Homo sapiens	Activity	%	100.0
	19230877	CHEMBL4397145	Inhibition of human ALK kinase domain (1058 to 1620 residues) expressed in baculovirus expression system using biotin-poly-GT as substrate pre-incubated for 10 mins followed by ATP addition and measured after 60 mins by HTRF method	B	Cc1cc(-c2cnc3ccc(N[C@@H](C)c4ccc(F)cc4F)nn23)[nH]n1		CHEMBL4562879	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	nM	2.0
	19230878	CHEMBL4397145	Inhibition of human ALK kinase domain (1058 to 1620 residues) expressed in baculovirus expression system using biotin-poly-GT as substrate pre-incubated for 10 mins followed by ATP addition and measured after 60 mins by HTRF method	B	Cc1cc(-n2ccc3ccc(N[C@@H](C)c4ccc(F)cc4F)nc32)[nH]n1		CHEMBL4448434	=	IC50	nM	14.0	CHEMBL4247	Homo sapiens	IC50	nM	14.0
	19230879	CHEMBL4397145	Inhibition of human ALK kinase domain (1058 to 1620 residues) expressed in baculovirus expression system using biotin-poly-GT as substrate pre-incubated for 10 mins followed by ATP addition and measured after 60 mins by HTRF method	B	Cc1cc(-n2cc(S(C)(=O)=O)c3ccc(N[C@@H](C)c4ccc(F)cc4F)nc32)n[nH]1		CHEMBL4460367	=	IC50	nM	1.2	CHEMBL4247	Homo sapiens	IC50	nM	1.2
	19230880	CHEMBL4397145	Inhibition of human ALK kinase domain (1058 to 1620 residues) expressed in baculovirus expression system using biotin-poly-GT as substrate pre-incubated for 10 mins followed by ATP addition and measured after 60 mins by HTRF method	B	Cc1cc(-n2cc(S(C)(=O)=O)c3ccc(N[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL4535072	=	IC50	nM	3.3	CHEMBL4247	Homo sapiens	IC50	nM	3.3
	19230881	CHEMBL4397145	Inhibition of human ALK kinase domain (1058 to 1620 residues) expressed in baculovirus expression system using biotin-poly-GT as substrate pre-incubated for 10 mins followed by ATP addition and measured after 60 mins by HTRF method	B	CCS(=O)(=O)c1cn(-c2cc(C)[nH]n2)c2nc(N[C@@H](C)c3ccc(F)cn3)ccc12		CHEMBL4443254	=	IC50	nM	9.6	CHEMBL4247	Homo sapiens	IC50	nM	9.6
	19230882	CHEMBL4397145	Inhibition of human ALK kinase domain (1058 to 1620 residues) expressed in baculovirus expression system using biotin-poly-GT as substrate pre-incubated for 10 mins followed by ATP addition and measured after 60 mins by HTRF method	B	Cc1cc(-n2cc(S(=O)(=O)C(C)C)c3ccc(N[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL4435574	=	IC50	nM	18.0	CHEMBL4247	Homo sapiens	IC50	nM	18.0
	19230883	CHEMBL4397145	Inhibition of human ALK kinase domain (1058 to 1620 residues) expressed in baculovirus expression system using biotin-poly-GT as substrate pre-incubated for 10 mins followed by ATP addition and measured after 60 mins by HTRF method	B	Cc1cc(-n2cc(S(=O)(=O)C3COC3)c3ccc(N[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL4516124	=	IC50	nM	20.0	CHEMBL4247	Homo sapiens	IC50	nM	20.0
	19230884	CHEMBL4397145	Inhibition of human ALK kinase domain (1058 to 1620 residues) expressed in baculovirus expression system using biotin-poly-GT as substrate pre-incubated for 10 mins followed by ATP addition and measured after 60 mins by HTRF method	B	Cc1cc(-n2cc(C(=O)N(C)C)c3ccc(N[C@@H](C)c4ccc(F)cn4)nc32)[nH]n1		CHEMBL4516801	=	IC50	nM	1.8	CHEMBL4247	Homo sapiens	IC50	nM	1.8
	19230885	CHEMBL4397145	Inhibition of human ALK kinase domain (1058 to 1620 residues) expressed in baculovirus expression system using biotin-poly-GT as substrate pre-incubated for 10 mins followed by ATP addition and measured after 60 mins by HTRF method	B	Cc1cc(-n2cc(C(=O)N3CCOCC3)c3ccc(N[C@@H](C)c4ccc(F)cn4)nc32)[nH]n1		CHEMBL4437605	=	IC50	nM	2.5	CHEMBL4247	Homo sapiens	IC50	nM	2.5
	19230886	CHEMBL4397145	Inhibition of human ALK kinase domain (1058 to 1620 residues) expressed in baculovirus expression system using biotin-poly-GT as substrate pre-incubated for 10 mins followed by ATP addition and measured after 60 mins by HTRF method	B	Cc1cc(-n2cc(C(=O)N3CCN(C)CC3)c3ccc(N[C@@H](C)c4ccc(F)cn4)nc32)[nH]n1		CHEMBL4586773	=	IC50	nM	6.1	CHEMBL4247	Homo sapiens	IC50	nM	6.1
	19230887	CHEMBL4397145	Inhibition of human ALK kinase domain (1058 to 1620 residues) expressed in baculovirus expression system using biotin-poly-GT as substrate pre-incubated for 10 mins followed by ATP addition and measured after 60 mins by HTRF method	B	Cc1cc(-n2cc(C3=CCOCC3)c3ccc(N[C@@H](C)c4ccc(F)cn4)nc32)[nH]n1		CHEMBL4458269	=	IC50	nM	1.9	CHEMBL4247	Homo sapiens	IC50	nM	1.9
	19230888	CHEMBL4397145	Inhibition of human ALK kinase domain (1058 to 1620 residues) expressed in baculovirus expression system using biotin-poly-GT as substrate pre-incubated for 10 mins followed by ATP addition and measured after 60 mins by HTRF method	B	Cc1cc(-n2cc(C(=O)N3CCOCC3)c3ccc(OC(C)c4ccc(F)cn4)nc32)[nH]n1		CHEMBL4476859	=	IC50	nM	6.2	CHEMBL4247	Homo sapiens	IC50	nM	6.2
	19230889	CHEMBL4397145	Inhibition of human ALK kinase domain (1058 to 1620 residues) expressed in baculovirus expression system using biotin-poly-GT as substrate pre-incubated for 10 mins followed by ATP addition and measured after 60 mins by HTRF method	B	Cc1cc(-n2cc(C(=O)N3CCO[C@@H](C)C3)c3ccc(O[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL4440381	=	IC50	nM	2.9	CHEMBL4247	Homo sapiens	IC50	nM	2.9
	19230890	CHEMBL4397145	Inhibition of human ALK kinase domain (1058 to 1620 residues) expressed in baculovirus expression system using biotin-poly-GT as substrate pre-incubated for 10 mins followed by ATP addition and measured after 60 mins by HTRF method	B	Cc1cc(-n2cc(C(=O)N3CCO[C@H](C)C3)c3ccc(O[C@H](C)c4ccc(F)cn4)nc32)[nH]n1		CHEMBL4573505	=	IC50	nM	4.6	CHEMBL4247	Homo sapiens	IC50	nM	4.6
	19230891	CHEMBL4397145	Inhibition of human ALK kinase domain (1058 to 1620 residues) expressed in baculovirus expression system using biotin-poly-GT as substrate pre-incubated for 10 mins followed by ATP addition and measured after 60 mins by HTRF method	B	COCc1cn(-c2cc(C)n[nH]2)c2nc(OC(C)c3ccc(F)cn3)ccc12		CHEMBL4434659	=	IC50	nM	3.2	CHEMBL4247	Homo sapiens	IC50	nM	3.2
	19230892	CHEMBL4397145	Inhibition of human ALK kinase domain (1058 to 1620 residues) expressed in baculovirus expression system using biotin-poly-GT as substrate pre-incubated for 10 mins followed by ATP addition and measured after 60 mins by HTRF method	B	COCc1cn(-c2cc(C)n[nH]2)c2nc(OC(C)c3ccc(F)cn3)ccc12		CHEMBL4434659	=	IC50	nM	2800.0	CHEMBL4247	Homo sapiens	IC50	nM	2800.0
	19230909	CHEMBL4397147	Inhibition of recombinant human ALK expressed in HEK293 cells assessed as reduction in ALK autophosphorylation at Tyr1604 residue incubated for 60 mins by sandwich ELISA	B	Cc1cc(-c2cnc3ccc(N[C@@H](C)c4ccc(F)cc4F)nn23)[nH]n1		CHEMBL4562879	=	IC50	nM	6.0	CHEMBL4247	Homo sapiens	IC50	nM	6.0
	19230910	CHEMBL4397147	Inhibition of recombinant human ALK expressed in HEK293 cells assessed as reduction in ALK autophosphorylation at Tyr1604 residue incubated for 60 mins by sandwich ELISA	B	Cc1cc(-n2ccc3ccc(N[C@@H](C)c4ccc(F)cc4F)nc32)[nH]n1		CHEMBL4448434	=	IC50	nM	140.0	CHEMBL4247	Homo sapiens	IC50	nM	140.0
	19230911	CHEMBL4397147	Inhibition of recombinant human ALK expressed in HEK293 cells assessed as reduction in ALK autophosphorylation at Tyr1604 residue incubated for 60 mins by sandwich ELISA	B	Cc1cc(-n2cc(S(C)(=O)=O)c3ccc(N[C@@H](C)c4ccc(F)cc4F)nc32)n[nH]1		CHEMBL4460367	=	IC50	nM	27.0	CHEMBL4247	Homo sapiens	IC50	nM	27.0
	19230912	CHEMBL4397147	Inhibition of recombinant human ALK expressed in HEK293 cells assessed as reduction in ALK autophosphorylation at Tyr1604 residue incubated for 60 mins by sandwich ELISA	B	Cc1cc(-n2cc(S(C)(=O)=O)c3ccc(N[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL4535072	=	IC50	nM	13.0	CHEMBL4247	Homo sapiens	IC50	nM	13.0
	19230913	CHEMBL4397147	Inhibition of recombinant human ALK expressed in HEK293 cells assessed as reduction in ALK autophosphorylation at Tyr1604 residue incubated for 60 mins by sandwich ELISA	B	CCS(=O)(=O)c1cn(-c2cc(C)[nH]n2)c2nc(N[C@@H](C)c3ccc(F)cn3)ccc12		CHEMBL4443254	=	IC50	nM	37.0	CHEMBL4247	Homo sapiens	IC50	nM	37.0
	19230914	CHEMBL4397147	Inhibition of recombinant human ALK expressed in HEK293 cells assessed as reduction in ALK autophosphorylation at Tyr1604 residue incubated for 60 mins by sandwich ELISA	B	Cc1cc(-n2cc(S(=O)(=O)C(C)C)c3ccc(N[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL4435574	=	IC50	nM	270.0	CHEMBL4247	Homo sapiens	IC50	nM	270.0
	19230915	CHEMBL4397147	Inhibition of recombinant human ALK expressed in HEK293 cells assessed as reduction in ALK autophosphorylation at Tyr1604 residue incubated for 60 mins by sandwich ELISA	B	Cc1cc(-n2cc(S(=O)(=O)C3COC3)c3ccc(N[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL4516124	=	IC50	nM	60.0	CHEMBL4247	Homo sapiens	IC50	nM	60.0
	19230916	CHEMBL4397147	Inhibition of recombinant human ALK expressed in HEK293 cells assessed as reduction in ALK autophosphorylation at Tyr1604 residue incubated for 60 mins by sandwich ELISA	B	Cc1cc(-n2cc(C(=O)N(C)C)c3ccc(N[C@@H](C)c4ccc(F)cn4)nc32)[nH]n1		CHEMBL4516801	=	IC50	nM	16.0	CHEMBL4247	Homo sapiens	IC50	nM	16.0
	19230917	CHEMBL4397147	Inhibition of recombinant human ALK expressed in HEK293 cells assessed as reduction in ALK autophosphorylation at Tyr1604 residue incubated for 60 mins by sandwich ELISA	B	Cc1cc(-n2cc(C(=O)N3CCOCC3)c3ccc(N[C@@H](C)c4ccc(F)cn4)nc32)[nH]n1		CHEMBL4437605	=	IC50	nM	23.0	CHEMBL4247	Homo sapiens	IC50	nM	23.0
	19230918	CHEMBL4397147	Inhibition of recombinant human ALK expressed in HEK293 cells assessed as reduction in ALK autophosphorylation at Tyr1604 residue incubated for 60 mins by sandwich ELISA	B	Cc1cc(-n2cc(C(=O)N3CCN(C)CC3)c3ccc(N[C@@H](C)c4ccc(F)cn4)nc32)[nH]n1		CHEMBL4586773	=	IC50	nM	37.0	CHEMBL4247	Homo sapiens	IC50	nM	37.0
	19230919	CHEMBL4397147	Inhibition of recombinant human ALK expressed in HEK293 cells assessed as reduction in ALK autophosphorylation at Tyr1604 residue incubated for 60 mins by sandwich ELISA	B	Cc1cc(-n2cc(C3=CCOCC3)c3ccc(N[C@@H](C)c4ccc(F)cn4)nc32)[nH]n1		CHEMBL4458269	=	IC50	nM	9.4	CHEMBL4247	Homo sapiens	IC50	nM	9.4
	19230920	CHEMBL4397147	Inhibition of recombinant human ALK expressed in HEK293 cells assessed as reduction in ALK autophosphorylation at Tyr1604 residue incubated for 60 mins by sandwich ELISA	B	Cc1cc(-n2cc(C(=O)N3CCOCC3)c3ccc(OC(C)c4ccc(F)cn4)nc32)[nH]n1		CHEMBL4476859	=	IC50	nM	69.0	CHEMBL4247	Homo sapiens	IC50	nM	69.0
	19230921	CHEMBL4397147	Inhibition of recombinant human ALK expressed in HEK293 cells assessed as reduction in ALK autophosphorylation at Tyr1604 residue incubated for 60 mins by sandwich ELISA	B	Cc1cc(-n2cc(C(=O)N3CCO[C@@H](C)C3)c3ccc(O[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL4440381	=	IC50	nM	27.0	CHEMBL4247	Homo sapiens	IC50	nM	27.0
	19230922	CHEMBL4397147	Inhibition of recombinant human ALK expressed in HEK293 cells assessed as reduction in ALK autophosphorylation at Tyr1604 residue incubated for 60 mins by sandwich ELISA	B	Cc1cc(-n2cc(C(=O)N3CCO[C@H](C)C3)c3ccc(O[C@H](C)c4ccc(F)cn4)nc32)[nH]n1		CHEMBL4573505	=	IC50	nM	42.0	CHEMBL4247	Homo sapiens	IC50	nM	42.0
	19230952	CHEMBL4397145	Inhibition of human ALK kinase domain (1058 to 1620 residues) expressed in baculovirus expression system using biotin-poly-GT as substrate pre-incubated for 10 mins followed by ATP addition and measured after 60 mins by HTRF method	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	1.8	CHEMBL4247	Homo sapiens	IC50	nM	1.8
	19230953	CHEMBL4397147	Inhibition of recombinant human ALK expressed in HEK293 cells assessed as reduction in ALK autophosphorylation at Tyr1604 residue incubated for 60 mins by sandwich ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	37.0	CHEMBL4247	Homo sapiens	IC50	nM	37.0
	19230954	CHEMBL4397145	Inhibition of human ALK kinase domain (1058 to 1620 residues) expressed in baculovirus expression system using biotin-poly-GT as substrate pre-incubated for 10 mins followed by ATP addition and measured after 60 mins by HTRF method	B	Cc1cc(-c2cnc3ccc(N[C@H](C)c4ccc(F)cc4F)nn23)[nH]n1		CHEMBL4529040	=	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	19236750	CHEMBL4398823	Inhibition of ALK (unknown origin) at 100 nM relative to control	B	COc1cc2c(Nc3ccc(NC(=O)C(c4cc(F)ccc4F)N4Cc5ccccc5C4=O)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL4443483	<	Inhibition	%	25.0	CHEMBL4247	Homo sapiens	INH	%	25.0
	19242704	CHEMBL4400039	Inhibition of human recombinant ALK (1058 to end residues) assessed as residual activity at 10 uM using KKKSPGEYVNIEF as substrate incubated for 40 mins in presence of [gamma-33P]ATP at Km concentration by radiometric assay relative to control	B	COc1ccc2c(CCNc3nc(NCc4ccc(=O)[nH]c4)c4nc[nH]c4n3)c[nH]c2c1		CHEMBL4555782	=	Activity	%	88.0	CHEMBL4247	Homo sapiens	Activity	%	88.0
	19244227	CHEMBL4400313	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) cytoplasmic domain expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(N2CCCC2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2NC(C)=O)n1		CHEMBL4471142	=	IC50	nM	6.2	CHEMBL4247	Homo sapiens	IC50	nM	6.2
	19244228	CHEMBL4400313	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) cytoplasmic domain expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(N2CCCNC2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2NC(C)=O)n1		CHEMBL4536955	=	IC50	nM	4.7	CHEMBL4247	Homo sapiens	IC50	nM	4.7
	19244229	CHEMBL4400313	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) cytoplasmic domain expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(NC(=O)C2CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NC(C)=O)n1		CHEMBL4462528	=	IC50	nM	4.1	CHEMBL4247	Homo sapiens	IC50	nM	4.1
	19244230	CHEMBL4400313	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) cytoplasmic domain expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	2.7	CHEMBL4247	Homo sapiens	IC50	nM	2.7
	19244231	CHEMBL4400313	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) cytoplasmic domain expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(NC(=O)NC2CCC(=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NC(C)=O)n1		CHEMBL4546844	=	IC50	nM	2.5	CHEMBL4247	Homo sapiens	IC50	nM	2.5
	19244232	CHEMBL4400313	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) cytoplasmic domain expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(NC(=O)N2CCCC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NC(C)=O)n1		CHEMBL4448400	=	IC50	nM	5.1	CHEMBL4247	Homo sapiens	IC50	nM	5.1
	19244233	CHEMBL4400313	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) cytoplasmic domain expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(NC(=O)N2CCOCC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NC(C)=O)n1		CHEMBL4562805	=	IC50	nM	2.1	CHEMBL4247	Homo sapiens	IC50	nM	2.1
	19244234	CHEMBL4400313	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) cytoplasmic domain expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(NC(=O)N2CCN(CCO)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NC(C)=O)n1		CHEMBL4468370	=	IC50	nM	6.3	CHEMBL4247	Homo sapiens	IC50	nM	6.3
	19244235	CHEMBL4400312	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) cytoplasmic domain L1196M mutant expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(N2CCCC2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2NC(C)=O)n1		CHEMBL4471142	=	IC50	nM	2.9	CHEMBL4247	Homo sapiens	IC50	nM	2.9
	19244236	CHEMBL4400312	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) cytoplasmic domain L1196M mutant expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(N2CCCNC2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2NC(C)=O)n1		CHEMBL4536955	=	IC50	nM	5.1	CHEMBL4247	Homo sapiens	IC50	nM	5.1
	19244237	CHEMBL4400312	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) cytoplasmic domain L1196M mutant expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(NC(=O)C2CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NC(C)=O)n1		CHEMBL4462528	=	IC50	nM	6.6	CHEMBL4247	Homo sapiens	IC50	nM	6.6
	19244238	CHEMBL4400312	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) cytoplasmic domain L1196M mutant expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	3.1	CHEMBL4247	Homo sapiens	IC50	nM	3.1
	19244239	CHEMBL4400312	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) cytoplasmic domain L1196M mutant expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(NC(=O)NC2CCC(=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NC(C)=O)n1		CHEMBL4546844	=	IC50	nM	3.9	CHEMBL4247	Homo sapiens	IC50	nM	3.9
	19244240	CHEMBL4400312	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) cytoplasmic domain L1196M mutant expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(NC(=O)N2CCCC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NC(C)=O)n1		CHEMBL4448400	=	IC50	nM	3.7	CHEMBL4247	Homo sapiens	IC50	nM	3.7
	19244241	CHEMBL4400312	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) cytoplasmic domain L1196M mutant expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(NC(=O)N2CCOCC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NC(C)=O)n1		CHEMBL4562805	=	IC50	nM	0.91	CHEMBL4247	Homo sapiens	IC50	nM	0.91
	19244242	CHEMBL4400312	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) cytoplasmic domain L1196M mutant expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(NC(=O)N2CCN(CCO)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NC(C)=O)n1		CHEMBL4468370	=	IC50	nM	2.7	CHEMBL4247	Homo sapiens	IC50	nM	2.7
	19244267	CHEMBL4400323	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) cytoplasmic domain G1202R mutant using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(N2CCCC2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2NC(C)=O)n1		CHEMBL4471142	=	IC50	nM	15.7	CHEMBL4247	Homo sapiens	IC50	nM	15.7
	19244268	CHEMBL4400323	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) cytoplasmic domain G1202R mutant using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(N2CCCNC2=O)ccc1Nc1ncc(Cl)c(Nc2ccccc2NC(C)=O)n1		CHEMBL4536955	=	IC50	nM	10.2	CHEMBL4247	Homo sapiens	IC50	nM	10.2
	19244269	CHEMBL4400323	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) cytoplasmic domain G1202R mutant using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(NC(=O)C2CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NC(C)=O)n1		CHEMBL4462528	=	IC50	nM	11.5	CHEMBL4247	Homo sapiens	IC50	nM	11.5
	19244270	CHEMBL4400323	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) cytoplasmic domain G1202R mutant using srctide as substrate incubated for 1 hr by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	197.0	CHEMBL4247	Homo sapiens	IC50	nM	197.0
	19244271	CHEMBL4400323	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) cytoplasmic domain G1202R mutant using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(NC(=O)NC2CCC(=O)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NC(C)=O)n1		CHEMBL4546844	=	IC50	nM	9.3	CHEMBL4247	Homo sapiens	IC50	nM	9.3
	19244272	CHEMBL4400323	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) cytoplasmic domain G1202R mutant using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(NC(=O)N2CCCC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NC(C)=O)n1		CHEMBL4448400	=	IC50	nM	7.1	CHEMBL4247	Homo sapiens	IC50	nM	7.1
	19244273	CHEMBL4400323	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) cytoplasmic domain G1202R mutant using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(NC(=O)N2CCOCC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NC(C)=O)n1		CHEMBL4562805	=	IC50	nM	4.3	CHEMBL4247	Homo sapiens	IC50	nM	4.3
	19244274	CHEMBL4400323	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) cytoplasmic domain G1202R mutant using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(NC(=O)N2CCN(CCO)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NC(C)=O)n1		CHEMBL4468370	=	IC50	nM	6.3	CHEMBL4247	Homo sapiens	IC50	nM	6.3
	19244275	CHEMBL4400324	Potency index, ratio of IC50 of ceritinib to IC50 of compound for inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) cytoplasmic domain expressed in baculovirus expression system L1196M mutant using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(NC(=O)N2CCOCC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NC(C)=O)n1		CHEMBL4562805	=	Ratio IC50		3.4	CHEMBL4247	Homo sapiens	Ratio IC50		3.4
	19244277	CHEMBL4400326	Potency index, ratio of IC50 of ceritinib to IC50 of compound for inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) cytoplasmic domain G1202R mutant expressed in baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(NC(=O)N2CCOCC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NC(C)=O)n1		CHEMBL4562805	=	Ratio IC50		45.0	CHEMBL4247	Homo sapiens	Ratio IC50		45.0
	19251995	CHEMBL4401876	Displacement of kinase tracer 236 from human N-terminal GST-tagged ALK F1174L mutant (1058 to 1620 residues) after 60 mins by LanthaScreen Eu--kinase binding assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	IC50	nM	180.0	CHEMBL4247	Homo sapiens	IC50	nM	180.0
	19251996	CHEMBL4401876	Displacement of kinase tracer 236 from human N-terminal GST-tagged ALK F1174L mutant (1058 to 1620 residues) after 60 mins by LanthaScreen Eu--kinase binding assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL4456099	=	IC50	nM	290.0	CHEMBL4247	Homo sapiens	IC50	nM	290.0
	19251997	CHEMBL4401876	Displacement of kinase tracer 236 from human N-terminal GST-tagged ALK F1174L mutant (1058 to 1620 residues) after 60 mins by LanthaScreen Eu--kinase binding assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OCC(C)C)nc2N1C1CCCC1		CHEMBL3609312	=	IC50	nM	1700.0	CHEMBL4247	Homo sapiens	IC50	nM	1700.0
	19251998	CHEMBL4401876	Displacement of kinase tracer 236 from human N-terminal GST-tagged ALK F1174L mutant (1058 to 1620 residues) after 60 mins by LanthaScreen Eu--kinase binding assay	B	CCOc1cc(C(=O)NC2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)[C@H](CC)C(=O)N2C		CHEMBL4464826	=	IC50	nM	380.0	CHEMBL4247	Homo sapiens	IC50	nM	380.0
	19251999	CHEMBL4401876	Displacement of kinase tracer 236 from human N-terminal GST-tagged ALK F1174L mutant (1058 to 1620 residues) after 60 mins by LanthaScreen Eu--kinase binding assay	B	CCOc1cc(C(=O)NC2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)[C@@H](CC)C(=O)N2C		CHEMBL4551421	=	IC50	nM	3400.0	CHEMBL4247	Homo sapiens	IC50	nM	3400.0
	19252000	CHEMBL4401876	Displacement of kinase tracer 236 from human N-terminal GST-tagged ALK F1174L mutant (1058 to 1620 residues) after 60 mins by LanthaScreen Eu--kinase binding assay	B	CCOc1cc(C(=O)NC2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C1CCCC1)CC(=O)N2C		CHEMBL4436006	=	IC50	nM	520.0	CHEMBL4247	Homo sapiens	IC50	nM	520.0
	19252001	CHEMBL4401876	Displacement of kinase tracer 236 from human N-terminal GST-tagged ALK F1174L mutant (1058 to 1620 residues) after 60 mins by LanthaScreen Eu--kinase binding assay	B	CCOc1cc(C(=O)NC2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(Cc1cccc(Br)c1)[C@H](CC)C(=O)N2C		CHEMBL4469756	=	IC50	nM	490.0	CHEMBL4247	Homo sapiens	IC50	nM	490.0
	19252002	CHEMBL4401876	Displacement of kinase tracer 236 from human N-terminal GST-tagged ALK F1174L mutant (1058 to 1620 residues) after 60 mins by LanthaScreen Eu--kinase binding assay	B	CCOc1cc(C(=O)NC2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(Cc1ccccc1)[C@H](CC)C(=O)N2C		CHEMBL4457809	=	IC50	nM	440.0	CHEMBL4247	Homo sapiens	IC50	nM	440.0
	19252003	CHEMBL4401876	Displacement of kinase tracer 236 from human N-terminal GST-tagged ALK F1174L mutant (1058 to 1620 residues) after 60 mins by LanthaScreen Eu--kinase binding assay	B	CCOc1cc(C2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(Cc1cccc(Br)c1)[C@H](CC)C(=O)N2C		CHEMBL4451065	=	IC50	nM	290.0	CHEMBL4247	Homo sapiens	IC50	nM	290.0
	19252004	CHEMBL4401876	Displacement of kinase tracer 236 from human N-terminal GST-tagged ALK F1174L mutant (1058 to 1620 residues) after 60 mins by LanthaScreen Eu--kinase binding assay	B	CCOc1cc(C2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(Cc1ccccc1)[C@H](CC)C(=O)N2C		CHEMBL4469087	=	IC50	nM	85.0	CHEMBL4247	Homo sapiens	IC50	nM	85.0
	19252005	CHEMBL4401876	Displacement of kinase tracer 236 from human N-terminal GST-tagged ALK F1174L mutant (1058 to 1620 residues) after 60 mins by LanthaScreen Eu--kinase binding assay	B	CCOc1cc(C2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(Cc1cccc(Cl)c1)[C@H](CC)C(=O)N2C		CHEMBL4448214	=	IC50	nM	210.0	CHEMBL4247	Homo sapiens	IC50	nM	210.0
	19252006	CHEMBL4401876	Displacement of kinase tracer 236 from human N-terminal GST-tagged ALK F1174L mutant (1058 to 1620 residues) after 60 mins by LanthaScreen Eu--kinase binding assay	B	CCOc1cc(C2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(Cc1cccc(C#N)c1)[C@H](CC)C(=O)N2C		CHEMBL4588843	=	IC50	nM	370.0	CHEMBL4247	Homo sapiens	IC50	nM	370.0
	19252007	CHEMBL4401876	Displacement of kinase tracer 236 from human N-terminal GST-tagged ALK F1174L mutant (1058 to 1620 residues) after 60 mins by LanthaScreen Eu--kinase binding assay	B	CCOc1cc(C2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(Cc1cccc(OC)c1)[C@H](CC)C(=O)N2C		CHEMBL4454885	=	IC50	nM	350.0	CHEMBL4247	Homo sapiens	IC50	nM	350.0
	19252008	CHEMBL4401876	Displacement of kinase tracer 236 from human N-terminal GST-tagged ALK F1174L mutant (1058 to 1620 residues) after 60 mins by LanthaScreen Eu--kinase binding assay	B	CCOc1cc(C2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(Cc1ccccc1Br)[C@H](CC)C(=O)N2C		CHEMBL4557730	=	IC50	nM	150.0	CHEMBL4247	Homo sapiens	IC50	nM	150.0
	19252009	CHEMBL4401876	Displacement of kinase tracer 236 from human N-terminal GST-tagged ALK F1174L mutant (1058 to 1620 residues) after 60 mins by LanthaScreen Eu--kinase binding assay	B	CCOc1cc(C2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(Cc1ccc(Br)cc1)[C@H](CC)C(=O)N2C		CHEMBL4459025	=	IC50	nM	680.0	CHEMBL4247	Homo sapiens	IC50	nM	680.0
	19252010	CHEMBL4401876	Displacement of kinase tracer 236 from human N-terminal GST-tagged ALK F1174L mutant (1058 to 1620 residues) after 60 mins by LanthaScreen Eu--kinase binding assay	B	CCOc1cc(C2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(Cc1sccc1C)[C@H](CC)C(=O)N2C		CHEMBL4543331	=	IC50	nM	63.0	CHEMBL4247	Homo sapiens	IC50	nM	63.0
	19252011	CHEMBL4401876	Displacement of kinase tracer 236 from human N-terminal GST-tagged ALK F1174L mutant (1058 to 1620 residues) after 60 mins by LanthaScreen Eu--kinase binding assay	B	CCOc1cc(C2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(Cc1cc(C)cs1)[C@H](CC)C(=O)N2C		CHEMBL4449858	=	IC50	nM	17.0	CHEMBL4247	Homo sapiens	IC50	nM	17.0
	19252012	CHEMBL4401876	Displacement of kinase tracer 236 from human N-terminal GST-tagged ALK F1174L mutant (1058 to 1620 residues) after 60 mins by LanthaScreen Eu--kinase binding assay	B	CCOc1cc(C2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(Cc1ccc(C)s1)[C@H](CC)C(=O)N2C		CHEMBL4519103	=	IC50	nM	220.0	CHEMBL4247	Homo sapiens	IC50	nM	220.0
	19252013	CHEMBL4401876	Displacement of kinase tracer 236 from human N-terminal GST-tagged ALK F1174L mutant (1058 to 1620 residues) after 60 mins by LanthaScreen Eu--kinase binding assay	B	CCOc1cc(C2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(Cc1scnc1C)[C@H](CC)C(=O)N2C		CHEMBL4549308	=	IC50	nM	370.0	CHEMBL4247	Homo sapiens	IC50	nM	370.0
	19252072	CHEMBL4401884	Binding affinity to wild type human ALK (1088 to 1409 residues) expressed in mammalian expression system by kinome scan-based assay	B	CCOc1cc(C2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(Cc1cc(C)cs1)[C@H](CC)C(=O)N2C		CHEMBL4449858	=	Kd	nM	89.0	CHEMBL4247	Homo sapiens	Kd	nM	89.0
	19252076	CHEMBL4401888	Binding affinity to human ALK F1174L mutant (1088 to 1409 residues) expressed in mammalian expression system by kinome scan-based assay	B	CCOc1cc(C2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(Cc1cc(C)cs1)[C@H](CC)C(=O)N2C		CHEMBL4449858	=	Kd	nM	23.0	CHEMBL4247	Homo sapiens	Kd	nM	23.0
	19252077	CHEMBL4401889	Binding affinity to wild type human ALK (1088 to 1409 residues) expressed in mammalian expression system assessed as unbound protein level at 1 uM by kinome scan-based assay	B	CCOc1cc(C2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(Cc1cc(C)cs1)[C@H](CC)C(=O)N2C		CHEMBL4449858	=	Activity	%	7.1	CHEMBL4247	Homo sapiens	Activity	%	7.1
	19252081	CHEMBL4401893	Inhibition of ALK F1174L mutant auto-phosphorylation in human Kelly cells after 3 hrs by MSD assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	IC50	nM	9400.0	CHEMBL4247	Homo sapiens	IC50	uM	9.4
	19252082	CHEMBL4401893	Inhibition of ALK F1174L mutant auto-phosphorylation in human Kelly cells after 3 hrs by MSD assay	B	CCOc1cc(C2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(Cc1cc(C)cs1)[C@H](CC)C(=O)N2C		CHEMBL4449858	=	IC50	nM	1500.0	CHEMBL4247	Homo sapiens	IC50	uM	1.5
	19252083	CHEMBL4401893	Inhibition of ALK F1174L mutant auto-phosphorylation in human Kelly cells after 3 hrs by MSD assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	79.0	CHEMBL4247	Homo sapiens	IC50	nM	79.0
	19252088	CHEMBL4401895	Inhibition of full-length C-terminal NanoLuc-tagged ALK (unknown origin) expressed in human HEK293 cells after 2 hrs by NanoBRET target engagement assay	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	IC50	nM	890.0	CHEMBL4247	Homo sapiens	IC50	uM	0.89
	19252089	CHEMBL4401895	Inhibition of full-length C-terminal NanoLuc-tagged ALK (unknown origin) expressed in human HEK293 cells after 2 hrs by NanoBRET target engagement assay	B	CCOc1cc(C2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(Cc1ccccc1)[C@H](CC)C(=O)N2C		CHEMBL4469087	=	IC50	nM	1640.0	CHEMBL4247	Homo sapiens	IC50	uM	1.64
	19252090	CHEMBL4401895	Inhibition of full-length C-terminal NanoLuc-tagged ALK (unknown origin) expressed in human HEK293 cells after 2 hrs by NanoBRET target engagement assay	B	CCOc1cc(C2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(Cc1sccc1C)[C@H](CC)C(=O)N2C		CHEMBL4543331	=	IC50	nM	1020.0	CHEMBL4247	Homo sapiens	IC50	uM	1.02
	19252091	CHEMBL4401895	Inhibition of full-length C-terminal NanoLuc-tagged ALK (unknown origin) expressed in human HEK293 cells after 2 hrs by NanoBRET target engagement assay	B	CCOc1cc(C2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(Cc1cc(C)cs1)[C@H](CC)C(=O)N2C		CHEMBL4449858	=	IC50	nM	470.0	CHEMBL4247	Homo sapiens	IC50	uM	0.47
	19252104	CHEMBL4401909	Inhibition of ALK (unknown origin)	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	IC50	nM	390.0	CHEMBL4247	Homo sapiens	IC50	nM	390.0
	19266304	CHEMBL4405254	Inhibition of wild-type human partial length ALK (I1088 to E1409 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	19273826	CHEMBL4407376	Inhibition of human ALK at 0.5 uM by mobility shift assay relative to control	B	CNC(=O)C[C@@H]1C[C@@H](c2ccc(F)c(F)c2)[C@H](NC(=O)c2cc(-c3c(Cl)cnn3C)c(Cl)o2)CN1		CHEMBL4440965	=	Inhibition	%	8.5	CHEMBL4247	Homo sapiens	INH	%	8.5
	19273827	CHEMBL4407376	Inhibition of human ALK at 0.5 uM by mobility shift assay relative to control	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CN[C@H](CCO)C[C@H]2c2ccc(F)c(F)c2)oc1Cl		CHEMBL4441825	=	Inhibition	%	13.8	CHEMBL4247	Homo sapiens	INH	%	13.8
	19273828	CHEMBL4407376	Inhibition of human ALK at 0.5 uM by mobility shift assay relative to control	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(F)c(F)c2)oc1Cl.O=C(O)[C@H](O)[C@@H](O)C(=O)O		CHEMBL4457064	=	Inhibition	%	20.8	CHEMBL4247	Homo sapiens	INH	%	20.8
	19273829	CHEMBL4407376	Inhibition of human ALK at 0.5 uM by mobility shift assay relative to control	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	=	Inhibition	%	5.8	CHEMBL4247	Homo sapiens	INH	%	5.8
	19275924	CHEMBL4407927	Inhibition of recombinant human ALK (1058 to end residues) at 1 uM using KKKSPGEYVNIEF as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	18.0	CHEMBL4247	Homo sapiens	INH	%	18.0
	19282210	CHEMBL4409451	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated with enzyme and substrate for 5 mins followed by ATP addition followed by further incubation for 30 mins by HTRF assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	30.0	CHEMBL4247	Homo sapiens	IC50	nM	30.0
	19282211	CHEMBL4409451	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated with enzyme and substrate for 5 mins followed by ATP addition followed by further incubation for 30 mins by HTRF assay	B	C[C@@H](Oc1cc(-c2cc[nH]c(=O)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL4437893	=	IC50	nM	12.0	CHEMBL4247	Homo sapiens	IC50	nM	12.0
	19282212	CHEMBL4409451	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated with enzyme and substrate for 5 mins followed by ATP addition followed by further incubation for 30 mins by HTRF assay	B	C[C@@H](Oc1cc(-c2ccn(C)c(=O)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL4586704	=	IC50	nM	21.0	CHEMBL4247	Homo sapiens	IC50	nM	21.0
	19282213	CHEMBL4409451	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated with enzyme and substrate for 5 mins followed by ATP addition followed by further incubation for 30 mins by HTRF assay	B	C[C@@H](Oc1cc(-c2ccn(Cc3ccccc3)c(=O)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL4537507	=	IC50	nM	43.0	CHEMBL4247	Homo sapiens	IC50	nM	43.0
	19282214	CHEMBL4409451	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated with enzyme and substrate for 5 mins followed by ATP addition followed by further incubation for 30 mins by HTRF assay	B	C[C@@H](Oc1cc(-c2ccn(CCN(C)C)c(=O)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL4559485	=	IC50	nM	19.0	CHEMBL4247	Homo sapiens	IC50	nM	19.0
	19282215	CHEMBL4409451	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated with enzyme and substrate for 5 mins followed by ATP addition followed by further incubation for 30 mins by HTRF assay	B	CCn1ccc(-c2cnc(N)c(O[C@H](C)c3c(Cl)ccc(F)c3Cl)c2)cc1=O		CHEMBL4454858	=	IC50	nM	21.0	CHEMBL4247	Homo sapiens	IC50	nM	21.0
	19282216	CHEMBL4409452	Inhibition of recombinant human N-terminal GST-tagged ALK L1196M mutant (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated with enzyme and substrate for 5 mins followed by ATP addition followed by further incubation for 30 mins by HTRF assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	366.0	CHEMBL4247	Homo sapiens	IC50	nM	366.0
	19282217	CHEMBL4409452	Inhibition of recombinant human N-terminal GST-tagged ALK L1196M mutant (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated with enzyme and substrate for 5 mins followed by ATP addition followed by further incubation for 30 mins by HTRF assay	B	C[C@@H](Oc1cc(-c2cc[nH]c(=O)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL4437893	=	IC50	nM	66.0	CHEMBL4247	Homo sapiens	IC50	nM	66.0
	19282218	CHEMBL4409452	Inhibition of recombinant human N-terminal GST-tagged ALK L1196M mutant (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated with enzyme and substrate for 5 mins followed by ATP addition followed by further incubation for 30 mins by HTRF assay	B	C[C@@H](Oc1cc(-c2ccn(C)c(=O)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL4586704	=	IC50	nM	85.0	CHEMBL4247	Homo sapiens	IC50	nM	85.0
	19282219	CHEMBL4409452	Inhibition of recombinant human N-terminal GST-tagged ALK L1196M mutant (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated with enzyme and substrate for 5 mins followed by ATP addition followed by further incubation for 30 mins by HTRF assay	B	C[C@@H](Oc1cc(-c2ccn(Cc3ccccc3)c(=O)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL4537507	=	IC50	nM	393.0	CHEMBL4247	Homo sapiens	IC50	nM	393.0
	19282220	CHEMBL4409452	Inhibition of recombinant human N-terminal GST-tagged ALK L1196M mutant (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated with enzyme and substrate for 5 mins followed by ATP addition followed by further incubation for 30 mins by HTRF assay	B	C[C@@H](Oc1cc(-c2ccn(CCN(C)C)c(=O)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL4559485	=	IC50	nM	45.0	CHEMBL4247	Homo sapiens	IC50	nM	45.0
	19282221	CHEMBL4409452	Inhibition of recombinant human N-terminal GST-tagged ALK L1196M mutant (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated with enzyme and substrate for 5 mins followed by ATP addition followed by further incubation for 30 mins by HTRF assay	B	CCn1ccc(-c2cnc(N)c(O[C@H](C)c3c(Cl)ccc(F)c3Cl)c2)cc1=O		CHEMBL4454858	=	IC50	nM	136.0	CHEMBL4247	Homo sapiens	IC50	nM	136.0
	19282222	CHEMBL4409453	Inhibition of recombinant human N-terminal GST-tagged ALK G1202R mutant (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated with enzyme and substrate for 5 mins followed by ATP addition followed by further incubation for 30 mins by HTRF assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	IC50	nM	500.0	CHEMBL4247	Homo sapiens	IC50	nM	500.0
	19282223	CHEMBL4409453	Inhibition of recombinant human N-terminal GST-tagged ALK G1202R mutant (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated with enzyme and substrate for 5 mins followed by ATP addition followed by further incubation for 30 mins by HTRF assay	B	C[C@@H](Oc1cc(-c2cc[nH]c(=O)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL4437893	=	IC50	nM	43.0	CHEMBL4247	Homo sapiens	IC50	nM	43.0
	19282224	CHEMBL4409453	Inhibition of recombinant human N-terminal GST-tagged ALK G1202R mutant (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated with enzyme and substrate for 5 mins followed by ATP addition followed by further incubation for 30 mins by HTRF assay	B	C[C@@H](Oc1cc(-c2ccn(C)c(=O)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL4586704	=	IC50	nM	44.0	CHEMBL4247	Homo sapiens	IC50	nM	44.0
	19282225	CHEMBL4409453	Inhibition of recombinant human N-terminal GST-tagged ALK G1202R mutant (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated with enzyme and substrate for 5 mins followed by ATP addition followed by further incubation for 30 mins by HTRF assay	B	C[C@@H](Oc1cc(-c2ccn(CCN(C)C)c(=O)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL4559485	=	IC50	nM	22.0	CHEMBL4247	Homo sapiens	IC50	nM	22.0
	19295856	CHEMBL4412333	Inhibition of ALK (unknown origin) at 1000 nM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	Inhibition	%	93.5	CHEMBL4247	Homo sapiens	INH	%	93.5
	19295886	CHEMBL4412363	Inhibition of ALK (unknown origin) at 100 nM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	Inhibition	%	71.7	CHEMBL4247	Homo sapiens	INH	%	71.7
	19295916	CHEMBL4412393	Inhibition of ALK (unknown origin) at 10 nM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	Inhibition	%	60.0	CHEMBL4247	Homo sapiens	INH	%	60.0
	19328969	CHEMBL4418515	Inhibition of N-terminal GST-tagged human ALK cytoplasmic domain (1058 to 1620 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCN(C)CC3)cc2)nc1N[C@H]1CC[C@H](O)CC1.O=C(O)/C=C/C(=O)O		CHEMBL4441604	>=	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	19328970	CHEMBL4418515	Inhibition of N-terminal GST-tagged human ALK cytoplasmic domain (1058 to 1620 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)cc2)nc1N[C@H]1CC[C@H](O)CC1.O=C(O)/C=C/C(=O)O		CHEMBL4465661	>=	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	19328971	CHEMBL4418515	Inhibition of N-terminal GST-tagged human ALK cytoplasmic domain (1058 to 1620 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	CC(C)c1nc(C(N)=O)c(Nc2ccc(N3CCN(C)CC3)cc2)nc1N[C@H]1CC[C@H](O)CC1.O=C(O)/C=C/C(=O)O		CHEMBL4454732	>=	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	19328972	CHEMBL4418515	Inhibition of N-terminal GST-tagged human ALK cytoplasmic domain (1058 to 1620 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C(F)(F)F)c2)nc1N[C@H]1CC[C@H](O)CC1.O=C(O)/C=C/C(=O)O		CHEMBL4574005	>=	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	19328973	CHEMBL4418515	Inhibition of N-terminal GST-tagged human ALK cytoplasmic domain (1058 to 1620 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C)c2)nc1N[C@H]1CC[C@H](O)CC1.O=C(O)/C=C/C(=O)O		CHEMBL4466977	>=	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	19328974	CHEMBL4418515	Inhibition of N-terminal GST-tagged human ALK cytoplasmic domain (1058 to 1620 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	CC(C)c1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C(F)(F)F)c2)nc1N[C@H]1CC[C@H](O)CC1.O=C(O)/C=C/C(=O)O		CHEMBL4465573	>=	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	19328975	CHEMBL4418515	Inhibition of N-terminal GST-tagged human ALK cytoplasmic domain (1058 to 1620 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C)c2)nc1N[C@H]1CC[C@@](C)(O)CC1.O=C(O)/C=C/C(=O)O		CHEMBL4524842	>=	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	19328976	CHEMBL4418515	Inhibition of N-terminal GST-tagged human ALK cytoplasmic domain (1058 to 1620 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCN(C(C)C)CC3)c(C)c2)nc1N[C@H]1CC[C@H](O)CC1.O=C(O)/C=C/C(=O)O		CHEMBL4528166	>=	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	19328977	CHEMBL4418515	Inhibition of N-terminal GST-tagged human ALK cytoplasmic domain (1058 to 1620 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C)c2)nc1N[C@H]1CC[C@](C)(O)CC1.O=C(O)/C=C/C(=O)O		CHEMBL4438824	>=	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	19328978	CHEMBL4418515	Inhibition of N-terminal GST-tagged human ALK cytoplasmic domain (1058 to 1620 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(C)c2)nc1NC1CCOCC1.O=C(O)/C=C/C(=O)O		CHEMBL4580325	>=	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	19328979	CHEMBL4418515	Inhibition of N-terminal GST-tagged human ALK cytoplasmic domain (1058 to 1620 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	Cc1cc(Nc2nc(N[C@H]3CC[C@H](O)CC3)c(Cl)nc2C(N)=O)ccc1N1CCC(N2CCN(C)CC2)CC1.O=C(O)/C=C/C(=O)O		CHEMBL4580299	>=	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	19328980	CHEMBL4418515	Inhibition of N-terminal GST-tagged human ALK cytoplasmic domain (1058 to 1620 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)cc2)nc1NC1CCOCC1.O=C(O)/C=C/C(=O)O		CHEMBL4463071	>=	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	19328981	CHEMBL4418515	Inhibition of N-terminal GST-tagged human ALK cytoplasmic domain (1058 to 1620 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1.O=C(O)/C=C/C(=O)O		CHEMBL4524472	>=	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	19328982	CHEMBL4418515	Inhibition of N-terminal GST-tagged human ALK cytoplasmic domain (1058 to 1620 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	CC(C)c1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)cc2)nc1NC1CCOCC1.O=C(O)/C=C/C(=O)O		CHEMBL4483656	>=	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	19328983	CHEMBL4418515	Inhibition of N-terminal GST-tagged human ALK cytoplasmic domain (1058 to 1620 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCN(C)CC3)c(F)c2)nc1NC1CCOCC1.O=C(O)/C=C/C(=O)O		CHEMBL4461418	>=	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	19328984	CHEMBL4418515	Inhibition of N-terminal GST-tagged human ALK cytoplasmic domain (1058 to 1620 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	COc1cc(Nc2nc(NC3CCOCC3)c(C(C)C)nc2C(N)=O)ccc1N1CCN(C)CC1.O=C(O)/C=C/C(=O)O		CHEMBL4438727	>=	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	19328985	CHEMBL4418515	Inhibition of N-terminal GST-tagged human ALK cytoplasmic domain (1058 to 1620 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	CC(C)c1nc(C(N)=O)c(Nc2ccc(N3CCN(C)CC3)cc2)nc1NC1CCOCC1.O=C(O)/C=C/C(=O)O		CHEMBL4591953	>=	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	19328986	CHEMBL4418515	Inhibition of N-terminal GST-tagged human ALK cytoplasmic domain (1058 to 1620 amino acids) expressed in baculovirus expression system at 5 nM relative to control	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCN(C4CCN(C)CC4)CC3)c(C)c2)nc1NC1CCOCC1.O=C(O)/C=C/C(=O)O		CHEMBL4591308	>=	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	19407723	CHEMBL4426894	Binding affinity to human ALK	B	CCc1ccc2c(c1)c(=O)c(C(=O)Nc1ccc(Oc3ncnc4cc(OC)c(OC)cc34)c(F)c1)c(C)n2C		CHEMBL4571241	>	Kd	nM	1000.0	CHEMBL4247	Homo sapiens	Kd	nM	1000.0
	19440238	CHEMBL4431275	Inhibition of ALK (unknown origin) at 20 nM relative to control	B	c1ccc(Nc2nc(Nc3cn[nH]c3)nc3[nH]ccc23)cc1		CHEMBL4448847	=	Inhibition	%	15.1	CHEMBL4247	Homo sapiens	INH	%	15.1
	19440239	CHEMBL4431275	Inhibition of ALK (unknown origin) at 20 nM relative to control	B	Clc1cccc(Nc2nc(Nc3cn[nH]c3)ncc2Cl)c1		CHEMBL4453646	=	Inhibition	%	6.9	CHEMBL4247	Homo sapiens	INH	%	6.9
	19445441	CHEMBL4432482	Inhibition of recombinant ALK (unknown origin) at 1 uM using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	Nc1nccc(Oc2ccc(NC(=O)c3cc4ccccc4n(-c4ccccc4)c3=O)cc2F)c1Cl		CHEMBL4582423	=	Inhibition	%	18.1	CHEMBL4247	Homo sapiens	INH	%	18.1
	19445467	CHEMBL4432482	Inhibition of recombinant ALK (unknown origin) at 1 uM using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	Inhibition	%	1.8	CHEMBL4247	Homo sapiens	INH	%	1.8
	19475349	CHEMBL4479444	Inhibition of human ALK	B	C[C@@H](c1cc2cccnc2cc1F)n1cnc2ncc(-c3cnn(C)c3)nc21		CHEMBL4068255	>	IC50	nM	30000.0	CHEMBL4247	Homo sapiens	IC50	nM	30000.0
	20602478	CHEMBL4604031	Inhibition of ALK (unknown origin) by enzymatic assay	B	O=C(Nc1ccc(Oc2ccnc3[nH]ccc23)c(F)c1)c1cn(-c2ccc(F)cc2)c2ccccc2c1=O		CHEMBL4645353	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
	20683591	CHEMBL4623611	Inhibition of ALK (unknown origin) at 10 nM relative to control	B	C[C@@H](Oc1cncc(-c2cnn(C3CCNCC3)c2)c1)c1c(Cl)ccc(F)c1Cl.Cl		CHEMBL4644985	=	Inhibition	%	31.0	CHEMBL4247	Homo sapiens	INH	%	31.0
	20683592	CHEMBL4623610	Inhibition of ALK (unknown origin) at 100 nM relative to control	B	C[C@@H](Oc1cncc(-c2cnn(C3CCNCC3)c2)c1)c1c(Cl)ccc(F)c1Cl.Cl	Outside typical range	CHEMBL4644985	=	Inhibition	%	-11.0	CHEMBL4247	Homo sapiens	INH	%	-11.0
	22392007	CHEMBL4667102	Inhibition of recombinant human GST-tagged ALK2 (1058 to 1620 residues) expressed in baculovirus expression system using Tyr 01 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	3.0	CHEMBL4247	Homo sapiens	INH	%	3.0
	22395828	CHEMBL4668357	Inhibition of human ALK G1202R mutant using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP assay by radiometric HotSpot assay	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3545311	=	IC50	nM	4.9	CHEMBL4247	Homo sapiens	IC50	nM	4.9
	22395837	CHEMBL4668362	Inhibition of human ALK L1196M mutant using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP assay by radiometric HotSpot assay	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2P(C)(C)=O)n1		CHEMBL3545311	=	IC50	nM	1.7	CHEMBL4247	Homo sapiens	IC50	nM	1.7
	22416671	CHEMBL4672456	Potency index, ratio of ceritinib IC50 to test compound IC50 for inhibition of ALK (unknown origin) using peptide substrate incubated for 60 mins in presence of ATP by HTRF assay	B	CCN1CCN(C(=O)CS(=O)(=O)c2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)c(OC)c2)CC1		CHEMBL4749215	=	Ratio IC50		1.1	CHEMBL4247	Homo sapiens	Ratio IC50		1.1
	22416672	CHEMBL4672457	Potency index, ratio of ceritinib IC50 to test compound IC50 for inhibition of ALK G1202R mutant (unknown origin) using peptide substrate incubated for 60 mins in presence of ATP by HTRF assay	B	CCN1CCN(C(=O)CS(=O)(=O)c2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)c(OC)c2)CC1		CHEMBL4749215	=	Ratio IC50		8.2	CHEMBL4247	Homo sapiens	Ratio IC50		8.2
	22416674	CHEMBL4672459	Potency index, ratio of ceritinib IC50 to test compound IC50 for inhibition of ALK L1196M mutant (unknown origin) using peptide substrate incubated for 60 mins in presence of ATP by HTRF assay	B	CCN1CCN(C(=O)CS(=O)(=O)c2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)c(OC)c2)CC1		CHEMBL4749215	=	Ratio IC50		4.7	CHEMBL4247	Homo sapiens	Ratio IC50		4.7
	22416675	CHEMBL4672460	Potency index, ratio of crizotinib IC50 to test compound IC50 for inhibition of ALK (unknown origin) using peptide substrate incubated for 60 mins in presence of ATP by HTRF assay	B	CCN1CCN(C(=O)CS(=O)(=O)c2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)c(OC)c2)CC1		CHEMBL4749215	=	Ratio IC50		1.1	CHEMBL4247	Homo sapiens	Ratio IC50		1.1
	22416688	CHEMBL4672463	Inhibition of ALK G1202R mutant (unknown origin) using peptide substrate incubated for 60 mins in presence of ATP by HTRF assay	B	CCN1CCN(CCS(=O)(=O)c2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)c(OC)c2)CC1		CHEMBL4750810	=	IC50	nM	13.0	CHEMBL4247	Homo sapiens	IC50	nM	13.0
	22416689	CHEMBL4672463	Inhibition of ALK G1202R mutant (unknown origin) using peptide substrate incubated for 60 mins in presence of ATP by HTRF assay	B	COc1cc(S(=O)(=O)CC(=O)N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4754109	=	IC50	nM	47.0	CHEMBL4247	Homo sapiens	IC50	nM	47.0
	22416690	CHEMBL4672463	Inhibition of ALK G1202R mutant (unknown origin) using peptide substrate incubated for 60 mins in presence of ATP by HTRF assay	B	CCN1CCN(C(=O)CS(=O)(=O)c2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)c(OC)c2)CC1		CHEMBL4749215	=	IC50	nM	8.9	CHEMBL4247	Homo sapiens	IC50	nM	8.9
	22416691	CHEMBL4672463	Inhibition of ALK G1202R mutant (unknown origin) using peptide substrate incubated for 60 mins in presence of ATP by HTRF assay	B	COc1cc(NC(=O)/C=C/CN2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4787426	=	IC50	nM	9.8	CHEMBL4247	Homo sapiens	IC50	nM	9.8
Not Determined	22416692	CHEMBL4672463	Inhibition of ALK G1202R mutant (unknown origin) using peptide substrate incubated for 60 mins in presence of ATP by HTRF assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719		IC50			CHEMBL4247	Homo sapiens	IC50		
	22416693	CHEMBL4672463	Inhibition of ALK G1202R mutant (unknown origin) using peptide substrate incubated for 60 mins in presence of ATP by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	80.0	CHEMBL4247	Homo sapiens	IC50	nM	80.0
	22416694	CHEMBL4672464	Inhibition of ALK L1196M mutant (unknown origin) using peptide substrate incubated for 60 mins in presence of ATP by HTRF assay	B	CCN1CCN(CCS(=O)(=O)c2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)c(OC)c2)CC1		CHEMBL4750810	=	IC50	nM	18.0	CHEMBL4247	Homo sapiens	IC50	nM	18.0
	22416695	CHEMBL4672464	Inhibition of ALK L1196M mutant (unknown origin) using peptide substrate incubated for 60 mins in presence of ATP by HTRF assay	B	COc1cc(S(=O)(=O)CC(=O)N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4754109	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	nM	10.0
	22416696	CHEMBL4672464	Inhibition of ALK L1196M mutant (unknown origin) using peptide substrate incubated for 60 mins in presence of ATP by HTRF assay	B	CCN1CCN(C(=O)CS(=O)(=O)c2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)c(OC)c2)CC1		CHEMBL4749215	=	IC50	nM	3.7	CHEMBL4247	Homo sapiens	IC50	nM	3.7
	22416697	CHEMBL4672464	Inhibition of ALK L1196M mutant (unknown origin) using peptide substrate incubated for 60 mins in presence of ATP by HTRF assay	B	COc1cc(NC(=O)/C=C/CN2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4787426	=	IC50	nM	7.4	CHEMBL4247	Homo sapiens	IC50	nM	7.4
	22416698	CHEMBL4672464	Inhibition of ALK L1196M mutant (unknown origin) using peptide substrate incubated for 60 mins in presence of ATP by HTRF assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	891.0	CHEMBL4247	Homo sapiens	IC50	nM	891.0
	22416699	CHEMBL4672464	Inhibition of ALK L1196M mutant (unknown origin) using peptide substrate incubated for 60 mins in presence of ATP by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	35.0	CHEMBL4247	Homo sapiens	IC50	nM	35.0
	22416774	CHEMBL4672469	Inhibition of ALK (unknown origin) using peptide substrate incubated for 60 mins in presence of ATP by HTRF assay	B	CCN1CCN(CCS(=O)(=O)c2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)c(OC)c2)CC1		CHEMBL4750810	=	IC50	nM	4.3	CHEMBL4247	Homo sapiens	IC50	nM	4.3
	22416775	CHEMBL4672469	Inhibition of ALK (unknown origin) using peptide substrate incubated for 60 mins in presence of ATP by HTRF assay	B	COc1cc(S(=O)(=O)CC(=O)N2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4754109	=	IC50	nM	7.9	CHEMBL4247	Homo sapiens	IC50	nM	7.9
	22416776	CHEMBL4672469	Inhibition of ALK (unknown origin) using peptide substrate incubated for 60 mins in presence of ATP by HTRF assay	B	CCN1CCN(C(=O)CS(=O)(=O)c2ccc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)c(OC)c2)CC1		CHEMBL4749215	=	IC50	nM	2.3	CHEMBL4247	Homo sapiens	IC50	nM	2.3
	22416777	CHEMBL4672469	Inhibition of ALK (unknown origin) using peptide substrate incubated for 60 mins in presence of ATP by HTRF assay	B	COc1cc(NC(=O)/C=C/CN2CCN(C)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4787426	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
	22416778	CHEMBL4672469	Inhibition of ALK (unknown origin) using peptide substrate incubated for 60 mins in presence of ATP by HTRF assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	32.0	CHEMBL4247	Homo sapiens	IC50	nM	32.0
	22416779	CHEMBL4672469	Inhibition of ALK (unknown origin) using peptide substrate incubated for 60 mins in presence of ATP by HTRF assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	2.9	CHEMBL4247	Homo sapiens	IC50	nM	2.9
	22416948	CHEMBL4672519	Inhibition of wild-type ALK (unknown origin) incubated for 1 hr	B	CCN1CCN(C(=O)c2cccn2-c2ccc(Nc3ncc(Cl)c(Nc4ccccc4NS(C)(=O)=O)n3)c(OC)c2)CC1		CHEMBL4756753	=	IC50	nM	8.5	CHEMBL4247	Homo sapiens	IC50	nM	8.5
	22416949	CHEMBL4672519	Inhibition of wild-type ALK (unknown origin) incubated for 1 hr	B	COc1cc(-n2cccc2C(=O)N2CCSCC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4779513	=	IC50	nM	4.5	CHEMBL4247	Homo sapiens	IC50	nM	4.5
	22416950	CHEMBL4672519	Inhibition of wild-type ALK (unknown origin) incubated for 1 hr	B	COc1cc(-n2cccc2C(=O)NCCO)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4778125	=	IC50	nM	1.9	CHEMBL4247	Homo sapiens	IC50	nM	1.9
	22416951	CHEMBL4672519	Inhibition of wild-type ALK (unknown origin) incubated for 1 hr	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(-n3cccc3C(=O)NCCO)cc2OC)ncc1Cl		CHEMBL4758571	=	IC50	nM	9.6	CHEMBL4247	Homo sapiens	IC50	nM	9.6
	22416952	CHEMBL4672519	Inhibition of wild-type ALK (unknown origin) incubated for 1 hr	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	2.4	CHEMBL4247	Homo sapiens	IC50	nM	2.4
	22416953	CHEMBL4672520	Inhibition of ALK L1196M (unknown origin) incubated for 1 hr	B	CCN1CCN(C(=O)c2cccn2-c2ccc(Nc3ncc(Cl)c(Nc4ccccc4NS(C)(=O)=O)n3)c(OC)c2)CC1		CHEMBL4756753	=	IC50	nM	11.7	CHEMBL4247	Homo sapiens	IC50	nM	11.7
	22416954	CHEMBL4672520	Inhibition of ALK L1196M (unknown origin) incubated for 1 hr	B	COc1cc(-n2cccc2C(=O)N2CCSCC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4779513	=	IC50	nM	8.3	CHEMBL4247	Homo sapiens	IC50	nM	8.3
	22416955	CHEMBL4672520	Inhibition of ALK L1196M (unknown origin) incubated for 1 hr	B	COc1cc(-n2cccc2C(=O)NCCO)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4778125	=	IC50	nM	3.1	CHEMBL4247	Homo sapiens	IC50	nM	3.1
	22416956	CHEMBL4672520	Inhibition of ALK L1196M (unknown origin) incubated for 1 hr	B	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(-n3cccc3C(=O)NCCO)cc2OC)ncc1Cl		CHEMBL4758571	=	IC50	nM	13.4	CHEMBL4247	Homo sapiens	IC50	nM	13.4
	22416957	CHEMBL4672520	Inhibition of ALK L1196M (unknown origin) incubated for 1 hr	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	7.4	CHEMBL4247	Homo sapiens	IC50	nM	7.4
	22423125	CHEMBL4674138	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate at 0.5 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1OC1CCCCC1		CHEMBL4790293	<	Inhibition	%	35.0	CHEMBL4247	Homo sapiens	INH	%	35.0
	22423126	CHEMBL4674138	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate at 0.5 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnn(C3CCNCC3)c2)cc1OCc1ccncc1		CHEMBL4788727	<	Inhibition	%	35.0	CHEMBL4247	Homo sapiens	INH	%	35.0
	22423127	CHEMBL4674138	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate at 0.5 uM by [gamma-33P]-ATP assay relative to control	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Inhibition	%	80.0	CHEMBL4247	Homo sapiens	INH	%	80.0
	22423843	CHEMBL4674497	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	52.89	CHEMBL4247	Homo sapiens	Activity	%	52.89
	22423844	CHEMBL4674497	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	56.59	CHEMBL4247	Homo sapiens	Activity	%	56.59
	22424883	CHEMBL4674746	Potency index, ratio of Ki for crizotinib to lorlatinib Ki for inhibition of ALK L1196M (unknown origin)	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286830	=	Ratio Ki		12.0	CHEMBL4247	Homo sapiens	Ratio Ki		12.0
	22424889	CHEMBL4674751	Inhibition of ALK L1196M mutant (unknown origin)	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Ki	nM	8.2	CHEMBL4247	Homo sapiens	Ki	nM	8.2
	22424890	CHEMBL4674751	Inhibition of ALK L1196M mutant (unknown origin)	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286830	=	Ki	nM	0.7	CHEMBL4247	Homo sapiens	Ki	nM	0.7
	22775264	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	0.61	CHEMBL4247	Homo sapiens	IC50	nM	0.61
	22775265	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	=	IC50	nM	0.59	CHEMBL4247	Homo sapiens	IC50	nM	0.59
	22775266	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	34.5	CHEMBL4247	Homo sapiens	IC50	nM	34.5
	22775267	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2c(F)c1N1C[C@H](C)N(C)[C@H](C)C1		CHEMBL4764610	=	IC50	nM	2.2	CHEMBL4247	Homo sapiens	IC50	nM	2.2
	22775268	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2c(F)c1N1C[C@H](C)N[C@H](C)C1		CHEMBL4747053	=	IC50	nM	2.6	CHEMBL4247	Homo sapiens	IC50	nM	2.6
	22775269	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2c(F)c1N1CCN(C)C(C)(C)C1		CHEMBL4778853	=	IC50	nM	1.5	CHEMBL4247	Homo sapiens	IC50	nM	1.5
	22775270	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2c(F)c1N1CCN(C)[C@H](C)C1		CHEMBL4747806	=	IC50	nM	2.2	CHEMBL4247	Homo sapiens	IC50	nM	2.2
	22775271	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2c(F)c1N1CCN(C)[C@@H](C)C1		CHEMBL4741360	=	IC50	nM	4.8	CHEMBL4247	Homo sapiens	IC50	nM	4.8
	22775272	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2c(F)c1N1CCNC(C)(C)C1		CHEMBL4779307	=	IC50	nM	2.6	CHEMBL4247	Homo sapiens	IC50	nM	2.6
	22775273	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2c(F)c1N1CCN[C@H](C)C1		CHEMBL4745824	=	IC50	nM	3.9	CHEMBL4247	Homo sapiens	IC50	nM	3.9
	22775274	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2c(F)c1N1CCN[C@@H](C)C1		CHEMBL4797642	=	IC50	nM	4.9	CHEMBL4247	Homo sapiens	IC50	nM	4.9
	22775275	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2c(F)c1C1CCN(CCO)CC1		CHEMBL4799217	=	IC50	nM	0.62	CHEMBL4247	Homo sapiens	IC50	nM	0.62
	22775276	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2c(F)c1C1CCN(C2COC2)CC1		CHEMBL4776403	=	IC50	nM	5.5	CHEMBL4247	Homo sapiens	IC50	nM	5.5
	22775277	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2c(F)c1C1CCN(C2CCOCC2)CC1		CHEMBL4778565	=	IC50	nM	1.3	CHEMBL4247	Homo sapiens	IC50	nM	1.3
	22775278	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2c(F)c1C1CCN(C(C)C)CC1		CHEMBL4787453	=	IC50	nM	2.5	CHEMBL4247	Homo sapiens	IC50	nM	2.5
	22775279	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2c(F)c1C1CCN(C)CC1		CHEMBL4790570	=	IC50	nM	0.49	CHEMBL4247	Homo sapiens	IC50	nM	0.49
	22775280	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2c(F)c1N1CCC(N(C)C)CC1		CHEMBL4795844	=	IC50	nM	5.8	CHEMBL4247	Homo sapiens	IC50	nM	5.8
	22775281	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2c(F)c1N1CCC(N2CCOCC2)CC1		CHEMBL4777376	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
	22775282	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C3CCCCC3)c2cc1N1CCN(C)CC1		CHEMBL4798441	=	IC50	nM	1.6	CHEMBL4247	Homo sapiens	IC50	nM	1.6
	22775283	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C3CCCC3)c2cc1N1CCN(C)CC1		CHEMBL4788534	=	IC50	nM	5.2	CHEMBL4247	Homo sapiens	IC50	nM	5.2
	22775284	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C3CCC3)c2cc1N1CCN(C)CC1		CHEMBL4744052	=	IC50	nM	12.7	CHEMBL4247	Homo sapiens	IC50	nM	12.7
	22775285	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C3CC3)c2cc1N1CCN(C)CC1		CHEMBL4744640	=	IC50	nM	16.5	CHEMBL4247	Homo sapiens	IC50	nM	16.5
	22775286	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	CCCC(C)n1c2cc(N3CCN(C)CC3)c(OC)cc2c(=O)c2c3ccc(C#N)cc3[nH]c21		CHEMBL4753546	=	IC50	nM	8.2	CHEMBL4247	Homo sapiens	IC50	nM	8.2
	22775287	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	CCC(C)n1c2cc(N3CCN(C)CC3)c(OC)cc2c(=O)c2c3ccc(C#N)cc3[nH]c21		CHEMBL4760756	=	IC50	nM	5.3	CHEMBL4247	Homo sapiens	IC50	nM	5.3
	22775288	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	CCCn1c2cc(N3CCN(C)CC3)c(OC)cc2c(=O)c2c3ccc(C#N)cc3[nH]c21		CHEMBL4780297	=	IC50	nM	13.5	CHEMBL4247	Homo sapiens	IC50	nM	13.5
	22775289	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	CCn1c2cc(N3CCN(C)CC3)c(OC)cc2c(=O)c2c3ccc(C#N)cc3[nH]c21		CHEMBL4789803	=	IC50	nM	20.6	CHEMBL4247	Homo sapiens	IC50	nM	20.6
	22775290	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2c(F)c1N1CCN(C)CC1		CHEMBL4781439	=	IC50	nM	8.9	CHEMBL4247	Homo sapiens	IC50	nM	8.9
	22775291	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	CC(C)n1c2[nH]c3cc(C#N)ccc3c2c(=O)c2cc(F)c(N3CCN(C)CC3)c(F)c21		CHEMBL4785020	=	IC50	nM	6.6	CHEMBL4247	Homo sapiens	IC50	nM	6.6
	22775292	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	CC(C)n1c2[nH]c3cc(C#N)ccc3c2c(=O)c2ccc(N3CCN(C)CC3)c(F)c21		CHEMBL4787543	=	IC50	nM	19.8	CHEMBL4247	Homo sapiens	IC50	nM	19.8
	22775293	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	CC(C)Oc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2cc1N1CCN(C)CC1		CHEMBL4795124	=	IC50	nM	5.8	CHEMBL4247	Homo sapiens	IC50	nM	5.8
	22775294	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	CCCCOc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2cc1N1CCN(C)CC1		CHEMBL4781855	=	IC50	nM	5.4	CHEMBL4247	Homo sapiens	IC50	nM	5.4
	22775295	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	CCCOc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2cc1N1CCN(C)CC1		CHEMBL4749002	=	IC50	nM	3.7	CHEMBL4247	Homo sapiens	IC50	nM	3.7
	22775296	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2cc1N1CCN(C)CC1		CHEMBL4755960	=	IC50	nM	4.8	CHEMBL4247	Homo sapiens	IC50	nM	4.8
	22775297	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	CC(C)c1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2cc1N1CCN(C)CC1		CHEMBL4796970	=	IC50	nM	40.5	CHEMBL4247	Homo sapiens	IC50	nM	40.5
	22775298	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	CC(C)Cc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2cc1N1CCN(C)CC1		CHEMBL4756825	=	IC50	nM	2.5	CHEMBL4247	Homo sapiens	IC50	nM	2.5
	22775299	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	CCCc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2cc1N1CCN(C)CC1		CHEMBL4754012	=	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	nM	1.0
	22775300	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	CCc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2cc1N1CCN(C)CC1		CHEMBL4764107	=	IC50	nM	2.1	CHEMBL4247	Homo sapiens	IC50	nM	2.1
	22775301	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	CC(C)n1c2cc(N3CCN(C)CC3)c(Br)cc2c(=O)c2c3ccc(C#N)cc3[nH]c21		CHEMBL4761644	=	IC50	nM	1.3	CHEMBL4247	Homo sapiens	IC50	nM	1.3
	22775302	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	CC(C)n1c2cc(N3CCN(C)CC3)ccc2c(=O)c2c3ccc(C#N)cc3[nH]c21		CHEMBL4741676	=	IC50	nM	21.3	CHEMBL4247	Homo sapiens	IC50	nM	21.3
	22775303	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	CC(C)n1c2cc(N3CCC(N4CCOCC4)CC3)ccc2c(=O)c2c3ccc(C#N)cc3[nH]c21		CHEMBL4748562	=	IC50	nM	28.6	CHEMBL4247	Homo sapiens	IC50	nM	28.6
	22775304	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	Cn1c2cc(N3CCC(N4CCOCC4)CC3)ccc2c(=O)c2c3ccc(C#N)cc3[nH]c21		CHEMBL4743395	=	IC50	nM	2503.0	CHEMBL4247	Homo sapiens	IC50	nM	2503.0
	22775305	CHEMBL4705469	Inhibition of N-terminal GST tagged wild-type human ALK cytoplasmic domain (1058-1620 amino acids) expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	O=c1c2ccc(N3CCC(N4CCOCC4)CC3)cc2[nH]c2[nH]c3ccccc3c12		CHEMBL4757803	>	IC50	nM	50000.0	CHEMBL4247	Homo sapiens	IC50	nM	50000.0
	22775381	CHEMBL4705507	Inhibition of human ALK G1269A mutant expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2c(F)c1N1C[C@H](C)N(C)[C@H](C)C1		CHEMBL4764610	=	IC50	nM	8.8	CHEMBL4247	Homo sapiens	IC50	nM	8.8
	22775382	CHEMBL4705507	Inhibition of human ALK G1269A mutant expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	1035.0	CHEMBL4247	Homo sapiens	IC50	nM	1035.0
	22775383	CHEMBL4705507	Inhibition of human ALK G1269A mutant expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	=	IC50	nM	3.9	CHEMBL4247	Homo sapiens	IC50	nM	3.9
	22775384	CHEMBL4705507	Inhibition of human ALK G1269A mutant expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	1.9	CHEMBL4247	Homo sapiens	IC50	nM	1.9
	22775385	CHEMBL4705508	Inhibition of human ALK L1196M mutant expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2c(F)c1N1C[C@H](C)N(C)[C@H](C)C1		CHEMBL4764610	=	IC50	nM	6.3	CHEMBL4247	Homo sapiens	IC50	nM	6.3
	22775386	CHEMBL4705508	Inhibition of human ALK L1196M mutant expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	1540.0	CHEMBL4247	Homo sapiens	IC50	nM	1540.0
	22775387	CHEMBL4705508	Inhibition of human ALK L1196M mutant expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	=	IC50	nM	1.5	CHEMBL4247	Homo sapiens	IC50	nM	1.5
	22775388	CHEMBL4705508	Inhibition of human ALK L1196M mutant expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	1.1	CHEMBL4247	Homo sapiens	IC50	nM	1.1
	22775389	CHEMBL4705509	Inhibition of human ALK S1206Y mutant expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2c(F)c1N1C[C@H](C)N(C)[C@H](C)C1		CHEMBL4764610	=	IC50	nM	8.9	CHEMBL4247	Homo sapiens	IC50	nM	8.9
	22775390	CHEMBL4705509	Inhibition of human ALK S1206Y mutant expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	1066.0	CHEMBL4247	Homo sapiens	IC50	nM	1066.0
	22775391	CHEMBL4705509	Inhibition of human ALK S1206Y mutant expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	=	IC50	nM	0.96	CHEMBL4247	Homo sapiens	IC50	nM	0.96
	22775392	CHEMBL4705509	Inhibition of human ALK S1206Y mutant expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	1.6	CHEMBL4247	Homo sapiens	IC50	nM	1.6
	22775406	CHEMBL4705515	Potency index, ratio of IC50 for crizotinib to IC50 for test compound for inhibition of human ALK G1269A mutant expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2c(F)c1N1C[C@H](C)N(C)[C@H](C)C1		CHEMBL4764610	>	Ratio IC50		100.0	CHEMBL4247	Homo sapiens	Ratio IC50		100.0
	22775407	CHEMBL4705516	Potency index, ratio of IC50 for crizotinib to IC50 for test compound for inhibition of human ALK L1196M mutant expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2c(F)c1N1C[C@H](C)N(C)[C@H](C)C1		CHEMBL4764610	>	Ratio IC50		100.0	CHEMBL4247	Homo sapiens	Ratio IC50		100.0
	22775408	CHEMBL4705517	Potency index, ratio of IC50 for crizotinib to IC50 for test compound for inhibition of human ALK S1206Y mutant expressed Sf9 cells pre-incubated for 30 mins before addition of Ulight-CKKSRGDYMTMQIG substrate and measured after 90 mins by fluorescence based assay	B	COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2c(F)c1N1C[C@H](C)N(C)[C@H](C)C1		CHEMBL4764610	>	Ratio IC50		100.0	CHEMBL4247	Homo sapiens	Ratio IC50		100.0
	22775409	CHEMBL4705518	Inhibition of human ALK	B	COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2c(F)c1N1C[C@H](C)N(C)[C@H](C)C1		CHEMBL4764610	=	IC50	nM	5.6	CHEMBL4247	Homo sapiens	IC50	nM	5.6
	22775410	CHEMBL4705519	Inhibition of human ALK C1156Y mutant	B	COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2c(F)c1N1C[C@H](C)N(C)[C@H](C)C1		CHEMBL4764610	=	IC50	nM	1.2	CHEMBL4247	Homo sapiens	IC50	nM	1.2
	22775411	CHEMBL4705520	Inhibition of human ALK L1196M mutant	B	COc1cc2c(=O)c3c4ccc(C#N)cc4[nH]c3n(C(C)C)c2c(F)c1N1C[C@H](C)N(C)[C@H](C)C1		CHEMBL4764610	=	IC50	nM	4.8	CHEMBL4247	Homo sapiens	IC50	nM	4.8
	22782806	CHEMBL4707747	Inhibition of human recombinant GST-tagged ALK cytoplasmic domain (1058-1620 residues) expressed in baculovirus expression system at 1 uM by Z-lyte assay relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-n3c(SC)nnc3-c3ccc(F)cc3)ccn2)c(OC)cc1N(C)CCN(C)C		CHEMBL4798177	=	Inhibition	%	10.0	CHEMBL4247	Homo sapiens	INH	%	10.0
	22790969	CHEMBL4709474	Inhibition of ALK (unknown origin) assessed as residual activity at 0.1 uM preincubated for 20 min followed by [gamma33P]ATP addition and measured after 120 mins by Hotspot assay relative to control	B	Cc1cccn(-c2ccc(-c3ccc4c(C(=O)NCc5ccncc5)n[nH]c4c3)c(Cl)c2)c1=O		CHEMBL4758500	=	Activity	%	96.99	CHEMBL4247	Homo sapiens	Activity	%	96.99
	22809731	CHEMBL4713266	Inhibition of recombinant human ALK (1058 to end residues) assessed as residual activity at 1 uM incubated for 40 mins using KKKSPGEYVNIEF as substrate in presence of Km ATP by radiometric scintillation counting analysis relative to control	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1		CHEMBL4761365	=	Activity	%	72.0	CHEMBL4247	Homo sapiens	Activity	%	72.0
	22810536	CHEMBL4713585	Inhibition of N-terminal GST tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in Sf21 cells by mobility shift assay	B	C=CC(=O)NCCOCCNC(=O)CCN1CCC(c2cc(OC(C)C)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL4753933	=	IC50	nM	0.5	CHEMBL4247	Homo sapiens	IC50	nM	0.5
	22810537	CHEMBL4713585	Inhibition of N-terminal GST tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in Sf21 cells by mobility shift assay	B	CCC(=O)NCCOCCNC(=O)CCN1CCC(c2cc(OC(C)C)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL4757631	=	IC50	nM	13.2	CHEMBL4247	Homo sapiens	IC50	nM	13.2
	22810542	CHEMBL4713590	Covalent binding affinity to ALK (unknown origin) assessed as mass to charge ratio incubated for 4 hrs by LC-MSD analysis	B	C=CC(=O)NCCOCCNC(=O)CCN1CCC(c2cc(OC(C)C)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL4753933	=	Ratio		20276.81	CHEMBL4247	Homo sapiens	Ratio		20276.81
	22810544	CHEMBL4713592	Covalent inhibition of N-terminal GST tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in Sf21 cells incubated for 2 hrs in presence of high ATP levels	B	C=CC(=O)NCCOCCNC(=O)CCN1CCC(c2cc(OC(C)C)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL4753933	=	IC50	nM	1.4	CHEMBL4247	Homo sapiens	IC50	nM	1.4
Active	22810545	CHEMBL4713593	Inhibition of N-terminal GST tagged human ALK L1196M mutant cytoplasmic domain (1058 to 1620 residues) expressed in Sf21 cells incubated for 10 mins by mobility shift assay	B	C=CC(=O)NCCOCCNC(=O)CCN1CCC(c2cc(OC(C)C)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL4753933		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	22810546	CHEMBL4713593	Inhibition of N-terminal GST tagged human ALK L1196M mutant cytoplasmic domain (1058 to 1620 residues) expressed in Sf21 cells incubated for 10 mins by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Not Active	22810547	CHEMBL4713594	Inhibition of N-terminal GST tagged human ALK G1202R mutant cytoplasmic domain (1058 to 1620 residues) expressed in Sf21 cells incubated for 10 mins by mobility shift assay	B	C=CC(=O)NCCOCCNC(=O)CCN1CCC(c2cc(OC(C)C)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL4753933		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	22810548	CHEMBL4713594	Inhibition of N-terminal GST tagged human ALK G1202R mutant cytoplasmic domain (1058 to 1620 residues) expressed in Sf21 cells incubated for 10 mins by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	22810549	CHEMBL4713595	Covalent inhibition of ALK L1196M mutant (unknown origin) expressed in mouse BAF3 cells	B	C=CC(=O)NCCOCCNC(=O)CCN1CCC(c2cc(OC(C)C)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL4753933		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	22810550	CHEMBL4713595	Covalent inhibition of ALK L1196M mutant (unknown origin) expressed in mouse BAF3 cells	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	22810553	CHEMBL4713597	Inhibition of ALK phosphorylation in human NCI-H3122 cells at 10 to 500 nM incubated for 24 hrs by western blot analysis	B	C=CC(=O)NCCOCCNC(=O)CCN1CCC(c2cc(OC(C)C)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL4753933		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	22810554	CHEMBL4713598	Inhibition of ALK in human NCI-H3122 cells assessed as decrease in phosphorylation of AKT at 10 to 500 nM incubated for 24 hrs by western blot analysis	B	C=CC(=O)NCCOCCNC(=O)CCN1CCC(c2cc(OC(C)C)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL4753933		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	22810555	CHEMBL4713599	Inhibition of ALK in human NCI-H3122 cells assessed as decrease in STAT3 expression levels at 10 to 500 nM incubated for 24 hrs by western blot analysis	B	C=CC(=O)NCCOCCNC(=O)CCN1CCC(c2cc(OC(C)C)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL4753933		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	22810556	CHEMBL4713600	Inhibition of ALK in human NCI-H3122 cells assessed as downregulation of AKT expression levels at 10 to 500 nM incubated for 24 hrs by western blot analysis	B	C=CC(=O)NCCOCCNC(=O)CCN1CCC(c2cc(OC(C)C)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL4753933		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	22810557	CHEMBL4713601	Inhibition of ALK in human NCI-H3122 cells assessed as downregulation of STAT3 phosphorylation levels at 10 to 500 nM incubated for 24 hrs by western blot analysis	B	C=CC(=O)NCCOCCNC(=O)CCN1CCC(c2cc(OC(C)C)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL4753933		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	22810571	CHEMBL4713614	Inhibition of N-terminal GST tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in Sf21 cells at 20 nM incubated for 10 mins by mobility shift assay	B	C=CC(=O)NCCOCCNC(=O)CCN1CCC(c2cc(OC(C)C)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL4753933		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	22810572	CHEMBL4713614	Inhibition of N-terminal GST tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in Sf21 cells at 20 nM incubated for 10 mins by mobility shift assay	B	C=CC(=O)NCCOCCOCCNC(=O)CCN1CCC(c2cc(OC(C)C)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL4781797		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	22810573	CHEMBL4713614	Inhibition of N-terminal GST tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in Sf21 cells at 20 nM incubated for 10 mins by mobility shift assay	B	C=CC(=O)NCCCCNC(=O)CCN1CCC(c2cc(OC(C)C)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL4753448		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	22810574	CHEMBL4713614	Inhibition of N-terminal GST tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in Sf21 cells at 20 nM incubated for 10 mins by mobility shift assay	B	C=CC(=O)NCCOCCOCCOCCNC(=O)CCN1CCC(c2cc(OC(C)C)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL4796566		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	22810575	CHEMBL4713614	Inhibition of N-terminal GST tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in Sf21 cells at 20 nM incubated for 10 mins by mobility shift assay	B	C=CC(=O)NCCCCCCCCNC(=O)CCN1CCC(c2cc(OC(C)C)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL4784816		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	22810576	CHEMBL4713614	Inhibition of N-terminal GST tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in Sf21 cells at 20 nM incubated for 10 mins by mobility shift assay	B	C=CC(=O)NCCCCCCNC(=O)CCN1CCC(c2cc(OC(C)C)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL4797902		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	22810577	CHEMBL4713614	Inhibition of N-terminal GST tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in Sf21 cells at 20 nM incubated for 10 mins by mobility shift assay	B	C=CC(=O)NCCCNC(=O)CCN1CCC(c2cc(OC(C)C)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL4740534		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	22810578	CHEMBL4713615	Inhibition of N-terminal GST tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in Sf21 cells at 200 nM incubated for 10 mins by mobility shift assay	B	C=CC(=O)NCCOCCNC(=O)CCN1CCC(c2cc(OC(C)C)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL4753933		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	22810579	CHEMBL4713615	Inhibition of N-terminal GST tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in Sf21 cells at 200 nM incubated for 10 mins by mobility shift assay	B	C=CC(=O)NCCOCCOCCNC(=O)CCN1CCC(c2cc(OC(C)C)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL4781797		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	22810580	CHEMBL4713615	Inhibition of N-terminal GST tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in Sf21 cells at 200 nM incubated for 10 mins by mobility shift assay	B	C=CC(=O)NCCCCNC(=O)CCN1CCC(c2cc(OC(C)C)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL4753448		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	22810581	CHEMBL4713615	Inhibition of N-terminal GST tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in Sf21 cells at 200 nM incubated for 10 mins by mobility shift assay	B	C=CC(=O)NCCOCCOCCOCCNC(=O)CCN1CCC(c2cc(OC(C)C)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL4796566		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	22810582	CHEMBL4713615	Inhibition of N-terminal GST tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in Sf21 cells at 200 nM incubated for 10 mins by mobility shift assay	B	C=CC(=O)NCCCCCCCCNC(=O)CCN1CCC(c2cc(OC(C)C)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL4784816		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	22810583	CHEMBL4713615	Inhibition of N-terminal GST tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in Sf21 cells at 200 nM incubated for 10 mins by mobility shift assay	B	C=CC(=O)NCCCCCCNC(=O)CCN1CCC(c2cc(OC(C)C)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL4797902		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	22810584	CHEMBL4713615	Inhibition of N-terminal GST tagged human ALK cytoplasmic domain (1058 to 1620 residues) expressed in Sf21 cells at 200 nM incubated for 10 mins by mobility shift assay	B	C=CC(=O)NCCCNC(=O)CCN1CCC(c2cc(OC(C)C)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C)CC1		CHEMBL4740534		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	22815260	CHEMBL4714580	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 insect cells using Srctide as substrate measured after 1 hr by mobility shift assay	B	CN(C)Cc1nc2ccc(Nc3ncc(Cl)c(Nc4ccccc4NS(C)(=O)=O)n3)cc2[nH]1		CHEMBL4747513	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
	22815261	CHEMBL4714580	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 insect cells using Srctide as substrate measured after 1 hr by mobility shift assay	B	CN(C)Cc1nc2ccc(Nc3ncc(Cl)c(Nc4ccccc4C(=O)N(C)C)n3)cc2[nH]1		CHEMBL4753667	=	IC50	nM	3.2	CHEMBL4247	Homo sapiens	IC50	nM	3.2
	22815262	CHEMBL4714580	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 insect cells using Srctide as substrate measured after 1 hr by mobility shift assay	B	CN1CCN(Cc2nc3ccc(Nc4ncc(Cl)c(Nc5ccccc5NS(C)(=O)=O)n4)cc3[nH]2)CC1		CHEMBL4760438	=	IC50	nM	3.6	CHEMBL4247	Homo sapiens	IC50	nM	3.6
	22815263	CHEMBL4714580	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 insect cells using Srctide as substrate measured after 1 hr by mobility shift assay	B	CN1CCN(Cc2nc3ccc(Nc4ncc(Cl)c(Nc5ccccc5C(=O)N(C)C)n4)cc3[nH]2)CC1		CHEMBL4790721	=	IC50	nM	2.7	CHEMBL4247	Homo sapiens	IC50	nM	2.7
	22815264	CHEMBL4714580	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 insect cells using Srctide as substrate measured after 1 hr by mobility shift assay	B	CS(=O)(=O)Nc1ccccc1Nc1nc(Nc2ccc3nc(CN4CCCCC4)[nH]c3c2)ncc1Cl		CHEMBL4743188	=	IC50	nM	5.3	CHEMBL4247	Homo sapiens	IC50	nM	5.3
	22815265	CHEMBL4714580	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 insect cells using Srctide as substrate measured after 1 hr by mobility shift assay	B	CN(C)C(=O)c1ccccc1Nc1nc(Nc2ccc3nc(CN4CCCC4)[nH]c3c2)ncc1Cl		CHEMBL4746688	=	IC50	nM	3.4	CHEMBL4247	Homo sapiens	IC50	nM	3.4
	22815266	CHEMBL4714580	Inhibition of human N-terminal GST-fused ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 insect cells using Srctide as substrate measured after 1 hr by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	3.2	CHEMBL4247	Homo sapiens	IC50	nM	3.2
	22815267	CHEMBL4714581	Inhibition of human N-terminal GST-fused ALK L1196M mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 insect cells using Srctide as substrate measured after 1 hr by mobility shift assay	B	CN(C)Cc1nc2ccc(Nc3ncc(Cl)c(Nc4ccccc4NS(C)(=O)=O)n3)cc2[nH]1		CHEMBL4747513	=	IC50	nM	3.7	CHEMBL4247	Homo sapiens	IC50	nM	3.7
	22815268	CHEMBL4714581	Inhibition of human N-terminal GST-fused ALK L1196M mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 insect cells using Srctide as substrate measured after 1 hr by mobility shift assay	B	CN(C)Cc1nc2ccc(Nc3ncc(Cl)c(Nc4ccccc4C(=O)N(C)C)n3)cc2[nH]1		CHEMBL4753667	=	IC50	nM	3.8	CHEMBL4247	Homo sapiens	IC50	nM	3.8
	22815269	CHEMBL4714581	Inhibition of human N-terminal GST-fused ALK L1196M mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 insect cells using Srctide as substrate measured after 1 hr by mobility shift assay	B	CN1CCN(Cc2nc3ccc(Nc4ncc(Cl)c(Nc5ccccc5NS(C)(=O)=O)n4)cc3[nH]2)CC1		CHEMBL4760438	=	IC50	nM	4.9	CHEMBL4247	Homo sapiens	IC50	nM	4.9
	22815270	CHEMBL4714581	Inhibition of human N-terminal GST-fused ALK L1196M mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 insect cells using Srctide as substrate measured after 1 hr by mobility shift assay	B	CN1CCN(Cc2nc3ccc(Nc4ncc(Cl)c(Nc5ccccc5C(=O)N(C)C)n4)cc3[nH]2)CC1		CHEMBL4790721	=	IC50	nM	3.8	CHEMBL4247	Homo sapiens	IC50	nM	3.8
	22815271	CHEMBL4714581	Inhibition of human N-terminal GST-fused ALK L1196M mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 insect cells using Srctide as substrate measured after 1 hr by mobility shift assay	B	CS(=O)(=O)Nc1ccccc1Nc1nc(Nc2ccc3nc(CN4CCCCC4)[nH]c3c2)ncc1Cl		CHEMBL4743188	=	IC50	nM	8.4	CHEMBL4247	Homo sapiens	IC50	nM	8.4
	22815272	CHEMBL4714581	Inhibition of human N-terminal GST-fused ALK L1196M mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 insect cells using Srctide as substrate measured after 1 hr by mobility shift assay	B	CN(C)C(=O)c1ccccc1Nc1nc(Nc2ccc3nc(CN4CCCC4)[nH]c3c2)ncc1Cl		CHEMBL4746688	=	IC50	nM	5.3	CHEMBL4247	Homo sapiens	IC50	nM	5.3
	22815273	CHEMBL4714581	Inhibition of human N-terminal GST-fused ALK L1196M mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 insect cells using Srctide as substrate measured after 1 hr by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	7.6	CHEMBL4247	Homo sapiens	IC50	nM	7.6
	22815274	CHEMBL4714582	Inhibition of human N-terminal GST-fused ALK G1202R mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 insect cells using Srctide as substrate measured after 1 hr by mobility shift assay	B	CN(C)Cc1nc2ccc(Nc3ncc(Cl)c(Nc4ccccc4NS(C)(=O)=O)n3)cc2[nH]1		CHEMBL4747513	=	IC50	nM	8.2	CHEMBL4247	Homo sapiens	IC50	nM	8.2
	22815275	CHEMBL4714582	Inhibition of human N-terminal GST-fused ALK G1202R mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 insect cells using Srctide as substrate measured after 1 hr by mobility shift assay	B	CN(C)Cc1nc2ccc(Nc3ncc(Cl)c(Nc4ccccc4C(=O)N(C)C)n3)cc2[nH]1		CHEMBL4753667	=	IC50	nM	6.9	CHEMBL4247	Homo sapiens	IC50	nM	6.9
	22815276	CHEMBL4714582	Inhibition of human N-terminal GST-fused ALK G1202R mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 insect cells using Srctide as substrate measured after 1 hr by mobility shift assay	B	CN1CCN(Cc2nc3ccc(Nc4ncc(Cl)c(Nc5ccccc5NS(C)(=O)=O)n4)cc3[nH]2)CC1		CHEMBL4760438	=	IC50	nM	7.0	CHEMBL4247	Homo sapiens	IC50	nM	7.0
	22815277	CHEMBL4714582	Inhibition of human N-terminal GST-fused ALK G1202R mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 insect cells using Srctide as substrate measured after 1 hr by mobility shift assay	B	CN1CCN(Cc2nc3ccc(Nc4ncc(Cl)c(Nc5ccccc5C(=O)N(C)C)n4)cc3[nH]2)CC1		CHEMBL4790721	=	IC50	nM	5.7	CHEMBL4247	Homo sapiens	IC50	nM	5.7
	22815278	CHEMBL4714582	Inhibition of human N-terminal GST-fused ALK G1202R mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 insect cells using Srctide as substrate measured after 1 hr by mobility shift assay	B	CS(=O)(=O)Nc1ccccc1Nc1nc(Nc2ccc3nc(CN4CCCCC4)[nH]c3c2)ncc1Cl		CHEMBL4743188	=	IC50	nM	7.1	CHEMBL4247	Homo sapiens	IC50	nM	7.1
	22815279	CHEMBL4714582	Inhibition of human N-terminal GST-fused ALK G1202R mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 insect cells using Srctide as substrate measured after 1 hr by mobility shift assay	B	CN(C)C(=O)c1ccccc1Nc1nc(Nc2ccc3nc(CN4CCCC4)[nH]c3c2)ncc1Cl		CHEMBL4746688	=	IC50	nM	13.3	CHEMBL4247	Homo sapiens	IC50	nM	13.3
	22815280	CHEMBL4714582	Inhibition of human N-terminal GST-fused ALK G1202R mutant cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 insect cells using Srctide as substrate measured after 1 hr by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	172.0	CHEMBL4247	Homo sapiens	IC50	nM	172.0
	22818091	CHEMBL4715314	Inhibition of recombinant N-terminal His6-tagged human ALK (1058 to end residues) expressed in baculovirus infected Sf21 insect cells at 2 uM using IGF-1Rtide as substrate relative to control	B	C[C@@H](c1ccc2ncccc2c1)c1nnc2sc(-c3cnn(C)c3)nn12		CHEMBL4791034	<	Inhibition	%	50.0	CHEMBL4247	Homo sapiens	INH	%	50.0
	22820245	CHEMBL4716187	Inhibition of ALK (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CN(S(N)(=O)=O)CC2		CHEMBL4747624	=	IC50	nM	8.0	CHEMBL4247	Homo sapiens	IC50	uM	0.008
	22820246	CHEMBL4716187	Inhibition of ALK (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	CCNC(=O)N1CCc2cc(OC)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C1		CHEMBL4794675	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	uM	0.01
	22820247	CHEMBL4716187	Inhibition of ALK (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CN(C(=O)CO)CC2		CHEMBL4752172	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	uM	0.004
	22820248	CHEMBL4716187	Inhibition of ALK (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CN(C(C)=O)CC2		CHEMBL4764866	=	IC50	nM	5.0	CHEMBL4247	Homo sapiens	IC50	uM	0.005
	22820249	CHEMBL4716187	Inhibition of ALK (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CN(CC(=O)N(C)C)CC2		CHEMBL4777397	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	uM	0.003
	22820250	CHEMBL4716187	Inhibition of ALK (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CN(CCN(C)C)CC2		CHEMBL4781279	=	IC50	nM	16.0	CHEMBL4247	Homo sapiens	IC50	uM	0.016
	22820251	CHEMBL4716187	Inhibition of ALK (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CN(CCO)CC2		CHEMBL4794942	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	uM	0.002
	22820252	CHEMBL4716187	Inhibition of ALK (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	CCN1CCc2cc(OC)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C1		CHEMBL4794087	=	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	uM	0.001
	22820253	CHEMBL4716187	Inhibition of ALK (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CN(C)CC2		CHEMBL4754657	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	uM	0.003
	22820254	CHEMBL4716187	Inhibition of ALK (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CNCC2		CHEMBL4743579	=	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	uM	0.001
	22820255	CHEMBL4716187	Inhibition of ALK (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2cnccc2cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4754849	=	IC50	nM	130.0	CHEMBL4247	Homo sapiens	IC50	uM	0.13
	22820256	CHEMBL4716187	Inhibition of ALK (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCN=C2		CHEMBL4777614	=	IC50	nM	7.8	CHEMBL4247	Homo sapiens	IC50	uM	0.0078
	22820257	CHEMBL4716187	Inhibition of ALK (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CC[N+](C)(C)C2.[I-]		CHEMBL4762215	=	IC50	nM	1.5	CHEMBL4247	Homo sapiens	IC50	uM	0.0015
	22820258	CHEMBL4716187	Inhibition of ALK (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	CCC(C)Oc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4745560	=	IC50	nM	1.2	CHEMBL4247	Homo sapiens	IC50	uM	0.0012
	22820259	CHEMBL4716187	Inhibition of ALK (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	CC(C)COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4780333	=	IC50	nM	1.2	CHEMBL4247	Homo sapiens	IC50	uM	0.0012
	22820260	CHEMBL4716187	Inhibition of ALK (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	CC(C)Oc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4758611	=	IC50	nM	0.54	CHEMBL4247	Homo sapiens	IC50	uM	0.00054
	22820261	CHEMBL4716187	Inhibition of ALK (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCN(S(N)(=O)=O)C2		CHEMBL4739896	=	IC50	nM	7.0	CHEMBL4247	Homo sapiens	IC50	uM	0.006999999999999999
	22820262	CHEMBL4716187	Inhibition of ALK (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	CCNC(=O)N1CCc2cc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)c(OC)cc2C1		CHEMBL4762173	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	uM	0.002
	22820263	CHEMBL4716187	Inhibition of ALK (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCN(C(=O)CO)C2		CHEMBL4757036	=	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	uM	0.001
	22820264	CHEMBL4716187	Inhibition of ALK (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCN(C(C)=O)C2		CHEMBL4755723	=	IC50	nM	2.0	CHEMBL4247	Homo sapiens	IC50	uM	0.002
	22820265	CHEMBL4716187	Inhibition of ALK (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCN(CC(=O)N(C)C)C2		CHEMBL4740616	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	uM	0.003
	22820266	CHEMBL4716187	Inhibition of ALK (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCN(CCN(C)C)C2		CHEMBL4756562	=	IC50	nM	18.0	CHEMBL4247	Homo sapiens	IC50	uM	0.018000000000000002
	22820267	CHEMBL4716187	Inhibition of ALK (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCN(CCO)C2		CHEMBL4765021	=	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	uM	0.001
	22820268	CHEMBL4716187	Inhibition of ALK (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	CCN1CCc2cc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)c(OC)cc2C1		CHEMBL4765052	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	uM	0.003
	22820269	CHEMBL4716187	Inhibition of ALK (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCN(C)C2		CHEMBL4760370	=	IC50	nM	40.0	CHEMBL4247	Homo sapiens	IC50	uM	0.04
	22820270	CHEMBL4716187	Inhibition of ALK (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	uM	0.001
	22820271	CHEMBL4716187	Inhibition of ALK (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	14.0	CHEMBL4247	Homo sapiens	IC50	uM	0.013999999999999999
	22820272	CHEMBL4716188	Inhibition of crizotinib-resistant ALK G1202R mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CNCC2		CHEMBL4743579	=	IC50	nM	1.3	CHEMBL4247	Homo sapiens	IC50	uM	0.0013
	22820273	CHEMBL4716188	Inhibition of crizotinib-resistant ALK G1202R mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	IC50	nM	5.9	CHEMBL4247	Homo sapiens	IC50	uM	0.0059
	22820274	CHEMBL4716188	Inhibition of crizotinib-resistant ALK G1202R mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	20.0	CHEMBL4247	Homo sapiens	IC50	uM	0.02
	22820275	CHEMBL4716189	Inhibition of crizotinib-resistant ALK L1196M mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CN(S(N)(=O)=O)CC2		CHEMBL4747624	=	IC50	nM	50.0	CHEMBL4247	Homo sapiens	IC50	uM	0.05
	22820276	CHEMBL4716189	Inhibition of crizotinib-resistant ALK L1196M mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	CCNC(=O)N1CCc2cc(OC)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C1		CHEMBL4794675	=	IC50	nM	150.0	CHEMBL4247	Homo sapiens	IC50	uM	0.15
	22820277	CHEMBL4716189	Inhibition of crizotinib-resistant ALK L1196M mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CN(C(=O)CO)CC2		CHEMBL4752172	=	IC50	nM	30.0	CHEMBL4247	Homo sapiens	IC50	uM	0.03
	22820278	CHEMBL4716189	Inhibition of crizotinib-resistant ALK L1196M mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CN(C(C)=O)CC2		CHEMBL4764866	=	IC50	nM	50.0	CHEMBL4247	Homo sapiens	IC50	uM	0.05
	22820279	CHEMBL4716189	Inhibition of crizotinib-resistant ALK L1196M mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CN(CC(=O)N(C)C)CC2		CHEMBL4777397	=	IC50	nM	34.0	CHEMBL4247	Homo sapiens	IC50	uM	0.034
	22820280	CHEMBL4716189	Inhibition of crizotinib-resistant ALK L1196M mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CN(CCN(C)C)CC2		CHEMBL4781279	=	IC50	nM	72.0	CHEMBL4247	Homo sapiens	IC50	uM	0.07200000000000001
	22820281	CHEMBL4716189	Inhibition of crizotinib-resistant ALK L1196M mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CN(CCO)CC2		CHEMBL4794942	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	uM	0.01
	22820282	CHEMBL4716189	Inhibition of crizotinib-resistant ALK L1196M mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	CCN1CCc2cc(OC)c(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)cc2C1		CHEMBL4794087	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	uM	0.01
	22820283	CHEMBL4716189	Inhibition of crizotinib-resistant ALK L1196M mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CN(C)CC2		CHEMBL4754657	=	IC50	nM	30.0	CHEMBL4247	Homo sapiens	IC50	uM	0.03
	22820284	CHEMBL4716189	Inhibition of crizotinib-resistant ALK L1196M mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CNCC2		CHEMBL4743579	=	IC50	nM	7.0	CHEMBL4247	Homo sapiens	IC50	uM	0.006999999999999999
Not Determined	22820285	CHEMBL4716189	Inhibition of crizotinib-resistant ALK L1196M mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2cnccc2cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4754849		IC50			CHEMBL4247	Homo sapiens	IC50		
	22820286	CHEMBL4716189	Inhibition of crizotinib-resistant ALK L1196M mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCN=C2		CHEMBL4777614	=	IC50	nM	39.0	CHEMBL4247	Homo sapiens	IC50	uM	0.039
	22820287	CHEMBL4716189	Inhibition of crizotinib-resistant ALK L1196M mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CC[N+](C)(C)C2.[I-]		CHEMBL4762215	=	IC50	nM	3.3	CHEMBL4247	Homo sapiens	IC50	uM	0.0033
	22820288	CHEMBL4716189	Inhibition of crizotinib-resistant ALK L1196M mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	CCC(C)Oc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4745560	=	IC50	nM	2.3	CHEMBL4247	Homo sapiens	IC50	uM	0.0023
	22820289	CHEMBL4716189	Inhibition of crizotinib-resistant ALK L1196M mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	CC(C)COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4780333	=	IC50	nM	1.2	CHEMBL4247	Homo sapiens	IC50	uM	0.0012
	22820290	CHEMBL4716189	Inhibition of crizotinib-resistant ALK L1196M mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	CC(C)Oc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4758611	=	IC50	nM	13.0	CHEMBL4247	Homo sapiens	IC50	uM	0.013000000000000001
	22820291	CHEMBL4716189	Inhibition of crizotinib-resistant ALK L1196M mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCN(S(N)(=O)=O)C2		CHEMBL4739896	=	IC50	nM	70.0	CHEMBL4247	Homo sapiens	IC50	uM	0.07
	22820292	CHEMBL4716189	Inhibition of crizotinib-resistant ALK L1196M mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	CCNC(=O)N1CCc2cc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)c(OC)cc2C1		CHEMBL4762173	=	IC50	nM	50.0	CHEMBL4247	Homo sapiens	IC50	uM	0.05
	22820293	CHEMBL4716189	Inhibition of crizotinib-resistant ALK L1196M mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCN(C(=O)CO)C2		CHEMBL4757036	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	uM	0.01
	22820294	CHEMBL4716189	Inhibition of crizotinib-resistant ALK L1196M mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCN(C(C)=O)C2		CHEMBL4755723	=	IC50	nM	30.0	CHEMBL4247	Homo sapiens	IC50	uM	0.03
	22820295	CHEMBL4716189	Inhibition of crizotinib-resistant ALK L1196M mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCN(CC(=O)N(C)C)C2		CHEMBL4740616	=	IC50	nM	54.0	CHEMBL4247	Homo sapiens	IC50	uM	0.054000000000000006
	22820296	CHEMBL4716189	Inhibition of crizotinib-resistant ALK L1196M mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCN(CCN(C)C)C2		CHEMBL4756562	=	IC50	nM	1180.0	CHEMBL4247	Homo sapiens	IC50	uM	1.18
	22820297	CHEMBL4716189	Inhibition of crizotinib-resistant ALK L1196M mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCN(CCO)C2		CHEMBL4765021	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	uM	0.01
	22820298	CHEMBL4716189	Inhibition of crizotinib-resistant ALK L1196M mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	CCN1CCc2cc(Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3)c(OC)cc2C1		CHEMBL4765052	=	IC50	nM	20.0	CHEMBL4247	Homo sapiens	IC50	uM	0.02
	22820299	CHEMBL4716189	Inhibition of crizotinib-resistant ALK L1196M mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCN(C)C2		CHEMBL4760370	=	IC50	nM	710.0	CHEMBL4247	Homo sapiens	IC50	uM	0.71
	22820300	CHEMBL4716189	Inhibition of crizotinib-resistant ALK L1196M mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	IC50	nM	10.0	CHEMBL4247	Homo sapiens	IC50	uM	0.01
	22820301	CHEMBL4716189	Inhibition of crizotinib-resistant ALK L1196M mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	29.0	CHEMBL4247	Homo sapiens	IC50	uM	0.028999999999999998
	22820302	CHEMBL4716190	Inhibition of crizotinib-resistant ALK G1269A mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CNCC2		CHEMBL4743579	=	IC50	nM	0.24	CHEMBL4247	Homo sapiens	IC50	uM	0.00023999999999999998
	22820303	CHEMBL4716190	Inhibition of crizotinib-resistant ALK G1269A mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	IC50	nM	1.7	CHEMBL4247	Homo sapiens	IC50	uM	0.0017
	22820304	CHEMBL4716190	Inhibition of crizotinib-resistant ALK G1269A mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	2.1	CHEMBL4247	Homo sapiens	IC50	uM	0.0021
	22820308	CHEMBL4716192	Inhibition of crizotinib-resistant ALK F1174L mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CNCC2		CHEMBL4743579	=	IC50	nM	0.46	CHEMBL4247	Homo sapiens	IC50	uM	0.00045999999999999996
	22820309	CHEMBL4716192	Inhibition of crizotinib-resistant ALK F1174L mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	IC50	nM	2.1	CHEMBL4247	Homo sapiens	IC50	uM	0.0021
	22820310	CHEMBL4716192	Inhibition of crizotinib-resistant ALK F1174L mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	2.4	CHEMBL4247	Homo sapiens	IC50	uM	0.0024
	22820311	CHEMBL4716193	Inhibition of crizotinib-resistant ALK C1156Y mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CNCC2		CHEMBL4743579	=	IC50	nM	0.45	CHEMBL4247	Homo sapiens	IC50	uM	0.00045
	22820312	CHEMBL4716193	Inhibition of crizotinib-resistant ALK C1156Y mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	uM	0.003
	22820313	CHEMBL4716193	Inhibition of crizotinib-resistant ALK C1156Y mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	4.2	CHEMBL4247	Homo sapiens	IC50	uM	0.0042
	22820395	CHEMBL4716197	Potency index, ratio of LDK378 IC50 to test compound IC50 for inhibition of ALK L1196M mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CNCC2		CHEMBL4743579	=	Ratio IC50		5.0	CHEMBL4247	Homo sapiens	Ratio IC50		5.0
	22820396	CHEMBL4716198	Potency index, ratio of LDK378 IC50 to test compound IC50 for inhibition of ALK G1202R mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	Ratio IC50		3.0	CHEMBL4247	Homo sapiens	Ratio IC50		3.0
	22820397	CHEMBL4716198	Potency index, ratio of LDK378 IC50 to test compound IC50 for inhibition of ALK G1202R mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CNCC2		CHEMBL4743579	=	Ratio IC50		5.0	CHEMBL4247	Homo sapiens	Ratio IC50		5.0
	22820398	CHEMBL4716199	Potency index, ratio of LDK378 IC50 to test compound IC50 for inhibition of ALK G1269A mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CNCC2		CHEMBL4743579	=	Ratio IC50		5.0	CHEMBL4247	Homo sapiens	Ratio IC50		5.0
	22820400	CHEMBL4716201	Potency index, ratio of LDK378 IC50 to test compound IC50 for inhibition of ALK F1174L mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CNCC2		CHEMBL4743579	=	Ratio IC50		5.0	CHEMBL4247	Homo sapiens	Ratio IC50		5.0
	22820401	CHEMBL4716202	Potency index, ratio of LDK378 IC50 to test compound IC50 for inhibition of ALK C1156Y mutant (unknown origin) using peptide substrate incubated for 30 mins in presence of ATP by fluorescence assay	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CNCC2		CHEMBL4743579	=	Ratio IC50		5.0	CHEMBL4247	Homo sapiens	Ratio IC50		5.0
	22820420	CHEMBL4716212	Inhibition of N-terminal His6-tagged human recombinant ALK (1058 to end residues) expressed in baculovirus infected Sf21 cells assessed as residual activity at 1 uM relative to control	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Activity	%	3.0	CHEMBL4247	Homo sapiens	Activity	%	3.0
	22820421	CHEMBL4716212	Inhibition of N-terminal His6-tagged human recombinant ALK (1058 to end residues) expressed in baculovirus infected Sf21 cells assessed as residual activity at 1 uM relative to control	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	Activity	%	2.0	CHEMBL4247	Homo sapiens	Activity	%	2.0
	22822917	CHEMBL4716834	Inhibition of ALK (unknown origin)	B	Cc1cc(NC2=NC3NCCCC3C(Nc3ccccc3S(=O)(=O)C(C)C)=N2)c(OC(C)C)cc1C1CCNCC1		CHEMBL4795530	=	IC50	nM	212.0	CHEMBL4247	Homo sapiens	IC50	nM	212.0
	22822918	CHEMBL4716834	Inhibition of ALK (unknown origin)	B	COc1ccc2nc(Nc3cc(C)c(C4CCN(C)CC4)cc3OC(C)C)nc(Nc3ccccc3S(=O)(=O)C(C)C)c2c1		CHEMBL4762929	=	IC50	nM	1930.0	CHEMBL4247	Homo sapiens	IC50	nM	1930.0
	22822919	CHEMBL4716834	Inhibition of ALK (unknown origin)	B	Cc1cc(Nc2cc(Nc3ccccc3S(=O)(=O)C(C)C)nc3[nH]ccc23)c(OC(C)C)cc1C1CCN(C)CC1		CHEMBL4739938	=	IC50	nM	186.0	CHEMBL4247	Homo sapiens	IC50	nM	186.0
	22822920	CHEMBL4716834	Inhibition of ALK (unknown origin)	B	Cc1cc(Nc2cc(Nc3ccccc3S(=O)(=O)C(C)C)c3cc[nH]c3n2)c(OC(C)C)cc1C1CCN(C)CC1		CHEMBL4787280	>	IC50	nM	25000.0	CHEMBL4247	Homo sapiens	IC50	nM	25000.0
	22822921	CHEMBL4716834	Inhibition of ALK (unknown origin)	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)[nH]nc3n2)c(OC(C)C)cc1C1CCN(C)CC1		CHEMBL3651854	=	IC50	nM	4.0	CHEMBL4247	Homo sapiens	IC50	nM	4.0
	22822922	CHEMBL4716834	Inhibition of ALK (unknown origin)	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)n[nH]c3n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL4762861	=	IC50	nM	5.0	CHEMBL4247	Homo sapiens	IC50	nM	5.0
	22822923	CHEMBL4716834	Inhibition of ALK (unknown origin)	B	Cc1cc2c(Nc3ccccc3S(=O)(=O)C(C)C)nc(Nc3cc(C)c(C4CCNCC4)cc3OC(C)C)nc2[nH]1		CHEMBL4780490	=	IC50	nM	3878.0	CHEMBL4247	Homo sapiens	IC50	nM	3878.0
	22822924	CHEMBL4716834	Inhibition of ALK (unknown origin)	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3cc[nH]c3n2)c(OC(C)C)cc1C1CCN(C)CC1		CHEMBL4762256	=	IC50	nM	8.0	CHEMBL4247	Homo sapiens	IC50	nM	8.0
	22822925	CHEMBL4716834	Inhibition of ALK (unknown origin)	B	C[C@@H](Oc1cc(-c2ccn(C3CCNCC3)n2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL3734798	=	IC50	nM	7.0	CHEMBL4247	Homo sapiens	IC50	nM	7.0
	22826312	CHEMBL4717497	Inhibition of N-terminal His6-tagged human recombinant ALK (1058 to end residues) expressed in baculovirus infected Sf21 cells assessed as residual activity at 10 uM relative to control	B	CN1CCN(CCCOc2cccc3nc(Nc4ccc(Cl)c(C(F)(F)F)c4)ccc23)CC1		CHEMBL4797203	<	Activity	%	60.0	CHEMBL4247	Homo sapiens	Activity	%	60.0
	22837413	CHEMBL4719087	Inhibition of recombinant GST-tagged human ALK (1058 to 1620 residues) expressed in baculovirus expression system at 10 uM by TR-FRET assay relative to control	B	C/C1=C\[C@H](OC(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)C[C@](C)(O)/C=C/[C@H](C(C)C)CC/C(C)=C/CC1		CHEMBL4756514	=	Inhibition	%	10.0	CHEMBL4247	Homo sapiens	INH	%	10.0
	22843848	CHEMBL4720834	Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.09	CHEMBL4247	Homo sapiens	IC50	10^-9M	1.09
	22844324	CHEMBL4721187	Inhibition of human ALK assessed as residual activity using poly[Glu:Tyr] (4:1) as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	92.83	CHEMBL4247	Homo sapiens	Activity	%	92.83
	22844614	CHEMBL4721289	Inhibition of wild-type human partial length ALK (I1088 to E1409 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	7.52	CHEMBL4247	Homo sapiens	Activity	%	7.52
	22887369	CHEMBL4728471	Inhibition of ALK (unknown origin)	B	CCOc1cc(C2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(Cc1cc(C)cs1)[C@H](CC)C(=O)N2C		CHEMBL4449858	=	IC50	nM	17.0	CHEMBL4247	Homo sapiens	IC50	nM	17.0
Not Active	22889484	CHEMBL4729003	Inhibition of wild-type human partial length ALK (I1088 to E1409 residues) expressed in mammalian expression system at 1 uM by Kinomescan method	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	22919212	CHEMBL4736191	Inhibition of ALK G1202R mutant (unknown origin) expressed in BaF3 cells	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCC(=O)NCOCCOCCOCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4751009		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	22919213	CHEMBL4736191	Inhibition of ALK G1202R mutant (unknown origin) expressed in BaF3 cells	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	22919214	CHEMBL4736192	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 cells using kinase substrate22 by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCC(=O)NCCCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4791950	=	IC50	nM	19300.0	CHEMBL4247	Homo sapiens	IC50	uM	19.3
	22919215	CHEMBL4736192	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 cells using kinase substrate22 by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCC(=O)NCCCCCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4745400	=	IC50	nM	15800.0	CHEMBL4247	Homo sapiens	IC50	uM	15.8
	22919216	CHEMBL4736192	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 cells using kinase substrate22 by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCC(=O)NCCCCCCCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4786817	=	IC50	nM	19800.0	CHEMBL4247	Homo sapiens	IC50	uM	19.8
	22919217	CHEMBL4736192	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 cells using kinase substrate22 by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCC(=O)NCCOCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4752205	=	IC50	nM	10200.0	CHEMBL4247	Homo sapiens	IC50	uM	10.2
	22919218	CHEMBL4736192	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 cells using kinase substrate22 by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCC(=O)NCCOCCOCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4743068	=	IC50	nM	2300.0	CHEMBL4247	Homo sapiens	IC50	uM	2.3
	22919219	CHEMBL4736192	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 cells using kinase substrate22 by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCC(=O)NCOCCOCCOCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4751009	=	IC50	nM	1600.0	CHEMBL4247	Homo sapiens	IC50	uM	1.6
	22919220	CHEMBL4736192	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 cells using kinase substrate22 by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCC(=O)NCCOCCOCCOCCOCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4791837	=	IC50	nM	11400.0	CHEMBL4247	Homo sapiens	IC50	uM	11.4
	22919221	CHEMBL4736192	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 cells using kinase substrate22 by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCC(=O)NCCCCNCC(=O)Nc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4741115	=	IC50	nM	8300.0	CHEMBL4247	Homo sapiens	IC50	uM	8.3
	22919222	CHEMBL4736192	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 cells using kinase substrate22 by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCC(=O)NCCCCCCNCC(=O)Nc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4747187	=	IC50	nM	50900.0	CHEMBL4247	Homo sapiens	IC50	uM	50.9
	22919223	CHEMBL4736192	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 cells using kinase substrate22 by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCC(=O)NCCCCCCCCNCC(=O)Nc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4797636	=	IC50	nM	12800.0	CHEMBL4247	Homo sapiens	IC50	uM	12.8
	22919224	CHEMBL4736192	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 cells using kinase substrate22 by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCC(=O)NCCOCCNCC(=O)Nc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4787978	=	IC50	nM	4600.0	CHEMBL4247	Homo sapiens	IC50	uM	4.6
	22919225	CHEMBL4736192	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 cells using kinase substrate22 by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCC(=O)NCCOCCOCCNCC(=O)Nc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4764130	=	IC50	nM	4800.0	CHEMBL4247	Homo sapiens	IC50	uM	4.8
	22919226	CHEMBL4736192	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 cells using kinase substrate22 by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCC(=O)NCCOCCOCCOCCNCC(=O)Nc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4784856	=	IC50	nM	5400.0	CHEMBL4247	Homo sapiens	IC50	uM	5.4
	22919227	CHEMBL4736192	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 cells using kinase substrate22 by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCC(=O)NCCCCNCCC(=O)Nc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4739968	=	IC50	nM	1500.0	CHEMBL4247	Homo sapiens	IC50	uM	1.5
	22919228	CHEMBL4736192	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 cells using kinase substrate22 by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCC(=O)NCCCCCCNCCC(=O)Nc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4789495	=	IC50	nM	12600.0	CHEMBL4247	Homo sapiens	IC50	uM	12.6
	22919229	CHEMBL4736192	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 cells using kinase substrate22 by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCC(=O)NCCOCCNCCC(=O)Nc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4785681	=	IC50	nM	1400.0	CHEMBL4247	Homo sapiens	IC50	uM	1.4
	22919230	CHEMBL4736192	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 cells using kinase substrate22 by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCC(=O)NCCOCCOCCNCCC(=O)Nc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4748604	=	IC50	nM	1900.0	CHEMBL4247	Homo sapiens	IC50	uM	1.9
	22919231	CHEMBL4736192	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 cells using kinase substrate22 by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCC(=O)NCCCCNC(=O)COc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4755011	=	IC50	nM	15800.0	CHEMBL4247	Homo sapiens	IC50	uM	15.8
	22919232	CHEMBL4736192	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 cells using kinase substrate22 by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCC(=O)NCCCCCCNC(=O)COc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4783455	=	IC50	nM	2100.0	CHEMBL4247	Homo sapiens	IC50	uM	2.1
	22919233	CHEMBL4736192	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 cells using kinase substrate22 by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCC(=O)NCCCCCCCCNC(=O)COc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4762634	=	IC50	nM	5400.0	CHEMBL4247	Homo sapiens	IC50	uM	5.4
	22919234	CHEMBL4736192	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 cells using kinase substrate22 by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCC(=O)NCCOCCNC(=O)COc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4748837	=	IC50	nM	3600.0	CHEMBL4247	Homo sapiens	IC50	uM	3.6
	22919235	CHEMBL4736192	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 cells using kinase substrate22 by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCC(=O)NCCOCCOCCNC(=O)COc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4754307	=	IC50	nM	1900.0	CHEMBL4247	Homo sapiens	IC50	uM	1.9
	22919236	CHEMBL4736192	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 cells using kinase substrate22 by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCC(=O)NCCOCCOCCOCCNC(=O)COc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4740690	=	IC50	nM	1500.0	CHEMBL4247	Homo sapiens	IC50	uM	1.5
	22919237	CHEMBL4736192	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 cells using kinase substrate22 by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCC(=O)O)CC1		CHEMBL4784162	=	IC50	nM	3900.0	CHEMBL4247	Homo sapiens	IC50	uM	3.9
	22919238	CHEMBL4736192	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 cells using kinase substrate22 by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	810.0	CHEMBL4247	Homo sapiens	IC50	uM	0.81
	22919239	CHEMBL4736192	Inhibition of recombinant human N-terminal GST-tagged ALK cytoplasmic domain (1058 to 1620 residues) expressed in baculovirus infected Sf21 cells using kinase substrate22 by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCC(=O)NCCCCCCCCNCCC(=O)Nc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4787351	=	IC50	nM	8200.0	CHEMBL4247	Homo sapiens	IC50	uM	8.2
Active	22919306	CHEMBL4736204	Inhibition of ALK L1196M mutant (unknown origin) expressed in BaF3 cells	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCN(CCC(=O)NCOCCOCCOCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)CC1		CHEMBL4751009		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	22919307	CHEMBL4736204	Inhibition of ALK L1196M mutant (unknown origin) expressed in BaF3 cells	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	22927936	CHEMBL4737903	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(NCC2CCCO2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4787021	=	IC50	nM	3.2	CHEMBL4247	Homo sapiens	IC50	nM	3.2
	22927937	CHEMBL4737903	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(OCC2CCCO2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4748361	=	IC50	nM	3.0	CHEMBL4247	Homo sapiens	IC50	nM	3.0
	22927938	CHEMBL4737903	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(SCc2ccc(CN3CCCC3)o2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4741967	=	IC50	nM	3.4	CHEMBL4247	Homo sapiens	IC50	nM	3.4
	22927939	CHEMBL4737903	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(SCc2ccc(CN(C)C)o2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4753590	=	IC50	nM	2.8	CHEMBL4247	Homo sapiens	IC50	nM	2.8
	22927940	CHEMBL4737903	Inhibition of recombinant human N-terminal GST-tagged ALK (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated for 1 hr by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	3.5	CHEMBL4247	Homo sapiens	IC50	nM	3.5
	22927941	CHEMBL4737904	Inhibition of recombinant human N-terminal GST-tagged ALK L1196M mutant (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(NCC2CCCO2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4787021	=	IC50	nM	5.8	CHEMBL4247	Homo sapiens	IC50	nM	5.8
	22927942	CHEMBL4737904	Inhibition of recombinant human N-terminal GST-tagged ALK L1196M mutant (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(OCC2CCCO2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4748361	=	IC50	nM	3.3	CHEMBL4247	Homo sapiens	IC50	nM	3.3
	22927943	CHEMBL4737904	Inhibition of recombinant human N-terminal GST-tagged ALK L1196M mutant (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(SCc2ccc(CN3CCCC3)o2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4741967	=	IC50	nM	2.8	CHEMBL4247	Homo sapiens	IC50	nM	2.8
	22927944	CHEMBL4737904	Inhibition of recombinant human N-terminal GST-tagged ALK L1196M mutant (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(SCc2ccc(CN(C)C)o2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4753590	=	IC50	nM	2.6	CHEMBL4247	Homo sapiens	IC50	nM	2.6
	22927945	CHEMBL4737904	Inhibition of recombinant human N-terminal GST-tagged ALK L1196M mutant (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated for 1 hr by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	12.9	CHEMBL4247	Homo sapiens	IC50	nM	12.9
	22927946	CHEMBL4737905	Inhibition of recombinant human N-terminal GST-tagged ALK G1202R mutant (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(NCC2CCCO2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4787021	=	IC50	nM	4.5	CHEMBL4247	Homo sapiens	IC50	nM	4.5
	22927947	CHEMBL4737905	Inhibition of recombinant human N-terminal GST-tagged ALK G1202R mutant (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(OCC2CCCO2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4748361	=	IC50	nM	2.1	CHEMBL4247	Homo sapiens	IC50	nM	2.1
	22927948	CHEMBL4737905	Inhibition of recombinant human N-terminal GST-tagged ALK G1202R mutant (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(SCc2ccc(CN3CCCC3)o2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4741967	=	IC50	nM	3.9	CHEMBL4247	Homo sapiens	IC50	nM	3.9
	22927949	CHEMBL4737905	Inhibition of recombinant human N-terminal GST-tagged ALK G1202R mutant (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(SCc2ccc(CN(C)C)o2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4753590	=	IC50	nM	3.8	CHEMBL4247	Homo sapiens	IC50	nM	3.8
	22927950	CHEMBL4737905	Inhibition of recombinant human N-terminal GST-tagged ALK G1202R mutant (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated for 1 hr by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	108.0	CHEMBL4247	Homo sapiens	IC50	nM	108.0
	22927961	CHEMBL4737908	Potency index, ratio of IC50 of ceritinib to IC50 of compound for inhibition of recombinant human N-terminal GST-tagged ALK L1196M mutant (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(SCc2ccc(CN(C)C)o2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4753590	=	Ratio IC50		5.0	CHEMBL4247	Homo sapiens	Ratio IC50		5.0
	22927962	CHEMBL4737909	Potency index, ratio of IC50 of ceritinib to IC50 of compound for inhibition of recombinant human N-terminal GST-tagged ALK G1202R mutant (1058 to 1620 residues) expressed in baculovirus expression system using Srctide as substrate incubated for 1 hr by mobility shift assay	B	COc1cc(SCc2ccc(CN(C)C)o2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4753590	=	Ratio IC50		5.0	CHEMBL4247	Homo sapiens	Ratio IC50		5.0
Dose-dependent effect	22927963	CHEMBL4737910	Inhibition of ALK in human NCI-H2228 cells assessed as reduction in ALK phosphorylation incubated for 24 hrs by Western blot analysis	B	COc1cc(SCc2ccc(CN(C)C)o2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4753590		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	22927964	CHEMBL4737911	Inhibition of ALK in human NCI-H2228 cells assessed as reduction in ALK phosphorylation at 100 nM incubated for 24 hrs by Western blot analysis relative to control	B	COc1cc(SCc2ccc(CN(C)C)o2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4753590	=	Inhibition	%	100.0	CHEMBL4247	Homo sapiens	INH	%	100.0
Active	22927965	CHEMBL4737912	Inhibition of ALK in human NCI-H2228 cells assessed as reduction in Akt phosphorylation at 25 to 100 nM incubated for 24 hrs by Western blot analysis	B	COc1cc(SCc2ccc(CN(C)C)o2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4753590		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	22927966	CHEMBL4737913	Inhibition of ALK in human NCI-H2228 cells assessed as reduction in Erk phosphorylation at 25 to 100 nM incubated for 24 hrs by Western blot analysis	B	COc1cc(SCc2ccc(CN(C)C)o2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4753590		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	22927967	CHEMBL4737914	Inhibition of ALK in human NCI-H2228 cells assessed as reduction in Akt expression at 25 to 100 nM incubated for 24 hrs by Western blot analysis	B	COc1cc(SCc2ccc(CN(C)C)o2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4753590		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	22927968	CHEMBL4737915	Inhibition of ALK in human NCI-H2228 cells assessed as reduction in ERK expression at 25 to 100 nM incubated for 24 hrs by Western blot analysis	B	COc1cc(SCc2ccc(CN(C)C)o2)ccc1Nc1ncc(Cl)c(Nc2ccccc2NS(C)(=O)=O)n1		CHEMBL4753590		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	22952746	CHEMBL4766683	Inhibition of human ALK (1058 to end residues) assessed as residual activity at 10 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	60.0	CHEMBL4247	Homo sapiens	Activity	%	60.0
	22955539	CHEMBL4767596	Inhibition of GST-tagged human ALK expressed in baculovirus expression system at 1 uM by Selectscreen kinase assay	B	COc1ccccc1-c1csc2cnc(Nc3ccc(C(=O)NC4CCNCC4)c(F)c3)nc12		CHEMBL4785582	=	Inhibition	%	95.0	CHEMBL4247	Homo sapiens	INH	%	95.0
	22972847	CHEMBL4771081	Inhibition of ALK (unknown origin) using poly (Glu, Tyr)4:1 as substrate in presence of ATP measured after 30 mins by HTRF assay	B	COCC/C(=N\S(=O)(=O)Cc1ccc(Cl)cc1)Nc1ccc(Oc2ccnc3cc(OCCCN4CCOCC4)c(OC)cc23)c(F)c1		CHEMBL4799113	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
	22972848	CHEMBL4771081	Inhibition of ALK (unknown origin) using poly (Glu, Tyr)4:1 as substrate in presence of ATP measured after 30 mins by HTRF assay	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	IC50	nM	5000.0	CHEMBL4247	Homo sapiens	IC50	nM	5000.0
	22979764	CHEMBL4772646	Binding affinity to wild-type human partial length ALK (I1088 to E1409 residues) expressed in mammalian expression system by Kinomescan method relative to control	B	C[C@@H](Nc1ccc2[nH]nc(/C=C/c3ccccn3)c2c1)c1cc(F)cc(F)c1		CHEMBL4792981	=	Kd	nM	150.0	CHEMBL4247	Homo sapiens	Kd	nM	150.0
	22979798	CHEMBL4772680	Inhibition of wild-type human partial length ALK (I1088 to E1409 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C[C@@H](Nc1ccc2[nH]nc(/C=C/c3ccccn3)c2c1)c1cc(F)cc(F)c1		CHEMBL4792981	>	Activity	%	90.0	CHEMBL4247	Homo sapiens	Activity	%	90.0
	23122441	CHEMBL4804792	Inhibition of human ALK assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	89.0	CHEMBL4247	Homo sapiens	Activity	%	89.0
	23122442	CHEMBL4804793	Inhibition of human ALK C1156Y mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	83.0	CHEMBL4247	Homo sapiens	Activity	%	83.0
	23122443	CHEMBL4804794	Inhibition of human ALK L1196M mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	92.0	CHEMBL4247	Homo sapiens	Activity	%	92.0
	23123136	CHEMBL4805380	Inhibition of human ALK assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	61.0	CHEMBL4247	Homo sapiens	Activity	%	61.0
	23123137	CHEMBL4805381	Inhibition of human ALK C1156Y mutant assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	92.0	CHEMBL4247	Homo sapiens	Activity	%	92.0
	23123138	CHEMBL4805382	Inhibition of human ALK L1196M mutant assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	78.0	CHEMBL4247	Homo sapiens	Activity	%	78.0
	23123749	CHEMBL4805993	Inhibition of DNA-tagged human ALK assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	97.0	CHEMBL4247	Homo sapiens	Activity	%	97.0
	23124362	CHEMBL4806397	Inhibition of human ALK assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	81.0	CHEMBL4247	Homo sapiens	Activity	%	81.0
	23124363	CHEMBL4806397	Inhibition of human ALK assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	78.0	CHEMBL4247	Homo sapiens	Activity	%	78.0
	23124364	CHEMBL4806398	Inhibition of human ALK C1156Y mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL4247	Homo sapiens	Activity	%	100.0
	23124365	CHEMBL4806398	Inhibition of human ALK C1156Y mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	78.0	CHEMBL4247	Homo sapiens	Activity	%	78.0
	23124366	CHEMBL4806399	Inhibition of human ALK L1196M mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	96.0	CHEMBL4247	Homo sapiens	Activity	%	96.0
	23124367	CHEMBL4806399	Inhibition of human ALK L1196M mutant assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	92.0	CHEMBL4247	Homo sapiens	Activity	%	92.0
	23127810	CHEMBL4807745	Inhibition of GST-HIS-tagged ALK (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL4247	Homo sapiens	Activity	%	75.0
	23127811	CHEMBL4807745	Inhibition of GST-HIS-tagged ALK (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL4247	Homo sapiens	Activity	%	75.0
	23127812	CHEMBL4807745	Inhibition of GST-HIS-tagged ALK (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL4247	Homo sapiens	Activity	%	75.0
	23155102	CHEMBL4811214	Inhibition of human ALK assessed as decreased enzymatic reactions measured after 1 hr by mobility shift assay	B	O=C(Nc1ccc(N2CCOCC2)c(C(=O)N2CCSCC2)c1)[C@@H]1CCCN1c1nc(Nc2cc(F)cc(F)c2)ncc1Cl		CHEMBL4856927	=	IC50	nM	17.0	CHEMBL4247	Homo sapiens	IC50	nM	17.0
	23155103	CHEMBL4811214	Inhibition of human ALK assessed as decreased enzymatic reactions measured after 1 hr by mobility shift assay	B	CN1CCN(C(=O)c2cc(NC(=O)[C@@H]3CCCN3c3nc(Nc4cc(F)cc(F)c4)ncc3Cl)ccc2N2CCOCC2)CC1		CHEMBL4852786	=	IC50	nM	23.0	CHEMBL4247	Homo sapiens	IC50	nM	23.0
	23155104	CHEMBL4811214	Inhibition of human ALK assessed as decreased enzymatic reactions measured after 1 hr by mobility shift assay	B	CN1CCN(c2ccc(NC(=O)[C@@H]3CCCN3c3nc(Nc4cc(F)cc(F)c4)ncc3Cl)cc2C(=O)N(C)C)CC1		CHEMBL4853913	=	IC50	nM	8.5	CHEMBL4247	Homo sapiens	IC50	nM	8.5
	23155105	CHEMBL4811214	Inhibition of human ALK assessed as decreased enzymatic reactions measured after 1 hr by mobility shift assay	B	CN1CCN(c2ccc(NC(=O)[C@@H]3CCCN3c3nc(Nc4cc(F)cc(F)c4)ncc3Cl)cc2C(=O)N2CCSCC2)CC1		CHEMBL4854103	=	IC50	nM	9.3	CHEMBL4247	Homo sapiens	IC50	nM	9.3
	23155106	CHEMBL4811214	Inhibition of human ALK assessed as decreased enzymatic reactions measured after 1 hr by mobility shift assay	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	=	IC50	nM	15.0	CHEMBL4247	Homo sapiens	IC50	nM	15.0
	23155107	CHEMBL4811214	Inhibition of human ALK assessed as decreased enzymatic reactions measured after 1 hr by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	3.1	CHEMBL4247	Homo sapiens	IC50	nM	3.1
	23155108	CHEMBL4811215	Inhibition of human ALK secondary L1196M mutant assessed as decreased enzymatic reactions measured after 1 hr by mobility shift assay	B	O=C(Nc1ccc(N2CCOCC2)c(C(=O)N2CCSCC2)c1)[C@@H]1CCCN1c1nc(Nc2cc(F)cc(F)c2)ncc1Cl		CHEMBL4856927	=	IC50	nM	53.0	CHEMBL4247	Homo sapiens	IC50	nM	53.0
	23155109	CHEMBL4811215	Inhibition of human ALK secondary L1196M mutant assessed as decreased enzymatic reactions measured after 1 hr by mobility shift assay	B	CN1CCN(C(=O)c2cc(NC(=O)[C@@H]3CCCN3c3nc(Nc4cc(F)cc(F)c4)ncc3Cl)ccc2N2CCOCC2)CC1		CHEMBL4852786	=	IC50	nM	60.0	CHEMBL4247	Homo sapiens	IC50	nM	60.0
	23155110	CHEMBL4811215	Inhibition of human ALK secondary L1196M mutant assessed as decreased enzymatic reactions measured after 1 hr by mobility shift assay	B	CN1CCN(c2ccc(NC(=O)[C@@H]3CCCN3c3nc(Nc4cc(F)cc(F)c4)ncc3Cl)cc2C(=O)N(C)C)CC1		CHEMBL4853913	=	IC50	nM	33.0	CHEMBL4247	Homo sapiens	IC50	nM	33.0
	23155111	CHEMBL4811215	Inhibition of human ALK secondary L1196M mutant assessed as decreased enzymatic reactions measured after 1 hr by mobility shift assay	B	CN1CCN(c2ccc(NC(=O)[C@@H]3CCCN3c3nc(Nc4cc(F)cc(F)c4)ncc3Cl)cc2C(=O)N2CCSCC2)CC1		CHEMBL4854103	=	IC50	nM	38.0	CHEMBL4247	Homo sapiens	IC50	nM	38.0
	23155112	CHEMBL4811215	Inhibition of human ALK secondary L1196M mutant assessed as decreased enzymatic reactions measured after 1 hr by mobility shift assay	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	=	IC50	nM	124.0	CHEMBL4247	Homo sapiens	IC50	nM	124.0
	23155113	CHEMBL4811215	Inhibition of human ALK secondary L1196M mutant assessed as decreased enzymatic reactions measured after 1 hr by mobility shift assay	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	27.0	CHEMBL4247	Homo sapiens	IC50	nM	27.0
	23158849	CHEMBL4812101	Inhibition of ALK (1058 to 1620 residues) (unknown origin) expressed in Sf21 cells at 10 uM preincubated for 10 mins followed by peptide substrate addition relative to control	B	CC(C)(C)OC(=O)c1ccc(NC(=O)c2ccc(Cl)c(S(N)(=O)=O)c2)cc1		CHEMBL4860361	=	Inhibition	%	5.19	CHEMBL4247	Homo sapiens	INH	%	5.19
	23177568	CHEMBL4815766	Inhibition of ALK (unknown origin) using FAM-labelled peptide as substrate in presence of ATP at 10 uM measured by microplate reader method	B	O=C(Nc1ccc(Oc2ncnc3[nH]ccc23)cc1)c1cn(-c2ccc(C(F)(F)F)cc2Cl)c2ncccc2c1=O		CHEMBL4864264	=	Inhibition	%	23.6	CHEMBL4247	Homo sapiens	INH	%	23.6
	23180257	CHEMBL4816260	Inhibition of human ALK at 0.1 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP by radiometric assay relative to control	B	Cc1ccc(NC(=O)c2ccc(C(F)(F)F)nc2)cc1NC(=O)c1cnc2ccccn12		CHEMBL4846916	=	Inhibition	%	41.0	CHEMBL4247	Homo sapiens	INH	%	41.0
Not Active	23185079	CHEMBL4817403	Inhibition of ALK phosphorylation in human SR cells at 0.5 nM	B	CCc1cc2c(cc1N1CCC(N3CCN(C(=O)CNc4cccc5c4CN(C4CCC(=O)NC4=O)C5=O)CC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL4849206		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	23185080	CHEMBL4817403	Inhibition of ALK phosphorylation in human SR cells at 0.5 nM	B	CCc1cc2c(cc1N1CCC(N3CCN(CCCC#Cc4cccc5c4CN(C4CCC(=O)NC4=O)C5=O)CC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL4851806		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Not Active	23185081	CHEMBL4817404	Inhibition of ALK in human SR cells assessed as reduction in STAT3 phosphorylation at 50 nM	B	CCc1cc2c(cc1N1CCC(N3CCN(C(=O)CNc4cccc5c4CN(C4CCC(=O)NC4=O)C5=O)CC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL4849206		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	23185082	CHEMBL4817404	Inhibition of ALK in human SR cells assessed as reduction in STAT3 phosphorylation at 50 nM	B	CCc1cc2c(cc1N1CCC(N3CCN(CCCC#Cc4cccc5c4CN(C4CCC(=O)NC4=O)C5=O)CC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL4851806		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	23185083	CHEMBL4817405	Inhibition of ALK (unknown origin)	B	CCc1cc2c(cc1N1CCC(N3CCN(C(=O)CNc4cccc5c4CN(C4CCC(=O)NC4=O)C5=O)CC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL4849206	=	IC50	nM	4700.0	CHEMBL4247	Homo sapiens	IC50	uM	4.7
	23185084	CHEMBL4817405	Inhibition of ALK (unknown origin)	B	CCc1cc2c(cc1N1CCC(N3CCN(CCCC#Cc4cccc5c4CN(C4CCC(=O)NC4=O)C5=O)CC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL4851806	=	IC50	nM	3300.0	CHEMBL4247	Homo sapiens	IC50	uM	3.3
	23185085	CHEMBL4817406	Inhibition of ALK G1202R mutant (unknown origin)	B	CCc1cc2c(cc1N1CCC(N3CCN(C(=O)CNc4cccc5c4CN(C4CCC(=O)NC4=O)C5=O)CC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL4849206	=	IC50	nM	90500.0	CHEMBL4247	Homo sapiens	IC50	uM	90.5
	23185086	CHEMBL4817406	Inhibition of ALK G1202R mutant (unknown origin)	B	CCc1cc2c(cc1N1CCC(N3CCN(CCCC#Cc4cccc5c4CN(C4CCC(=O)NC4=O)C5=O)CC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL4851806	=	IC50	nM	94600.0	CHEMBL4247	Homo sapiens	IC50	uM	94.6
	23216083	CHEMBL4823598	Inhibition of human ALK (1058 to end residues) using KKKSPGEYVNIEFG as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc(NC(=O)C4CC4)c3)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4873571	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	23239802	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)NO)cc2)ncc1Cl		CHEMBL4877722	=	Inhibition	%	81.1	CHEMBL4247	Homo sapiens	INH	%	81.1
	23239803	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)NCCC(=O)NO)cc2)ncc1Cl		CHEMBL4857644	=	Inhibition	%	86.7	CHEMBL4247	Homo sapiens	INH	%	86.7
	23239804	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)NCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4853344	=	Inhibition	%	91.2	CHEMBL4247	Homo sapiens	INH	%	91.2
	23239805	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)NCCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4875594	=	Inhibition	%	85.2	CHEMBL4247	Homo sapiens	INH	%	85.2
	23239806	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)NCCCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4849164	=	Inhibition	%	89.4	CHEMBL4247	Homo sapiens	INH	%	89.4
	23239807	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)NCCCCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4849606	=	Inhibition	%	84.5	CHEMBL4247	Homo sapiens	INH	%	84.5
	23239808	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)ccc1C(=O)NCCCCCC(=O)NO		CHEMBL4872384	=	Inhibition	%	97.8	CHEMBL4247	Homo sapiens	INH	%	97.8
	23239809	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)ccc1C(=O)NCCCCCCC(=O)NO		CHEMBL4874637	=	Inhibition	%	98.1	CHEMBL4247	Homo sapiens	INH	%	98.1
	23239810	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)NCCCCCC(=O)NO)c(Cl)c2)ncc1Cl		CHEMBL4851359	=	Inhibition	%	87.7	CHEMBL4247	Homo sapiens	INH	%	87.7
	23239811	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)NCCCCCCC(=O)NO)c(Cl)c2)ncc1Cl		CHEMBL4859120	=	Inhibition	%	70.3	CHEMBL4247	Homo sapiens	INH	%	70.3
	23239812	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	COc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)ccc1C(=O)NCCCCCC(=O)NO		CHEMBL4878672	=	Inhibition	%	99.0	CHEMBL4247	Homo sapiens	INH	%	99.0
	23239813	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	COc1cc(C(=O)NCCCCCC(=O)NO)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4859870	=	Inhibition	%	97.3	CHEMBL4247	Homo sapiens	INH	%	97.3
	23239814	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	Cc1cc(C(=O)NCCCCCC(=O)NO)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4868502	=	Inhibition	%	93.1	CHEMBL4247	Homo sapiens	INH	%	93.1
Not Determined	23239815	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(C(=O)NO)c2)ncc1Cl		CHEMBL4872550		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	23239816	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(C(=O)NCCC(=O)NO)c2)ncc1Cl		CHEMBL4850340	=	Inhibition	%	81.0	CHEMBL4247	Homo sapiens	INH	%	81.0
	23239817	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(C(=O)NCCCC(=O)NO)c2)ncc1Cl		CHEMBL4865026	=	Inhibition	%	85.7	CHEMBL4247	Homo sapiens	INH	%	85.7
	23239818	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(C(=O)NCCCCC(=O)NO)c2)ncc1Cl		CHEMBL4861392	=	Inhibition	%	81.0	CHEMBL4247	Homo sapiens	INH	%	81.0
	23239819	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(C(=O)NCCCCCC(=O)NO)c2)ncc1Cl		CHEMBL4854027	=	Inhibition	%	83.2	CHEMBL4247	Homo sapiens	INH	%	83.2
	23239820	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(C(=O)NCCCCCCC(=O)NO)c2)ncc1Cl		CHEMBL4864925	=	Inhibition	%	82.6	CHEMBL4247	Homo sapiens	INH	%	82.6
	23239821	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	Cc1c(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)cccc1C(=O)NCCCCCC(=O)NO		CHEMBL4867067	=	Inhibition	%	86.8	CHEMBL4247	Homo sapiens	INH	%	86.8
	23239822	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(NC(=O)CC(=O)NO)cc2)ncc1Cl		CHEMBL4847204	=	Inhibition	%	92.1	CHEMBL4247	Homo sapiens	INH	%	92.1
Not Determined	23239823	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(NC(=O)CCC(=O)NO)cc2)ncc1Cl		CHEMBL4848656		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	23239824	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(NC(=O)CCCC(=O)NO)cc2)ncc1Cl		CHEMBL4876580	=	Inhibition	%	87.6	CHEMBL4247	Homo sapiens	INH	%	87.6
	23239825	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(NC(=O)CCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4877733	=	Inhibition	%	84.7	CHEMBL4247	Homo sapiens	INH	%	84.7
	23239826	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(NC(=O)CCCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4867407	=	Inhibition	%	86.5	CHEMBL4247	Homo sapiens	INH	%	86.5
	23239827	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(NC(=O)CCCCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4855319	=	Inhibition	%	80.8	CHEMBL4247	Homo sapiens	INH	%	80.8
	23239828	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CCCC(=O)NO)c2)ncc1Cl		CHEMBL4871962	=	Inhibition	%	87.0	CHEMBL4247	Homo sapiens	INH	%	87.0
	23239829	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CCCCC(=O)NO)c2)ncc1Cl		CHEMBL4872099	=	Inhibition	%	87.2	CHEMBL4247	Homo sapiens	INH	%	87.2
	23239830	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CCCCCC(=O)NO)c2)ncc1Cl		CHEMBL4863269	=	Inhibition	%	89.4	CHEMBL4247	Homo sapiens	INH	%	89.4
	23239831	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	Cc1ccc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)cc1NC(=O)CCCCC(=O)NO		CHEMBL4855624	=	Inhibition	%	76.9	CHEMBL4247	Homo sapiens	INH	%	76.9
	23239832	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(/C=C/C(=O)NO)cc2)ncc1Cl		CHEMBL4853688	=	Inhibition	%	71.6	CHEMBL4247	Homo sapiens	INH	%	71.6
	23239833	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	O=C(CCCCCCC(=O)Nc1ccc(Nc2ncc(Cl)c(Nc3ccccc3)n2)cc1)NO		CHEMBL4852926	=	Inhibition	%	4.9	CHEMBL4247	Homo sapiens	INH	%	4.9
	23239834	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	Cc1ccccc1Nc1nc(Nc2ccc(NC(=O)CCCCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4866961	=	Inhibition	%	1.2	CHEMBL4247	Homo sapiens	INH	%	1.2
	23239835	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	Cc1cccc(Nc2nc(Nc3ccc(NC(=O)CCCCCCC(=O)NO)cc3)ncc2Cl)c1		CHEMBL4850683	=	Inhibition	%	0.2	CHEMBL4247	Homo sapiens	INH	%	0.2
	23239836	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	Cc1ccc(Nc2nc(Nc3ccc(NC(=O)CCCCCCC(=O)NO)cc3)ncc2Cl)cc1		CHEMBL4853378	=	Inhibition	%	7.2	CHEMBL4247	Homo sapiens	INH	%	7.2
	23239837	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	O=C(CCCCCCC(=O)Nc1ccc(Nc2ncc(Cl)c(Nc3ccccc3Cl)n2)cc1)NO		CHEMBL4871427	=	Inhibition	%	3.1	CHEMBL4247	Homo sapiens	INH	%	3.1
	23239838	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	O=C(CCCCCCC(=O)Nc1ccc(Nc2ncc(Cl)c(Nc3ccccc3Br)n2)cc1)NO		CHEMBL4867827	=	Inhibition	%	0.2	CHEMBL4247	Homo sapiens	INH	%	0.2
	23239839	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	COc1cccc(Nc2nc(Nc3ccc(NC(=O)CCCCCCC(=O)NO)cc3)ncc2Cl)c1		CHEMBL4846440	=	Inhibition	%	1.2	CHEMBL4247	Homo sapiens	INH	%	1.2
	23239840	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	COc1ccc(C)c(Nc2nc(Nc3ccc(NC(=O)CCCCCCC(=O)NO)cc3)ncc2Cl)c1		CHEMBL4858028	=	Inhibition	%	-0.7	CHEMBL4247	Homo sapiens	INH	%	-0.7
	23239841	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	COc1ccc(Nc2nc(Nc3ccc(NC(=O)CCCCCCC(=O)NO)cc3)ncc2Cl)cc1OC		CHEMBL4851204	=	Inhibition	%	3.1	CHEMBL4247	Homo sapiens	INH	%	3.1
	23239842	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	COc1cccc(Nc2nc(Nc3ccc(NC(=O)CCCCCCC(=O)NO)cc3)ncc2C(F)(F)F)c1		CHEMBL4851419	=	Inhibition	%	4.9	CHEMBL4247	Homo sapiens	INH	%	4.9
	23239843	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(NC(=O)CCCCCCC(=O)NO)cc2)ncc1F		CHEMBL4879096	=	Inhibition	%	66.3	CHEMBL4247	Homo sapiens	INH	%	66.3
	23239844	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	Cc1cnc(Nc2ccc(NC(=O)CCCCCCC(=O)NO)cc2)nc1Nc1ccccc1S(=O)(=O)C(C)C		CHEMBL4867091	=	Inhibition	%	83.5	CHEMBL4247	Homo sapiens	INH	%	83.5
	23239845	CHEMBL4828941	Inhibition of ALK (unknown origin) at 10 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	COc1cnc(Nc2ccc(NC(=O)CCCCCCC(=O)NO)cc2)nc1Nc1ccccc1S(=O)(=O)C(C)C		CHEMBL4866452	=	Inhibition	%	60.4	CHEMBL4247	Homo sapiens	INH	%	60.4
Not Determined	23239846	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)NO)cc2)ncc1Cl		CHEMBL4877722		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	23239847	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)NCCC(=O)NO)cc2)ncc1Cl		CHEMBL4857644	=	Inhibition	%	97.3	CHEMBL4247	Homo sapiens	INH	%	97.3
	23239848	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)NCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4853344	=	Inhibition	%	97.9	CHEMBL4247	Homo sapiens	INH	%	97.9
	23239849	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)NCCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4875594	=	Inhibition	%	98.8	CHEMBL4247	Homo sapiens	INH	%	98.8
	23239850	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)NCCCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4849164	=	Inhibition	%	98.1	CHEMBL4247	Homo sapiens	INH	%	98.1
	23239851	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)NCCCCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4849606	=	Inhibition	%	102.7	CHEMBL4247	Homo sapiens	INH	%	102.7
	23239852	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)ccc1C(=O)NCCCCCC(=O)NO		CHEMBL4872384	=	Inhibition	%	101.5	CHEMBL4247	Homo sapiens	INH	%	101.5
	23239853	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)ccc1C(=O)NCCCCCCC(=O)NO		CHEMBL4874637	=	Inhibition	%	101.1	CHEMBL4247	Homo sapiens	INH	%	101.1
	23239854	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)NCCCCCC(=O)NO)c(Cl)c2)ncc1Cl		CHEMBL4851359	=	Inhibition	%	97.8	CHEMBL4247	Homo sapiens	INH	%	97.8
	23239855	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)NCCCCCCC(=O)NO)c(Cl)c2)ncc1Cl		CHEMBL4859120	=	Inhibition	%	100.4	CHEMBL4247	Homo sapiens	INH	%	100.4
	23239856	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	COc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)ccc1C(=O)NCCCCCC(=O)NO		CHEMBL4878672	=	Inhibition	%	100.9	CHEMBL4247	Homo sapiens	INH	%	100.9
	23239857	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	COc1cc(C(=O)NCCCCCC(=O)NO)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4859870	=	Inhibition	%	98.5	CHEMBL4247	Homo sapiens	INH	%	98.5
	23239858	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	Cc1cc(C(=O)NCCCCCC(=O)NO)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL4868502	=	Inhibition	%	97.3	CHEMBL4247	Homo sapiens	INH	%	97.3
Not Determined	23239859	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(C(=O)NO)c2)ncc1Cl		CHEMBL4872550		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	23239860	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(C(=O)NCCC(=O)NO)c2)ncc1Cl		CHEMBL4850340	=	Inhibition	%	99.1	CHEMBL4247	Homo sapiens	INH	%	99.1
	23239861	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(C(=O)NCCCC(=O)NO)c2)ncc1Cl		CHEMBL4865026	=	Inhibition	%	98.0	CHEMBL4247	Homo sapiens	INH	%	98.0
	23239862	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(C(=O)NCCCCC(=O)NO)c2)ncc1Cl		CHEMBL4861392	=	Inhibition	%	97.7	CHEMBL4247	Homo sapiens	INH	%	97.7
	23239863	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(C(=O)NCCCCCC(=O)NO)c2)ncc1Cl		CHEMBL4854027	=	Inhibition	%	97.3	CHEMBL4247	Homo sapiens	INH	%	97.3
	23239864	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(C(=O)NCCCCCCC(=O)NO)c2)ncc1Cl		CHEMBL4864925	=	Inhibition	%	96.6	CHEMBL4247	Homo sapiens	INH	%	96.6
	23239865	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	Cc1c(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)cccc1C(=O)NCCCCCC(=O)NO		CHEMBL4867067	=	Inhibition	%	98.5	CHEMBL4247	Homo sapiens	INH	%	98.5
	23239866	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(NC(=O)CC(=O)NO)cc2)ncc1Cl		CHEMBL4847204	=	Inhibition	%	98.2	CHEMBL4247	Homo sapiens	INH	%	98.2
Not Determined	23239867	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(NC(=O)CCC(=O)NO)cc2)ncc1Cl		CHEMBL4848656		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	23239868	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(NC(=O)CCCC(=O)NO)cc2)ncc1Cl		CHEMBL4876580	=	Inhibition	%	98.5	CHEMBL4247	Homo sapiens	INH	%	98.5
	23239869	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(NC(=O)CCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4877733	=	Inhibition	%	99.0	CHEMBL4247	Homo sapiens	INH	%	99.0
	23239870	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(NC(=O)CCCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4867407	=	Inhibition	%	98.8	CHEMBL4247	Homo sapiens	INH	%	98.8
	23239871	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(NC(=O)CCCCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4855319	=	Inhibition	%	96.6	CHEMBL4247	Homo sapiens	INH	%	96.6
	23239872	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CCCC(=O)NO)c2)ncc1Cl		CHEMBL4871962	=	Inhibition	%	98.1	CHEMBL4247	Homo sapiens	INH	%	98.1
	23239873	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CCCCC(=O)NO)c2)ncc1Cl		CHEMBL4872099	=	Inhibition	%	98.0	CHEMBL4247	Homo sapiens	INH	%	98.0
	23239874	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CCCCCC(=O)NO)c2)ncc1Cl		CHEMBL4863269	=	Inhibition	%	98.0	CHEMBL4247	Homo sapiens	INH	%	98.0
	23239875	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	Cc1ccc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)cc1NC(=O)CCCCC(=O)NO		CHEMBL4855624	=	Inhibition	%	98.5	CHEMBL4247	Homo sapiens	INH	%	98.5
	23239876	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(/C=C/C(=O)NO)cc2)ncc1Cl		CHEMBL4853688	=	Inhibition	%	101.1	CHEMBL4247	Homo sapiens	INH	%	101.1
	23239877	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	O=C(CCCCCCC(=O)Nc1ccc(Nc2ncc(Cl)c(Nc3ccccc3)n2)cc1)NO		CHEMBL4852926	=	Inhibition	%	36.9	CHEMBL4247	Homo sapiens	INH	%	36.9
	23239878	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	Cc1ccccc1Nc1nc(Nc2ccc(NC(=O)CCCCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4866961	=	Inhibition	%	27.8	CHEMBL4247	Homo sapiens	INH	%	27.8
	23239879	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	Cc1cccc(Nc2nc(Nc3ccc(NC(=O)CCCCCCC(=O)NO)cc3)ncc2Cl)c1		CHEMBL4850683	=	Inhibition	%	4.9	CHEMBL4247	Homo sapiens	INH	%	4.9
	23239880	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	Cc1ccc(Nc2nc(Nc3ccc(NC(=O)CCCCCCC(=O)NO)cc3)ncc2Cl)cc1		CHEMBL4853378	=	Inhibition	%	30.1	CHEMBL4247	Homo sapiens	INH	%	30.1
	23239881	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	O=C(CCCCCCC(=O)Nc1ccc(Nc2ncc(Cl)c(Nc3ccccc3Cl)n2)cc1)NO		CHEMBL4871427	=	Inhibition	%	21.2	CHEMBL4247	Homo sapiens	INH	%	21.2
	23239882	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	O=C(CCCCCCC(=O)Nc1ccc(Nc2ncc(Cl)c(Nc3ccccc3Br)n2)cc1)NO		CHEMBL4867827	=	Inhibition	%	25.0	CHEMBL4247	Homo sapiens	INH	%	25.0
	23239883	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	COc1cccc(Nc2nc(Nc3ccc(NC(=O)CCCCCCC(=O)NO)cc3)ncc2Cl)c1		CHEMBL4846440	=	Inhibition	%	20.0	CHEMBL4247	Homo sapiens	INH	%	20.0
	23239884	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	COc1ccc(C)c(Nc2nc(Nc3ccc(NC(=O)CCCCCCC(=O)NO)cc3)ncc2Cl)c1		CHEMBL4858028	=	Inhibition	%	4.9	CHEMBL4247	Homo sapiens	INH	%	4.9
	23239885	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	COc1ccc(Nc2nc(Nc3ccc(NC(=O)CCCCCCC(=O)NO)cc3)ncc2Cl)cc1OC		CHEMBL4851204	=	Inhibition	%	17.6	CHEMBL4247	Homo sapiens	INH	%	17.6
	23239886	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	COc1cccc(Nc2nc(Nc3ccc(NC(=O)CCCCCCC(=O)NO)cc3)ncc2C(F)(F)F)c1		CHEMBL4851419	=	Inhibition	%	7.6	CHEMBL4247	Homo sapiens	INH	%	7.6
	23239887	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(NC(=O)CCCCCCC(=O)NO)cc2)ncc1F		CHEMBL4879096	=	Inhibition	%	96.0	CHEMBL4247	Homo sapiens	INH	%	96.0
	23239888	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	Cc1cnc(Nc2ccc(NC(=O)CCCCCCC(=O)NO)cc2)nc1Nc1ccccc1S(=O)(=O)C(C)C		CHEMBL4867091	=	Inhibition	%	97.9	CHEMBL4247	Homo sapiens	INH	%	97.9
	23239889	CHEMBL4828942	Inhibition of ALK (unknown origin) at 100 nM preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	COc1cnc(Nc2ccc(NC(=O)CCCCCCC(=O)NO)cc2)nc1Nc1ccccc1S(=O)(=O)C(C)C		CHEMBL4866452	=	Inhibition	%	94.9	CHEMBL4247	Homo sapiens	INH	%	94.9
	23239908	CHEMBL4828946	Inhibition of ALK (unknown origin) preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)NCCCCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4849606	=	IC50	nM	4.3	CHEMBL4247	Homo sapiens	IC50	nM	4.3
	23239909	CHEMBL4828946	Inhibition of ALK (unknown origin) preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(NC(=O)CCCCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4855319	=	IC50	nM	2.1	CHEMBL4247	Homo sapiens	IC50	nM	2.1
	23239910	CHEMBL4828946	Inhibition of ALK (unknown origin) preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	2.6	CHEMBL4247	Homo sapiens	IC50	nM	2.6
	23239911	CHEMBL4828946	Inhibition of ALK (unknown origin) preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	<	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	nM	1.0
Not Determined	23239912	CHEMBL4828946	Inhibition of ALK (unknown origin) preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	C[C@H]1CNC(=O)c2cnn3ccc(nc23)N[C@H](C)c2cc(F)ccc2O1		CHEMBL4298138		IC50			CHEMBL4247	Homo sapiens	IC50		
Not Determined	23239913	CHEMBL4828946	Inhibition of ALK (unknown origin) preincubated for 10 mins followed by addition of substrate and ATP for 25 mins by caliper EZ reader method	B	O=C(CCCCCCC(=O)Nc1ccccc1)NO		CHEMBL98		IC50			CHEMBL4247	Homo sapiens	IC50		
	23239914	CHEMBL4828947	Inhibition of ALK L1196M mutant (unknown origin)	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)NCCCCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4849606	=	IC50	nM	2.4	CHEMBL4247	Homo sapiens	IC50	nM	2.4
	23239915	CHEMBL4828947	Inhibition of ALK L1196M mutant (unknown origin)	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(NC(=O)CCCCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4855319	=	IC50	nM	1.7	CHEMBL4247	Homo sapiens	IC50	nM	1.7
	23239916	CHEMBL4828947	Inhibition of ALK L1196M mutant (unknown origin)	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	16.0	CHEMBL4247	Homo sapiens	IC50	nM	16.0
	23239917	CHEMBL4828947	Inhibition of ALK L1196M mutant (unknown origin)	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	0.25	CHEMBL4247	Homo sapiens	IC50	nM	0.25
Not Determined	23239918	CHEMBL4828947	Inhibition of ALK L1196M mutant (unknown origin)	B	C[C@H]1CNC(=O)c2cnn3ccc(nc23)N[C@H](C)c2cc(F)ccc2O1		CHEMBL4298138		IC50			CHEMBL4247	Homo sapiens	IC50		
Not Determined	23239919	CHEMBL4828947	Inhibition of ALK L1196M mutant (unknown origin)	B	O=C(CCCCCCC(=O)Nc1ccccc1)NO		CHEMBL98		IC50			CHEMBL4247	Homo sapiens	IC50		
	23239920	CHEMBL4828948	Inhibition of ALK G1202R mutant (unknown origin)	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(C(=O)NCCCCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4849606	=	IC50	nM	1.0	CHEMBL4247	Homo sapiens	IC50	nM	1.0
	23239921	CHEMBL4828948	Inhibition of ALK G1202R mutant (unknown origin)	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(NC(=O)CCCCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4855319	=	IC50	nM	0.4	CHEMBL4247	Homo sapiens	IC50	nM	0.4
	23239922	CHEMBL4828948	Inhibition of ALK G1202R mutant (unknown origin)	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	IC50	nM	12.0	CHEMBL4247	Homo sapiens	IC50	nM	12.0
	23239923	CHEMBL4828948	Inhibition of ALK G1202R mutant (unknown origin)	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	IC50	nM	3.3	CHEMBL4247	Homo sapiens	IC50	nM	3.3
	23239924	CHEMBL4828948	Inhibition of ALK G1202R mutant (unknown origin)	B	C[C@H]1CNC(=O)c2cnn3ccc(nc23)N[C@H](C)c2cc(F)ccc2O1		CHEMBL4298138	=	IC50	nM	4.5	CHEMBL4247	Homo sapiens	IC50	nM	4.5
Not Determined	23239925	CHEMBL4828948	Inhibition of ALK G1202R mutant (unknown origin)	B	O=C(CCCCCCC(=O)Nc1ccccc1)NO		CHEMBL98		IC50			CHEMBL4247	Homo sapiens	IC50		
Active	23240005	CHEMBL4829004	Inhibition of ALK in human MDA-MB-231 cells assessed as inhibition of ALK phosphorylation at Tyr1278 residue at 4 uM measured after 24 hrs by Western blot assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(NC(=O)CCCCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4855319		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	23240006	CHEMBL4829005	Inhibition of ALK in human MDA-MB-231 cells assessed as inhibition of ERK phosphorylation at Thr202/Tyr204 residue at 4 uM measured after 24 hrs by Western blot assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(NC(=O)CCCCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4855319		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	23240007	CHEMBL4829006	Inhibition of ALK in human MDA-MB-231 cells assessed as inhibition of AKT phosphorylation at Ser473 residue at 4 uM measured after 24 hrs by Western blot assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(NC(=O)CCCCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4855319		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	23240008	CHEMBL4829007	Inhibition of human ALK in human SH-SY5Y cells assessed as inhibition of ALK phosphorylation at Tyr1278 residue at 4 uM measured after 24 hrs by Western blot assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(NC(=O)CCCCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4855319		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	23240009	CHEMBL4829008	Inhibition of human ALK in human SH-SY5Y cells assessed as inhibition of ERK phosphorylation at Thr202/Tyr204 residue at 4 uM measured after 24 hrs by Western blot assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(NC(=O)CCCCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4855319		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Active	23240010	CHEMBL4829009	Inhibition of human ALK at 1 uM	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(NC(=O)CCCCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4855319		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	23240023	CHEMBL4829022	Potency index, ratio of ceritinib IC50 to test compound IC50 for inhibition of ALK G1202R mutant (unknown origin)	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(NC(=O)CCCCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4855319	=	Ratio IC50		10.0	CHEMBL4247	Homo sapiens	Ratio IC50		10.0
	23240024	CHEMBL4829023	Potency index, ratio of repotrectinib IC50 to test compound IC50 for inhibition of ALK G1202R mutant (unknown origin)	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(NC(=O)CCCCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4855319	=	Ratio IC50		10.0	CHEMBL4247	Homo sapiens	Ratio IC50		10.0
Active	23240050	CHEMBL4829037	Inhibition of human ALK in human SH-SY5Y cells assessed as inhibition of Akt phosphorylation at Ser473 residue at 4 uM measured after 24 hrs by Western blot assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(NC(=O)CCCCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4855319		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-Dependent Effect	23240051	CHEMBL4829038	Inhibition of ALK in human MDA-MB-231 cells assessed as inhibition of ALK phosphorylation at Tyr1278 residue measured after 24 hrs by Western blot assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(NC(=O)CCCCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4855319		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-Dependent Effect	23240052	CHEMBL4829039	Inhibition of ALK in human MDA-MB-231 cells assessed as inhibition of ERK phosphorylation at Thr202/Tyr204 residue measured after 24 hrs by Western blot assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(NC(=O)CCCCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4855319		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-Dependent Effect	23240053	CHEMBL4829040	Inhibition of ALK in human MDA-MB-231 cells assessed as inhibition of Akt phosphorylation at Ser473 residue measured after 24 hrs by Western blot assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(NC(=O)CCCCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4855319		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-Dependent Effect	23240054	CHEMBL4829041	Inhibition of human ALK in human SH-SY5Y cells assessed as inhibition of ALK phosphorylation at Tyr1278 residue measured after 24 hrs by Western blot assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(NC(=O)CCCCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4855319		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-Dependent Effect	23240055	CHEMBL4829042	Inhibition of human ALK in human SH-SY5Y cells assessed as inhibition of ERK phosphorylation at Thr202/Tyr204 residue measured after 24 hrs by Western blot assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(NC(=O)CCCCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4855319		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
Dose-Dependent Effect	23240056	CHEMBL4829043	Inhibition of human ALK in human SH-SY5Y cells assessed as inhibition of Akt phosphorylation at Ser473 residue measured after 24 hrs by Western blot assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(NC(=O)CCCCCCC(=O)NO)cc2)ncc1Cl		CHEMBL4855319		Inhibition	%		CHEMBL4247	Homo sapiens	INH		
	23246355	CHEMBL4830047	Inhibition of ALK (unknown origin)	B	Cl.Cn1nccc1-c1ccc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(F)c(F)c2)c(F)c1		CHEMBL4556790	>	IC50	nM	10000.0	CHEMBL4247	Homo sapiens	IC50	nM	10000.0
	23295508	CHEMBL4840520	Inhibition of recombinant GST-tagged human ALK expressed in baculovirus expression system at 1 uM measured by select screen assay relative to control	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4c3CN(Cc3cc(F)cc(F)c3)C4(C)C)cc2)CC1		CHEMBL4849505	=	Inhibition	%	82.0	CHEMBL4247	Homo sapiens	INH	%	82.0
	23297784	CHEMBL4841264	Inhibition of ALK (unknown origin)	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3Cl)cc12		CHEMBL4876497	>	IC50	nM	1000.0	CHEMBL4247	Homo sapiens	IC50	nM	1000.0
	23299270	CHEMBL4841735	Inhibition of ALK (unknown origin) at 1000 nM relative to control	B	Nc1c(-c2nc3cc(N4CCN(C(=O)CCCCCNc5cccc6c5C(=O)N(C5CCC(=O)NC5=O)C6=O)CC4)ccc3[nH]2)c(=O)[nH]c2cccc(F)c12		CHEMBL4860038	=	Inhibition	%	25.0	CHEMBL4247	Homo sapiens	INH	%	25.0
	23299271	CHEMBL4841735	Inhibition of ALK (unknown origin) at 1000 nM relative to control	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Inhibition	%	55.0	CHEMBL4247	Homo sapiens	INH	%	55.0
Not Active	23317276	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	87.0	CHEMBL4247	Homo sapiens	% Control	%	87.0
Not Active	23317277	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	77.0	CHEMBL4247	Homo sapiens	% Control	%	77.0
Not Active	23317278	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	71.0	CHEMBL4247	Homo sapiens	% Control	%	71.0
Not Active	23317744	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	97.0	CHEMBL4247	Homo sapiens	% Control	%	97.0
Not Active	23317745	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23317746	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23318418	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23318419	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	92.0	CHEMBL4247	Homo sapiens	% Control	%	92.0
Not Active	23318420	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23318894	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	70.0	CHEMBL4247	Homo sapiens	% Control	%	70.0
Not Active	23318895	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	98.0	CHEMBL4247	Homo sapiens	% Control	%	98.0
Not Active	23318896	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23319534	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	58.3	CHEMBL4247	Homo sapiens	% Control	%	58.3
Not Active	23319535	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23319536	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23320006	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23320007	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	95.4	CHEMBL4247	Homo sapiens	% Control	%	95.4
Not Active	23320008	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23320684	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	91.0	CHEMBL4247	Homo sapiens	% Control	%	91.0
Not Active	23320685	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23320686	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	97.0	CHEMBL4247	Homo sapiens	% Control	%	97.0
Not Active	23321152	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	70.0	CHEMBL4247	Homo sapiens	% Control	%	70.0
Not Active	23321153	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	93.0	CHEMBL4247	Homo sapiens	% Control	%	93.0
Not Active	23321154	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23321782	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23321783	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	98.0	CHEMBL4247	Homo sapiens	% Control	%	98.0
Not Active	23321784	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	91.0	CHEMBL4247	Homo sapiens	% Control	%	91.0
Not Active	23322250	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23322251	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	79.0	CHEMBL4247	Homo sapiens	% Control	%	79.0
Not Active	23322252	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	78.0	CHEMBL4247	Homo sapiens	% Control	%	78.0
Not Active	23322939	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23322940	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	84.0	CHEMBL4247	Homo sapiens	% Control	%	84.0
Not Active	23322941	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	90.0	CHEMBL4247	Homo sapiens	% Control	%	90.0
Not Active	23323407	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23323408	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23323409	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23323948	CHEMBL4880567	ALK (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1	Outside typical range	CHEMBL4593677		Inhibition	%	-11.0	CHEMBL4247	Homo sapiens	% inhibition	%	-11.0
Not Active	23324261	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	84.7	CHEMBL4247	Homo sapiens	% Control	%	84.7
Not Active	23324262	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23324263	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23324896	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23324897	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23324898	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	81.0	CHEMBL4247	Homo sapiens	% Control	%	81.0
Not Active	23325364	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23325365	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23325366	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	93.0	CHEMBL4247	Homo sapiens	% Control	%	93.0
Not Active	23326011	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23326012	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	88.0	CHEMBL4247	Homo sapiens	% Control	%	88.0
Not Active	23326013	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	62.0	CHEMBL4247	Homo sapiens	% Control	%	62.0
Not Active	23326479	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	85.0	CHEMBL4247	Homo sapiens	% Control	%	85.0
Not Active	23326480	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23326481	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	85.0	CHEMBL4247	Homo sapiens	% Control	%	85.0
Not Active	23327179	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	98.0	CHEMBL4247	Homo sapiens	% Control	%	98.0
Not Active	23327180	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	82.0	CHEMBL4247	Homo sapiens	% Control	%	82.0
Not Active	23327181	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	76.0	CHEMBL4247	Homo sapiens	% Control	%	76.0
Not Active	23327647	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	73.0	CHEMBL4247	Homo sapiens	% Control	%	73.0
Not Active	23327648	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23327649	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	87.0	CHEMBL4247	Homo sapiens	% Control	%	87.0
Not Active	23328234	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	87.0	CHEMBL4247	Homo sapiens	% Control	%	87.0
Not Active	23328235	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	98.0	CHEMBL4247	Homo sapiens	% Control	%	98.0
Not Active	23328236	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	83.0	CHEMBL4247	Homo sapiens	% Control	%	83.0
Not Active	23328702	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	96.0	CHEMBL4247	Homo sapiens	% Control	%	96.0
Not Active	23328703	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23328704	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	83.0	CHEMBL4247	Homo sapiens	% Control	%	83.0
Not Active	23329240	CHEMBL4880947	ALK(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	121.0	CHEMBL4247	Homo sapiens	% residual kinase activity	%	121.0
Not Active	23329648	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	99.0	CHEMBL4247	Homo sapiens	% Control	%	99.0
Not Active	23329649	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23329650	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23330116	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	89.0	CHEMBL4247	Homo sapiens	% Control	%	89.0
Not Active	23330117	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23330118	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	98.0	CHEMBL4247	Homo sapiens	% Control	%	98.0
Not Active	23330872	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23330873	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	79.0	CHEMBL4247	Homo sapiens	% Control	%	79.0
Not Active	23330874	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	65.0	CHEMBL4247	Homo sapiens	% Control	%	65.0
Not Active	23331340	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23331341	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23331342	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23331927	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	94.4	CHEMBL4247	Homo sapiens	% Control	%	94.4
Not Active	23331928	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	76.6	CHEMBL4247	Homo sapiens	% Control	%	76.6
Not Active	23331929	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	99.6	CHEMBL4247	Homo sapiens	% Control	%	99.6
Not Active	23332395	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	68.1	CHEMBL4247	Homo sapiens	% Control	%	68.1
Not Active	23332396	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23332397	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23333111	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23333112	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23333113	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	94.1	CHEMBL4247	Homo sapiens	% Control	%	94.1
Not Active	23333750	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	79.0	CHEMBL4247	Homo sapiens	% Control	%	79.0
Not Active	23333751	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23333752	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23334218	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	73.0	CHEMBL4247	Homo sapiens	% Control	%	73.0
Not Active	23334219	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23334220	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	93.0	CHEMBL4247	Homo sapiens	% Control	%	93.0
Not Active	23334862	CHEMBL4881486	ALK (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	78.0	CHEMBL4247	Homo sapiens	% inhibition	%	78.0
Not Active	23335197	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	95.0	CHEMBL4247	Homo sapiens	% Control	%	95.0
Not Active	23335198	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23335199	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	99.0	CHEMBL4247	Homo sapiens	% Control	%	99.0
Not Active	23335665	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	89.0	CHEMBL4247	Homo sapiens	% Control	%	89.0
Not Active	23335666	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23335667	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23336292	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	79.0	CHEMBL4247	Homo sapiens	% Control	%	79.0
Not Active	23336293	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	94.0	CHEMBL4247	Homo sapiens	% Control	%	94.0
Not Active	23336294	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23336760	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	87.0	CHEMBL4247	Homo sapiens	% Control	%	87.0
Not Active	23336761	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	76.0	CHEMBL4247	Homo sapiens	% Control	%	76.0
Not Active	23336762	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	93.0	CHEMBL4247	Homo sapiens	% Control	%	93.0
Not Active	23337514	CHEMBL4881885	ALK Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	97.0	CHEMBL4247	Homo sapiens	% Ctrl	%	97.0
Not Active	23337841	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	85.0	CHEMBL4247	Homo sapiens	% Control	%	85.0
Not Active	23337842	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	98.0	CHEMBL4247	Homo sapiens	% Control	%	98.0
Not Active	23337843	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	90.0	CHEMBL4247	Homo sapiens	% Control	%	90.0
Not Active	23338309	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	77.0	CHEMBL4247	Homo sapiens	% Control	%	77.0
Not Active	23338310	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23338311	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	92.0	CHEMBL4247	Homo sapiens	% Control	%	92.0
Not Active	23338921	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23338922	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	96.0	CHEMBL4247	Homo sapiens	% Control	%	96.0
Not Active	23338923	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	87.0	CHEMBL4247	Homo sapiens	% Control	%	87.0
Not Active	23339389	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23339390	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23339391	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23340026	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23340027	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23340028	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23340494	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23340495	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23340496	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23341151	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	93.0	CHEMBL4247	Homo sapiens	% Control	%	93.0
Not Active	23341152	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23341153	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	96.0	CHEMBL4247	Homo sapiens	% Control	%	96.0
Not Active	23341619	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	89.0	CHEMBL4247	Homo sapiens	% Control	%	89.0
Not Active	23341620	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23341621	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	70.0	CHEMBL4247	Homo sapiens	% Control	%	70.0
Not Active	23342235	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	86.0	CHEMBL4247	Homo sapiens	% Control	%	86.0
Not Active	23342236	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23342237	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	93.0	CHEMBL4247	Homo sapiens	% Control	%	93.0
Not Active	23342703	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	99.0	CHEMBL4247	Homo sapiens	% Control	%	99.0
Not Active	23342704	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23342705	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23343333	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	98.0	CHEMBL4247	Homo sapiens	% Control	%	98.0
Not Active	23343334	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	82.0	CHEMBL4247	Homo sapiens	% Control	%	82.0
Not Active	23343335	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	98.0	CHEMBL4247	Homo sapiens	% Control	%	98.0
Not Active	23343801	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	80.0	CHEMBL4247	Homo sapiens	% Control	%	80.0
Not Active	23343802	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	65.0	CHEMBL4247	Homo sapiens	% Control	%	65.0
Not Active	23343803	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23344439	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	79.0	CHEMBL4247	Homo sapiens	% Control	%	79.0
Not Active	23344440	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23344441	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	73.0	CHEMBL4247	Homo sapiens	% Control	%	73.0
Not Active	23345012	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	74.0	CHEMBL4247	Homo sapiens	% Control	%	74.0
Not Active	23345013	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23345014	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	97.0	CHEMBL4247	Homo sapiens	% Control	%	97.0
Not Active	23345480	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23345481	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23345482	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23346057	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	93.8	CHEMBL4247	Homo sapiens	% Control	%	93.8
Not Active	23346058	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23346059	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23346526	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23346527	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23346528	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23347136	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	89.9	CHEMBL4247	Homo sapiens	% Control	%	89.9
Not Active	23347137	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23347138	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	96.9	CHEMBL4247	Homo sapiens	% Control	%	96.9
Not Active	23347617	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	85.4	CHEMBL4247	Homo sapiens	% Control	%	85.4
Not Active	23347618	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23347619	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23348196	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23348197	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23348198	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23348664	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	95.0	CHEMBL4247	Homo sapiens	% Control	%	95.0
Not Active	23348665	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23348666	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	97.0	CHEMBL4247	Homo sapiens	% Control	%	97.0
Not Active	23349251	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23349252	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23349253	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	94.0	CHEMBL4247	Homo sapiens	% Control	%	94.0
Not Active	23349869	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23349870	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23349871	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23350337	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	92.0	CHEMBL4247	Homo sapiens	% Control	%	92.0
Not Active	23350338	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23350339	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	91.0	CHEMBL4247	Homo sapiens	% Control	%	91.0
Not Active	23350942	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	78.0	CHEMBL4247	Homo sapiens	% Control	%	78.0
Not Active	23350943	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	98.0	CHEMBL4247	Homo sapiens	% Control	%	98.0
Not Active	23350944	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	74.0	CHEMBL4247	Homo sapiens	% Control	%	74.0
Not Active	23351410	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	80.0	CHEMBL4247	Homo sapiens	% Control	%	80.0
Not Active	23351411	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	72.0	CHEMBL4247	Homo sapiens	% Control	%	72.0
Not Active	23351412	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	89.0	CHEMBL4247	Homo sapiens	% Control	%	89.0
Not Active	23352434	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	65.0	CHEMBL4247	Homo sapiens	% Control	%	65.0
Not Active	23352435	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	89.0	CHEMBL4247	Homo sapiens	% Control	%	89.0
Not Active	23352436	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	78.0	CHEMBL4247	Homo sapiens	% Control	%	78.0
Not Active	23352902	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	64.0	CHEMBL4247	Homo sapiens	% Control	%	64.0
Not Active	23352903	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	82.0	CHEMBL4247	Homo sapiens	% Control	%	82.0
Not Active	23352904	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	98.0	CHEMBL4247	Homo sapiens	% Control	%	98.0
Not Active	23353784	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23353785	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23353786	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23354252	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23354253	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23354254	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23354984	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	91.0	CHEMBL4247	Homo sapiens	% Control	%	91.0
Not Active	23354985	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23354986	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23355452	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	91.0	CHEMBL4247	Homo sapiens	% Control	%	91.0
Not Active	23355453	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23355454	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23356088	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	77.0	CHEMBL4247	Homo sapiens	% Control	%	77.0
Not Active	23356089	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23356090	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23356556	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23356557	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23356558	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23357165	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	94.0	CHEMBL4247	Homo sapiens	% Control	%	94.0
Not Active	23357166	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	69.0	CHEMBL4247	Homo sapiens	% Control	%	69.0
Not Active	23357167	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	76.0	CHEMBL4247	Homo sapiens	% Control	%	76.0
Not Active	23357812	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23357813	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23357814	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23358280	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	97.0	CHEMBL4247	Homo sapiens	% Control	%	97.0
Not Active	23358281	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	81.0	CHEMBL4247	Homo sapiens	% Control	%	81.0
Not Active	23358282	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	82.0	CHEMBL4247	Homo sapiens	% Control	%	82.0
Not Active	23358866	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	92.0	CHEMBL4247	Homo sapiens	% Control	%	92.0
Not Active	23358867	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23358868	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	94.8	CHEMBL4247	Homo sapiens	% Control	%	94.8
Not Active	23359464	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	79.0	CHEMBL4247	Homo sapiens	% Control	%	79.0
Not Active	23359465	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	89.0	CHEMBL4247	Homo sapiens	% Control	%	89.0
Not Active	23359466	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	76.0	CHEMBL4247	Homo sapiens	% Control	%	76.0
Not Active	23359932	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	83.0	CHEMBL4247	Homo sapiens	% Control	%	83.0
Not Active	23359933	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	98.0	CHEMBL4247	Homo sapiens	% Control	%	98.0
Not Active	23359934	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	82.0	CHEMBL4247	Homo sapiens	% Control	%	82.0
Not Active	23360517	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	80.0	CHEMBL4247	Homo sapiens	% Control	%	80.0
Not Active	23360518	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	72.0	CHEMBL4247	Homo sapiens	% Control	%	72.0
Not Active	23360519	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	78.0	CHEMBL4247	Homo sapiens	% Control	%	78.0
Not Active	23360985	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23360986	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23360987	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	81.0	CHEMBL4247	Homo sapiens	% Control	%	81.0
Not Active	23361558	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	81.0	CHEMBL4247	Homo sapiens	% Control	%	81.0
Not Active	23361559	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23361560	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	98.0	CHEMBL4247	Homo sapiens	% Control	%	98.0
Not Active	23362094	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23362095	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23362096	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23362562	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	99.0	CHEMBL4247	Homo sapiens	% Control	%	99.0
Not Active	23362563	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	68.0	CHEMBL4247	Homo sapiens	% Control	%	68.0
Not Active	23362564	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23364204	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23364205	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23364206	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23364672	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	94.0	CHEMBL4247	Homo sapiens	% Control	%	94.0
Not Active	23364673	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23364674	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23365411	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23365412	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23365413	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23365954	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	94.0	CHEMBL4247	Homo sapiens	% Control	%	94.0
Not Active	23365955	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23365956	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	94.0	CHEMBL4247	Homo sapiens	% Control	%	94.0
Not Active	23366544	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23366545	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23366546	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23367012	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23367013	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23367014	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23367470	CHEMBL4883823	ALK ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	104.0	CHEMBL4247	Homo sapiens	% Residual activity with Skepinone-L	%	104.0
Not Active	23367890	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	99.0	CHEMBL4247	Homo sapiens	% Control	%	99.0
Not Active	23367891	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	90.0	CHEMBL4247	Homo sapiens	% Control	%	90.0
Not Active	23367892	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23368358	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23368359	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	93.0	CHEMBL4247	Homo sapiens	% Control	%	93.0
Not Active	23368360	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23368957	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	97.0	CHEMBL4247	Homo sapiens	% Control	%	97.0
Not Active	23368958	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23368959	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23369425	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	75.0	CHEMBL4247	Homo sapiens	% Control	%	75.0
Not Active	23369426	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	59.0	CHEMBL4247	Homo sapiens	% Control	%	59.0
Not Active	23369427	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	79.0	CHEMBL4247	Homo sapiens	% Control	%	79.0
Not Active	23369965	CHEMBL4884212	ALK(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	103.0	CHEMBL4247	Homo sapiens	% residual kinase activity	%	103.0
Not Active	23370393	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	98.0	CHEMBL4247	Homo sapiens	% Control	%	98.0
Not Active	23370394	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23370395	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	83.0	CHEMBL4247	Homo sapiens	% Control	%	83.0
Not Active	23370861	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23370862	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	96.0	CHEMBL4247	Homo sapiens	% Control	%	96.0
Not Active	23370863	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	80.0	CHEMBL4247	Homo sapiens	% Control	%	80.0
Not Active	23371670	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23371671	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23371672	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	94.0	CHEMBL4247	Homo sapiens	% Control	%	94.0
Not Active	23372138	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23372139	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23372140	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
	23372659	CHEMBL4884624	ALK(ALK1LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL4247	Homo sapiens	pIC50		6.0
	23373068	CHEMBL4884915	ALK(ALK1LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL4247	Homo sapiens	pIC50		6.0
	23373429	CHEMBL4885206	ALK(ALK1LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL4247	Homo sapiens	pIC50		6.0
Not Active	23375565	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	82.0	CHEMBL4247	Homo sapiens	% Control	%	82.0
Not Active	23375566	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	91.0	CHEMBL4247	Homo sapiens	% Control	%	91.0
Not Active	23375567	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23376033	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23376034	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23376035	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23376611	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	84.0	CHEMBL4247	Homo sapiens	% Control	%	84.0
Not Active	23376612	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23376613	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	93.0	CHEMBL4247	Homo sapiens	% Control	%	93.0
Not Active	23377080	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	89.0	CHEMBL4247	Homo sapiens	% Control	%	89.0
Not Active	23377081	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	84.0	CHEMBL4247	Homo sapiens	% Control	%	84.0
Not Active	23377082	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	97.0	CHEMBL4247	Homo sapiens	% Control	%	97.0
Not Active	23377938	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	68.0	CHEMBL4247	Homo sapiens	% Control	%	68.0
Not Active	23377939	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	88.0	CHEMBL4247	Homo sapiens	% Control	%	88.0
Not Active	23377940	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	75.0	CHEMBL4247	Homo sapiens	% Control	%	75.0
Not Active	23378406	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	77.0	CHEMBL4247	Homo sapiens	% Control	%	77.0
Not Active	23378407	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23378408	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	88.0	CHEMBL4247	Homo sapiens	% Control	%	88.0
Not Active	23379573	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23379574	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23379575	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23380041	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23380042	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23380043	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23380735	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	79.0	CHEMBL4247	Homo sapiens	% Control	%	79.0
Not Active	23380736	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	79.0	CHEMBL4247	Homo sapiens	% Control	%	79.0
Not Active	23380737	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23381383	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23381384	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23381385	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23381851	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23381852	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23381853	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23382475	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	58.0	CHEMBL4247	Homo sapiens	% Control	%	58.0
Not Active	23382476	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	74.0	CHEMBL4247	Homo sapiens	% Control	%	74.0
Not Active	23382477	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	85.0	CHEMBL4247	Homo sapiens	% Control	%	85.0
Not Active	23382943	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	81.0	CHEMBL4247	Homo sapiens	% Control	%	81.0
Not Active	23382944	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	77.0	CHEMBL4247	Homo sapiens	% Control	%	77.0
Not Active	23382945	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	65.0	CHEMBL4247	Homo sapiens	% Control	%	65.0
Not Active	23383698	CHEMBL4887351	ALK Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	80.0	CHEMBL4247	Homo sapiens	% Ctrl	%	80.0
Not Active	23383699	CHEMBL4887351	ALK Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	74.0	CHEMBL4247	Homo sapiens	% Ctrl	%	74.0
Not Active	23384172	CHEMBL4887767	ALK(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O	Outside typical range	CHEMBL4802045		Inhibition	%	-33.12	CHEMBL4247	Homo sapiens	% inhibition	%	-33.12
Not Active	23384630	CHEMBL4888156	ALK SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1		CHEMBL4795065		Inhibition	%	-2.0	CHEMBL4247	Homo sapiens	% Inhibition	%	-2.0
Not Active	23384858	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23384859	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	89.0	CHEMBL4247	Homo sapiens	% Control	%	89.0
Not Active	23384860	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23385325	CHEMBL4879582	KinomeScan assay: inhibition of ALK	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL4247	Homo sapiens	% Control	%	100.0
Not Active	23385326	CHEMBL4879583	KinomeScan assay: inhibition of ALK(C1156Y)	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	79.0	CHEMBL4247	Homo sapiens	% Control	%	79.0
Not Active	23385327	CHEMBL4879584	KinomeScan assay: inhibition of ALK(L1196M)	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	94.0	CHEMBL4247	Homo sapiens	% Control	%	94.0
